data_2ldr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ldr _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 350' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 29.0 t . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 110.016 -0.364 . . . . 65.140000000000001 110.016 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . 0.462 ' HB2' ' CG2' ' A' ' 421' ' ' ILE . 10.8 m-20 -78.54 174.45 11.34 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.429 1.081 . . . . 72.129999999999995 109.266 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . 0.459 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 28.2 m-70 -131.43 126.46 35.17 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.478 1.111 . . . . 70.150000000000006 109.597 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 9.0 mt -111.34 149.16 14.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.481 1.113 . . . . 75.439999999999998 109.302 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 32.1 tptt -112.77 133.25 54.86 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.468 1.105 . . . . 72.409999999999997 109.353 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 40.0 t -87.75 149.53 4.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 73.299999999999997 109.33 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 5.9 p -114.15 149.19 36.02 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 72.239999999999995 110.413 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' GLN . . . . . 0.556 ' CG ' ' CE1' ' A' ' 426' ' ' PHE . 27.6 mt-30 -50.15 -34.33 21.99 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.479 1.112 . . . . 72.319999999999993 110.344 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -56.34 -52.53 64.2 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.497 1.123 . . . . 74.439999999999998 110.294 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -55.8 -67.18 0.31 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.521 1.138 . . . . 74.439999999999998 110.329 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 364' ' ' CYS . 1.2 t80 -44.25 -45.77 8.71 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.473 1.108 . . . . 74.420000000000002 111.021 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -61.61 -42.67 99.2 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.499 1.124 . . . . 72.129999999999995 110.314 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 7.8 mt . . . . . 0 C--N 1.325 -0.488 0 O-C-N 124.472 1.107 . . . . 74.409999999999997 109.257 -179.969 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.6 m . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 108.345 -0.983 . . . . 63.43 108.345 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -68.67 -7.79 36.55 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.476 1.11 . . . . 75.150000000000006 110.316 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 7.4 mmt -106.2 -35.01 7.33 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.501 1.126 . . . . 74.349999999999994 111.015 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 90.55 46.97 3.87 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.54 1.15 . . . . 72.129999999999995 110.977 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 8.3 t -142.95 -174.63 4.23 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.489 0.758 . . . . 74.510000000000005 109.978 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' THR . . . . . 0.439 ' O ' ' NZ ' ' A' ' 374' ' ' LYS . 2.0 p -126.47 140.89 52.12 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.492 1.12 . . . . 61.0 110.422 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.445 ' O ' ' N ' ' A' ' 372' ' ' LEU . 76.0 t80 -56.18 -70.96 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.522 1.139 . . . . 74.430000000000007 111.027 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' GLN . . . . . 0.54 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -38.52 -30.44 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 75.209999999999994 110.27 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 370' ' ' PHE . 0.0 OUTLIER -71.46 122.78 21.02 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.506 1.129 . . . . 75.510000000000005 109.327 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 14.8 p -59.13 134.8 57.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.035 -0.984 . . . . 61.140000000000001 110.919 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.445 ' NZ ' ' O ' ' A' ' 372' ' ' LEU . 23.0 mmtm -97.31 32.35 2.24 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.47 1.106 . . . . 74.129999999999995 109.33 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 2.7 mt -113.42 -59.62 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.116 . . . . 74.310000000000002 109.29 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 20.7 p -108.27 -13.92 14.8 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 64.400000000000006 108.293 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 47.66 41.83 14.28 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.482 1.114 . . . . 75.120000000000005 109.32 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -122.92 -41.02 2.37 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.128 . . . . 74.200000000000003 110.28 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.58 170.75 11.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.512 1.133 . . . . 74.319999999999993 109.313 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -76.72 175.47 9.35 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 75.140000000000001 109.33 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.455 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 21.9 mttt -73.78 -62.38 1.51 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.486 1.116 . . . . 72.299999999999997 109.314 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 59.91 25.93 15.12 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.478 1.112 . . . . 70.420000000000002 109.315 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -158.01 171.8 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.502 1.127 . . . . 64.239999999999995 109.292 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . 0.464 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 40.4 tttp -155.21 142.05 19.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.47 1.106 . . . . 73.109999999999999 109.303 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' A' ' 389' ' ' GLY . 21.7 mm -105.22 133.93 48.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.479 1.112 . . . . 72.519999999999996 109.297 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.488 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.1 mt-10 -137.84 161.19 61.39 Favored Pre-proline 0 C--N 1.324 -0.532 0 O-C-N 124.531 1.144 . . . . 72.430000000000007 110.293 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.488 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.02 -5.82 21.88 Favored 'Cis proline' 0 C--N 1.361 1.197 0 C-N-CA 120.982 -2.507 . . . . 75.109999999999999 111.035 0.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . 0.432 ' SG ' ' ND1' ' A' ' 390' ' ' HIS . 43.1 t -37.43 -76.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.017 -0.992 . . . . 73.409999999999997 110.905 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 118.22 34.79 1.08 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.499 1.124 . . . . 64.420000000000002 111.018 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.432 ' ND1' ' SG ' ' A' ' 388' ' ' CYS . 46.1 m170 -105.79 130.82 53.7 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.529 0.782 . . . . 73.030000000000001 109.569 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.464 ' CD1' ' HG3' ' A' ' 384' ' ' LYS . 0.0 OUTLIER -101.06 156.73 17.24 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 74.349999999999994 109.257 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' MET . . . . . 0.553 ' HE1' ' CE1' ' A' ' 410' ' ' PHE . 19.8 ptp -173.64 176.19 2.79 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.517 1.136 . . . . 75.040000000000006 110.98 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . 1.432 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 7.3 p -94.04 114.93 27.19 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.508 1.13 . . . . 64.409999999999997 108.276 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 397' ' ' LEU . 94.6 m -48.43 -56.6 7.79 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.539 1.149 . . . . 72.120000000000005 110.422 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.5 t -45.82 -25.96 0.6 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 74.319999999999993 109.944 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . 1.432 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 1.8 m -87.63 -42.53 12.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.478 1.111 . . . . 64.239999999999995 108.322 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 400' ' ' TRP . 1.0 OUTLIER -48.0 -54.55 12.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 74.120000000000005 109.31 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 61.6 m -45.63 -36.48 4.84 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.465 1.103 . . . . 70.319999999999993 110.438 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.61 95.22 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.513 1.133 . . . . 62.149999999999999 109.272 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' TRP . . . . . 0.508 ' CD2' ' HB3' ' A' ' 409' ' ' PRO . 2.1 t-105 -69.2 -52.61 26.11 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.496 1.123 . . . . 74.019999999999996 108.01 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -62.68 -16.3 56.52 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.546 1.154 . . . . 72.209999999999994 110.339 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -86.78 -11.4 51.1 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.448 1.092 . . . . 74.129999999999995 110.268 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.4 t -111.9 -23.0 10.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 72.0 109.985 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 404' ' ' ASP . 8.7 t0 -153.19 -88.46 0.05 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.483 1.115 . . . . 71.430000000000007 109.307 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 108.3 32.62 3.17 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.493 1.121 . . . . 64.540000000000006 111.004 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . 0.433 ' O ' ' CG ' ' A' ' 406' ' ' GLN . 3.1 tt0 -91.27 79.28 5.69 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.514 0.773 . . . . 72.219999999999999 110.286 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 43.91 -159.06 0.12 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.53 1.144 . . . . 73.140000000000001 111.013 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 412' ' ' ARG . 4.9 t -56.38 125.61 66.37 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 108.319 -0.993 . . . . 75.319999999999993 108.319 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.508 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.2 Cg_endo -74.98 -2.48 12.59 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.48 1.779 . . . . 75.409999999999997 110.968 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . 0.553 ' CE1' ' HE1' ' A' ' 392' ' ' MET . 6.7 m-85 -89.12 -37.93 14.71 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.466 1.104 . . . . 73.510000000000005 110.975 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' CYS . . . . . . . . . . . . . 1.2 p -121.17 10.37 10.66 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.492 1.12 . . . . 74.120000000000005 108.286 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 408' ' ' CYS . 49.1 mmm-85 38.68 49.94 1.54 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.507 1.129 . . . . 64.430000000000007 110.343 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 41.8 t -138.14 148.84 45.33 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.511 1.132 . . . . 74.010000000000005 108.328 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -52.2 159.0 1.01 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.561 1.163 . . . . 74.200000000000003 110.273 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.433 HG22 ' CG2' ' A' ' 418' ' ' THR . 2.3 mt -113.83 147.36 17.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.429 1.081 . . . . 75.230000000000004 109.293 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -114.85 -44.31 3.06 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.138 . . . . 73.219999999999999 109.312 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . 0.479 ' O ' ' CG2' ' A' ' 418' ' ' THR . . . -111.77 127.78 8.29 Favored Glycine 0 CA--C 1.531 1.053 0 O-C-N 124.537 1.148 . . . . 72.439999999999998 110.984 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' THR . . . . . 0.479 ' CG2' ' O ' ' A' ' 417' ' ' GLY . 38.8 p -156.15 136.26 12.86 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.547 0.792 . . . . 71.219999999999999 110.405 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -171.98 156.13 3.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.495 1.122 . . . . 74.439999999999998 110.304 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.439 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.5 Cg_endo -74.94 101.87 1.52 Allowed 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.445 1.761 . . . . 73.400000000000006 111.011 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . 0.471 ' CD1' ' C ' ' A' ' 421' ' ' ILE . 1.1 pp -103.93 167.69 2.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.496 1.123 . . . . 74.140000000000001 109.326 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . 0.459 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 10.4 mm -113.97 112.22 39.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.53 1.144 . . . . 74.450000000000003 109.252 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.459 HG23 ' CD1' ' A' ' 421' ' ' ILE . 2.2 t -77.43 136.68 23.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.473 1.108 . . . . 75.5 109.27 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -131.33 131.85 23.26 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.477 1.111 . . . . 75.519999999999996 109.282 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 176.96 9.22 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.467 1.772 . . . . 70.109999999999999 110.999 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . 0.556 ' CE1' ' CG ' ' A' ' 357' ' ' GLN . 19.6 t80 . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.489 1.118 . . . . 74.150000000000006 111.052 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 69.8 m . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 110.045 -0.354 . . . . 74.109999999999999 110.045 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -91.31 169.46 10.79 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 74.329999999999998 109.29 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -124.71 114.52 19.41 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.547 1.154 . . . . 74.329999999999998 109.629 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . 0.465 ' CD1' HD11 ' A' ' 421' ' ' ILE . 1.6 mp -102.96 142.68 16.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.469 1.106 . . . . 74.519999999999996 109.309 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . 0.431 ' NZ ' ' OD2' ' A' ' 424' ' ' ASP . 17.6 tppt? -124.91 117.93 25.16 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.465 1.103 . . . . 72.439999999999998 109.289 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.25 154.8 7.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.492 1.12 . . . . 73.120000000000005 109.315 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 15.0 p -126.25 161.35 27.94 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.509 1.13 . . . . 72.340000000000003 110.43 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -56.05 -38.69 70.94 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.509 1.131 . . . . 74.319999999999993 110.332 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.14 -32.15 54.39 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.481 1.113 . . . . 75.329999999999998 110.29 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -83.79 -66.89 0.84 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.546 1.154 . . . . 74.400000000000006 110.281 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -41.89 -35.9 0.94 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.568 1.168 . . . . 74.340000000000003 111.039 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -66.41 -62.51 1.43 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.507 1.129 . . . . 73.5 110.281 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 9.8 tt . . . . . 0 C--N 1.325 -0.459 0 O-C-N 124.462 1.101 . . . . 74.409999999999997 109.326 179.999 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 108.314 -0.995 . . . . 73.439999999999998 108.314 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.25 -21.13 62.15 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 73.439999999999998 110.305 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 2.0 mtm -103.33 -28.2 11.99 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 72.510000000000005 111.016 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 87.68 40.15 6.87 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.479 1.112 . . . . 63.32 110.954 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 20.8 t -139.22 177.73 7.69 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.502 0.766 . . . . 75.109999999999999 109.969 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' THR . . . . . 0.41 ' HB ' ' NE2' ' A' ' 371' ' ' GLN . 12.7 p -113.4 179.53 3.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 73.430000000000007 110.402 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.516 ' CD2' HG13 ' A' ' 423' ' ' VAL . 43.9 t80 -85.17 -65.97 0.95 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.555 1.159 . . . . 75.310000000000002 111.039 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' GLN . . . . . 0.55 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -40.0 -31.72 0.13 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.522 1.139 . . . . 75.120000000000005 110.319 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . 0.442 ' O ' ' NZ ' ' A' ' 374' ' ' LYS . 1.5 tm? -66.89 136.73 55.84 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.525 1.141 . . . . 71.219999999999999 109.259 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 13.2 t -79.47 130.18 35.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.965 -1.016 . . . . 72.519999999999996 110.931 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.442 ' NZ ' ' O ' ' A' ' 372' ' ' LEU . 10.8 mmtm -87.31 11.31 14.66 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.539 1.15 . . . . 74.319999999999993 109.305 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 3.9 mt -102.83 -40.5 6.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.464 1.103 . . . . 75.519999999999996 109.262 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' CYS . . . . . 1.209 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 86.1 m -110.21 -35.63 6.04 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.494 1.121 . . . . 64.230000000000004 108.321 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 55.87 35.9 26.31 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.514 1.134 . . . . 72.239999999999995 109.327 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -131.79 -44.74 0.97 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.465 1.103 . . . . 74.099999999999994 110.314 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -113.69 -176.54 2.92 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.511 1.132 . . . . 74.319999999999993 109.32 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -97.66 158.93 15.23 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.502 1.126 . . . . 74.430000000000007 109.319 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.416 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 23.9 mttt -59.48 -62.46 1.86 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.47 1.106 . . . . 74.519999999999996 109.303 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 13.6 t70 59.54 27.0 16.08 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.459 1.099 . . . . 72.430000000000007 109.312 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . 0.461 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -157.84 173.43 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.536 1.147 . . . . 61.140000000000001 109.29 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 23.5 tttp -156.68 137.39 13.28 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.469 1.105 . . . . 74.430000000000007 109.27 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.454 ' O ' ' N ' ' A' ' 389' ' ' GLY . 10.4 mm -101.02 132.32 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 75.540000000000006 109.341 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.498 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 7.9 mt-10 -137.8 161.16 61.62 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 75.510000000000005 110.314 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.498 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.94 -4.73 20.57 Favored 'Cis proline' 0 C--N 1.36 1.159 0 C-N-CA 121.004 -2.498 . . . . 74.239999999999995 111.035 -0.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . 0.502 ' SG ' ' CE1' ' A' ' 390' ' ' HIS . 44.1 t -37.45 -76.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.96 -1.018 . . . . 73.319999999999993 110.907 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 118.15 34.65 1.1 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.512 1.132 . . . . 73.420000000000002 111.0 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.502 ' CE1' ' SG ' ' A' ' 388' ' ' CYS . 66.4 m170 -108.6 127.88 54.34 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.509 0.77 . . . . 72.340000000000003 109.594 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.443 ' CD1' ' HG3' ' A' ' 384' ' ' LYS . 0.0 OUTLIER -97.46 157.86 15.78 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.463 1.102 . . . . 75.329999999999998 109.353 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' MET . . . . . 0.461 ' O ' ' CG1' ' A' ' 383' ' ' VAL . 19.5 ptp -174.37 175.38 2.62 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.452 1.095 . . . . 74.530000000000001 110.991 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . 1.192 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 23.4 p -97.91 115.51 28.26 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.527 1.142 . . . . 71.549999999999997 108.29 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 396' ' ' CYS . 85.5 m -46.15 -60.0 2.55 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.53 1.144 . . . . 74.120000000000005 110.415 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 8.1 m -39.91 -29.7 0.07 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.471 1.107 . . . . 74.049999999999997 109.956 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . 1.209 ' SG ' ' SG ' ' A' ' 376' ' ' CYS . 2.8 m -85.44 -53.88 4.92 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.524 1.14 . . . . 73.340000000000003 108.296 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . 0.499 ' C ' ' CD2' ' A' ' 397' ' ' LEU . 2.1 tt -43.01 -55.4 3.81 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.513 1.133 . . . . 75.140000000000001 109.319 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 61.3 m -45.56 -38.14 6.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.508 1.13 . . . . 74.200000000000003 110.413 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -64.22 -38.49 91.24 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.121 . . . . 73.129999999999995 109.313 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' TRP . . . . . 0.449 ' N ' ' O ' ' A' ' 397' ' ' LEU . 2.8 t-105 -63.35 -47.12 83.47 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.549 1.156 . . . . 74.349999999999994 107.986 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -58.65 -35.72 73.0 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.482 1.114 . . . . 74.329999999999998 110.25 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -74.36 -2.74 26.58 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.512 1.133 . . . . 75.109999999999999 110.268 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 29.4 t -113.73 -23.13 9.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 1.131 . . . . 71.109999999999999 109.956 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.16 -78.34 0.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.452 1.095 . . . . 74.409999999999997 109.259 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 100.1 32.86 5.41 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.473 1.108 . . . . 33.549999999999997 110.988 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -93.94 76.51 4.16 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.478 0.752 . . . . 73.530000000000001 110.29 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 44.41 -157.68 0.18 Allowed Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.522 1.139 . . . . 62.509999999999998 111.026 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . 0.448 ' O ' ' N ' ' A' ' 412' ' ' ARG . 5.3 t -56.14 127.01 69.22 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.323 -0.991 . . . . 72.209999999999994 108.323 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 0.63 8.69 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.511 1.795 . . . . 74.310000000000002 110.986 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . 0.429 ' CD2' ' HE1' ' A' ' 392' ' ' MET . 15.8 m-85 -94.76 -36.5 11.68 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.455 1.097 . . . . 75.209999999999994 110.984 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' CYS . . . . . 0.449 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.8 OUTLIER -122.83 12.63 9.82 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.464 1.103 . . . . 75.310000000000002 108.335 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 408' ' ' CYS . 1.6 tpt180 38.19 30.75 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.513 1.133 . . . . 74.049999999999997 110.313 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' CYS . . . . . 0.449 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.7 m -113.82 150.5 33.43 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.523 1.139 . . . . 71.439999999999998 108.278 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -55.96 149.24 15.6 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.437 1.086 . . . . 70.349999999999994 110.299 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.47 HG22 ' CG2' ' A' ' 418' ' ' THR . 2.1 mt -99.02 136.29 30.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.499 1.124 . . . . 75.209999999999994 109.308 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -114.67 -54.72 2.55 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.499 1.124 . . . . 72.420000000000002 109.286 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . 0.499 ' O ' ' CG2' ' A' ' 418' ' ' THR . . . -95.89 127.78 9.29 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.467 1.104 . . . . 73.519999999999996 110.956 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' THR . . . . . 0.499 ' CG2' ' O ' ' A' ' 417' ' ' GLY . 18.2 p -157.47 137.01 12.09 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.541 0.789 . . . . 72.540000000000006 110.367 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -172.18 155.97 3.67 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.407 1.067 . . . . 75.430000000000007 110.348 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.431 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.4 Cg_endo -75.04 102.82 1.64 Allowed 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.458 1.768 . . . . 74.510000000000005 110.974 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . 0.483 ' CD1' ' C ' ' A' ' 421' ' ' ILE . 0.7 OUTLIER -103.82 155.27 5.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.491 1.119 . . . . 65.5 109.301 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . 0.42 ' N ' HD13 ' A' ' 421' ' ' ILE . 17.1 mt -108.0 108.49 25.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.545 1.153 . . . . 75.120000000000005 109.261 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.516 HG13 ' CD2' ' A' ' 370' ' ' PHE . 14.6 t -76.57 146.42 8.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.489 1.118 . . . . 72.239999999999995 109.25 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.431 ' OD2' ' NZ ' ' A' ' 354' ' ' LYS . 3.0 t70 -127.98 127.97 23.83 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.536 1.147 . . . . 75.329999999999998 109.336 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 179.52 6.0 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.535 1.808 . . . . 75.230000000000004 110.983 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 76.9 t80 . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.461 1.1 . . . . 72.319999999999993 111.047 179.939 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 109.951 -0.389 . . . . 73.150000000000006 109.951 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -90.64 179.83 5.72 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.483 1.114 . . . . 73.219999999999999 109.296 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . 0.461 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 61.2 m-70 -138.23 150.17 46.46 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 73.030000000000001 109.595 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 17.2 mt -136.55 156.68 36.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.496 1.122 . . . . 74.140000000000001 109.308 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 12.0 tptm -117.92 152.66 34.98 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.464 1.102 . . . . 74.239999999999995 109.322 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 32.1 t -109.09 156.72 9.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.454 1.096 . . . . 73.549999999999997 109.337 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 12.3 p -122.7 152.87 40.13 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.507 1.13 . . . . 71.030000000000001 110.402 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' GLN . . . . . 0.545 ' HG2' ' CE2' ' A' ' 426' ' ' PHE . 1.7 mm100 -45.84 -53.36 9.84 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.475 1.109 . . . . 72.310000000000002 110.325 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -43.55 -40.27 3.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.537 1.148 . . . . 73.340000000000003 110.308 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -70.89 -66.49 0.6 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.486 1.116 . . . . 72.530000000000001 110.282 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 364' ' ' CYS . 7.4 t80 -45.07 -63.77 0.86 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 73.219999999999999 110.997 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -45.34 -52.28 10.05 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.52 1.137 . . . . 71.540000000000006 110.267 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.3 tt . . . . . 0 C--N 1.324 -0.503 0 O-C-N 124.548 1.155 . . . . 74.530000000000001 109.312 -179.996 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . 0.449 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.9 m . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 108.283 -1.006 . . . . 71.510000000000005 108.283 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -79.51 -2.71 43.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.545 1.153 . . . . 74.25 110.277 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 8.3 mmt -108.3 -34.82 6.7 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.54 1.15 . . . . 71.030000000000001 110.982 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.02 4.61 41.63 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.479 1.112 . . . . 63.329999999999998 110.968 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 1.2 m -127.92 -176.2 3.71 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.529 0.782 . . . . 73.200000000000003 109.992 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' THR . . . . . 0.434 ' O ' ' CE ' ' A' ' 374' ' ' LYS . 15.1 p -114.29 -179.34 3.6 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.518 1.136 . . . . 75.040000000000006 110.394 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.436 ' C ' ' N ' ' A' ' 372' ' ' LEU . 62.7 t80 -78.49 -67.63 0.72 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 1.12 . . . . 75.109999999999999 110.979 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' GLN . . . . . 0.547 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -38.89 -29.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.538 1.149 . . . . 73.400000000000006 110.3 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . 0.436 ' N ' ' C ' ' A' ' 370' ' ' PHE . 0.5 OUTLIER -72.56 136.54 45.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.547 1.154 . . . . 74.209999999999994 109.273 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . 0.421 ' N ' ' CD2' ' A' ' 372' ' ' LEU . 11.5 t -70.97 133.54 46.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.004 -0.998 . . . . 70.010000000000005 110.928 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.434 ' CE ' ' O ' ' A' ' 369' ' ' THR . 29.8 mmtp -93.9 24.39 4.25 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.547 1.154 . . . . 71.299999999999997 109.285 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 36.3 mt -107.38 -56.17 4.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.498 1.124 . . . . 75.310000000000002 109.308 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' CYS . . . . . 0.951 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 1.8 m -104.75 -23.15 13.09 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.482 1.114 . . . . 64.5 108.309 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 50.61 39.77 22.2 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.516 1.135 . . . . 62.539999999999999 109.302 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -124.57 -42.13 2.1 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.13 . . . . 73.519999999999996 110.271 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -123.62 171.0 9.88 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.52 1.138 . . . . 72.209999999999994 109.303 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -81.35 164.59 22.04 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.484 1.115 . . . . 64.129999999999995 109.302 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.458 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 20.0 mttt -67.75 -62.47 1.4 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.55 1.156 . . . . 74.340000000000003 109.292 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 1.9 t70 59.29 24.55 13.06 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.546 1.154 . . . . 63.229999999999997 109.283 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.6 OUTLIER -155.42 171.01 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.478 1.111 . . . . 75.219999999999999 109.305 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -154.19 147.25 24.61 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.462 1.101 . . . . 70.439999999999998 109.307 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.443 ' O ' ' N ' ' A' ' 389' ' ' GLY . 22.8 mm -110.4 134.33 52.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.477 1.11 . . . . 74.340000000000003 109.285 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.495 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 9.8 mt-10 -137.65 160.97 62.93 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.546 1.154 . . . . 71.439999999999998 110.276 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.495 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.5 Cg_endo -74.97 -5.13 21.03 Favored 'Cis proline' 0 C--N 1.36 1.14 0 C-N-CA 121.003 -2.499 . . . . 74.129999999999995 111.056 -0.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . 0.594 ' SG ' ' CE1' ' A' ' 390' ' ' HIS . 43.0 t -38.11 -79.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.964 -1.016 . . . . 71.030000000000001 110.942 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 119.92 36.98 0.79 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.485 1.115 . . . . 63.119999999999997 111.012 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.594 ' CE1' ' SG ' ' A' ' 388' ' ' CYS . 65.6 m170 -108.45 130.89 55.23 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 0.76 . . . . 74.319999999999993 109.6 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.458 ' HB2' ' CE ' ' A' ' 381' ' ' LYS . 0.0 OUTLIER -98.43 157.48 16.18 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.133 . . . . 73.109999999999999 109.28 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' MET . . . . . 0.468 ' O ' ' CG1' ' A' ' 383' ' ' VAL . 15.5 ptp -171.81 174.38 4.24 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.509 1.13 . . . . 74.329999999999998 111.036 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . 1.147 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 26.3 p -98.13 115.98 29.4 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.531 1.145 . . . . 72.349999999999994 108.291 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 26.2 m -42.12 -59.37 1.79 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.559 1.162 . . . . 74.230000000000004 110.421 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.7 t -42.82 -37.09 1.68 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.553 1.158 . . . . 64.239999999999995 109.983 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . 1.147 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 3.5 m -73.69 -53.6 10.02 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.542 1.151 . . . . 71.430000000000007 108.297 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . 0.467 ' C ' ' CD1' ' A' ' 397' ' ' LEU . 0.8 OUTLIER -43.89 -37.18 2.71 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.536 1.147 . . . . 71.340000000000003 109.265 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 53.1 m -61.14 -46.07 92.07 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.514 1.134 . . . . 74.230000000000004 110.406 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -59.97 -19.88 54.59 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.498 1.124 . . . . 73.420000000000002 109.33 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' TRP . . . . . 0.605 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 9.7 t-105 -85.75 -64.94 1.07 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.5 1.125 . . . . 71.040000000000006 108.022 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.489 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 10.3 mm-40 -52.44 -17.18 1.1 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.457 1.098 . . . . 73.439999999999998 110.313 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 401' ' ' GLN . 2.3 mm-40 -37.19 -63.31 0.44 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.516 1.135 . . . . 73.450000000000003 110.281 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 2.5 m -121.0 -24.57 5.55 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.512 1.133 . . . . 71.510000000000005 110.004 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . 0.605 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 13.2 m-20 -82.05 -94.25 0.05 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.45 1.094 . . . . 73.0 109.298 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.489 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 69.18 30.89 71.67 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 124.5 1.125 . . . . 72.5 111.002 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -90.66 57.34 3.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.569 0.805 . . . . 75.310000000000002 110.326 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 69.27 -160.54 52.65 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.472 1.108 . . . . 35.539999999999999 110.971 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 412' ' ' ARG . 1.4 t -56.53 121.74 45.64 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 108.282 -1.007 . . . . 74.5 108.282 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.405 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.0 Cg_endo -75.07 0.3 9.1 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.538 1.809 . . . . 73.150000000000006 110.969 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . 0.46 ' CE1' ' HE2' ' A' ' 392' ' ' MET . 10.8 m-85 -89.35 -38.83 13.86 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 62.229999999999997 111.0 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' CYS . . . . . 0.402 ' O ' ' C ' ' A' ' 412' ' ' ARG . 0.7 OUTLIER -126.49 15.85 7.64 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 73.200000000000003 108.322 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 408' ' ' CYS . 0.4 OUTLIER 38.71 41.27 0.48 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.561 1.163 . . . . 63.520000000000003 110.279 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 14.9 t -124.19 140.48 52.93 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 51.229999999999997 108.316 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -47.63 157.44 0.24 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.543 1.152 . . . . 74.329999999999998 110.307 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.466 HG23 ' CG2' ' A' ' 418' ' ' THR . 2.3 mt -111.75 155.12 13.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.442 1.089 . . . . 75.25 109.319 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -120.91 -46.11 2.35 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.499 1.124 . . . . 72.209999999999994 109.308 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . 0.493 ' O ' ' CG2' ' A' ' 418' ' ' THR . . . -115.55 132.73 10.47 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.525 1.14 . . . . 71.510000000000005 110.967 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' THR . . . . . 0.493 ' CG2' ' O ' ' A' ' 417' ' ' GLY . 21.0 p -157.23 117.37 3.48 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.443 0.731 . . . . 63.450000000000003 110.397 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -144.82 151.55 49.82 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.51 1.131 . . . . 74.530000000000001 110.291 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 100.82 1.4 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.502 1.791 . . . . 64.040000000000006 110.995 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . 0.437 ' CD1' HG22 ' A' ' 423' ' ' VAL . 0.7 OUTLIER -104.68 169.51 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.502 1.126 . . . . 75.099999999999994 109.312 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . 0.461 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 9.7 mt -124.95 105.43 15.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.518 1.136 . . . . 71.430000000000007 109.304 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.437 HG22 ' CD1' ' A' ' 421' ' ' ILE . 11.2 t -78.51 142.29 14.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.472 1.107 . . . . 64.200000000000003 109.301 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.92 143.7 48.72 Favored Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.486 1.116 . . . . 74.129999999999995 109.324 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 176.44 9.92 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.451 1.764 . . . . 71.310000000000002 110.983 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . 0.545 ' CE2' ' HG2' ' A' ' 357' ' ' GLN . 3.3 t80 . . . . . 0 C--N 1.325 -0.48 0 O-C-N 124.55 1.156 . . . . 73.030000000000001 111.04 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 63.8 m . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.998 -0.371 . . . . 55.409999999999997 109.998 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -96.3 -174.33 3.04 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.527 1.142 . . . . 65.230000000000004 109.318 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . 0.519 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 31.3 m-70 -138.99 140.66 38.25 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.461 1.101 . . . . 73.400000000000006 109.55 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 3.9 mm -122.07 156.19 26.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.503 1.127 . . . . 73.430000000000007 109.336 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -122.28 138.86 54.36 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.526 1.141 . . . . 65.209999999999994 109.322 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 37.3 t -97.58 148.92 5.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.49 1.119 . . . . 75.25 109.347 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.6 p -108.55 141.86 39.83 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.547 1.154 . . . . 74.019999999999996 110.392 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' GLN . . . . . 0.537 ' HG2' ' CE2' ' A' ' 426' ' ' PHE . 4.9 mt-30 -39.66 -32.98 0.16 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.483 1.114 . . . . 72.010000000000005 110.32 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -57.05 -53.51 57.28 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.499 1.125 . . . . 75.430000000000007 110.322 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -66.07 -22.67 66.42 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.546 1.154 . . . . 72.140000000000001 110.331 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -86.82 -23.73 25.24 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.492 1.12 . . . . 75.430000000000007 111.03 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 357' ' ' GLN . 4.6 mm-40 -84.41 -50.27 7.94 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.519 1.137 . . . . 72.430000000000007 110.235 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.468 ' N ' ' CD1' ' A' ' 362' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.515 1.134 . . . . 72.040000000000006 109.288 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 108.284 -1.006 . . . . 71.049999999999997 108.284 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -43.35 -68.31 0.21 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.514 1.134 . . . . 74.409999999999997 110.326 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 21.7 ptp -56.65 -31.12 64.06 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.53 1.144 . . . . 73.349999999999994 111.001 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 82.42 50.9 4.57 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.533 1.145 . . . . 63.539999999999999 111.015 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 1.5 t -126.29 -179.24 4.64 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.477 0.751 . . . . 75.519999999999996 110.026 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' THR . . . . . 0.406 ' HB ' ' NE2' ' A' ' 371' ' ' GLN . 2.8 p -129.1 140.46 51.56 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.521 1.138 . . . . 72.319999999999993 110.365 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.541 ' CE2' HG12 ' A' ' 423' ' ' VAL . 60.8 t80 -64.52 -68.2 0.37 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.451 1.094 . . . . 74.040000000000006 111.035 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' GLN . . . . . 0.56 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -39.44 -30.02 0.06 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.124 . . . . 61.0 110.327 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . 0.435 ' CD2' ' N ' ' A' ' 373' ' ' CYS . 0.4 OUTLIER -73.4 136.14 44.3 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.489 1.118 . . . . 74.019999999999996 109.339 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . 0.435 ' N ' ' CD2' ' A' ' 372' ' ' LEU . 26.9 p -67.88 131.85 46.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.015 -0.993 . . . . 34.509999999999998 110.926 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -93.21 29.57 1.87 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 72.409999999999997 109.328 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 17.1 mt -107.65 -59.78 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.469 1.106 . . . . 71.040000000000006 109.315 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 3.7 m -107.71 -23.17 12.21 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.516 1.135 . . . . 74.030000000000001 108.279 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 56.81 42.55 26.43 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 72.409999999999997 109.321 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -124.17 -42.45 2.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.516 1.135 . . . . 71.299999999999997 110.296 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -121.89 170.57 9.66 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.553 1.158 . . . . 63.240000000000002 109.309 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 17.3 p30 -83.24 162.1 21.29 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.472 1.108 . . . . 73.120000000000005 109.294 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -64.37 -55.57 20.25 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.489 1.118 . . . . 73.329999999999998 109.298 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 1.1 p30 52.22 25.71 3.51 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 74.439999999999998 109.308 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . 0.473 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -153.21 176.09 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.53 1.143 . . . . 74.129999999999995 109.286 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -160.94 142.23 11.83 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.448 1.093 . . . . 74.349999999999994 109.294 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.456 ' O ' ' N ' ' A' ' 389' ' ' GLY . 10.4 mm -108.12 138.58 34.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 124.554 1.159 . . . . 72.230000000000004 109.308 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.502 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.1 OUTLIER -138.06 161.39 59.9 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.511 1.132 . . . . 72.299999999999997 110.27 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.502 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.98 -7.16 22.99 Favored 'Cis proline' 0 C--N 1.36 1.158 0 C-N-CA 120.983 -2.507 . . . . 75.209999999999994 111.024 -0.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . 0.442 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 41.2 t -36.83 -73.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.002 -0.999 . . . . 71.219999999999999 110.919 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 115.95 16.5 6.78 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.478 1.111 . . . . 73.200000000000003 111.043 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.514 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 49.6 m170 -86.85 131.42 34.12 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.525 0.779 . . . . 73.299999999999997 109.623 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.408 ' CD2' ' N ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -100.78 161.8 13.35 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.506 1.129 . . . . 74.299999999999997 109.285 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' MET . . . . . 0.473 ' O ' ' CG1' ' A' ' 383' ' ' VAL . 18.6 ptp -174.72 174.83 2.55 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.508 1.13 . . . . 73.430000000000007 110.973 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . 1.171 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 7.0 p -96.55 119.56 35.25 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.521 1.138 . . . . 75.120000000000005 108.289 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 44.1 m -44.01 -59.22 2.4 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.486 1.117 . . . . 74.209999999999994 110.365 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 14.6 m -43.41 -34.2 1.23 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.499 1.124 . . . . 71.400000000000006 109.999 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . 1.171 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 1.8 m -76.1 -57.81 3.65 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.531 1.144 . . . . 65.109999999999999 108.34 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' A' ' 397' ' ' LEU . 1.2 tm? -41.96 -39.03 1.75 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.452 1.095 . . . . 72.109999999999999 109.242 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 2.8 m -60.59 -46.52 89.93 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.509 1.131 . . . . 71.549999999999997 110.418 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -58.8 -20.65 52.0 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.142 . . . . 73.200000000000003 109.293 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' TRP . . . . . 0.607 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 7.7 t-105 -85.94 -64.92 1.07 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.526 1.141 . . . . 72.129999999999995 108.005 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.483 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.1 mm-40 -52.23 -17.4 1.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.498 1.124 . . . . 73.409999999999997 110.297 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 401' ' ' GLN . 2.3 mm-40 -37.14 -63.36 0.44 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.525 1.14 . . . . 74.200000000000003 110.26 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.6 m -120.82 -24.65 5.61 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.482 1.114 . . . . 73.109999999999999 110.01 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . 0.607 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 12.2 m-20 -81.58 -93.86 0.05 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.516 1.135 . . . . 75.230000000000004 109.312 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.483 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 69.93 29.67 70.69 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.485 1.115 . . . . 52.0 111.009 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -92.02 68.13 5.22 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.528 0.781 . . . . 74.120000000000005 110.312 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 63.34 -167.01 24.37 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 124.502 1.126 . . . . 52.5 111.005 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . 0.415 ' O ' ' N ' ' A' ' 412' ' ' ARG . 2.0 t -56.21 123.22 53.61 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 108.307 -0.997 . . . . 52.32 108.307 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.421 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.2 Cg_endo -74.99 0.3 9.07 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.451 1.763 . . . . 71.319999999999993 110.986 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . 0.514 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 3.3 m-30 -91.38 -40.77 11.26 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.478 1.111 . . . . 74.140000000000001 110.986 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' CYS . . . . . 0.442 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.8 OUTLIER -122.36 16.19 10.54 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.533 1.145 . . . . 74.120000000000005 108.267 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 408' ' ' CYS . 5.3 tpt180 38.6 30.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.54 1.15 . . . . 74.540000000000006 110.32 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' CYS . . . . . 0.442 ' N ' ' O ' ' A' ' 411' ' ' CYS . 6.9 t -111.97 142.65 44.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 65.230000000000004 108.265 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . 0.445 ' CG ' ' N ' ' A' ' 415' ' ' ILE . 24.7 tt0 -50.9 158.88 0.63 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.462 1.101 . . . . 74.549999999999997 110.34 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.445 ' N ' ' CG ' ' A' ' 414' ' ' GLU . 2.3 mt -110.44 157.33 11.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.478 1.112 . . . . 72.319999999999993 109.244 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -119.91 -44.56 2.51 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.48 1.112 . . . . 75.129999999999995 109.303 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . 0.433 ' O ' ' CG2' ' A' ' 418' ' ' THR . . . -134.72 146.55 18.55 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.549 1.156 . . . . 61.049999999999997 110.964 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' THR . . . . . 0.433 ' CG2' ' O ' ' A' ' 417' ' ' GLY . 2.3 p -157.52 117.68 3.44 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.533 0.784 . . . . 73.150000000000006 110.394 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -138.17 151.27 69.42 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.51 1.131 . . . . 74.329999999999998 110.346 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 101.68 1.5 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.51 1.795 . . . . 74.510000000000005 111.0 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -104.14 155.72 5.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.488 1.117 . . . . 74.5 109.247 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . 0.519 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 17.0 mt -107.01 105.41 18.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.502 1.126 . . . . 75.129999999999995 109.281 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.541 HG12 ' CE2' ' A' ' 370' ' ' PHE . 38.2 t -76.86 146.98 7.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 54.539999999999999 109.247 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.08 143.66 50.01 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.461 1.101 . . . . 70.310000000000002 109.237 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 170.35 20.61 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.497 1.788 . . . . 73.329999999999998 111.001 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . 0.537 ' CE2' ' HG2' ' A' ' 357' ' ' GLN . 3.3 t80 . . . . . 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 73.409999999999997 111.006 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 110.037 -0.357 . . . . 75.239999999999995 110.037 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -97.46 176.85 5.72 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.466 1.104 . . . . 75.209999999999994 109.323 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . 0.44 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 42.5 m-70 -136.47 134.57 37.78 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.498 1.124 . . . . 73.450000000000003 109.604 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 67.0 mt -114.69 135.87 53.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.517 1.135 . . . . 74.519999999999996 109.302 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -107.84 118.94 38.06 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.473 1.108 . . . . 74.209999999999994 109.282 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . 0.464 ' O ' ' CD2' ' A' ' 426' ' ' PHE . 8.6 t -64.33 140.55 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.539 1.149 . . . . 62.310000000000002 109.317 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' THR . . . . . 0.44 ' OG1' ' CG ' ' A' ' 359' ' ' GLN . 27.0 p -91.85 156.55 17.42 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 72.150000000000006 110.365 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -57.99 -32.5 67.95 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.454 1.096 . . . . 73.129999999999995 110.321 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . 0.462 ' CG ' ' N ' ' A' ' 359' ' ' GLN . 18.0 pt-20 -66.05 -47.48 74.2 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.517 1.136 . . . . 74.450000000000003 110.305 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . 0.462 ' N ' ' CG ' ' A' ' 358' ' ' GLU . 11.9 mm-40 -60.73 -52.77 63.69 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.518 1.136 . . . . 74.450000000000003 110.313 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -51.15 -60.63 2.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.527 1.142 . . . . 71.340000000000003 111.031 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -58.52 -36.76 74.34 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.491 1.119 . . . . 74.400000000000006 110.334 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.0 tp . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.505 1.128 . . . . 72.519999999999996 109.289 -179.997 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 108.258 -1.016 . . . . 73.239999999999995 108.258 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -59.25 -17.64 30.2 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.5 1.125 . . . . 74.049999999999997 110.291 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 5.0 mtt -109.0 -16.18 14.19 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.487 1.117 . . . . 73.549999999999997 110.991 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 65.5 40.25 96.07 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.486 1.116 . . . . 74.430000000000007 111.006 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 16.1 m -125.13 -175.34 3.28 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.446 0.733 . . . . 73.0 109.971 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' THR . . . . . 0.403 ' HB ' ' NE2' ' A' ' 371' ' ' GLN . 2.3 p -128.22 136.36 50.95 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.456 1.098 . . . . 75.239999999999995 110.451 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.469 ' CE2' HD11 ' A' ' 391' ' ' LEU . 73.7 t80 -60.58 -68.42 0.3 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.5 1.125 . . . . 75.140000000000001 111.002 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' GLN . . . . . 0.527 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -40.09 -29.23 0.07 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 71.349999999999994 110.255 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . 0.416 ' N ' ' C ' ' A' ' 370' ' ' PHE . 0.0 OUTLIER -69.48 115.01 8.25 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.127 . . . . 63.340000000000003 109.344 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 30.3 p -45.96 145.87 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.009 -0.996 . . . . 73.319999999999993 110.937 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -105.53 31.6 4.86 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.512 1.133 . . . . 74.510000000000005 109.31 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 46.4 mt -112.42 -58.39 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.51 1.131 . . . . 75.219999999999999 109.282 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 5.3 p -107.98 -21.81 12.67 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.479 1.112 . . . . 73.140000000000001 108.312 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 56.46 41.51 28.69 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.524 1.14 . . . . 52.310000000000002 109.336 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -126.16 -49.06 1.58 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.463 1.102 . . . . 73.219999999999999 110.329 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 49.4 m-20 -109.4 167.92 9.77 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.543 1.152 . . . . 63.25 109.323 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 16.6 p30 -84.6 162.66 19.7 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.486 1.116 . . . . 73.329999999999998 109.276 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.403 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 22.7 mttt -63.07 -62.4 1.73 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.469 1.106 . . . . 74.129999999999995 109.294 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 58.45 25.04 12.48 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.513 1.133 . . . . 74.150000000000006 109.262 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . 0.459 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.7 OUTLIER -154.85 170.64 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 74.430000000000007 109.268 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -154.61 144.45 21.66 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.484 1.115 . . . . 71.349999999999994 109.314 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.442 ' O ' ' N ' ' A' ' 389' ' ' GLY . 11.1 mm -107.79 133.66 51.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.505 1.128 . . . . 73.239999999999995 109.293 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.497 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 10.5 mt-10 -137.67 160.98 62.86 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 73.439999999999998 110.297 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.497 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -75.07 -5.19 21.46 Favored 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 120.995 -2.502 . . . . 74.329999999999998 110.995 0.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . 0.512 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 16.5 t -38.13 -79.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.985 -1.007 . . . . 74.540000000000006 110.92 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 119.64 36.58 0.83 Allowed Glycine 0 CA--C 1.531 1.068 0 O-C-N 124.537 1.148 . . . . 61.119999999999997 110.965 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.559 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 67.4 m170 -108.54 127.14 53.68 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.545 0.791 . . . . 74.120000000000005 109.596 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.469 HD11 ' CE2' ' A' ' 370' ' ' PHE . 1.8 mt -95.65 157.27 15.97 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.507 1.13 . . . . 72.329999999999998 109.297 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' MET . . . . . 0.563 ' HE1' ' CE1' ' A' ' 410' ' ' PHE . 14.2 ptp -171.17 174.57 4.57 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.492 1.12 . . . . 74.5 111.001 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . 1.059 ' SG ' ' CB ' ' A' ' 396' ' ' CYS . 2.8 p -97.85 120.82 38.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.562 1.164 . . . . 73.230000000000004 108.289 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 48.8 m -41.11 -59.17 1.56 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.501 1.126 . . . . 64.319999999999993 110.339 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 2.7 t -49.3 -36.24 20.32 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.518 1.136 . . . . 73.439999999999998 109.999 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . 1.059 ' CB ' ' SG ' ' A' ' 393' ' ' CYS . 2.2 m -71.06 -38.17 72.51 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.461 1.101 . . . . 73.430000000000007 108.3 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . 0.42 ' C ' ' CD1' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -65.03 -36.57 84.8 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.511 1.132 . . . . 75.219999999999999 109.32 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 45.8 m -61.96 -45.47 93.51 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.54 1.15 . . . . 71.409999999999997 110.392 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -56.77 -23.87 46.14 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.496 1.123 . . . . 55.420000000000002 109.304 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' TRP . . . . . 0.601 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 15.8 t-105 -85.13 -65.22 1.03 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.498 1.124 . . . . 72.140000000000001 108.023 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.502 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 39.8 mm-40 -48.94 -20.85 0.56 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.53 1.144 . . . . 74.239999999999995 110.349 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 401' ' ' GLN . 2.7 mm-40 -37.45 -63.66 0.43 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.123 . . . . 74.319999999999993 110.347 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 42.6 t -122.77 -24.46 4.84 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 74.030000000000001 110.006 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . 0.601 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 18.6 m-20 -82.42 -93.67 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.503 1.127 . . . . 71.049999999999997 109.326 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.502 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 66.8 21.74 71.43 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 124.493 1.121 . . . . 74.310000000000002 110.991 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -80.34 59.72 3.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.476 0.75 . . . . 71.200000000000003 110.337 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 71.67 -165.58 53.6 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.481 1.113 . . . . 73.010000000000005 110.99 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 412' ' ' ARG . 1.8 t -56.2 120.9 38.24 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.296 -1.001 . . . . 74.319999999999993 108.296 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.427 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.3 Cg_endo -75.04 -0.01 9.47 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.496 1.787 . . . . 72.209999999999994 111.015 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . 0.563 ' CE1' ' HE1' ' A' ' 392' ' ' MET . 3.5 m-85 -91.51 -37.01 13.4 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.46 1.1 . . . . 72.329999999999998 111.014 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.6 OUTLIER -127.38 17.33 7.06 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.106 . . . . 63.32 108.253 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 408' ' ' CYS . 6.3 tpp180 38.69 30.12 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.505 1.128 . . . . 75.540000000000006 110.279 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 411' ' ' CYS . 51.1 t -114.41 138.72 50.21 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.545 1.153 . . . . 65.409999999999997 108.325 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . 0.444 ' CG ' ' N ' ' A' ' 415' ' ' ILE . 34.1 tt0 -45.11 159.0 0.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 1.113 . . . . 74.140000000000001 110.317 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.451 HG21 ' CG2' ' A' ' 418' ' ' THR . 2.3 mt -113.22 157.04 14.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 72.439999999999998 109.271 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 10.4 mttm -132.3 -47.17 0.91 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.53 1.144 . . . . 74.519999999999996 109.286 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . 0.494 ' O ' ' CG2' ' A' ' 418' ' ' THR . . . -109.51 130.78 10.15 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.493 1.121 . . . . 75.340000000000003 111.015 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' THR . . . . . 0.494 ' CG2' ' O ' ' A' ' 417' ' ' GLY . 20.8 p -157.2 118.5 3.68 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.492 0.76 . . . . 74.109999999999999 110.409 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -141.57 151.44 60.55 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.539 1.149 . . . . 71.219999999999999 110.28 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.03 101.3 1.45 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.474 1.776 . . . . 65.109999999999999 110.988 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . 0.486 ' CD1' ' N ' ' A' ' 422' ' ' ILE . 1.1 pp -105.94 178.19 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.463 1.102 . . . . 64.349999999999994 109.253 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . 0.486 ' N ' ' CD1' ' A' ' 421' ' ' ILE . 6.1 mt -139.69 111.81 5.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.502 1.126 . . . . 72.530000000000001 109.292 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.406 ' CG1' ' HB3' ' A' ' 371' ' ' GLN . 18.5 t -84.04 142.71 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.477 1.111 . . . . 74.430000000000007 109.304 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -131.1 143.73 50.62 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 62.32 109.309 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 174.98 11.86 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.489 1.784 . . . . 73.400000000000006 110.956 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . 0.464 ' CD2' ' O ' ' A' ' 355' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.521 1.138 . . . . 75.150000000000006 111.004 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 69.9 m . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.973 -0.38 . . . . 74.519999999999996 109.973 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . 0.432 ' HB2' ' CG2' ' A' ' 421' ' ' ILE . 11.4 m-20 -98.43 171.99 7.81 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.476 1.11 . . . . 74.5 109.281 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . 0.415 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 22.4 m-70 -130.37 126.59 37.48 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.474 1.109 . . . . 74.450000000000003 109.581 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 48.0 mt -115.76 127.39 73.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.486 1.116 . . . . 73.140000000000001 109.326 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 8.4 tptp -105.58 118.85 37.64 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.544 1.152 . . . . 74.329999999999998 109.304 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . 0.455 ' CG1' ' N ' ' A' ' 356' ' ' THR . 48.5 t -59.39 164.03 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.528 1.142 . . . . 71.0 109.288 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' THR . . . . . 0.455 ' N ' ' CG1' ' A' ' 355' ' ' VAL . 3.0 p -122.89 146.12 47.86 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.506 1.129 . . . . 74.140000000000001 110.37 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' GLN . . . . . 0.577 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 5.8 mt-30 -42.46 -53.72 4.17 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 73.0 110.288 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -39.95 -41.22 1.15 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.468 1.105 . . . . 72.450000000000003 110.327 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -67.06 -66.84 0.51 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.475 1.109 . . . . 74.150000000000006 110.305 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . 0.431 ' O ' ' N ' ' A' ' 364' ' ' CYS . 8.4 t80 -40.61 -52.22 2.9 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.434 1.084 . . . . 75.099999999999994 110.991 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -55.4 -44.02 75.76 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.493 1.12 . . . . 72.120000000000005 110.273 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.1 tt . . . . . 0 C--N 1.325 -0.462 0 O-C-N 124.481 1.113 . . . . 72.209999999999994 109.331 -179.997 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 108.327 -0.99 . . . . 71.219999999999999 108.327 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -62.29 -18.62 61.79 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.472 1.107 . . . . 63.32 110.29 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -128.4 8.52 5.98 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.473 1.108 . . . . 73.150000000000006 110.995 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 38.04 63.61 0.89 Allowed Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.521 1.138 . . . . 72.129999999999995 111.042 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 64.1 p -132.09 -174.03 3.32 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.463 0.743 . . . . 75.340000000000003 110.009 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' THR . . . . . 0.484 ' O ' ' CE ' ' A' ' 374' ' ' LYS . 33.7 p -126.47 146.53 50.06 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.535 1.147 . . . . 72.150000000000006 110.388 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.42 ' C ' ' N ' ' A' ' 372' ' ' LEU . 31.8 t80 -77.23 -63.83 1.28 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.489 1.118 . . . . 74.109999999999999 111.003 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' GLN . . . . . 0.552 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -40.71 -28.78 0.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.489 1.118 . . . . 74.209999999999994 110.323 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . 0.42 ' N ' ' C ' ' A' ' 370' ' ' PHE . 3.0 tm? -67.3 139.91 57.29 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.116 . . . . 74.409999999999997 109.283 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 1.9 t -76.16 126.17 30.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.016 -0.993 . . . . 75.299999999999997 110.925 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.484 ' CE ' ' O ' ' A' ' 369' ' ' THR . 12.9 mmtm -91.06 18.51 6.69 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.527 1.142 . . . . 75.319999999999993 109.297 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 20.3 mt -99.17 -51.61 9.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.457 1.098 . . . . 75.219999999999999 109.306 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.54 -30.3 8.32 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.512 1.132 . . . . 71.420000000000002 108.305 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . 0.412 ' HA ' ' CD1' ' A' ' 372' ' ' LEU . . . 65.82 43.69 3.05 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.545 1.153 . . . . 74.049999999999997 109.279 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -136.29 -61.89 0.68 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.53 1.144 . . . . 73.239999999999995 110.301 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -96.88 161.43 13.85 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.471 1.107 . . . . 72.109999999999999 109.298 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 37.4 p30 -81.14 160.73 24.33 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.517 1.136 . . . . 74.209999999999994 109.314 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.461 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 23.4 mttt -65.01 -62.49 1.52 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.49 1.119 . . . . 73.099999999999994 109.308 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 9.7 t70 60.07 27.05 16.44 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.501 1.126 . . . . 73.319999999999993 109.309 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -157.94 175.26 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.442 1.089 . . . . 72.349999999999994 109.313 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . 0.424 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 17.0 tttp -159.4 140.86 13.02 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.481 1.113 . . . . 75.420000000000002 109.316 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 389' ' ' GLY . 24.6 mm -104.91 132.74 50.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.511 1.132 . . . . 72.150000000000006 109.268 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.489 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 10.8 mt-10 -137.79 161.08 62.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 74.310000000000002 110.312 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.489 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -75.01 -4.65 20.7 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 121.012 -2.495 . . . . 74.239999999999995 110.989 0.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . 0.523 ' SG ' ' CD2' ' A' ' 390' ' ' HIS . 25.2 t -37.6 -77.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.986 -1.007 . . . . 72.200000000000003 110.939 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 118.72 35.45 0.98 Allowed Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.566 1.166 . . . . 62.450000000000003 111.01 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.523 ' CD2' ' SG ' ' A' ' 388' ' ' CYS . 51.7 m170 -108.51 126.89 53.43 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.504 0.767 . . . . 71.219999999999999 109.579 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.461 ' HB2' ' CE ' ' A' ' 381' ' ' LYS . 0.0 OUTLIER -97.56 157.53 15.97 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.465 1.103 . . . . 74.310000000000002 109.306 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' MET . . . . . 0.468 ' O ' ' CG1' ' A' ' 383' ' ' VAL . 11.4 ptp -173.81 173.71 3.23 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.492 1.12 . . . . 74.340000000000003 110.99 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . 1.309 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 19.4 p -90.39 140.88 29.29 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 73.400000000000006 108.303 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 48.4 m -61.93 -43.35 99.03 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.433 1.083 . . . . 75.340000000000003 110.394 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 23.3 t -55.37 -64.54 0.81 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.459 1.099 . . . . 74.230000000000004 110.021 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . 1.309 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 1.6 p -50.24 -51.38 45.02 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.518 1.136 . . . . 74.510000000000005 108.323 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -45.13 -49.53 11.8 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.496 1.123 . . . . 75.219999999999999 109.292 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 76.5 m -54.59 -38.63 66.97 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.509 1.131 . . . . 75.540000000000006 110.427 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -60.71 -25.13 66.2 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.461 1.1 . . . . 75.209999999999994 109.375 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' TRP . . . . . 0.602 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 10.7 t-105 -85.7 -62.75 1.45 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.498 1.124 . . . . 74.239999999999995 108.02 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.484 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 8.2 mm-40 -55.98 -14.34 2.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.545 1.153 . . . . 63.32 110.323 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 401' ' ' GLN . 0.6 OUTLIER -37.23 -63.29 0.44 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.495 1.122 . . . . 70.340000000000003 110.302 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 7.8 t -121.13 -24.58 5.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.499 1.124 . . . . 74.239999999999995 109.968 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . 0.602 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 8.7 m-20 -83.0 -94.86 0.06 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.484 1.115 . . . . 74.019999999999996 109.327 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.484 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 73.3 28.99 64.94 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.469 1.106 . . . . 72.230000000000004 111.01 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -90.91 70.36 6.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.446 0.733 . . . . 72.019999999999996 110.307 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 66.58 -169.03 34.31 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.559 1.162 . . . . 55.310000000000002 110.993 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 6.0 t -56.55 131.55 77.21 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.329 -0.989 . . . . 64.030000000000001 108.329 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 0.34 9.05 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.475 1.776 . . . . 74.310000000000002 110.958 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -93.66 -55.63 3.19 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.462 1.101 . . . . 63.420000000000002 110.969 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' CYS . . . . . 0.451 ' O ' ' N ' ' A' ' 413' ' ' CYS . 2.6 p -98.56 10.07 41.8 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.558 1.161 . . . . 63.520000000000003 108.319 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 411' ' ' CYS . 3.4 tpt85 38.59 30.19 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.475 1.11 . . . . 74.319999999999993 110.325 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' CYS . . . . . 0.451 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.5 m -115.48 154.24 29.67 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.489 1.118 . . . . 62.409999999999997 108.309 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -59.35 156.6 12.43 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.531 1.144 . . . . 75.450000000000003 110.284 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.462 HG23 ' CG2' ' A' ' 418' ' ' THR . 5.6 mt -115.48 157.1 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 63.43 109.345 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . 0.405 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 5.9 mmtp -120.26 -44.5 2.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.529 1.143 . . . . 75.239999999999995 109.269 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . 0.49 ' O ' ' CG2' ' A' ' 418' ' ' THR . . . -112.44 127.78 8.19 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.461 1.1 . . . . 64.310000000000002 111.009 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' THR . . . . . 0.49 ' CG2' ' O ' ' A' ' 417' ' ' GLY . 34.9 p -156.56 125.51 5.97 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.531 0.783 . . . . 71.400000000000006 110.419 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -158.06 151.43 18.94 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.484 1.115 . . . . 71.530000000000001 110.3 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 99.17 1.23 Allowed 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.551 1.817 . . . . 73.319999999999993 111.031 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . 0.432 ' CG2' ' HB2' ' A' ' 351' ' ' ASP . 0.8 OUTLIER -104.38 163.93 3.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.48 1.113 . . . . 71.450000000000003 109.341 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . 0.415 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 3.3 mp -113.18 105.44 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.496 1.123 . . . . 75.5 109.301 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.422 HG23 ' CD1' ' A' ' 421' ' ' ILE . 12.9 t -78.22 140.19 17.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.465 1.103 . . . . 72.540000000000006 109.307 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.412 ' O ' ' CG2' ' A' ' 355' ' ' VAL . 23.6 m-20 -130.2 143.72 50.32 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.519 1.137 . . . . 73.120000000000005 109.309 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 160.29 40.29 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.493 1.786 . . . . 71.219999999999999 110.96 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . 0.577 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 26.4 t80 . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.481 1.113 . . . . 74.109999999999999 111.033 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 109.967 -0.383 . . . . 63.420000000000002 109.967 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -87.22 -177.28 5.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.463 1.102 . . . . 74.209999999999994 109.263 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . 0.542 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 25.0 m-70 -138.3 149.9 46.12 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.509 1.13 . . . . 73.230000000000004 109.588 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . 0.411 ' CG2' ' N ' ' A' ' 354' ' ' LYS . 7.7 mt -136.11 158.65 38.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.564 1.165 . . . . 72.549999999999997 109.266 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . 0.411 ' N ' ' CG2' ' A' ' 353' ' ' ILE . 0.1 OUTLIER -123.38 152.74 41.23 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.461 1.1 . . . . 74.409999999999997 109.317 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . 0.628 ' CG2' ' CD2' ' A' ' 370' ' ' PHE . 9.2 t -107.94 162.05 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 72.420000000000002 109.288 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' THR . . . . . 0.466 ' N ' ' CG1' ' A' ' 355' ' ' VAL . 13.1 p -112.95 158.7 19.91 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.499 1.124 . . . . 71.430000000000007 110.43 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' GLN . . . . . 0.525 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 11.5 mt-30 -59.87 -45.7 91.66 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.54 1.15 . . . . 71.319999999999993 110.341 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -49.25 -44.92 44.08 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.495 1.122 . . . . 71.140000000000001 110.299 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -66.42 -43.49 85.57 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.445 1.091 . . . . 73.209999999999994 110.311 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -58.26 -27.22 63.81 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.453 1.095 . . . . 74.430000000000007 110.953 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -89.58 -40.39 12.64 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.527 1.142 . . . . 72.200000000000003 110.358 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.487 ' O ' ' CD1' ' A' ' 362' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.127 . . . . 65.140000000000001 109.3 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 108.287 -1.005 . . . . 63.119999999999997 108.287 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -41.55 -66.68 0.32 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.546 1.154 . . . . 72.040000000000006 110.264 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 19.1 ptp -53.73 -34.49 59.09 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.486 1.116 . . . . 71.349999999999994 111.001 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 88.45 50.21 3.45 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.429 1.081 . . . . 61.350000000000001 110.953 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 3.3 m -146.21 179.05 7.77 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.498 0.763 . . . . 70.349999999999994 109.989 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' THR . . . . . 0.419 HG21 ' NE2' ' A' ' 371' ' ' GLN . 2.3 m -117.89 160.66 21.04 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.528 1.143 . . . . 74.120000000000005 110.395 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.628 ' CD2' ' CG2' ' A' ' 355' ' ' VAL . 64.3 t80 -62.59 -68.67 0.31 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.53 1.144 . . . . 64.129999999999995 111.015 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' GLN . . . . . 0.419 ' NE2' HG21 ' A' ' 369' ' ' THR . 0.1 OUTLIER -47.33 -24.95 0.87 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.529 1.143 . . . . 73.230000000000004 110.283 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . 0.406 ' CD2' ' HA ' ' A' ' 377' ' ' ALA . 0.0 OUTLIER -69.75 117.7 11.67 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 74.409999999999997 109.236 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 25.1 t -52.22 145.24 11.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.947 -1.024 . . . . 64.140000000000001 110.89 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -103.36 24.26 11.25 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.463 1.102 . . . . 73.400000000000006 109.267 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 52.8 mt -111.47 -49.29 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.451 1.094 . . . . 74.400000000000006 109.316 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' CYS . . . . . 0.763 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 3.5 m -109.04 -32.65 7.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.501 1.126 . . . . 62.530000000000001 108.285 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . 0.406 ' HA ' ' CD2' ' A' ' 372' ' ' LEU . . . 61.03 28.21 18.0 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.499 1.124 . . . . 65.010000000000005 109.322 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -121.83 -40.32 2.54 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.497 1.123 . . . . 75.109999999999999 110.28 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -115.53 169.65 9.02 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.514 1.134 . . . . 74.5 109.294 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -87.52 166.19 14.94 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 72.450000000000003 109.354 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.454 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 19.2 mttt -67.12 -62.53 1.38 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.476 1.11 . . . . 73.030000000000001 109.268 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 4.8 t0 60.56 20.89 10.71 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.452 1.095 . . . . 75.319999999999993 109.281 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . 0.48 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -151.19 175.42 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.539 1.149 . . . . 74.140000000000001 109.285 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -158.13 156.66 31.32 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.492 1.12 . . . . 74.049999999999997 109.318 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.499 ' CG2' ' SG ' ' A' ' 388' ' ' CYS . 11.8 mm -122.72 144.3 32.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.562 1.164 . . . . 62.210000000000001 109.331 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.514 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.4 mt-10 -137.74 162.4 54.72 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.501 1.125 . . . . 73.409999999999997 110.282 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.514 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.03 -12.15 24.12 Favored 'Cis proline' 0 C--N 1.36 1.172 0 C-N-CA 121.032 -2.487 . . . . 55.219999999999999 110.986 0.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . 0.512 ' HB2' ' CE1' ' A' ' 390' ' ' HIS . 0.8 OUTLIER -36.63 -71.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.04 -0.982 . . . . 72.329999999999998 110.881 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 115.77 18.15 6.16 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.492 1.12 . . . . 72.450000000000003 111.022 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 388' ' ' CYS . 20.0 m170 -75.58 147.13 39.88 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.529 0.782 . . . . 74.239999999999995 109.565 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.55 ' CD2' ' N ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -117.3 156.47 27.75 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.132 . . . . 72.219999999999999 109.308 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' MET . . . . . 0.543 ' HE3' ' CE1' ' A' ' 410' ' ' PHE . 18.8 ptp -172.01 173.54 4.36 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.502 1.126 . . . . 75.230000000000004 110.958 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . 1.182 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 26.1 p -95.18 126.08 40.26 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.471 1.107 . . . . 74.519999999999996 108.278 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 6.4 m -54.12 -56.25 19.86 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.508 1.13 . . . . 74.040000000000006 110.381 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.6 t -43.61 -30.71 0.64 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.546 1.153 . . . . 64.519999999999996 109.988 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . 1.182 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 2.5 m -80.79 -52.32 7.64 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.544 1.153 . . . . 71.010000000000005 108.287 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . 0.408 ' C ' ' CD1' ' A' ' 397' ' ' LEU . 0.7 OUTLIER -43.56 -37.91 2.72 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.452 1.095 . . . . 74.310000000000002 109.326 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 1.1 m -60.75 -46.8 89.07 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.482 1.114 . . . . 74.409999999999997 110.413 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -58.12 -21.94 48.68 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.482 1.114 . . . . 71.239999999999995 109.308 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' TRP . . . . . 0.608 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 8.9 t-105 -84.77 -64.88 1.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.523 1.139 . . . . 75.099999999999994 108.006 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.485 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.6 mm-40 -52.77 -16.99 1.13 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.472 1.107 . . . . 74.120000000000005 110.319 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 401' ' ' GLN . 5.8 mm-40 -37.09 -63.42 0.43 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.492 1.12 . . . . 73.140000000000001 110.303 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 2.8 m -120.61 -24.51 5.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.496 1.122 . . . . 74.239999999999995 109.995 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . 0.608 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 16.6 m-20 -82.09 -94.51 0.05 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.114 . . . . 70.129999999999995 109.282 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.485 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 70.5 29.96 69.38 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.488 1.117 . . . . 74.209999999999994 110.981 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -91.71 68.0 5.48 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.567 0.804 . . . . 75.439999999999998 110.279 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 66.0 -166.46 36.55 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.471 1.107 . . . . 72.420000000000002 110.976 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . 0.408 ' O ' ' N ' ' A' ' 412' ' ' ARG . 6.5 t -57.31 128.9 79.37 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 108.324 -0.991 . . . . 65.540000000000006 108.324 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 0.3 9.07 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.511 1.795 . . . . 72.030000000000001 110.958 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . 0.543 ' CE1' ' HE3' ' A' ' 392' ' ' MET . 3.2 m-85 -97.91 -41.54 7.96 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.505 1.128 . . . . 74.340000000000003 111.019 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' CYS . . . . . 0.444 ' SG ' ' CE1' ' A' ' 390' ' ' HIS . 0.1 OUTLIER -111.32 8.98 21.58 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.522 1.138 . . . . 61.039999999999999 108.284 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 408' ' ' CYS . 8.0 tpp85 38.49 30.28 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.546 1.154 . . . . 72.230000000000004 110.294 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' CYS . . . . . 0.444 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.3 m -123.09 164.85 17.83 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.501 1.126 . . . . 74.299999999999997 108.265 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -63.07 145.08 56.23 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.494 1.121 . . . . 71.120000000000005 110.281 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.523 ' CG2' ' CG2' ' A' ' 418' ' ' THR . 1.6 mt -94.92 147.01 6.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.522 1.139 . . . . 74.409999999999997 109.304 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -117.26 -43.78 2.82 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.489 1.118 . . . . 75.120000000000005 109.305 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -119.21 130.0 8.34 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.452 1.095 . . . . 75.329999999999998 110.976 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' THR . . . . . 0.523 ' CG2' ' CG2' ' A' ' 415' ' ' ILE . 80.6 p -152.69 138.86 18.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.477 0.751 . . . . 73.150000000000006 110.359 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -171.86 151.12 2.69 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.458 1.099 . . . . 74.049999999999997 110.275 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.08 101.66 1.5 Allowed 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.518 1.799 . . . . 63.0 110.981 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -104.18 159.42 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.444 1.09 . . . . 73.150000000000006 109.289 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . 0.542 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 8.1 mt -111.47 105.51 18.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.488 1.118 . . . . 72.329999999999998 109.27 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.464 HG13 ' CE2' ' A' ' 370' ' ' PHE . 39.5 t -76.97 146.78 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.509 1.131 . . . . 75.310000000000002 109.322 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -129.49 143.87 50.63 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.478 1.111 . . . . 64.519999999999996 109.34 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.96 174.05 13.45 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.492 1.785 . . . . 72.099999999999994 110.993 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . 0.525 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 4.8 t80 . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.118 . . . . 74.400000000000006 111.058 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 67.0 m . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 109.966 -0.383 . . . . 75.510000000000005 109.966 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -94.22 -174.75 3.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.488 1.117 . . . . 72.239999999999995 109.28 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . 0.567 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 28.9 m-70 -140.15 141.55 36.04 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.551 1.157 . . . . 74.349999999999994 109.578 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' A' ' 354' ' ' LYS . 3.7 mm -128.2 158.46 40.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.445 1.091 . . . . 72.25 109.293 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . 0.404 ' N ' ' CG2' ' A' ' 353' ' ' ILE . 0.0 OUTLIER -117.91 153.66 33.21 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.498 1.124 . . . . 74.019999999999996 109.304 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . 0.437 HG22 ' CG ' ' A' ' 370' ' ' PHE . 14.3 t -105.44 149.12 9.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.115 . . . . 75.200000000000003 109.272 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 19.8 p -117.2 176.9 4.93 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.485 1.116 . . . . 72.349999999999994 110.395 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -74.49 -33.85 62.94 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.497 1.123 . . . . 73.219999999999999 110.292 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . 0.41 ' CG ' ' N ' ' A' ' 359' ' ' GLN . 15.3 pt-20 -57.98 -47.64 82.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.474 1.109 . . . . 75.219999999999999 110.305 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . 0.41 ' N ' ' CG ' ' A' ' 358' ' ' GLU . 29.1 mm-40 -60.9 -66.65 0.5 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 74.140000000000001 110.297 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . 0.41 ' O ' ' N ' ' A' ' 364' ' ' CYS . 4.9 t80 -44.02 -42.9 6.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 75.109999999999999 110.995 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -65.71 -42.38 91.19 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.453 1.096 . . . . 75.129999999999995 110.263 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.7 tp . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.47 1.106 . . . . 71.319999999999993 109.338 -179.988 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . 0.41 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.7 m . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 108.302 -0.999 . . . . 71.25 108.302 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -75.47 -29.28 59.55 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.525 1.141 . . . . 62.200000000000003 110.305 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' MET . . . . . 0.405 ' SD ' ' N ' ' A' ' 366' ' ' MET . 0.0 OUTLIER -113.49 21.02 15.55 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.514 1.134 . . . . 72.019999999999996 110.979 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 37.78 47.71 1.8 Allowed Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.448 1.093 . . . . 75.140000000000001 110.987 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 31.6 m -121.42 152.84 38.61 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.504 0.767 . . . . 71.329999999999998 109.989 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 2.2 m -98.51 159.77 14.72 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 73.099999999999994 110.369 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.437 ' CG ' HG22 ' A' ' 355' ' ' VAL . 5.9 t80 -66.34 -65.66 0.65 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.483 1.114 . . . . 74.530000000000001 110.981 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.34 -32.8 50.85 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.128 . . . . 64.439999999999998 110.322 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . 0.424 HD21 ' N ' ' A' ' 373' ' ' CYS . 0.7 OUTLIER -58.67 135.87 57.52 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.507 1.129 . . . . 65.129999999999995 109.278 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . 0.424 ' N ' HD21 ' A' ' 372' ' ' LEU . 16.4 t -76.68 135.91 39.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.965 -1.016 . . . . 74.430000000000007 110.896 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 374' ' ' LYS . 0.6 OUTLIER -92.94 22.17 5.13 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.506 1.129 . . . . 73.450000000000003 109.317 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 5.0 mt -110.68 -52.18 6.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.524 1.14 . . . . 74.340000000000003 109.33 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' CYS . . . . . 1.171 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 7.5 m -102.75 -27.04 12.93 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.485 1.116 . . . . 65.150000000000006 108.313 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 55.52 29.05 12.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.464 1.103 . . . . 72.099999999999994 109.327 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -122.45 -40.86 2.43 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.468 1.105 . . . . 74.450000000000003 110.31 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -119.06 -179.94 3.98 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.463 1.102 . . . . 71.329999999999998 109.348 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -89.55 171.76 9.46 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.52 1.137 . . . . 73.120000000000005 109.327 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.449 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 11.6 mttt -79.14 -62.49 1.68 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 74.420000000000002 109.284 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 15.7 t0 62.4 22.2 13.07 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.464 1.102 . . . . 74.150000000000006 109.324 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . 0.4 ' CG1' ' HG2' ' A' ' 392' ' ' MET . 0.5 OUTLIER -158.25 172.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.488 1.117 . . . . 71.5 109.298 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . 0.404 ' CE ' ' HA2' ' A' ' 389' ' ' GLY . 76.4 tttt -156.74 159.5 38.39 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.464 1.102 . . . . 74.239999999999995 109.312 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.474 ' CG2' ' SG ' ' A' ' 388' ' ' CYS . 18.1 mm -117.21 139.92 42.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.522 1.138 . . . . 75.239999999999995 109.298 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.519 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.9 mt-10 -130.61 162.26 55.93 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.446 1.091 . . . . 70.219999999999999 110.271 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.519 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.4 Cg_endo -74.93 -14.72 22.76 Favored 'Cis proline' 0 C--N 1.36 1.157 0 C-N-CA 121.034 -2.486 . . . . 73.439999999999998 110.986 -0.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . 0.474 ' SG ' ' CG2' ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.82 -87.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.047 -0.979 . . . . 71.049999999999997 110.915 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 130.91 42.9 0.19 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.467 1.104 . . . . 61.310000000000002 111.027 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.414 ' O ' ' N ' ' A' ' 385' ' ' ILE . 27.8 m170 -97.45 131.49 44.04 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.49 0.759 . . . . 73.439999999999998 109.643 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.449 ' HB2' ' CE ' ' A' ' 381' ' ' LYS . 0.0 OUTLIER -100.21 151.83 20.99 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.462 1.102 . . . . 70.25 109.309 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' MET . . . . . 0.4 ' HG2' ' CG1' ' A' ' 383' ' ' VAL . 16.8 ptp -167.61 170.74 10.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.536 1.147 . . . . 75.219999999999999 110.933 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . 1.208 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 26.1 p -97.14 115.28 27.25 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.452 1.095 . . . . 74.209999999999994 108.334 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 24.3 m -39.71 -58.69 1.28 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.552 1.157 . . . . 73.409999999999997 110.389 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.4 t -42.64 -43.61 3.91 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.513 1.133 . . . . 54.030000000000001 110.004 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . 1.208 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 3.6 m -67.52 -55.2 14.44 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.474 1.109 . . . . 75.530000000000001 108.293 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . 0.463 ' C ' ' CD1' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -44.15 -36.26 2.55 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.476 1.11 . . . . 73.310000000000002 109.308 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 17.5 m -61.35 -46.06 91.79 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 71.5 110.436 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -56.89 -22.6 38.46 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.458 1.098 . . . . 75.040000000000006 109.302 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' TRP . . . . . 0.605 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 9.1 t-105 -85.56 -64.77 1.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.982 -1.118 . . . . 74.239999999999995 107.982 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.489 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 10.1 mm-40 -52.94 -16.88 1.16 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 73.120000000000005 110.316 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 401' ' ' GLN . 5.1 mt-10 -37.16 -63.29 0.44 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.489 1.118 . . . . 73.230000000000004 110.323 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 5.4 t -120.51 -24.46 5.81 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.443 1.089 . . . . 55.439999999999998 109.986 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . 0.605 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 4.6 m-20 -82.62 -95.08 0.05 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.478 1.111 . . . . 65.340000000000003 109.288 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.489 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 70.57 32.45 67.6 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.57 1.169 . . . . 62.520000000000003 110.992 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -92.02 66.94 5.06 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 0.773 . . . . 74.310000000000002 110.344 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 66.19 -161.89 44.1 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.532 1.145 . . . . 64.549999999999997 111.05 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . 0.403 ' O ' ' N ' ' A' ' 412' ' ' ARG . 5.5 t -60.21 126.25 83.58 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 108.332 -0.988 . . . . 74.120000000000005 108.332 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.06 -1.56 11.39 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.518 1.799 . . . . 65.040000000000006 110.998 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -94.9 -42.19 8.8 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 1.136 . . . . 65.319999999999993 111.001 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' CYS . . . . . 0.445 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.2 OUTLIER -111.79 10.45 20.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.135 . . . . 71.150000000000006 108.265 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 408' ' ' CYS . 4.8 tpt180 38.48 30.35 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.534 1.146 . . . . 75.340000000000003 110.316 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' CYS . . . . . 0.445 ' N ' ' O ' ' A' ' 411' ' ' CYS . 16.0 t -125.3 145.65 49.92 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.487 1.117 . . . . 74.530000000000001 108.311 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -46.59 152.67 0.44 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.552 1.158 . . . . 73.319999999999993 110.292 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.526 ' CG2' ' CG2' ' A' ' 418' ' ' THR . 2.1 mt -100.54 153.11 4.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.463 1.102 . . . . 72.329999999999998 109.323 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . 0.468 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 5.1 mmtt -113.98 -46.24 3.02 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 75.239999999999995 109.273 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -121.5 129.66 7.81 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.466 1.103 . . . . 74.140000000000001 111.03 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' THR . . . . . 0.526 ' CG2' ' CG2' ' A' ' 415' ' ' ILE . 82.8 p -152.96 136.17 15.7 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.473 0.749 . . . . 74.109999999999999 110.378 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 13.4 pm0 -168.1 150.54 5.27 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.534 1.146 . . . . 74.430000000000007 110.327 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.4 Cg_endo -74.95 102.11 1.55 Allowed 'Trans proline' 0 C--N 1.359 1.11 0 O-C-N 124.514 1.797 . . . . 74.25 111.052 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . 0.456 HD13 ' CG2' ' A' ' 423' ' ' VAL . 0.7 OUTLIER -103.9 156.4 5.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.475 1.11 . . . . 70.200000000000003 109.308 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . 0.567 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 14.2 mt -110.39 105.9 19.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.501 1.125 . . . . 74.329999999999998 109.293 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.456 ' CG2' HD13 ' A' ' 421' ' ' ILE . 18.7 t -77.79 146.74 7.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.493 1.12 . . . . 74.340000000000003 109.302 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -129.2 143.55 49.28 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.504 1.127 . . . . 64.129999999999995 109.299 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 174.03 13.5 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.529 1.805 . . . . 64.030000000000001 111.018 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . 0.483 ' C ' ' CD1' ' A' ' 426' ' ' PHE . 2.8 t80 . . . . . 0 C--N 1.325 -0.491 0 O-C-N 124.482 1.114 . . . . 73.530000000000001 111.01 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 109.993 -0.373 . . . . 73.299999999999997 109.993 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -91.28 -178.09 5.04 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.539 1.149 . . . . 74.010000000000005 109.297 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . 0.534 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 25.9 m-70 -138.95 140.87 38.41 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.53 1.143 . . . . 72.010000000000005 109.608 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 35.8 mt -130.16 136.02 59.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.125 . . . . 74.409999999999997 109.311 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -103.37 129.93 50.56 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.471 1.107 . . . . 74.140000000000001 109.319 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 424' ' ' ASP . 12.7 t -77.56 157.62 5.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 75.099999999999994 109.328 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.5 p -122.25 148.81 44.54 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.505 1.128 . . . . 63.25 110.398 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' GLN . . . . . 0.618 ' CG ' ' CE2' ' A' ' 426' ' ' PHE . 3.1 mt-30 -47.52 -38.44 14.06 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.133 . . . . 72.010000000000005 110.29 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -58.28 -37.1 74.32 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.511 1.132 . . . . 71.019999999999996 110.296 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -74.56 -66.74 0.7 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.52 1.138 . . . . 62.240000000000002 110.292 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . 0.42 ' O ' ' N ' ' A' ' 364' ' ' CYS . 7.0 t80 -40.98 -62.07 0.88 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.553 1.158 . . . . 75.510000000000005 111.056 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -48.84 -48.83 41.47 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.535 1.147 . . . . 73.409999999999997 110.303 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 9.9 tt . . . . . 0 C--N 1.325 -0.468 0 O-C-N 124.493 1.121 . . . . 72.219999999999999 109.313 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . 0.42 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 108.318 -0.993 . . . . 74.540000000000006 108.318 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -77.23 -8.24 57.25 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.493 1.121 . . . . 63.130000000000003 110.342 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 8.0 mmt -102.61 -29.93 11.25 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.528 1.143 . . . . 74.099999999999994 111.003 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 89.93 30.01 14.04 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.498 1.124 . . . . 71.439999999999998 110.997 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 1.1 p -144.66 -175.01 4.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.469 0.746 . . . . 71.319999999999993 109.991 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' THR . . . . . 0.416 ' O ' ' CE ' ' A' ' 374' ' ' LYS . 11.7 p -118.79 167.32 11.81 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.452 1.095 . . . . 72.299999999999997 110.395 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.553 ' CD2' HG11 ' A' ' 423' ' ' VAL . 38.2 t80 -71.2 -65.37 0.75 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 74.430000000000007 110.999 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' GLN . . . . . 0.528 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.3 OUTLIER -43.67 -27.2 0.29 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 72.140000000000001 110.335 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . 0.417 HD23 ' N ' ' A' ' 373' ' ' CYS . 0.5 OUTLIER -74.16 136.08 42.86 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.472 1.108 . . . . 71.010000000000005 109.309 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . 0.417 ' N ' HD23 ' A' ' 372' ' ' LEU . 32.1 p -68.48 130.75 43.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.008 -0.996 . . . . 71.549999999999997 110.878 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.416 ' CE ' ' O ' ' A' ' 369' ' ' THR . 28.8 mmtp -92.97 31.46 1.41 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.488 1.118 . . . . 75.209999999999994 109.337 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 18.8 mt -112.31 -59.74 3.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.509 1.13 . . . . 74.150000000000006 109.276 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 4.0 m -107.41 -22.01 12.72 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.471 1.107 . . . . 75.230000000000004 108.312 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 54.76 40.3 31.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.511 1.132 . . . . 65.439999999999998 109.335 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -121.51 -40.28 2.58 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.499 1.125 . . . . 75.140000000000001 110.322 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -124.03 179.18 4.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.527 1.142 . . . . 71.299999999999997 109.278 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -89.45 165.84 14.07 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.557 1.161 . . . . 72.5 109.307 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.466 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 17.2 mttt -66.49 -62.63 1.36 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.561 1.163 . . . . 75.219999999999999 109.28 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 33.9 t0 59.91 22.71 11.74 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.51 1.131 . . . . 71.400000000000006 109.301 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . 0.462 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -156.75 174.62 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.524 1.14 . . . . 73.340000000000003 109.29 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . 0.405 ' CG ' ' N ' ' A' ' 385' ' ' ILE . 47.1 tttt -158.44 158.48 34.23 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.442 1.089 . . . . 74.349999999999994 109.311 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.446 ' CG2' ' SG ' ' A' ' 388' ' ' CYS . 14.8 mm -118.32 144.75 25.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.521 1.138 . . . . 74.030000000000001 109.268 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.517 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.0 mt-10 -136.86 162.35 56.36 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.435 1.084 . . . . 74.030000000000001 110.291 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.517 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.04 -13.69 23.59 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 121.023 -2.491 . . . . 75.319999999999993 111.02 0.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . 0.45 ' HB2' ' CE1' ' A' ' 390' ' ' HIS . 0.8 OUTLIER -36.8 -84.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.953 -1.021 . . . . 72.239999999999995 110.892 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 128.36 41.99 0.26 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.507 1.129 . . . . 73.549999999999997 110.964 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.521 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 27.2 m80 -97.55 137.9 35.78 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.526 0.78 . . . . 73.329999999999998 109.56 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.466 ' HB2' ' CE ' ' A' ' 381' ' ' LYS . 0.0 OUTLIER -106.64 150.82 25.83 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.501 1.126 . . . . 62.020000000000003 109.286 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' MET . . . . . 0.509 ' HE1' ' CE1' ' A' ' 410' ' ' PHE . 16.3 ptp -167.48 166.33 14.33 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.467 1.104 . . . . 73.140000000000001 111.011 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . 1.169 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 8.8 p -90.9 124.54 35.27 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 1.128 . . . . 61.5 108.254 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 10.6 m -47.93 -56.85 6.64 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.5 1.125 . . . . 72.5 110.39 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 4.1 m -44.94 -27.15 0.5 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.521 1.138 . . . . 72.549999999999997 110.019 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . 1.169 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 1.9 m -83.26 -51.61 7.3 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.495 1.122 . . . . 72.349999999999994 108.346 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -40.97 -52.25 3.14 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.532 1.145 . . . . 75.549999999999997 109.292 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 402' ' ' GLU . 2.7 m -53.04 -43.11 66.36 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.525 1.141 . . . . 71.219999999999999 110.416 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -57.19 -26.13 60.14 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.538 1.149 . . . . 75.010000000000005 109.329 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' TRP . . . . . 0.596 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 10.3 t-105 -85.62 -62.52 1.51 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.998 -1.112 . . . . 72.420000000000002 107.998 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.489 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.4 mm-40 -56.13 -14.15 2.5 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.514 1.134 . . . . 64.140000000000001 110.342 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 398' ' ' THR . 3.0 mm-40 -37.12 -63.39 0.43 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.488 1.118 . . . . 75.319999999999993 110.292 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.4 t -121.3 -24.61 5.42 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.543 1.152 . . . . 75.219999999999999 109.978 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . 0.596 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 15.0 m-20 -82.63 -94.28 0.06 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.458 1.098 . . . . 75.209999999999994 109.334 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.489 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 72.56 30.23 64.59 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.516 1.135 . . . . 63.509999999999998 111.002 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . 0.687 HE21 ' NH2' ' A' ' 412' ' ' ARG . 0.6 OUTLIER -91.36 71.37 6.09 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.508 0.769 . . . . 74.400000000000006 110.322 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 61.74 -167.81 14.58 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.547 1.154 . . . . 72.219999999999999 111.011 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 5.7 t -56.26 125.99 66.77 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 108.29 -1.004 . . . . 75.25 108.29 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.94 0.17 9.2 Favored 'Trans proline' 0 C--N 1.359 1.104 0 O-C-N 124.521 1.801 . . . . 74.519999999999996 111.003 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . 0.521 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 3.6 m-85 -94.67 -55.78 3.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.107 . . . . 73.450000000000003 111.027 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' CYS . . . . . 0.436 ' O ' ' N ' ' A' ' 413' ' ' CYS . 2.4 p -98.95 12.86 34.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 64.030000000000001 108.293 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' ARG . . . . . 0.687 ' NH2' HE21 ' A' ' 406' ' ' GLN . 14.2 mmm-85 38.55 30.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.476 1.11 . . . . 64.530000000000001 110.288 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.3 m -119.76 163.22 17.79 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.53 1.144 . . . . 75.209999999999994 108.332 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.31 154.8 34.15 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.525 1.141 . . . . 74.409999999999997 110.293 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.506 ' CG2' ' CG2' ' A' ' 418' ' ' THR . 1.9 mt -104.61 143.49 16.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.438 1.087 . . . . 65.349999999999994 109.279 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . 0.451 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 3.5 mmtp -109.85 -46.37 3.5 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.559 1.162 . . . . 73.129999999999995 109.321 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . 0.422 ' O ' ' CG2' ' A' ' 418' ' ' THR . . . -124.36 139.66 12.05 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.541 1.151 . . . . 73.120000000000005 110.994 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' THR . . . . . 0.506 ' CG2' ' CG2' ' A' ' 415' ' ' ILE . 72.3 p -153.92 126.43 8.07 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.517 0.775 . . . . 71.010000000000005 110.359 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.21 151.12 23.65 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.489 1.118 . . . . 73.129999999999995 110.332 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.96 102.11 1.55 Allowed 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.514 1.797 . . . . 73.109999999999999 111.037 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . 0.416 ' CD1' HG21 ' A' ' 423' ' ' VAL . 0.7 OUTLIER -103.87 155.03 5.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.131 . . . . 71.340000000000003 109.29 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . 0.534 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 19.4 mt -109.37 105.99 19.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.567 1.167 . . . . 75.450000000000003 109.307 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.553 HG11 ' CD2' ' A' ' 370' ' ' PHE . 17.1 t -76.23 146.94 8.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.434 1.084 . . . . 74.340000000000003 109.265 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.488 ' O ' ' CG2' ' A' ' 355' ' ' VAL . 1.8 t70 -128.68 143.5 48.7 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.523 1.139 . . . . 73.109999999999999 109.352 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 176.19 10.22 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.481 1.779 . . . . 63.299999999999997 111.053 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . 0.618 ' CE2' ' CG ' ' A' ' 357' ' ' GLN . 5.9 t80 . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.542 1.151 . . . . 74.510000000000005 111.042 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 110.043 -0.355 . . . . 74.420000000000002 110.043 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -87.89 -175.07 4.99 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.514 1.134 . . . . 73.510000000000005 109.28 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . 0.547 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 39.0 m-70 -142.05 146.93 36.04 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.517 1.136 . . . . 73.129999999999995 109.627 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 58.4 mt -130.83 158.63 43.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.484 1.115 . . . . 75.239999999999995 109.247 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -128.36 134.03 48.77 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.547 1.154 . . . . 74.510000000000005 109.3 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . 0.475 HG21 ' CD2' ' A' ' 370' ' ' PHE . 43.8 t -95.28 164.29 2.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.487 1.117 . . . . 74.239999999999995 109.274 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' THR . . . . . 0.468 ' N ' ' CG1' ' A' ' 355' ' ' VAL . 71.2 p -125.69 157.39 37.45 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.542 1.151 . . . . 74.450000000000003 110.406 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' GLN . . . . . 0.597 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 7.1 mt-30 -53.9 -46.29 71.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.469 1.105 . . . . 72.329999999999998 110.275 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -44.04 -30.46 0.74 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.504 1.127 . . . . 75.099999999999994 110.339 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . 0.529 ' OE1' ' CD1' ' A' ' 370' ' ' PHE . 58.8 mt-30 -83.58 -66.86 0.84 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.471 1.107 . . . . 64.409999999999997 110.287 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 364' ' ' CYS . 3.9 t80 -38.15 -38.56 0.34 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.499 1.124 . . . . 64.329999999999998 110.999 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -63.71 -52.36 60.86 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.431 1.082 . . . . 74.340000000000003 110.292 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 2.1 tp . . . . . 0 C--N 1.326 -0.447 0 O-C-N 124.442 1.089 . . . . 71.140000000000001 109.287 -179.953 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 108.317 -0.994 . . . . 74.420000000000002 108.317 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -75.14 -51.95 12.16 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.461 1.101 . . . . 74.519999999999996 110.306 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 24.3 ptp -68.06 -15.14 63.47 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.506 1.128 . . . . 75.230000000000004 111.0 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 75.04 34.65 51.88 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.482 1.114 . . . . 54.219999999999999 111.012 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.1 -178.03 4.91 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 0.759 . . . . 72.530000000000001 110.026 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' THR . . . . . 0.461 ' CG2' ' NE2' ' A' ' 371' ' ' GLN . 2.0 m -117.35 161.22 19.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.132 . . . . 72.049999999999997 110.424 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.529 ' CD1' ' OE1' ' A' ' 359' ' ' GLN . 67.2 t80 -62.51 -69.39 0.26 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.51 1.131 . . . . 74.430000000000007 110.954 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' GLN . . . . . 0.461 ' NE2' ' CG2' ' A' ' 369' ' ' THR . 0.2 OUTLIER -44.95 -25.9 0.36 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.533 1.146 . . . . 73.310000000000002 110.295 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.26 132.32 52.32 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.479 1.112 . . . . 72.299999999999997 109.263 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 5.1 t -68.32 124.43 23.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.954 -1.021 . . . . 73.109999999999999 110.893 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.423 ' N ' ' HD2' ' A' ' 374' ' ' LYS . 1.4 mmmm -90.88 18.46 6.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.517 1.136 . . . . 74.030000000000001 109.294 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . 0.544 HD12 ' CE2' ' A' ' 410' ' ' PHE . 64.2 mt -109.81 -25.7 3.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.524 1.14 . . . . 73.200000000000003 109.283 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' CYS . . . . . 0.848 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 5.8 p -132.28 -48.66 0.92 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.131 . . . . 72.230000000000004 108.31 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 73.79 44.54 0.27 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.459 1.1 . . . . 75.200000000000003 109.318 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -123.68 -42.27 2.21 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.497 1.123 . . . . 75.140000000000001 110.297 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -133.82 176.83 8.21 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.509 1.131 . . . . 74.5 109.316 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -84.96 149.53 25.56 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.499 1.124 . . . . 75.329999999999998 109.264 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.401 ' CA ' ' O ' ' A' ' 392' ' ' MET . 22.1 mttt -51.83 -55.9 17.22 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.455 1.097 . . . . 72.019999999999996 109.313 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 1.1 p30 52.28 25.45 3.4 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.511 1.132 . . . . 72.140000000000001 109.301 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . 0.465 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -153.92 176.09 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.475 1.109 . . . . 71.219999999999999 109.343 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -158.46 148.26 19.63 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.498 1.124 . . . . 74.200000000000003 109.347 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.464 ' O ' ' N ' ' A' ' 389' ' ' GLY . 16.8 mm -112.16 141.25 28.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.53 1.144 . . . . 73.319999999999993 109.283 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.503 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.2 mt-10 -138.14 161.34 60.02 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.498 1.124 . . . . 73.5 110.331 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.503 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.99 -9.76 24.02 Favored 'Cis proline' 0 C--N 1.36 1.144 0 C-N-CA 121.006 -2.498 . . . . 74.019999999999996 111.031 0.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . 0.446 ' SG ' ' ND1' ' A' ' 390' ' ' HIS . 4.2 t -36.68 -72.96 0.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.965 -1.016 . . . . 73.349999999999994 110.936 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.34 15.72 6.94 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.47 1.106 . . . . 73.319999999999993 111.018 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.446 ' ND1' ' SG ' ' A' ' 388' ' ' CYS . 16.6 m170 -82.08 135.94 35.26 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 0.767 . . . . 73.439999999999998 109.627 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.416 ' CD2' ' N ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -102.63 160.1 14.87 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.537 1.148 . . . . 73.109999999999999 109.327 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' MET . . . . . 0.465 ' O ' ' CG1' ' A' ' 383' ' ' VAL . 15.2 ptp -173.07 175.31 3.25 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 1.131 . . . . 74.140000000000001 111.016 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . 1.112 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 20.0 p -96.94 114.92 26.58 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.55 1.156 . . . . 62.130000000000003 108.307 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 28.6 m -38.85 -59.8 0.92 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.49 1.119 . . . . 74.140000000000001 110.4 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.3 p -43.27 -42.46 4.41 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.509 1.13 . . . . 62.009999999999998 109.976 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . 1.112 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 2.8 m -67.8 -51.39 49.37 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.456 1.098 . . . . 73.140000000000001 108.312 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . 0.423 ' C ' ' CD1' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -45.67 -46.51 14.74 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.5 1.125 . . . . 74.030000000000001 109.319 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 1.1 m -56.67 -35.55 68.54 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 74.239999999999995 110.434 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -69.08 -21.13 64.08 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.522 1.139 . . . . 73.140000000000001 109.283 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' TRP . . . . . 0.602 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 8.9 t-105 -85.71 -61.29 1.79 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.506 1.129 . . . . 72.439999999999998 108.025 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.49 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 8.6 mm-40 -56.2 -14.24 2.63 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.121 . . . . 74.340000000000003 110.34 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 401' ' ' GLN . 1.0 OUTLIER -37.14 -63.36 0.44 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.513 1.133 . . . . 74.230000000000004 110.277 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.5 m -121.08 -24.57 5.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.102 . . . . 75.430000000000007 109.959 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . 0.602 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 3.1 m-20 -83.21 -95.09 0.06 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 70.510000000000005 109.341 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.49 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 73.96 27.6 66.32 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.548 1.155 . . . . 61.32 111.001 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -89.37 67.83 7.82 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.497 0.763 . . . . 75.310000000000002 110.279 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 61.86 -163.25 24.9 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.546 1.154 . . . . 71.25 110.989 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 4.9 t -56.23 127.6 70.98 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 108.325 -0.991 . . . . 54.229999999999997 108.325 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 0.3 9.06 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.452 1.764 . . . . 72.219999999999999 111.014 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . 0.544 ' CE2' HD12 ' A' ' 375' ' ' ILE . 9.1 m-85 -93.37 -48.15 6.55 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.56 1.162 . . . . 71.209999999999994 111.016 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' CYS . . . . . 0.44 ' O ' ' N ' ' A' ' 413' ' ' CYS . 1.1 p -109.35 13.06 24.4 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.535 1.147 . . . . 74.510000000000005 108.312 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 38.48 30.46 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.471 1.107 . . . . 74.109999999999999 110.282 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' CYS . . . . . 0.44 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.6 m -113.31 155.06 25.82 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.587 1.179 . . . . 73.549999999999997 108.296 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -59.25 158.95 8.3 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.451 1.094 . . . . 63.119999999999997 110.307 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.468 HG23 ' CG2' ' A' ' 418' ' ' THR . 7.2 mt -114.31 156.86 15.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.518 1.136 . . . . 74.420000000000002 109.329 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . 0.428 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 20.3 mmtt -125.63 -46.72 1.72 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 74.349999999999994 109.305 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . 0.497 ' O ' ' CG2' ' A' ' 418' ' ' THR . . . -111.28 133.56 11.59 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.494 1.122 . . . . 72.519999999999996 111.008 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' THR . . . . . 0.497 ' CG2' ' O ' ' A' ' 417' ' ' GLY . 23.4 p -157.06 116.21 3.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.513 0.772 . . . . 74.450000000000003 110.386 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.65 151.42 42.7 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.501 1.125 . . . . 74.400000000000006 110.325 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 101.79 1.51 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.56 1.821 . . . . 74.219999999999999 111.047 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -103.89 158.67 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.484 1.115 . . . . 74.340000000000003 109.248 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . 0.547 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 11.4 mt -112.29 107.16 22.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.532 1.145 . . . . 70.0 109.277 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . . . . . . . . . 20.5 t -75.39 149.6 6.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.472 1.107 . . . . 73.25 109.293 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -126.73 132.95 24.53 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.498 1.124 . . . . 73.340000000000003 109.336 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 163.03 36.21 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.543 1.812 . . . . 71.120000000000005 111.039 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . 0.597 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 1.1 t80 . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.485 1.116 . . . . 72.340000000000003 111.037 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' SER . . . . . 0.459 ' HB3' ' CD1' ' A' ' 422' ' ' ILE . 60.7 m . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 110.026 -0.361 . . . . 73.530000000000001 110.026 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -90.68 172.75 8.45 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.533 1.146 . . . . 71.430000000000007 109.309 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . 0.522 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 27.3 m-70 -132.99 130.93 40.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 1.14 . . . . 73.420000000000002 109.653 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . 0.414 HD11 ' CD1' ' A' ' 421' ' ' ILE . 61.9 mt -119.0 150.71 21.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 74.019999999999996 109.29 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.29 139.12 50.72 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.569 1.168 . . . . 72.25 109.285 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . 0.492 ' CG2' ' O ' ' A' ' 424' ' ' ASP . 21.9 t -87.74 122.59 39.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.504 1.127 . . . . 70.310000000000002 109.281 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.7 p -84.52 140.97 31.08 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.532 1.145 . . . . 75.439999999999998 110.391 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' GLN . . . . . 0.456 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 7.1 mt-30 -41.06 -33.66 0.35 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.537 1.148 . . . . 72.540000000000006 110.304 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -56.55 -49.1 75.82 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.531 1.144 . . . . 74.200000000000003 110.306 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -60.24 -66.76 0.47 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 74.329999999999998 110.325 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . 0.442 ' O ' ' N ' ' A' ' 364' ' ' CYS . 5.7 t80 -38.89 -41.36 0.74 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.481 1.113 . . . . 74.349999999999994 110.985 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -63.63 -54.03 42.22 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.5 1.125 . . . . 75.099999999999994 110.301 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.6 tp . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.485 1.116 . . . . 62.539999999999999 109.329 179.97 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . 0.442 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.9 m . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 108.304 -0.999 . . . . 74.540000000000006 108.304 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -65.38 -15.21 62.35 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.485 1.116 . . . . 75.430000000000007 110.269 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 2.5 ptp -126.0 2.07 7.28 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.54 1.15 . . . . 74.540000000000006 110.979 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 49.96 48.38 38.3 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.492 1.12 . . . . 73.439999999999998 111.034 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 6.5 t -115.88 177.99 4.48 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.45 0.735 . . . . 73.239999999999995 110.003 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 2.2 p -124.37 135.21 53.14 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.539 1.149 . . . . 74.420000000000002 110.373 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.542 ' CD2' HG11 ' A' ' 423' ' ' VAL . 32.5 t80 -64.1 -66.08 0.59 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.126 . . . . 65.129999999999995 110.997 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' GLN . . . . . 0.573 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.3 OUTLIER -43.08 -27.16 0.19 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.499 1.124 . . . . 75.239999999999995 110.345 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . 0.437 ' CD2' ' N ' ' A' ' 373' ' ' CYS . 0.4 OUTLIER -73.18 135.91 44.68 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.539 1.149 . . . . 72.329999999999998 109.281 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . 0.437 ' N ' ' CD2' ' A' ' 372' ' ' LEU . 31.6 p -64.13 128.53 36.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.025 -0.989 . . . . 64.349999999999994 110.908 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -93.07 29.26 1.9 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.491 1.119 . . . . 73.25 109.279 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 35.4 mt -108.29 -60.5 2.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.539 1.149 . . . . 73.239999999999995 109.276 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 14.3 p -107.93 -22.36 12.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 72.310000000000002 108.278 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 58.79 46.97 13.35 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.463 1.102 . . . . 75.329999999999998 109.306 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -131.64 -44.77 0.98 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.453 1.096 . . . . 63.420000000000002 110.275 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -113.24 -179.98 3.8 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.492 1.12 . . . . 72.420000000000002 109.283 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -94.63 162.73 13.67 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.458 1.099 . . . . 72.510000000000005 109.284 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.44 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 20.3 mttt -65.76 -62.54 1.45 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.461 1.1 . . . . 75.099999999999994 109.324 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 4.1 t70 60.17 20.34 9.67 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.487 1.117 . . . . 64.340000000000003 109.314 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . 0.47 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -149.71 176.09 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.483 1.114 . . . . 74.340000000000003 109.296 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 17.5 tttm -159.13 156.39 28.98 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.478 1.111 . . . . 73.340000000000003 109.27 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.496 ' CG2' ' SG ' ' A' ' 388' ' ' CYS . 11.5 mm -122.67 144.16 33.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.51 1.132 . . . . 75.329999999999998 109.277 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.518 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.0 OUTLIER -137.68 162.34 55.18 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.554 1.159 . . . . 75.109999999999999 110.283 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.518 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.99 -12.46 23.95 Favored 'Cis proline' 0 C--N 1.36 1.153 0 C-N-CA 120.983 -2.507 . . . . 75.129999999999995 110.98 -0.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . 0.541 ' HB2' ' CE1' ' A' ' 390' ' ' HIS . 0.8 OUTLIER -36.34 -71.72 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.011 -0.995 . . . . 74.420000000000002 110.925 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.0 16.86 6.57 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.545 1.153 . . . . 74.109999999999999 110.981 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.564 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 20.0 m80 -74.46 146.41 42.82 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.483 0.755 . . . . 73.150000000000006 109.622 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.55 ' CD2' ' N ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -116.85 158.2 24.35 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.527 1.142 . . . . 65.140000000000001 109.301 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' MET . . . . . 0.563 ' HE2' ' CE1' ' A' ' 410' ' ' PHE . 14.2 ptp -173.45 173.37 3.49 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.507 1.129 . . . . 71.420000000000002 111.032 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 4.7 p -97.33 119.13 35.29 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.489 1.118 . . . . 74.209999999999994 108.309 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 4.5 m -47.05 -41.04 16.09 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.543 1.152 . . . . 74.310000000000002 110.378 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.5 p -55.42 -43.12 75.02 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 73.430000000000007 110.028 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 399' ' ' ALA . 4.9 m -70.17 -44.32 69.02 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.133 . . . . 55.109999999999999 108.32 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . 0.423 ' CD1' ' HG3' ' A' ' 401' ' ' GLN . 1.6 tm? -44.97 -47.84 11.41 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.529 1.143 . . . . 75.319999999999993 109.27 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 3.2 m -55.75 -35.24 65.97 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.464 1.103 . . . . 74.340000000000003 110.388 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -66.93 -23.45 65.97 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.127 . . . . 65.400000000000006 109.271 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' TRP . . . . . 0.414 ' O ' ' HB2' ' A' ' 404' ' ' ASP . 7.7 t-105 -85.91 -58.69 2.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 73.540000000000006 107.985 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.494 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 5.5 mm-40 -62.45 -9.84 9.73 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.564 1.165 . . . . 75.510000000000005 110.314 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 401' ' ' GLN . 1.0 OUTLIER -37.14 -63.9 0.4 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.428 1.08 . . . . 75.200000000000003 110.311 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 6.2 p -121.98 -25.04 5.04 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.505 1.128 . . . . 74.340000000000003 109.987 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 400' ' ' TRP . 3.1 m-20 -82.33 -92.52 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 61.130000000000003 109.289 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.494 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 75.53 32.19 55.17 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.516 1.135 . . . . 73.120000000000005 111.006 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -89.35 75.56 7.68 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.473 0.749 . . . . 73.510000000000005 110.275 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 57.34 -161.58 8.75 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.471 1.107 . . . . 71.329999999999998 110.986 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . 0.406 ' O ' ' N ' ' A' ' 412' ' ' ARG . 6.8 t -58.02 130.03 82.81 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 108.291 -1.003 . . . . 72.420000000000002 108.291 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -0.16 9.63 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.449 1.763 . . . . 72.439999999999998 110.994 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . 0.564 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 3.8 m-85 -97.64 -41.46 8.11 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.492 1.12 . . . . 72.329999999999998 111.004 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' CYS . . . . . 0.442 ' C ' ' N ' ' A' ' 413' ' ' CYS . 0.1 OUTLIER -111.19 8.75 21.73 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.537 1.148 . . . . 74.230000000000004 108.322 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 408' ' ' CYS . 12.7 tpp85 38.44 30.35 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.462 1.101 . . . . 73.510000000000005 110.275 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' CYS . . . . . 0.442 ' N ' ' C ' ' A' ' 411' ' ' CYS . 1.2 m -124.97 160.77 28.18 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.534 1.146 . . . . 74.010000000000005 108.335 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -55.79 149.06 15.29 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.516 1.135 . . . . 75.010000000000005 110.276 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.539 ' CG2' ' CG2' ' A' ' 418' ' ' THR . 1.7 mt -94.06 146.35 6.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.544 1.152 . . . . 75.5 109.28 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.93 -49.11 3.18 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.523 1.139 . . . . 74.019999999999996 109.305 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . 0.419 ' C ' ' CG2' ' A' ' 418' ' ' THR . . . -129.19 139.24 10.82 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.532 1.145 . . . . 63.119999999999997 111.015 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' THR . . . . . 0.539 ' CG2' ' CG2' ' A' ' 415' ' ' ILE . 50.7 p -151.84 141.21 21.52 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.503 0.766 . . . . 74.540000000000006 110.369 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -170.25 149.66 3.28 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.466 1.104 . . . . 73.230000000000004 110.325 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 102.24 1.57 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.505 1.792 . . . . 73.329999999999998 111.013 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . 0.414 ' CD1' HD11 ' A' ' 353' ' ' ILE . 0.9 OUTLIER -103.86 162.76 4.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.559 1.162 . . . . 63.149999999999999 109.315 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . 0.522 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 3.3 mp -113.27 106.41 20.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 71.329999999999998 109.322 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.542 HG11 ' CD2' ' A' ' 370' ' ' PHE . 40.5 t -76.95 144.65 11.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.482 1.114 . . . . 74.319999999999993 109.307 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.492 ' O ' ' CG2' ' A' ' 355' ' ' VAL . 1.1 m-20 -130.72 143.68 50.34 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.501 1.125 . . . . 74.200000000000003 109.323 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 172.46 16.33 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.51 1.795 . . . . 75.0 110.992 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . 0.456 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 7.5 t80 . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.502 1.126 . . . . 73.120000000000005 110.958 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 64.8 m . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 109.944 -0.391 . . . . 43.32 109.944 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.55 176.64 8.49 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.507 1.129 . . . . 71.239999999999995 109.308 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -134.62 137.65 43.85 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.529 1.143 . . . . 72.239999999999995 109.567 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 2.1 mm -117.45 155.54 19.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.511 1.132 . . . . 64.400000000000006 109.276 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.09 137.54 53.5 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.459 1.1 . . . . 73.510000000000005 109.289 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . 0.478 ' CG2' ' O ' ' A' ' 424' ' ' ASP . 23.5 t -96.81 140.23 17.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.521 1.138 . . . . 73.230000000000004 109.254 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 22.0 p -107.31 154.14 21.72 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.54 1.15 . . . . 72.109999999999999 110.404 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' GLN . . . . . 0.557 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 12.4 mt-30 -49.92 -44.21 50.16 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.517 1.136 . . . . 74.409999999999997 110.31 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -45.13 -38.13 4.92 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.455 1.097 . . . . 75.120000000000005 110.283 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -74.22 -59.41 2.74 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.444 1.09 . . . . 75.329999999999998 110.304 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -43.48 -55.46 4.19 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.488 1.117 . . . . 73.409999999999997 111.035 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -55.33 -37.69 67.75 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.539 1.149 . . . . 71.349999999999994 110.325 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.48 1.113 . . . . 70.310000000000002 109.309 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 108.344 -0.984 . . . . 74.409999999999997 108.344 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -71.74 -20.61 61.87 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.486 1.116 . . . . 64.510000000000005 110.326 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -124.06 6.13 8.58 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.443 1.09 . . . . 55.049999999999997 110.993 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 45.27 52.91 8.21 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.47 1.106 . . . . 62.119999999999997 110.985 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 10.6 t -119.91 -174.83 2.84 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.522 0.778 . . . . 74.400000000000006 110.011 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 5.6 p -127.87 133.66 49.35 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.496 1.123 . . . . 74.319999999999993 110.42 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.421 ' CD2' HG22 ' A' ' 355' ' ' VAL . 68.0 t80 -64.33 -63.95 1.01 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.466 1.104 . . . . 65.200000000000003 110.997 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' GLN . . . . . 0.544 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -44.1 -26.85 0.33 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.564 1.165 . . . . 72.109999999999999 110.301 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . 0.431 ' CD1' ' HA ' ' A' ' 377' ' ' ALA . 2.0 tm? -78.81 141.82 37.43 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.496 1.123 . . . . 73.430000000000007 109.279 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . 0.401 ' O ' ' CD1' ' A' ' 372' ' ' LEU . 15.1 t -75.63 150.99 37.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.967 -1.015 . . . . 72.439999999999998 110.89 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -110.9 23.7 13.84 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.534 1.146 . . . . 75.030000000000001 109.282 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 12.0 mt -108.12 -50.81 7.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 75.540000000000006 109.265 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' CYS . . . . . 1.091 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 1.6 m -107.52 -42.55 4.75 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.524 1.14 . . . . 75.549999999999997 108.283 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . 0.431 ' HA ' ' CD1' ' A' ' 372' ' ' LEU . . . 72.09 47.43 0.3 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.533 1.146 . . . . 74.25 109.306 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -132.25 -66.56 0.69 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.517 1.136 . . . . 61.009999999999998 110.321 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -99.49 159.73 14.81 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.495 1.122 . . . . 70.450000000000003 109.304 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -73.14 152.05 41.31 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.506 1.129 . . . . 73.310000000000002 109.274 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.465 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 23.5 mttt -49.88 -62.51 1.52 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.476 1.11 . . . . 71.319999999999993 109.284 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 59.73 24.96 13.9 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.472 1.108 . . . . 75.140000000000001 109.253 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . 0.469 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -156.08 172.83 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.462 1.101 . . . . 72.420000000000002 109.289 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . 0.451 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 48.5 tttp -155.67 136.58 13.61 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.491 1.119 . . . . 71.349999999999994 109.293 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 389' ' ' GLY . 15.2 mm -102.18 137.3 30.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.467 1.104 . . . . 73.239999999999995 109.317 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.482 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.0 OUTLIER -138.02 161.31 60.4 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.5 1.125 . . . . 71.25 110.298 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.482 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.97 -7.17 22.95 Favored 'Cis proline' 0 C--N 1.36 1.136 0 C-N-CA 120.982 -2.508 . . . . 74.120000000000005 111.034 -0.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . 0.54 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 50.7 t -36.8 -73.89 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.967 -1.015 . . . . 64.099999999999994 110.932 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.32 15.52 7.05 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.544 1.152 . . . . 75.549999999999997 110.987 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.54 ' CG ' ' SG ' ' A' ' 388' ' ' CYS . 68.3 m170 -86.7 126.07 34.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.538 0.787 . . . . 74.010000000000005 109.605 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.465 ' HB2' ' CE ' ' A' ' 381' ' ' LYS . 0.0 OUTLIER -96.11 158.83 15.26 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.475 1.109 . . . . 64.530000000000001 109.272 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' MET . . . . . 0.565 ' HE1' ' CE2' ' A' ' 410' ' ' PHE . 20.4 ptp -172.78 175.87 3.27 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 73.239999999999995 110.996 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . 0.818 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 2.3 p -99.64 114.75 28.02 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.478 1.111 . . . . 74.0 108.293 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 29.2 m -46.54 -24.81 0.58 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.492 1.12 . . . . 75.049999999999997 110.448 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.4 p -67.11 -42.49 84.43 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.102 . . . . 72.420000000000002 109.99 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . 1.091 ' SG ' ' SG ' ' A' ' 376' ' ' CYS . 76.1 m -80.74 -49.83 10.66 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.507 1.129 . . . . 64.409999999999997 108.279 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . 0.497 ' CD1' ' SD ' ' A' ' 392' ' ' MET . 2.7 tt -45.62 -48.3 14.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.116 . . . . 73.519999999999996 109.315 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.11 -34.77 61.09 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.533 1.145 . . . . 73.230000000000004 110.398 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -62.83 -27.11 69.1 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.436 1.085 . . . . 74.329999999999998 109.275 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' TRP . . . . . 0.52 ' CD2' ' HB3' ' A' ' 409' ' ' PRO . 3.7 t-105 -79.59 -53.15 7.13 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.518 1.136 . . . . 73.400000000000006 108.019 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.489 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 7.1 mm-40 -62.13 -10.02 9.2 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.49 1.119 . . . . 75.430000000000007 110.318 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 401' ' ' GLN . 5.3 mm-40 -37.08 -63.59 0.42 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.103 . . . . 73.439999999999998 110.293 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 18.2 t -121.54 -24.58 5.32 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.525 1.14 . . . . 73.219999999999999 110.015 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . 0.46 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 3.1 m-20 -83.88 -94.76 0.06 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.492 1.12 . . . . 74.019999999999996 109.281 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.489 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 73.93 32.59 58.65 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.504 1.128 . . . . 52.350000000000001 111.022 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -89.02 63.18 6.6 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.541 0.789 . . . . 75.409999999999997 110.304 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 68.52 -162.59 50.03 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.52 1.138 . . . . 65.219999999999999 110.978 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 3.2 t -56.56 122.86 53.48 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.313 -0.995 . . . . 54.310000000000002 108.313 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.52 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.3 Cg_endo -74.98 -1.87 11.79 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.497 1.788 . . . . 74.340000000000003 111.017 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . 0.565 ' CE2' ' HE1' ' A' ' 392' ' ' MET . 2.6 m-85 -89.16 -41.3 12.34 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 73.010000000000005 111.031 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' A' ' 412' ' ' ARG . 0.7 OUTLIER -117.56 11.86 13.91 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.527 1.142 . . . . 44.509999999999998 108.3 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 411' ' ' CYS . 14.5 tpp85 38.53 46.14 0.94 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.517 1.136 . . . . 73.099999999999994 110.294 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 4.1 t -131.04 150.44 52.15 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.499 1.124 . . . . 61.100000000000001 108.297 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -58.07 152.76 15.99 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.489 1.118 . . . . 75.420000000000002 110.329 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.415 ' CG2' ' CG2' ' A' ' 418' ' ' THR . 2.2 mt -107.2 154.81 8.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.457 1.098 . . . . 73.340000000000003 109.318 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -119.56 -41.44 2.7 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.478 1.111 . . . . 64.040000000000006 109.334 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . 0.429 ' O ' ' CG2' ' A' ' 418' ' ' THR . . . -119.0 127.73 7.35 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.506 1.129 . . . . 73.099999999999994 110.987 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' THR . . . . . 0.429 ' CG2' ' O ' ' A' ' 417' ' ' GLY . 42.2 p -154.26 125.09 7.15 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.526 0.78 . . . . 73.5 110.356 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -155.4 151.97 23.68 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.484 1.115 . . . . 73.329999999999998 110.287 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.451 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.3 Cg_endo -74.99 100.32 1.35 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.501 1.79 . . . . 63.420000000000002 111.014 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . 0.445 ' CD1' HG21 ' A' ' 423' ' ' VAL . 1.0 OUTLIER -107.18 171.09 2.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 124.512 1.132 . . . . 73.140000000000001 109.296 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 6.2 mm -121.22 109.92 26.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 73.310000000000002 109.3 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.445 HG21 ' CD1' ' A' ' 421' ' ' ILE . 2.5 t -75.86 140.38 17.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 74.030000000000001 109.317 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.478 ' O ' ' CG2' ' A' ' 355' ' ' VAL . 44.9 m-20 -130.19 143.79 50.57 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.516 1.135 . . . . 75.200000000000003 109.282 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 164.97 32.28 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.439 1.757 . . . . 72.310000000000002 111.02 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . 0.557 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 19.3 t80 . . . . . 0 C--N 1.324 -0.506 0 O-C-N 124.503 1.127 . . . . 74.400000000000006 111.028 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 67.0 m . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.983 -0.377 . . . . 73.430000000000007 109.983 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . 0.444 ' HB2' ' CG2' ' A' ' 421' ' ' ILE . 1.3 m-20 -77.12 -177.95 4.77 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.541 1.151 . . . . 63.450000000000003 109.324 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -137.41 125.94 23.59 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 73.319999999999993 109.586 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 2.2 mm -118.04 111.88 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.51 1.131 . . . . 74.319999999999993 109.262 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.31 149.84 28.76 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.459 1.099 . . . . 75.120000000000005 109.3 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' A' ' 424' ' ' ASP . 13.1 t -96.19 136.54 26.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.534 1.146 . . . . 71.099999999999994 109.315 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 11.6 p -95.21 143.16 26.84 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.514 1.134 . . . . 64.109999999999999 110.425 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' GLN . . . . . 0.508 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 12.0 mt-30 -42.4 -43.4 3.56 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.156 . . . . 75.349999999999994 110.3 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -46.8 -50.14 18.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.469 1.106 . . . . 74.140000000000001 110.245 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 362' ' ' LEU . 9.9 mm100 -60.09 -66.79 0.46 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.523 1.139 . . . . 74.319999999999993 110.285 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -38.25 -39.23 0.41 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 74.150000000000006 110.985 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -70.91 -47.38 59.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.494 1.121 . . . . 71.109999999999999 110.253 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 359' ' ' GLN . 4.9 tt . . . . . 0 C--N 1.326 -0.453 0 O-C-N 124.456 1.098 . . . . 75.329999999999998 109.293 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 108.308 -0.997 . . . . 72.019999999999996 108.308 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -66.68 -18.72 65.52 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.462 1.102 . . . . 74.519999999999996 110.338 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -126.58 8.6 7.02 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 74.439999999999998 110.959 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 42.74 54.61 4.95 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.538 1.149 . . . . 74.120000000000005 111.007 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 62.2 m -121.25 179.0 4.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.523 0.778 . . . . 72.319999999999993 110.008 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 2.3 p -124.81 131.38 53.45 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.489 1.118 . . . . 74.209999999999994 110.44 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.563 ' CE2' HG11 ' A' ' 423' ' ' VAL . 34.9 t80 -60.7 -65.1 0.74 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.472 1.108 . . . . 74.439999999999998 111.025 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' GLN . . . . . 0.532 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -43.54 -26.93 0.25 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.522 1.138 . . . . 73.430000000000007 110.227 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . 0.413 ' N ' ' C ' ' A' ' 370' ' ' PHE . 0.0 OUTLIER -71.65 123.28 22.17 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.505 1.128 . . . . 71.129999999999995 109.285 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 30.4 p -55.07 132.51 47.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.006 -0.997 . . . . 73.439999999999998 110.94 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.402 ' NZ ' ' O ' ' A' ' 372' ' ' LEU . 29.8 mmtm -92.93 32.2 1.3 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.465 1.103 . . . . 75.540000000000006 109.284 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 5.5 mt -113.35 -60.46 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.543 1.152 . . . . 65.329999999999998 109.315 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' CYS . . . . . 0.823 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 0.9 OUTLIER -108.28 -20.87 12.99 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 75.340000000000003 108.294 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 55.3 41.12 31.55 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.503 1.127 . . . . 75.230000000000004 109.308 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -128.38 -44.71 1.39 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.436 1.085 . . . . 74.310000000000002 110.324 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -110.21 174.15 6.0 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 75.150000000000006 109.293 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -89.03 162.09 16.21 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.517 1.135 . . . . 74.040000000000006 109.323 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 382' ' ' ASP . 21.9 mttt -65.21 -55.47 18.31 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.132 . . . . 73.109999999999999 109.292 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 381' ' ' LYS . 1.8 p30 50.62 25.58 2.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.462 1.101 . . . . 72.109999999999999 109.259 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . 0.476 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.3 OUTLIER -154.08 174.76 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.478 1.111 . . . . 74.510000000000005 109.263 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 21.1 tttm -158.67 155.77 28.75 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.464 1.102 . . . . 75.540000000000006 109.326 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.497 ' CG2' ' SG ' ' A' ' 388' ' ' CYS . 11.6 mm -121.69 143.78 33.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 73.129999999999995 109.314 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.522 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 5.3 mt-10 -137.6 162.49 54.44 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.443 1.089 . . . . 75.099999999999994 110.287 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.522 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.99 -12.29 23.98 Favored 'Cis proline' 0 C--N 1.361 1.211 0 C-N-CA 120.977 -2.51 . . . . 74.549999999999997 111.017 -0.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . 0.569 ' HB2' ' CE1' ' A' ' 390' ' ' HIS . 0.8 OUTLIER -36.48 -71.81 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.953 -1.021 . . . . 74.409999999999997 110.927 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 115.73 18.58 6.0 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.533 1.145 . . . . 75.219999999999999 111.028 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.569 ' CE1' ' HB2' ' A' ' 388' ' ' CYS . 20.6 m80 -76.56 145.52 38.96 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.524 0.779 . . . . 72.200000000000003 109.58 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.55 ' CD2' ' N ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -117.3 155.47 29.47 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.477 1.11 . . . . 62.32 109.273 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' MET . . . . . 0.547 ' HE1' ' CE1' ' A' ' 410' ' ' PHE . 18.7 ptp -172.14 172.85 4.48 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 72.409999999999997 111.016 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 4.5 p -91.69 115.3 27.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.444 1.09 . . . . 73.439999999999998 108.295 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 397' ' ' LEU . 27.3 m -47.83 -57.54 5.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.514 1.134 . . . . 70.109999999999999 110.401 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.9 t -45.56 -26.11 0.55 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.534 1.146 . . . . 71.439999999999998 109.976 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . 0.823 ' SG ' ' SG ' ' A' ' 376' ' ' CYS . 2.2 m -88.01 -41.33 13.19 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.533 1.146 . . . . 74.409999999999997 108.288 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . 0.465 ' CD2' ' HG3' ' A' ' 401' ' ' GLN . 3.4 tt -51.61 -45.79 63.35 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.458 1.098 . . . . 74.299999999999997 109.306 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.54 -35.91 61.23 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.551 1.157 . . . . 74.450000000000003 110.428 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -62.05 -27.87 69.19 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.467 1.105 . . . . 72.109999999999999 109.325 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' TRP . . . . . 0.579 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 5.1 t-105 -79.38 -52.42 8.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.026 -1.101 . . . . 75.150000000000006 108.026 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.503 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 10.0 mm-40 -62.99 -9.78 11.28 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 1.106 . . . . 65.450000000000003 110.291 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 401' ' ' GLN . 9.8 mm-40 -37.05 -63.78 0.4 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.44 1.088 . . . . 54.420000000000002 110.298 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 6.6 t -123.61 -24.8 4.46 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.481 1.113 . . . . 74.409999999999997 109.972 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . 0.579 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 0.9 OUTLIER -81.61 -90.18 0.07 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.456 1.098 . . . . 74.219999999999999 109.295 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.503 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 67.51 32.65 79.4 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.493 1.121 . . . . 70.319999999999993 111.037 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -91.74 66.93 5.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 0.772 . . . . 65.420000000000002 110.331 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 70.04 -161.21 53.16 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.497 1.123 . . . . 65.409999999999997 111.041 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . 0.41 ' O ' ' N ' ' A' ' 412' ' ' ARG . 7.1 t -62.45 130.68 93.52 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.314 -0.995 . . . . 64.120000000000005 108.314 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.94 -1.77 11.64 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.504 1.792 . . . . 75.400000000000006 111.003 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . 0.547 ' CE1' ' HE1' ' A' ' 392' ' ' MET . 3.2 m-85 -95.63 -41.32 8.96 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.529 1.143 . . . . 72.340000000000003 110.982 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' CYS . . . . . 0.452 ' SG ' ' CE1' ' A' ' 390' ' ' HIS . 0.1 OUTLIER -111.08 8.59 21.86 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 75.239999999999995 108.277 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 408' ' ' CYS . 5.7 tpt85 38.39 30.71 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.488 1.117 . . . . 73.530000000000001 110.318 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' CYS . . . . . 0.441 ' N ' ' O ' ' A' ' 411' ' ' CYS . 42.1 t -127.77 151.1 49.44 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.512 1.133 . . . . 75.0 108.326 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -49.81 151.1 1.9 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.46 1.1 . . . . 75.150000000000006 110.292 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.549 ' CG2' ' CG2' ' A' ' 418' ' ' THR . 1.9 mt -99.38 150.43 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.484 1.115 . . . . 73.329999999999998 109.355 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . 0.459 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 15.2 mmtt -110.51 -45.37 3.54 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.515 1.134 . . . . 74.319999999999993 109.299 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -129.07 135.0 8.22 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.498 1.124 . . . . 60.32 110.987 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' THR . . . . . 0.549 ' CG2' ' CG2' ' A' ' 415' ' ' ILE . 80.9 p -152.47 130.53 11.85 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.534 0.785 . . . . 73.439999999999998 110.421 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -158.26 153.36 21.6 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.534 1.146 . . . . 74.420000000000002 110.263 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.44 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.2 Cg_endo -75.01 102.64 1.61 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.498 1.788 . . . . 73.099999999999994 110.977 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . 0.444 ' CG2' ' HB2' ' A' ' 351' ' ' ASP . 1.0 OUTLIER -103.85 167.73 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.47 1.106 . . . . 73.549999999999997 109.304 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 6.0 mm -118.9 109.65 27.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.453 1.096 . . . . 75.420000000000002 109.277 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.563 HG11 ' CE2' ' A' ' 370' ' ' PHE . 23.7 t -79.74 144.35 10.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.495 1.122 . . . . 75.129999999999995 109.261 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.491 ' O ' ' CG2' ' A' ' 355' ' ' VAL . 4.1 m-20 -131.4 143.5 49.5 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.437 1.086 . . . . 71.439999999999998 109.299 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 160.47 40.09 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.467 1.772 . . . . 71.400000000000006 111.005 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . 0.508 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 3.3 t80 . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.494 1.121 . . . . 75.019999999999996 111.013 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 44.6 m . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 109.973 -0.381 . . . . 75.230000000000004 109.973 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -88.77 162.7 16.08 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.522 1.139 . . . . 71.099999999999994 109.295 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . 0.425 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 14.2 m-70 -126.18 138.64 53.67 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.488 1.117 . . . . 75.439999999999998 109.579 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 21.9 mt -121.72 137.1 56.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.47 1.106 . . . . 74.319999999999993 109.298 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -107.93 123.55 48.79 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.513 1.133 . . . . 72.129999999999995 109.345 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . 0.46 ' CG2' ' O ' ' A' ' 424' ' ' ASP . 4.4 t -72.42 156.6 6.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.456 1.097 . . . . 72.030000000000001 109.29 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 359' ' ' GLN . 2.8 p -124.04 145.29 49.32 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.527 1.142 . . . . 71.109999999999999 110.414 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' GLN . . . . . 0.518 ' HG2' ' CE2' ' A' ' 426' ' ' PHE . 10.7 mt-30 -40.86 -46.75 2.81 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.47 1.106 . . . . 75.420000000000002 110.305 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -50.16 -45.07 53.03 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 1.139 . . . . 72.310000000000002 110.299 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 356' ' ' THR . 70.4 mt-30 -64.28 -66.55 0.53 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.521 1.138 . . . . 75.349999999999994 110.309 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . 0.421 ' O ' ' N ' ' A' ' 364' ' ' CYS . 2.4 t80 -41.47 -39.12 1.43 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.562 1.164 . . . . 73.420000000000002 110.987 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -66.67 -54.11 26.66 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.522 1.139 . . . . 72.310000000000002 110.278 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.8 tp . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.562 1.163 . . . . 72.540000000000006 109.281 179.98 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . 0.421 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 108.293 -1.002 . . . . 71.120000000000005 108.293 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.84 -2.73 44.78 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 74.530000000000001 110.28 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 8.1 mmt -105.88 -34.91 7.49 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.518 1.137 . . . . 74.439999999999998 111.026 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 100.79 16.88 24.98 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.461 1.101 . . . . 54.450000000000003 110.998 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 7.0 m -142.84 172.57 12.52 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.521 0.777 . . . . 72.420000000000002 110.019 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 11.6 p -98.9 -175.19 2.97 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.532 1.145 . . . . 71.319999999999993 110.411 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.507 ' CD2' HG12 ' A' ' 423' ' ' VAL . 27.6 t80 -83.55 -67.18 0.81 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.539 1.149 . . . . 74.25 111.02 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' GLN . . . . . 0.534 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -39.41 -29.76 0.05 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.499 1.125 . . . . 75.299999999999997 110.275 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . 0.427 ' N ' ' C ' ' A' ' 370' ' ' PHE . 0.0 OUTLIER -69.97 115.43 9.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.508 1.13 . . . . 74.049999999999997 109.322 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 25.3 p -47.48 149.82 1.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.99 -1.005 . . . . 73.420000000000002 110.9 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -106.08 24.14 12.9 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 74.099999999999994 109.307 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 14.6 mt -100.73 -61.13 2.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 74.409999999999997 109.271 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 26.9 p -107.92 -22.41 12.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 74.420000000000002 108.274 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 61.89 41.39 11.53 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.109 . . . . 72.319999999999993 109.294 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -134.64 -45.93 0.74 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.481 1.113 . . . . 75.329999999999998 110.249 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -101.41 168.28 9.62 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.538 1.149 . . . . 72.230000000000004 109.314 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.82 157.27 17.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.564 1.165 . . . . 73.519999999999996 109.296 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 382' ' ' ASP . 0.7 OUTLIER -70.22 -62.1 1.52 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.442 1.089 . . . . 74.319999999999993 109.311 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . 0.405 ' CG ' ' O ' ' A' ' 381' ' ' LYS . 1.3 p30 51.86 21.85 1.57 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.509 1.131 . . . . 74.450000000000003 109.306 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . 0.463 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.3 OUTLIER -152.75 154.69 7.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.122 . . . . 72.299999999999997 109.24 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -141.73 153.72 44.81 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 73.010000000000005 109.292 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.441 ' CG2' ' SG ' ' A' ' 388' ' ' CYS . 22.8 mm -113.85 138.71 42.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.514 1.134 . . . . 72.0 109.275 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.541 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 1.8 mt-10 -129.73 163.32 47.76 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.472 1.108 . . . . 63.310000000000002 110.278 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.541 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.98 -18.56 18.59 Favored 'Cis proline' 0 C--N 1.36 1.158 0 C-N-CA 120.975 -2.51 . . . . 61.420000000000002 111.022 -0.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . 0.441 ' SG ' ' CG2' ' A' ' 385' ' ' ILE . 0.8 OUTLIER -35.61 -91.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.991 -1.004 . . . . 72.040000000000006 110.899 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 136.22 44.24 0.1 OUTLIER Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.499 1.124 . . . . 73.209999999999994 110.995 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.543 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 19.6 m170 -104.37 114.12 28.14 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.461 0.742 . . . . 64.549999999999997 109.648 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 5.9 mp -84.72 169.73 13.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.123 . . . . 73.450000000000003 109.311 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' MET . . . . . 0.463 ' O ' ' CG1' ' A' ' 383' ' ' VAL . 17.2 ptp -179.76 165.6 1.3 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.54 1.15 . . . . 71.420000000000002 111.01 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . 1.4 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 4.8 p -90.78 115.43 27.84 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.493 1.121 . . . . 64.5 108.301 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 20.7 m -38.72 -59.45 0.94 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.46 1.1 . . . . 75.230000000000004 110.4 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 6.7 m -42.24 -41.97 2.91 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.533 1.146 . . . . 72.099999999999994 109.983 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . 1.4 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 3.6 m -68.86 -56.68 7.17 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.463 1.102 . . . . 75.450000000000003 108.34 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . 0.432 ' C ' ' CD1' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -40.95 -36.02 0.6 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.503 1.127 . . . . 74.200000000000003 109.283 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 22.7 m -62.61 -49.44 75.21 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 72.140000000000001 110.394 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -54.33 -22.45 12.15 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.475 1.109 . . . . 75.019999999999996 109.313 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' TRP . . . . . 0.606 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 11.8 t-105 -85.44 -64.9 1.08 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.483 1.115 . . . . 75.230000000000004 108.01 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.488 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 12.5 mm-40 -52.34 -17.5 1.19 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.478 1.111 . . . . 74.349999999999994 110.312 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 401' ' ' GLN . 7.5 mt-10 -37.02 -63.31 0.43 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.481 1.113 . . . . 74.319999999999993 110.332 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 10.3 t -121.65 -24.5 5.3 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.5 1.125 . . . . 63.149999999999999 110.006 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . 0.606 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 19.5 m-20 -82.34 -93.78 0.06 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.501 1.125 . . . . 75.450000000000003 109.293 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.488 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 68.1 27.63 73.63 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.477 1.11 . . . . 73.439999999999998 111.03 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -88.68 67.04 8.3 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.539 0.788 . . . . 74.409999999999997 110.263 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 67.87 -162.7 48.17 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.537 1.148 . . . . 73.0 110.993 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 5.6 t -59.11 125.76 79.42 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 108.324 -0.991 . . . . 63.509999999999998 108.324 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.403 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.3 Cg_endo -74.97 -0.28 9.76 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.48 1.779 . . . . 62.039999999999999 111.012 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . 0.543 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 5.4 m-85 -95.85 -41.64 8.72 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.48 1.112 . . . . 70.540000000000006 110.996 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' CYS . . . . . 0.447 ' SG ' ' ND1' ' A' ' 390' ' ' HIS . 0.4 OUTLIER -112.8 10.43 19.16 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.525 1.14 . . . . 75.329999999999998 108.333 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 411' ' ' CYS . 27.5 mmm-85 38.5 31.75 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.448 1.092 . . . . 75.510000000000005 110.291 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' CYS . . . . . 0.42 ' N ' ' O ' ' A' ' 411' ' ' CYS . 10.5 t -125.09 146.36 49.49 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.419 1.074 . . . . 65.329999999999998 108.289 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -46.42 155.74 0.21 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.533 1.146 . . . . 75.400000000000006 110.351 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.434 HG21 ' CG2' ' A' ' 418' ' ' THR . 2.3 mt -102.44 156.91 4.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.449 1.093 . . . . 75.430000000000007 109.313 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . 0.409 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 10.3 mmtt -120.28 -43.48 2.52 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.471 1.107 . . . . 73.150000000000006 109.297 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . 0.488 ' O ' ' CG2' ' A' ' 418' ' ' THR . . . -126.78 140.54 12.02 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.486 1.116 . . . . 63.020000000000003 111.001 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' THR . . . . . 0.488 ' CG2' ' O ' ' A' ' 417' ' ' GLY . 17.3 p -157.53 116.7 3.28 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.46 0.741 . . . . 61.439999999999998 110.407 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.423 ' N ' ' OE1' ' A' ' 419' ' ' GLU . 23.3 pm0 -139.82 150.5 62.97 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.537 1.148 . . . . 74.340000000000003 110.313 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.99 102.34 1.58 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.504 1.791 . . . . 74.400000000000006 111.005 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . 0.471 ' CD1' ' N ' ' A' ' 422' ' ' ILE . 1.3 pp -103.85 -178.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.535 1.147 . . . . 73.109999999999999 109.258 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . 0.471 ' N ' ' CD1' ' A' ' 421' ' ' ILE . 15.2 mt -144.64 115.49 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 75.049999999999997 109.305 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.507 HG12 ' CD2' ' A' ' 370' ' ' PHE . 38.9 t -86.45 144.89 8.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.51 1.131 . . . . 73.5 109.326 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.46 ' O ' ' CG2' ' A' ' 355' ' ' VAL . 5.1 t70 -131.31 143.64 50.14 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.456 1.098 . . . . 74.120000000000005 109.345 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . 0.415 ' CD ' ' OE1' ' A' ' 371' ' ' GLN . 18.2 Cg_endo -75.04 170.67 19.91 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.475 1.776 . . . . 71.519999999999996 110.963 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . 0.518 ' CE2' ' HG2' ' A' ' 357' ' ' GLN . 6.5 t80 . . . . . 0 C--N 1.325 -0.468 0 O-C-N 124.503 1.127 . . . . 73.329999999999998 111.013 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 110.061 -0.348 . . . . 61.119999999999997 110.061 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -96.59 179.63 4.93 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.5 1.125 . . . . 73.319999999999993 109.292 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . 0.487 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 29.1 m-70 -134.2 135.44 43.03 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.48 1.113 . . . . 70.049999999999997 109.587 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 11.2 mt -116.21 149.14 18.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 75.239999999999995 109.262 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.79 137.29 52.84 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 74.239999999999995 109.326 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . 0.417 ' HB ' ' N ' ' A' ' 426' ' ' PHE . 5.0 t -89.03 141.62 14.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.472 1.107 . . . . 75.120000000000005 109.31 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' THR . . . . . 0.414 ' OG1' ' CG ' ' A' ' 359' ' ' GLN . 16.6 p -91.55 135.98 33.46 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.486 1.117 . . . . 70.310000000000002 110.371 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' GLN . . . . . 0.696 ' CG ' ' CE1' ' A' ' 426' ' ' PHE . 4.4 mt-30 -41.13 -33.15 0.32 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.523 1.139 . . . . 75.109999999999999 110.311 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . 0.449 ' CG ' ' N ' ' A' ' 359' ' ' GLN . 13.5 pt-20 -63.56 -50.41 69.59 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.515 1.134 . . . . 72.099999999999994 110.324 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . 0.449 ' N ' ' CG ' ' A' ' 358' ' ' GLU . 9.4 mm100 -56.57 -66.72 0.39 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.453 1.096 . . . . 75.450000000000003 110.329 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 364' ' ' CYS . 10.1 t80 -38.37 -51.94 1.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.522 1.139 . . . . 73.409999999999997 110.961 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -58.28 -60.96 2.95 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.493 1.121 . . . . 65.439999999999998 110.275 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 6.0 mt . . . . . 0 C--N 1.324 -0.514 0 O-C-N 124.514 1.134 . . . . 73.239999999999995 109.271 179.99 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . 0.404 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.5 m . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 108.275 -1.009 . . . . 72.430000000000007 108.275 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -73.54 -3.74 29.66 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.511 1.132 . . . . 74.319999999999993 110.297 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 8.0 mmt -114.38 -33.5 5.59 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.527 1.142 . . . . 71.430000000000007 110.995 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.14 35.52 3.14 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.499 1.125 . . . . 73.219999999999999 110.994 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 24.0 m -148.76 161.16 42.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 0.771 . . . . 74.420000000000002 109.965 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' THR . . . . . 0.408 ' HB ' ' NE2' ' A' ' 371' ' ' GLN . 11.5 p -96.48 178.93 5.18 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.506 1.129 . . . . 73.299999999999997 110.364 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -85.03 -58.91 2.5 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 74.230000000000004 110.992 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' GLN . . . . . 0.449 ' CB ' ' HB ' ' A' ' 423' ' ' VAL . 0.1 OUTLIER -54.66 -19.37 5.99 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.49 1.119 . . . . 74.010000000000005 110.254 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . 0.442 ' O ' ' NZ ' ' A' ' 374' ' ' LYS . 1.2 tm? -73.15 135.5 44.69 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.503 1.127 . . . . 73.329999999999998 109.307 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . 0.426 ' N ' HD23 ' A' ' 372' ' ' LEU . 7.6 t -72.2 132.37 44.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.987 -1.006 . . . . 72.510000000000005 110.901 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.442 ' NZ ' ' O ' ' A' ' 372' ' ' LEU . 12.5 mmtm -90.19 17.12 7.41 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.51 1.131 . . . . 72.010000000000005 109.289 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . 0.415 HD11 ' CE1' ' A' ' 410' ' ' PHE . 83.0 mt -102.45 -41.62 7.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.505 1.128 . . . . 71.25 109.328 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.6 -44.49 2.96 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.534 1.146 . . . . 64.310000000000002 108.317 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . 0.431 ' HA ' ' CD2' ' A' ' 372' ' ' LEU . . . 70.23 37.96 1.54 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.477 1.111 . . . . 71.450000000000003 109.299 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -131.63 -44.48 0.99 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.483 1.114 . . . . 72.439999999999998 110.311 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -107.38 172.79 6.63 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.453 1.096 . . . . 65.510000000000005 109.34 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -95.52 147.58 23.4 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.512 1.132 . . . . 73.310000000000002 109.274 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.466 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 27.4 mttt -55.41 -62.53 1.62 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 74.209999999999994 109.3 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 57.89 28.25 15.81 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 63.43 109.284 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . 0.466 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -158.38 175.83 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.515 1.134 . . . . 72.010000000000005 109.293 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . 0.455 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 72.6 tttt -157.83 149.34 21.62 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.502 1.126 . . . . 72.349999999999994 109.314 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.478 ' CG1' ' O ' ' A' ' 390' ' ' HIS . 2.6 mm -114.13 138.16 44.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.115 . . . . 75.340000000000003 109.328 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.488 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.2 OUTLIER -138.04 160.86 62.68 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.544 1.153 . . . . 74.340000000000003 110.303 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.488 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.98 -8.91 23.79 Favored 'Cis proline' 0 C--N 1.36 1.163 0 C-N-CA 120.979 -2.509 . . . . 74.230000000000004 111.012 -0.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . 0.539 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 17.5 t -36.84 -75.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.956 -1.02 . . . . 74.400000000000006 110.912 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 120.62 7.41 8.9 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.532 1.145 . . . . 72.209999999999994 111.015 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.539 ' CG ' ' SG ' ' A' ' 388' ' ' CYS . 56.6 m170 -77.0 131.78 38.63 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.524 0.779 . . . . 74.209999999999994 109.612 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.466 ' HB2' ' CE ' ' A' ' 381' ' ' LYS . 0.0 OUTLIER -102.48 168.09 9.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.447 1.092 . . . . 72.150000000000006 109.317 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' MET . . . . . 0.564 ' HE3' ' CE1' ' A' ' 410' ' ' PHE . 17.3 ptp -179.25 173.84 1.09 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.51 1.131 . . . . 74.420000000000002 111.006 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . 0.418 ' O ' ' N ' ' A' ' 396' ' ' CYS . 1.7 p -102.66 117.69 35.21 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 75.530000000000001 108.281 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 397' ' ' LEU . 2.5 m -38.7 -60.11 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.484 1.115 . . . . 72.219999999999999 110.441 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.8 m -39.3 -41.64 0.93 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.505 1.128 . . . . 53.310000000000002 110.042 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 393' ' ' CYS . 38.3 t -73.9 -49.85 22.94 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.471 1.107 . . . . 75.230000000000004 108.284 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . 0.436 ' CD1' ' HG3' ' A' ' 401' ' ' GLN . 1.5 tm? -42.61 -51.03 5.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.469 1.106 . . . . 73.010000000000005 109.328 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 402' ' ' GLU . 1.2 m -53.89 -42.05 68.25 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.509 1.131 . . . . 72.209999999999994 110.411 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -57.98 -26.59 62.53 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.505 1.128 . . . . 63.219999999999999 109.276 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' TRP . . . . . 0.601 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 10.5 t-105 -85.42 -62.58 1.5 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.52 1.137 . . . . 75.129999999999995 108.023 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.491 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 8.3 mm-40 -55.94 -14.37 2.46 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 1.122 . . . . 74.030000000000001 110.284 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 398' ' ' THR . 2.9 mm-40 -37.12 -63.36 0.44 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 74.129999999999995 110.32 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 22.7 t -121.4 -24.59 5.38 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.508 1.13 . . . . 64.519999999999996 109.995 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . 0.601 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 6.9 m-20 -82.51 -94.05 0.06 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.475 1.109 . . . . 75.200000000000003 109.326 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.491 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 72.42 31.04 63.73 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.475 1.109 . . . . 51.399999999999999 110.993 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -88.65 54.13 2.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 0.765 . . . . 74.400000000000006 110.272 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 72.02 -163.88 54.39 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.541 1.151 . . . . 72.299999999999997 111.024 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . 0.455 ' O ' ' N ' ' A' ' 412' ' ' ARG . 3.7 t -56.05 121.3 40.23 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.31 -0.996 . . . . 63.439999999999998 108.31 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 0.69 8.62 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.492 1.785 . . . . 71.310000000000002 110.998 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . 0.564 ' CE1' ' HE3' ' A' ' 392' ' ' MET . 24.3 m-85 -90.24 -36.34 14.79 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.518 1.136 . . . . 72.200000000000003 111.046 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.13 13.69 6.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 73.400000000000006 108.31 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 408' ' ' CYS . 14.8 tpp85 38.61 48.82 1.34 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.541 1.151 . . . . 73.310000000000002 110.347 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 1.2 m -125.89 150.92 47.55 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.468 1.105 . . . . 51.43 108.281 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 415' ' ' ILE . 5.1 tt0 -59.29 147.62 35.15 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.486 1.117 . . . . 71.010000000000005 110.271 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.467 HG21 ' CG2' ' A' ' 418' ' ' THR . 1.2 mt -89.04 149.11 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.484 1.115 . . . . 72.439999999999998 109.283 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.74 -49.82 2.63 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 74.219999999999999 109.324 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -140.58 131.89 5.2 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 124.498 1.124 . . . . 74.129999999999995 110.993 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' THR . . . . . 0.467 ' CG2' HG21 ' A' ' 415' ' ' ILE . 1.5 p -147.56 117.89 7.38 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.571 0.807 . . . . 64.120000000000005 110.434 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.428 ' HG3' ' CG2' ' A' ' 421' ' ' ILE . 20.5 pt-20 -128.08 150.83 74.85 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.459 1.099 . . . . 70.209999999999994 110.309 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 98.51 1.17 Allowed 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.467 1.772 . . . . 72.0 110.994 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . 0.459 ' CD1' HG23 ' A' ' 423' ' ' VAL . 0.7 OUTLIER -107.45 154.88 8.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.5 1.125 . . . . 73.510000000000005 109.292 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . 0.487 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 4.0 mp -110.67 105.39 18.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.502 1.126 . . . . 74.329999999999998 109.306 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.459 HG23 ' CD1' ' A' ' 421' ' ' ILE . 38.9 t -77.1 145.62 9.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.488 1.118 . . . . 74.5 109.294 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -130.54 143.53 49.67 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.491 1.119 . . . . 75.530000000000001 109.283 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 161.63 38.46 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.516 1.798 . . . . 62.399999999999999 110.997 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . 0.696 ' CE1' ' CG ' ' A' ' 357' ' ' GLN . 3.5 t80 . . . . . 0 C--N 1.326 -0.453 0 O-C-N 124.509 1.131 . . . . 73.140000000000001 111.004 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 109.964 -0.384 . . . . 73.299999999999997 109.964 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -99.67 169.24 9.41 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.511 1.132 . . . . 74.340000000000003 109.259 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . 0.505 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 38.4 m-70 -136.3 125.15 24.05 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 74.219999999999999 109.629 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . 0.453 ' CD1' HD21 ' A' ' 391' ' ' LEU . 7.7 mt -105.47 149.76 8.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.521 1.138 . . . . 64.340000000000003 109.322 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 13.0 tptp -123.27 123.32 40.49 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.458 1.099 . . . . 73.329999999999998 109.3 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 55.2 t -79.71 148.87 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.487 1.117 . . . . 74.010000000000005 109.298 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 40.2 p -114.2 -178.47 3.38 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.493 1.121 . . . . 74.349999999999994 110.385 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -72.81 -36.7 67.59 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 54.340000000000003 110.336 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -54.94 -35.33 64.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.537 1.148 . . . . 75.230000000000004 110.322 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -79.6 -66.73 0.83 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 1.135 . . . . 75.150000000000006 110.306 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 364' ' ' CYS . 12.3 t80 -38.2 -43.23 0.75 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.499 1.124 . . . . 64.010000000000005 111.004 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -61.48 -54.15 47.17 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.464 1.103 . . . . 75.349999999999994 110.266 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.4 tt . . . . . 0 C--N 1.325 -0.466 0 O-C-N 124.485 1.116 . . . . 70.129999999999995 109.267 -179.952 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 360' ' ' TYR . 3.3 m . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 108.255 -1.017 . . . . 72.400000000000006 108.255 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -71.79 -16.09 62.17 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.535 1.147 . . . . 74.319999999999993 110.29 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.94 2.6 6.59 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.461 1.101 . . . . 75.129999999999995 110.973 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 50.79 58.69 8.92 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.522 1.139 . . . . 72.340000000000003 111.019 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' SER . . . . . 0.532 ' HG ' ' NZ ' ' A' ' 374' ' ' LYS . 84.5 p -129.36 177.99 6.78 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 0.757 . . . . 73.129999999999995 109.969 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 2.3 p -126.03 142.11 51.67 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.479 1.112 . . . . 71.109999999999999 110.388 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.615 ' CZ ' ' CD1' ' A' ' 391' ' ' LEU . 54.1 t80 -66.22 -67.96 0.41 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.485 1.116 . . . . 75.310000000000002 111.056 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' GLN . . . . . 0.529 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -41.32 -31.8 0.26 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.453 1.096 . . . . 71.25 110.295 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . 0.422 ' CD2' ' N ' ' A' ' 373' ' ' CYS . 0.5 OUTLIER -67.07 136.39 55.13 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.436 1.085 . . . . 72.349999999999994 109.293 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . 0.422 ' N ' ' CD2' ' A' ' 372' ' ' LEU . 19.3 p -72.17 129.61 38.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.004 -0.998 . . . . 70.019999999999996 110.925 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.532 ' NZ ' ' HG ' ' A' ' 368' ' ' SER . 24.2 mmtp -90.99 18.35 6.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.453 1.096 . . . . 73.099999999999994 109.334 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 12.1 mt -92.13 -60.45 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.485 1.116 . . . . 73.140000000000001 109.282 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 23.9 p -107.68 -24.04 11.88 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.472 1.108 . . . . 65.519999999999996 108.284 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 60.93 43.24 11.91 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.462 1.102 . . . . 74.129999999999995 109.315 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -127.75 -43.65 1.54 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.522 1.139 . . . . 73.239999999999995 110.307 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 39.0 m-20 -119.7 177.7 4.85 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.452 1.095 . . . . 74.340000000000003 109.349 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -88.3 169.41 11.86 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 73.510000000000005 109.303 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.427 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 24.5 mttt -70.55 -62.07 1.53 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.499 1.124 . . . . 74.430000000000007 109.312 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 59.92 25.05 14.17 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 75.049999999999997 109.301 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -160.8 155.34 3.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 74.219999999999999 109.293 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . 0.422 ' HE3' ' CD2' ' A' ' 391' ' ' LEU . 4.1 ttmt -139.29 137.32 35.75 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.516 1.135 . . . . 74.209999999999994 109.274 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.464 ' O ' ' N ' ' A' ' 389' ' ' GLY . 20.2 mm -97.99 139.57 19.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.523 1.139 . . . . 74.25 109.284 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.496 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.0 OUTLIER -138.0 161.39 60.0 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.46 1.1 . . . . 72.430000000000007 110.28 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.496 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.0 -8.94 23.86 Favored 'Cis proline' 0 C--N 1.36 1.147 0 C-N-CA 121.021 -2.491 . . . . 74.239999999999995 111.017 -0.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . 0.544 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 31.3 t -36.55 -72.89 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.951 -1.022 . . . . 75.510000000000005 110.926 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 115.58 18.28 6.19 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.485 1.115 . . . . 75.010000000000005 111.004 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.544 ' CG ' ' SG ' ' A' ' 388' ' ' CYS . 61.7 m170 -87.77 129.3 35.22 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.518 0.775 . . . . 65.129999999999995 109.546 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.615 ' CD1' ' CZ ' ' A' ' 370' ' ' PHE . 0.8 OUTLIER -96.1 160.31 14.51 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.459 1.099 . . . . 72.109999999999999 109.262 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' MET . . . . . 0.413 ' O ' ' CA ' ' A' ' 381' ' ' LYS . 15.5 ptp -170.52 173.44 5.53 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.477 1.111 . . . . 74.140000000000001 111.019 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . 1.404 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 5.0 p -99.15 115.0 28.04 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.483 1.115 . . . . 74.519999999999996 108.333 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 17.4 m -42.0 -59.7 1.65 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.496 1.123 . . . . 75.310000000000002 110.425 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 10.6 t -41.62 -36.58 0.97 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.478 1.111 . . . . 74.230000000000004 109.985 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . 1.404 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 2.3 m -75.88 -54.93 6.14 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.467 1.105 . . . . 74.329999999999998 108.281 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . 0.456 ' C ' ' CD1' ' A' ' 397' ' ' LEU . 0.3 OUTLIER -41.34 -35.19 0.61 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.128 . . . . 75.209999999999994 109.28 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 83.2 m -62.05 -49.76 74.7 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.512 1.133 . . . . 61.109999999999999 110.431 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -55.16 -22.16 16.13 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.473 1.108 . . . . 72.430000000000007 109.349 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' TRP . . . . . 0.602 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 16.3 t-105 -84.6 -65.16 1.04 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.516 1.135 . . . . 74.430000000000007 108.048 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.507 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 38.3 mm-40 -49.18 -20.81 0.65 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.544 1.152 . . . . 71.319999999999993 110.304 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 401' ' ' GLN . 10.4 mt-10 -37.47 -63.53 0.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.479 1.112 . . . . 75.439999999999998 110.345 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 3.3 m -122.41 -24.22 5.05 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.497 1.123 . . . . 74.209999999999994 109.97 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . 0.602 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 16.9 m-20 -83.54 -95.17 0.06 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.51 1.131 . . . . 74.439999999999998 109.253 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.507 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 67.92 23.22 74.29 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.479 1.112 . . . . 75.540000000000006 111.01 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -81.51 58.11 3.56 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.556 0.797 . . . . 75.230000000000004 110.326 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 69.95 -160.74 53.18 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.503 1.127 . . . . 70.450000000000003 111.023 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . 0.442 ' O ' ' N ' ' A' ' 412' ' ' ARG . 4.7 t -56.3 120.3 34.23 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.267 -1.012 . . . . 72.409999999999997 108.267 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.411 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.2 Cg_endo -74.95 0.43 8.89 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.454 1.765 . . . . 74.329999999999998 110.978 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . 0.502 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 3.6 m-30 -93.8 -37.23 11.88 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.485 1.116 . . . . 74.299999999999997 111.0 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -123.26 13.49 9.61 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.49 1.119 . . . . 72.140000000000001 108.321 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 408' ' ' CYS . 11.4 mmt85 38.43 40.45 0.37 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 74.540000000000006 110.285 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 16.0 t -126.66 140.1 52.66 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.49 1.119 . . . . 73.430000000000007 108.301 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -45.32 154.25 0.18 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.467 1.104 . . . . 73.340000000000003 110.228 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.453 HG23 ' CG2' ' A' ' 385' ' ' ILE . 2.7 mt -109.8 157.19 10.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.48 1.113 . . . . 74.109999999999999 109.327 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -129.9 -46.6 1.14 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.492 1.12 . . . . 73.519999999999996 109.259 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . 0.498 ' O ' ' CG2' ' A' ' 418' ' ' THR . . . -107.22 127.14 8.68 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.53 1.144 . . . . 45.140000000000001 110.964 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' THR . . . . . 0.498 ' CG2' ' O ' ' A' ' 417' ' ' GLY . 17.5 p -157.47 128.65 6.73 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 0.76 . . . . 75.340000000000003 110.395 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.02 166.39 15.96 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.466 1.104 . . . . 73.109999999999999 110.283 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 101.85 1.52 Allowed 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.541 1.811 . . . . 74.099999999999994 110.984 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . 0.468 ' CD1' ' N ' ' A' ' 422' ' ' ILE . 0.6 OUTLIER -103.89 170.18 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.146 . . . . 73.439999999999998 109.313 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . 0.505 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 5.9 mt -137.8 107.63 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.448 1.093 . . . . 74.099999999999994 109.284 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.455 ' HB ' ' CB ' ' A' ' 371' ' ' GLN . 30.7 t -78.16 147.42 7.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.436 1.085 . . . . 70.420000000000002 109.264 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -129.68 143.72 50.09 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.478 1.112 . . . . 74.400000000000006 109.292 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 173.42 14.55 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.489 1.784 . . . . 75.140000000000001 111.007 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 15.5 t80 . . . . . 0 C--N 1.324 -0.503 0 O-C-N 124.556 1.16 . . . . 74.219999999999999 111.023 179.994 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 64.5 m . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 110.007 -0.368 . . . . 74.519999999999996 110.007 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.91 168.41 19.27 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.502 1.126 . . . . 63.130000000000003 109.312 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . 0.519 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 26.3 m-70 -132.94 135.85 45.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 74.409999999999997 109.578 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 3.3 mm -113.78 153.34 15.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.545 1.153 . . . . 62.030000000000001 109.308 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . 0.413 ' CD ' ' O ' ' A' ' 355' ' ' VAL . 0.8 OUTLIER -114.31 136.24 53.19 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.471 1.107 . . . . 75.540000000000006 109.298 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . 0.532 HG22 ' CD2' ' A' ' 370' ' ' PHE . 5.7 t -98.77 163.74 2.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.539 1.149 . . . . 74.409999999999997 109.342 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' THR . . . . . 0.494 ' N ' ' CG1' ' A' ' 355' ' ' VAL . 2.4 p -125.63 179.68 5.04 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.536 1.147 . . . . 71.510000000000005 110.438 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' GLN . . . . . 0.564 ' HG3' ' CZ ' ' A' ' 426' ' ' PHE . 13.0 mt-30 -75.38 -37.54 60.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.545 1.153 . . . . 75.430000000000007 110.281 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -60.88 -31.19 70.66 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.502 1.126 . . . . 65.329999999999998 110.305 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . 0.438 ' NE2' ' OG1' ' A' ' 356' ' ' THR . 62.3 mt-30 -74.2 -66.92 0.66 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.5 1.125 . . . . 72.120000000000005 110.293 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -47.07 -34.95 6.33 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.531 1.144 . . . . 75.299999999999997 111.031 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -73.53 -57.54 3.93 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.439 1.087 . . . . 73.219999999999999 110.273 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 7.0 tt . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.555 1.159 . . . . 74.430000000000007 109.28 -179.977 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 108.268 -1.012 . . . . 75.219999999999999 108.268 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -75.56 -3.93 37.01 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.5 1.125 . . . . 72.219999999999999 110.293 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 19.4 mtm -111.38 -33.91 6.27 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.504 1.127 . . . . 72.099999999999994 110.98 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 99.66 13.97 36.2 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.485 1.116 . . . . 73.430000000000007 111.028 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 66.1 m -120.86 -176.43 3.25 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.505 0.767 . . . . 75.310000000000002 109.99 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' THR . . . . . 0.443 ' CG2' ' NE2' ' A' ' 371' ' ' GLN . 1.9 m -115.81 161.54 18.6 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.463 1.102 . . . . 70.400000000000006 110.4 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.532 ' CD2' HG22 ' A' ' 355' ' ' VAL . 89.1 t80 -64.39 -68.76 0.33 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.138 . . . . 74.5 110.981 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' GLN . . . . . 0.443 ' NE2' ' CG2' ' A' ' 369' ' ' THR . 0.1 OUTLIER -46.69 -34.1 4.83 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.52 1.138 . . . . 71.239999999999995 110.268 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . 0.457 ' CD1' ' O ' ' A' ' 373' ' ' CYS . 2.3 tm? -60.49 141.13 56.86 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 75.299999999999997 109.332 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . 0.457 ' O ' ' CD1' ' A' ' 372' ' ' LEU . 24.0 p -72.13 159.95 33.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.03 -0.986 . . . . 74.120000000000005 110.882 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -117.17 28.54 8.43 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.523 1.14 . . . . 72.430000000000007 109.314 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 11.5 mt -112.72 -59.64 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.453 1.096 . . . . 74.109999999999999 109.329 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 2.0 m -105.05 -14.85 15.27 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.484 1.115 . . . . 55.119999999999997 108.334 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . 0.415 ' HA ' ' CD1' ' A' ' 372' ' ' LEU . . . 52.14 44.98 29.16 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.505 1.128 . . . . 73.099999999999994 109.311 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -131.6 -61.93 0.88 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 70.150000000000006 110.298 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -95.18 162.88 13.52 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 70.329999999999998 109.313 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -85.42 167.89 15.1 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.514 1.134 . . . . 73.340000000000003 109.305 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.417 ' NZ ' ' CD1' ' A' ' 391' ' ' LEU . 0.7 OUTLIER -70.17 -61.05 1.93 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.117 . . . . 73.319999999999993 109.282 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . 0.406 ' CG ' ' C ' ' A' ' 381' ' ' LYS . 0.2 OUTLIER 47.51 25.04 0.57 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 72.450000000000003 109.278 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . 0.491 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.3 OUTLIER -150.91 170.17 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.528 1.143 . . . . 74.329999999999998 109.274 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 22.9 tttm -155.29 147.03 23.23 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.454 1.096 . . . . 73.540000000000006 109.274 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 389' ' ' GLY . 20.6 mm -108.97 135.06 48.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.504 1.127 . . . . 74.25 109.29 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.49 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.8 mt-10 -137.76 161.11 62.01 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.448 1.093 . . . . 74.099999999999994 110.326 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.49 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.99 -5.63 21.6 Favored 'Cis proline' 0 C--N 1.36 1.155 0 C-N-CA 120.985 -2.506 . . . . 70.519999999999996 110.979 0.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . 0.541 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 17.6 t -37.99 -78.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.008 -0.996 . . . . 55.020000000000003 110.892 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 119.23 36.46 0.86 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.485 1.115 . . . . 74.430000000000007 110.965 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.541 ' CG ' ' SG ' ' A' ' 388' ' ' CYS . 63.3 m170 -108.5 129.73 55.28 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.52 0.777 . . . . 72.319999999999993 109.543 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.417 ' CD1' ' NZ ' ' A' ' 381' ' ' LYS . 0.8 OUTLIER -98.66 160.41 14.29 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.471 1.107 . . . . 72.439999999999998 109.307 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' MET . . . . . 0.555 ' HE1' ' CE1' ' A' ' 410' ' ' PHE . 20.5 ptp -177.99 170.9 1.82 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.544 1.152 . . . . 74.25 110.999 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 5.0 p -89.83 114.78 26.58 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.463 1.102 . . . . 75.409999999999997 108.296 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 397' ' ' LEU . 3.4 m -46.98 -55.53 7.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.48 1.113 . . . . 73.209999999999994 110.447 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 71.5 m -46.41 -29.29 1.64 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 61.409999999999997 110.047 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 1.9 m -86.19 -37.92 18.2 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.565 1.166 . . . . 71.120000000000005 108.266 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . 0.479 ' C ' ' CD2' ' A' ' 397' ' ' LEU . 3.0 tt -53.88 -47.05 71.46 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.534 1.146 . . . . 74.319999999999993 109.338 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.09 -35.28 61.93 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 1.114 . . . . 73.129999999999995 110.409 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -63.01 -26.49 68.88 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.515 1.135 . . . . 73.140000000000001 109.305 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' TRP . . . . . 0.492 ' CD2' ' HB3' ' A' ' 409' ' ' PRO . 3.7 t-105 -80.85 -52.87 7.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.97 -1.122 . . . . 74.439999999999998 107.97 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.496 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.2 mm-40 -61.74 -10.28 8.41 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.512 1.132 . . . . 70.319999999999993 110.339 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 401' ' ' GLN . 37.7 mt-10 -37.23 -63.7 0.42 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.531 1.145 . . . . 73.439999999999998 110.287 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.8 m -123.12 -24.88 4.62 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.487 1.117 . . . . 73.340000000000003 109.985 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . 0.491 ' OD2' ' CH2' ' A' ' 400' ' ' TRP . 0.6 OUTLIER -81.71 -90.9 0.07 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.486 1.116 . . . . 65.219999999999999 109.283 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.496 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 69.41 32.51 71.79 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.461 1.101 . . . . 54.399999999999999 111.02 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -91.11 64.85 5.4 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.503 0.766 . . . . 74.200000000000003 110.295 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 66.07 -156.41 49.96 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.528 1.143 . . . . 74.010000000000005 111.006 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . 0.426 ' O ' ' N ' ' A' ' 412' ' ' ARG . 5.4 t -57.39 127.22 76.78 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 108.267 -1.012 . . . . 71.319999999999993 108.267 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.492 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.3 Cg_endo -75.04 0.33 9.05 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.506 1.793 . . . . 75.439999999999998 110.99 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . 0.555 ' CE1' ' HE1' ' A' ' 392' ' ' MET . 3.3 m-85 -93.59 -39.49 10.8 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.54 1.15 . . . . 74.010000000000005 110.991 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.5 OUTLIER -119.8 12.47 12.14 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.505 1.128 . . . . 72.430000000000007 108.254 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' ARG . . . . . 0.442 ' HD2' ' CH2' ' A' ' 400' ' ' TRP . 37.4 mmm-85 38.5 31.73 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.509 1.131 . . . . 75.450000000000003 110.274 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' CYS . . . . . 0.422 ' N ' ' O ' ' A' ' 411' ' ' CYS . 42.8 t -114.74 151.12 34.24 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.513 1.133 . . . . 75.319999999999993 108.255 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -55.16 149.1 12.93 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.516 1.135 . . . . 75.109999999999999 110.335 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.456 HG23 ' CG2' ' A' ' 418' ' ' THR . 4.0 mt -107.24 157.2 7.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.546 1.154 . . . . 73.140000000000001 109.294 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -126.64 -46.78 1.57 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.48 1.113 . . . . 74.340000000000003 109.275 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . 0.487 ' O ' ' CG2' ' A' ' 418' ' ' THR . . . -107.32 127.08 8.64 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.535 1.147 . . . . 74.329999999999998 110.97 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' THR . . . . . 0.487 ' CG2' ' O ' ' A' ' 417' ' ' GLY . 17.1 p -157.57 117.79 3.44 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.48 0.753 . . . . 75.329999999999998 110.413 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -143.6 150.59 51.27 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.521 1.138 . . . . 73.329999999999998 110.273 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.49 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.3 Cg_endo -75.06 102.47 1.59 Allowed 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.475 1.776 . . . . 74.209999999999994 110.972 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . 0.419 HD13 ' N ' ' A' ' 422' ' ' ILE . 1.2 pp -103.88 172.05 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.466 1.104 . . . . 71.430000000000007 109.267 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . 0.519 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 19.5 mm -130.83 115.14 29.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.512 1.133 . . . . 72.239999999999995 109.266 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . . . . . . . . . 18.9 t -84.68 141.67 14.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.488 1.118 . . . . 74.129999999999995 109.326 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.443 ' O ' ' CG2' ' A' ' 355' ' ' VAL . 1.0 OUTLIER -128.61 143.44 48.43 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.506 1.129 . . . . 74.230000000000004 109.327 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.04 174.44 12.79 Favored 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.5 1.789 . . . . 73.200000000000003 110.974 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . 0.564 ' CZ ' ' HG3' ' A' ' 357' ' ' GLN . 10.1 t80 . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.489 1.118 . . . . 73.030000000000001 111.037 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.979 -0.378 . . . . 73.409999999999997 109.979 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -93.48 -178.88 4.87 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 1.12 . . . . 65.230000000000004 109.306 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . 0.529 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 30.8 m-70 -139.31 145.96 39.74 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.469 1.105 . . . . 63.43 109.58 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 96.5 mt -133.71 142.6 41.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.528 1.142 . . . . 74.439999999999998 109.33 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.84 148.2 29.87 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.503 1.127 . . . . 74.299999999999997 109.258 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . 0.488 HG23 ' CD2' ' A' ' 370' ' ' PHE . 51.8 t -112.99 164.18 9.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.499 1.124 . . . . 74.519999999999996 109.331 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' THR . . . . . 0.46 ' N ' ' CG1' ' A' ' 355' ' ' VAL . 2.5 p -124.17 171.92 9.45 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.51 1.131 . . . . 71.230000000000004 110.441 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' GLN . . . . . 0.544 ' HG3' ' CZ ' ' A' ' 426' ' ' PHE . 5.4 mt-30 -66.32 -35.88 81.51 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.514 1.134 . . . . 75.239999999999995 110.28 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -55.94 -47.62 77.23 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.51 1.131 . . . . 74.530000000000001 110.351 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -59.48 -58.67 7.57 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.477 1.11 . . . . 73.409999999999997 110.305 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . 0.438 ' O ' ' N ' ' A' ' 364' ' ' CYS . 13.1 t80 -55.0 -33.12 62.31 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.486 1.116 . . . . 73.129999999999995 110.992 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -60.73 -47.71 85.09 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.466 1.104 . . . . 62.520000000000003 110.247 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.427 ' N ' ' CD1' ' A' ' 362' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.325 -0.461 0 O-C-N 124.493 1.12 . . . . 73.450000000000003 109.309 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 108.287 -1.005 . . . . 73.019999999999996 108.287 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -77.64 -4.65 47.09 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.485 1.115 . . . . 74.310000000000002 110.312 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 19.8 ptp -116.44 -32.24 5.32 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.47 1.106 . . . . 74.209999999999994 110.978 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.62 40.37 3.65 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.566 1.166 . . . . 45.200000000000003 111.01 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 68.5 m -145.1 171.84 13.93 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.539 0.788 . . . . 74.219999999999999 109.987 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' THR . . . . . 0.434 ' CG2' ' NE2' ' A' ' 371' ' ' GLN . 1.8 m -115.07 162.71 16.64 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.547 1.155 . . . . 73.239999999999995 110.37 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.488 ' CD2' HG23 ' A' ' 355' ' ' VAL . 43.7 t80 -66.46 -68.53 0.37 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 63.119999999999997 111.004 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' GLN . . . . . 0.491 ' OE1' ' CD ' ' A' ' 425' ' ' PRO . 0.2 OUTLIER -46.05 -26.82 0.8 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.493 1.121 . . . . 74.230000000000004 110.29 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 373' ' ' CYS . 0.4 OUTLIER -71.18 135.74 47.73 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.501 1.126 . . . . 74.340000000000003 109.298 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . 0.441 ' N ' ' CD2' ' A' ' 372' ' ' LEU . 12.3 p -67.19 134.23 51.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.018 -0.992 . . . . 72.25 110.928 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -92.41 34.5 1.05 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.565 1.166 . . . . 74.519999999999996 109.312 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 49.8 mt -112.6 -60.35 2.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.545 1.153 . . . . 72.340000000000003 109.292 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -109.04 -18.31 13.69 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.484 1.115 . . . . 63.219999999999999 108.298 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 52.57 52.86 13.25 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.485 1.116 . . . . 63.32 109.328 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -135.19 -49.41 0.73 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.504 1.128 . . . . 75.420000000000002 110.326 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -111.89 165.36 12.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.531 1.144 . . . . 75.430000000000007 109.305 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -79.89 163.01 24.68 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 74.450000000000003 109.28 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.463 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 22.5 mttt -70.13 -62.6 1.32 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.475 1.109 . . . . 75.200000000000003 109.286 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 26.5 t0 60.25 23.74 13.14 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.541 1.151 . . . . 73.420000000000002 109.291 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . 0.476 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.4 OUTLIER -153.4 176.12 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.463 1.102 . . . . 62.329999999999998 109.312 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -157.91 154.66 28.25 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.475 1.109 . . . . 72.230000000000004 109.296 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' A' ' 390' ' ' HIS . 11.6 mm -122.04 142.48 38.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.455 1.097 . . . . 73.140000000000001 109.321 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.529 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.1 mt-10 -136.9 162.91 53.1 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.467 1.104 . . . . 65.409999999999997 110.29 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.529 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.02 -13.47 23.65 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 120.97 -2.513 . . . . 70.239999999999995 110.999 -0.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . 0.554 ' HB2' ' CE1' ' A' ' 390' ' ' HIS . 0.8 OUTLIER -36.12 -71.53 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.978 -1.01 . . . . 52.25 110.911 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.97 16.38 6.28 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.497 1.123 . . . . 74.319999999999993 110.985 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.566 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 20.9 m80 -73.48 145.16 45.87 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 0.763 . . . . 72.319999999999993 109.568 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.542 ' CD2' ' N ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -117.37 156.57 27.66 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.126 . . . . 75.340000000000003 109.345 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' MET . . . . . 0.568 ' HE3' ' CD1' ' A' ' 410' ' ' PHE . 12.3 ptp -173.9 173.93 3.14 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.512 1.133 . . . . 73.299999999999997 110.999 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . 1.127 ' SG ' ' CB ' ' A' ' 396' ' ' CYS . 5.3 p -91.39 137.45 32.35 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.446 1.091 . . . . 63.229999999999997 108.286 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 98.4 m -65.81 -31.54 72.56 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.466 1.104 . . . . 62.340000000000003 110.386 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 60.9 m -72.46 -58.2 3.57 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.523 1.139 . . . . 75.040000000000006 109.99 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . 1.127 ' CB ' ' SG ' ' A' ' 393' ' ' CYS . 1.9 p -55.87 -42.84 76.49 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.508 1.13 . . . . 73.140000000000001 108.285 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -45.12 -44.02 10.22 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.519 1.137 . . . . 72.109999999999999 109.311 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 402' ' ' GLU . 86.2 m -54.61 -38.47 66.83 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.527 1.142 . . . . 75.439999999999998 110.414 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -55.35 -26.91 43.8 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.46 1.1 . . . . 74.150000000000006 109.299 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' TRP . . . . . 0.602 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 8.1 t-105 -85.0 -60.91 1.9 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.985 -1.117 . . . . 73.439999999999998 107.985 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.482 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 7.3 mm-40 -56.69 -13.75 2.72 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.482 1.114 . . . . 74.219999999999999 110.265 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 398' ' ' THR . 3.6 mm-40 -37.14 -63.41 0.43 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.506 1.129 . . . . 74.329999999999998 110.303 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 5.2 t -121.23 -24.62 5.44 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.567 1.167 . . . . 75.019999999999996 109.938 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . 0.602 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 17.1 m-20 -82.87 -94.54 0.06 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.457 1.098 . . . . 73.099999999999994 109.296 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.482 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 73.17 29.72 64.07 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.46 1.1 . . . . 62.439999999999998 110.97 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -88.07 66.09 8.44 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.513 0.773 . . . . 73.239999999999995 110.308 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 68.45 -160.03 51.6 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.479 1.112 . . . . 72.219999999999999 111.018 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 7.5 t -59.98 131.79 89.44 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 108.282 -1.007 . . . . 74.019999999999996 108.282 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -0.07 9.53 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.547 1.814 . . . . 73.030000000000001 110.988 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . 0.568 ' CD1' ' HE3' ' A' ' 392' ' ' MET . 8.4 m-85 -95.11 -43.02 8.3 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 72.319999999999993 111.002 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' CYS . . . . . 0.445 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.5 OUTLIER -111.67 9.18 20.98 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.518 1.136 . . . . 73.25 108.285 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' ARG . . . . . . . . . . . . . 39.8 mmm-85 38.58 30.24 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.478 1.111 . . . . 74.420000000000002 110.253 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' CYS . . . . . 0.445 ' N ' ' O ' ' A' ' 411' ' ' CYS . 24.2 t -127.46 146.15 50.59 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.463 1.102 . . . . 75.019999999999996 108.287 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -42.58 152.13 0.1 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 72.439999999999998 110.296 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.532 ' CG2' ' CG2' ' A' ' 418' ' ' THR . 2.1 mt -98.86 148.67 5.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.493 1.121 . . . . 72.420000000000002 109.303 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -112.29 -48.42 3.03 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.504 1.128 . . . . 74.430000000000007 109.331 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . 0.403 ' C ' ' CG2' ' A' ' 418' ' ' THR . . . -116.51 129.04 8.23 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.489 1.118 . . . . 61.329999999999998 110.979 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' THR . . . . . 0.532 ' CG2' ' CG2' ' A' ' 415' ' ' ILE . 82.0 p -152.82 138.95 18.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.492 0.76 . . . . 72.329999999999998 110.386 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -167.14 150.84 6.26 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.499 1.124 . . . . 74.329999999999998 110.309 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 101.08 1.43 Allowed 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.451 1.764 . . . . 74.019999999999996 110.977 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -105.32 157.55 6.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 72.430000000000007 109.303 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . 0.529 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 13.2 mt -114.82 105.39 18.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.529 1.143 . . . . 73.340000000000003 109.3 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.425 ' CG1' ' HB3' ' A' ' 371' ' ' GLN . 42.5 t -75.18 146.8 8.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.447 1.092 . . . . 75.129999999999995 109.267 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.73 133.59 25.36 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.462 1.101 . . . . 75.209999999999994 109.297 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . 0.491 ' CD ' ' OE1' ' A' ' 371' ' ' GLN . 18.2 Cg_endo -74.96 169.71 22.03 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.513 1.796 . . . . 74.519999999999996 110.961 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . 0.544 ' CZ ' ' HG3' ' A' ' 357' ' ' GLN . 5.1 t80 . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.449 1.093 . . . . 72.209999999999994 111.012 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 70.5 m . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 109.997 -0.371 . . . . 65.030000000000001 109.997 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -83.59 178.39 8.01 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.511 1.132 . . . . 74.209999999999994 109.327 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . 0.536 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 37.6 m-70 -141.97 134.73 28.52 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.534 1.146 . . . . 74.329999999999998 109.609 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 23.4 mt -124.86 158.7 32.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.529 1.143 . . . . 71.109999999999999 109.302 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 355' ' ' VAL . 0.3 OUTLIER -124.12 150.51 44.99 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.492 1.12 . . . . 75.239999999999995 109.312 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . 0.517 HG23 ' CG ' ' A' ' 370' ' ' PHE . 70.3 t -109.09 146.96 14.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.539 1.149 . . . . 74.239999999999995 109.293 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 58.1 p -117.96 -173.16 2.39 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.464 1.103 . . . . 75.200000000000003 110.369 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' GLN . . . . . 0.4 ' HG2' ' CE1' ' A' ' 426' ' ' PHE . 4.6 mm100 -77.52 -35.04 53.81 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.508 1.13 . . . . 74.109999999999999 110.285 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . 0.439 ' O ' ' CD1' ' A' ' 362' ' ' LEU . 4.7 pt-20 -60.27 -31.4 70.19 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.102 . . . . 74.409999999999997 110.281 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . 0.421 ' OE1' ' CE2' ' A' ' 370' ' ' PHE . 73.3 mt-30 -77.34 -63.42 1.38 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.46 1.1 . . . . 74.409999999999997 110.287 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -39.07 -42.87 0.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.518 1.136 . . . . 74.129999999999995 111.036 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -61.2 -53.87 51.49 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.482 1.114 . . . . 72.430000000000007 110.28 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.439 ' CD1' ' O ' ' A' ' 358' ' ' GLU . 3.7 mt . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.125 . . . . 64.140000000000001 109.33 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 108.318 -0.993 . . . . 64.310000000000002 108.318 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.21 -65.82 0.5 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.487 1.117 . . . . 74.340000000000003 110.301 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 23.2 ptp -55.23 -34.2 63.77 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.425 1.078 . . . . 74.25 110.975 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 88.92 50.01 3.41 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.488 1.118 . . . . 64.430000000000007 110.988 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 3.6 m -145.58 179.39 7.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.508 0.77 . . . . 70.030000000000001 109.963 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' THR . . . . . 0.526 ' CG2' ' NE2' ' A' ' 371' ' ' GLN . 2.0 m -118.42 161.11 20.52 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.508 1.13 . . . . 71.200000000000003 110.383 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.517 ' CG ' HG23 ' A' ' 355' ' ' VAL . 2.7 t80 -59.31 -64.51 0.92 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.507 1.129 . . . . 74.540000000000006 111.028 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' GLN . . . . . 0.526 ' NE2' ' CG2' ' A' ' 369' ' ' THR . 0.2 OUTLIER -60.7 -29.52 69.38 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.488 1.117 . . . . 64.299999999999997 110.325 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . 0.43 HD21 ' N ' ' A' ' 373' ' ' CYS . 1.2 tm? -60.93 135.61 57.84 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 75.420000000000002 109.337 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . 0.43 ' N ' HD21 ' A' ' 372' ' ' LEU . 32.1 p -77.9 136.01 37.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.02 -0.991 . . . . 72.140000000000001 110.884 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.536 ' CD ' ' N ' ' A' ' 374' ' ' LYS . 0.2 OUTLIER -92.66 26.45 2.68 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.514 1.134 . . . . 64.0 109.306 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 7.0 mt -107.79 -56.67 4.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.495 1.122 . . . . 74.400000000000006 109.268 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' CYS . . . . . 0.409 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 14.2 m -108.28 -21.73 12.64 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.513 1.133 . . . . 63.409999999999997 108.354 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 57.71 38.01 27.41 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.511 1.132 . . . . 74.430000000000007 109.298 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -129.57 -43.92 1.24 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.448 1.093 . . . . 64.5 110.274 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -108.81 -172.96 2.16 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 72.239999999999995 109.287 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.15 175.47 6.28 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.528 1.142 . . . . 74.099999999999994 109.332 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.469 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 16.8 mttt -78.59 -50.79 10.92 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 71.530000000000001 109.301 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . 0.406 ' CG ' ' C ' ' A' ' 381' ' ' LYS . 0.1 OUTLIER 47.65 26.61 0.88 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.473 1.108 . . . . 74.109999999999999 109.261 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . 0.479 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.3 OUTLIER -156.13 176.1 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.481 1.113 . . . . 73.239999999999995 109.274 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -160.52 157.33 27.29 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.522 1.139 . . . . 75.439999999999998 109.29 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.491 ' CG2' ' SG ' ' A' ' 388' ' ' CYS . 11.6 mm -123.82 143.76 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.542 1.152 . . . . 64.5 109.301 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.525 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 7.0 mt-10 -137.72 162.39 54.82 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.575 1.172 . . . . 74.25 110.282 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.525 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.95 -12.49 23.85 Favored 'Cis proline' 0 C--N 1.36 1.163 0 C-N-CA 120.981 -2.508 . . . . 72.439999999999998 111.026 -0.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . 0.491 ' SG ' ' CG2' ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.41 -71.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.983 -1.008 . . . . 75.230000000000004 110.914 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.49 15.9 6.77 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.441 1.088 . . . . 52.520000000000003 110.946 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.567 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 21.4 m80 -73.07 148.0 44.46 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.522 0.777 . . . . 73.109999999999999 109.591 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.469 ' HB2' ' CE ' ' A' ' 381' ' ' LYS . 1.3 mt -119.47 158.14 26.85 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.518 1.136 . . . . 73.099999999999994 109.302 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' MET . . . . . 0.568 ' HE3' ' CD1' ' A' ' 410' ' ' PHE . 12.6 ptp -174.41 172.18 3.23 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.524 1.14 . . . . 74.019999999999996 111.016 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . 1.273 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 7.2 p -89.69 118.07 29.03 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.497 1.123 . . . . 71.200000000000003 108.275 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 73.4 m -52.51 -45.13 66.13 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.529 1.143 . . . . 75.219999999999999 110.374 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 37.2 m -55.69 -29.51 59.51 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.468 1.105 . . . . 64.299999999999997 109.971 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . 1.273 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 2.5 m -81.15 -47.51 13.37 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.452 1.095 . . . . 62.539999999999999 108.25 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . 0.441 ' C ' ' CD1' ' A' ' 397' ' ' LEU . 0.5 OUTLIER -41.49 -36.09 0.82 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 75.200000000000003 109.327 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' THR . . . . . 0.486 ' CG2' ' N ' ' A' ' 399' ' ' ALA . 0.5 OUTLIER -61.17 -52.54 64.41 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.43 1.081 . . . . 75.140000000000001 110.38 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 398' ' ' THR . . . -51.44 -23.23 3.68 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.543 1.152 . . . . 73.109999999999999 109.285 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' TRP . . . . . 0.607 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 8.9 t-105 -84.44 -64.91 1.08 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.534 1.146 . . . . 74.340000000000003 108.034 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.487 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.7 mm-40 -52.34 -17.37 1.14 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.487 1.117 . . . . 74.099999999999994 110.316 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 401' ' ' GLN . 7.0 mm-40 -37.18 -63.41 0.43 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 74.200000000000003 110.29 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.6 m -120.39 -24.56 5.84 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.515 1.134 . . . . 74.319999999999993 110.006 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . 0.607 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 8.2 m-20 -82.25 -94.92 0.05 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 64.519999999999996 109.327 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.487 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 70.5 28.73 70.69 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.475 1.11 . . . . 54.109999999999999 111.036 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -90.17 68.19 7.02 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.465 0.744 . . . . 72.540000000000006 110.297 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 65.34 -163.81 38.32 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.517 1.136 . . . . 73.409999999999997 111.01 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' A' ' 412' ' ' ARG . 6.3 t -58.21 129.27 82.98 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 108.363 -0.977 . . . . 71.439999999999998 108.363 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 -3.57 14.12 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.489 1.784 . . . . 75.299999999999997 111.042 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . 0.568 ' CD1' ' HE3' ' A' ' 392' ' ' MET . 4.5 m-85 -92.91 -41.48 10.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.119 . . . . 72.340000000000003 111.01 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' CYS . . . . . 0.456 ' SG ' ' CE1' ' A' ' 390' ' ' HIS . 0.1 OUTLIER -111.01 9.02 22.14 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.123 . . . . 71.030000000000001 108.285 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 408' ' ' CYS . 9.1 mmt85 38.56 30.23 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.555 1.159 . . . . 73.510000000000005 110.333 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' CYS . . . . . 0.442 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.3 m -125.55 163.01 23.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.531 1.144 . . . . 72.329999999999998 108.289 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -59.02 146.99 36.3 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.435 1.085 . . . . 75.420000000000002 110.275 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.466 HG21 ' CG2' ' A' ' 418' ' ' THR . 1.4 mt -93.06 153.41 3.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.477 1.111 . . . . 72.519999999999996 109.278 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.11 -46.33 3.01 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.526 1.141 . . . . 72.530000000000001 109.258 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . 0.494 ' O ' ' CG2' ' A' ' 418' ' ' THR . . . -131.11 144.73 16.28 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.501 1.125 . . . . 71.239999999999995 110.985 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' THR . . . . . 0.494 ' CG2' ' O ' ' A' ' 417' ' ' GLY . 17.6 p -157.59 116.26 3.2 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.512 0.772 . . . . 75.299999999999997 110.428 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -136.32 149.21 67.13 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.509 1.131 . . . . 75.340000000000003 110.314 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.491 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.3 Cg_endo -74.97 102.46 1.59 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.492 1.785 . . . . 73.239999999999995 111.0 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . 0.467 HD12 ' CG2' ' A' ' 423' ' ' VAL . 0.6 OUTLIER -103.83 158.9 5.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.46 1.1 . . . . 75.329999999999998 109.244 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . 0.536 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 11.2 mt -118.61 105.39 17.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.482 1.114 . . . . 74.200000000000003 109.311 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.467 ' CG2' HD12 ' A' ' 421' ' ' ILE . 21.5 t -76.78 149.25 6.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.502 1.127 . . . . 71.299999999999997 109.293 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.502 ' O ' ' CG2' ' A' ' 355' ' ' VAL . 9.2 m-20 -127.64 143.33 47.1 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.494 1.121 . . . . 73.239999999999995 109.32 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 179.25 6.26 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.488 1.783 . . . . 71.439999999999998 111.032 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . 0.4 ' CE1' ' HG2' ' A' ' 357' ' ' GLN . 10.5 t80 . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.499 1.125 . . . . 74.219999999999999 111.011 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 29.6 p . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 110.03 -0.359 . . . . 74.409999999999997 110.03 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.14 175.08 10.97 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.501 1.126 . . . . 75.219999999999999 109.347 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -136.6 138.86 41.65 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 70.129999999999995 109.582 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 52.7 mt -121.73 158.75 24.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.525 1.141 . . . . 72.329999999999998 109.323 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -123.2 139.61 53.87 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.476 1.11 . . . . 74.25 109.269 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . 0.454 HG22 ' CG ' ' A' ' 370' ' ' PHE . 24.6 t -99.49 144.23 12.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.494 1.121 . . . . 75.230000000000004 109.318 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.9 p -110.19 153.02 25.35 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.505 1.128 . . . . 64.099999999999994 110.386 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' GLN . . . . . 0.464 ' HG3' ' CE1' ' A' ' 426' ' ' PHE . 24.7 mt-30 -43.35 -52.04 6.08 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.481 1.113 . . . . 74.209999999999994 110.284 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -43.85 -49.83 8.11 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 72.099999999999994 110.297 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . 0.485 ' OE1' ' CD1' ' A' ' 370' ' ' PHE . 18.2 mt-30 -59.62 -32.8 70.76 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.49 1.119 . . . . 75.430000000000007 110.274 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . 0.443 ' O ' ' N ' ' A' ' 364' ' ' CYS . 3.7 t80 -71.02 -62.07 1.53 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.537 1.148 . . . . 74.209999999999994 111.016 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -53.67 -53.69 48.38 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.535 1.147 . . . . 75.120000000000005 110.28 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.508 1.13 . . . . 72.200000000000003 109.244 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 108.319 -0.993 . . . . 75.519999999999996 108.319 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -73.96 -13.64 60.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.462 1.101 . . . . 73.420000000000002 110.286 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 12.0 ptp -121.49 -0.98 9.66 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.493 1.12 . . . . 74.349999999999994 111.02 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 57.0 43.79 93.07 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.434 1.084 . . . . 71.439999999999998 110.966 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 3.6 p -132.85 173.96 10.83 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.438 0.728 . . . . 74.430000000000007 109.967 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' THR . . . . . 0.41 HG21 ' NE2' ' A' ' 371' ' ' GLN . 2.2 m -116.94 161.57 19.15 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.484 1.115 . . . . 74.030000000000001 110.383 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.485 ' CD1' ' OE1' ' A' ' 359' ' ' GLN . 78.2 t80 -64.02 -68.63 0.33 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.519 1.137 . . . . 73.109999999999999 110.982 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' GLN . . . . . 0.438 ' OE1' ' N ' ' A' ' 425' ' ' PRO . 0.0 OUTLIER -44.31 -35.82 2.5 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.541 1.15 . . . . 75.230000000000004 110.31 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . 0.494 ' CD1' ' O ' ' A' ' 373' ' ' CYS . 1.8 tm? -50.93 140.85 14.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.484 1.115 . . . . 75.340000000000003 109.247 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . 0.494 ' O ' ' CD1' ' A' ' 372' ' ' LEU . 19.7 p -85.42 147.08 26.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.97 -1.014 . . . . 63.439999999999998 110.913 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.557 ' CD ' ' N ' ' A' ' 374' ' ' LYS . 0.7 OUTLIER -99.54 17.44 20.41 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 71.400000000000006 109.29 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 5.9 mt -94.5 -61.69 2.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.458 1.099 . . . . 74.319999999999993 109.3 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' CYS . . . . . 0.656 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 2.6 m -102.67 -24.65 13.74 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.532 1.145 . . . . 72.219999999999999 108.273 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . 0.47 ' HA ' ' CD1' ' A' ' 372' ' ' LEU . . . 63.04 46.42 4.73 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.478 1.111 . . . . 75.329999999999998 109.323 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -139.53 -49.58 0.49 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.548 1.155 . . . . 74.299999999999997 110.279 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -104.91 174.35 5.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 72.329999999999998 109.333 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -85.86 173.18 10.19 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.542 1.151 . . . . 72.310000000000002 109.292 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.422 ' CA ' ' O ' ' A' ' 392' ' ' MET . 15.3 mttt -79.33 -54.86 5.53 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.515 1.134 . . . . 72.319999999999993 109.265 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . 0.401 ' OD2' ' O ' ' A' ' 381' ' ' LYS . 1.2 p30 51.87 26.78 3.8 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.478 1.111 . . . . 73.150000000000006 109.267 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' VAL . . . . . 0.472 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.4 OUTLIER -156.03 175.4 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.116 . . . . 71.049999999999997 109.35 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . 0.417 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 62.5 tttt -158.53 151.81 22.87 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.503 1.127 . . . . 74.319999999999993 109.293 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.441 ' O ' ' N ' ' A' ' 389' ' ' GLY . 24.7 mm -115.28 133.59 61.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.126 . . . . 72.030000000000001 109.337 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.495 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 5.9 mt-10 -137.67 161.11 62.13 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.534 1.146 . . . . 73.120000000000005 110.286 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.495 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.4 Cg_endo -75.01 -5.2 21.25 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 121.034 -2.486 . . . . 73.25 111.004 -0.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 32.6 t -37.99 -78.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.0 -1.0 . . . . 71.530000000000001 110.946 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 119.53 36.51 0.84 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.483 1.114 . . . . 73.150000000000006 111.002 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.55 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 51.0 m170 -108.5 131.9 54.36 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.491 0.759 . . . . 74.409999999999997 109.581 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.417 ' CD1' ' HG3' ' A' ' 384' ' ' LYS . 0.0 OUTLIER -99.87 158.55 15.72 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.486 1.116 . . . . 74.239999999999995 109.303 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' MET . . . . . 0.472 ' O ' ' CG1' ' A' ' 383' ' ' VAL . 17.1 ptp -172.6 174.42 3.74 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.473 1.108 . . . . 74.519999999999996 111.04 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' CYS . . . . . 1.187 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 28.1 p -97.53 115.55 28.06 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.469 1.106 . . . . 72.530000000000001 108.296 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 3.8 m -44.61 -58.99 2.69 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 75.329999999999998 110.364 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 29.6 m -41.11 -36.59 0.73 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.527 1.142 . . . . 73.510000000000005 109.989 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . 1.187 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 2.5 m -76.76 -50.42 13.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.477 1.11 . . . . 75.299999999999997 108.257 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . 0.424 ' C ' ' CD1' ' A' ' 397' ' ' LEU . 0.3 OUTLIER -43.0 -35.69 1.32 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.492 1.12 . . . . 75.319999999999993 109.282 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 53.4 m -63.01 -45.31 92.98 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.481 1.113 . . . . 63.549999999999997 110.447 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -57.65 -21.72 41.43 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.451 1.094 . . . . 72.329999999999998 109.309 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' TRP . . . . . 0.588 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 14.7 t-105 -86.09 -65.21 1.04 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.496 1.123 . . . . 73.340000000000003 107.98 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.499 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 40.1 mm-40 -48.83 -20.96 0.55 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.479 1.112 . . . . 74.140000000000001 110.288 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 401' ' ' GLN . 7.3 mt-10 -37.64 -63.65 0.44 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.538 1.149 . . . . 74.519999999999996 110.276 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 23.0 t -122.41 -24.45 5.0 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.477 1.111 . . . . 74.439999999999998 109.98 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . 0.588 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 3.0 m-20 -82.85 -94.42 0.06 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.512 1.133 . . . . 75.409999999999997 109.311 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.499 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 67.29 21.37 72.1 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.435 1.084 . . . . 73.409999999999997 110.965 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -81.0 62.46 4.99 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 0.767 . . . . 73.219999999999999 110.287 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 68.15 -163.46 48.2 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.536 1.147 . . . . 70.109999999999999 111.002 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' CYS . . . . . 0.435 ' O ' ' N ' ' A' ' 412' ' ' ARG . 2.3 t -56.12 121.45 41.56 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.303 -0.999 . . . . 73.239999999999995 108.303 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.448 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.3 Cg_endo -75.03 0.65 8.67 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.53 1.805 . . . . 73.25 110.965 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . 0.55 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 2.7 m-85 -92.49 -37.99 12.21 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 74.299999999999997 111.047 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' CYS . . . . . 0.435 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.8 OUTLIER -126.02 17.13 7.89 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.475 1.109 . . . . 73.120000000000005 108.335 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 408' ' ' CYS . 47.5 mmm-85 38.43 30.99 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.526 1.141 . . . . 73.010000000000005 110.302 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 411' ' ' CYS . 15.2 t -115.35 139.15 50.24 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 74.209999999999994 108.302 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -45.8 158.97 0.08 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.443 1.09 . . . . 64.239999999999995 110.344 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.455 HG23 ' CG2' ' A' ' 418' ' ' THR . 2.2 mt -114.45 157.24 15.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.448 1.093 . . . . 74.209999999999994 109.309 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -128.98 -47.79 1.23 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.514 1.134 . . . . 71.129999999999995 109.295 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . 0.491 ' O ' ' CG2' ' A' ' 418' ' ' THR . . . -108.76 127.9 8.8 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.541 1.15 . . . . 60.100000000000001 111.031 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' THR . . . . . 0.491 ' CG2' ' O ' ' A' ' 417' ' ' GLY . 17.5 p -157.51 116.74 3.29 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.502 0.766 . . . . 75.530000000000001 110.357 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -140.61 151.29 63.08 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.115 . . . . 71.540000000000006 110.296 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.2 Cg_endo -75.05 101.64 1.5 Allowed 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.485 1.781 . . . . 71.219999999999999 110.979 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . 0.453 HD11 ' CG2' ' A' ' 423' ' ' VAL . 0.7 OUTLIER -105.71 167.58 3.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.441 1.088 . . . . 74.310000000000002 109.335 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 12.7 mt -126.52 106.32 15.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.505 1.128 . . . . 75.230000000000004 109.293 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.461 HG12 ' CD2' ' A' ' 370' ' ' PHE . 15.4 t -78.89 145.74 9.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.479 1.112 . . . . 74.239999999999995 109.284 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -128.38 143.68 49.1 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 75.239999999999995 109.302 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . 0.438 ' N ' ' OE1' ' A' ' 371' ' ' GLN . 18.1 Cg_endo -75.01 175.65 10.97 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.559 1.82 . . . . 75.140000000000001 110.999 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' PHE . . . . . 0.464 ' CE1' ' HG3' ' A' ' 357' ' ' GLN . 39.8 t80 . . . . . 0 C--N 1.324 -0.507 0 O-C-N 124.505 1.128 . . . . 75.319999999999993 111.015 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.999 0 N-CA-C 111.012 -0.835 . . . . 52.439999999999998 111.012 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 177.87 7.99 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.497 1.788 . . . . 52.030000000000001 111.002 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 7.0 m80 70.77 47.33 0.46 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.48 1.113 . . . . 72.420000000000002 109.631 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -46.07 -75.34 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 74.519999999999996 111.039 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -57.6 178.47 1.1 Allowed Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.526 1.141 . . . . 71.439999999999998 110.984 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 29.0 t -91.46 135.25 33.98 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.472 0.748 . . . . 65.140000000000001 110.016 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . 0.462 ' HB2' ' CG2' ' A' ' 421' ' ' ILE . 10.8 m-20 -78.54 174.45 11.34 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.429 1.081 . . . . 72.129999999999995 109.266 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . 0.459 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 28.2 m-70 -131.43 126.46 35.17 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.478 1.111 . . . . 70.150000000000006 109.597 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 9.0 mt -111.34 149.16 14.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.481 1.113 . . . . 75.439999999999998 109.302 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 32.1 tptt -112.77 133.25 54.86 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.468 1.105 . . . . 72.409999999999997 109.353 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 40.0 t -87.75 149.53 4.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 73.299999999999997 109.33 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 5.9 p -114.15 149.19 36.02 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 72.239999999999995 110.413 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' GLN . . . . . 0.556 ' CG ' ' CE1' ' A' ' 426' ' ' PHE . 27.6 mt-30 -50.15 -34.33 21.99 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.479 1.112 . . . . 72.319999999999993 110.344 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -56.34 -52.53 64.2 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.497 1.123 . . . . 74.439999999999998 110.294 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -55.8 -67.18 0.31 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.521 1.138 . . . . 74.439999999999998 110.329 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 364' ' ' CYS . 1.2 t80 -44.25 -45.77 8.71 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.473 1.108 . . . . 74.420000000000002 111.021 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -61.61 -42.67 99.2 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.499 1.124 . . . . 72.129999999999995 110.314 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 7.8 mt -61.12 -49.4 77.43 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.472 1.107 . . . . 74.409999999999997 109.257 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' PTR . . . . . 0.415 ' O2P' ' NZ ' ' A' ' 374' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.6 m -64.9 -36.48 84.5 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.488 1.117 . . . . 63.43 108.345 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -68.67 -7.79 36.55 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.476 1.11 . . . . 75.150000000000006 110.316 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 7.4 mmt -106.2 -35.01 7.33 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.501 1.126 . . . . 74.349999999999994 111.015 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 90.55 46.97 3.87 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.54 1.15 . . . . 72.129999999999995 110.977 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 8.3 t -142.95 -174.63 4.23 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.489 0.758 . . . . 74.510000000000005 109.978 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.439 ' O ' ' NZ ' ' A' ' 374' ' ' LYS . 2.0 p -126.47 140.89 52.12 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.492 1.12 . . . . 61.0 110.422 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.445 ' O ' ' N ' ' A' ' 372' ' ' LEU . 76.0 t80 -56.18 -70.96 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.522 1.139 . . . . 74.430000000000007 111.027 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.54 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -38.52 -30.44 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 75.209999999999994 110.27 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 370' ' ' PHE . 0.0 OUTLIER -71.46 122.78 21.02 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.506 1.129 . . . . 75.510000000000005 109.327 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 14.8 p -59.13 134.8 57.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.035 -0.984 . . . . 61.140000000000001 110.919 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.445 ' NZ ' ' O ' ' A' ' 372' ' ' LEU . 23.0 mmtm -97.31 32.35 2.24 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.47 1.106 . . . . 74.129999999999995 109.33 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 2.7 mt -113.42 -59.62 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.116 . . . . 74.310000000000002 109.29 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 20.7 p -108.27 -13.92 14.8 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 64.400000000000006 108.293 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 47.66 41.83 14.28 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.482 1.114 . . . . 75.120000000000005 109.32 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -122.92 -41.02 2.37 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.128 . . . . 74.200000000000003 110.28 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.58 170.75 11.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.512 1.133 . . . . 74.319999999999993 109.313 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -76.72 175.47 9.35 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 75.140000000000001 109.33 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.455 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 21.9 mttt -73.78 -62.38 1.51 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.486 1.116 . . . . 72.299999999999997 109.314 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 59.91 25.93 15.12 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.478 1.112 . . . . 70.420000000000002 109.315 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -158.01 171.8 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.502 1.127 . . . . 64.239999999999995 109.292 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . 0.464 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 40.4 tttp -155.21 142.05 19.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.47 1.106 . . . . 73.109999999999999 109.303 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' A' ' 389' ' ' GLY . 21.7 mm -105.22 133.93 48.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.479 1.112 . . . . 72.519999999999996 109.297 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.488 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.1 mt-10 -137.84 161.19 61.39 Favored Pre-proline 0 C--N 1.324 -0.532 0 O-C-N 124.531 1.144 . . . . 72.430000000000007 110.293 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.488 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.02 -5.82 21.88 Favored 'Cis proline' 0 C--N 1.361 1.197 0 C-N-CA 120.982 -2.507 . . . . 75.109999999999999 111.035 0.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . 0.432 ' SG ' ' ND1' ' A' ' 390' ' ' HIS . 43.1 t -37.43 -76.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.017 -0.992 . . . . 73.409999999999997 110.905 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 118.22 34.79 1.08 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.499 1.124 . . . . 64.420000000000002 111.018 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.432 ' ND1' ' SG ' ' A' ' 388' ' ' CYS . 46.1 m170 -105.79 130.82 53.7 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.529 0.782 . . . . 73.030000000000001 109.569 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.464 ' CD1' ' HG3' ' A' ' 384' ' ' LYS . 0.0 OUTLIER -101.06 156.73 17.24 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 74.349999999999994 109.257 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' MET . . . . . 0.553 ' HE1' ' CE1' ' A' ' 410' ' ' PHE . 19.8 ptp -173.64 176.19 2.79 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.517 1.136 . . . . 75.040000000000006 110.98 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 7.3 p -94.04 114.93 27.19 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.508 1.13 . . . . 64.409999999999997 108.276 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 397' ' ' LEU . 94.6 m -48.43 -56.6 7.79 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.539 1.149 . . . . 72.120000000000005 110.422 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.5 t -45.82 -25.96 0.6 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 74.319999999999993 109.944 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 1.8 m -87.63 -42.53 12.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.478 1.111 . . . . 64.239999999999995 108.322 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 400' ' ' TRP . 1.0 OUTLIER -48.0 -54.55 12.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 74.120000000000005 109.31 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 61.6 m -45.63 -36.48 4.84 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.465 1.103 . . . . 70.319999999999993 110.438 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.61 95.22 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.513 1.133 . . . . 62.149999999999999 109.272 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' TRP . . . . . 0.508 ' CD2' ' HB3' ' A' ' 409' ' ' PRO . 2.1 t-105 -69.2 -52.61 26.11 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.496 1.123 . . . . 74.019999999999996 108.01 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -62.68 -16.3 56.52 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.546 1.154 . . . . 72.209999999999994 110.339 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -86.78 -11.4 51.1 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.448 1.092 . . . . 74.129999999999995 110.268 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.4 t -111.9 -23.0 10.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 72.0 109.985 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 404' ' ' ASP . 8.7 t0 -153.19 -88.46 0.05 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.483 1.115 . . . . 71.430000000000007 109.307 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 108.3 32.62 3.17 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.493 1.121 . . . . 64.540000000000006 111.004 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . 0.433 ' O ' ' CG ' ' A' ' 406' ' ' GLN . 3.1 tt0 -91.27 79.28 5.69 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.514 0.773 . . . . 72.219999999999999 110.286 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 43.91 -159.06 0.12 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.53 1.144 . . . . 73.140000000000001 111.013 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 412' ' ' ARG . 4.9 t -56.38 125.61 66.37 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 108.319 -0.993 . . . . 75.319999999999993 108.319 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.508 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.2 Cg_endo -74.98 -2.48 12.59 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.48 1.779 . . . . 75.409999999999997 110.968 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . 0.553 ' CE1' ' HE1' ' A' ' 392' ' ' MET . 6.7 m-85 -89.12 -37.93 14.71 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.466 1.104 . . . . 73.510000000000005 110.975 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' CYS . . . . . . . . . . . . . 1.2 p -121.17 10.37 10.66 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.492 1.12 . . . . 74.120000000000005 108.286 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 408' ' ' CYS . 49.1 mmm-85 38.68 49.94 1.54 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.507 1.129 . . . . 64.430000000000007 110.343 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 41.8 t -138.14 148.84 45.33 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.511 1.132 . . . . 74.010000000000005 108.328 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -52.2 159.0 1.01 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.561 1.163 . . . . 74.200000000000003 110.273 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.433 HG22 ' CG2' ' A' ' 418' ' ' THR . 2.3 mt -113.83 147.36 17.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.429 1.081 . . . . 75.230000000000004 109.293 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -114.85 -44.31 3.06 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.138 . . . . 73.219999999999999 109.312 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . 0.479 ' O ' ' CG2' ' A' ' 418' ' ' THR . . . -111.77 127.78 8.29 Favored Glycine 0 CA--C 1.531 1.053 0 O-C-N 124.537 1.148 . . . . 72.439999999999998 110.984 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' THR . . . . . 0.479 ' CG2' ' O ' ' A' ' 417' ' ' GLY . 38.8 p -156.15 136.26 12.86 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.547 0.792 . . . . 71.219999999999999 110.405 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -171.98 156.13 3.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.495 1.122 . . . . 74.439999999999998 110.304 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.439 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.5 Cg_endo -74.94 101.87 1.52 Allowed 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.445 1.761 . . . . 73.400000000000006 111.011 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . 0.471 ' CD1' ' C ' ' A' ' 421' ' ' ILE . 1.1 pp -103.93 167.69 2.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.496 1.123 . . . . 74.140000000000001 109.326 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . 0.459 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 10.4 mm -113.97 112.22 39.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.53 1.144 . . . . 74.450000000000003 109.252 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.459 HG23 ' CD1' ' A' ' 421' ' ' ILE . 2.2 t -77.43 136.68 23.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.473 1.108 . . . . 75.5 109.27 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -131.33 131.85 23.26 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.477 1.111 . . . . 75.519999999999996 109.282 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 176.96 9.22 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.467 1.772 . . . . 70.109999999999999 110.999 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . 0.556 ' CE1' ' CG ' ' A' ' 357' ' ' GLN . 19.6 t80 . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.489 1.118 . . . . 74.150000000000006 111.052 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.956 0 N-CA-C 111.027 -0.829 . . . . 74.140000000000001 111.027 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 178.61 7.03 Favored 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.45 1.763 . . . . 64.409999999999997 110.966 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -74.82 -175.0 2.35 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.507 1.129 . . . . 74.209999999999994 109.586 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 4.6 ttp -119.01 177.13 4.98 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.498 1.124 . . . . 71.409999999999997 111.03 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 109.24 154.31 15.75 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.486 1.117 . . . . 61.340000000000003 111.002 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 69.8 m -74.91 124.75 27.48 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.484 0.756 . . . . 74.109999999999999 110.045 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -91.31 169.46 10.79 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 74.329999999999998 109.29 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -124.71 114.52 19.41 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.547 1.154 . . . . 74.329999999999998 109.629 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . 0.465 ' CD1' HD11 ' A' ' 421' ' ' ILE . 1.6 mp -102.96 142.68 16.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.469 1.106 . . . . 74.519999999999996 109.309 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.431 ' NZ ' ' OD2' ' A' ' 424' ' ' ASP . 17.6 tppt? -124.91 117.93 25.16 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.465 1.103 . . . . 72.439999999999998 109.289 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.25 154.8 7.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.492 1.12 . . . . 73.120000000000005 109.315 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 15.0 p -126.25 161.35 27.94 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.509 1.13 . . . . 72.340000000000003 110.43 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -56.05 -38.69 70.94 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.509 1.131 . . . . 74.319999999999993 110.332 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.14 -32.15 54.39 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.481 1.113 . . . . 75.329999999999998 110.29 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -83.79 -66.89 0.84 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.546 1.154 . . . . 74.400000000000006 110.281 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -41.89 -35.9 0.94 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.568 1.168 . . . . 74.340000000000003 111.039 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -66.41 -62.51 1.43 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.507 1.129 . . . . 73.5 110.281 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 9.8 tt -52.24 -30.53 28.02 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.462 1.101 . . . . 74.409999999999997 109.326 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' PTR . . . . . 0.416 ' CE1' ' O2P' ' A' ' 363' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.8 m -67.08 -24.16 65.93 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.465 1.103 . . . . 73.439999999999998 108.314 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.25 -21.13 62.15 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 73.439999999999998 110.305 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 2.0 mtm -103.33 -28.2 11.99 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 72.510000000000005 111.016 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 87.68 40.15 6.87 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.479 1.112 . . . . 63.32 110.954 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 20.8 t -139.22 177.73 7.69 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.502 0.766 . . . . 75.109999999999999 109.969 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.41 ' HB ' ' NE2' ' A' ' 371' ' ' GLN . 12.7 p -113.4 179.53 3.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 73.430000000000007 110.402 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.516 ' CD2' HG13 ' A' ' 423' ' ' VAL . 43.9 t80 -85.17 -65.97 0.95 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.555 1.159 . . . . 75.310000000000002 111.039 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.55 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -40.0 -31.72 0.13 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.522 1.139 . . . . 75.120000000000005 110.319 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . 0.442 ' O ' ' NZ ' ' A' ' 374' ' ' LYS . 1.5 tm? -66.89 136.73 55.84 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.525 1.141 . . . . 71.219999999999999 109.259 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 13.2 t -79.47 130.18 35.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.965 -1.016 . . . . 72.519999999999996 110.931 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.442 ' NZ ' ' O ' ' A' ' 372' ' ' LEU . 10.8 mmtm -87.31 11.31 14.66 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.539 1.15 . . . . 74.319999999999993 109.305 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 3.9 mt -102.83 -40.5 6.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.464 1.103 . . . . 75.519999999999996 109.262 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 86.1 m -110.21 -35.63 6.04 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.494 1.121 . . . . 64.230000000000004 108.321 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 55.87 35.9 26.31 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.514 1.134 . . . . 72.239999999999995 109.327 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -131.79 -44.74 0.97 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.465 1.103 . . . . 74.099999999999994 110.314 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -113.69 -176.54 2.92 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.511 1.132 . . . . 74.319999999999993 109.32 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -97.66 158.93 15.23 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.502 1.126 . . . . 74.430000000000007 109.319 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.416 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 23.9 mttt -59.48 -62.46 1.86 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.47 1.106 . . . . 74.519999999999996 109.303 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 13.6 t70 59.54 27.0 16.08 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.459 1.099 . . . . 72.430000000000007 109.312 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . 0.461 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -157.84 173.43 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.536 1.147 . . . . 61.140000000000001 109.29 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 23.5 tttp -156.68 137.39 13.28 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.469 1.105 . . . . 74.430000000000007 109.27 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.454 ' O ' ' N ' ' A' ' 389' ' ' GLY . 10.4 mm -101.02 132.32 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 75.540000000000006 109.341 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.498 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 7.9 mt-10 -137.8 161.16 61.62 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 75.510000000000005 110.314 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.498 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.94 -4.73 20.57 Favored 'Cis proline' 0 C--N 1.36 1.159 0 C-N-CA 121.004 -2.498 . . . . 74.239999999999995 111.035 -0.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . 0.502 ' SG ' ' CE1' ' A' ' 390' ' ' HIS . 44.1 t -37.45 -76.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.96 -1.018 . . . . 73.319999999999993 110.907 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 118.15 34.65 1.1 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.512 1.132 . . . . 73.420000000000002 111.0 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.502 ' CE1' ' SG ' ' A' ' 388' ' ' CYS . 66.4 m170 -108.6 127.88 54.34 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.509 0.77 . . . . 72.340000000000003 109.594 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.443 ' CD1' ' HG3' ' A' ' 384' ' ' LYS . 0.0 OUTLIER -97.46 157.86 15.78 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.463 1.102 . . . . 75.329999999999998 109.353 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' MET . . . . . 0.461 ' O ' ' CG1' ' A' ' 383' ' ' VAL . 19.5 ptp -174.37 175.38 2.62 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.452 1.095 . . . . 74.530000000000001 110.991 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 23.4 p -97.91 115.51 28.26 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.527 1.142 . . . . 71.549999999999997 108.29 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 396' ' ' CYS . 85.5 m -46.15 -60.0 2.55 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.53 1.144 . . . . 74.120000000000005 110.415 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 8.1 m -39.91 -29.7 0.07 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.471 1.107 . . . . 74.049999999999997 109.956 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . 0.426 ' N ' ' O ' ' A' ' 394' ' ' THR . 2.8 m -85.44 -53.88 4.92 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.524 1.14 . . . . 73.340000000000003 108.296 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . 0.499 ' C ' ' CD2' ' A' ' 397' ' ' LEU . 2.1 tt -43.01 -55.4 3.81 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.513 1.133 . . . . 75.140000000000001 109.319 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 61.3 m -45.56 -38.14 6.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.508 1.13 . . . . 74.200000000000003 110.413 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -64.22 -38.49 91.24 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.121 . . . . 73.129999999999995 109.313 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' TRP . . . . . 0.449 ' N ' ' O ' ' A' ' 397' ' ' LEU . 2.8 t-105 -63.35 -47.12 83.47 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.549 1.156 . . . . 74.349999999999994 107.986 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -58.65 -35.72 73.0 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.482 1.114 . . . . 74.329999999999998 110.25 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -74.36 -2.74 26.58 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.512 1.133 . . . . 75.109999999999999 110.268 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 29.4 t -113.73 -23.13 9.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 1.131 . . . . 71.109999999999999 109.956 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.16 -78.34 0.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.452 1.095 . . . . 74.409999999999997 109.259 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 100.1 32.86 5.41 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.473 1.108 . . . . 33.549999999999997 110.988 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -93.94 76.51 4.16 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.478 0.752 . . . . 73.530000000000001 110.29 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 44.41 -157.68 0.18 Allowed Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.522 1.139 . . . . 62.509999999999998 111.026 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . 0.448 ' O ' ' N ' ' A' ' 412' ' ' ARG . 5.3 t -56.14 127.01 69.22 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.323 -0.991 . . . . 72.209999999999994 108.323 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 0.63 8.69 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.511 1.795 . . . . 74.310000000000002 110.986 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . 0.429 ' CD2' ' HE1' ' A' ' 392' ' ' MET . 15.8 m-85 -94.76 -36.5 11.68 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.455 1.097 . . . . 75.209999999999994 110.984 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' CYS . . . . . 0.449 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.8 OUTLIER -122.83 12.63 9.82 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.464 1.103 . . . . 75.310000000000002 108.335 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 408' ' ' CYS . 1.6 tpt180 38.19 30.75 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.513 1.133 . . . . 74.049999999999997 110.313 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' CYS . . . . . 0.449 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.7 m -113.82 150.5 33.43 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.523 1.139 . . . . 71.439999999999998 108.278 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -55.96 149.24 15.6 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.437 1.086 . . . . 70.349999999999994 110.299 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.47 HG22 ' CG2' ' A' ' 418' ' ' THR . 2.1 mt -99.02 136.29 30.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.499 1.124 . . . . 75.209999999999994 109.308 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -114.67 -54.72 2.55 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.499 1.124 . . . . 72.420000000000002 109.286 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . 0.499 ' O ' ' CG2' ' A' ' 418' ' ' THR . . . -95.89 127.78 9.29 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.467 1.104 . . . . 73.519999999999996 110.956 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' THR . . . . . 0.499 ' CG2' ' O ' ' A' ' 417' ' ' GLY . 18.2 p -157.47 137.01 12.09 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.541 0.789 . . . . 72.540000000000006 110.367 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -172.18 155.97 3.67 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.407 1.067 . . . . 75.430000000000007 110.348 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.431 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.4 Cg_endo -75.04 102.82 1.64 Allowed 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.458 1.768 . . . . 74.510000000000005 110.974 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . 0.483 ' CD1' ' C ' ' A' ' 421' ' ' ILE . 0.7 OUTLIER -103.82 155.27 5.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.491 1.119 . . . . 65.5 109.301 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . 0.42 ' N ' HD13 ' A' ' 421' ' ' ILE . 17.1 mt -108.0 108.49 25.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.545 1.153 . . . . 75.120000000000005 109.261 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.516 HG13 ' CD2' ' A' ' 370' ' ' PHE . 14.6 t -76.57 146.42 8.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.489 1.118 . . . . 72.239999999999995 109.25 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.431 ' OD2' ' NZ ' ' A' ' 354' ' ' LYS . 3.0 t70 -127.98 127.97 23.83 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.536 1.147 . . . . 75.329999999999998 109.336 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 179.52 6.0 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.535 1.808 . . . . 75.230000000000004 110.983 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 76.9 t80 . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.461 1.1 . . . . 72.319999999999993 111.047 179.939 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.021 0 N-CA-C 111.009 -0.836 . . . . 71.329999999999998 111.009 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.04 178.19 7.61 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.521 1.801 . . . . 74.439999999999998 110.996 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -100.56 148.57 24.65 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.468 1.105 . . . . 74.230000000000004 109.56 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -122.27 1.8 9.69 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.51 1.131 . . . . 74.219999999999999 111.012 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -94.77 23.82 30.99 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.516 1.135 . . . . 71.219999999999999 110.992 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 4.3 m -143.46 136.46 27.73 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.529 0.782 . . . . 73.150000000000006 109.951 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -90.64 179.83 5.72 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.483 1.114 . . . . 73.219999999999999 109.296 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . 0.461 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 61.2 m-70 -138.23 150.17 46.46 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 73.030000000000001 109.595 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 17.2 mt -136.55 156.68 36.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.496 1.122 . . . . 74.140000000000001 109.308 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 12.0 tptm -117.92 152.66 34.98 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.464 1.102 . . . . 74.239999999999995 109.322 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 32.1 t -109.09 156.72 9.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.454 1.096 . . . . 73.549999999999997 109.337 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 12.3 p -122.7 152.87 40.13 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.507 1.13 . . . . 71.030000000000001 110.402 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' GLN . . . . . 0.545 ' HG2' ' CE2' ' A' ' 426' ' ' PHE . 1.7 mm100 -45.84 -53.36 9.84 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.475 1.109 . . . . 72.310000000000002 110.325 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -43.55 -40.27 3.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.537 1.148 . . . . 73.340000000000003 110.308 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -70.89 -66.49 0.6 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.486 1.116 . . . . 72.530000000000001 110.282 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 364' ' ' CYS . 7.4 t80 -45.07 -63.77 0.86 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 73.219999999999999 110.997 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -45.34 -52.28 10.05 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.52 1.137 . . . . 71.540000000000006 110.267 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.3 tt -55.18 -33.46 63.02 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.548 1.155 . . . . 74.530000000000001 109.312 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' PTR . . . . . 0.545 ' CD1' ' NZ ' ' A' ' 374' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . 0.449 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.9 m -66.79 -21.89 66.04 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.515 1.134 . . . . 71.510000000000005 108.283 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -79.51 -2.71 43.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.545 1.153 . . . . 74.25 110.277 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 8.3 mmt -108.3 -34.82 6.7 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.54 1.15 . . . . 71.030000000000001 110.982 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.02 4.61 41.63 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.479 1.112 . . . . 63.329999999999998 110.968 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 1.2 m -127.92 -176.2 3.71 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.529 0.782 . . . . 73.200000000000003 109.992 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.434 ' O ' ' CE ' ' A' ' 374' ' ' LYS . 15.1 p -114.29 -179.34 3.6 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.518 1.136 . . . . 75.040000000000006 110.394 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.512 ' HA ' ' CE1' ' A' ' 363' ' ' PTR . 62.7 t80 -78.49 -67.63 0.72 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 1.12 . . . . 75.109999999999999 110.979 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.547 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -38.89 -29.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.538 1.149 . . . . 73.400000000000006 110.3 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . 0.436 ' N ' ' C ' ' A' ' 370' ' ' PHE . 0.5 OUTLIER -72.56 136.54 45.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.547 1.154 . . . . 74.209999999999994 109.273 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . 0.421 ' N ' ' CD2' ' A' ' 372' ' ' LEU . 11.5 t -70.97 133.54 46.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.004 -0.998 . . . . 70.010000000000005 110.928 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.545 ' NZ ' ' CD1' ' A' ' 363' ' ' PTR . 29.8 mmtp -93.9 24.39 4.25 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.547 1.154 . . . . 71.299999999999997 109.285 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 36.3 mt -107.38 -56.17 4.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.498 1.124 . . . . 75.310000000000002 109.308 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 1.8 m -104.75 -23.15 13.09 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.482 1.114 . . . . 64.5 108.309 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 50.61 39.77 22.2 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.516 1.135 . . . . 62.539999999999999 109.302 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -124.57 -42.13 2.1 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.13 . . . . 73.519999999999996 110.271 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -123.62 171.0 9.88 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.52 1.138 . . . . 72.209999999999994 109.303 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -81.35 164.59 22.04 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.484 1.115 . . . . 64.129999999999995 109.302 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.458 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 20.0 mttt -67.75 -62.47 1.4 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.55 1.156 . . . . 74.340000000000003 109.292 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 1.9 t70 59.29 24.55 13.06 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.546 1.154 . . . . 63.229999999999997 109.283 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.6 OUTLIER -155.42 171.01 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.478 1.111 . . . . 75.219999999999999 109.305 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -154.19 147.25 24.61 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.462 1.101 . . . . 70.439999999999998 109.307 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.443 ' O ' ' N ' ' A' ' 389' ' ' GLY . 22.8 mm -110.4 134.33 52.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.477 1.11 . . . . 74.340000000000003 109.285 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.495 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 9.8 mt-10 -137.65 160.97 62.93 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.546 1.154 . . . . 71.439999999999998 110.276 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.495 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.5 Cg_endo -74.97 -5.13 21.03 Favored 'Cis proline' 0 C--N 1.36 1.14 0 C-N-CA 121.003 -2.499 . . . . 74.129999999999995 111.056 -0.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . 0.594 ' SG ' ' CE1' ' A' ' 390' ' ' HIS . 43.0 t -38.11 -79.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.964 -1.016 . . . . 71.030000000000001 110.942 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 119.92 36.98 0.79 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.485 1.115 . . . . 63.119999999999997 111.012 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.594 ' CE1' ' SG ' ' A' ' 388' ' ' CYS . 65.6 m170 -108.45 130.89 55.23 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 0.76 . . . . 74.319999999999993 109.6 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.458 ' HB2' ' CE ' ' A' ' 381' ' ' LYS . 0.0 OUTLIER -98.43 157.48 16.18 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.133 . . . . 73.109999999999999 109.28 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' MET . . . . . 0.468 ' O ' ' CG1' ' A' ' 383' ' ' VAL . 15.5 ptp -171.81 174.38 4.24 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.509 1.13 . . . . 74.329999999999998 111.036 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 26.3 p -98.13 115.98 29.4 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.531 1.145 . . . . 72.349999999999994 108.291 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 26.2 m -42.12 -59.37 1.79 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.559 1.162 . . . . 74.230000000000004 110.421 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.7 t -42.82 -37.09 1.68 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.553 1.158 . . . . 64.239999999999995 109.983 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 3.5 m -73.69 -53.6 10.02 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.542 1.151 . . . . 71.430000000000007 108.297 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . 0.467 ' C ' ' CD1' ' A' ' 397' ' ' LEU . 0.8 OUTLIER -43.89 -37.18 2.71 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.536 1.147 . . . . 71.340000000000003 109.265 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 53.1 m -61.14 -46.07 92.07 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.514 1.134 . . . . 74.230000000000004 110.406 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -59.97 -19.88 54.59 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.498 1.124 . . . . 73.420000000000002 109.33 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' TRP . . . . . 0.605 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 9.7 t-105 -85.75 -64.94 1.07 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.5 1.125 . . . . 71.040000000000006 108.022 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.489 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 10.3 mm-40 -52.44 -17.18 1.1 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.457 1.098 . . . . 73.439999999999998 110.313 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 401' ' ' GLN . 2.3 mm-40 -37.19 -63.31 0.44 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.516 1.135 . . . . 73.450000000000003 110.281 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 2.5 m -121.0 -24.57 5.55 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.512 1.133 . . . . 71.510000000000005 110.004 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . 0.605 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 13.2 m-20 -82.05 -94.25 0.05 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.45 1.094 . . . . 73.0 109.298 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.489 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 69.18 30.89 71.67 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 124.5 1.125 . . . . 72.5 111.002 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -90.66 57.34 3.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.569 0.805 . . . . 75.310000000000002 110.326 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 69.27 -160.54 52.65 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.472 1.108 . . . . 35.539999999999999 110.971 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 412' ' ' ARG . 1.4 t -56.53 121.74 45.64 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 108.282 -1.007 . . . . 74.5 108.282 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.405 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.0 Cg_endo -75.07 0.3 9.1 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.538 1.809 . . . . 73.150000000000006 110.969 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . 0.46 ' CE1' ' HE2' ' A' ' 392' ' ' MET . 10.8 m-85 -89.35 -38.83 13.86 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 62.229999999999997 111.0 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' CYS . . . . . 0.402 ' O ' ' C ' ' A' ' 412' ' ' ARG . 0.7 OUTLIER -126.49 15.85 7.64 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 73.200000000000003 108.322 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 408' ' ' CYS . 0.4 OUTLIER 38.71 41.27 0.48 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.561 1.163 . . . . 63.520000000000003 110.279 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 14.9 t -124.19 140.48 52.93 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 51.229999999999997 108.316 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -47.63 157.44 0.24 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.543 1.152 . . . . 74.329999999999998 110.307 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.466 HG23 ' CG2' ' A' ' 418' ' ' THR . 2.3 mt -111.75 155.12 13.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.442 1.089 . . . . 75.25 109.319 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -120.91 -46.11 2.35 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.499 1.124 . . . . 72.209999999999994 109.308 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . 0.493 ' O ' ' CG2' ' A' ' 418' ' ' THR . . . -115.55 132.73 10.47 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.525 1.14 . . . . 71.510000000000005 110.967 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' THR . . . . . 0.493 ' CG2' ' O ' ' A' ' 417' ' ' GLY . 21.0 p -157.23 117.37 3.48 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.443 0.731 . . . . 63.450000000000003 110.397 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -144.82 151.55 49.82 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.51 1.131 . . . . 74.530000000000001 110.291 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 100.82 1.4 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.502 1.791 . . . . 64.040000000000006 110.995 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . 0.437 ' CD1' HG22 ' A' ' 423' ' ' VAL . 0.7 OUTLIER -104.68 169.51 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.502 1.126 . . . . 75.099999999999994 109.312 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . 0.461 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 9.7 mt -124.95 105.43 15.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.518 1.136 . . . . 71.430000000000007 109.304 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.437 HG22 ' CD1' ' A' ' 421' ' ' ILE . 11.2 t -78.51 142.29 14.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.472 1.107 . . . . 64.200000000000003 109.301 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.92 143.7 48.72 Favored Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.486 1.116 . . . . 74.129999999999995 109.324 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 176.44 9.92 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.451 1.764 . . . . 71.310000000000002 110.983 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . 0.545 ' CE2' ' HG2' ' A' ' 357' ' ' GLN . 3.3 t80 . . . . . 0 C--N 1.325 -0.48 0 O-C-N 124.55 1.156 . . . . 73.030000000000001 111.04 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.969 0 N-CA-C 111.036 -0.826 . . . . 60.350000000000001 111.036 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 178.59 7.06 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.464 1.77 . . . . 74.340000000000003 111.015 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -115.04 112.7 23.03 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 1.136 . . . . 75.299999999999997 109.628 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 11.3 mmt -92.51 20.64 6.06 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.554 1.159 . . . . 71.120000000000005 111.03 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -142.94 20.36 2.33 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.527 1.142 . . . . 70.230000000000004 110.958 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 63.8 m -142.7 140.43 31.52 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.534 0.785 . . . . 55.409999999999997 109.998 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -96.3 -174.33 3.04 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.527 1.142 . . . . 65.230000000000004 109.318 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . 0.519 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 31.3 m-70 -138.99 140.66 38.25 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.461 1.101 . . . . 73.400000000000006 109.55 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 3.9 mm -122.07 156.19 26.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.503 1.127 . . . . 73.430000000000007 109.336 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -122.28 138.86 54.36 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.526 1.141 . . . . 65.209999999999994 109.322 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 37.3 t -97.58 148.92 5.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.49 1.119 . . . . 75.25 109.347 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.6 p -108.55 141.86 39.83 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.547 1.154 . . . . 74.019999999999996 110.392 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' GLN . . . . . 0.537 ' HG2' ' CE2' ' A' ' 426' ' ' PHE . 4.9 mt-30 -39.66 -32.98 0.16 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.483 1.114 . . . . 72.010000000000005 110.32 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -57.05 -53.51 57.28 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.499 1.125 . . . . 75.430000000000007 110.322 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -66.07 -22.67 66.42 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.546 1.154 . . . . 72.140000000000001 110.331 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -86.82 -23.73 25.24 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.492 1.12 . . . . 75.430000000000007 111.03 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 357' ' ' GLN . 4.6 mm-40 -84.41 -50.27 7.94 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.519 1.137 . . . . 72.430000000000007 110.235 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.468 ' N ' ' CD1' ' A' ' 362' ' ' LEU . 0.2 OUTLIER -59.97 -41.04 91.1 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.515 1.134 . . . . 72.040000000000006 109.288 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -53.26 60.23 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.119 . . . . 71.049999999999997 108.284 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -43.35 -68.31 0.21 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.514 1.134 . . . . 74.409999999999997 110.326 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 21.7 ptp -56.65 -31.12 64.06 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.53 1.144 . . . . 73.349999999999994 111.001 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 82.42 50.9 4.57 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.533 1.145 . . . . 63.539999999999999 111.015 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 1.5 t -126.29 -179.24 4.64 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.477 0.751 . . . . 75.519999999999996 110.026 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.406 ' HB ' ' NE2' ' A' ' 371' ' ' GLN . 2.8 p -129.1 140.46 51.56 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.521 1.138 . . . . 72.319999999999993 110.365 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.541 ' CE2' HG12 ' A' ' 423' ' ' VAL . 60.8 t80 -64.52 -68.2 0.37 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.451 1.094 . . . . 74.040000000000006 111.035 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.56 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -39.44 -30.02 0.06 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.124 . . . . 61.0 110.327 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . 0.435 ' CD2' ' N ' ' A' ' 373' ' ' CYS . 0.4 OUTLIER -73.4 136.14 44.3 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.489 1.118 . . . . 74.019999999999996 109.339 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . 0.435 ' N ' ' CD2' ' A' ' 372' ' ' LEU . 26.9 p -67.88 131.85 46.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.015 -0.993 . . . . 34.509999999999998 110.926 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -93.21 29.57 1.87 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 72.409999999999997 109.328 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 17.1 mt -107.65 -59.78 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.469 1.106 . . . . 71.040000000000006 109.315 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 3.7 m -107.71 -23.17 12.21 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.516 1.135 . . . . 74.030000000000001 108.279 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 56.81 42.55 26.43 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 72.409999999999997 109.321 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -124.17 -42.45 2.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.516 1.135 . . . . 71.299999999999997 110.296 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -121.89 170.57 9.66 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.553 1.158 . . . . 63.240000000000002 109.309 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 17.3 p30 -83.24 162.1 21.29 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.472 1.108 . . . . 73.120000000000005 109.294 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -64.37 -55.57 20.25 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.489 1.118 . . . . 73.329999999999998 109.298 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 1.1 p30 52.22 25.71 3.51 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 74.439999999999998 109.308 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . 0.473 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -153.21 176.09 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.53 1.143 . . . . 74.129999999999995 109.286 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -160.94 142.23 11.83 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.448 1.093 . . . . 74.349999999999994 109.294 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.456 ' O ' ' N ' ' A' ' 389' ' ' GLY . 10.4 mm -108.12 138.58 34.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 124.554 1.159 . . . . 72.230000000000004 109.308 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.502 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.1 OUTLIER -138.06 161.39 59.9 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.511 1.132 . . . . 72.299999999999997 110.27 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.502 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.98 -7.16 22.99 Favored 'Cis proline' 0 C--N 1.36 1.158 0 C-N-CA 120.983 -2.507 . . . . 75.209999999999994 111.024 -0.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . 0.442 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 41.2 t -36.83 -73.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.002 -0.999 . . . . 71.219999999999999 110.919 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 115.95 16.5 6.78 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.478 1.111 . . . . 73.200000000000003 111.043 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.514 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 49.6 m170 -86.85 131.42 34.12 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.525 0.779 . . . . 73.299999999999997 109.623 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.408 ' CD2' ' N ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -100.78 161.8 13.35 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.506 1.129 . . . . 74.299999999999997 109.285 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' MET . . . . . 0.473 ' O ' ' CG1' ' A' ' 383' ' ' VAL . 18.6 ptp -174.72 174.83 2.55 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.508 1.13 . . . . 73.430000000000007 110.973 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 7.0 p -96.55 119.56 35.25 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.521 1.138 . . . . 75.120000000000005 108.289 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 44.1 m -44.01 -59.22 2.4 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.486 1.117 . . . . 74.209999999999994 110.365 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 14.6 m -43.41 -34.2 1.23 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.499 1.124 . . . . 71.400000000000006 109.999 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . 0.435 ' O ' ' N ' ' A' ' 399' ' ' ALA . 1.8 m -76.1 -57.81 3.65 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.531 1.144 . . . . 65.109999999999999 108.34 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' A' ' 397' ' ' LEU . 1.2 tm? -41.96 -39.03 1.75 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.452 1.095 . . . . 72.109999999999999 109.242 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 2.8 m -60.59 -46.52 89.93 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.509 1.131 . . . . 71.549999999999997 110.418 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -58.8 -20.65 52.0 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.142 . . . . 73.200000000000003 109.293 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' TRP . . . . . 0.607 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 7.7 t-105 -85.94 -64.92 1.07 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.526 1.141 . . . . 72.129999999999995 108.005 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.483 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.1 mm-40 -52.23 -17.4 1.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.498 1.124 . . . . 73.409999999999997 110.297 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 401' ' ' GLN . 2.3 mm-40 -37.14 -63.36 0.44 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.525 1.14 . . . . 74.200000000000003 110.26 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.6 m -120.82 -24.65 5.61 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.482 1.114 . . . . 73.109999999999999 110.01 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . 0.607 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 12.2 m-20 -81.58 -93.86 0.05 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.516 1.135 . . . . 75.230000000000004 109.312 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.483 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 69.93 29.67 70.69 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.485 1.115 . . . . 52.0 111.009 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -92.02 68.13 5.22 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.528 0.781 . . . . 74.120000000000005 110.312 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 63.34 -167.01 24.37 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 124.502 1.126 . . . . 52.5 111.005 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . 0.415 ' O ' ' N ' ' A' ' 412' ' ' ARG . 2.0 t -56.21 123.22 53.61 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 108.307 -0.997 . . . . 52.32 108.307 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.421 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.2 Cg_endo -74.99 0.3 9.07 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.451 1.763 . . . . 71.319999999999993 110.986 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . 0.514 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 3.3 m-30 -91.38 -40.77 11.26 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.478 1.111 . . . . 74.140000000000001 110.986 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' CYS . . . . . 0.442 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.8 OUTLIER -122.36 16.19 10.54 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.533 1.145 . . . . 74.120000000000005 108.267 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 408' ' ' CYS . 5.3 tpt180 38.6 30.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.54 1.15 . . . . 74.540000000000006 110.32 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' CYS . . . . . 0.442 ' N ' ' O ' ' A' ' 411' ' ' CYS . 6.9 t -111.97 142.65 44.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 65.230000000000004 108.265 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . 0.445 ' CG ' ' N ' ' A' ' 415' ' ' ILE . 24.7 tt0 -50.9 158.88 0.63 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.462 1.101 . . . . 74.549999999999997 110.34 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.445 ' N ' ' CG ' ' A' ' 414' ' ' GLU . 2.3 mt -110.44 157.33 11.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.478 1.112 . . . . 72.319999999999993 109.244 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -119.91 -44.56 2.51 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.48 1.112 . . . . 75.129999999999995 109.303 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . 0.433 ' O ' ' CG2' ' A' ' 418' ' ' THR . . . -134.72 146.55 18.55 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.549 1.156 . . . . 61.049999999999997 110.964 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' THR . . . . . 0.433 ' CG2' ' O ' ' A' ' 417' ' ' GLY . 2.3 p -157.52 117.68 3.44 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.533 0.784 . . . . 73.150000000000006 110.394 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -138.17 151.27 69.42 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.51 1.131 . . . . 74.329999999999998 110.346 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 101.68 1.5 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.51 1.795 . . . . 74.510000000000005 111.0 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -104.14 155.72 5.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.488 1.117 . . . . 74.5 109.247 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . 0.519 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 17.0 mt -107.01 105.41 18.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.502 1.126 . . . . 75.129999999999995 109.281 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.541 HG12 ' CE2' ' A' ' 370' ' ' PHE . 38.2 t -76.86 146.98 7.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 54.539999999999999 109.247 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.08 143.66 50.01 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.461 1.101 . . . . 70.310000000000002 109.237 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 170.35 20.61 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.497 1.788 . . . . 73.329999999999998 111.001 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . 0.537 ' CE2' ' HG2' ' A' ' 357' ' ' GLN . 3.3 t80 . . . . . 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 73.409999999999997 111.006 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.99 0 N-CA-C 111.006 -0.838 . . . . 72.310000000000002 111.006 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 178.61 7.04 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.557 1.819 . . . . 73.200000000000003 111.026 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -119.7 125.39 48.55 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.504 1.127 . . . . 74.299999999999997 109.626 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 26.9 tpp -105.62 91.78 3.9 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.531 1.145 . . . . 73.219999999999999 111.018 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -125.52 55.69 0.72 Allowed Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.502 1.126 . . . . 52.32 110.977 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 3.0 p -132.7 139.33 47.6 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.48 0.753 . . . . 75.239999999999995 110.037 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -97.46 176.85 5.72 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.466 1.104 . . . . 75.209999999999994 109.323 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . 0.44 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 42.5 m-70 -136.47 134.57 37.78 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.498 1.124 . . . . 73.450000000000003 109.604 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 67.0 mt -114.69 135.87 53.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.517 1.135 . . . . 74.519999999999996 109.302 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -107.84 118.94 38.06 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.473 1.108 . . . . 74.209999999999994 109.282 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . 0.464 ' O ' ' CD2' ' A' ' 426' ' ' PHE . 8.6 t -64.33 140.55 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.539 1.149 . . . . 62.310000000000002 109.317 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' THR . . . . . 0.44 ' OG1' ' CG ' ' A' ' 359' ' ' GLN . 27.0 p -91.85 156.55 17.42 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 72.150000000000006 110.365 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -57.99 -32.5 67.95 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.454 1.096 . . . . 73.129999999999995 110.321 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . 0.462 ' CG ' ' N ' ' A' ' 359' ' ' GLN . 18.0 pt-20 -66.05 -47.48 74.2 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.517 1.136 . . . . 74.450000000000003 110.305 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . 0.462 ' N ' ' CG ' ' A' ' 358' ' ' GLU . 11.9 mm-40 -60.73 -52.77 63.69 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.518 1.136 . . . . 74.450000000000003 110.313 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -51.15 -60.63 2.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.527 1.142 . . . . 71.340000000000003 111.031 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -58.52 -36.76 74.34 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.491 1.119 . . . . 74.400000000000006 110.334 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.0 tp -61.53 -39.51 91.31 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.505 1.128 . . . . 72.519999999999996 109.289 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' PTR . . . . . 0.404 ' HD1' ' N ' ' A' ' 363' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 2.1 m -62.01 -41.27 97.9 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.529 1.143 . . . . 73.239999999999995 108.258 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -59.25 -17.64 30.2 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.5 1.125 . . . . 74.049999999999997 110.291 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 5.0 mtt -109.0 -16.18 14.19 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.487 1.117 . . . . 73.549999999999997 110.991 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 65.5 40.25 96.07 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.486 1.116 . . . . 74.430000000000007 111.006 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 16.1 m -125.13 -175.34 3.28 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.446 0.733 . . . . 73.0 109.971 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.403 ' HB ' ' NE2' ' A' ' 371' ' ' GLN . 2.3 p -128.22 136.36 50.95 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.456 1.098 . . . . 75.239999999999995 110.451 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.469 ' CE2' HD11 ' A' ' 391' ' ' LEU . 73.7 t80 -60.58 -68.42 0.3 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.5 1.125 . . . . 75.140000000000001 111.002 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.527 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -40.09 -29.23 0.07 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 71.349999999999994 110.255 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . 0.416 ' N ' ' C ' ' A' ' 370' ' ' PHE . 0.0 OUTLIER -69.48 115.01 8.25 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.127 . . . . 63.340000000000003 109.344 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 30.3 p -45.96 145.87 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.009 -0.996 . . . . 73.319999999999993 110.937 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -105.53 31.6 4.86 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.512 1.133 . . . . 74.510000000000005 109.31 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 46.4 mt -112.42 -58.39 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.51 1.131 . . . . 75.219999999999999 109.282 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 5.3 p -107.98 -21.81 12.67 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.479 1.112 . . . . 73.140000000000001 108.312 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 56.46 41.51 28.69 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.524 1.14 . . . . 52.310000000000002 109.336 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -126.16 -49.06 1.58 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.463 1.102 . . . . 73.219999999999999 110.329 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 49.4 m-20 -109.4 167.92 9.77 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.543 1.152 . . . . 63.25 109.323 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 16.6 p30 -84.6 162.66 19.7 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.486 1.116 . . . . 73.329999999999998 109.276 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.403 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 22.7 mttt -63.07 -62.4 1.73 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.469 1.106 . . . . 74.129999999999995 109.294 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 58.45 25.04 12.48 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.513 1.133 . . . . 74.150000000000006 109.262 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . 0.459 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.7 OUTLIER -154.85 170.64 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 74.430000000000007 109.268 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -154.61 144.45 21.66 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.484 1.115 . . . . 71.349999999999994 109.314 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.442 ' O ' ' N ' ' A' ' 389' ' ' GLY . 11.1 mm -107.79 133.66 51.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.505 1.128 . . . . 73.239999999999995 109.293 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.497 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 10.5 mt-10 -137.67 160.98 62.86 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 73.439999999999998 110.297 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.497 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -75.07 -5.19 21.46 Favored 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 120.995 -2.502 . . . . 74.329999999999998 110.995 0.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . 0.512 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 16.5 t -38.13 -79.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.985 -1.007 . . . . 74.540000000000006 110.92 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 119.64 36.58 0.83 Allowed Glycine 0 CA--C 1.531 1.068 0 O-C-N 124.537 1.148 . . . . 61.119999999999997 110.965 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.559 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 67.4 m170 -108.54 127.14 53.68 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.545 0.791 . . . . 74.120000000000005 109.596 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.469 HD11 ' CE2' ' A' ' 370' ' ' PHE . 1.8 mt -95.65 157.27 15.97 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.507 1.13 . . . . 72.329999999999998 109.297 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' MET . . . . . 0.563 ' HE1' ' CE1' ' A' ' 410' ' ' PHE . 14.2 ptp -171.17 174.57 4.57 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.492 1.12 . . . . 74.5 111.001 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . 0.438 ' O ' ' N ' ' A' ' 396' ' ' CYS . 2.8 p -97.85 120.82 38.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.562 1.164 . . . . 73.230000000000004 108.289 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 48.8 m -41.11 -59.17 1.56 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.501 1.126 . . . . 64.319999999999993 110.339 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 2.7 t -49.3 -36.24 20.32 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.518 1.136 . . . . 73.439999999999998 109.999 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 393' ' ' CYS . 2.2 m -71.06 -38.17 72.51 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.461 1.101 . . . . 73.430000000000007 108.3 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . 0.42 ' C ' ' CD1' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -65.03 -36.57 84.8 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.511 1.132 . . . . 75.219999999999999 109.32 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 45.8 m -61.96 -45.47 93.51 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.54 1.15 . . . . 71.409999999999997 110.392 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -56.77 -23.87 46.14 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.496 1.123 . . . . 55.420000000000002 109.304 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' TRP . . . . . 0.601 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 15.8 t-105 -85.13 -65.22 1.03 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.498 1.124 . . . . 72.140000000000001 108.023 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.502 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 39.8 mm-40 -48.94 -20.85 0.56 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.53 1.144 . . . . 74.239999999999995 110.349 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 401' ' ' GLN . 2.7 mm-40 -37.45 -63.66 0.43 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.123 . . . . 74.319999999999993 110.347 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 42.6 t -122.77 -24.46 4.84 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 74.030000000000001 110.006 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . 0.601 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 18.6 m-20 -82.42 -93.67 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.503 1.127 . . . . 71.049999999999997 109.326 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.502 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 66.8 21.74 71.43 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 124.493 1.121 . . . . 74.310000000000002 110.991 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -80.34 59.72 3.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.476 0.75 . . . . 71.200000000000003 110.337 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 71.67 -165.58 53.6 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.481 1.113 . . . . 73.010000000000005 110.99 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 412' ' ' ARG . 1.8 t -56.2 120.9 38.24 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.296 -1.001 . . . . 74.319999999999993 108.296 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.427 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.3 Cg_endo -75.04 -0.01 9.47 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.496 1.787 . . . . 72.209999999999994 111.015 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . 0.563 ' CE1' ' HE1' ' A' ' 392' ' ' MET . 3.5 m-85 -91.51 -37.01 13.4 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.46 1.1 . . . . 72.329999999999998 111.014 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.6 OUTLIER -127.38 17.33 7.06 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.106 . . . . 63.32 108.253 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 408' ' ' CYS . 6.3 tpp180 38.69 30.12 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.505 1.128 . . . . 75.540000000000006 110.279 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 411' ' ' CYS . 51.1 t -114.41 138.72 50.21 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.545 1.153 . . . . 65.409999999999997 108.325 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . 0.444 ' CG ' ' N ' ' A' ' 415' ' ' ILE . 34.1 tt0 -45.11 159.0 0.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 1.113 . . . . 74.140000000000001 110.317 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.451 HG21 ' CG2' ' A' ' 418' ' ' THR . 2.3 mt -113.22 157.04 14.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 72.439999999999998 109.271 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 10.4 mttm -132.3 -47.17 0.91 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.53 1.144 . . . . 74.519999999999996 109.286 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . 0.494 ' O ' ' CG2' ' A' ' 418' ' ' THR . . . -109.51 130.78 10.15 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.493 1.121 . . . . 75.340000000000003 111.015 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' THR . . . . . 0.494 ' CG2' ' O ' ' A' ' 417' ' ' GLY . 20.8 p -157.2 118.5 3.68 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.492 0.76 . . . . 74.109999999999999 110.409 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -141.57 151.44 60.55 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.539 1.149 . . . . 71.219999999999999 110.28 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.03 101.3 1.45 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.474 1.776 . . . . 65.109999999999999 110.988 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . 0.486 ' CD1' ' N ' ' A' ' 422' ' ' ILE . 1.1 pp -105.94 178.19 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.463 1.102 . . . . 64.349999999999994 109.253 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . 0.486 ' N ' ' CD1' ' A' ' 421' ' ' ILE . 6.1 mt -139.69 111.81 5.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.502 1.126 . . . . 72.530000000000001 109.292 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.406 ' CG1' ' HB3' ' A' ' 371' ' ' GLN . 18.5 t -84.04 142.71 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.477 1.111 . . . . 74.430000000000007 109.304 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -131.1 143.73 50.62 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 62.32 109.309 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 174.98 11.86 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.489 1.784 . . . . 73.400000000000006 110.956 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . 0.464 ' CD2' ' O ' ' A' ' 355' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.521 1.138 . . . . 75.150000000000006 111.004 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.028 0 N-CA-C 111.027 -0.829 . . . . 65.430000000000007 111.027 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 178.31 7.44 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.536 1.809 . . . . 70.329999999999998 110.992 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -174.49 150.19 1.38 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.537 1.148 . . . . 73.329999999999998 109.57 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 39.7 mtp -154.19 133.63 12.72 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.464 1.102 . . . . 72.239999999999995 111.014 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 97.94 50.34 1.64 Allowed Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.527 1.142 . . . . 61.229999999999997 111.008 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 69.9 m -143.37 154.28 43.57 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.502 0.766 . . . . 74.519999999999996 109.973 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . 0.432 ' HB2' ' CG2' ' A' ' 421' ' ' ILE . 11.4 m-20 -98.43 171.99 7.81 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.476 1.11 . . . . 74.5 109.281 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . 0.415 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 22.4 m-70 -130.37 126.59 37.48 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.474 1.109 . . . . 74.450000000000003 109.581 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 48.0 mt -115.76 127.39 73.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.486 1.116 . . . . 73.140000000000001 109.326 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 8.4 tptp -105.58 118.85 37.64 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.544 1.152 . . . . 74.329999999999998 109.304 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . 0.455 ' CG1' ' N ' ' A' ' 356' ' ' THR . 48.5 t -59.39 164.03 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.528 1.142 . . . . 71.0 109.288 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' THR . . . . . 0.455 ' N ' ' CG1' ' A' ' 355' ' ' VAL . 3.0 p -122.89 146.12 47.86 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.506 1.129 . . . . 74.140000000000001 110.37 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' GLN . . . . . 0.577 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 5.8 mt-30 -42.46 -53.72 4.17 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 73.0 110.288 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -39.95 -41.22 1.15 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.468 1.105 . . . . 72.450000000000003 110.327 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -67.06 -66.84 0.51 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.475 1.109 . . . . 74.150000000000006 110.305 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . 0.431 ' O ' ' N ' ' A' ' 364' ' ' CYS . 8.4 t80 -40.61 -52.22 2.9 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.434 1.084 . . . . 75.099999999999994 110.991 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -55.4 -44.02 75.76 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.493 1.12 . . . . 72.120000000000005 110.273 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.1 tt -63.12 -34.24 77.19 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.481 1.113 . . . . 72.209999999999994 109.331 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' PTR . . . . . 0.438 ' O ' ' N ' ' A' ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m -65.59 -34.27 77.86 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.508 1.13 . . . . 71.219999999999999 108.327 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -62.29 -18.62 61.79 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.472 1.107 . . . . 63.32 110.29 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -128.4 8.52 5.98 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.473 1.108 . . . . 73.150000000000006 110.995 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 363' ' ' PTR . . . 38.04 63.61 0.89 Allowed Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.521 1.138 . . . . 72.129999999999995 111.042 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 64.1 p -132.09 -174.03 3.32 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.463 0.743 . . . . 75.340000000000003 110.009 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.484 ' O ' ' CE ' ' A' ' 374' ' ' LYS . 33.7 p -126.47 146.53 50.06 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.535 1.147 . . . . 72.150000000000006 110.388 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.42 ' C ' ' N ' ' A' ' 372' ' ' LEU . 31.8 t80 -77.23 -63.83 1.28 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.489 1.118 . . . . 74.109999999999999 111.003 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.552 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -40.71 -28.78 0.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.489 1.118 . . . . 74.209999999999994 110.323 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . 0.42 ' N ' ' C ' ' A' ' 370' ' ' PHE . 3.0 tm? -67.3 139.91 57.29 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.116 . . . . 74.409999999999997 109.283 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 1.9 t -76.16 126.17 30.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.016 -0.993 . . . . 75.299999999999997 110.925 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.484 ' CE ' ' O ' ' A' ' 369' ' ' THR . 12.9 mmtm -91.06 18.51 6.69 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.527 1.142 . . . . 75.319999999999993 109.297 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 20.3 mt -99.17 -51.61 9.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.457 1.098 . . . . 75.219999999999999 109.306 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.54 -30.3 8.32 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.512 1.132 . . . . 71.420000000000002 108.305 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . 0.412 ' HA ' ' CD1' ' A' ' 372' ' ' LEU . . . 65.82 43.69 3.05 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.545 1.153 . . . . 74.049999999999997 109.279 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -136.29 -61.89 0.68 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.53 1.144 . . . . 73.239999999999995 110.301 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -96.88 161.43 13.85 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.471 1.107 . . . . 72.109999999999999 109.298 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 37.4 p30 -81.14 160.73 24.33 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.517 1.136 . . . . 74.209999999999994 109.314 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.461 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 23.4 mttt -65.01 -62.49 1.52 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.49 1.119 . . . . 73.099999999999994 109.308 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 9.7 t70 60.07 27.05 16.44 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.501 1.126 . . . . 73.319999999999993 109.309 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -157.94 175.26 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.442 1.089 . . . . 72.349999999999994 109.313 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . 0.424 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 17.0 tttp -159.4 140.86 13.02 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.481 1.113 . . . . 75.420000000000002 109.316 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 389' ' ' GLY . 24.6 mm -104.91 132.74 50.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.511 1.132 . . . . 72.150000000000006 109.268 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.489 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 10.8 mt-10 -137.79 161.08 62.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 74.310000000000002 110.312 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.489 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -75.01 -4.65 20.7 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 121.012 -2.495 . . . . 74.239999999999995 110.989 0.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . 0.523 ' SG ' ' CD2' ' A' ' 390' ' ' HIS . 25.2 t -37.6 -77.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.986 -1.007 . . . . 72.200000000000003 110.939 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 118.72 35.45 0.98 Allowed Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.566 1.166 . . . . 62.450000000000003 111.01 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.523 ' CD2' ' SG ' ' A' ' 388' ' ' CYS . 51.7 m170 -108.51 126.89 53.43 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.504 0.767 . . . . 71.219999999999999 109.579 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.461 ' HB2' ' CE ' ' A' ' 381' ' ' LYS . 0.0 OUTLIER -97.56 157.53 15.97 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.465 1.103 . . . . 74.310000000000002 109.306 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' MET . . . . . 0.468 ' O ' ' CG1' ' A' ' 383' ' ' VAL . 11.4 ptp -173.81 173.71 3.23 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.492 1.12 . . . . 74.340000000000003 110.99 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 19.4 p -90.39 140.88 29.29 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 73.400000000000006 108.303 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 48.4 m -61.93 -43.35 99.03 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.433 1.083 . . . . 75.340000000000003 110.394 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 23.3 t -55.37 -64.54 0.81 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.459 1.099 . . . . 74.230000000000004 110.021 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 1.6 p -50.24 -51.38 45.02 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.518 1.136 . . . . 74.510000000000005 108.323 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -45.13 -49.53 11.8 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.496 1.123 . . . . 75.219999999999999 109.292 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 76.5 m -54.59 -38.63 66.97 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.509 1.131 . . . . 75.540000000000006 110.427 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -60.71 -25.13 66.2 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.461 1.1 . . . . 75.209999999999994 109.375 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' TRP . . . . . 0.602 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 10.7 t-105 -85.7 -62.75 1.45 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.498 1.124 . . . . 74.239999999999995 108.02 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.484 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 8.2 mm-40 -55.98 -14.34 2.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.545 1.153 . . . . 63.32 110.323 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 401' ' ' GLN . 0.6 OUTLIER -37.23 -63.29 0.44 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.495 1.122 . . . . 70.340000000000003 110.302 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 7.8 t -121.13 -24.58 5.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.499 1.124 . . . . 74.239999999999995 109.968 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . 0.602 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 8.7 m-20 -83.0 -94.86 0.06 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.484 1.115 . . . . 74.019999999999996 109.327 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.484 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 73.3 28.99 64.94 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.469 1.106 . . . . 72.230000000000004 111.01 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -90.91 70.36 6.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.446 0.733 . . . . 72.019999999999996 110.307 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 66.58 -169.03 34.31 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.559 1.162 . . . . 55.310000000000002 110.993 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 6.0 t -56.55 131.55 77.21 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.329 -0.989 . . . . 64.030000000000001 108.329 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 0.34 9.05 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.475 1.776 . . . . 74.310000000000002 110.958 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -93.66 -55.63 3.19 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.462 1.101 . . . . 63.420000000000002 110.969 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' CYS . . . . . 0.451 ' O ' ' N ' ' A' ' 413' ' ' CYS . 2.6 p -98.56 10.07 41.8 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.558 1.161 . . . . 63.520000000000003 108.319 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 411' ' ' CYS . 3.4 tpt85 38.59 30.19 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.475 1.11 . . . . 74.319999999999993 110.325 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' CYS . . . . . 0.451 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.5 m -115.48 154.24 29.67 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.489 1.118 . . . . 62.409999999999997 108.309 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -59.35 156.6 12.43 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.531 1.144 . . . . 75.450000000000003 110.284 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.462 HG23 ' CG2' ' A' ' 418' ' ' THR . 5.6 mt -115.48 157.1 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 63.43 109.345 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . 0.405 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 5.9 mmtp -120.26 -44.5 2.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.529 1.143 . . . . 75.239999999999995 109.269 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . 0.49 ' O ' ' CG2' ' A' ' 418' ' ' THR . . . -112.44 127.78 8.19 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.461 1.1 . . . . 64.310000000000002 111.009 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' THR . . . . . 0.49 ' CG2' ' O ' ' A' ' 417' ' ' GLY . 34.9 p -156.56 125.51 5.97 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.531 0.783 . . . . 71.400000000000006 110.419 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -158.06 151.43 18.94 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.484 1.115 . . . . 71.530000000000001 110.3 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 99.17 1.23 Allowed 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.551 1.817 . . . . 73.319999999999993 111.031 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . 0.432 ' CG2' ' HB2' ' A' ' 351' ' ' ASP . 0.8 OUTLIER -104.38 163.93 3.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.48 1.113 . . . . 71.450000000000003 109.341 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . 0.415 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 3.3 mp -113.18 105.44 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.496 1.123 . . . . 75.5 109.301 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.422 HG23 ' CD1' ' A' ' 421' ' ' ILE . 12.9 t -78.22 140.19 17.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.465 1.103 . . . . 72.540000000000006 109.307 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.412 ' O ' ' CG2' ' A' ' 355' ' ' VAL . 23.6 m-20 -130.2 143.72 50.32 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.519 1.137 . . . . 73.120000000000005 109.309 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 160.29 40.29 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.493 1.786 . . . . 71.219999999999999 110.96 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . 0.577 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 26.4 t80 . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.481 1.113 . . . . 74.109999999999999 111.033 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.994 0 N-CA-C 111.024 -0.83 . . . . 70.319999999999993 111.024 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.92 178.65 6.96 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.446 1.761 . . . . 74.519999999999996 111.02 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -95.61 -177.05 3.94 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.456 1.098 . . . . 74.299999999999997 109.587 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 7.4 mmt -109.86 19.23 19.31 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.127 . . . . 74.340000000000003 111.001 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -97.45 -16.96 32.74 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.48 1.113 . . . . 73.519999999999996 110.991 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 3.2 p -77.86 137.08 38.19 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.521 0.777 . . . . 63.420000000000002 109.967 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -87.22 -177.28 5.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.463 1.102 . . . . 74.209999999999994 109.263 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . 0.542 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 25.0 m-70 -138.3 149.9 46.12 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.509 1.13 . . . . 73.230000000000004 109.588 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . 0.411 ' CG2' ' N ' ' A' ' 354' ' ' LYS . 7.7 mt -136.11 158.65 38.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.564 1.165 . . . . 72.549999999999997 109.266 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.411 ' N ' ' CG2' ' A' ' 353' ' ' ILE . 0.1 OUTLIER -123.38 152.74 41.23 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.461 1.1 . . . . 74.409999999999997 109.317 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . 0.628 ' CG2' ' CD2' ' A' ' 370' ' ' PHE . 9.2 t -107.94 162.05 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 72.420000000000002 109.288 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' THR . . . . . 0.466 ' N ' ' CG1' ' A' ' 355' ' ' VAL . 13.1 p -112.95 158.7 19.91 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.499 1.124 . . . . 71.430000000000007 110.43 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' GLN . . . . . 0.525 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 11.5 mt-30 -59.87 -45.7 91.66 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.54 1.15 . . . . 71.319999999999993 110.341 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -49.25 -44.92 44.08 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.495 1.122 . . . . 71.140000000000001 110.299 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -66.42 -43.49 85.57 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.445 1.091 . . . . 73.209999999999994 110.311 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -58.26 -27.22 63.81 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.453 1.095 . . . . 74.430000000000007 110.953 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -89.58 -40.39 12.64 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.527 1.142 . . . . 72.200000000000003 110.358 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.487 ' O ' ' CD1' ' A' ' 362' ' ' LEU . 0.5 OUTLIER -63.87 -32.82 74.47 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.127 . . . . 65.140000000000001 109.3 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' PTR . . . . . 0.597 ' CE1' ' NZ ' ' A' ' 374' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.64 -54.87 37.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.517 1.135 . . . . 63.119999999999997 108.287 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -41.55 -66.68 0.32 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.546 1.154 . . . . 72.040000000000006 110.264 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' MET . . . . . 0.41 ' CG ' ' O ' ' A' ' 363' ' ' PTR . 19.1 ptp -53.73 -34.49 59.09 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.486 1.116 . . . . 71.349999999999994 111.001 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 88.45 50.21 3.45 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.429 1.081 . . . . 61.350000000000001 110.953 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 3.3 m -146.21 179.05 7.77 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.498 0.763 . . . . 70.349999999999994 109.989 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.419 HG21 ' NE2' ' A' ' 371' ' ' GLN . 2.3 m -117.89 160.66 21.04 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.528 1.143 . . . . 74.120000000000005 110.395 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.628 ' CD2' ' CG2' ' A' ' 355' ' ' VAL . 64.3 t80 -62.59 -68.67 0.31 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.53 1.144 . . . . 64.129999999999995 111.015 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.419 ' NE2' HG21 ' A' ' 369' ' ' THR . 0.1 OUTLIER -47.33 -24.95 0.87 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.529 1.143 . . . . 73.230000000000004 110.283 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . 0.406 ' CD2' ' HA ' ' A' ' 377' ' ' ALA . 0.0 OUTLIER -69.75 117.7 11.67 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 74.409999999999997 109.236 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 25.1 t -52.22 145.24 11.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.947 -1.024 . . . . 64.140000000000001 110.89 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.597 ' NZ ' ' CE1' ' A' ' 363' ' ' PTR . 25.5 mmtp -103.36 24.26 11.25 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.463 1.102 . . . . 73.400000000000006 109.267 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 52.8 mt -111.47 -49.29 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.451 1.094 . . . . 74.400000000000006 109.316 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 3.5 m -109.04 -32.65 7.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.501 1.126 . . . . 62.530000000000001 108.285 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . 0.406 ' HA ' ' CD2' ' A' ' 372' ' ' LEU . . . 61.03 28.21 18.0 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.499 1.124 . . . . 65.010000000000005 109.322 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -121.83 -40.32 2.54 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.497 1.123 . . . . 75.109999999999999 110.28 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -115.53 169.65 9.02 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.514 1.134 . . . . 74.5 109.294 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -87.52 166.19 14.94 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 72.450000000000003 109.354 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.454 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 19.2 mttt -67.12 -62.53 1.38 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.476 1.11 . . . . 73.030000000000001 109.268 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 4.8 t0 60.56 20.89 10.71 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.452 1.095 . . . . 75.319999999999993 109.281 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . 0.48 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -151.19 175.42 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.539 1.149 . . . . 74.140000000000001 109.285 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -158.13 156.66 31.32 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.492 1.12 . . . . 74.049999999999997 109.318 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.499 ' CG2' ' SG ' ' A' ' 388' ' ' CYS . 11.8 mm -122.72 144.3 32.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.562 1.164 . . . . 62.210000000000001 109.331 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.514 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.4 mt-10 -137.74 162.4 54.72 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.501 1.125 . . . . 73.409999999999997 110.282 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.514 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.03 -12.15 24.12 Favored 'Cis proline' 0 C--N 1.36 1.172 0 C-N-CA 121.032 -2.487 . . . . 55.219999999999999 110.986 0.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . 0.512 ' HB2' ' CE1' ' A' ' 390' ' ' HIS . 0.8 OUTLIER -36.63 -71.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.04 -0.982 . . . . 72.329999999999998 110.881 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 115.77 18.15 6.16 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.492 1.12 . . . . 72.450000000000003 111.022 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 388' ' ' CYS . 20.0 m170 -75.58 147.13 39.88 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.529 0.782 . . . . 74.239999999999995 109.565 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.55 ' CD2' ' N ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -117.3 156.47 27.75 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.132 . . . . 72.219999999999999 109.308 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' MET . . . . . 0.543 ' HE3' ' CE1' ' A' ' 410' ' ' PHE . 18.8 ptp -172.01 173.54 4.36 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.502 1.126 . . . . 75.230000000000004 110.958 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 26.1 p -95.18 126.08 40.26 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.471 1.107 . . . . 74.519999999999996 108.278 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 6.4 m -54.12 -56.25 19.86 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.508 1.13 . . . . 74.040000000000006 110.381 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.6 t -43.61 -30.71 0.64 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.546 1.153 . . . . 64.519999999999996 109.988 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 2.5 m -80.79 -52.32 7.64 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.544 1.153 . . . . 71.010000000000005 108.287 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . 0.408 ' C ' ' CD1' ' A' ' 397' ' ' LEU . 0.7 OUTLIER -43.56 -37.91 2.72 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.452 1.095 . . . . 74.310000000000002 109.326 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 1.1 m -60.75 -46.8 89.07 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.482 1.114 . . . . 74.409999999999997 110.413 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -58.12 -21.94 48.68 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.482 1.114 . . . . 71.239999999999995 109.308 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' TRP . . . . . 0.608 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 8.9 t-105 -84.77 -64.88 1.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.523 1.139 . . . . 75.099999999999994 108.006 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.485 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.6 mm-40 -52.77 -16.99 1.13 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.472 1.107 . . . . 74.120000000000005 110.319 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 401' ' ' GLN . 5.8 mm-40 -37.09 -63.42 0.43 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.492 1.12 . . . . 73.140000000000001 110.303 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 2.8 m -120.61 -24.51 5.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.496 1.122 . . . . 74.239999999999995 109.995 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . 0.608 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 16.6 m-20 -82.09 -94.51 0.05 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.114 . . . . 70.129999999999995 109.282 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.485 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 70.5 29.96 69.38 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.488 1.117 . . . . 74.209999999999994 110.981 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -91.71 68.0 5.48 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.567 0.804 . . . . 75.439999999999998 110.279 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 66.0 -166.46 36.55 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.471 1.107 . . . . 72.420000000000002 110.976 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . 0.408 ' O ' ' N ' ' A' ' 412' ' ' ARG . 6.5 t -57.31 128.9 79.37 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 108.324 -0.991 . . . . 65.540000000000006 108.324 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 0.3 9.07 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.511 1.795 . . . . 72.030000000000001 110.958 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . 0.543 ' CE1' ' HE3' ' A' ' 392' ' ' MET . 3.2 m-85 -97.91 -41.54 7.96 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.505 1.128 . . . . 74.340000000000003 111.019 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' CYS . . . . . 0.444 ' SG ' ' CE1' ' A' ' 390' ' ' HIS . 0.1 OUTLIER -111.32 8.98 21.58 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.522 1.138 . . . . 61.039999999999999 108.284 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 408' ' ' CYS . 8.0 tpp85 38.49 30.28 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.546 1.154 . . . . 72.230000000000004 110.294 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' CYS . . . . . 0.444 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.3 m -123.09 164.85 17.83 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.501 1.126 . . . . 74.299999999999997 108.265 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -63.07 145.08 56.23 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.494 1.121 . . . . 71.120000000000005 110.281 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.523 ' CG2' ' CG2' ' A' ' 418' ' ' THR . 1.6 mt -94.92 147.01 6.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.522 1.139 . . . . 74.409999999999997 109.304 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -117.26 -43.78 2.82 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.489 1.118 . . . . 75.120000000000005 109.305 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -119.21 130.0 8.34 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.452 1.095 . . . . 75.329999999999998 110.976 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' THR . . . . . 0.523 ' CG2' ' CG2' ' A' ' 415' ' ' ILE . 80.6 p -152.69 138.86 18.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.477 0.751 . . . . 73.150000000000006 110.359 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -171.86 151.12 2.69 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.458 1.099 . . . . 74.049999999999997 110.275 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.08 101.66 1.5 Allowed 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.518 1.799 . . . . 63.0 110.981 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -104.18 159.42 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.444 1.09 . . . . 73.150000000000006 109.289 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . 0.542 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 8.1 mt -111.47 105.51 18.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.488 1.118 . . . . 72.329999999999998 109.27 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.464 HG13 ' CE2' ' A' ' 370' ' ' PHE . 39.5 t -76.97 146.78 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.509 1.131 . . . . 75.310000000000002 109.322 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -129.49 143.87 50.63 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.478 1.111 . . . . 64.519999999999996 109.34 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.96 174.05 13.45 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.492 1.785 . . . . 72.099999999999994 110.993 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . 0.525 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 4.8 t80 . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.118 . . . . 74.400000000000006 111.058 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.966 0 N-CA-C 111.018 -0.833 . . . . 74.409999999999997 111.018 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 178.39 7.33 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.502 1.791 . . . . 74.450000000000003 110.958 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -78.63 129.13 34.41 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.479 1.112 . . . . 74.010000000000005 109.612 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 18.9 mtt -118.97 -47.64 2.49 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.486 1.116 . . . . 75.140000000000001 111.044 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 125.6 -21.11 6.39 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.496 1.123 . . . . 65.510000000000005 110.983 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 67.0 m -51.99 148.95 5.45 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.484 0.755 . . . . 75.510000000000005 109.966 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -94.22 -174.75 3.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.488 1.117 . . . . 72.239999999999995 109.28 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . 0.567 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 28.9 m-70 -140.15 141.55 36.04 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.551 1.157 . . . . 74.349999999999994 109.578 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' A' ' 354' ' ' LYS . 3.7 mm -128.2 158.46 40.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.445 1.091 . . . . 72.25 109.293 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.404 ' N ' ' CG2' ' A' ' 353' ' ' ILE . 0.0 OUTLIER -117.91 153.66 33.21 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.498 1.124 . . . . 74.019999999999996 109.304 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . 0.437 HG22 ' CG ' ' A' ' 370' ' ' PHE . 14.3 t -105.44 149.12 9.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.115 . . . . 75.200000000000003 109.272 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 19.8 p -117.2 176.9 4.93 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.485 1.116 . . . . 72.349999999999994 110.395 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -74.49 -33.85 62.94 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.497 1.123 . . . . 73.219999999999999 110.292 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . 0.41 ' CG ' ' N ' ' A' ' 359' ' ' GLN . 15.3 pt-20 -57.98 -47.64 82.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.474 1.109 . . . . 75.219999999999999 110.305 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . 0.41 ' N ' ' CG ' ' A' ' 358' ' ' GLU . 29.1 mm-40 -60.9 -66.65 0.5 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 74.140000000000001 110.297 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . 0.41 ' O ' ' N ' ' A' ' 364' ' ' CYS . 4.9 t80 -44.02 -42.9 6.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 75.109999999999999 110.995 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -65.71 -42.38 91.19 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.453 1.096 . . . . 75.129999999999995 110.263 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.7 tp -62.03 -39.36 92.06 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.47 1.106 . . . . 71.319999999999993 109.338 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . 0.41 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.7 m -63.27 -21.93 66.55 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.491 1.119 . . . . 71.25 108.302 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -75.47 -29.28 59.55 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.525 1.141 . . . . 62.200000000000003 110.305 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' MET . . . . . 0.405 ' SD ' ' N ' ' A' ' 366' ' ' MET . 0.0 OUTLIER -113.49 21.02 15.55 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.514 1.134 . . . . 72.019999999999996 110.979 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 37.78 47.71 1.8 Allowed Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.448 1.093 . . . . 75.140000000000001 110.987 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 31.6 m -121.42 152.84 38.61 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.504 0.767 . . . . 71.329999999999998 109.989 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 2.2 m -98.51 159.77 14.72 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 73.099999999999994 110.369 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.437 ' CG ' HG22 ' A' ' 355' ' ' VAL . 5.9 t80 -66.34 -65.66 0.65 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.483 1.114 . . . . 74.530000000000001 110.981 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.34 -32.8 50.85 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.128 . . . . 64.439999999999998 110.322 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . 0.424 HD21 ' N ' ' A' ' 373' ' ' CYS . 0.7 OUTLIER -58.67 135.87 57.52 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.507 1.129 . . . . 65.129999999999995 109.278 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . 0.424 ' N ' HD21 ' A' ' 372' ' ' LEU . 16.4 t -76.68 135.91 39.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.965 -1.016 . . . . 74.430000000000007 110.896 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 374' ' ' LYS . 0.6 OUTLIER -92.94 22.17 5.13 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.506 1.129 . . . . 73.450000000000003 109.317 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 5.0 mt -110.68 -52.18 6.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.524 1.14 . . . . 74.340000000000003 109.33 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 7.5 m -102.75 -27.04 12.93 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.485 1.116 . . . . 65.150000000000006 108.313 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 55.52 29.05 12.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.464 1.103 . . . . 72.099999999999994 109.327 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -122.45 -40.86 2.43 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.468 1.105 . . . . 74.450000000000003 110.31 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -119.06 -179.94 3.98 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.463 1.102 . . . . 71.329999999999998 109.348 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -89.55 171.76 9.46 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.52 1.137 . . . . 73.120000000000005 109.327 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.449 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 11.6 mttt -79.14 -62.49 1.68 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 74.420000000000002 109.284 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 15.7 t0 62.4 22.2 13.07 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.464 1.102 . . . . 74.150000000000006 109.324 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . 0.4 ' CG1' ' HG2' ' A' ' 392' ' ' MET . 0.5 OUTLIER -158.25 172.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.488 1.117 . . . . 71.5 109.298 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . 0.404 ' CE ' ' HA2' ' A' ' 389' ' ' GLY . 76.4 tttt -156.74 159.5 38.39 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.464 1.102 . . . . 74.239999999999995 109.312 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.474 ' CG2' ' SG ' ' A' ' 388' ' ' CYS . 18.1 mm -117.21 139.92 42.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.522 1.138 . . . . 75.239999999999995 109.298 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.519 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.9 mt-10 -130.61 162.26 55.93 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.446 1.091 . . . . 70.219999999999999 110.271 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.519 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.4 Cg_endo -74.93 -14.72 22.76 Favored 'Cis proline' 0 C--N 1.36 1.157 0 C-N-CA 121.034 -2.486 . . . . 73.439999999999998 110.986 -0.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . 0.474 ' SG ' ' CG2' ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.82 -87.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.047 -0.979 . . . . 71.049999999999997 110.915 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 130.91 42.9 0.19 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.467 1.104 . . . . 61.310000000000002 111.027 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.414 ' O ' ' N ' ' A' ' 385' ' ' ILE . 27.8 m170 -97.45 131.49 44.04 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.49 0.759 . . . . 73.439999999999998 109.643 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.449 ' HB2' ' CE ' ' A' ' 381' ' ' LYS . 0.0 OUTLIER -100.21 151.83 20.99 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.462 1.102 . . . . 70.25 109.309 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' MET . . . . . 0.4 ' HG2' ' CG1' ' A' ' 383' ' ' VAL . 16.8 ptp -167.61 170.74 10.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.536 1.147 . . . . 75.219999999999999 110.933 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 26.1 p -97.14 115.28 27.25 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.452 1.095 . . . . 74.209999999999994 108.334 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 24.3 m -39.71 -58.69 1.28 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.552 1.157 . . . . 73.409999999999997 110.389 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.4 t -42.64 -43.61 3.91 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.513 1.133 . . . . 54.030000000000001 110.004 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . 0.401 ' O ' ' N ' ' A' ' 399' ' ' ALA . 3.6 m -67.52 -55.2 14.44 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.474 1.109 . . . . 75.530000000000001 108.293 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . 0.463 ' C ' ' CD1' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -44.15 -36.26 2.55 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.476 1.11 . . . . 73.310000000000002 109.308 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 17.5 m -61.35 -46.06 91.79 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 71.5 110.436 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -56.89 -22.6 38.46 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.458 1.098 . . . . 75.040000000000006 109.302 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' TRP . . . . . 0.605 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 9.1 t-105 -85.56 -64.77 1.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.982 -1.118 . . . . 74.239999999999995 107.982 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.489 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 10.1 mm-40 -52.94 -16.88 1.16 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 73.120000000000005 110.316 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 401' ' ' GLN . 5.1 mt-10 -37.16 -63.29 0.44 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.489 1.118 . . . . 73.230000000000004 110.323 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 5.4 t -120.51 -24.46 5.81 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.443 1.089 . . . . 55.439999999999998 109.986 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . 0.605 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 4.6 m-20 -82.62 -95.08 0.05 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.478 1.111 . . . . 65.340000000000003 109.288 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.489 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 70.57 32.45 67.6 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.57 1.169 . . . . 62.520000000000003 110.992 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -92.02 66.94 5.06 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 0.773 . . . . 74.310000000000002 110.344 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 66.19 -161.89 44.1 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.532 1.145 . . . . 64.549999999999997 111.05 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . 0.403 ' O ' ' N ' ' A' ' 412' ' ' ARG . 5.5 t -60.21 126.25 83.58 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 108.332 -0.988 . . . . 74.120000000000005 108.332 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.06 -1.56 11.39 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.518 1.799 . . . . 65.040000000000006 110.998 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -94.9 -42.19 8.8 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 1.136 . . . . 65.319999999999993 111.001 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' CYS . . . . . 0.445 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.2 OUTLIER -111.79 10.45 20.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.135 . . . . 71.150000000000006 108.265 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 408' ' ' CYS . 4.8 tpt180 38.48 30.35 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.534 1.146 . . . . 75.340000000000003 110.316 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' CYS . . . . . 0.445 ' N ' ' O ' ' A' ' 411' ' ' CYS . 16.0 t -125.3 145.65 49.92 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.487 1.117 . . . . 74.530000000000001 108.311 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -46.59 152.67 0.44 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.552 1.158 . . . . 73.319999999999993 110.292 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.526 ' CG2' ' CG2' ' A' ' 418' ' ' THR . 2.1 mt -100.54 153.11 4.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.463 1.102 . . . . 72.329999999999998 109.323 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . 0.468 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 5.1 mmtt -113.98 -46.24 3.02 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 75.239999999999995 109.273 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -121.5 129.66 7.81 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.466 1.103 . . . . 74.140000000000001 111.03 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' THR . . . . . 0.526 ' CG2' ' CG2' ' A' ' 415' ' ' ILE . 82.8 p -152.96 136.17 15.7 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.473 0.749 . . . . 74.109999999999999 110.378 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 13.4 pm0 -168.1 150.54 5.27 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.534 1.146 . . . . 74.430000000000007 110.327 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.4 Cg_endo -74.95 102.11 1.55 Allowed 'Trans proline' 0 C--N 1.359 1.11 0 O-C-N 124.514 1.797 . . . . 74.25 111.052 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . 0.456 HD13 ' CG2' ' A' ' 423' ' ' VAL . 0.7 OUTLIER -103.9 156.4 5.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.475 1.11 . . . . 70.200000000000003 109.308 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . 0.567 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 14.2 mt -110.39 105.9 19.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.501 1.125 . . . . 74.329999999999998 109.293 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.456 ' CG2' HD13 ' A' ' 421' ' ' ILE . 18.7 t -77.79 146.74 7.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.493 1.12 . . . . 74.340000000000003 109.302 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -129.2 143.55 49.28 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.504 1.127 . . . . 64.129999999999995 109.299 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 174.03 13.5 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.529 1.805 . . . . 64.030000000000001 111.018 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . 0.483 ' C ' ' CD1' ' A' ' 426' ' ' PHE . 2.8 t80 . . . . . 0 C--N 1.325 -0.491 0 O-C-N 124.482 1.114 . . . . 73.530000000000001 111.01 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.019 0 N-CA-C 111.009 -0.836 . . . . 73.150000000000006 111.009 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 178.68 6.94 Favored 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.54 1.81 . . . . 71.219999999999999 111.005 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -69.33 -174.6 0.68 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.449 1.093 . . . . 71.340000000000003 109.626 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 6.0 ptt? -130.98 6.31 4.6 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.499 1.124 . . . . 71.040000000000006 111.031 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -90.54 -10.56 63.39 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.502 1.126 . . . . 62.210000000000001 111.02 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 2.3 p -87.36 144.43 26.77 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.473 0.749 . . . . 73.299999999999997 109.993 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -91.28 -178.09 5.04 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.539 1.149 . . . . 74.010000000000005 109.297 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . 0.534 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 25.9 m-70 -138.95 140.87 38.41 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.53 1.143 . . . . 72.010000000000005 109.608 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 35.8 mt -130.16 136.02 59.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.125 . . . . 74.409999999999997 109.311 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -103.37 129.93 50.56 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.471 1.107 . . . . 74.140000000000001 109.319 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 424' ' ' ASP . 12.7 t -77.56 157.62 5.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 75.099999999999994 109.328 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.5 p -122.25 148.81 44.54 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.505 1.128 . . . . 63.25 110.398 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' GLN . . . . . 0.618 ' CG ' ' CE2' ' A' ' 426' ' ' PHE . 3.1 mt-30 -47.52 -38.44 14.06 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.133 . . . . 72.010000000000005 110.29 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -58.28 -37.1 74.32 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.511 1.132 . . . . 71.019999999999996 110.296 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -74.56 -66.74 0.7 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.52 1.138 . . . . 62.240000000000002 110.292 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . 0.42 ' O ' ' N ' ' A' ' 364' ' ' CYS . 7.0 t80 -40.98 -62.07 0.88 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.553 1.158 . . . . 75.510000000000005 111.056 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -48.84 -48.83 41.47 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.535 1.147 . . . . 73.409999999999997 110.303 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 9.9 tt -58.62 -32.4 68.99 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.493 1.121 . . . . 72.219999999999999 109.313 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' PTR . . . . . 0.595 ' CD1' ' NZ ' ' A' ' 374' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . 0.42 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m -67.5 -27.33 66.91 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.55 1.156 . . . . 74.540000000000006 108.318 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -77.23 -8.24 57.25 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.493 1.121 . . . . 63.130000000000003 110.342 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 8.0 mmt -102.61 -29.93 11.25 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.528 1.143 . . . . 74.099999999999994 111.003 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 89.93 30.01 14.04 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.498 1.124 . . . . 71.439999999999998 110.997 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 1.1 p -144.66 -175.01 4.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.469 0.746 . . . . 71.319999999999993 109.991 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.416 ' O ' ' CE ' ' A' ' 374' ' ' LYS . 11.7 p -118.79 167.32 11.81 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.452 1.095 . . . . 72.299999999999997 110.395 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.553 ' CD2' HG11 ' A' ' 423' ' ' VAL . 38.2 t80 -71.2 -65.37 0.75 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 74.430000000000007 110.999 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.528 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.3 OUTLIER -43.67 -27.2 0.29 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 72.140000000000001 110.335 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . 0.417 HD23 ' N ' ' A' ' 373' ' ' CYS . 0.5 OUTLIER -74.16 136.08 42.86 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.472 1.108 . . . . 71.010000000000005 109.309 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . 0.417 ' N ' HD23 ' A' ' 372' ' ' LEU . 32.1 p -68.48 130.75 43.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.008 -0.996 . . . . 71.549999999999997 110.878 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.595 ' NZ ' ' CD1' ' A' ' 363' ' ' PTR . 28.8 mmtp -92.97 31.46 1.41 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.488 1.118 . . . . 75.209999999999994 109.337 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 18.8 mt -112.31 -59.74 3.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.509 1.13 . . . . 74.150000000000006 109.276 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 4.0 m -107.41 -22.01 12.72 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.471 1.107 . . . . 75.230000000000004 108.312 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 54.76 40.3 31.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.511 1.132 . . . . 65.439999999999998 109.335 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -121.51 -40.28 2.58 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.499 1.125 . . . . 75.140000000000001 110.322 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -124.03 179.18 4.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.527 1.142 . . . . 71.299999999999997 109.278 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -89.45 165.84 14.07 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.557 1.161 . . . . 72.5 109.307 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.466 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 17.2 mttt -66.49 -62.63 1.36 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.561 1.163 . . . . 75.219999999999999 109.28 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 33.9 t0 59.91 22.71 11.74 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.51 1.131 . . . . 71.400000000000006 109.301 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . 0.462 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -156.75 174.62 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.524 1.14 . . . . 73.340000000000003 109.29 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . 0.405 ' CG ' ' N ' ' A' ' 385' ' ' ILE . 47.1 tttt -158.44 158.48 34.23 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.442 1.089 . . . . 74.349999999999994 109.311 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.446 ' CG2' ' SG ' ' A' ' 388' ' ' CYS . 14.8 mm -118.32 144.75 25.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.521 1.138 . . . . 74.030000000000001 109.268 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.517 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.0 mt-10 -136.86 162.35 56.36 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.435 1.084 . . . . 74.030000000000001 110.291 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.517 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.04 -13.69 23.59 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 121.023 -2.491 . . . . 75.319999999999993 111.02 0.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . 0.45 ' HB2' ' CE1' ' A' ' 390' ' ' HIS . 0.8 OUTLIER -36.8 -84.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.953 -1.021 . . . . 72.239999999999995 110.892 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 128.36 41.99 0.26 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.507 1.129 . . . . 73.549999999999997 110.964 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.521 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 27.2 m80 -97.55 137.9 35.78 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.526 0.78 . . . . 73.329999999999998 109.56 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.466 ' HB2' ' CE ' ' A' ' 381' ' ' LYS . 0.0 OUTLIER -106.64 150.82 25.83 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.501 1.126 . . . . 62.020000000000003 109.286 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' MET . . . . . 0.509 ' HE1' ' CE1' ' A' ' 410' ' ' PHE . 16.3 ptp -167.48 166.33 14.33 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.467 1.104 . . . . 73.140000000000001 111.011 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 8.8 p -90.9 124.54 35.27 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 1.128 . . . . 61.5 108.254 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 10.6 m -47.93 -56.85 6.64 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.5 1.125 . . . . 72.5 110.39 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 4.1 m -44.94 -27.15 0.5 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.521 1.138 . . . . 72.549999999999997 110.019 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . 0.417 ' O ' ' N ' ' A' ' 399' ' ' ALA . 1.9 m -83.26 -51.61 7.3 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.495 1.122 . . . . 72.349999999999994 108.346 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -40.97 -52.25 3.14 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.532 1.145 . . . . 75.549999999999997 109.292 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 402' ' ' GLU . 2.7 m -53.04 -43.11 66.36 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.525 1.141 . . . . 71.219999999999999 110.416 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -57.19 -26.13 60.14 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.538 1.149 . . . . 75.010000000000005 109.329 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' TRP . . . . . 0.596 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 10.3 t-105 -85.62 -62.52 1.51 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.998 -1.112 . . . . 72.420000000000002 107.998 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.489 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.4 mm-40 -56.13 -14.15 2.5 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.514 1.134 . . . . 64.140000000000001 110.342 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 398' ' ' THR . 3.0 mm-40 -37.12 -63.39 0.43 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.488 1.118 . . . . 75.319999999999993 110.292 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.4 t -121.3 -24.61 5.42 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.543 1.152 . . . . 75.219999999999999 109.978 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . 0.596 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 15.0 m-20 -82.63 -94.28 0.06 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.458 1.098 . . . . 75.209999999999994 109.334 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.489 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 72.56 30.23 64.59 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.516 1.135 . . . . 63.509999999999998 111.002 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . 0.687 HE21 ' NH2' ' A' ' 412' ' ' ARG . 0.6 OUTLIER -91.36 71.37 6.09 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.508 0.769 . . . . 74.400000000000006 110.322 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 61.74 -167.81 14.58 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.547 1.154 . . . . 72.219999999999999 111.011 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 5.7 t -56.26 125.99 66.77 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 108.29 -1.004 . . . . 75.25 108.29 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.94 0.17 9.2 Favored 'Trans proline' 0 C--N 1.359 1.104 0 O-C-N 124.521 1.801 . . . . 74.519999999999996 111.003 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . 0.521 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 3.6 m-85 -94.67 -55.78 3.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.107 . . . . 73.450000000000003 111.027 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' CYS . . . . . 0.436 ' O ' ' N ' ' A' ' 413' ' ' CYS . 2.4 p -98.95 12.86 34.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 64.030000000000001 108.293 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' ARG . . . . . 0.687 ' NH2' HE21 ' A' ' 406' ' ' GLN . 14.2 mmm-85 38.55 30.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.476 1.11 . . . . 64.530000000000001 110.288 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.3 m -119.76 163.22 17.79 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.53 1.144 . . . . 75.209999999999994 108.332 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.31 154.8 34.15 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.525 1.141 . . . . 74.409999999999997 110.293 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.506 ' CG2' ' CG2' ' A' ' 418' ' ' THR . 1.9 mt -104.61 143.49 16.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.438 1.087 . . . . 65.349999999999994 109.279 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . 0.451 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 3.5 mmtp -109.85 -46.37 3.5 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.559 1.162 . . . . 73.129999999999995 109.321 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . 0.422 ' O ' ' CG2' ' A' ' 418' ' ' THR . . . -124.36 139.66 12.05 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.541 1.151 . . . . 73.120000000000005 110.994 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' THR . . . . . 0.506 ' CG2' ' CG2' ' A' ' 415' ' ' ILE . 72.3 p -153.92 126.43 8.07 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.517 0.775 . . . . 71.010000000000005 110.359 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.21 151.12 23.65 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.489 1.118 . . . . 73.129999999999995 110.332 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.96 102.11 1.55 Allowed 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.514 1.797 . . . . 73.109999999999999 111.037 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . 0.416 ' CD1' HG21 ' A' ' 423' ' ' VAL . 0.7 OUTLIER -103.87 155.03 5.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.131 . . . . 71.340000000000003 109.29 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . 0.534 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 19.4 mt -109.37 105.99 19.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.567 1.167 . . . . 75.450000000000003 109.307 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.553 HG11 ' CD2' ' A' ' 370' ' ' PHE . 17.1 t -76.23 146.94 8.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.434 1.084 . . . . 74.340000000000003 109.265 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.488 ' O ' ' CG2' ' A' ' 355' ' ' VAL . 1.8 t70 -128.68 143.5 48.7 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.523 1.139 . . . . 73.109999999999999 109.352 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 176.19 10.22 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.481 1.779 . . . . 63.299999999999997 111.053 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . 0.618 ' CE2' ' CG ' ' A' ' 357' ' ' GLN . 5.9 t80 . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.542 1.151 . . . . 74.510000000000005 111.042 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.005 0 N-CA-C 110.995 -0.842 . . . . 70.310000000000002 110.995 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 178.73 6.88 Favored 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.496 1.788 . . . . 75.209999999999994 111.056 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -136.83 124.02 21.76 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.551 1.157 . . . . 73.010000000000005 109.61 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 55.4 tpp -151.07 144.99 25.19 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.5 1.125 . . . . 72.120000000000005 110.966 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -88.54 67.72 2.99 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.51 1.131 . . . . 70.25 111.032 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.7 p -122.95 134.46 54.34 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.481 0.754 . . . . 74.420000000000002 110.043 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -87.89 -175.07 4.99 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.514 1.134 . . . . 73.510000000000005 109.28 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . 0.547 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 39.0 m-70 -142.05 146.93 36.04 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.517 1.136 . . . . 73.129999999999995 109.627 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 58.4 mt -130.83 158.63 43.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.484 1.115 . . . . 75.239999999999995 109.247 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -128.36 134.03 48.77 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.547 1.154 . . . . 74.510000000000005 109.3 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . 0.475 HG21 ' CD2' ' A' ' 370' ' ' PHE . 43.8 t -95.28 164.29 2.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.487 1.117 . . . . 74.239999999999995 109.274 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' THR . . . . . 0.468 ' N ' ' CG1' ' A' ' 355' ' ' VAL . 71.2 p -125.69 157.39 37.45 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.542 1.151 . . . . 74.450000000000003 110.406 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' GLN . . . . . 0.597 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 7.1 mt-30 -53.9 -46.29 71.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.469 1.105 . . . . 72.329999999999998 110.275 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -44.04 -30.46 0.74 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.504 1.127 . . . . 75.099999999999994 110.339 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . 0.529 ' OE1' ' CD1' ' A' ' 370' ' ' PHE . 58.8 mt-30 -83.58 -66.86 0.84 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.471 1.107 . . . . 64.409999999999997 110.287 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 364' ' ' CYS . 3.9 t80 -38.15 -38.56 0.34 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.499 1.124 . . . . 64.329999999999998 110.999 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -63.71 -52.36 60.86 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.431 1.082 . . . . 74.340000000000003 110.292 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 2.1 tp -61.59 -32.11 72.2 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.442 1.089 . . . . 71.140000000000001 109.287 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' PTR . . . . . 0.519 ' CE2' ' HA ' ' A' ' 370' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m -72.92 -21.68 60.86 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.531 1.145 . . . . 74.420000000000002 108.317 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -75.14 -51.95 12.16 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.461 1.101 . . . . 74.519999999999996 110.306 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 24.3 ptp -68.06 -15.14 63.47 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.506 1.128 . . . . 75.230000000000004 111.0 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 75.04 34.65 51.88 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.482 1.114 . . . . 54.219999999999999 111.012 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.1 -178.03 4.91 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 0.759 . . . . 72.530000000000001 110.026 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.461 ' CG2' ' NE2' ' A' ' 371' ' ' GLN . 2.0 m -117.35 161.22 19.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.132 . . . . 72.049999999999997 110.424 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.529 ' CD1' ' OE1' ' A' ' 359' ' ' GLN . 67.2 t80 -62.51 -69.39 0.26 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.51 1.131 . . . . 74.430000000000007 110.954 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.461 ' NE2' ' CG2' ' A' ' 369' ' ' THR . 0.2 OUTLIER -44.95 -25.9 0.36 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.533 1.146 . . . . 73.310000000000002 110.295 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.26 132.32 52.32 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.479 1.112 . . . . 72.299999999999997 109.263 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 5.1 t -68.32 124.43 23.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.954 -1.021 . . . . 73.109999999999999 110.893 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.423 ' N ' ' HD2' ' A' ' 374' ' ' LYS . 1.4 mmmm -90.88 18.46 6.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.517 1.136 . . . . 74.030000000000001 109.294 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . 0.544 HD12 ' CE2' ' A' ' 410' ' ' PHE . 64.2 mt -109.81 -25.7 3.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.524 1.14 . . . . 73.200000000000003 109.283 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 5.8 p -132.28 -48.66 0.92 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.131 . . . . 72.230000000000004 108.31 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 73.79 44.54 0.27 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.459 1.1 . . . . 75.200000000000003 109.318 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -123.68 -42.27 2.21 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.497 1.123 . . . . 75.140000000000001 110.297 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -133.82 176.83 8.21 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.509 1.131 . . . . 74.5 109.316 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -84.96 149.53 25.56 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.499 1.124 . . . . 75.329999999999998 109.264 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.401 ' CA ' ' O ' ' A' ' 392' ' ' MET . 22.1 mttt -51.83 -55.9 17.22 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.455 1.097 . . . . 72.019999999999996 109.313 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 1.1 p30 52.28 25.45 3.4 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.511 1.132 . . . . 72.140000000000001 109.301 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . 0.465 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -153.92 176.09 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.475 1.109 . . . . 71.219999999999999 109.343 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -158.46 148.26 19.63 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.498 1.124 . . . . 74.200000000000003 109.347 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.464 ' O ' ' N ' ' A' ' 389' ' ' GLY . 16.8 mm -112.16 141.25 28.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.53 1.144 . . . . 73.319999999999993 109.283 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.503 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.2 mt-10 -138.14 161.34 60.02 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.498 1.124 . . . . 73.5 110.331 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.503 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.99 -9.76 24.02 Favored 'Cis proline' 0 C--N 1.36 1.144 0 C-N-CA 121.006 -2.498 . . . . 74.019999999999996 111.031 0.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . 0.446 ' SG ' ' ND1' ' A' ' 390' ' ' HIS . 4.2 t -36.68 -72.96 0.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.965 -1.016 . . . . 73.349999999999994 110.936 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.34 15.72 6.94 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.47 1.106 . . . . 73.319999999999993 111.018 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.446 ' ND1' ' SG ' ' A' ' 388' ' ' CYS . 16.6 m170 -82.08 135.94 35.26 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 0.767 . . . . 73.439999999999998 109.627 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.416 ' CD2' ' N ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -102.63 160.1 14.87 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.537 1.148 . . . . 73.109999999999999 109.327 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' MET . . . . . 0.465 ' O ' ' CG1' ' A' ' 383' ' ' VAL . 15.2 ptp -173.07 175.31 3.25 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 1.131 . . . . 74.140000000000001 111.016 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . 0.424 ' O ' ' N ' ' A' ' 396' ' ' CYS . 20.0 p -96.94 114.92 26.58 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.55 1.156 . . . . 62.130000000000003 108.307 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 28.6 m -38.85 -59.8 0.92 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.49 1.119 . . . . 74.140000000000001 110.4 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.3 p -43.27 -42.46 4.41 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.509 1.13 . . . . 62.009999999999998 109.976 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . 0.424 ' N ' ' O ' ' A' ' 393' ' ' CYS . 2.8 m -67.8 -51.39 49.37 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.456 1.098 . . . . 73.140000000000001 108.312 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . 0.423 ' C ' ' CD1' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -45.67 -46.51 14.74 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.5 1.125 . . . . 74.030000000000001 109.319 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 1.1 m -56.67 -35.55 68.54 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 74.239999999999995 110.434 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -69.08 -21.13 64.08 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.522 1.139 . . . . 73.140000000000001 109.283 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' TRP . . . . . 0.602 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 8.9 t-105 -85.71 -61.29 1.79 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.506 1.129 . . . . 72.439999999999998 108.025 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.49 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 8.6 mm-40 -56.2 -14.24 2.63 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.121 . . . . 74.340000000000003 110.34 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 401' ' ' GLN . 1.0 OUTLIER -37.14 -63.36 0.44 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.513 1.133 . . . . 74.230000000000004 110.277 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.5 m -121.08 -24.57 5.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.102 . . . . 75.430000000000007 109.959 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . 0.602 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 3.1 m-20 -83.21 -95.09 0.06 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 70.510000000000005 109.341 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.49 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 73.96 27.6 66.32 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.548 1.155 . . . . 61.32 111.001 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -89.37 67.83 7.82 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.497 0.763 . . . . 75.310000000000002 110.279 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 61.86 -163.25 24.9 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.546 1.154 . . . . 71.25 110.989 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 4.9 t -56.23 127.6 70.98 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 108.325 -0.991 . . . . 54.229999999999997 108.325 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 0.3 9.06 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.452 1.764 . . . . 72.219999999999999 111.014 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . 0.544 ' CE2' HD12 ' A' ' 375' ' ' ILE . 9.1 m-85 -93.37 -48.15 6.55 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.56 1.162 . . . . 71.209999999999994 111.016 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' CYS . . . . . 0.44 ' O ' ' N ' ' A' ' 413' ' ' CYS . 1.1 p -109.35 13.06 24.4 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.535 1.147 . . . . 74.510000000000005 108.312 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 38.48 30.46 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.471 1.107 . . . . 74.109999999999999 110.282 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' CYS . . . . . 0.44 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.6 m -113.31 155.06 25.82 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.587 1.179 . . . . 73.549999999999997 108.296 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -59.25 158.95 8.3 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.451 1.094 . . . . 63.119999999999997 110.307 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.468 HG23 ' CG2' ' A' ' 418' ' ' THR . 7.2 mt -114.31 156.86 15.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.518 1.136 . . . . 74.420000000000002 109.329 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . 0.428 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 20.3 mmtt -125.63 -46.72 1.72 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 74.349999999999994 109.305 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . 0.497 ' O ' ' CG2' ' A' ' 418' ' ' THR . . . -111.28 133.56 11.59 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.494 1.122 . . . . 72.519999999999996 111.008 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' THR . . . . . 0.497 ' CG2' ' O ' ' A' ' 417' ' ' GLY . 23.4 p -157.06 116.21 3.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.513 0.772 . . . . 74.450000000000003 110.386 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.65 151.42 42.7 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.501 1.125 . . . . 74.400000000000006 110.325 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 101.79 1.51 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.56 1.821 . . . . 74.219999999999999 111.047 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -103.89 158.67 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.484 1.115 . . . . 74.340000000000003 109.248 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . 0.547 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 11.4 mt -112.29 107.16 22.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.532 1.145 . . . . 70.0 109.277 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . . . . . . . . . 20.5 t -75.39 149.6 6.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.472 1.107 . . . . 73.25 109.293 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -126.73 132.95 24.53 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.498 1.124 . . . . 73.340000000000003 109.336 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 163.03 36.21 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.543 1.812 . . . . 71.120000000000005 111.039 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . 0.597 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 1.1 t80 . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.485 1.116 . . . . 72.340000000000003 111.037 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.028 0 N-CA-C 111.002 -0.839 . . . . 60.009999999999998 111.002 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 178.59 7.05 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.501 1.79 . . . . 73.430000000000007 110.998 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -111.39 121.37 45.04 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 1.135 . . . . 73.030000000000001 109.621 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 6.9 mtt -91.15 134.21 34.72 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.473 1.108 . . . . 74.030000000000001 110.991 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 152.21 -51.29 0.5 Allowed Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.484 1.115 . . . . 61.119999999999997 111.022 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' SER . . . . . 0.459 ' HB3' ' CD1' ' A' ' 422' ' ' ILE . 60.7 m -64.95 140.48 58.87 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.497 0.763 . . . . 73.530000000000001 110.026 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -90.68 172.75 8.45 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.533 1.146 . . . . 71.430000000000007 109.309 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . 0.522 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 27.3 m-70 -132.99 130.93 40.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 1.14 . . . . 73.420000000000002 109.653 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . 0.414 HD11 ' CD1' ' A' ' 421' ' ' ILE . 61.9 mt -119.0 150.71 21.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 74.019999999999996 109.29 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.29 139.12 50.72 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.569 1.168 . . . . 72.25 109.285 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . 0.492 ' CG2' ' O ' ' A' ' 424' ' ' ASP . 21.9 t -87.74 122.59 39.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.504 1.127 . . . . 70.310000000000002 109.281 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.7 p -84.52 140.97 31.08 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.532 1.145 . . . . 75.439999999999998 110.391 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' GLN . . . . . 0.456 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 7.1 mt-30 -41.06 -33.66 0.35 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.537 1.148 . . . . 72.540000000000006 110.304 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -56.55 -49.1 75.82 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.531 1.144 . . . . 74.200000000000003 110.306 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -60.24 -66.76 0.47 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 74.329999999999998 110.325 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . 0.442 ' O ' ' N ' ' A' ' 364' ' ' CYS . 5.7 t80 -38.89 -41.36 0.74 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.481 1.113 . . . . 74.349999999999994 110.985 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -63.63 -54.03 42.22 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.5 1.125 . . . . 75.099999999999994 110.301 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.6 tp -56.26 -33.83 65.82 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.485 1.116 . . . . 62.539999999999999 109.329 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' PTR . . . . . 0.414 ' HD1' ' N ' ' A' ' 363' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . 0.442 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.9 m -70.15 -32.36 70.3 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.523 1.14 . . . . 74.540000000000006 108.304 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -65.38 -15.21 62.35 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.485 1.116 . . . . 75.430000000000007 110.269 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 2.5 ptp -126.0 2.07 7.28 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.54 1.15 . . . . 74.540000000000006 110.979 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 49.96 48.38 38.3 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.492 1.12 . . . . 73.439999999999998 111.034 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 6.5 t -115.88 177.99 4.48 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.45 0.735 . . . . 73.239999999999995 110.003 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 2.2 p -124.37 135.21 53.14 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.539 1.149 . . . . 74.420000000000002 110.373 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.542 ' CD2' HG11 ' A' ' 423' ' ' VAL . 32.5 t80 -64.1 -66.08 0.59 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.126 . . . . 65.129999999999995 110.997 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.573 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.3 OUTLIER -43.08 -27.16 0.19 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.499 1.124 . . . . 75.239999999999995 110.345 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . 0.437 ' CD2' ' N ' ' A' ' 373' ' ' CYS . 0.4 OUTLIER -73.18 135.91 44.68 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.539 1.149 . . . . 72.329999999999998 109.281 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . 0.437 ' N ' ' CD2' ' A' ' 372' ' ' LEU . 31.6 p -64.13 128.53 36.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.025 -0.989 . . . . 64.349999999999994 110.908 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -93.07 29.26 1.9 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.491 1.119 . . . . 73.25 109.279 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 35.4 mt -108.29 -60.5 2.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.539 1.149 . . . . 73.239999999999995 109.276 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 14.3 p -107.93 -22.36 12.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 72.310000000000002 108.278 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 58.79 46.97 13.35 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.463 1.102 . . . . 75.329999999999998 109.306 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -131.64 -44.77 0.98 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.453 1.096 . . . . 63.420000000000002 110.275 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -113.24 -179.98 3.8 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.492 1.12 . . . . 72.420000000000002 109.283 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -94.63 162.73 13.67 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.458 1.099 . . . . 72.510000000000005 109.284 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.44 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 20.3 mttt -65.76 -62.54 1.45 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.461 1.1 . . . . 75.099999999999994 109.324 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 4.1 t70 60.17 20.34 9.67 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.487 1.117 . . . . 64.340000000000003 109.314 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . 0.47 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -149.71 176.09 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.483 1.114 . . . . 74.340000000000003 109.296 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 17.5 tttm -159.13 156.39 28.98 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.478 1.111 . . . . 73.340000000000003 109.27 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.496 ' CG2' ' SG ' ' A' ' 388' ' ' CYS . 11.5 mm -122.67 144.16 33.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.51 1.132 . . . . 75.329999999999998 109.277 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.518 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.0 OUTLIER -137.68 162.34 55.18 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.554 1.159 . . . . 75.109999999999999 110.283 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.518 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.99 -12.46 23.95 Favored 'Cis proline' 0 C--N 1.36 1.153 0 C-N-CA 120.983 -2.507 . . . . 75.129999999999995 110.98 -0.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . 0.541 ' HB2' ' CE1' ' A' ' 390' ' ' HIS . 0.8 OUTLIER -36.34 -71.72 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.011 -0.995 . . . . 74.420000000000002 110.925 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.0 16.86 6.57 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.545 1.153 . . . . 74.109999999999999 110.981 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.564 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 20.0 m80 -74.46 146.41 42.82 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.483 0.755 . . . . 73.150000000000006 109.622 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.55 ' CD2' ' N ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -116.85 158.2 24.35 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.527 1.142 . . . . 65.140000000000001 109.301 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' MET . . . . . 0.563 ' HE2' ' CE1' ' A' ' 410' ' ' PHE . 14.2 ptp -173.45 173.37 3.49 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.507 1.129 . . . . 71.420000000000002 111.032 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 4.7 p -97.33 119.13 35.29 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.489 1.118 . . . . 74.209999999999994 108.309 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 4.5 m -47.05 -41.04 16.09 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.543 1.152 . . . . 74.310000000000002 110.378 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.5 p -55.42 -43.12 75.02 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 73.430000000000007 110.028 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 399' ' ' ALA . 4.9 m -70.17 -44.32 69.02 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.133 . . . . 55.109999999999999 108.32 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . 0.423 ' CD1' ' HG3' ' A' ' 401' ' ' GLN . 1.6 tm? -44.97 -47.84 11.41 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.529 1.143 . . . . 75.319999999999993 109.27 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 3.2 m -55.75 -35.24 65.97 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.464 1.103 . . . . 74.340000000000003 110.388 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -66.93 -23.45 65.97 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.127 . . . . 65.400000000000006 109.271 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' TRP . . . . . 0.414 ' O ' ' HB2' ' A' ' 404' ' ' ASP . 7.7 t-105 -85.91 -58.69 2.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 73.540000000000006 107.985 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.494 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 5.5 mm-40 -62.45 -9.84 9.73 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.564 1.165 . . . . 75.510000000000005 110.314 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 401' ' ' GLN . 1.0 OUTLIER -37.14 -63.9 0.4 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.428 1.08 . . . . 75.200000000000003 110.311 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 6.2 p -121.98 -25.04 5.04 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.505 1.128 . . . . 74.340000000000003 109.987 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 400' ' ' TRP . 3.1 m-20 -82.33 -92.52 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 61.130000000000003 109.289 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.494 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 75.53 32.19 55.17 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.516 1.135 . . . . 73.120000000000005 111.006 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -89.35 75.56 7.68 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.473 0.749 . . . . 73.510000000000005 110.275 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 57.34 -161.58 8.75 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.471 1.107 . . . . 71.329999999999998 110.986 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . 0.406 ' O ' ' N ' ' A' ' 412' ' ' ARG . 6.8 t -58.02 130.03 82.81 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 108.291 -1.003 . . . . 72.420000000000002 108.291 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -0.16 9.63 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.449 1.763 . . . . 72.439999999999998 110.994 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . 0.564 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 3.8 m-85 -97.64 -41.46 8.11 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.492 1.12 . . . . 72.329999999999998 111.004 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' CYS . . . . . 0.442 ' C ' ' N ' ' A' ' 413' ' ' CYS . 0.1 OUTLIER -111.19 8.75 21.73 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.537 1.148 . . . . 74.230000000000004 108.322 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 408' ' ' CYS . 12.7 tpp85 38.44 30.35 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.462 1.101 . . . . 73.510000000000005 110.275 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' CYS . . . . . 0.442 ' N ' ' C ' ' A' ' 411' ' ' CYS . 1.2 m -124.97 160.77 28.18 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.534 1.146 . . . . 74.010000000000005 108.335 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -55.79 149.06 15.29 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.516 1.135 . . . . 75.010000000000005 110.276 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.539 ' CG2' ' CG2' ' A' ' 418' ' ' THR . 1.7 mt -94.06 146.35 6.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.544 1.152 . . . . 75.5 109.28 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.93 -49.11 3.18 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.523 1.139 . . . . 74.019999999999996 109.305 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . 0.419 ' C ' ' CG2' ' A' ' 418' ' ' THR . . . -129.19 139.24 10.82 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.532 1.145 . . . . 63.119999999999997 111.015 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' THR . . . . . 0.539 ' CG2' ' CG2' ' A' ' 415' ' ' ILE . 50.7 p -151.84 141.21 21.52 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.503 0.766 . . . . 74.540000000000006 110.369 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -170.25 149.66 3.28 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.466 1.104 . . . . 73.230000000000004 110.325 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 102.24 1.57 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.505 1.792 . . . . 73.329999999999998 111.013 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . 0.414 ' CD1' HD11 ' A' ' 353' ' ' ILE . 0.9 OUTLIER -103.86 162.76 4.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.559 1.162 . . . . 63.149999999999999 109.315 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . 0.522 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 3.3 mp -113.27 106.41 20.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 71.329999999999998 109.322 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.542 HG11 ' CD2' ' A' ' 370' ' ' PHE . 40.5 t -76.95 144.65 11.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.482 1.114 . . . . 74.319999999999993 109.307 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.492 ' O ' ' CG2' ' A' ' 355' ' ' VAL . 1.1 m-20 -130.72 143.68 50.34 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.501 1.125 . . . . 74.200000000000003 109.323 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 172.46 16.33 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.51 1.795 . . . . 75.0 110.992 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . 0.456 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 7.5 t80 . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.502 1.126 . . . . 73.120000000000005 110.958 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.97 0 N-CA-C 111.024 -0.83 . . . . 54.43 111.024 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 178.65 6.99 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.523 1.802 . . . . 74.439999999999998 111.03 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -152.58 153.46 33.43 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.538 1.149 . . . . 61.240000000000002 109.608 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 29.7 ttp -103.2 -67.42 0.88 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.51 1.131 . . . . 73.140000000000001 110.983 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -155.29 99.08 0.18 Allowed Glycine 0 CA--C 1.531 1.053 0 O-C-N 124.488 1.118 . . . . 51.140000000000001 111.002 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 64.8 m -143.38 153.28 42.54 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.55 0.794 . . . . 43.32 109.944 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.55 176.64 8.49 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.507 1.129 . . . . 71.239999999999995 109.308 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -134.62 137.65 43.85 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.529 1.143 . . . . 72.239999999999995 109.567 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 2.1 mm -117.45 155.54 19.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.511 1.132 . . . . 64.400000000000006 109.276 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.09 137.54 53.5 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.459 1.1 . . . . 73.510000000000005 109.289 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . 0.478 ' CG2' ' O ' ' A' ' 424' ' ' ASP . 23.5 t -96.81 140.23 17.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.521 1.138 . . . . 73.230000000000004 109.254 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 22.0 p -107.31 154.14 21.72 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.54 1.15 . . . . 72.109999999999999 110.404 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' GLN . . . . . 0.557 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 12.4 mt-30 -49.92 -44.21 50.16 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.517 1.136 . . . . 74.409999999999997 110.31 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -45.13 -38.13 4.92 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.455 1.097 . . . . 75.120000000000005 110.283 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -74.22 -59.41 2.74 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.444 1.09 . . . . 75.329999999999998 110.304 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -43.48 -55.46 4.19 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.488 1.117 . . . . 73.409999999999997 111.035 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -55.33 -37.69 67.75 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.539 1.149 . . . . 71.349999999999994 110.325 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.29 -38.4 91.02 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.48 1.113 . . . . 70.310000000000002 109.309 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' PTR . . . . . 0.484 ' CE1' ' HA ' ' A' ' 370' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 3.0 m -66.7 -25.61 66.62 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.472 1.108 . . . . 74.409999999999997 108.344 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -71.74 -20.61 61.87 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.486 1.116 . . . . 64.510000000000005 110.326 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -124.06 6.13 8.58 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.443 1.09 . . . . 55.049999999999997 110.993 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 363' ' ' PTR . . . 45.27 52.91 8.21 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.47 1.106 . . . . 62.119999999999997 110.985 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 10.6 t -119.91 -174.83 2.84 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.522 0.778 . . . . 74.400000000000006 110.011 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 5.6 p -127.87 133.66 49.35 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.496 1.123 . . . . 74.319999999999993 110.42 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.484 ' HA ' ' CE1' ' A' ' 363' ' ' PTR . 68.0 t80 -64.33 -63.95 1.01 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.466 1.104 . . . . 65.200000000000003 110.997 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.544 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -44.1 -26.85 0.33 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.564 1.165 . . . . 72.109999999999999 110.301 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . 0.431 ' CD1' ' HA ' ' A' ' 377' ' ' ALA . 2.0 tm? -78.81 141.82 37.43 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.496 1.123 . . . . 73.430000000000007 109.279 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . 0.401 ' O ' ' CD1' ' A' ' 372' ' ' LEU . 15.1 t -75.63 150.99 37.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.967 -1.015 . . . . 72.439999999999998 110.89 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -110.9 23.7 13.84 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.534 1.146 . . . . 75.030000000000001 109.282 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 12.0 mt -108.12 -50.81 7.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 75.540000000000006 109.265 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 1.6 m -107.52 -42.55 4.75 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.524 1.14 . . . . 75.549999999999997 108.283 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . 0.431 ' HA ' ' CD1' ' A' ' 372' ' ' LEU . . . 72.09 47.43 0.3 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.533 1.146 . . . . 74.25 109.306 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -132.25 -66.56 0.69 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.517 1.136 . . . . 61.009999999999998 110.321 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -99.49 159.73 14.81 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.495 1.122 . . . . 70.450000000000003 109.304 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -73.14 152.05 41.31 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.506 1.129 . . . . 73.310000000000002 109.274 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.465 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 23.5 mttt -49.88 -62.51 1.52 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.476 1.11 . . . . 71.319999999999993 109.284 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 59.73 24.96 13.9 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.472 1.108 . . . . 75.140000000000001 109.253 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . 0.469 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -156.08 172.83 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.462 1.101 . . . . 72.420000000000002 109.289 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . 0.451 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 48.5 tttp -155.67 136.58 13.61 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.491 1.119 . . . . 71.349999999999994 109.293 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 389' ' ' GLY . 15.2 mm -102.18 137.3 30.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.467 1.104 . . . . 73.239999999999995 109.317 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.482 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.0 OUTLIER -138.02 161.31 60.4 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.5 1.125 . . . . 71.25 110.298 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.482 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.97 -7.17 22.95 Favored 'Cis proline' 0 C--N 1.36 1.136 0 C-N-CA 120.982 -2.508 . . . . 74.120000000000005 111.034 -0.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . 0.54 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 50.7 t -36.8 -73.89 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.967 -1.015 . . . . 64.099999999999994 110.932 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.32 15.52 7.05 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.544 1.152 . . . . 75.549999999999997 110.987 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.54 ' CG ' ' SG ' ' A' ' 388' ' ' CYS . 68.3 m170 -86.7 126.07 34.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.538 0.787 . . . . 74.010000000000005 109.605 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.465 ' HB2' ' CE ' ' A' ' 381' ' ' LYS . 0.0 OUTLIER -96.11 158.83 15.26 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.475 1.109 . . . . 64.530000000000001 109.272 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' MET . . . . . 0.565 ' HE1' ' CE2' ' A' ' 410' ' ' PHE . 20.4 ptp -172.78 175.87 3.27 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 73.239999999999995 110.996 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 2.3 p -99.64 114.75 28.02 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.478 1.111 . . . . 74.0 108.293 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 29.2 m -46.54 -24.81 0.58 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.492 1.12 . . . . 75.049999999999997 110.448 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.4 p -67.11 -42.49 84.43 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.102 . . . . 72.420000000000002 109.99 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . 0.419 ' O ' ' N ' ' A' ' 399' ' ' ALA . 76.1 m -80.74 -49.83 10.66 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.507 1.129 . . . . 64.409999999999997 108.279 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . 0.497 ' CD1' ' SD ' ' A' ' 392' ' ' MET . 2.7 tt -45.62 -48.3 14.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.116 . . . . 73.519999999999996 109.315 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.11 -34.77 61.09 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.533 1.145 . . . . 73.230000000000004 110.398 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -62.83 -27.11 69.1 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.436 1.085 . . . . 74.329999999999998 109.275 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' TRP . . . . . 0.52 ' CD2' ' HB3' ' A' ' 409' ' ' PRO . 3.7 t-105 -79.59 -53.15 7.13 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.518 1.136 . . . . 73.400000000000006 108.019 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.489 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 7.1 mm-40 -62.13 -10.02 9.2 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.49 1.119 . . . . 75.430000000000007 110.318 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 401' ' ' GLN . 5.3 mm-40 -37.08 -63.59 0.42 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.103 . . . . 73.439999999999998 110.293 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 18.2 t -121.54 -24.58 5.32 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.525 1.14 . . . . 73.219999999999999 110.015 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . 0.46 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 3.1 m-20 -83.88 -94.76 0.06 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.492 1.12 . . . . 74.019999999999996 109.281 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.489 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 73.93 32.59 58.65 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.504 1.128 . . . . 52.350000000000001 111.022 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -89.02 63.18 6.6 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.541 0.789 . . . . 75.409999999999997 110.304 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 68.52 -162.59 50.03 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.52 1.138 . . . . 65.219999999999999 110.978 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 3.2 t -56.56 122.86 53.48 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.313 -0.995 . . . . 54.310000000000002 108.313 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.52 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.3 Cg_endo -74.98 -1.87 11.79 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.497 1.788 . . . . 74.340000000000003 111.017 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . 0.565 ' CE2' ' HE1' ' A' ' 392' ' ' MET . 2.6 m-85 -89.16 -41.3 12.34 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 73.010000000000005 111.031 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' A' ' 412' ' ' ARG . 0.7 OUTLIER -117.56 11.86 13.91 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.527 1.142 . . . . 44.509999999999998 108.3 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 411' ' ' CYS . 14.5 tpp85 38.53 46.14 0.94 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.517 1.136 . . . . 73.099999999999994 110.294 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 4.1 t -131.04 150.44 52.15 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.499 1.124 . . . . 61.100000000000001 108.297 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -58.07 152.76 15.99 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.489 1.118 . . . . 75.420000000000002 110.329 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.415 ' CG2' ' CG2' ' A' ' 418' ' ' THR . 2.2 mt -107.2 154.81 8.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.457 1.098 . . . . 73.340000000000003 109.318 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -119.56 -41.44 2.7 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.478 1.111 . . . . 64.040000000000006 109.334 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . 0.429 ' O ' ' CG2' ' A' ' 418' ' ' THR . . . -119.0 127.73 7.35 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.506 1.129 . . . . 73.099999999999994 110.987 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' THR . . . . . 0.429 ' CG2' ' O ' ' A' ' 417' ' ' GLY . 42.2 p -154.26 125.09 7.15 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.526 0.78 . . . . 73.5 110.356 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -155.4 151.97 23.68 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.484 1.115 . . . . 73.329999999999998 110.287 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.451 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.3 Cg_endo -74.99 100.32 1.35 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.501 1.79 . . . . 63.420000000000002 111.014 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . 0.445 ' CD1' HG21 ' A' ' 423' ' ' VAL . 1.0 OUTLIER -107.18 171.09 2.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 124.512 1.132 . . . . 73.140000000000001 109.296 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 6.2 mm -121.22 109.92 26.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 73.310000000000002 109.3 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.445 HG21 ' CD1' ' A' ' 421' ' ' ILE . 2.5 t -75.86 140.38 17.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 74.030000000000001 109.317 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.478 ' O ' ' CG2' ' A' ' 355' ' ' VAL . 44.9 m-20 -130.19 143.79 50.57 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.516 1.135 . . . . 75.200000000000003 109.282 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 164.97 32.28 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.439 1.757 . . . . 72.310000000000002 111.02 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . 0.557 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 19.3 t80 . . . . . 0 C--N 1.324 -0.506 0 O-C-N 124.503 1.127 . . . . 74.400000000000006 111.028 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.011 0 N-CA-C 110.984 -0.846 . . . . 75.510000000000005 110.984 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.96 178.26 7.48 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.538 1.81 . . . . 74.510000000000005 111.033 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.26 167.24 13.47 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.505 1.128 . . . . 74.340000000000003 109.586 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' MET . . . . . 0.418 ' N ' ' SD ' ' A' ' 348' ' ' MET . 0.0 OUTLIER -119.58 122.91 42.64 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.483 1.115 . . . . 72.409999999999997 110.985 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -120.56 47.89 0.99 Allowed Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.53 1.144 . . . . 72.209999999999994 110.973 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 67.0 m -58.9 134.3 56.8 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.473 0.749 . . . . 73.430000000000007 109.983 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . 0.444 ' HB2' ' CG2' ' A' ' 421' ' ' ILE . 1.3 m-20 -77.12 -177.95 4.77 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.541 1.151 . . . . 63.450000000000003 109.324 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -137.41 125.94 23.59 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 73.319999999999993 109.586 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 2.2 mm -118.04 111.88 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.51 1.131 . . . . 74.319999999999993 109.262 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.31 149.84 28.76 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.459 1.099 . . . . 75.120000000000005 109.3 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' A' ' 424' ' ' ASP . 13.1 t -96.19 136.54 26.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.534 1.146 . . . . 71.099999999999994 109.315 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 11.6 p -95.21 143.16 26.84 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.514 1.134 . . . . 64.109999999999999 110.425 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' GLN . . . . . 0.508 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 12.0 mt-30 -42.4 -43.4 3.56 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.156 . . . . 75.349999999999994 110.3 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -46.8 -50.14 18.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.469 1.106 . . . . 74.140000000000001 110.245 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 362' ' ' LEU . 9.9 mm100 -60.09 -66.79 0.46 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.523 1.139 . . . . 74.319999999999993 110.285 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -38.25 -39.23 0.41 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 74.150000000000006 110.985 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -70.91 -47.38 59.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.494 1.121 . . . . 71.109999999999999 110.253 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 359' ' ' GLN . 4.9 tt -58.05 -33.57 69.15 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.456 1.098 . . . . 75.329999999999998 109.293 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' PTR . . . . . 0.452 ' CE1' ' O2P' ' A' ' 363' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 2.4 m -64.18 -29.61 70.71 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.504 1.127 . . . . 72.019999999999996 108.308 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -66.68 -18.72 65.52 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.462 1.102 . . . . 74.519999999999996 110.338 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -126.58 8.6 7.02 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 74.439999999999998 110.959 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 42.74 54.61 4.95 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.538 1.149 . . . . 74.120000000000005 111.007 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 62.2 m -121.25 179.0 4.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.523 0.778 . . . . 72.319999999999993 110.008 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 2.3 p -124.81 131.38 53.45 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.489 1.118 . . . . 74.209999999999994 110.44 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.563 ' CE2' HG11 ' A' ' 423' ' ' VAL . 34.9 t80 -60.7 -65.1 0.74 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.472 1.108 . . . . 74.439999999999998 111.025 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.532 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -43.54 -26.93 0.25 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.522 1.138 . . . . 73.430000000000007 110.227 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . 0.413 ' N ' ' C ' ' A' ' 370' ' ' PHE . 0.0 OUTLIER -71.65 123.28 22.17 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.505 1.128 . . . . 71.129999999999995 109.285 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 30.4 p -55.07 132.51 47.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.006 -0.997 . . . . 73.439999999999998 110.94 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.402 ' NZ ' ' O ' ' A' ' 372' ' ' LEU . 29.8 mmtm -92.93 32.2 1.3 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.465 1.103 . . . . 75.540000000000006 109.284 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 5.5 mt -113.35 -60.46 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.543 1.152 . . . . 65.329999999999998 109.315 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -108.28 -20.87 12.99 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 75.340000000000003 108.294 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 55.3 41.12 31.55 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.503 1.127 . . . . 75.230000000000004 109.308 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -128.38 -44.71 1.39 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.436 1.085 . . . . 74.310000000000002 110.324 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -110.21 174.15 6.0 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 75.150000000000006 109.293 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -89.03 162.09 16.21 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.517 1.135 . . . . 74.040000000000006 109.323 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 382' ' ' ASP . 21.9 mttt -65.21 -55.47 18.31 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.132 . . . . 73.109999999999999 109.292 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 381' ' ' LYS . 1.8 p30 50.62 25.58 2.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.462 1.101 . . . . 72.109999999999999 109.259 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . 0.476 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.3 OUTLIER -154.08 174.76 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.478 1.111 . . . . 74.510000000000005 109.263 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 21.1 tttm -158.67 155.77 28.75 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.464 1.102 . . . . 75.540000000000006 109.326 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.497 ' CG2' ' SG ' ' A' ' 388' ' ' CYS . 11.6 mm -121.69 143.78 33.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 73.129999999999995 109.314 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.522 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 5.3 mt-10 -137.6 162.49 54.44 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.443 1.089 . . . . 75.099999999999994 110.287 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.522 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.99 -12.29 23.98 Favored 'Cis proline' 0 C--N 1.361 1.211 0 C-N-CA 120.977 -2.51 . . . . 74.549999999999997 111.017 -0.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . 0.569 ' HB2' ' CE1' ' A' ' 390' ' ' HIS . 0.8 OUTLIER -36.48 -71.81 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.953 -1.021 . . . . 74.409999999999997 110.927 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 115.73 18.58 6.0 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.533 1.145 . . . . 75.219999999999999 111.028 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.569 ' CE1' ' HB2' ' A' ' 388' ' ' CYS . 20.6 m80 -76.56 145.52 38.96 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.524 0.779 . . . . 72.200000000000003 109.58 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.55 ' CD2' ' N ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -117.3 155.47 29.47 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.477 1.11 . . . . 62.32 109.273 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' MET . . . . . 0.547 ' HE1' ' CE1' ' A' ' 410' ' ' PHE . 18.7 ptp -172.14 172.85 4.48 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 72.409999999999997 111.016 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 4.5 p -91.69 115.3 27.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.444 1.09 . . . . 73.439999999999998 108.295 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 397' ' ' LEU . 27.3 m -47.83 -57.54 5.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.514 1.134 . . . . 70.109999999999999 110.401 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.9 t -45.56 -26.11 0.55 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.534 1.146 . . . . 71.439999999999998 109.976 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 2.2 m -88.01 -41.33 13.19 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.533 1.146 . . . . 74.409999999999997 108.288 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . 0.465 ' CD2' ' HG3' ' A' ' 401' ' ' GLN . 3.4 tt -51.61 -45.79 63.35 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.458 1.098 . . . . 74.299999999999997 109.306 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.54 -35.91 61.23 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.551 1.157 . . . . 74.450000000000003 110.428 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -62.05 -27.87 69.19 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.467 1.105 . . . . 72.109999999999999 109.325 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' TRP . . . . . 0.579 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 5.1 t-105 -79.38 -52.42 8.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.026 -1.101 . . . . 75.150000000000006 108.026 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.503 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 10.0 mm-40 -62.99 -9.78 11.28 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 1.106 . . . . 65.450000000000003 110.291 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 401' ' ' GLN . 9.8 mm-40 -37.05 -63.78 0.4 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.44 1.088 . . . . 54.420000000000002 110.298 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 6.6 t -123.61 -24.8 4.46 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.481 1.113 . . . . 74.409999999999997 109.972 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . 0.579 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 0.9 OUTLIER -81.61 -90.18 0.07 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.456 1.098 . . . . 74.219999999999999 109.295 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.503 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 67.51 32.65 79.4 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.493 1.121 . . . . 70.319999999999993 111.037 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -91.74 66.93 5.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 0.772 . . . . 65.420000000000002 110.331 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 70.04 -161.21 53.16 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.497 1.123 . . . . 65.409999999999997 111.041 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . 0.41 ' O ' ' N ' ' A' ' 412' ' ' ARG . 7.1 t -62.45 130.68 93.52 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.314 -0.995 . . . . 64.120000000000005 108.314 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.94 -1.77 11.64 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.504 1.792 . . . . 75.400000000000006 111.003 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . 0.547 ' CE1' ' HE1' ' A' ' 392' ' ' MET . 3.2 m-85 -95.63 -41.32 8.96 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.529 1.143 . . . . 72.340000000000003 110.982 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' CYS . . . . . 0.452 ' SG ' ' CE1' ' A' ' 390' ' ' HIS . 0.1 OUTLIER -111.08 8.59 21.86 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 75.239999999999995 108.277 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 408' ' ' CYS . 5.7 tpt85 38.39 30.71 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.488 1.117 . . . . 73.530000000000001 110.318 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' CYS . . . . . 0.441 ' N ' ' O ' ' A' ' 411' ' ' CYS . 42.1 t -127.77 151.1 49.44 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.512 1.133 . . . . 75.0 108.326 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -49.81 151.1 1.9 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.46 1.1 . . . . 75.150000000000006 110.292 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.549 ' CG2' ' CG2' ' A' ' 418' ' ' THR . 1.9 mt -99.38 150.43 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.484 1.115 . . . . 73.329999999999998 109.355 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . 0.459 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 15.2 mmtt -110.51 -45.37 3.54 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.515 1.134 . . . . 74.319999999999993 109.299 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -129.07 135.0 8.22 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.498 1.124 . . . . 60.32 110.987 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' THR . . . . . 0.549 ' CG2' ' CG2' ' A' ' 415' ' ' ILE . 80.9 p -152.47 130.53 11.85 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.534 0.785 . . . . 73.439999999999998 110.421 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -158.26 153.36 21.6 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.534 1.146 . . . . 74.420000000000002 110.263 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.44 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.2 Cg_endo -75.01 102.64 1.61 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.498 1.788 . . . . 73.099999999999994 110.977 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . 0.444 ' CG2' ' HB2' ' A' ' 351' ' ' ASP . 1.0 OUTLIER -103.85 167.73 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.47 1.106 . . . . 73.549999999999997 109.304 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 6.0 mm -118.9 109.65 27.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.453 1.096 . . . . 75.420000000000002 109.277 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.563 HG11 ' CE2' ' A' ' 370' ' ' PHE . 23.7 t -79.74 144.35 10.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.495 1.122 . . . . 75.129999999999995 109.261 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.491 ' O ' ' CG2' ' A' ' 355' ' ' VAL . 4.1 m-20 -131.4 143.5 49.5 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.437 1.086 . . . . 71.439999999999998 109.299 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 160.47 40.09 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.467 1.772 . . . . 71.400000000000006 111.005 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . 0.508 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 3.3 t80 . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.494 1.121 . . . . 75.019999999999996 111.013 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.031 0 N-CA-C 110.994 -0.842 . . . . 65.25 110.994 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 178.16 7.63 Favored 'Trans proline' 0 C--N 1.359 1.115 0 O-C-N 124.558 1.82 . . . . 74.549999999999997 111.004 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 48.0 54.43 10.08 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.483 1.114 . . . . 72.340000000000003 109.59 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 8.0 ttp -61.42 97.81 0.07 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.524 1.14 . . . . 73.5 111.047 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -173.47 152.82 16.31 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.506 1.129 . . . . 73.420000000000002 110.975 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 44.6 m -90.32 134.23 34.45 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.519 0.776 . . . . 75.230000000000004 109.973 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -88.77 162.7 16.08 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.522 1.139 . . . . 71.099999999999994 109.295 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . 0.425 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 14.2 m-70 -126.18 138.64 53.67 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.488 1.117 . . . . 75.439999999999998 109.579 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 21.9 mt -121.72 137.1 56.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.47 1.106 . . . . 74.319999999999993 109.298 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -107.93 123.55 48.79 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.513 1.133 . . . . 72.129999999999995 109.345 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . 0.46 ' CG2' ' O ' ' A' ' 424' ' ' ASP . 4.4 t -72.42 156.6 6.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.456 1.097 . . . . 72.030000000000001 109.29 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 359' ' ' GLN . 2.8 p -124.04 145.29 49.32 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.527 1.142 . . . . 71.109999999999999 110.414 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' GLN . . . . . 0.518 ' HG2' ' CE2' ' A' ' 426' ' ' PHE . 10.7 mt-30 -40.86 -46.75 2.81 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.47 1.106 . . . . 75.420000000000002 110.305 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -50.16 -45.07 53.03 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 1.139 . . . . 72.310000000000002 110.299 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 356' ' ' THR . 70.4 mt-30 -64.28 -66.55 0.53 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.521 1.138 . . . . 75.349999999999994 110.309 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . 0.421 ' O ' ' N ' ' A' ' 364' ' ' CYS . 2.4 t80 -41.47 -39.12 1.43 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.562 1.164 . . . . 73.420000000000002 110.987 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -66.67 -54.11 26.66 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.522 1.139 . . . . 72.310000000000002 110.278 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.8 tp -54.89 -34.33 62.91 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.562 1.163 . . . . 72.540000000000006 109.281 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' PTR . . . . . 0.483 ' O3P' ' CD1' ' A' ' 370' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . 0.421 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m -63.99 -25.25 68.04 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.435 1.085 . . . . 71.120000000000005 108.293 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.84 -2.73 44.78 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 74.530000000000001 110.28 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 8.1 mmt -105.88 -34.91 7.49 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.518 1.137 . . . . 74.439999999999998 111.026 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 100.79 16.88 24.98 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.461 1.101 . . . . 54.450000000000003 110.998 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 7.0 m -142.84 172.57 12.52 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.521 0.777 . . . . 72.420000000000002 110.019 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 11.6 p -98.9 -175.19 2.97 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.532 1.145 . . . . 71.319999999999993 110.411 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.507 ' CD2' HG12 ' A' ' 423' ' ' VAL . 27.6 t80 -83.55 -67.18 0.81 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.539 1.149 . . . . 74.25 111.02 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.534 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -39.41 -29.76 0.05 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.499 1.125 . . . . 75.299999999999997 110.275 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . 0.427 ' N ' ' C ' ' A' ' 370' ' ' PHE . 0.0 OUTLIER -69.97 115.43 9.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.508 1.13 . . . . 74.049999999999997 109.322 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 25.3 p -47.48 149.82 1.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.99 -1.005 . . . . 73.420000000000002 110.9 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.427 ' NZ ' ' CD1' ' A' ' 363' ' ' PTR . 24.5 mmtp -106.08 24.14 12.9 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 74.099999999999994 109.307 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 14.6 mt -100.73 -61.13 2.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 74.409999999999997 109.271 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 26.9 p -107.92 -22.41 12.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 74.420000000000002 108.274 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 61.89 41.39 11.53 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.109 . . . . 72.319999999999993 109.294 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -134.64 -45.93 0.74 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.481 1.113 . . . . 75.329999999999998 110.249 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -101.41 168.28 9.62 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.538 1.149 . . . . 72.230000000000004 109.314 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.82 157.27 17.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.564 1.165 . . . . 73.519999999999996 109.296 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 382' ' ' ASP . 0.7 OUTLIER -70.22 -62.1 1.52 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.442 1.089 . . . . 74.319999999999993 109.311 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . 0.405 ' CG ' ' O ' ' A' ' 381' ' ' LYS . 1.3 p30 51.86 21.85 1.57 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.509 1.131 . . . . 74.450000000000003 109.306 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . 0.463 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.3 OUTLIER -152.75 154.69 7.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.122 . . . . 72.299999999999997 109.24 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -141.73 153.72 44.81 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 73.010000000000005 109.292 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.441 ' CG2' ' SG ' ' A' ' 388' ' ' CYS . 22.8 mm -113.85 138.71 42.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.514 1.134 . . . . 72.0 109.275 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.541 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 1.8 mt-10 -129.73 163.32 47.76 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.472 1.108 . . . . 63.310000000000002 110.278 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.541 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.98 -18.56 18.59 Favored 'Cis proline' 0 C--N 1.36 1.158 0 C-N-CA 120.975 -2.51 . . . . 61.420000000000002 111.022 -0.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . 0.441 ' SG ' ' CG2' ' A' ' 385' ' ' ILE . 0.8 OUTLIER -35.61 -91.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.991 -1.004 . . . . 72.040000000000006 110.899 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 136.22 44.24 0.1 OUTLIER Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.499 1.124 . . . . 73.209999999999994 110.995 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.543 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 19.6 m170 -104.37 114.12 28.14 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.461 0.742 . . . . 64.549999999999997 109.648 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 5.9 mp -84.72 169.73 13.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.123 . . . . 73.450000000000003 109.311 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' MET . . . . . 0.463 ' O ' ' CG1' ' A' ' 383' ' ' VAL . 17.2 ptp -179.76 165.6 1.3 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.54 1.15 . . . . 71.420000000000002 111.01 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 396' ' ' CYS . 4.8 p -90.78 115.43 27.84 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.493 1.121 . . . . 64.5 108.301 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 20.7 m -38.72 -59.45 0.94 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.46 1.1 . . . . 75.230000000000004 110.4 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 6.7 m -42.24 -41.97 2.91 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.533 1.146 . . . . 72.099999999999994 109.983 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . 0.445 ' O ' ' N ' ' A' ' 399' ' ' ALA . 3.6 m -68.86 -56.68 7.17 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.463 1.102 . . . . 75.450000000000003 108.34 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . 0.432 ' C ' ' CD1' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -40.95 -36.02 0.6 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.503 1.127 . . . . 74.200000000000003 109.283 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 22.7 m -62.61 -49.44 75.21 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 72.140000000000001 110.394 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -54.33 -22.45 12.15 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.475 1.109 . . . . 75.019999999999996 109.313 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' TRP . . . . . 0.606 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 11.8 t-105 -85.44 -64.9 1.08 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.483 1.115 . . . . 75.230000000000004 108.01 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.488 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 12.5 mm-40 -52.34 -17.5 1.19 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.478 1.111 . . . . 74.349999999999994 110.312 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 401' ' ' GLN . 7.5 mt-10 -37.02 -63.31 0.43 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.481 1.113 . . . . 74.319999999999993 110.332 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 10.3 t -121.65 -24.5 5.3 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.5 1.125 . . . . 63.149999999999999 110.006 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . 0.606 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 19.5 m-20 -82.34 -93.78 0.06 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.501 1.125 . . . . 75.450000000000003 109.293 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.488 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 68.1 27.63 73.63 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.477 1.11 . . . . 73.439999999999998 111.03 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -88.68 67.04 8.3 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.539 0.788 . . . . 74.409999999999997 110.263 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 67.87 -162.7 48.17 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.537 1.148 . . . . 73.0 110.993 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 5.6 t -59.11 125.76 79.42 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 108.324 -0.991 . . . . 63.509999999999998 108.324 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.403 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.3 Cg_endo -74.97 -0.28 9.76 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.48 1.779 . . . . 62.039999999999999 111.012 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . 0.543 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 5.4 m-85 -95.85 -41.64 8.72 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.48 1.112 . . . . 70.540000000000006 110.996 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' CYS . . . . . 0.447 ' SG ' ' ND1' ' A' ' 390' ' ' HIS . 0.4 OUTLIER -112.8 10.43 19.16 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.525 1.14 . . . . 75.329999999999998 108.333 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 411' ' ' CYS . 27.5 mmm-85 38.5 31.75 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.448 1.092 . . . . 75.510000000000005 110.291 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' CYS . . . . . 0.42 ' N ' ' O ' ' A' ' 411' ' ' CYS . 10.5 t -125.09 146.36 49.49 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.419 1.074 . . . . 65.329999999999998 108.289 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -46.42 155.74 0.21 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.533 1.146 . . . . 75.400000000000006 110.351 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.434 HG21 ' CG2' ' A' ' 418' ' ' THR . 2.3 mt -102.44 156.91 4.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.449 1.093 . . . . 75.430000000000007 109.313 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . 0.409 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 10.3 mmtt -120.28 -43.48 2.52 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.471 1.107 . . . . 73.150000000000006 109.297 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . 0.488 ' O ' ' CG2' ' A' ' 418' ' ' THR . . . -126.78 140.54 12.02 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.486 1.116 . . . . 63.020000000000003 111.001 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' THR . . . . . 0.488 ' CG2' ' O ' ' A' ' 417' ' ' GLY . 17.3 p -157.53 116.7 3.28 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.46 0.741 . . . . 61.439999999999998 110.407 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.423 ' N ' ' OE1' ' A' ' 419' ' ' GLU . 23.3 pm0 -139.82 150.5 62.97 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.537 1.148 . . . . 74.340000000000003 110.313 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.99 102.34 1.58 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.504 1.791 . . . . 74.400000000000006 111.005 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . 0.471 ' CD1' ' N ' ' A' ' 422' ' ' ILE . 1.3 pp -103.85 -178.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.535 1.147 . . . . 73.109999999999999 109.258 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . 0.471 ' N ' ' CD1' ' A' ' 421' ' ' ILE . 15.2 mt -144.64 115.49 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 75.049999999999997 109.305 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.507 HG12 ' CD2' ' A' ' 370' ' ' PHE . 38.9 t -86.45 144.89 8.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.51 1.131 . . . . 73.5 109.326 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.46 ' O ' ' CG2' ' A' ' 355' ' ' VAL . 5.1 t70 -131.31 143.64 50.14 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.456 1.098 . . . . 74.120000000000005 109.345 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . 0.415 ' CD ' ' OE1' ' A' ' 371' ' ' GLN . 18.2 Cg_endo -75.04 170.67 19.91 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.475 1.776 . . . . 71.519999999999996 110.963 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . 0.518 ' CE2' ' HG2' ' A' ' 357' ' ' GLN . 6.5 t80 . . . . . 0 C--N 1.325 -0.468 0 O-C-N 124.503 1.127 . . . . 73.329999999999998 111.013 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.972 0 N-CA-C 111.016 -0.833 . . . . 73.420000000000002 111.016 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 178.7 6.91 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.519 1.8 . . . . 72.530000000000001 111.035 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -72.42 82.46 1.07 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 72.230000000000004 109.554 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 12.8 mmt -56.57 129.43 40.85 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.53 1.144 . . . . 74.400000000000006 110.983 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 163.66 43.06 0.02 OUTLIER Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.512 1.133 . . . . 63.299999999999997 111.01 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 2.6 p -118.45 132.07 56.25 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.467 0.746 . . . . 61.119999999999997 110.061 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -96.59 179.63 4.93 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.5 1.125 . . . . 73.319999999999993 109.292 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . 0.487 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 29.1 m-70 -134.2 135.44 43.03 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.48 1.113 . . . . 70.049999999999997 109.587 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 11.2 mt -116.21 149.14 18.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 75.239999999999995 109.262 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.79 137.29 52.84 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 74.239999999999995 109.326 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . 0.417 ' HB ' ' N ' ' A' ' 426' ' ' PHE . 5.0 t -89.03 141.62 14.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.472 1.107 . . . . 75.120000000000005 109.31 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' THR . . . . . 0.414 ' OG1' ' CG ' ' A' ' 359' ' ' GLN . 16.6 p -91.55 135.98 33.46 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.486 1.117 . . . . 70.310000000000002 110.371 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' GLN . . . . . 0.696 ' CG ' ' CE1' ' A' ' 426' ' ' PHE . 4.4 mt-30 -41.13 -33.15 0.32 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.523 1.139 . . . . 75.109999999999999 110.311 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . 0.449 ' CG ' ' N ' ' A' ' 359' ' ' GLN . 13.5 pt-20 -63.56 -50.41 69.59 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.515 1.134 . . . . 72.099999999999994 110.324 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . 0.449 ' N ' ' CG ' ' A' ' 358' ' ' GLU . 9.4 mm100 -56.57 -66.72 0.39 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.453 1.096 . . . . 75.450000000000003 110.329 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 364' ' ' CYS . 10.1 t80 -38.37 -51.94 1.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.522 1.139 . . . . 73.409999999999997 110.961 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -58.28 -60.96 2.95 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.493 1.121 . . . . 65.439999999999998 110.275 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 6.0 mt -45.47 -63.9 0.85 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.514 1.134 . . . . 73.239999999999995 109.271 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . 0.404 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.5 m -69.06 -23.29 64.02 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.472 1.108 . . . . 72.430000000000007 108.275 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -73.54 -3.74 29.66 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.511 1.132 . . . . 74.319999999999993 110.297 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 8.0 mmt -114.38 -33.5 5.59 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.527 1.142 . . . . 71.430000000000007 110.995 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.14 35.52 3.14 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.499 1.125 . . . . 73.219999999999999 110.994 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 24.0 m -148.76 161.16 42.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 0.771 . . . . 74.420000000000002 109.965 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.408 ' HB ' ' NE2' ' A' ' 371' ' ' GLN . 11.5 p -96.48 178.93 5.18 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.506 1.129 . . . . 73.299999999999997 110.364 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -85.03 -58.91 2.5 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 74.230000000000004 110.992 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.449 ' CB ' ' HB ' ' A' ' 423' ' ' VAL . 0.1 OUTLIER -54.66 -19.37 5.99 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.49 1.119 . . . . 74.010000000000005 110.254 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . 0.442 ' O ' ' NZ ' ' A' ' 374' ' ' LYS . 1.2 tm? -73.15 135.5 44.69 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.503 1.127 . . . . 73.329999999999998 109.307 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . 0.426 ' N ' HD23 ' A' ' 372' ' ' LEU . 7.6 t -72.2 132.37 44.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.987 -1.006 . . . . 72.510000000000005 110.901 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.442 ' NZ ' ' O ' ' A' ' 372' ' ' LEU . 12.5 mmtm -90.19 17.12 7.41 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.51 1.131 . . . . 72.010000000000005 109.289 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . 0.415 HD11 ' CE1' ' A' ' 410' ' ' PHE . 83.0 mt -102.45 -41.62 7.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.505 1.128 . . . . 71.25 109.328 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.6 -44.49 2.96 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.534 1.146 . . . . 64.310000000000002 108.317 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . 0.431 ' HA ' ' CD2' ' A' ' 372' ' ' LEU . . . 70.23 37.96 1.54 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.477 1.111 . . . . 71.450000000000003 109.299 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -131.63 -44.48 0.99 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.483 1.114 . . . . 72.439999999999998 110.311 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -107.38 172.79 6.63 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.453 1.096 . . . . 65.510000000000005 109.34 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -95.52 147.58 23.4 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.512 1.132 . . . . 73.310000000000002 109.274 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.466 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 27.4 mttt -55.41 -62.53 1.62 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 74.209999999999994 109.3 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 57.89 28.25 15.81 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 63.43 109.284 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . 0.466 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -158.38 175.83 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.515 1.134 . . . . 72.010000000000005 109.293 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . 0.455 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 72.6 tttt -157.83 149.34 21.62 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.502 1.126 . . . . 72.349999999999994 109.314 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.478 ' CG1' ' O ' ' A' ' 390' ' ' HIS . 2.6 mm -114.13 138.16 44.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.115 . . . . 75.340000000000003 109.328 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.488 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.2 OUTLIER -138.04 160.86 62.68 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.544 1.153 . . . . 74.340000000000003 110.303 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.488 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.98 -8.91 23.79 Favored 'Cis proline' 0 C--N 1.36 1.163 0 C-N-CA 120.979 -2.509 . . . . 74.230000000000004 111.012 -0.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . 0.539 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 17.5 t -36.84 -75.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.956 -1.02 . . . . 74.400000000000006 110.912 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 120.62 7.41 8.9 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.532 1.145 . . . . 72.209999999999994 111.015 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.539 ' CG ' ' SG ' ' A' ' 388' ' ' CYS . 56.6 m170 -77.0 131.78 38.63 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.524 0.779 . . . . 74.209999999999994 109.612 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.466 ' HB2' ' CE ' ' A' ' 381' ' ' LYS . 0.0 OUTLIER -102.48 168.09 9.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.447 1.092 . . . . 72.150000000000006 109.317 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' MET . . . . . 0.564 ' HE3' ' CE1' ' A' ' 410' ' ' PHE . 17.3 ptp -179.25 173.84 1.09 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.51 1.131 . . . . 74.420000000000002 111.006 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . 0.418 ' O ' ' N ' ' A' ' 396' ' ' CYS . 1.7 p -102.66 117.69 35.21 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 75.530000000000001 108.281 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 397' ' ' LEU . 2.5 m -38.7 -60.11 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.484 1.115 . . . . 72.219999999999999 110.441 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.8 m -39.3 -41.64 0.93 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.505 1.128 . . . . 53.310000000000002 110.042 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 393' ' ' CYS . 38.3 t -73.9 -49.85 22.94 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.471 1.107 . . . . 75.230000000000004 108.284 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . 0.436 ' CD1' ' HG3' ' A' ' 401' ' ' GLN . 1.5 tm? -42.61 -51.03 5.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.469 1.106 . . . . 73.010000000000005 109.328 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 402' ' ' GLU . 1.2 m -53.89 -42.05 68.25 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.509 1.131 . . . . 72.209999999999994 110.411 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -57.98 -26.59 62.53 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.505 1.128 . . . . 63.219999999999999 109.276 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' TRP . . . . . 0.601 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 10.5 t-105 -85.42 -62.58 1.5 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.52 1.137 . . . . 75.129999999999995 108.023 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.491 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 8.3 mm-40 -55.94 -14.37 2.46 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 1.122 . . . . 74.030000000000001 110.284 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 398' ' ' THR . 2.9 mm-40 -37.12 -63.36 0.44 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 74.129999999999995 110.32 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 22.7 t -121.4 -24.59 5.38 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.508 1.13 . . . . 64.519999999999996 109.995 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . 0.601 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 6.9 m-20 -82.51 -94.05 0.06 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.475 1.109 . . . . 75.200000000000003 109.326 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.491 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 72.42 31.04 63.73 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.475 1.109 . . . . 51.399999999999999 110.993 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -88.65 54.13 2.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 0.765 . . . . 74.400000000000006 110.272 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 72.02 -163.88 54.39 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.541 1.151 . . . . 72.299999999999997 111.024 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . 0.455 ' O ' ' N ' ' A' ' 412' ' ' ARG . 3.7 t -56.05 121.3 40.23 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.31 -0.996 . . . . 63.439999999999998 108.31 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 0.69 8.62 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.492 1.785 . . . . 71.310000000000002 110.998 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . 0.564 ' CE1' ' HE3' ' A' ' 392' ' ' MET . 24.3 m-85 -90.24 -36.34 14.79 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.518 1.136 . . . . 72.200000000000003 111.046 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.13 13.69 6.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 73.400000000000006 108.31 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 408' ' ' CYS . 14.8 tpp85 38.61 48.82 1.34 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.541 1.151 . . . . 73.310000000000002 110.347 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 1.2 m -125.89 150.92 47.55 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.468 1.105 . . . . 51.43 108.281 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 415' ' ' ILE . 5.1 tt0 -59.29 147.62 35.15 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.486 1.117 . . . . 71.010000000000005 110.271 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.467 HG21 ' CG2' ' A' ' 418' ' ' THR . 1.2 mt -89.04 149.11 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.484 1.115 . . . . 72.439999999999998 109.283 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.74 -49.82 2.63 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 74.219999999999999 109.324 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -140.58 131.89 5.2 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 124.498 1.124 . . . . 74.129999999999995 110.993 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' THR . . . . . 0.467 ' CG2' HG21 ' A' ' 415' ' ' ILE . 1.5 p -147.56 117.89 7.38 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.571 0.807 . . . . 64.120000000000005 110.434 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.428 ' HG3' ' CG2' ' A' ' 421' ' ' ILE . 20.5 pt-20 -128.08 150.83 74.85 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.459 1.099 . . . . 70.209999999999994 110.309 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 98.51 1.17 Allowed 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.467 1.772 . . . . 72.0 110.994 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . 0.459 ' CD1' HG23 ' A' ' 423' ' ' VAL . 0.7 OUTLIER -107.45 154.88 8.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.5 1.125 . . . . 73.510000000000005 109.292 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . 0.487 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 4.0 mp -110.67 105.39 18.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.502 1.126 . . . . 74.329999999999998 109.306 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.459 HG23 ' CD1' ' A' ' 421' ' ' ILE . 38.9 t -77.1 145.62 9.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.488 1.118 . . . . 74.5 109.294 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -130.54 143.53 49.67 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.491 1.119 . . . . 75.530000000000001 109.283 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 161.63 38.46 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.516 1.798 . . . . 62.399999999999999 110.997 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . 0.696 ' CE1' ' CG ' ' A' ' 357' ' ' GLN . 3.5 t80 . . . . . 0 C--N 1.326 -0.453 0 O-C-N 124.509 1.131 . . . . 73.140000000000001 111.004 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.028 0 N-CA-C 111.022 -0.831 . . . . 53.439999999999998 111.022 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 178.66 6.97 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.503 1.791 . . . . 65.140000000000001 111.008 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 8.5 m170 62.51 25.6 15.25 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.512 1.133 . . . . 73.129999999999995 109.635 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 14.4 ptm -90.68 17.01 8.1 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.481 1.113 . . . . 72.349999999999994 111.04 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -83.48 69.52 3.35 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.473 1.108 . . . . 65.120000000000005 111.008 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 16.2 m -49.14 145.39 4.26 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.443 0.731 . . . . 73.299999999999997 109.964 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -99.67 169.24 9.41 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.511 1.132 . . . . 74.340000000000003 109.259 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . 0.505 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 38.4 m-70 -136.3 125.15 24.05 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 74.219999999999999 109.629 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . 0.453 ' CD1' HD21 ' A' ' 391' ' ' LEU . 7.7 mt -105.47 149.76 8.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.521 1.138 . . . . 64.340000000000003 109.322 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 13.0 tptp -123.27 123.32 40.49 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.458 1.099 . . . . 73.329999999999998 109.3 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 55.2 t -79.71 148.87 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.487 1.117 . . . . 74.010000000000005 109.298 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 40.2 p -114.2 -178.47 3.38 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.493 1.121 . . . . 74.349999999999994 110.385 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -72.81 -36.7 67.59 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 54.340000000000003 110.336 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -54.94 -35.33 64.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.537 1.148 . . . . 75.230000000000004 110.322 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -79.6 -66.73 0.83 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 1.135 . . . . 75.150000000000006 110.306 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 364' ' ' CYS . 12.3 t80 -38.2 -43.23 0.75 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.499 1.124 . . . . 64.010000000000005 111.004 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -61.48 -54.15 47.17 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.464 1.103 . . . . 75.349999999999994 110.266 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.4 tt -55.36 -35.75 65.59 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.485 1.116 . . . . 70.129999999999995 109.267 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 360' ' ' TYR . 3.3 m -71.65 -25.6 62.2 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.463 1.102 . . . . 72.400000000000006 108.255 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -71.79 -16.09 62.17 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.535 1.147 . . . . 74.319999999999993 110.29 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.94 2.6 6.59 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.461 1.101 . . . . 75.129999999999995 110.973 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 50.79 58.69 8.92 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.522 1.139 . . . . 72.340000000000003 111.019 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' SER . . . . . 0.532 ' HG ' ' NZ ' ' A' ' 374' ' ' LYS . 84.5 p -129.36 177.99 6.78 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 0.757 . . . . 73.129999999999995 109.969 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 2.3 p -126.03 142.11 51.67 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.479 1.112 . . . . 71.109999999999999 110.388 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.615 ' CZ ' ' CD1' ' A' ' 391' ' ' LEU . 54.1 t80 -66.22 -67.96 0.41 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.485 1.116 . . . . 75.310000000000002 111.056 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.529 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -41.32 -31.8 0.26 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.453 1.096 . . . . 71.25 110.295 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . 0.422 ' CD2' ' N ' ' A' ' 373' ' ' CYS . 0.5 OUTLIER -67.07 136.39 55.13 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.436 1.085 . . . . 72.349999999999994 109.293 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . 0.422 ' N ' ' CD2' ' A' ' 372' ' ' LEU . 19.3 p -72.17 129.61 38.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.004 -0.998 . . . . 70.019999999999996 110.925 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.532 ' NZ ' ' HG ' ' A' ' 368' ' ' SER . 24.2 mmtp -90.99 18.35 6.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.453 1.096 . . . . 73.099999999999994 109.334 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 12.1 mt -92.13 -60.45 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.485 1.116 . . . . 73.140000000000001 109.282 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 23.9 p -107.68 -24.04 11.88 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.472 1.108 . . . . 65.519999999999996 108.284 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 60.93 43.24 11.91 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.462 1.102 . . . . 74.129999999999995 109.315 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -127.75 -43.65 1.54 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.522 1.139 . . . . 73.239999999999995 110.307 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 39.0 m-20 -119.7 177.7 4.85 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.452 1.095 . . . . 74.340000000000003 109.349 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -88.3 169.41 11.86 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 73.510000000000005 109.303 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.427 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 24.5 mttt -70.55 -62.07 1.53 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.499 1.124 . . . . 74.430000000000007 109.312 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 59.92 25.05 14.17 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 75.049999999999997 109.301 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -160.8 155.34 3.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 74.219999999999999 109.293 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . 0.422 ' HE3' ' CD2' ' A' ' 391' ' ' LEU . 4.1 ttmt -139.29 137.32 35.75 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.516 1.135 . . . . 74.209999999999994 109.274 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.464 ' O ' ' N ' ' A' ' 389' ' ' GLY . 20.2 mm -97.99 139.57 19.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.523 1.139 . . . . 74.25 109.284 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.496 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.0 OUTLIER -138.0 161.39 60.0 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.46 1.1 . . . . 72.430000000000007 110.28 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.496 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.0 -8.94 23.86 Favored 'Cis proline' 0 C--N 1.36 1.147 0 C-N-CA 121.021 -2.491 . . . . 74.239999999999995 111.017 -0.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . 0.544 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 31.3 t -36.55 -72.89 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.951 -1.022 . . . . 75.510000000000005 110.926 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 115.58 18.28 6.19 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.485 1.115 . . . . 75.010000000000005 111.004 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.544 ' CG ' ' SG ' ' A' ' 388' ' ' CYS . 61.7 m170 -87.77 129.3 35.22 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.518 0.775 . . . . 65.129999999999995 109.546 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.615 ' CD1' ' CZ ' ' A' ' 370' ' ' PHE . 0.8 OUTLIER -96.1 160.31 14.51 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.459 1.099 . . . . 72.109999999999999 109.262 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' MET . . . . . 0.413 ' O ' ' CA ' ' A' ' 381' ' ' LYS . 15.5 ptp -170.52 173.44 5.53 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.477 1.111 . . . . 74.140000000000001 111.019 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 5.0 p -99.15 115.0 28.04 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.483 1.115 . . . . 74.519999999999996 108.333 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 17.4 m -42.0 -59.7 1.65 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.496 1.123 . . . . 75.310000000000002 110.425 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 10.6 t -41.62 -36.58 0.97 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.478 1.111 . . . . 74.230000000000004 109.985 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' A' ' 399' ' ' ALA . 2.3 m -75.88 -54.93 6.14 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.467 1.105 . . . . 74.329999999999998 108.281 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . 0.456 ' C ' ' CD1' ' A' ' 397' ' ' LEU . 0.3 OUTLIER -41.34 -35.19 0.61 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.128 . . . . 75.209999999999994 109.28 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 83.2 m -62.05 -49.76 74.7 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.512 1.133 . . . . 61.109999999999999 110.431 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -55.16 -22.16 16.13 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.473 1.108 . . . . 72.430000000000007 109.349 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' TRP . . . . . 0.602 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 16.3 t-105 -84.6 -65.16 1.04 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.516 1.135 . . . . 74.430000000000007 108.048 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.507 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 38.3 mm-40 -49.18 -20.81 0.65 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.544 1.152 . . . . 71.319999999999993 110.304 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 401' ' ' GLN . 10.4 mt-10 -37.47 -63.53 0.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.479 1.112 . . . . 75.439999999999998 110.345 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 3.3 m -122.41 -24.22 5.05 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.497 1.123 . . . . 74.209999999999994 109.97 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . 0.602 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 16.9 m-20 -83.54 -95.17 0.06 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.51 1.131 . . . . 74.439999999999998 109.253 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.507 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 67.92 23.22 74.29 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.479 1.112 . . . . 75.540000000000006 111.01 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -81.51 58.11 3.56 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.556 0.797 . . . . 75.230000000000004 110.326 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 69.95 -160.74 53.18 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.503 1.127 . . . . 70.450000000000003 111.023 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . 0.442 ' O ' ' N ' ' A' ' 412' ' ' ARG . 4.7 t -56.3 120.3 34.23 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.267 -1.012 . . . . 72.409999999999997 108.267 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.411 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.2 Cg_endo -74.95 0.43 8.89 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.454 1.765 . . . . 74.329999999999998 110.978 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . 0.502 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 3.6 m-30 -93.8 -37.23 11.88 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.485 1.116 . . . . 74.299999999999997 111.0 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -123.26 13.49 9.61 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.49 1.119 . . . . 72.140000000000001 108.321 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 408' ' ' CYS . 11.4 mmt85 38.43 40.45 0.37 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 74.540000000000006 110.285 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 16.0 t -126.66 140.1 52.66 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.49 1.119 . . . . 73.430000000000007 108.301 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -45.32 154.25 0.18 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.467 1.104 . . . . 73.340000000000003 110.228 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.453 HG23 ' CG2' ' A' ' 385' ' ' ILE . 2.7 mt -109.8 157.19 10.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.48 1.113 . . . . 74.109999999999999 109.327 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -129.9 -46.6 1.14 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.492 1.12 . . . . 73.519999999999996 109.259 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . 0.498 ' O ' ' CG2' ' A' ' 418' ' ' THR . . . -107.22 127.14 8.68 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.53 1.144 . . . . 45.140000000000001 110.964 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' THR . . . . . 0.498 ' CG2' ' O ' ' A' ' 417' ' ' GLY . 17.5 p -157.47 128.65 6.73 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 0.76 . . . . 75.340000000000003 110.395 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.02 166.39 15.96 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.466 1.104 . . . . 73.109999999999999 110.283 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 101.85 1.52 Allowed 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.541 1.811 . . . . 74.099999999999994 110.984 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . 0.468 ' CD1' ' N ' ' A' ' 422' ' ' ILE . 0.6 OUTLIER -103.89 170.18 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.146 . . . . 73.439999999999998 109.313 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . 0.505 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 5.9 mt -137.8 107.63 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.448 1.093 . . . . 74.099999999999994 109.284 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.455 ' HB ' ' CB ' ' A' ' 371' ' ' GLN . 30.7 t -78.16 147.42 7.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.436 1.085 . . . . 70.420000000000002 109.264 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -129.68 143.72 50.09 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.478 1.112 . . . . 74.400000000000006 109.292 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 173.42 14.55 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.489 1.784 . . . . 75.140000000000001 111.007 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 15.5 t80 . . . . . 0 C--N 1.324 -0.503 0 O-C-N 124.556 1.16 . . . . 74.219999999999999 111.023 179.994 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.01 0 N-CA-C 111.02 -0.832 . . . . 55.119999999999997 111.02 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 178.72 6.88 Favored 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.56 1.821 . . . . 71.439999999999998 110.985 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -98.22 177.14 5.48 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.46 1.1 . . . . 72.120000000000005 109.551 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' MET . . . . . 0.41 ' N ' ' SD ' ' A' ' 348' ' ' MET . 1.9 mpt? -123.73 140.66 52.77 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.53 1.144 . . . . 73.439999999999998 110.98 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 107.3 -5.68 35.96 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.451 1.094 . . . . 74.129999999999995 110.997 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 64.5 m -113.13 144.36 42.78 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.457 0.739 . . . . 74.519999999999996 110.007 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.91 168.41 19.27 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.502 1.126 . . . . 63.130000000000003 109.312 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . 0.519 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 26.3 m-70 -132.94 135.85 45.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 74.409999999999997 109.578 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 3.3 mm -113.78 153.34 15.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.545 1.153 . . . . 62.030000000000001 109.308 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.413 ' CD ' ' O ' ' A' ' 355' ' ' VAL . 0.8 OUTLIER -114.31 136.24 53.19 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.471 1.107 . . . . 75.540000000000006 109.298 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . 0.532 HG22 ' CD2' ' A' ' 370' ' ' PHE . 5.7 t -98.77 163.74 2.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.539 1.149 . . . . 74.409999999999997 109.342 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' THR . . . . . 0.494 ' N ' ' CG1' ' A' ' 355' ' ' VAL . 2.4 p -125.63 179.68 5.04 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.536 1.147 . . . . 71.510000000000005 110.438 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' GLN . . . . . 0.564 ' HG3' ' CZ ' ' A' ' 426' ' ' PHE . 13.0 mt-30 -75.38 -37.54 60.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.545 1.153 . . . . 75.430000000000007 110.281 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -60.88 -31.19 70.66 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.502 1.126 . . . . 65.329999999999998 110.305 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . 0.438 ' NE2' ' OG1' ' A' ' 356' ' ' THR . 62.3 mt-30 -74.2 -66.92 0.66 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.5 1.125 . . . . 72.120000000000005 110.293 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -47.07 -34.95 6.33 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.531 1.144 . . . . 75.299999999999997 111.031 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -73.53 -57.54 3.93 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.439 1.087 . . . . 73.219999999999999 110.273 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 7.0 tt -51.15 -32.3 22.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.555 1.159 . . . . 74.430000000000007 109.28 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' PTR . . . . . 0.593 ' CE2' ' NZ ' ' A' ' 374' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.8 m -66.68 -24.35 66.26 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.523 1.14 . . . . 75.219999999999999 108.268 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -75.56 -3.93 37.01 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.5 1.125 . . . . 72.219999999999999 110.293 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 19.4 mtm -111.38 -33.91 6.27 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.504 1.127 . . . . 72.099999999999994 110.98 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 99.66 13.97 36.2 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.485 1.116 . . . . 73.430000000000007 111.028 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 66.1 m -120.86 -176.43 3.25 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.505 0.767 . . . . 75.310000000000002 109.99 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.443 ' CG2' ' NE2' ' A' ' 371' ' ' GLN . 1.9 m -115.81 161.54 18.6 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.463 1.102 . . . . 70.400000000000006 110.4 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.532 ' CD2' HG22 ' A' ' 355' ' ' VAL . 89.1 t80 -64.39 -68.76 0.33 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.138 . . . . 74.5 110.981 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.443 ' NE2' ' CG2' ' A' ' 369' ' ' THR . 0.1 OUTLIER -46.69 -34.1 4.83 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.52 1.138 . . . . 71.239999999999995 110.268 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . 0.457 ' CD1' ' O ' ' A' ' 373' ' ' CYS . 2.3 tm? -60.49 141.13 56.86 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 75.299999999999997 109.332 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . 0.457 ' O ' ' CD1' ' A' ' 372' ' ' LEU . 24.0 p -72.13 159.95 33.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.03 -0.986 . . . . 74.120000000000005 110.882 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.593 ' NZ ' ' CE2' ' A' ' 363' ' ' PTR . 21.8 mmtp -117.17 28.54 8.43 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.523 1.14 . . . . 72.430000000000007 109.314 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 11.5 mt -112.72 -59.64 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.453 1.096 . . . . 74.109999999999999 109.329 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 2.0 m -105.05 -14.85 15.27 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.484 1.115 . . . . 55.119999999999997 108.334 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . 0.415 ' HA ' ' CD1' ' A' ' 372' ' ' LEU . . . 52.14 44.98 29.16 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.505 1.128 . . . . 73.099999999999994 109.311 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -131.6 -61.93 0.88 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 70.150000000000006 110.298 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -95.18 162.88 13.52 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 70.329999999999998 109.313 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -85.42 167.89 15.1 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.514 1.134 . . . . 73.340000000000003 109.305 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.417 ' NZ ' ' CD1' ' A' ' 391' ' ' LEU . 0.7 OUTLIER -70.17 -61.05 1.93 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.117 . . . . 73.319999999999993 109.282 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . 0.406 ' CG ' ' C ' ' A' ' 381' ' ' LYS . 0.2 OUTLIER 47.51 25.04 0.57 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 72.450000000000003 109.278 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . 0.491 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.3 OUTLIER -150.91 170.17 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.528 1.143 . . . . 74.329999999999998 109.274 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 22.9 tttm -155.29 147.03 23.23 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.454 1.096 . . . . 73.540000000000006 109.274 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 389' ' ' GLY . 20.6 mm -108.97 135.06 48.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.504 1.127 . . . . 74.25 109.29 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.49 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.8 mt-10 -137.76 161.11 62.01 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.448 1.093 . . . . 74.099999999999994 110.326 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.49 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.99 -5.63 21.6 Favored 'Cis proline' 0 C--N 1.36 1.155 0 C-N-CA 120.985 -2.506 . . . . 70.519999999999996 110.979 0.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . 0.541 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 17.6 t -37.99 -78.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.008 -0.996 . . . . 55.020000000000003 110.892 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 119.23 36.46 0.86 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.485 1.115 . . . . 74.430000000000007 110.965 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.541 ' CG ' ' SG ' ' A' ' 388' ' ' CYS . 63.3 m170 -108.5 129.73 55.28 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.52 0.777 . . . . 72.319999999999993 109.543 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.417 ' CD1' ' NZ ' ' A' ' 381' ' ' LYS . 0.8 OUTLIER -98.66 160.41 14.29 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.471 1.107 . . . . 72.439999999999998 109.307 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' MET . . . . . 0.555 ' HE1' ' CE1' ' A' ' 410' ' ' PHE . 20.5 ptp -177.99 170.9 1.82 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.544 1.152 . . . . 74.25 110.999 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 5.0 p -89.83 114.78 26.58 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.463 1.102 . . . . 75.409999999999997 108.296 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 397' ' ' LEU . 3.4 m -46.98 -55.53 7.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.48 1.113 . . . . 73.209999999999994 110.447 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 71.5 m -46.41 -29.29 1.64 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 61.409999999999997 110.047 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 1.9 m -86.19 -37.92 18.2 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.565 1.166 . . . . 71.120000000000005 108.266 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . 0.479 ' C ' ' CD2' ' A' ' 397' ' ' LEU . 3.0 tt -53.88 -47.05 71.46 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.534 1.146 . . . . 74.319999999999993 109.338 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.09 -35.28 61.93 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 1.114 . . . . 73.129999999999995 110.409 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -63.01 -26.49 68.88 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.515 1.135 . . . . 73.140000000000001 109.305 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' TRP . . . . . 0.492 ' CD2' ' HB3' ' A' ' 409' ' ' PRO . 3.7 t-105 -80.85 -52.87 7.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.97 -1.122 . . . . 74.439999999999998 107.97 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.496 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.2 mm-40 -61.74 -10.28 8.41 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.512 1.132 . . . . 70.319999999999993 110.339 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 401' ' ' GLN . 37.7 mt-10 -37.23 -63.7 0.42 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.531 1.145 . . . . 73.439999999999998 110.287 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.8 m -123.12 -24.88 4.62 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.487 1.117 . . . . 73.340000000000003 109.985 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . 0.491 ' OD2' ' CH2' ' A' ' 400' ' ' TRP . 0.6 OUTLIER -81.71 -90.9 0.07 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.486 1.116 . . . . 65.219999999999999 109.283 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.496 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 69.41 32.51 71.79 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.461 1.101 . . . . 54.399999999999999 111.02 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -91.11 64.85 5.4 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.503 0.766 . . . . 74.200000000000003 110.295 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 66.07 -156.41 49.96 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.528 1.143 . . . . 74.010000000000005 111.006 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . 0.426 ' O ' ' N ' ' A' ' 412' ' ' ARG . 5.4 t -57.39 127.22 76.78 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 108.267 -1.012 . . . . 71.319999999999993 108.267 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.492 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.3 Cg_endo -75.04 0.33 9.05 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.506 1.793 . . . . 75.439999999999998 110.99 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . 0.555 ' CE1' ' HE1' ' A' ' 392' ' ' MET . 3.3 m-85 -93.59 -39.49 10.8 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.54 1.15 . . . . 74.010000000000005 110.991 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.5 OUTLIER -119.8 12.47 12.14 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.505 1.128 . . . . 72.430000000000007 108.254 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' ARG . . . . . 0.442 ' HD2' ' CH2' ' A' ' 400' ' ' TRP . 37.4 mmm-85 38.5 31.73 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.509 1.131 . . . . 75.450000000000003 110.274 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' CYS . . . . . 0.422 ' N ' ' O ' ' A' ' 411' ' ' CYS . 42.8 t -114.74 151.12 34.24 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.513 1.133 . . . . 75.319999999999993 108.255 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -55.16 149.1 12.93 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.516 1.135 . . . . 75.109999999999999 110.335 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.456 HG23 ' CG2' ' A' ' 418' ' ' THR . 4.0 mt -107.24 157.2 7.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.546 1.154 . . . . 73.140000000000001 109.294 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -126.64 -46.78 1.57 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.48 1.113 . . . . 74.340000000000003 109.275 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . 0.487 ' O ' ' CG2' ' A' ' 418' ' ' THR . . . -107.32 127.08 8.64 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.535 1.147 . . . . 74.329999999999998 110.97 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' THR . . . . . 0.487 ' CG2' ' O ' ' A' ' 417' ' ' GLY . 17.1 p -157.57 117.79 3.44 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.48 0.753 . . . . 75.329999999999998 110.413 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -143.6 150.59 51.27 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.521 1.138 . . . . 73.329999999999998 110.273 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.49 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.3 Cg_endo -75.06 102.47 1.59 Allowed 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.475 1.776 . . . . 74.209999999999994 110.972 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . 0.419 HD13 ' N ' ' A' ' 422' ' ' ILE . 1.2 pp -103.88 172.05 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.466 1.104 . . . . 71.430000000000007 109.267 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . 0.519 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 19.5 mm -130.83 115.14 29.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.512 1.133 . . . . 72.239999999999995 109.266 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . . . . . . . . . 18.9 t -84.68 141.67 14.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.488 1.118 . . . . 74.129999999999995 109.326 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.443 ' O ' ' CG2' ' A' ' 355' ' ' VAL . 1.0 OUTLIER -128.61 143.44 48.43 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.506 1.129 . . . . 74.230000000000004 109.327 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.04 174.44 12.79 Favored 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.5 1.789 . . . . 73.200000000000003 110.974 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . 0.564 ' CZ ' ' HG3' ' A' ' 357' ' ' GLN . 10.1 t80 . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.489 1.118 . . . . 73.030000000000001 111.037 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.035 0 N-CA-C 110.964 -0.854 . . . . 73.319999999999993 110.964 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 178.71 6.9 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.513 1.796 . . . . 60.149999999999999 111.028 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.54 146.37 41.83 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.451 1.094 . . . . 72.5 109.596 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' MET . . . . . 0.45 ' N ' ' SD ' ' A' ' 348' ' ' MET . 0.0 OUTLIER -44.93 167.34 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.524 1.14 . . . . 64.400000000000006 110.978 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -59.48 108.51 1.7 Allowed Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.504 1.128 . . . . 71.209999999999994 111.006 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 5.7 p -142.73 143.47 32.27 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.496 0.763 . . . . 73.409999999999997 109.979 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -93.48 -178.88 4.87 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 1.12 . . . . 65.230000000000004 109.306 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . 0.529 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 30.8 m-70 -139.31 145.96 39.74 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.469 1.105 . . . . 63.43 109.58 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 96.5 mt -133.71 142.6 41.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.528 1.142 . . . . 74.439999999999998 109.33 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.84 148.2 29.87 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.503 1.127 . . . . 74.299999999999997 109.258 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . 0.488 HG23 ' CD2' ' A' ' 370' ' ' PHE . 51.8 t -112.99 164.18 9.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.499 1.124 . . . . 74.519999999999996 109.331 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' THR . . . . . 0.46 ' N ' ' CG1' ' A' ' 355' ' ' VAL . 2.5 p -124.17 171.92 9.45 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.51 1.131 . . . . 71.230000000000004 110.441 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' GLN . . . . . 0.544 ' HG3' ' CZ ' ' A' ' 426' ' ' PHE . 5.4 mt-30 -66.32 -35.88 81.51 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.514 1.134 . . . . 75.239999999999995 110.28 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -55.94 -47.62 77.23 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.51 1.131 . . . . 74.530000000000001 110.351 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -59.48 -58.67 7.57 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.477 1.11 . . . . 73.409999999999997 110.305 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . 0.438 ' O ' ' N ' ' A' ' 364' ' ' CYS . 13.1 t80 -55.0 -33.12 62.31 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.486 1.116 . . . . 73.129999999999995 110.992 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -60.73 -47.71 85.09 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.466 1.104 . . . . 62.520000000000003 110.247 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.427 ' N ' ' CD1' ' A' ' 362' ' ' LEU . 0.4 OUTLIER -70.44 -44.84 67.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.493 1.12 . . . . 73.450000000000003 109.309 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' PTR . . . . . 0.436 ' CE2' ' HA ' ' A' ' 370' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m -84.27 -21.57 31.06 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.456 1.097 . . . . 73.019999999999996 108.287 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -77.64 -4.65 47.09 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.485 1.115 . . . . 74.310000000000002 110.312 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' MET . . . . . 0.427 ' CG ' ' O ' ' A' ' 363' ' ' PTR . 19.8 ptp -116.44 -32.24 5.32 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.47 1.106 . . . . 74.209999999999994 110.978 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.62 40.37 3.65 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.566 1.166 . . . . 45.200000000000003 111.01 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 68.5 m -145.1 171.84 13.93 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.539 0.788 . . . . 74.219999999999999 109.987 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.434 ' CG2' ' NE2' ' A' ' 371' ' ' GLN . 1.8 m -115.07 162.71 16.64 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.547 1.155 . . . . 73.239999999999995 110.37 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.488 ' CD2' HG23 ' A' ' 355' ' ' VAL . 43.7 t80 -66.46 -68.53 0.37 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 63.119999999999997 111.004 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.491 ' OE1' ' CD ' ' A' ' 425' ' ' PRO . 0.2 OUTLIER -46.05 -26.82 0.8 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.493 1.121 . . . . 74.230000000000004 110.29 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 373' ' ' CYS . 0.4 OUTLIER -71.18 135.74 47.73 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.501 1.126 . . . . 74.340000000000003 109.298 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . 0.441 ' N ' ' CD2' ' A' ' 372' ' ' LEU . 12.3 p -67.19 134.23 51.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.018 -0.992 . . . . 72.25 110.928 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.412 ' NZ ' ' CD2' ' A' ' 363' ' ' PTR . 28.8 mmtp -92.41 34.5 1.05 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.565 1.166 . . . . 74.519999999999996 109.312 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 49.8 mt -112.6 -60.35 2.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.545 1.153 . . . . 72.340000000000003 109.292 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -109.04 -18.31 13.69 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.484 1.115 . . . . 63.219999999999999 108.298 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 52.57 52.86 13.25 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.485 1.116 . . . . 63.32 109.328 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -135.19 -49.41 0.73 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.504 1.128 . . . . 75.420000000000002 110.326 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -111.89 165.36 12.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.531 1.144 . . . . 75.430000000000007 109.305 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -79.89 163.01 24.68 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 74.450000000000003 109.28 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.463 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 22.5 mttt -70.13 -62.6 1.32 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.475 1.109 . . . . 75.200000000000003 109.286 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 26.5 t0 60.25 23.74 13.14 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.541 1.151 . . . . 73.420000000000002 109.291 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . 0.476 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.4 OUTLIER -153.4 176.12 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.463 1.102 . . . . 62.329999999999998 109.312 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -157.91 154.66 28.25 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.475 1.109 . . . . 72.230000000000004 109.296 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' A' ' 390' ' ' HIS . 11.6 mm -122.04 142.48 38.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.455 1.097 . . . . 73.140000000000001 109.321 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.529 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.1 mt-10 -136.9 162.91 53.1 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.467 1.104 . . . . 65.409999999999997 110.29 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.529 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.02 -13.47 23.65 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 120.97 -2.513 . . . . 70.239999999999995 110.999 -0.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . 0.554 ' HB2' ' CE1' ' A' ' 390' ' ' HIS . 0.8 OUTLIER -36.12 -71.53 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.978 -1.01 . . . . 52.25 110.911 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.97 16.38 6.28 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.497 1.123 . . . . 74.319999999999993 110.985 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.566 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 20.9 m80 -73.48 145.16 45.87 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 0.763 . . . . 72.319999999999993 109.568 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.542 ' CD2' ' N ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -117.37 156.57 27.66 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.126 . . . . 75.340000000000003 109.345 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' MET . . . . . 0.568 ' HE3' ' CD1' ' A' ' 410' ' ' PHE . 12.3 ptp -173.9 173.93 3.14 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.512 1.133 . . . . 73.299999999999997 110.999 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 5.3 p -91.39 137.45 32.35 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.446 1.091 . . . . 63.229999999999997 108.286 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 98.4 m -65.81 -31.54 72.56 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.466 1.104 . . . . 62.340000000000003 110.386 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 60.9 m -72.46 -58.2 3.57 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.523 1.139 . . . . 75.040000000000006 109.99 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . 0.423 ' O ' ' N ' ' A' ' 399' ' ' ALA . 1.9 p -55.87 -42.84 76.49 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.508 1.13 . . . . 73.140000000000001 108.285 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -45.12 -44.02 10.22 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.519 1.137 . . . . 72.109999999999999 109.311 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 402' ' ' GLU . 86.2 m -54.61 -38.47 66.83 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.527 1.142 . . . . 75.439999999999998 110.414 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -55.35 -26.91 43.8 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.46 1.1 . . . . 74.150000000000006 109.299 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' TRP . . . . . 0.602 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 8.1 t-105 -85.0 -60.91 1.9 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.985 -1.117 . . . . 73.439999999999998 107.985 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.482 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 7.3 mm-40 -56.69 -13.75 2.72 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.482 1.114 . . . . 74.219999999999999 110.265 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 398' ' ' THR . 3.6 mm-40 -37.14 -63.41 0.43 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.506 1.129 . . . . 74.329999999999998 110.303 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 5.2 t -121.23 -24.62 5.44 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.567 1.167 . . . . 75.019999999999996 109.938 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . 0.602 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 17.1 m-20 -82.87 -94.54 0.06 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.457 1.098 . . . . 73.099999999999994 109.296 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.482 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 73.17 29.72 64.07 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.46 1.1 . . . . 62.439999999999998 110.97 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -88.07 66.09 8.44 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.513 0.773 . . . . 73.239999999999995 110.308 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 68.45 -160.03 51.6 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.479 1.112 . . . . 72.219999999999999 111.018 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 7.5 t -59.98 131.79 89.44 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 108.282 -1.007 . . . . 74.019999999999996 108.282 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -0.07 9.53 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.547 1.814 . . . . 73.030000000000001 110.988 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . 0.568 ' CD1' ' HE3' ' A' ' 392' ' ' MET . 8.4 m-85 -95.11 -43.02 8.3 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 72.319999999999993 111.002 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' CYS . . . . . 0.445 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.5 OUTLIER -111.67 9.18 20.98 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.518 1.136 . . . . 73.25 108.285 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' ARG . . . . . . . . . . . . . 39.8 mmm-85 38.58 30.24 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.478 1.111 . . . . 74.420000000000002 110.253 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' CYS . . . . . 0.445 ' N ' ' O ' ' A' ' 411' ' ' CYS . 24.2 t -127.46 146.15 50.59 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.463 1.102 . . . . 75.019999999999996 108.287 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -42.58 152.13 0.1 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 72.439999999999998 110.296 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.532 ' CG2' ' CG2' ' A' ' 418' ' ' THR . 2.1 mt -98.86 148.67 5.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.493 1.121 . . . . 72.420000000000002 109.303 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -112.29 -48.42 3.03 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.504 1.128 . . . . 74.430000000000007 109.331 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . 0.403 ' C ' ' CG2' ' A' ' 418' ' ' THR . . . -116.51 129.04 8.23 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.489 1.118 . . . . 61.329999999999998 110.979 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' THR . . . . . 0.532 ' CG2' ' CG2' ' A' ' 415' ' ' ILE . 82.0 p -152.82 138.95 18.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.492 0.76 . . . . 72.329999999999998 110.386 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -167.14 150.84 6.26 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.499 1.124 . . . . 74.329999999999998 110.309 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 101.08 1.43 Allowed 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.451 1.764 . . . . 74.019999999999996 110.977 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -105.32 157.55 6.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 72.430000000000007 109.303 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . 0.529 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 13.2 mt -114.82 105.39 18.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.529 1.143 . . . . 73.340000000000003 109.3 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.425 ' CG1' ' HB3' ' A' ' 371' ' ' GLN . 42.5 t -75.18 146.8 8.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.447 1.092 . . . . 75.129999999999995 109.267 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.73 133.59 25.36 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.462 1.101 . . . . 75.209999999999994 109.297 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . 0.491 ' CD ' ' OE1' ' A' ' 371' ' ' GLN . 18.2 Cg_endo -74.96 169.71 22.03 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.513 1.796 . . . . 74.519999999999996 110.961 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . 0.544 ' CZ ' ' HG3' ' A' ' 357' ' ' GLN . 5.1 t80 . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.449 1.093 . . . . 72.209999999999994 111.012 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.003 0 N-CA-C 111.006 -0.838 . . . . 51.219999999999999 111.006 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 178.58 7.07 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.475 1.776 . . . . 74.420000000000002 110.979 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.401 ' C ' ' SD ' ' A' ' 348' ' ' MET . 2.5 m-70 -125.75 69.65 1.19 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.444 1.09 . . . . 75.239999999999995 109.601 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' MET . . . . . 0.401 ' SD ' ' C ' ' A' ' 347' ' ' HIS . 3.0 mpp? -150.37 157.25 42.84 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.504 1.127 . . . . 75.5 110.985 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 43.46 52.52 6.23 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.538 1.149 . . . . 63.229999999999997 110.996 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 70.5 m -143.67 144.71 31.99 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.44 0.729 . . . . 65.030000000000001 109.997 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -83.59 178.39 8.01 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.511 1.132 . . . . 74.209999999999994 109.327 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . 0.536 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 37.6 m-70 -141.97 134.73 28.52 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.534 1.146 . . . . 74.329999999999998 109.609 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 23.4 mt -124.86 158.7 32.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.529 1.143 . . . . 71.109999999999999 109.302 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 355' ' ' VAL . 0.3 OUTLIER -124.12 150.51 44.99 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.492 1.12 . . . . 75.239999999999995 109.312 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . 0.517 HG23 ' CG ' ' A' ' 370' ' ' PHE . 70.3 t -109.09 146.96 14.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.539 1.149 . . . . 74.239999999999995 109.293 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 58.1 p -117.96 -173.16 2.39 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.464 1.103 . . . . 75.200000000000003 110.369 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' GLN . . . . . 0.4 ' HG2' ' CE1' ' A' ' 426' ' ' PHE . 4.6 mm100 -77.52 -35.04 53.81 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.508 1.13 . . . . 74.109999999999999 110.285 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . 0.439 ' O ' ' CD1' ' A' ' 362' ' ' LEU . 4.7 pt-20 -60.27 -31.4 70.19 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.102 . . . . 74.409999999999997 110.281 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . 0.421 ' OE1' ' CE2' ' A' ' 370' ' ' PHE . 73.3 mt-30 -77.34 -63.42 1.38 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.46 1.1 . . . . 74.409999999999997 110.287 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -39.07 -42.87 0.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.518 1.136 . . . . 74.129999999999995 111.036 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -61.2 -53.87 51.49 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.482 1.114 . . . . 72.430000000000007 110.28 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.439 ' CD1' ' O ' ' A' ' 358' ' ' GLU . 3.7 mt -55.46 -54.5 43.12 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.125 . . . . 64.140000000000001 109.33 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' PTR . . . . . 0.473 ' CE1' ' HA ' ' A' ' 370' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -48.22 82.66 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.498 1.124 . . . . 64.310000000000002 108.318 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.21 -65.82 0.5 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.487 1.117 . . . . 74.340000000000003 110.301 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 23.2 ptp -55.23 -34.2 63.77 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.425 1.078 . . . . 74.25 110.975 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 88.92 50.01 3.41 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.488 1.118 . . . . 64.430000000000007 110.988 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 3.6 m -145.58 179.39 7.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.508 0.77 . . . . 70.030000000000001 109.963 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.526 ' CG2' ' NE2' ' A' ' 371' ' ' GLN . 2.0 m -118.42 161.11 20.52 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.508 1.13 . . . . 71.200000000000003 110.383 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.517 ' CG ' HG23 ' A' ' 355' ' ' VAL . 2.7 t80 -59.31 -64.51 0.92 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.507 1.129 . . . . 74.540000000000006 111.028 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.526 ' NE2' ' CG2' ' A' ' 369' ' ' THR . 0.2 OUTLIER -60.7 -29.52 69.38 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.488 1.117 . . . . 64.299999999999997 110.325 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . 0.43 HD21 ' N ' ' A' ' 373' ' ' CYS . 1.2 tm? -60.93 135.61 57.84 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 75.420000000000002 109.337 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . 0.43 ' N ' HD21 ' A' ' 372' ' ' LEU . 32.1 p -77.9 136.01 37.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.02 -0.991 . . . . 72.140000000000001 110.884 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.536 ' CD ' ' N ' ' A' ' 374' ' ' LYS . 0.2 OUTLIER -92.66 26.45 2.68 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.514 1.134 . . . . 64.0 109.306 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 7.0 mt -107.79 -56.67 4.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.495 1.122 . . . . 74.400000000000006 109.268 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 14.2 m -108.28 -21.73 12.64 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.513 1.133 . . . . 63.409999999999997 108.354 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 57.71 38.01 27.41 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.511 1.132 . . . . 74.430000000000007 109.298 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -129.57 -43.92 1.24 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.448 1.093 . . . . 64.5 110.274 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -108.81 -172.96 2.16 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 72.239999999999995 109.287 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.15 175.47 6.28 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.528 1.142 . . . . 74.099999999999994 109.332 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.469 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 16.8 mttt -78.59 -50.79 10.92 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 71.530000000000001 109.301 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . 0.406 ' CG ' ' C ' ' A' ' 381' ' ' LYS . 0.1 OUTLIER 47.65 26.61 0.88 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.473 1.108 . . . . 74.109999999999999 109.261 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . 0.479 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.3 OUTLIER -156.13 176.1 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.481 1.113 . . . . 73.239999999999995 109.274 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -160.52 157.33 27.29 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.522 1.139 . . . . 75.439999999999998 109.29 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.491 ' CG2' ' SG ' ' A' ' 388' ' ' CYS . 11.6 mm -123.82 143.76 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.542 1.152 . . . . 64.5 109.301 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.525 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 7.0 mt-10 -137.72 162.39 54.82 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.575 1.172 . . . . 74.25 110.282 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.525 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.95 -12.49 23.85 Favored 'Cis proline' 0 C--N 1.36 1.163 0 C-N-CA 120.981 -2.508 . . . . 72.439999999999998 111.026 -0.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . 0.491 ' SG ' ' CG2' ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.41 -71.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.983 -1.008 . . . . 75.230000000000004 110.914 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.49 15.9 6.77 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.441 1.088 . . . . 52.520000000000003 110.946 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.567 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 21.4 m80 -73.07 148.0 44.46 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.522 0.777 . . . . 73.109999999999999 109.591 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.469 ' HB2' ' CE ' ' A' ' 381' ' ' LYS . 1.3 mt -119.47 158.14 26.85 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.518 1.136 . . . . 73.099999999999994 109.302 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' MET . . . . . 0.568 ' HE3' ' CD1' ' A' ' 410' ' ' PHE . 12.6 ptp -174.41 172.18 3.23 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.524 1.14 . . . . 74.019999999999996 111.016 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 7.2 p -89.69 118.07 29.03 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.497 1.123 . . . . 71.200000000000003 108.275 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 73.4 m -52.51 -45.13 66.13 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.529 1.143 . . . . 75.219999999999999 110.374 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 37.2 m -55.69 -29.51 59.51 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.468 1.105 . . . . 64.299999999999997 109.971 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 2.5 m -81.15 -47.51 13.37 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.452 1.095 . . . . 62.539999999999999 108.25 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . 0.441 ' C ' ' CD1' ' A' ' 397' ' ' LEU . 0.5 OUTLIER -41.49 -36.09 0.82 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 75.200000000000003 109.327 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' THR . . . . . 0.486 ' CG2' ' N ' ' A' ' 399' ' ' ALA . 0.5 OUTLIER -61.17 -52.54 64.41 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.43 1.081 . . . . 75.140000000000001 110.38 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 398' ' ' THR . . . -51.44 -23.23 3.68 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.543 1.152 . . . . 73.109999999999999 109.285 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' TRP . . . . . 0.607 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 8.9 t-105 -84.44 -64.91 1.08 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.534 1.146 . . . . 74.340000000000003 108.034 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.487 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.7 mm-40 -52.34 -17.37 1.14 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.487 1.117 . . . . 74.099999999999994 110.316 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 401' ' ' GLN . 7.0 mm-40 -37.18 -63.41 0.43 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 74.200000000000003 110.29 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.6 m -120.39 -24.56 5.84 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.515 1.134 . . . . 74.319999999999993 110.006 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . 0.607 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 8.2 m-20 -82.25 -94.92 0.05 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 64.519999999999996 109.327 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.487 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 70.5 28.73 70.69 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.475 1.11 . . . . 54.109999999999999 111.036 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -90.17 68.19 7.02 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.465 0.744 . . . . 72.540000000000006 110.297 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 65.34 -163.81 38.32 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.517 1.136 . . . . 73.409999999999997 111.01 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' A' ' 412' ' ' ARG . 6.3 t -58.21 129.27 82.98 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 108.363 -0.977 . . . . 71.439999999999998 108.363 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 -3.57 14.12 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.489 1.784 . . . . 75.299999999999997 111.042 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . 0.568 ' CD1' ' HE3' ' A' ' 392' ' ' MET . 4.5 m-85 -92.91 -41.48 10.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.119 . . . . 72.340000000000003 111.01 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' CYS . . . . . 0.456 ' SG ' ' CE1' ' A' ' 390' ' ' HIS . 0.1 OUTLIER -111.01 9.02 22.14 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.123 . . . . 71.030000000000001 108.285 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 408' ' ' CYS . 9.1 mmt85 38.56 30.23 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.555 1.159 . . . . 73.510000000000005 110.333 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' CYS . . . . . 0.442 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.3 m -125.55 163.01 23.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.531 1.144 . . . . 72.329999999999998 108.289 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -59.02 146.99 36.3 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.435 1.085 . . . . 75.420000000000002 110.275 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.466 HG21 ' CG2' ' A' ' 418' ' ' THR . 1.4 mt -93.06 153.41 3.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.477 1.111 . . . . 72.519999999999996 109.278 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.11 -46.33 3.01 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.526 1.141 . . . . 72.530000000000001 109.258 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . 0.494 ' O ' ' CG2' ' A' ' 418' ' ' THR . . . -131.11 144.73 16.28 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.501 1.125 . . . . 71.239999999999995 110.985 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' THR . . . . . 0.494 ' CG2' ' O ' ' A' ' 417' ' ' GLY . 17.6 p -157.59 116.26 3.2 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.512 0.772 . . . . 75.299999999999997 110.428 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -136.32 149.21 67.13 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.509 1.131 . . . . 75.340000000000003 110.314 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.491 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.3 Cg_endo -74.97 102.46 1.59 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.492 1.785 . . . . 73.239999999999995 111.0 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . 0.467 HD12 ' CG2' ' A' ' 423' ' ' VAL . 0.6 OUTLIER -103.83 158.9 5.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.46 1.1 . . . . 75.329999999999998 109.244 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . 0.536 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 11.2 mt -118.61 105.39 17.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.482 1.114 . . . . 74.200000000000003 109.311 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.467 ' CG2' HD12 ' A' ' 421' ' ' ILE . 21.5 t -76.78 149.25 6.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.502 1.127 . . . . 71.299999999999997 109.293 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.502 ' O ' ' CG2' ' A' ' 355' ' ' VAL . 9.2 m-20 -127.64 143.33 47.1 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.494 1.121 . . . . 73.239999999999995 109.32 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 179.25 6.26 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.488 1.783 . . . . 71.439999999999998 111.032 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . 0.4 ' CE1' ' HG2' ' A' ' 357' ' ' GLN . 10.5 t80 . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.499 1.125 . . . . 74.219999999999999 111.011 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . 0.404 ' N ' ' CD ' ' A' ' 346' ' ' PRO . . . . . . . . 0 CA--C 1.53 1.001 0 N-CA-C 110.99 -0.844 . . . . 74.109999999999999 110.99 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . 0.523 ' O ' ' CG ' ' A' ' 347' ' ' HIS . 18.4 Cg_endo -74.95 178.65 6.97 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.446 1.761 . . . . 64.439999999999998 111.052 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.523 ' CG ' ' O ' ' A' ' 346' ' ' PRO . 54.3 m80 -161.9 124.27 2.92 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.507 1.13 . . . . 72.530000000000001 109.576 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 42.9 mtp -145.79 166.12 26.84 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.535 1.147 . . . . 74.019999999999996 111.024 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -70.11 -30.81 69.49 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.477 1.11 . . . . 63.130000000000003 110.996 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 29.6 p -40.86 151.46 0.06 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.544 0.791 . . . . 74.409999999999997 110.03 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.14 175.08 10.97 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.501 1.126 . . . . 75.219999999999999 109.347 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -136.6 138.86 41.65 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 70.129999999999995 109.582 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 52.7 mt -121.73 158.75 24.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.525 1.141 . . . . 72.329999999999998 109.323 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -123.2 139.61 53.87 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.476 1.11 . . . . 74.25 109.269 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . 0.454 HG22 ' CG ' ' A' ' 370' ' ' PHE . 24.6 t -99.49 144.23 12.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.494 1.121 . . . . 75.230000000000004 109.318 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.9 p -110.19 153.02 25.35 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.505 1.128 . . . . 64.099999999999994 110.386 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' GLN . . . . . 0.464 ' HG3' ' CE1' ' A' ' 426' ' ' PHE . 24.7 mt-30 -43.35 -52.04 6.08 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.481 1.113 . . . . 74.209999999999994 110.284 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -43.85 -49.83 8.11 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 72.099999999999994 110.297 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . 0.546 ' O ' ' CD1' ' A' ' 363' ' ' PTR . 18.2 mt-30 -59.62 -32.8 70.76 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.49 1.119 . . . . 75.430000000000007 110.274 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . 0.443 ' O ' ' N ' ' A' ' 364' ' ' CYS . 3.7 t80 -71.02 -62.07 1.53 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.537 1.148 . . . . 74.209999999999994 111.016 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -53.67 -53.69 48.38 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.535 1.147 . . . . 75.120000000000005 110.28 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.62 -34.96 39.91 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.508 1.13 . . . . 72.200000000000003 109.244 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' PTR . . . . . 0.546 ' CD1' ' O ' ' A' ' 359' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m -64.96 -21.76 66.89 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.414 1.071 . . . . 75.519999999999996 108.319 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -73.96 -13.64 60.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.462 1.101 . . . . 73.420000000000002 110.286 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' MET . . . . . 0.435 ' CG ' ' O ' ' A' ' 363' ' ' PTR . 12.0 ptp -121.49 -0.98 9.66 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.493 1.12 . . . . 74.349999999999994 111.02 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 57.0 43.79 93.07 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.434 1.084 . . . . 71.439999999999998 110.966 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 3.6 p -132.85 173.96 10.83 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.438 0.728 . . . . 74.430000000000007 109.967 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.41 HG21 ' NE2' ' A' ' 371' ' ' GLN . 2.2 m -116.94 161.57 19.15 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.484 1.115 . . . . 74.030000000000001 110.383 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.485 ' CD1' ' OE1' ' A' ' 359' ' ' GLN . 78.2 t80 -64.02 -68.63 0.33 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.519 1.137 . . . . 73.109999999999999 110.982 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' GLN . . . . . 0.438 ' OE1' ' N ' ' A' ' 425' ' ' PRO . 0.0 OUTLIER -44.31 -35.82 2.5 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.541 1.15 . . . . 75.230000000000004 110.31 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . 0.494 ' CD1' ' O ' ' A' ' 373' ' ' CYS . 1.8 tm? -50.93 140.85 14.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.484 1.115 . . . . 75.340000000000003 109.247 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . 0.494 ' O ' ' CD1' ' A' ' 372' ' ' LEU . 19.7 p -85.42 147.08 26.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.97 -1.014 . . . . 63.439999999999998 110.913 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.557 ' CD ' ' N ' ' A' ' 374' ' ' LYS . 0.7 OUTLIER -99.54 17.44 20.41 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 71.400000000000006 109.29 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 5.9 mt -94.5 -61.69 2.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.458 1.099 . . . . 74.319999999999993 109.3 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 2.6 m -102.67 -24.65 13.74 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.532 1.145 . . . . 72.219999999999999 108.273 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . 0.47 ' HA ' ' CD1' ' A' ' 372' ' ' LEU . . . 63.04 46.42 4.73 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.478 1.111 . . . . 75.329999999999998 109.323 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -139.53 -49.58 0.49 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.548 1.155 . . . . 74.299999999999997 110.279 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -104.91 174.35 5.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 72.329999999999998 109.333 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -85.86 173.18 10.19 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.542 1.151 . . . . 72.310000000000002 109.292 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.422 ' CA ' ' O ' ' A' ' 392' ' ' MET . 15.3 mttt -79.33 -54.86 5.53 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.515 1.134 . . . . 72.319999999999993 109.265 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . 0.401 ' OD2' ' O ' ' A' ' 381' ' ' LYS . 1.2 p30 51.87 26.78 3.8 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.478 1.111 . . . . 73.150000000000006 109.267 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' VAL . . . . . 0.472 ' CG1' ' O ' ' A' ' 392' ' ' MET . 0.4 OUTLIER -156.03 175.4 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.116 . . . . 71.049999999999997 109.35 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . 0.417 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 62.5 tttt -158.53 151.81 22.87 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.503 1.127 . . . . 74.319999999999993 109.293 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.441 ' O ' ' N ' ' A' ' 389' ' ' GLY . 24.7 mm -115.28 133.59 61.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.126 . . . . 72.030000000000001 109.337 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.495 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 5.9 mt-10 -137.67 161.11 62.13 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.534 1.146 . . . . 73.120000000000005 110.286 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.495 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.4 Cg_endo -75.01 -5.2 21.25 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 121.034 -2.486 . . . . 73.25 111.004 -0.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 32.6 t -37.99 -78.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.0 -1.0 . . . . 71.530000000000001 110.946 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 119.53 36.51 0.84 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.483 1.114 . . . . 73.150000000000006 111.002 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.55 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 51.0 m170 -108.5 131.9 54.36 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.491 0.759 . . . . 74.409999999999997 109.581 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.417 ' CD1' ' HG3' ' A' ' 384' ' ' LYS . 0.0 OUTLIER -99.87 158.55 15.72 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.486 1.116 . . . . 74.239999999999995 109.303 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' MET . . . . . 0.472 ' O ' ' CG1' ' A' ' 383' ' ' VAL . 17.1 ptp -172.6 174.42 3.74 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.473 1.108 . . . . 74.519999999999996 111.04 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 28.1 p -97.53 115.55 28.06 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.469 1.106 . . . . 72.530000000000001 108.296 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 3.8 m -44.61 -58.99 2.69 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 75.329999999999998 110.364 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 29.6 m -41.11 -36.59 0.73 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.527 1.142 . . . . 73.510000000000005 109.989 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 399' ' ' ALA . 2.5 m -76.76 -50.42 13.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.477 1.11 . . . . 75.299999999999997 108.257 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . 0.424 ' C ' ' CD1' ' A' ' 397' ' ' LEU . 0.3 OUTLIER -43.0 -35.69 1.32 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.492 1.12 . . . . 75.319999999999993 109.282 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 53.4 m -63.01 -45.31 92.98 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.481 1.113 . . . . 63.549999999999997 110.447 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -57.65 -21.72 41.43 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.451 1.094 . . . . 72.329999999999998 109.309 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' TRP . . . . . 0.588 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 14.7 t-105 -86.09 -65.21 1.04 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.496 1.123 . . . . 73.340000000000003 107.98 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.499 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 40.1 mm-40 -48.83 -20.96 0.55 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.479 1.112 . . . . 74.140000000000001 110.288 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 401' ' ' GLN . 7.3 mt-10 -37.64 -63.65 0.44 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.538 1.149 . . . . 74.519999999999996 110.276 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 23.0 t -122.41 -24.45 5.0 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.477 1.111 . . . . 74.439999999999998 109.98 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . 0.588 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 3.0 m-20 -82.85 -94.42 0.06 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.512 1.133 . . . . 75.409999999999997 109.311 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.499 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 67.29 21.37 72.1 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.435 1.084 . . . . 73.409999999999997 110.965 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -81.0 62.46 4.99 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 0.767 . . . . 73.219999999999999 110.287 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 68.15 -163.46 48.2 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.536 1.147 . . . . 70.109999999999999 111.002 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . 0.435 ' O ' ' N ' ' A' ' 412' ' ' ARG . 2.3 t -56.12 121.45 41.56 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.303 -0.999 . . . . 73.239999999999995 108.303 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.448 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.3 Cg_endo -75.03 0.65 8.67 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.53 1.805 . . . . 73.25 110.965 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . 0.55 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 2.7 m-85 -92.49 -37.99 12.21 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 74.299999999999997 111.047 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' CYS . . . . . 0.435 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.8 OUTLIER -126.02 17.13 7.89 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.475 1.109 . . . . 73.120000000000005 108.335 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 408' ' ' CYS . 47.5 mmm-85 38.43 30.99 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.526 1.141 . . . . 73.010000000000005 110.302 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 411' ' ' CYS . 15.2 t -115.35 139.15 50.24 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 74.209999999999994 108.302 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -45.8 158.97 0.08 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.443 1.09 . . . . 64.239999999999995 110.344 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.455 HG23 ' CG2' ' A' ' 418' ' ' THR . 2.2 mt -114.45 157.24 15.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.448 1.093 . . . . 74.209999999999994 109.309 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -128.98 -47.79 1.23 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.514 1.134 . . . . 71.129999999999995 109.295 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . 0.491 ' O ' ' CG2' ' A' ' 418' ' ' THR . . . -108.76 127.9 8.8 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.541 1.15 . . . . 60.100000000000001 111.031 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' THR . . . . . 0.491 ' CG2' ' O ' ' A' ' 417' ' ' GLY . 17.5 p -157.51 116.74 3.29 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.502 0.766 . . . . 75.530000000000001 110.357 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -140.61 151.29 63.08 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.115 . . . . 71.540000000000006 110.296 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.2 Cg_endo -75.05 101.64 1.5 Allowed 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.485 1.781 . . . . 71.219999999999999 110.979 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . 0.453 HD11 ' CG2' ' A' ' 423' ' ' VAL . 0.7 OUTLIER -105.71 167.58 3.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.441 1.088 . . . . 74.310000000000002 109.335 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 12.7 mt -126.52 106.32 15.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.505 1.128 . . . . 75.230000000000004 109.293 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.461 HG12 ' CD2' ' A' ' 370' ' ' PHE . 15.4 t -78.89 145.74 9.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.479 1.112 . . . . 74.239999999999995 109.284 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -128.38 143.68 49.1 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 75.239999999999995 109.302 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . 0.438 ' N ' ' OE1' ' A' ' 371' ' ' GLN . 18.1 Cg_endo -75.01 175.65 10.97 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.559 1.82 . . . . 75.140000000000001 110.999 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . 0.464 ' CE1' ' HG3' ' A' ' 357' ' ' GLN . 39.8 t80 . . . . . 0 C--N 1.324 -0.507 0 O-C-N 124.505 1.128 . . . . 75.319999999999993 111.015 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 350' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 29.0 t . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 110.016 -0.364 . . . . 65.14 110.016 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' ASP . . . . . 0.727 ' HB2' HG22 ' A' ' 421' ' ' ILE . 10.8 m-20 -78.54 174.45 11.34 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.429 1.081 . . . . 72.13 109.266 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 352' ' ' HIS . . . . . 0.459 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 28.2 m-70 -131.43 126.46 35.17 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.478 1.111 . . . . 64.23 109.597 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 353' ' ' ILE . . . . . 0.475 HD11 ' HD2' ' A' ' 384' ' ' LYS . 9.0 mt -111.34 149.16 14.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.481 1.113 . . . . 44.52 109.302 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 32.1 tptt -112.77 133.25 54.86 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.468 1.105 . . . . 72.03 109.353 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 424' ' ' ASP . 40.0 t -87.75 149.53 4.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 71.53 109.33 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 5.9 p -114.15 149.19 36.02 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 72.04 110.413 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' GLN . . . . . 0.556 ' CG ' ' CE1' ' A' ' 426' ' ' PHE . 27.6 mt-30 -50.15 -34.33 21.99 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.479 1.112 . . . . 72.32 110.344 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -56.34 -52.53 64.2 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.497 1.123 . . . . 74.44 110.294 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 359' ' ' GLN . . . . . 0.463 ' OE1' HG13 ' A' ' 355' ' ' VAL . 35.3 mt-30 -55.8 -67.18 0.31 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.521 1.138 . . . . 64.53 110.329 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 360' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 364' ' ' CYS . 1.2 t80 -44.25 -45.77 8.71 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.473 1.108 . . . . 72.53 111.021 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -61.61 -42.67 99.2 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.499 1.124 . . . . 72.13 110.314 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 7.8 mt . . . . . 0 C--N 1.325 -0.488 0 O-C-N 124.472 1.107 . . . . 50.02 109.257 -179.969 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 364' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.6 m . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 108.345 -0.983 . . . . 61.45 108.345 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -68.67 -7.79 36.55 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.476 1.11 . . . . 75.15 110.316 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 7.4 mmt -106.2 -35.01 7.33 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.501 1.126 . . . . 74.35 111.015 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 90.55 46.97 3.87 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.54 1.15 . . . . 72.13 110.977 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 8.3 t -142.95 -174.63 4.23 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.489 0.758 . . . . 72.53 109.978 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.437 ' O ' ' NZ ' ' A' ' 374' ' ' LYS . 2.0 p -126.47 140.89 52.12 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.492 1.12 . . . . 44.13 110.422 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.445 ' O ' ' N ' ' A' ' 372' ' ' LEU . 76.0 t80 -56.18 -70.96 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.522 1.139 . . . . 74.43 111.027 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 371' ' ' GLN . . . . . 0.552 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -38.52 -30.44 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 63.22 110.27 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 370' ' ' PHE . 0.0 OUTLIER -71.46 122.78 21.02 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.506 1.129 . . . . 72.14 109.327 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 373' ' ' CYS . . . . . 0.451 ' HG ' ' HG ' ' A' ' 376' ' ' CYS . 14.8 p -59.13 134.8 57.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.035 -0.984 . . . . 61.14 110.919 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.437 ' NZ ' ' O ' ' A' ' 369' ' ' THR . 23.0 mmtm -97.31 32.35 2.24 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.47 1.106 . . . . 71.35 109.33 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 2.7 mt -113.42 -59.62 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.116 . . . . 74.31 109.29 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' CYS . . . . . 0.451 ' HG ' ' HG ' ' A' ' 373' ' ' CYS . 20.7 p -108.27 -13.92 14.8 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 64.4 108.293 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 47.66 41.83 14.28 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.482 1.114 . . . . 75.12 109.32 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -122.92 -41.02 2.37 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.128 . . . . 71.1 110.28 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.58 170.75 11.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.512 1.133 . . . . 74.32 109.313 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -76.72 175.47 9.35 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 74.24 109.33 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.455 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 21.9 mttt -73.78 -62.38 1.51 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.486 1.116 . . . . 64.1 109.314 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 59.91 25.93 15.12 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.478 1.112 . . . . 64.11 109.315 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.909 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -158.01 171.8 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.502 1.127 . . . . 64.24 109.292 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.475 ' HD2' HD11 ' A' ' 353' ' ' ILE . 40.4 tttp -155.21 142.05 19.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.47 1.106 . . . . 71.15 109.303 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.84 HD12 HD13 ' A' ' 415' ' ' ILE . 21.7 mm -105.22 133.93 48.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.479 1.112 . . . . 71.13 109.297 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.511 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.1 mt-10 -137.84 161.19 61.39 Favored Pre-proline 0 C--N 1.324 -0.532 0 O-C-N 124.531 1.144 . . . . 72.43 110.293 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.511 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.02 -5.82 21.88 Favored 'Cis proline' 0 C--N 1.361 1.197 0 C-N-CA 120.982 -2.507 . . . . 75.11 111.035 0.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 388' ' ' CYS . . . . . 0.432 ' SG ' ' ND1' ' A' ' 390' ' ' HIS . 43.1 t -37.43 -76.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.017 -0.992 . . . . 73.41 110.905 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 389' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 118.22 34.79 1.08 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.499 1.124 . . . . 64.42 111.018 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.432 ' ND1' ' SG ' ' A' ' 388' ' ' CYS . 46.1 m170 -105.79 130.82 53.7 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.529 0.782 . . . . 72.21 109.569 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.697 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -101.06 156.73 17.24 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 74.22 109.257 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.909 ' O ' HG12 ' A' ' 383' ' ' VAL . 19.8 ptp -173.64 176.19 2.79 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.517 1.136 . . . . 60.35 110.98 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 393' ' ' CYS . . . . . 1.22 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 7.3 p -94.04 114.93 27.19 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.508 1.13 . . . . 64.41 108.276 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 397' ' ' LEU . 94.6 m -48.43 -56.6 7.79 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.539 1.149 . . . . 54.44 110.422 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.5 t -45.82 -25.96 0.6 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 74.32 109.944 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 396' ' ' CYS . . . . . 1.22 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 1.8 m -87.63 -42.53 12.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.478 1.111 . . . . 64.24 108.322 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 397' ' ' LEU . . . . . 0.619 HD13 ' C ' ' A' ' 397' ' ' LEU . 1.0 OUTLIER -48.0 -54.55 12.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 71.22 109.31 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 398' ' ' THR . . . . . 0.552 ' N ' HD13 ' A' ' 397' ' ' LEU . 61.6 m -45.63 -36.48 4.84 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.465 1.103 . . . . 70.32 110.438 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 399' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -63.06 -39.61 95.22 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.513 1.133 . . . . 55.44 109.272 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 400' ' ' TRP . . . . . 0.507 ' CD2' ' HB3' ' A' ' 409' ' ' PRO . 2.1 t-105 -69.2 -52.61 26.11 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.496 1.123 . . . . 74.02 108.01 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -62.68 -16.3 56.52 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.546 1.154 . . . . 70.53 110.339 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -86.78 -11.4 51.1 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.448 1.092 . . . . 70.41 110.268 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.4 t -111.9 -23.0 10.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 71.22 109.985 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 404' ' ' ASP . 8.7 t0 -153.19 -88.46 0.05 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.483 1.115 . . . . 71.43 109.307 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 108.3 32.62 3.17 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.493 1.121 . . . . 64.54 111.004 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 406' ' ' GLN . . . . . 0.433 ' O ' ' CG ' ' A' ' 406' ' ' GLN . 3.1 tt0 -91.27 79.28 5.69 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.514 0.773 . . . . 72.22 110.286 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 43.91 -159.06 0.12 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.53 1.144 . . . . 73.14 111.013 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 408' ' ' CYS . . . . . 0.633 ' SG ' HG21 ' A' ' 385' ' ' ILE . 4.9 t -56.38 125.61 66.37 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 108.319 -0.993 . . . . 75.32 108.319 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.507 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.2 Cg_endo -74.98 -2.48 12.59 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.48 1.779 . . . . 74.3 110.968 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 410' ' ' PHE . . . . . 0.455 ' CE1' ' HE2' ' A' ' 392' ' ' MET . 6.7 m-85 -89.12 -37.93 14.71 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.466 1.104 . . . . 73.51 110.975 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 411' ' ' CYS . . . . . . . . . . . . . 1.2 p -121.17 10.37 10.66 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.492 1.12 . . . . 62.23 108.286 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 408' ' ' CYS . 49.1 mmm-85 38.68 49.94 1.54 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.507 1.129 . . . . 63.2 110.343 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 41.8 t -138.14 148.84 45.33 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.511 1.132 . . . . 53.24 108.328 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -52.2 159.0 1.01 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.561 1.163 . . . . 65.15 110.273 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.84 HD13 HD12 ' A' ' 385' ' ' ILE . 2.3 mt -113.83 147.36 17.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.429 1.081 . . . . 71.34 109.293 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -114.85 -44.31 3.06 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.138 . . . . 73.22 109.312 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 417' ' ' GLY . . . . . 0.502 ' C ' HG23 ' A' ' 418' ' ' THR . . . -111.77 127.78 8.29 Favored Glycine 0 CA--C 1.531 1.053 0 O-C-N 124.537 1.148 . . . . 72.44 110.984 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 418' ' ' THR . . . . . 0.502 HG23 ' C ' ' A' ' 417' ' ' GLY . 38.8 p -156.15 136.26 12.86 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.547 0.792 . . . . 54.5 110.405 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -171.98 156.13 3.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.495 1.122 . . . . 72.43 110.304 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.439 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.5 Cg_endo -74.94 101.87 1.52 Allowed 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.445 1.761 . . . . 73.4 111.011 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.739 ' C ' HD12 ' A' ' 421' ' ' ILE . 1.1 pp -103.93 167.69 2.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.496 1.123 . . . . 74.14 109.326 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 422' ' ' ILE . . . . . 0.554 ' N ' HD12 ' A' ' 421' ' ' ILE . 10.4 mm -113.97 112.22 39.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.53 1.144 . . . . 72.42 109.252 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.631 HG22 HD11 ' A' ' 421' ' ' ILE . 2.2 t -77.43 136.68 23.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.473 1.108 . . . . 72.34 109.27 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.539 ' O ' HG23 ' A' ' 355' ' ' VAL . 10.3 m-20 -131.33 131.85 23.26 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.477 1.111 . . . . 74.45 109.282 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 176.96 9.22 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.467 1.772 . . . . 53.11 110.999 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' PHE . . . . . 0.556 ' CE1' ' CG ' ' A' ' 357' ' ' GLN . 19.6 t80 . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.489 1.118 . . . . 71.45 111.052 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 350' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 69.8 m . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 110.045 -0.354 . . . . 74.11 110.045 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 351' ' ' ASP . . . . . 0.428 ' H ' HG22 ' A' ' 421' ' ' ILE . 2.5 t70 -91.31 169.46 10.79 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 74.33 109.29 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -124.71 114.52 19.41 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.547 1.154 . . . . 74.33 109.629 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' ILE . . . . . 0.845 HD13 HD13 ' A' ' 421' ' ' ILE . 1.6 mp -102.96 142.68 16.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.469 1.106 . . . . 74.52 109.309 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.402 ' NZ ' ' OD2' ' A' ' 424' ' ' ASP . 17.6 tppt? -124.91 117.93 25.16 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.465 1.103 . . . . 72.44 109.289 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 424' ' ' ASP . 61.9 t -66.25 154.8 7.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.492 1.12 . . . . 73.12 109.315 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 15.0 p -126.25 161.35 27.94 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.509 1.13 . . . . 72.34 110.43 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -56.05 -38.69 70.94 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.509 1.131 . . . . 73.34 110.332 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.14 -32.15 54.39 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.481 1.113 . . . . 75.24 110.29 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -83.79 -66.89 0.84 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.546 1.154 . . . . 74.4 110.281 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -41.89 -35.9 0.94 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.568 1.168 . . . . 74.34 111.039 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -66.41 -62.51 1.43 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.507 1.129 . . . . 73.5 110.281 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 9.8 tt . . . . . 0 C--N 1.325 -0.459 0 O-C-N 124.462 1.101 . . . . 65.22 109.326 179.999 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 108.314 -0.995 . . . . 53.43 108.314 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.25 -21.13 62.15 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 64.22 110.305 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 2.0 mtm -103.33 -28.2 11.99 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 71.4 111.016 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 87.68 40.15 6.87 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.479 1.112 . . . . 61.41 110.954 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 20.8 t -139.22 177.73 7.69 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.502 0.766 . . . . 71.51 109.969 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 12.7 p -113.4 179.53 3.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 73.41 110.402 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.458 ' CD2' HG11 ' A' ' 423' ' ' VAL . 43.9 t80 -85.17 -65.97 0.95 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.555 1.159 . . . . 73.22 111.039 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 371' ' ' GLN . . . . . 0.677 HE22 ' HB3' ' A' ' 425' ' ' PRO . 0.5 OUTLIER -40.0 -31.72 0.13 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.522 1.139 . . . . 75.12 110.319 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.706 HD22 ' N ' ' A' ' 373' ' ' CYS . 1.5 tm? -66.89 136.73 55.84 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.525 1.141 . . . . 71.22 109.259 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 373' ' ' CYS . . . . . 0.706 ' N ' HD22 ' A' ' 372' ' ' LEU . 13.2 t -79.47 130.18 35.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.965 -1.016 . . . . 72.52 110.931 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.442 ' NZ ' ' O ' ' A' ' 372' ' ' LEU . 10.8 mmtm -87.31 11.31 14.66 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.539 1.15 . . . . 74.32 109.305 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 3.9 mt -102.83 -40.5 6.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.464 1.103 . . . . 75.52 109.262 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 376' ' ' CYS . . . . . 1.209 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 86.1 m -110.21 -35.63 6.04 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.494 1.121 . . . . 53.04 108.321 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.649 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 55.87 35.9 26.31 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.514 1.134 . . . . 72.24 109.327 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -131.79 -44.74 0.97 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.465 1.103 . . . . 74.1 110.314 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -113.69 -176.54 2.92 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.511 1.132 . . . . 74.32 109.32 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -97.66 158.93 15.23 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.502 1.126 . . . . 72.2 109.319 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.415 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 23.9 mttt -59.48 -62.46 1.86 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.47 1.106 . . . . 74.52 109.303 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 13.6 t70 59.54 27.0 16.08 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.459 1.099 . . . . 72.43 109.312 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.895 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -157.84 173.43 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.536 1.147 . . . . 52.32 109.29 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 23.5 tttp -156.68 137.39 13.28 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.469 1.105 . . . . 74.23 109.27 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.824 HG23 HG23 ' A' ' 415' ' ' ILE . 10.4 mm -101.02 132.32 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 63.24 109.341 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.51 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 7.9 mt-10 -137.8 161.16 61.62 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 75.51 110.314 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.51 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.94 -4.73 20.57 Favored 'Cis proline' 0 C--N 1.36 1.159 0 C-N-CA 121.004 -2.498 . . . . 73.52 111.035 -0.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 388' ' ' CYS . . . . . 0.502 ' SG ' ' CE1' ' A' ' 390' ' ' HIS . 44.1 t -37.45 -76.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.96 -1.018 . . . . 73.32 110.907 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 118.15 34.65 1.1 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.512 1.132 . . . . 73.42 111.0 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.502 ' CE1' ' SG ' ' A' ' 388' ' ' CYS . 66.4 m170 -108.6 127.88 54.34 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.509 0.77 . . . . 72.34 109.594 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.717 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -97.46 157.86 15.78 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.463 1.102 . . . . 71.51 109.353 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.895 ' O ' HG12 ' A' ' 383' ' ' VAL . 19.5 ptp -174.37 175.38 2.62 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.452 1.095 . . . . 74.34 110.991 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 393' ' ' CYS . . . . . 1.192 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 23.4 p -97.91 115.51 28.26 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.527 1.142 . . . . 70.53 108.29 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 396' ' ' CYS . 85.5 m -46.15 -60.0 2.55 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.53 1.144 . . . . 72.33 110.415 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 8.1 m -39.91 -29.7 0.07 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.471 1.107 . . . . 74.05 109.956 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 396' ' ' CYS . . . . . 1.209 ' SG ' ' SG ' ' A' ' 376' ' ' CYS . 2.8 m -85.44 -53.88 4.92 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.524 1.14 . . . . 73.34 108.296 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 397' ' ' LEU . . . . . 0.615 ' O ' HD23 ' A' ' 397' ' ' LEU . 2.1 tt -43.01 -55.4 3.81 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.513 1.133 . . . . 72.44 109.319 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 61.3 m -45.56 -38.14 6.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.508 1.13 . . . . 74.2 110.413 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 399' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -64.22 -38.49 91.24 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.121 . . . . 71.1 109.313 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 400' ' ' TRP . . . . . 0.449 ' N ' ' O ' ' A' ' 397' ' ' LEU . 2.8 t-105 -63.35 -47.12 83.47 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.549 1.156 . . . . 73.51 107.986 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -58.65 -35.72 73.0 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.482 1.114 . . . . 74.33 110.25 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -74.36 -2.74 26.58 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.512 1.133 . . . . 75.11 110.268 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 29.4 t -113.73 -23.13 9.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 1.131 . . . . 71.11 109.956 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.16 -78.34 0.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.452 1.095 . . . . 74.41 109.259 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 100.1 32.86 5.41 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.473 1.108 . . . . 33.55 110.988 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -93.94 76.51 4.16 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.478 0.752 . . . . 73.53 110.29 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 44.41 -157.68 0.18 Allowed Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.522 1.139 . . . . 53.52 111.026 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' CYS . . . . . 0.514 ' SG ' HG21 ' A' ' 385' ' ' ILE . 5.3 t -56.14 127.01 69.22 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.323 -0.991 . . . . 63.54 108.323 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 0.63 8.69 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.511 1.795 . . . . 74.31 110.986 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 410' ' ' PHE . . . . . 0.431 ' CD2' ' HE1' ' A' ' 392' ' ' MET . 15.8 m-85 -94.76 -36.5 11.68 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.455 1.097 . . . . 75.21 110.984 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 411' ' ' CYS . . . . . 0.449 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.8 OUTLIER -122.83 12.63 9.82 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.464 1.103 . . . . 75.31 108.335 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 412' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 408' ' ' CYS . 1.6 tpt180 38.19 30.75 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.513 1.133 . . . . 73.32 110.313 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 413' ' ' CYS . . . . . 0.449 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.7 m -113.82 150.5 33.43 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.523 1.139 . . . . 44.21 108.278 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -55.96 149.24 15.6 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.437 1.086 . . . . 70.35 110.299 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.824 HG23 HG23 ' A' ' 385' ' ' ILE . 2.1 mt -99.02 136.29 30.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.499 1.124 . . . . 55.0 109.308 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -114.67 -54.72 2.55 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.499 1.124 . . . . 72.24 109.286 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' GLY . . . . . 0.55 ' O ' HG23 ' A' ' 418' ' ' THR . . . -95.89 127.78 9.29 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.467 1.104 . . . . 73.52 110.956 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 418' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 417' ' ' GLY . 18.2 p -157.47 137.01 12.09 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.541 0.789 . . . . 61.33 110.367 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -172.18 155.97 3.67 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.407 1.067 . . . . 74.24 110.348 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.431 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.4 Cg_endo -75.04 102.82 1.64 Allowed 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.458 1.768 . . . . 74.51 110.974 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.845 HD13 HD13 ' A' ' 353' ' ' ILE . 0.7 OUTLIER -103.82 155.27 5.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.491 1.119 . . . . 65.5 109.301 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 422' ' ' ILE . . . . . 0.574 ' N ' HD12 ' A' ' 421' ' ' ILE . 17.1 mt -108.0 108.49 25.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.545 1.153 . . . . 75.12 109.261 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.773 HG22 HD11 ' A' ' 421' ' ' ILE . 14.6 t -76.57 146.42 8.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.489 1.118 . . . . 72.24 109.25 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.453 ' O ' HG23 ' A' ' 355' ' ' VAL . 3.0 t70 -127.98 127.97 23.83 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.536 1.147 . . . . 75.12 109.336 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 425' ' ' PRO . . . . . 0.677 ' HB3' HE22 ' A' ' 371' ' ' GLN . 18.3 Cg_endo -74.99 179.52 6.0 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.535 1.808 . . . . 71.21 110.983 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 76.9 t80 . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.461 1.1 . . . . 72.13 111.047 179.939 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 109.951 -0.389 . . . . 73.15 109.951 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -90.64 179.83 5.72 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.483 1.114 . . . . 72.13 109.296 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' HIS . . . . . 0.461 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 61.2 m-70 -138.23 150.17 46.46 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 73.03 109.595 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 17.2 mt -136.55 156.68 36.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.496 1.122 . . . . 74.14 109.308 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 12.0 tptm -117.92 152.66 34.98 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.464 1.102 . . . . 62.41 109.322 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 424' ' ' ASP . 32.1 t -109.09 156.72 9.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.454 1.096 . . . . 73.55 109.337 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 12.3 p -122.7 152.87 40.13 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.507 1.13 . . . . 63.32 110.402 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' GLN . . . . . 0.546 ' HG2' ' CE2' ' A' ' 426' ' ' PHE . 1.7 mm100 -45.84 -53.36 9.84 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.475 1.109 . . . . 72.31 110.325 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -43.55 -40.27 3.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.537 1.148 . . . . 73.04 110.308 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -70.89 -66.49 0.6 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.486 1.116 . . . . 72.53 110.282 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 360' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 364' ' ' CYS . 7.4 t80 -45.07 -63.77 0.86 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 73.22 110.997 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -45.34 -52.28 10.05 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.52 1.137 . . . . 71.54 110.267 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.3 tt . . . . . 0 C--N 1.324 -0.503 0 O-C-N 124.548 1.155 . . . . 74.51 109.312 -179.996 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 364' ' ' CYS . . . . . 0.449 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.9 m . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 108.283 -1.006 . . . . 71.51 108.283 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -79.51 -2.71 43.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.545 1.153 . . . . 74.11 110.277 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 8.3 mmt -108.3 -34.82 6.7 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.54 1.15 . . . . 64.51 110.982 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.02 4.61 41.63 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.479 1.112 . . . . 63.0 110.968 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 1.2 m -127.92 -176.2 3.71 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.529 0.782 . . . . 44.43 109.992 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.434 ' O ' ' CE ' ' A' ' 374' ' ' LYS . 15.1 p -114.29 -179.34 3.6 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.518 1.136 . . . . 75.04 110.394 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.436 ' C ' ' N ' ' A' ' 372' ' ' LEU . 62.7 t80 -78.49 -67.63 0.72 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 1.12 . . . . 75.11 110.979 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 371' ' ' GLN . . . . . 0.556 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -38.89 -29.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.538 1.149 . . . . 73.4 110.3 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.907 HD22 ' N ' ' A' ' 373' ' ' CYS . 0.5 OUTLIER -72.56 136.54 45.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.547 1.154 . . . . 74.21 109.273 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 373' ' ' CYS . . . . . 0.907 ' N ' HD22 ' A' ' 372' ' ' LEU . 11.5 t -70.97 133.54 46.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.004 -0.998 . . . . 63.42 110.928 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.434 ' CE ' ' O ' ' A' ' 369' ' ' THR . 29.8 mmtp -93.9 24.39 4.25 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.547 1.154 . . . . 71.3 109.285 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 375' ' ' ILE . . . . . 0.612 HD11 ' CE1' ' A' ' 410' ' ' PHE . 36.3 mt -107.38 -56.17 4.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.498 1.124 . . . . 75.31 109.308 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 376' ' ' CYS . . . . . 0.951 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 1.8 m -104.75 -23.15 13.09 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.482 1.114 . . . . 61.13 108.309 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.639 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 50.61 39.77 22.2 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.516 1.135 . . . . 62.54 109.302 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -124.57 -42.13 2.1 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.13 . . . . 73.52 110.271 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -123.62 171.0 9.88 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.52 1.138 . . . . 72.21 109.303 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -81.35 164.59 22.04 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.484 1.115 . . . . 64.13 109.302 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.458 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 20.0 mttt -67.75 -62.47 1.4 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.55 1.156 . . . . 74.34 109.292 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 1.9 t70 59.29 24.55 13.06 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.546 1.154 . . . . 63.23 109.283 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.923 HG12 ' O ' ' A' ' 392' ' ' MET . 0.6 OUTLIER -155.42 171.01 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.478 1.111 . . . . 75.22 109.305 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -154.19 147.25 24.61 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.462 1.101 . . . . 70.31 109.307 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.811 HG21 ' SG ' ' A' ' 408' ' ' CYS . 22.8 mm -110.4 134.33 52.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.477 1.11 . . . . 74.34 109.285 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.513 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 9.8 mt-10 -137.65 160.97 62.93 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.546 1.154 . . . . 60.5 110.276 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.513 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.5 Cg_endo -74.97 -5.13 21.03 Favored 'Cis proline' 0 C--N 1.36 1.14 0 C-N-CA 121.003 -2.499 . . . . 63.45 111.056 -0.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 388' ' ' CYS . . . . . 0.594 ' SG ' ' CE1' ' A' ' 390' ' ' HIS . 43.0 t -38.11 -79.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.964 -1.016 . . . . 64.33 110.942 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 389' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 119.92 36.98 0.79 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.485 1.115 . . . . 62.03 111.012 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.594 ' CE1' ' SG ' ' A' ' 388' ' ' CYS . 65.6 m170 -108.45 130.89 55.23 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 0.76 . . . . 74.32 109.6 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.708 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -98.43 157.48 16.18 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.133 . . . . 73.11 109.28 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.923 ' O ' HG12 ' A' ' 383' ' ' VAL . 15.5 ptp -171.81 174.38 4.24 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.509 1.13 . . . . 74.33 111.036 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 393' ' ' CYS . . . . . 1.142 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 26.3 p -98.13 115.98 29.4 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.531 1.145 . . . . 72.35 108.291 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 26.2 m -42.12 -59.37 1.79 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.559 1.162 . . . . 61.11 110.421 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.7 t -42.82 -37.09 1.68 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.553 1.158 . . . . 64.24 109.983 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' CYS . . . . . 1.142 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 3.5 m -73.69 -53.6 10.02 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.542 1.151 . . . . 52.2 108.297 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 397' ' ' LEU . . . . . 0.748 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.8 OUTLIER -43.89 -37.18 2.71 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.536 1.147 . . . . 43.22 109.265 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 53.1 m -61.14 -46.07 92.07 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.514 1.134 . . . . 74.23 110.406 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -59.97 -19.88 54.59 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.498 1.124 . . . . 61.5 109.33 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 400' ' ' TRP . . . . . 0.605 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 9.7 t-105 -85.75 -64.94 1.07 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.5 1.125 . . . . 71.04 108.022 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.495 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 10.3 mm-40 -52.44 -17.18 1.1 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.457 1.098 . . . . 73.44 110.313 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 401' ' ' GLN . 2.3 mm-40 -37.19 -63.31 0.44 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.516 1.135 . . . . 63.41 110.281 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 2.5 m -121.0 -24.57 5.55 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.512 1.133 . . . . 54.5 110.004 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' ASP . . . . . 0.605 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 13.2 m-20 -82.05 -94.25 0.05 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.45 1.094 . . . . 73.0 109.298 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.495 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 69.18 30.89 71.67 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 124.5 1.125 . . . . 72.5 111.002 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -90.66 57.34 3.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.569 0.805 . . . . 60.41 110.326 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 69.27 -160.54 52.65 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.472 1.108 . . . . 35.54 110.971 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 408' ' ' CYS . . . . . 0.811 ' SG ' HG21 ' A' ' 385' ' ' ILE . 1.4 t -56.53 121.74 45.64 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 108.282 -1.007 . . . . 74.5 108.282 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.405 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.0 Cg_endo -75.07 0.3 9.1 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.538 1.809 . . . . 73.15 110.969 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 410' ' ' PHE . . . . . 0.612 ' CE1' HD11 ' A' ' 375' ' ' ILE . 10.8 m-85 -89.35 -38.83 13.86 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 62.23 111.0 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 411' ' ' CYS . . . . . 0.402 ' O ' ' C ' ' A' ' 412' ' ' ARG . 0.7 OUTLIER -126.49 15.85 7.64 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 73.2 108.322 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 412' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 408' ' ' CYS . 0.4 OUTLIER 38.71 41.27 0.48 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.561 1.163 . . . . 63.52 110.279 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 14.9 t -124.19 140.48 52.93 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 51.12 108.316 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -47.63 157.44 0.24 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.543 1.152 . . . . 62.45 110.307 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.761 HD13 HD12 ' A' ' 385' ' ' ILE . 2.3 mt -111.75 155.12 13.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.442 1.089 . . . . 75.25 109.319 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -120.91 -46.11 2.35 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.499 1.124 . . . . 72.21 109.308 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 417' ' ' GLY . . . . . 0.52 ' O ' HG23 ' A' ' 418' ' ' THR . . . -115.55 132.73 10.47 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.525 1.14 . . . . 45.3 110.967 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 418' ' ' THR . . . . . 0.546 ' CG2' HG21 ' A' ' 415' ' ' ILE . 21.0 p -157.23 117.37 3.48 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.443 0.731 . . . . 60.51 110.397 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.401 ' O ' HG23 ' A' ' 421' ' ' ILE . 1.9 pm0 -144.82 151.55 49.82 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.51 1.131 . . . . 74.53 110.291 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 100.82 1.4 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.502 1.791 . . . . 64.04 110.995 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.875 HD11 HG22 ' A' ' 423' ' ' VAL . 0.7 OUTLIER -104.68 169.51 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.502 1.126 . . . . 75.1 109.312 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 422' ' ' ILE . . . . . 0.815 ' N ' HD12 ' A' ' 421' ' ' ILE . 9.7 mt -124.95 105.43 15.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.518 1.136 . . . . 53.42 109.304 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.875 HG22 HD11 ' A' ' 421' ' ' ILE . 11.2 t -78.51 142.29 14.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.472 1.107 . . . . 63.41 109.301 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.544 ' O ' HG23 ' A' ' 355' ' ' VAL . 0.8 OUTLIER -127.92 143.7 48.72 Favored Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.486 1.116 . . . . 74.13 109.324 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 176.44 9.92 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.451 1.764 . . . . 71.31 110.983 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' PHE . . . . . 0.546 ' CE2' ' HG2' ' A' ' 357' ' ' GLN . 3.3 t80 . . . . . 0 C--N 1.325 -0.48 0 O-C-N 124.55 1.156 . . . . 50.13 111.04 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 63.8 m . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.998 -0.371 . . . . 55.41 109.998 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -96.3 -174.33 3.04 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.527 1.142 . . . . 61.11 109.318 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' HIS . . . . . 0.518 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 31.3 m-70 -138.99 140.66 38.25 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.461 1.101 . . . . 72.34 109.55 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 3.9 mm -122.07 156.19 26.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.503 1.127 . . . . 73.43 109.336 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -122.28 138.86 54.36 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.526 1.141 . . . . 65.21 109.322 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 424' ' ' ASP . 37.3 t -97.58 148.92 5.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.49 1.119 . . . . 72.22 109.347 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.6 p -108.55 141.86 39.83 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.547 1.154 . . . . 65.44 110.392 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' GLN . . . . . 0.538 ' HG2' ' CE2' ' A' ' 426' ' ' PHE . 4.9 mt-30 -39.66 -32.98 0.16 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.483 1.114 . . . . 72.01 110.32 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -57.05 -53.51 57.28 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.499 1.125 . . . . 53.51 110.322 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' GLN . . . . . 0.466 ' HB2' HG13 ' A' ' 355' ' ' VAL . 5.8 mt-30 -66.07 -22.67 66.42 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.546 1.154 . . . . 64.0 110.331 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -86.82 -23.73 25.24 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.492 1.12 . . . . 75.24 111.03 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 357' ' ' GLN . 4.6 mm-40 -84.41 -50.27 7.94 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.519 1.137 . . . . 72.43 110.235 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.468 ' CD1' ' N ' ' A' ' 362' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.515 1.134 . . . . 72.04 109.288 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 108.284 -1.006 . . . . 32.55 108.284 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -43.35 -68.31 0.21 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.514 1.134 . . . . 73.43 110.326 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 21.7 ptp -56.65 -31.12 64.06 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.53 1.144 . . . . 73.35 111.001 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 82.42 50.9 4.57 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.533 1.145 . . . . 53.13 111.015 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 1.5 t -126.29 -179.24 4.64 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.477 0.751 . . . . 75.52 110.026 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 2.8 p -129.1 140.46 51.56 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.521 1.138 . . . . 72.32 110.365 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.529 ' CE2' HG11 ' A' ' 423' ' ' VAL . 60.8 t80 -64.52 -68.2 0.37 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.451 1.094 . . . . 74.04 111.035 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 371' ' ' GLN . . . . . 0.696 HE22 ' HB3' ' A' ' 425' ' ' PRO . 0.8 OUTLIER -39.44 -30.02 0.06 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.124 . . . . 61.0 110.327 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.926 HD22 ' N ' ' A' ' 373' ' ' CYS . 0.4 OUTLIER -73.4 136.14 44.3 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.489 1.118 . . . . 74.02 109.339 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 373' ' ' CYS . . . . . 0.926 ' N ' HD22 ' A' ' 372' ' ' LEU . 26.9 p -67.88 131.85 46.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.015 -0.993 . . . . 34.51 110.926 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -93.21 29.57 1.87 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 65.04 109.328 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 375' ' ' ILE . . . . . 0.776 HD11 ' HE1' ' A' ' 410' ' ' PHE . 17.1 mt -107.65 -59.78 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.469 1.106 . . . . 71.04 109.315 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 3.7 m -107.71 -23.17 12.21 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.516 1.135 . . . . 65.22 108.279 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.668 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 56.81 42.55 26.43 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 63.03 109.321 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -124.17 -42.45 2.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.516 1.135 . . . . 63.12 110.296 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -121.89 170.57 9.66 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.553 1.158 . . . . 61.14 109.309 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 17.3 p30 -83.24 162.1 21.29 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.472 1.108 . . . . 73.12 109.294 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 392' ' ' MET . 24.1 mttt -64.37 -55.57 20.25 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.489 1.118 . . . . 71.3 109.298 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 1.1 p30 52.22 25.71 3.51 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 74.44 109.308 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.869 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -153.21 176.09 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.53 1.143 . . . . 74.13 109.286 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.412 ' H ' HG22 ' A' ' 383' ' ' VAL . 79.0 tttt -160.94 142.23 11.83 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.448 1.093 . . . . 63.22 109.294 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.825 HD13 HG22 ' A' ' 418' ' ' THR . 10.4 mm -108.12 138.58 34.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 124.554 1.159 . . . . 72.23 109.308 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.518 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.1 OUTLIER -138.06 161.39 59.9 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.511 1.132 . . . . 64.12 110.27 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.518 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.98 -7.16 22.99 Favored 'Cis proline' 0 C--N 1.36 1.158 0 C-N-CA 120.983 -2.507 . . . . 75.21 111.024 -0.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 388' ' ' CYS . . . . . 0.442 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 41.2 t -36.83 -73.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.002 -0.999 . . . . 71.22 110.919 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 389' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 115.95 16.5 6.78 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.478 1.111 . . . . 73.2 111.043 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.513 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 49.6 m170 -86.85 131.42 34.12 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.525 0.779 . . . . 72.32 109.623 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.676 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -100.78 161.8 13.35 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.506 1.129 . . . . 74.3 109.285 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.869 ' O ' HG12 ' A' ' 383' ' ' VAL . 18.6 ptp -174.72 174.83 2.55 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.508 1.13 . . . . 64.03 110.973 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 393' ' ' CYS . . . . . 0.97 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 7.0 p -96.55 119.56 35.25 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.521 1.138 . . . . 75.12 108.289 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 44.1 m -44.01 -59.22 2.4 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.486 1.117 . . . . 74.21 110.365 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 14.6 m -43.41 -34.2 1.23 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.499 1.124 . . . . 61.44 109.999 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 396' ' ' CYS . . . . . 0.97 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 1.8 m -76.1 -57.81 3.65 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.531 1.144 . . . . 65.11 108.34 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 397' ' ' LEU . . . . . 0.667 HD13 ' C ' ' A' ' 397' ' ' LEU . 1.2 tm? -41.96 -39.03 1.75 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.452 1.095 . . . . 53.33 109.242 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 2.8 m -60.59 -46.52 89.93 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.509 1.131 . . . . 71.55 110.418 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -58.8 -20.65 52.0 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.142 . . . . 73.2 109.293 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 400' ' ' TRP . . . . . 0.607 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 7.7 t-105 -85.94 -64.92 1.07 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.526 1.141 . . . . 72.13 108.005 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.491 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.1 mm-40 -52.23 -17.4 1.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.498 1.124 . . . . 62.12 110.297 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 401' ' ' GLN . 2.3 mm-40 -37.14 -63.36 0.44 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.525 1.14 . . . . 74.2 110.26 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.6 m -120.82 -24.65 5.61 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.482 1.114 . . . . 73.11 110.01 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 404' ' ' ASP . . . . . 0.607 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 12.2 m-20 -81.58 -93.86 0.05 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.516 1.135 . . . . 75.23 109.312 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.491 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 69.93 29.67 70.69 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.485 1.115 . . . . 52.0 111.009 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -92.02 68.13 5.22 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.528 0.781 . . . . 74.12 110.312 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 63.34 -167.01 24.37 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 124.502 1.126 . . . . 50.01 111.005 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' CYS . . . . . 0.663 ' SG ' HG21 ' A' ' 385' ' ' ILE . 2.0 t -56.21 123.22 53.61 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 108.307 -0.997 . . . . 52.32 108.307 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.421 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.2 Cg_endo -74.99 0.3 9.07 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.451 1.763 . . . . 63.21 110.986 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 410' ' ' PHE . . . . . 0.776 ' HE1' HD11 ' A' ' 375' ' ' ILE . 3.3 m-30 -91.38 -40.77 11.26 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.478 1.111 . . . . 65.44 110.986 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 411' ' ' CYS . . . . . 0.442 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.8 OUTLIER -122.36 16.19 10.54 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.533 1.145 . . . . 74.12 108.267 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 412' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 408' ' ' CYS . 5.3 tpt180 38.6 30.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.54 1.15 . . . . 74.54 110.32 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 413' ' ' CYS . . . . . 0.442 ' N ' ' O ' ' A' ' 411' ' ' CYS . 6.9 t -111.97 142.65 44.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 63.13 108.265 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 414' ' ' GLU . . . . . 0.445 ' CG ' ' N ' ' A' ' 415' ' ' ILE . 24.7 tt0 -50.9 158.88 0.63 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.462 1.101 . . . . 74.55 110.34 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.766 HD13 HD12 ' A' ' 385' ' ' ILE . 2.3 mt -110.44 157.33 11.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.478 1.112 . . . . 72.32 109.244 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -119.91 -44.56 2.51 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.48 1.112 . . . . 64.34 109.303 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 417' ' ' GLY . . . . . 0.6 ' O ' HG23 ' A' ' 418' ' ' THR . . . -134.72 146.55 18.55 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.549 1.156 . . . . 61.05 110.964 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 418' ' ' THR . . . . . 0.825 HG22 HD13 ' A' ' 385' ' ' ILE . 2.3 p -157.52 117.68 3.44 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.533 0.784 . . . . 73.15 110.394 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -138.17 151.27 69.42 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.51 1.131 . . . . 74.33 110.346 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 101.68 1.5 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.51 1.795 . . . . 72.3 111.0 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.835 HD11 HG22 ' A' ' 423' ' ' VAL . 0.8 OUTLIER -104.14 155.72 5.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.488 1.117 . . . . 74.5 109.247 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 422' ' ' ILE . . . . . 0.532 ' N ' HD12 ' A' ' 421' ' ' ILE . 17.0 mt -107.01 105.41 18.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.502 1.126 . . . . 75.13 109.281 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.835 HG22 HD11 ' A' ' 421' ' ' ILE . 38.2 t -76.86 146.98 7.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 54.14 109.247 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.681 ' O ' HG23 ' A' ' 355' ' ' VAL . 0.8 OUTLIER -130.08 143.66 50.01 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.461 1.101 . . . . 54.41 109.237 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 425' ' ' PRO . . . . . 0.696 ' HB3' HE22 ' A' ' 371' ' ' GLN . 18.4 Cg_endo -75.02 170.35 20.61 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.497 1.788 . . . . 73.33 111.001 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 426' ' ' PHE . . . . . 0.538 ' CE2' ' HG2' ' A' ' 357' ' ' GLN . 3.3 t80 . . . . . 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 73.41 111.006 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 110.037 -0.357 . . . . 75.24 110.037 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -97.46 176.85 5.72 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.466 1.104 . . . . 75.21 109.323 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' HIS . . . . . 0.439 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 42.5 m-70 -136.47 134.57 37.78 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.498 1.124 . . . . 63.31 109.604 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 67.0 mt -114.69 135.87 53.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.517 1.135 . . . . 65.21 109.302 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -107.84 118.94 38.06 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.473 1.108 . . . . 64.21 109.282 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.464 ' O ' ' CD2' ' A' ' 426' ' ' PHE . 8.6 t -64.33 140.55 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.539 1.149 . . . . 62.31 109.317 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.44 ' OG1' ' CG ' ' A' ' 359' ' ' GLN . 27.0 p -91.85 156.55 17.42 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 70.1 110.365 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 357' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -57.99 -32.5 67.95 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.454 1.096 . . . . 73.13 110.321 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' GLU . . . . . 0.462 ' CG ' ' N ' ' A' ' 359' ' ' GLN . 18.0 pt-20 -66.05 -47.48 74.2 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.517 1.136 . . . . 74.45 110.305 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 359' ' ' GLN . . . . . 0.462 ' N ' ' CG ' ' A' ' 358' ' ' GLU . 11.9 mm-40 -60.73 -52.77 63.69 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.518 1.136 . . . . 43.22 110.313 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -51.15 -60.63 2.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.527 1.142 . . . . 71.34 111.031 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -58.52 -36.76 74.34 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.491 1.119 . . . . 74.4 110.334 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.0 tp . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.505 1.128 . . . . 64.14 109.289 -179.997 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 108.258 -1.016 . . . . 60.32 108.258 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -59.25 -17.64 30.2 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.5 1.125 . . . . 74.05 110.291 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 5.0 mtt -109.0 -16.18 14.19 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.487 1.117 . . . . 71.2 110.991 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 65.5 40.25 96.07 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.486 1.116 . . . . 74.43 111.006 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 16.1 m -125.13 -175.34 3.28 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.446 0.733 . . . . 73.0 109.971 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 2.3 p -128.22 136.36 50.95 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.456 1.098 . . . . 75.24 110.451 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.503 ' CZ ' HD12 ' A' ' 391' ' ' LEU . 73.7 t80 -60.58 -68.42 0.3 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.5 1.125 . . . . 75.14 111.002 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 371' ' ' GLN . . . . . 0.407 ' HB3' ' CG1' ' A' ' 423' ' ' VAL . 0.9 OUTLIER -40.09 -29.23 0.07 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 71.35 110.255 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.416 ' N ' ' C ' ' A' ' 370' ' ' PHE . 0.0 OUTLIER -69.48 115.01 8.25 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.127 . . . . 55.43 109.344 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 30.3 p -45.96 145.87 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.009 -0.996 . . . . 73.32 110.937 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -105.53 31.6 4.86 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.512 1.133 . . . . 62.1 109.31 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 375' ' ' ILE . . . . . 0.57 HG21 ' HB3' ' A' ' 396' ' ' CYS . 46.4 mt -112.42 -58.39 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.51 1.131 . . . . 72.45 109.282 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 5.3 p -107.98 -21.81 12.67 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.479 1.112 . . . . 73.14 108.312 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 56.46 41.51 28.69 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.524 1.14 . . . . 52.31 109.336 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -126.16 -49.06 1.58 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.463 1.102 . . . . 73.22 110.329 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 49.4 m-20 -109.4 167.92 9.77 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.543 1.152 . . . . 63.25 109.323 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 16.6 p30 -84.6 162.66 19.7 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.486 1.116 . . . . 73.33 109.276 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 392' ' ' MET . 22.7 mttt -63.07 -62.4 1.73 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.469 1.106 . . . . 74.13 109.294 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 58.45 25.04 12.48 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.513 1.133 . . . . 74.15 109.262 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.892 HG12 ' O ' ' A' ' 392' ' ' MET . 0.7 OUTLIER -154.85 170.64 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 71.32 109.268 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -154.61 144.45 21.66 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.484 1.115 . . . . 71.35 109.314 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.808 HG21 ' SG ' ' A' ' 408' ' ' CYS . 11.1 mm -107.79 133.66 51.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.505 1.128 . . . . 73.24 109.293 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.517 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 10.5 mt-10 -137.67 160.98 62.86 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 62.14 110.297 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.517 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -75.07 -5.19 21.46 Favored 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 120.995 -2.502 . . . . 63.14 110.995 0.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 388' ' ' CYS . . . . . 0.512 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 16.5 t -38.13 -79.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.985 -1.007 . . . . 74.54 110.92 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 119.64 36.58 0.83 Allowed Glycine 0 CA--C 1.531 1.068 0 O-C-N 124.537 1.148 . . . . 60.35 110.965 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.559 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 67.4 m170 -108.54 127.14 53.68 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.545 0.791 . . . . 74.12 109.596 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.503 HD12 ' CZ ' ' A' ' 370' ' ' PHE . 1.8 mt -95.65 157.27 15.97 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.507 1.13 . . . . 72.33 109.297 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.892 ' O ' HG12 ' A' ' 383' ' ' VAL . 14.2 ptp -171.17 174.57 4.57 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.492 1.12 . . . . 74.5 111.001 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 393' ' ' CYS . . . . . 1.059 ' SG ' ' CB ' ' A' ' 396' ' ' CYS . 2.8 p -97.85 120.82 38.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.562 1.164 . . . . 73.23 108.289 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 48.8 m -41.11 -59.17 1.56 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.501 1.126 . . . . 62.54 110.339 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 2.7 t -49.3 -36.24 20.32 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.518 1.136 . . . . 63.23 109.999 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 396' ' ' CYS . . . . . 1.059 ' CB ' ' SG ' ' A' ' 393' ' ' CYS . 2.2 m -71.06 -38.17 72.51 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.461 1.101 . . . . 73.24 108.3 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 397' ' ' LEU . . . . . 0.698 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -65.03 -36.57 84.8 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.511 1.132 . . . . 63.31 109.32 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 45.8 m -61.96 -45.47 93.51 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.54 1.15 . . . . 51.41 110.392 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -56.77 -23.87 46.14 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.496 1.123 . . . . 55.42 109.304 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 400' ' ' TRP . . . . . 0.601 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 15.8 t-105 -85.13 -65.22 1.03 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.498 1.124 . . . . 72.14 108.023 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.506 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 39.8 mm-40 -48.94 -20.85 0.56 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.53 1.144 . . . . 74.24 110.349 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 401' ' ' GLN . 2.7 mm-40 -37.45 -63.66 0.43 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.123 . . . . 74.32 110.347 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 42.6 t -122.77 -24.46 4.84 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 74.03 110.006 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 404' ' ' ASP . . . . . 0.601 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 18.6 m-20 -82.42 -93.67 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.503 1.127 . . . . 71.05 109.326 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.506 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 66.8 21.74 71.43 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 124.493 1.121 . . . . 74.31 110.991 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -80.34 59.72 3.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.476 0.75 . . . . 64.14 110.337 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 71.67 -165.58 53.6 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.481 1.113 . . . . 55.11 110.99 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 408' ' ' CYS . . . . . 0.808 ' SG ' HG21 ' A' ' 385' ' ' ILE . 1.8 t -56.2 120.9 38.24 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.296 -1.001 . . . . 73.31 108.296 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.427 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.3 Cg_endo -75.04 -0.01 9.47 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.496 1.787 . . . . 64.54 111.015 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 410' ' ' PHE . . . . . 0.559 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 3.5 m-85 -91.51 -37.01 13.4 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.46 1.1 . . . . 72.33 111.014 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 411' ' ' CYS . . . . . 0.456 ' HG ' ' CE1' ' A' ' 390' ' ' HIS . 0.6 OUTLIER -127.38 17.33 7.06 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.106 . . . . 63.32 108.253 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 412' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 408' ' ' CYS . 6.3 tpp180 38.69 30.12 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.505 1.128 . . . . 75.54 110.279 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 413' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 411' ' ' CYS . 51.1 t -114.41 138.72 50.21 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.545 1.153 . . . . 64.34 108.325 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 414' ' ' GLU . . . . . 0.444 ' CG ' ' N ' ' A' ' 415' ' ' ILE . 34.1 tt0 -45.11 159.0 0.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 1.113 . . . . 74.14 110.317 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.704 HG23 HG23 ' A' ' 385' ' ' ILE . 2.3 mt -113.22 157.04 14.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 72.44 109.271 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 10.4 mttm -132.3 -47.17 0.91 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.53 1.144 . . . . 74.52 109.286 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 417' ' ' GLY . . . . . 0.526 ' O ' HG23 ' A' ' 418' ' ' THR . . . -109.51 130.78 10.15 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.493 1.121 . . . . 71.53 111.015 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 418' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 417' ' ' GLY . 20.8 p -157.2 118.5 3.68 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.492 0.76 . . . . 51.55 110.409 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -141.57 151.44 60.55 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.539 1.149 . . . . 52.41 110.28 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.03 101.3 1.45 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.474 1.776 . . . . 65.11 110.988 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.898 HD12 ' N ' ' A' ' 422' ' ' ILE . 1.1 pp -105.94 178.19 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.463 1.102 . . . . 64.35 109.253 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 422' ' ' ILE . . . . . 0.898 ' N ' HD12 ' A' ' 421' ' ' ILE . 6.1 mt -139.69 111.81 5.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.502 1.126 . . . . 72.53 109.292 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.566 ' CG2' HD11 ' A' ' 421' ' ' ILE . 18.5 t -84.04 142.71 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.477 1.111 . . . . 74.43 109.304 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -131.1 143.73 50.62 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 50.42 109.309 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 174.98 11.86 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.489 1.784 . . . . 73.4 110.956 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' PHE . . . . . 0.464 ' CD2' ' O ' ' A' ' 355' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.521 1.138 . . . . 75.15 111.004 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 69.9 m . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.973 -0.38 . . . . 73.32 109.973 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 351' ' ' ASP . . . . . 0.566 ' HB2' HG22 ' A' ' 421' ' ' ILE . 11.4 m-20 -98.43 171.99 7.81 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.476 1.11 . . . . 74.5 109.281 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 352' ' ' HIS . . . . . 0.416 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 22.4 m-70 -130.37 126.59 37.48 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.474 1.109 . . . . 73.11 109.581 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 353' ' ' ILE . . . . . 0.518 HG13 HD13 ' A' ' 421' ' ' ILE . 48.0 mt -115.76 127.39 73.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.486 1.116 . . . . 72.33 109.326 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 8.4 tptp -105.58 118.85 37.64 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.544 1.152 . . . . 65.21 109.304 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 424' ' ' ASP . 48.5 t -59.39 164.03 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.528 1.142 . . . . 71.0 109.288 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.455 ' N ' ' CG1' ' A' ' 355' ' ' VAL . 3.0 p -122.89 146.12 47.86 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.506 1.129 . . . . 63.13 110.37 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 357' ' ' GLN . . . . . 0.577 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 16.5 mt-30 -42.46 -53.72 4.17 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 71.23 110.288 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -39.95 -41.22 1.15 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.468 1.105 . . . . 62.03 110.327 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -67.06 -66.84 0.51 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.475 1.109 . . . . 61.04 110.305 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 360' ' ' TYR . . . . . 0.431 ' O ' ' N ' ' A' ' 364' ' ' CYS . 8.4 t80 -40.61 -52.22 2.9 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.434 1.084 . . . . 65.51 110.991 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -55.4 -44.02 75.76 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.493 1.12 . . . . 72.12 110.273 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.1 tt . . . . . 0 C--N 1.325 -0.462 0 O-C-N 124.481 1.113 . . . . 63.53 109.331 -179.997 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 364' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 108.327 -0.99 . . . . 54.31 108.327 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -62.29 -18.62 61.79 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.472 1.107 . . . . 52.22 110.29 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -128.4 8.52 5.98 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.473 1.108 . . . . 73.15 110.995 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 38.04 63.61 0.89 Allowed Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.521 1.138 . . . . 71.5 111.042 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 64.1 p -132.09 -174.03 3.32 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.463 0.743 . . . . 71.14 110.009 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.484 ' O ' ' CE ' ' A' ' 374' ' ' LYS . 33.7 p -126.47 146.53 50.06 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.535 1.147 . . . . 62.03 110.388 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.456 ' CE2' HG11 ' A' ' 423' ' ' VAL . 31.8 t80 -77.23 -63.83 1.28 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.489 1.118 . . . . 62.4 111.003 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 371' ' ' GLN . . . . . 0.563 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -40.71 -28.78 0.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.489 1.118 . . . . 70.4 110.323 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.721 HD11 ' HA ' ' A' ' 377' ' ' ALA . 3.0 tm? -67.3 139.91 57.29 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.116 . . . . 65.44 109.283 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 373' ' ' CYS . . . . . 0.72 ' N ' HD13 ' A' ' 372' ' ' LEU . 1.9 t -76.16 126.17 30.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.016 -0.993 . . . . 75.3 110.925 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.484 ' CE ' ' O ' ' A' ' 369' ' ' THR . 12.9 mmtm -91.06 18.51 6.69 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.527 1.142 . . . . 53.24 109.297 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 20.3 mt -99.17 -51.61 9.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.457 1.098 . . . . 65.53 109.306 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.54 -30.3 8.32 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.512 1.132 . . . . 60.31 108.305 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.721 ' HA ' HD11 ' A' ' 372' ' ' LEU . . . 65.82 43.69 3.05 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.545 1.153 . . . . 74.05 109.279 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -136.29 -61.89 0.68 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.53 1.144 . . . . 73.24 110.301 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -96.88 161.43 13.85 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.471 1.107 . . . . 72.11 109.298 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 37.4 p30 -81.14 160.73 24.33 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.517 1.136 . . . . 74.21 109.314 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.461 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 23.4 mttt -65.01 -62.49 1.52 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.49 1.119 . . . . 73.1 109.308 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 9.7 t70 60.07 27.05 16.44 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.501 1.126 . . . . 73.32 109.309 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.922 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -157.94 175.26 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.442 1.089 . . . . 72.35 109.313 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.424 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 17.0 tttp -159.4 140.86 13.02 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.481 1.113 . . . . 75.42 109.316 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 1.059 HD12 HD13 ' A' ' 415' ' ' ILE . 24.6 mm -104.91 132.74 50.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.511 1.132 . . . . 71.13 109.268 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.511 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 10.8 mt-10 -137.79 161.08 62.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 74.31 110.312 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.511 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -75.01 -4.65 20.7 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 121.012 -2.495 . . . . 61.45 110.989 0.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 388' ' ' CYS . . . . . 0.523 ' SG ' ' CD2' ' A' ' 390' ' ' HIS . 25.2 t -37.6 -77.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.986 -1.007 . . . . 52.34 110.939 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 389' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 118.72 35.45 0.98 Allowed Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.566 1.166 . . . . 45.52 111.01 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.523 ' CD2' ' SG ' ' A' ' 388' ' ' CYS . 51.7 m170 -108.51 126.89 53.43 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.504 0.767 . . . . 71.22 109.579 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.71 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -97.56 157.53 15.97 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.465 1.103 . . . . 74.31 109.306 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.922 ' O ' HG12 ' A' ' 383' ' ' VAL . 11.4 ptp -173.81 173.71 3.23 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.492 1.12 . . . . 71.25 110.99 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 393' ' ' CYS . . . . . 1.128 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 19.4 p -90.39 140.88 29.29 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 73.4 108.303 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 48.4 m -61.93 -43.35 99.03 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.433 1.083 . . . . 75.31 110.394 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 23.3 t -55.37 -64.54 0.81 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.459 1.099 . . . . 74.23 110.021 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' CYS . . . . . 1.128 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 1.6 p -50.24 -51.38 45.02 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.518 1.136 . . . . 65.01 108.323 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 397' ' ' LEU . . . . . 0.447 HD13 ' C ' ' A' ' 397' ' ' LEU . 1.3 tm? -45.13 -49.53 11.8 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.496 1.123 . . . . 75.22 109.292 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 76.5 m -54.59 -38.63 66.97 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.509 1.131 . . . . 75.54 110.427 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 399' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -60.71 -25.13 66.2 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.461 1.1 . . . . 75.21 109.375 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 400' ' ' TRP . . . . . 0.602 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 10.7 t-105 -85.7 -62.75 1.45 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.498 1.124 . . . . 70.04 108.02 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.49 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 8.2 mm-40 -55.98 -14.34 2.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.545 1.153 . . . . 63.32 110.323 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 401' ' ' GLN . 0.6 OUTLIER -37.23 -63.29 0.44 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.495 1.122 . . . . 60.42 110.302 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 7.8 t -121.13 -24.58 5.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.499 1.124 . . . . 61.32 109.968 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' ASP . . . . . 0.602 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 8.7 m-20 -83.0 -94.86 0.06 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.484 1.115 . . . . 74.02 109.327 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.49 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 73.3 28.99 64.94 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.469 1.106 . . . . 72.23 111.01 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -90.91 70.36 6.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.446 0.733 . . . . 70.53 110.307 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 66.58 -169.03 34.31 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.559 1.162 . . . . 54.33 110.993 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 408' ' ' CYS . . . . . 0.464 ' HB2' HG21 ' A' ' 385' ' ' ILE . 6.0 t -56.55 131.55 77.21 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.329 -0.989 . . . . 63.14 108.329 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 0.34 9.05 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.475 1.776 . . . . 74.31 110.958 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -93.66 -55.63 3.19 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.462 1.101 . . . . 51.31 110.969 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 411' ' ' CYS . . . . . 0.451 ' O ' ' N ' ' A' ' 413' ' ' CYS . 2.6 p -98.56 10.07 41.8 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.558 1.161 . . . . 61.01 108.319 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 412' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 411' ' ' CYS . 3.4 tpt85 38.59 30.19 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.475 1.11 . . . . 63.01 110.325 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 413' ' ' CYS . . . . . 0.451 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.5 m -115.48 154.24 29.67 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.489 1.118 . . . . 54.41 108.309 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -59.35 156.6 12.43 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.531 1.144 . . . . 75.45 110.284 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 1.059 HD13 HD12 ' A' ' 385' ' ' ILE . 5.6 mt -115.48 157.1 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 61.03 109.345 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.405 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 5.9 mmtp -120.26 -44.5 2.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.529 1.143 . . . . 75.24 109.269 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 417' ' ' GLY . . . . . 0.506 ' C ' HG23 ' A' ' 418' ' ' THR . . . -112.44 127.78 8.19 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.461 1.1 . . . . 63.42 111.009 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 418' ' ' THR . . . . . 0.543 ' CG2' HG21 ' A' ' 415' ' ' ILE . 34.9 p -156.56 125.51 5.97 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.531 0.783 . . . . 71.13 110.419 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 421' ' ' ILE . 4.4 pt-20 -158.06 151.43 18.94 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.484 1.115 . . . . 61.42 110.3 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 99.17 1.23 Allowed 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.551 1.817 . . . . 73.32 111.031 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.877 HD11 HG22 ' A' ' 423' ' ' VAL . 0.8 OUTLIER -104.38 163.93 3.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.48 1.113 . . . . 71.45 109.341 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 422' ' ' ILE . . . . . 0.717 ' N ' HD12 ' A' ' 421' ' ' ILE . 3.3 mp -113.18 105.44 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.496 1.123 . . . . 74.23 109.301 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.877 HG22 HD11 ' A' ' 421' ' ' ILE . 12.9 t -78.22 140.19 17.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.465 1.103 . . . . 65.12 109.307 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.767 ' O ' HG23 ' A' ' 355' ' ' VAL . 23.6 m-20 -130.2 143.72 50.32 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.519 1.137 . . . . 70.14 109.309 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 160.29 40.29 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.493 1.786 . . . . 63.24 110.96 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 426' ' ' PHE . . . . . 0.577 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 26.4 t80 . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.481 1.113 . . . . 64.32 111.033 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 109.967 -0.383 . . . . 63.42 109.967 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -87.22 -177.28 5.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.463 1.102 . . . . 74.21 109.263 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' HIS . . . . . 0.543 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 25.0 m-70 -138.3 149.9 46.12 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.509 1.13 . . . . 71.3 109.588 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 353' ' ' ILE . . . . . 0.47 HG13 HD13 ' A' ' 421' ' ' ILE . 7.7 mt -136.11 158.65 38.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.564 1.165 . . . . 63.23 109.266 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.411 ' N ' ' CG2' ' A' ' 353' ' ' ILE . 0.1 OUTLIER -123.38 152.74 41.23 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.461 1.1 . . . . 64.31 109.317 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.667 HG22 ' CD2' ' A' ' 370' ' ' PHE . 9.2 t -107.94 162.05 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 71.31 109.288 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.466 ' N ' ' CG1' ' A' ' 355' ' ' VAL . 13.1 p -112.95 158.7 19.91 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.499 1.124 . . . . 71.43 110.43 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 357' ' ' GLN . . . . . 0.525 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 11.5 mt-30 -59.87 -45.7 91.66 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.54 1.15 . . . . 71.32 110.341 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -49.25 -44.92 44.08 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.495 1.122 . . . . 71.14 110.299 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -66.42 -43.49 85.57 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.445 1.091 . . . . 54.34 110.311 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -58.26 -27.22 63.81 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.453 1.095 . . . . 73.51 110.953 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -89.58 -40.39 12.64 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.527 1.142 . . . . 72.2 110.358 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.994 ' O ' HD12 ' A' ' 362' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.127 . . . . 65.14 109.3 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 108.287 -1.005 . . . . 63.12 108.287 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -41.55 -66.68 0.32 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.546 1.154 . . . . 72.04 110.264 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 19.1 ptp -53.73 -34.49 59.09 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.486 1.116 . . . . 71.32 111.001 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 88.45 50.21 3.45 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.429 1.081 . . . . 61.35 110.953 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 3.3 m -146.21 179.05 7.77 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.498 0.763 . . . . 70.35 109.989 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.772 HG22 ' NE2' ' A' ' 371' ' ' GLN . 2.3 m -117.89 160.66 21.04 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.528 1.143 . . . . 74.12 110.395 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.667 ' CD2' HG22 ' A' ' 355' ' ' VAL . 64.3 t80 -62.59 -68.67 0.31 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.53 1.144 . . . . 61.53 111.015 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 371' ' ' GLN . . . . . 0.772 ' NE2' HG22 ' A' ' 369' ' ' THR . 0.1 OUTLIER -47.33 -24.95 0.87 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.529 1.143 . . . . 73.23 110.283 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.418 ' CD2' ' HA ' ' A' ' 377' ' ' ALA . 0.0 OUTLIER -69.75 117.7 11.67 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 44.53 109.236 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 25.1 t -52.22 145.24 11.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.947 -1.024 . . . . 64.14 110.89 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -103.36 24.26 11.25 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.463 1.102 . . . . 42.32 109.267 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 375' ' ' ILE . . . . . 0.743 HD11 ' HE1' ' A' ' 410' ' ' PHE . 52.8 mt -111.47 -49.29 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.451 1.094 . . . . 62.24 109.316 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 376' ' ' CYS . . . . . 0.763 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 3.5 m -109.04 -32.65 7.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.501 1.126 . . . . 34.32 108.285 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.418 ' HA ' ' CD2' ' A' ' 372' ' ' LEU . . . 61.03 28.21 18.0 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.499 1.124 . . . . 33.2 109.322 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -121.83 -40.32 2.54 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.497 1.123 . . . . 53.3 110.28 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -115.53 169.65 9.02 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.514 1.134 . . . . 74.5 109.294 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -87.52 166.19 14.94 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 72.45 109.354 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.454 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 19.2 mttt -67.12 -62.53 1.38 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.476 1.11 . . . . 65.41 109.268 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 4.8 t0 60.56 20.89 10.71 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.452 1.095 . . . . 75.32 109.281 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.928 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -151.19 175.42 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.539 1.149 . . . . 61.25 109.285 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.416 ' H ' HG22 ' A' ' 383' ' ' VAL . 20.8 tttm -158.13 156.66 31.32 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.492 1.12 . . . . 64.03 109.318 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.859 HG22 ' SG ' ' A' ' 388' ' ' CYS . 11.8 mm -122.72 144.3 32.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.562 1.164 . . . . 54.31 109.331 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.536 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.4 mt-10 -137.74 162.4 54.72 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.501 1.125 . . . . 61.03 110.282 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.536 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.03 -12.15 24.12 Favored 'Cis proline' 0 C--N 1.36 1.172 0 C-N-CA 121.032 -2.487 . . . . 42.44 110.986 0.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 388' ' ' CYS . . . . . 0.859 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.63 -71.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.04 -0.982 . . . . 72.33 110.881 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 389' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 115.77 18.15 6.16 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.492 1.12 . . . . 72.45 111.022 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.529 ' CE1' ' HB2' ' A' ' 388' ' ' CYS . 20.0 m170 -75.58 147.13 39.88 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.529 0.782 . . . . 74.24 109.565 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.813 HD22 ' N ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -117.3 156.47 27.75 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.132 . . . . 65.3 109.308 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.928 ' O ' HG12 ' A' ' 383' ' ' VAL . 18.8 ptp -172.01 173.54 4.36 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.502 1.126 . . . . 75.23 110.958 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 393' ' ' CYS . . . . . 1.169 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 26.1 p -95.18 126.08 40.26 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.471 1.107 . . . . 70.34 108.278 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 6.4 m -54.12 -56.25 19.86 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.508 1.13 . . . . 74.04 110.381 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.6 t -43.61 -30.71 0.64 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.546 1.153 . . . . 42.32 109.988 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 396' ' ' CYS . . . . . 1.169 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 2.5 m -80.79 -52.32 7.64 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.544 1.153 . . . . 63.12 108.287 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 397' ' ' LEU . . . . . 0.683 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.7 OUTLIER -43.56 -37.91 2.72 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.452 1.095 . . . . 74.31 109.326 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 1.1 m -60.75 -46.8 89.07 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.482 1.114 . . . . 74.41 110.413 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -58.12 -21.94 48.68 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.482 1.114 . . . . 71.24 109.308 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 400' ' ' TRP . . . . . 0.608 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 8.9 t-105 -84.77 -64.88 1.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.523 1.139 . . . . 75.1 108.006 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.497 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.6 mm-40 -52.77 -16.99 1.13 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.472 1.107 . . . . 74.12 110.319 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 401' ' ' GLN . 5.8 mm-40 -37.09 -63.42 0.43 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.492 1.12 . . . . 73.14 110.303 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 2.8 m -120.61 -24.51 5.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.496 1.122 . . . . 72.21 109.995 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' ASP . . . . . 0.608 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 16.6 m-20 -82.09 -94.51 0.05 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.114 . . . . 70.13 109.282 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.497 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 70.5 29.96 69.38 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.488 1.117 . . . . 43.41 110.981 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -91.71 68.0 5.48 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.567 0.804 . . . . 75.44 110.279 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 66.0 -166.46 36.55 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.471 1.107 . . . . 64.1 110.976 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' CYS . . . . . 0.693 ' SG ' HG21 ' A' ' 385' ' ' ILE . 6.5 t -57.31 128.9 79.37 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 108.324 -0.991 . . . . 65.54 108.324 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 0.3 9.07 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.511 1.795 . . . . 71.25 110.958 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 410' ' ' PHE . . . . . 0.743 ' HE1' HD11 ' A' ' 375' ' ' ILE . 3.2 m-85 -97.91 -41.54 7.96 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.505 1.128 . . . . 74.34 111.019 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 411' ' ' CYS . . . . . 0.482 ' HG ' ' CE1' ' A' ' 390' ' ' HIS . 0.1 OUTLIER -111.32 8.98 21.58 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.522 1.138 . . . . 61.04 108.284 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 412' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 408' ' ' CYS . 8.0 tpp85 38.49 30.28 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.546 1.154 . . . . 72.23 110.294 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 413' ' ' CYS . . . . . 0.444 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.3 m -123.09 164.85 17.83 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.501 1.126 . . . . 74.3 108.265 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -63.07 145.08 56.23 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.494 1.121 . . . . 71.12 110.281 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.739 HG23 HG23 ' A' ' 385' ' ' ILE . 1.6 mt -94.92 147.01 6.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.522 1.139 . . . . 61.52 109.304 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -117.26 -43.78 2.82 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.489 1.118 . . . . 75.12 109.305 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 417' ' ' GLY . . . . . 0.453 ' C ' HG23 ' A' ' 418' ' ' THR . . . -119.21 130.0 8.34 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.452 1.095 . . . . 75.33 110.976 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 418' ' ' THR . . . . . 0.578 ' CG2' HG21 ' A' ' 415' ' ' ILE . 80.6 p -152.69 138.86 18.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.477 0.751 . . . . 62.22 110.359 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -171.86 151.12 2.69 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.458 1.099 . . . . 74.05 110.275 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.08 101.66 1.5 Allowed 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.518 1.799 . . . . 63.0 110.981 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.793 HD11 HG22 ' A' ' 423' ' ' VAL . 0.8 OUTLIER -104.18 159.42 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.444 1.09 . . . . 73.15 109.289 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 422' ' ' ILE . . . . . 0.543 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 8.1 mt -111.47 105.51 18.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.488 1.118 . . . . 45.11 109.27 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.793 HG22 HD11 ' A' ' 421' ' ' ILE . 39.5 t -76.97 146.78 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.509 1.131 . . . . 73.0 109.322 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.514 ' O ' HG23 ' A' ' 355' ' ' VAL . 9.3 m-20 -129.49 143.87 50.63 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.478 1.111 . . . . 60.41 109.34 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.96 174.05 13.45 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.492 1.785 . . . . 72.1 110.993 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' PHE . . . . . 0.525 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 4.8 t80 . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.118 . . . . 74.4 111.058 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 350' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 67.0 m . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 109.966 -0.383 . . . . 63.04 109.966 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -94.22 -174.75 3.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.488 1.117 . . . . 72.24 109.28 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' HIS . . . . . 0.568 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 28.9 m-70 -140.15 141.55 36.04 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.551 1.157 . . . . 74.35 109.578 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 353' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' A' ' 354' ' ' LYS . 3.7 mm -128.2 158.46 40.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.445 1.091 . . . . 64.04 109.293 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.404 ' N ' ' CG2' ' A' ' 353' ' ' ILE . 0.0 OUTLIER -117.91 153.66 33.21 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.498 1.124 . . . . 74.02 109.304 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 424' ' ' ASP . 14.3 t -105.44 149.12 9.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.115 . . . . 75.2 109.272 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 19.8 p -117.2 176.9 4.93 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.485 1.116 . . . . 72.35 110.395 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 357' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -74.49 -33.85 62.94 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.497 1.123 . . . . 73.22 110.292 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 358' ' ' GLU . . . . . 0.41 ' CG ' ' N ' ' A' ' 359' ' ' GLN . 15.3 pt-20 -57.98 -47.64 82.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.474 1.109 . . . . 75.22 110.305 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 359' ' ' GLN . . . . . 0.41 ' N ' ' CG ' ' A' ' 358' ' ' GLU . 29.1 mm-40 -60.9 -66.65 0.5 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 74.14 110.297 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 360' ' ' TYR . . . . . 0.41 ' O ' ' N ' ' A' ' 364' ' ' CYS . 4.9 t80 -44.02 -42.9 6.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 75.11 110.995 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -65.71 -42.38 91.19 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.453 1.096 . . . . 73.13 110.263 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.7 tp . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.47 1.106 . . . . 64.11 109.338 -179.988 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 364' ' ' CYS . . . . . 0.41 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.7 m . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 108.302 -0.999 . . . . 71.25 108.302 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -75.47 -29.28 59.55 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.525 1.141 . . . . 62.2 110.305 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' MET . . . . . 0.405 ' SD ' ' N ' ' A' ' 366' ' ' MET . 0.0 OUTLIER -113.49 21.02 15.55 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.514 1.134 . . . . 53.42 110.979 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 37.78 47.71 1.8 Allowed Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.448 1.093 . . . . 75.14 110.987 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 31.6 m -121.42 152.84 38.61 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.504 0.767 . . . . 62.42 109.989 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.527 HG22 ' OE1' ' A' ' 371' ' ' GLN . 2.2 m -98.51 159.77 14.72 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 72.24 110.369 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.535 ' CD1' HG11 ' A' ' 423' ' ' VAL . 5.9 t80 -66.34 -65.66 0.65 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.483 1.114 . . . . 74.53 110.981 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 371' ' ' GLN . . . . . 0.527 ' OE1' HG22 ' A' ' 369' ' ' THR . 0.0 OUTLIER -53.34 -32.8 50.85 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.128 . . . . 64.44 110.322 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.883 HD22 ' N ' ' A' ' 373' ' ' CYS . 0.7 OUTLIER -58.67 135.87 57.52 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.507 1.129 . . . . 65.13 109.278 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 373' ' ' CYS . . . . . 0.883 ' N ' HD22 ' A' ' 372' ' ' LEU . 16.4 t -76.68 135.91 39.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.965 -1.016 . . . . 74.43 110.896 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.402 ' HD2' ' N ' ' A' ' 374' ' ' LYS . 0.6 OUTLIER -92.94 22.17 5.13 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.506 1.129 . . . . 73.45 109.317 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 5.0 mt -110.68 -52.18 6.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.524 1.14 . . . . 61.54 109.33 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 376' ' ' CYS . . . . . 1.171 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 7.5 m -102.75 -27.04 12.93 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.485 1.116 . . . . 45.04 108.313 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.704 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 55.52 29.05 12.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.464 1.103 . . . . 54.01 109.327 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -122.45 -40.86 2.43 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.468 1.105 . . . . 74.45 110.31 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -119.06 -179.94 3.98 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.463 1.102 . . . . 65.3 109.348 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -89.55 171.76 9.46 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.52 1.137 . . . . 73.12 109.327 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.449 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 11.6 mttt -79.14 -62.49 1.68 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 74.42 109.284 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 15.7 t0 62.4 22.2 13.07 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.464 1.102 . . . . 74.15 109.324 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.872 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -158.25 172.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.488 1.117 . . . . 71.5 109.298 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.404 ' CE ' ' HA2' ' A' ' 389' ' ' GLY . 76.4 tttt -156.74 159.5 38.39 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.464 1.102 . . . . 74.24 109.312 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.886 HG22 ' SG ' ' A' ' 388' ' ' CYS . 18.1 mm -117.21 139.92 42.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.522 1.138 . . . . 70.25 109.298 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.534 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.9 mt-10 -130.61 162.26 55.93 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.446 1.091 . . . . 64.43 110.271 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.534 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.4 Cg_endo -74.93 -14.72 22.76 Favored 'Cis proline' 0 C--N 1.36 1.157 0 C-N-CA 121.034 -2.486 . . . . 63.41 110.986 -0.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 388' ' ' CYS . . . . . 0.886 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.82 -87.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.047 -0.979 . . . . 55.4 110.915 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 389' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 130.91 42.9 0.19 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.467 1.104 . . . . 41.33 111.027 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.499 ' C ' HD13 ' A' ' 391' ' ' LEU . 27.8 m170 -97.45 131.49 44.04 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.49 0.759 . . . . 73.44 109.643 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.697 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -100.21 151.83 20.99 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.462 1.102 . . . . 70.11 109.309 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.872 ' O ' HG12 ' A' ' 383' ' ' VAL . 16.8 ptp -167.61 170.74 10.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.536 1.147 . . . . 75.22 110.933 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 393' ' ' CYS . . . . . 1.208 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 26.1 p -97.14 115.28 27.25 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.452 1.095 . . . . 74.21 108.334 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 24.3 m -39.71 -58.69 1.28 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.552 1.157 . . . . 34.54 110.389 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.4 t -42.64 -43.61 3.91 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.513 1.133 . . . . 53.25 110.004 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 396' ' ' CYS . . . . . 1.208 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 3.6 m -67.52 -55.2 14.44 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.474 1.109 . . . . 61.34 108.293 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 397' ' ' LEU . . . . . 0.749 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -44.15 -36.26 2.55 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.476 1.11 . . . . 73.31 109.308 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 17.5 m -61.35 -46.06 91.79 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 71.5 110.436 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -56.89 -22.6 38.46 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.458 1.098 . . . . 75.04 109.302 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 400' ' ' TRP . . . . . 0.605 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 9.1 t-105 -85.56 -64.77 1.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.982 -1.118 . . . . 73.02 107.982 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.497 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 10.1 mm-40 -52.94 -16.88 1.16 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 72.24 110.316 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 401' ' ' GLN . 5.1 mt-10 -37.16 -63.29 0.44 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.489 1.118 . . . . 73.23 110.323 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 5.4 t -120.51 -24.46 5.81 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.443 1.089 . . . . 53.53 109.986 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' ASP . . . . . 0.605 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 4.6 m-20 -82.62 -95.08 0.05 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.478 1.111 . . . . 65.34 109.288 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.497 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 70.57 32.45 67.6 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.57 1.169 . . . . 62.52 110.992 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -92.02 66.94 5.06 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 0.773 . . . . 74.23 110.344 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 66.19 -161.89 44.1 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.532 1.145 . . . . 64.55 111.05 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 408' ' ' CYS . . . . . 0.673 ' SG ' HG21 ' A' ' 385' ' ' ILE . 5.5 t -60.21 126.25 83.58 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 108.332 -0.988 . . . . 74.12 108.332 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.06 -1.56 11.39 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.518 1.799 . . . . 65.04 110.998 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -94.9 -42.19 8.8 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 1.136 . . . . 65.32 111.001 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' CYS . . . . . 0.445 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.2 OUTLIER -111.79 10.45 20.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.135 . . . . 52.31 108.265 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 412' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 408' ' ' CYS . 4.8 tpt180 38.48 30.35 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.534 1.146 . . . . 75.34 110.316 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 413' ' ' CYS . . . . . 0.445 ' N ' ' O ' ' A' ' 411' ' ' CYS . 16.0 t -125.3 145.65 49.92 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.487 1.117 . . . . 74.53 108.311 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -46.59 152.67 0.44 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.552 1.158 . . . . 73.32 110.292 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.798 HG23 HG23 ' A' ' 385' ' ' ILE . 2.1 mt -100.54 153.11 4.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.463 1.102 . . . . 63.4 109.323 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.468 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 5.1 mmtt -113.98 -46.24 3.02 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 74.25 109.273 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 417' ' ' GLY . . . . . 0.457 ' C ' HG23 ' A' ' 418' ' ' THR . . . -121.5 129.66 7.81 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.466 1.103 . . . . 72.45 111.03 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 418' ' ' THR . . . . . 0.647 ' CG2' HG21 ' A' ' 415' ' ' ILE . 82.8 p -152.96 136.17 15.7 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.473 0.749 . . . . 64.5 110.378 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 13.4 pm0 -168.1 150.54 5.27 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.534 1.146 . . . . 63.32 110.327 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.4 Cg_endo -74.95 102.11 1.55 Allowed 'Trans proline' 0 C--N 1.359 1.11 0 O-C-N 124.514 1.797 . . . . 74.25 111.052 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.885 HD11 HG22 ' A' ' 423' ' ' VAL . 0.7 OUTLIER -103.9 156.4 5.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.475 1.11 . . . . 70.2 109.308 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 422' ' ' ILE . . . . . 0.568 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 14.2 mt -110.39 105.9 19.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.501 1.125 . . . . 74.33 109.293 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.885 HG22 HD11 ' A' ' 421' ' ' ILE . 18.7 t -77.79 146.74 7.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.493 1.12 . . . . 73.15 109.302 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.639 ' O ' HG23 ' A' ' 355' ' ' VAL . 76.0 m-20 -129.2 143.55 49.28 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.504 1.127 . . . . 64.13 109.299 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 174.03 13.5 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.529 1.805 . . . . 64.03 111.018 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' PHE . . . . . 0.483 ' CD1' ' C ' ' A' ' 426' ' ' PHE . 2.8 t80 . . . . . 0 C--N 1.325 -0.491 0 O-C-N 124.482 1.114 . . . . 73.53 111.01 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 109.993 -0.373 . . . . 73.3 109.993 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -91.28 -178.09 5.04 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.539 1.149 . . . . 74.01 109.297 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' HIS . . . . . 0.534 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 25.9 m-70 -138.95 140.87 38.41 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.53 1.143 . . . . 53.13 109.608 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 353' ' ' ILE . . . . . 0.454 HG13 HD13 ' A' ' 421' ' ' ILE . 35.8 mt -130.16 136.02 59.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.125 . . . . 74.41 109.311 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -103.37 129.93 50.56 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.471 1.107 . . . . 72.11 109.319 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 424' ' ' ASP . 12.7 t -77.56 157.62 5.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 75.1 109.328 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.5 p -122.25 148.81 44.54 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.505 1.128 . . . . 62.32 110.398 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' GLN . . . . . 0.618 ' CG ' ' CE2' ' A' ' 426' ' ' PHE . 3.1 mt-30 -47.52 -38.44 14.06 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.133 . . . . 72.01 110.29 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -58.28 -37.1 74.32 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.511 1.132 . . . . 71.02 110.296 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -74.56 -66.74 0.7 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.52 1.138 . . . . 44.44 110.292 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 360' ' ' TYR . . . . . 0.42 ' O ' ' N ' ' A' ' 364' ' ' CYS . 7.0 t80 -40.98 -62.07 0.88 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.553 1.158 . . . . 75.51 111.056 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -48.84 -48.83 41.47 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.535 1.147 . . . . 73.41 110.303 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 9.9 tt . . . . . 0 C--N 1.325 -0.468 0 O-C-N 124.493 1.121 . . . . 35.01 109.313 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 364' ' ' CYS . . . . . 0.42 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 108.318 -0.993 . . . . 71.31 108.318 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -77.23 -8.24 57.25 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.493 1.121 . . . . 52.22 110.342 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 8.0 mmt -102.61 -29.93 11.25 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.528 1.143 . . . . 55.41 111.003 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 89.93 30.01 14.04 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.498 1.124 . . . . 54.21 110.997 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 1.1 p -144.66 -175.01 4.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.469 0.746 . . . . 71.32 109.991 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.416 ' O ' ' CE ' ' A' ' 374' ' ' LYS . 11.7 p -118.79 167.32 11.81 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.452 1.095 . . . . 72.3 110.395 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.574 ' CD2' HG11 ' A' ' 423' ' ' VAL . 38.2 t80 -71.2 -65.37 0.75 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 63.41 110.999 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 371' ' ' GLN . . . . . 0.542 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.3 OUTLIER -43.67 -27.2 0.29 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 51.14 110.335 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.901 HD22 ' N ' ' A' ' 373' ' ' CYS . 0.5 OUTLIER -74.16 136.08 42.86 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.472 1.108 . . . . 71.01 109.309 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 373' ' ' CYS . . . . . 0.901 ' N ' HD22 ' A' ' 372' ' ' LEU . 32.1 p -68.48 130.75 43.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.008 -0.996 . . . . 71.55 110.878 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.416 ' CE ' ' O ' ' A' ' 369' ' ' THR . 28.8 mmtp -92.97 31.46 1.41 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.488 1.118 . . . . 75.21 109.337 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 375' ' ' ILE . . . . . 0.655 HD11 ' HE1' ' A' ' 410' ' ' PHE . 18.8 mt -112.31 -59.74 3.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.509 1.13 . . . . 34.52 109.276 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 4.0 m -107.41 -22.01 12.72 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.471 1.107 . . . . 54.24 108.312 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.703 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 54.76 40.3 31.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.511 1.132 . . . . 64.31 109.335 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -121.51 -40.28 2.58 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.499 1.125 . . . . 74.33 110.322 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -124.03 179.18 4.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.527 1.142 . . . . 71.3 109.278 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -89.45 165.84 14.07 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.557 1.161 . . . . 72.44 109.307 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.467 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 17.2 mttt -66.49 -62.63 1.36 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.561 1.163 . . . . 75.22 109.28 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 33.9 t0 59.91 22.71 11.74 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.51 1.131 . . . . 52.11 109.301 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.901 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -156.75 174.62 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.524 1.14 . . . . 53.13 109.29 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.405 ' CG ' ' N ' ' A' ' 385' ' ' ILE . 47.1 tttt -158.44 158.48 34.23 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.442 1.089 . . . . 64.22 109.311 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.831 HG22 ' SG ' ' A' ' 388' ' ' CYS . 14.8 mm -118.32 144.75 25.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.521 1.138 . . . . 74.03 109.268 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.537 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.0 mt-10 -136.86 162.35 56.36 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.435 1.084 . . . . 74.03 110.291 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.537 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.04 -13.69 23.59 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 121.023 -2.491 . . . . 75.32 111.02 0.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 388' ' ' CYS . . . . . 0.831 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.8 -84.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.953 -1.021 . . . . 45.52 110.892 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 128.36 41.99 0.26 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.507 1.129 . . . . 73.55 110.964 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.52 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 72.9 m-70 -97.55 137.9 35.78 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.526 0.78 . . . . 72.41 109.56 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.706 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -106.64 150.82 25.83 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.501 1.126 . . . . 62.02 109.286 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.901 ' O ' HG12 ' A' ' 383' ' ' VAL . 16.3 ptp -167.48 166.33 14.33 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.467 1.104 . . . . 44.15 111.011 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 393' ' ' CYS . . . . . 1.105 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 8.8 p -90.9 124.54 35.27 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 1.128 . . . . 61.5 108.254 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 10.6 m -47.93 -56.85 6.64 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.5 1.125 . . . . 52.32 110.39 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 4.1 m -44.94 -27.15 0.5 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.521 1.138 . . . . 72.55 110.019 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' CYS . . . . . 1.105 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 1.9 m -83.26 -51.61 7.3 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.495 1.122 . . . . 72.35 108.346 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 397' ' ' LEU . . . . . 0.661 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -40.97 -52.25 3.14 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.532 1.145 . . . . 75.55 109.292 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 398' ' ' THR . . . . . 0.63 ' N ' HD13 ' A' ' 397' ' ' LEU . 2.7 m -53.04 -43.11 66.36 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.525 1.141 . . . . 71.22 110.416 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 399' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -57.19 -26.13 60.14 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.538 1.149 . . . . 73.45 109.329 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 400' ' ' TRP . . . . . 0.596 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 10.3 t-105 -85.62 -62.52 1.51 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.998 -1.112 . . . . 70.23 107.998 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.499 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.4 mm-40 -56.13 -14.15 2.5 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.514 1.134 . . . . 64.14 110.342 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 398' ' ' THR . 3.0 mm-40 -37.12 -63.39 0.43 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.488 1.118 . . . . 75.32 110.292 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.4 t -121.3 -24.61 5.42 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.543 1.152 . . . . 75.22 109.978 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' ASP . . . . . 0.596 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 15.0 m-20 -82.63 -94.28 0.06 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.458 1.098 . . . . 74.3 109.334 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.499 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 72.56 30.23 64.59 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.516 1.135 . . . . 63.51 111.002 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 406' ' ' GLN . . . . . 0.531 ' NE2' ' C ' ' A' ' 406' ' ' GLN . 0.0 OUTLIER -91.36 71.37 6.09 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.508 0.769 . . . . 74.4 110.322 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 61.74 -167.81 14.58 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.547 1.154 . . . . 72.22 111.011 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 408' ' ' CYS . . . . . 0.657 ' SG ' HG21 ' A' ' 385' ' ' ILE . 5.7 t -56.26 125.99 66.77 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 108.29 -1.004 . . . . 75.25 108.29 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.94 0.17 9.2 Favored 'Trans proline' 0 C--N 1.359 1.104 0 O-C-N 124.521 1.801 . . . . 74.52 111.003 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' PHE . . . . . 0.655 ' HE1' HD11 ' A' ' 375' ' ' ILE . 3.6 m-85 -94.67 -55.78 3.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.107 . . . . 72.52 111.027 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 411' ' ' CYS . . . . . 0.436 ' O ' ' N ' ' A' ' 413' ' ' CYS . 2.4 p -98.95 12.86 34.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 62.23 108.293 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 412' ' ' ARG . . . . . . . . . . . . . 14.2 mmm-85 38.55 30.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.476 1.11 . . . . 61.42 110.288 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 413' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.3 m -119.76 163.22 17.79 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.53 1.144 . . . . 75.21 108.332 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.31 154.8 34.15 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.525 1.141 . . . . 74.41 110.293 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.749 HG23 HG23 ' A' ' 385' ' ' ILE . 1.9 mt -104.61 143.49 16.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.438 1.087 . . . . 64.33 109.279 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.451 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 3.5 mmtp -109.85 -46.37 3.5 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.559 1.162 . . . . 53.12 109.321 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 417' ' ' GLY . . . . . 0.479 ' C ' HG23 ' A' ' 418' ' ' THR . . . -124.36 139.66 12.05 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.541 1.151 . . . . 73.12 110.994 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 418' ' ' THR . . . . . 0.598 ' CG2' HG21 ' A' ' 415' ' ' ILE . 72.3 p -153.92 126.43 8.07 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.517 0.775 . . . . 63.41 110.359 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.21 151.12 23.65 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.489 1.118 . . . . 73.13 110.332 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.96 102.11 1.55 Allowed 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.514 1.797 . . . . 72.03 111.037 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.883 HD11 HG22 ' A' ' 423' ' ' VAL . 0.7 OUTLIER -103.87 155.03 5.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.131 . . . . 71.34 109.29 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 422' ' ' ILE . . . . . 0.541 ' N ' HD12 ' A' ' 421' ' ' ILE . 19.4 mt -109.37 105.99 19.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.567 1.167 . . . . 73.43 109.307 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.883 HG22 HD11 ' A' ' 421' ' ' ILE . 17.1 t -76.23 146.94 8.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.434 1.084 . . . . 74.34 109.265 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.768 ' O ' HG23 ' A' ' 355' ' ' VAL . 1.8 t70 -128.68 143.5 48.7 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.523 1.139 . . . . 73.11 109.352 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 176.19 10.22 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.481 1.779 . . . . 63.3 111.053 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' PHE . . . . . 0.618 ' CE2' ' CG ' ' A' ' 357' ' ' GLN . 5.9 t80 . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.542 1.151 . . . . 74.51 111.042 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 110.043 -0.355 . . . . 74.42 110.043 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -87.89 -175.07 4.99 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.514 1.134 . . . . 73.51 109.28 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 352' ' ' HIS . . . . . 0.547 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 39.0 m-70 -142.05 146.93 36.04 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.517 1.136 . . . . 73.13 109.627 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 58.4 mt -130.83 158.63 43.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.484 1.115 . . . . 62.42 109.247 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -128.36 134.03 48.77 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.547 1.154 . . . . 72.25 109.3 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 424' ' ' ASP . 43.8 t -95.28 164.29 2.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.487 1.117 . . . . 72.23 109.274 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.468 ' N ' ' CG1' ' A' ' 355' ' ' VAL . 71.2 p -125.69 157.39 37.45 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.542 1.151 . . . . 63.33 110.406 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 357' ' ' GLN . . . . . 0.597 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 20.4 mt-30 -53.9 -46.29 71.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.469 1.105 . . . . 72.33 110.275 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -44.04 -30.46 0.74 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.504 1.127 . . . . 75.1 110.339 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' GLN . . . . . 0.529 ' OE1' ' CD1' ' A' ' 370' ' ' PHE . 58.8 mt-30 -83.58 -66.86 0.84 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.471 1.107 . . . . 42.43 110.287 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 360' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 364' ' ' CYS . 3.9 t80 -38.15 -38.56 0.34 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.499 1.124 . . . . 64.33 110.999 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -63.71 -52.36 60.86 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.431 1.082 . . . . 63.55 110.292 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 2.1 tp . . . . . 0 C--N 1.326 -0.447 0 O-C-N 124.442 1.089 . . . . 55.43 109.287 -179.953 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 364' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 108.317 -0.994 . . . . 52.44 108.317 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -75.14 -51.95 12.16 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.461 1.101 . . . . 71.41 110.306 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 24.3 ptp -68.06 -15.14 63.47 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.506 1.128 . . . . 71.41 111.0 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 75.04 34.65 51.88 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.482 1.114 . . . . 54.22 111.012 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.1 -178.03 4.91 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 0.759 . . . . 64.24 110.026 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.823 HG22 ' NE2' ' A' ' 371' ' ' GLN . 2.0 m -117.35 161.22 19.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.132 . . . . 72.05 110.424 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.529 ' CD1' ' OE1' ' A' ' 359' ' ' GLN . 67.2 t80 -62.51 -69.39 0.26 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.51 1.131 . . . . 74.43 110.954 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 371' ' ' GLN . . . . . 0.823 ' NE2' HG22 ' A' ' 369' ' ' THR . 0.2 OUTLIER -44.95 -25.9 0.36 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.533 1.146 . . . . 73.31 110.295 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.511 HD22 ' HA ' ' A' ' 377' ' ' ALA . 0.2 OUTLIER -62.26 132.32 52.32 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.479 1.112 . . . . 71.35 109.263 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 5.1 t -68.32 124.43 23.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.954 -1.021 . . . . 73.11 110.893 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.458 ' HB3' ' HZ3' ' A' ' 374' ' ' LYS . 1.4 mmmm -90.88 18.46 6.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.517 1.136 . . . . 72.33 109.294 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 375' ' ' ILE . . . . . 1.011 HD11 ' CZ ' ' A' ' 410' ' ' PHE . 64.2 mt -109.81 -25.7 3.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.524 1.14 . . . . 64.35 109.283 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 376' ' ' CYS . . . . . 0.848 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 5.8 p -132.28 -48.66 0.92 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.131 . . . . 65.44 108.31 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 376' ' ' CYS . . . 73.79 44.54 0.27 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.459 1.1 . . . . 75.2 109.318 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -123.68 -42.27 2.21 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.497 1.123 . . . . 75.14 110.297 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -133.82 176.83 8.21 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.509 1.131 . . . . 74.5 109.316 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -84.96 149.53 25.56 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.499 1.124 . . . . 75.33 109.264 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 392' ' ' MET . 22.1 mttt -51.83 -55.9 17.22 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.455 1.097 . . . . 52.52 109.313 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 1.1 p30 52.28 25.45 3.4 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.511 1.132 . . . . 61.52 109.301 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.895 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -153.92 176.09 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.475 1.109 . . . . 71.22 109.343 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.601 ' HE3' HD11 ' A' ' 391' ' ' LEU . 8.9 ttmt -158.46 148.26 19.63 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.498 1.124 . . . . 74.2 109.347 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.738 HD12 HD13 ' A' ' 415' ' ' ILE . 16.8 mm -112.16 141.25 28.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.53 1.144 . . . . 73.32 109.283 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.523 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.2 mt-10 -138.14 161.34 60.02 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.498 1.124 . . . . 73.5 110.331 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.523 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.99 -9.76 24.02 Favored 'Cis proline' 0 C--N 1.36 1.144 0 C-N-CA 121.006 -2.498 . . . . 74.02 111.031 0.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 388' ' ' CYS . . . . . 0.446 ' SG ' ' ND1' ' A' ' 390' ' ' HIS . 4.2 t -36.68 -72.96 0.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.965 -1.016 . . . . 73.35 110.936 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 389' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.34 15.72 6.94 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.47 1.106 . . . . 73.32 111.018 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.446 ' ND1' ' SG ' ' A' ' 388' ' ' CYS . 16.6 m170 -82.08 135.94 35.26 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 0.767 . . . . 73.34 109.627 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.678 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -102.63 160.1 14.87 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.537 1.148 . . . . 73.11 109.327 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.895 ' O ' HG12 ' A' ' 383' ' ' VAL . 15.2 ptp -173.07 175.31 3.25 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 1.131 . . . . 74.14 111.016 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 393' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 20.0 p -96.94 114.92 26.58 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.55 1.156 . . . . 62.13 108.307 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 28.6 m -38.85 -59.8 0.92 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.49 1.119 . . . . 64.1 110.4 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.3 p -43.27 -42.46 4.41 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.509 1.13 . . . . 61.32 109.976 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 2.8 m -67.8 -51.39 49.37 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.456 1.098 . . . . 72.3 108.312 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 397' ' ' LEU . . . . . 0.688 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -45.67 -46.51 14.74 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.5 1.125 . . . . 71.24 109.319 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 398' ' ' THR . . . . . 0.559 ' N ' HD13 ' A' ' 397' ' ' LEU . 1.1 m -56.67 -35.55 68.54 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 74.14 110.434 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 399' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -69.08 -21.13 64.08 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.522 1.139 . . . . 62.25 109.283 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 400' ' ' TRP . . . . . 0.602 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 8.9 t-105 -85.71 -61.29 1.79 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.506 1.129 . . . . 63.12 108.025 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.501 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 8.6 mm-40 -56.2 -14.24 2.63 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.121 . . . . 63.31 110.34 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 401' ' ' GLN . 1.0 OUTLIER -37.14 -63.36 0.44 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.513 1.133 . . . . 74.23 110.277 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.5 m -121.08 -24.57 5.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.102 . . . . 75.43 109.959 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' ASP . . . . . 0.602 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 3.1 m-20 -83.21 -95.09 0.06 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 70.51 109.341 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.501 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 73.96 27.6 66.32 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.548 1.155 . . . . 61.32 111.001 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -89.37 67.83 7.82 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.497 0.763 . . . . 75.31 110.279 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 61.86 -163.25 24.9 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.546 1.154 . . . . 71.25 110.989 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' CYS . . . . . 0.424 ' SG ' HG21 ' A' ' 385' ' ' ILE . 4.9 t -56.23 127.6 70.98 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 108.325 -0.991 . . . . 54.23 108.325 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 0.3 9.06 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.452 1.764 . . . . 65.13 111.014 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 410' ' ' PHE . . . . . 1.011 ' CZ ' HD11 ' A' ' 375' ' ' ILE . 9.1 m-85 -93.37 -48.15 6.55 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.56 1.162 . . . . 71.21 111.016 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 411' ' ' CYS . . . . . 0.44 ' O ' ' N ' ' A' ' 413' ' ' CYS . 1.1 p -109.35 13.06 24.4 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.535 1.147 . . . . 74.51 108.312 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 412' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 38.48 30.46 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.471 1.107 . . . . 74.03 110.282 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 413' ' ' CYS . . . . . 0.44 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.6 m -113.31 155.06 25.82 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.587 1.179 . . . . 72.35 108.296 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -59.25 158.95 8.3 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.451 1.094 . . . . 63.12 110.307 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.738 HD13 HD12 ' A' ' 385' ' ' ILE . 7.2 mt -114.31 156.86 15.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.518 1.136 . . . . 54.43 109.329 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.428 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 20.3 mmtt -125.63 -46.72 1.72 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 73.24 109.305 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 417' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 418' ' ' THR . . . -111.28 133.56 11.59 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.494 1.122 . . . . 72.52 111.008 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 418' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 417' ' ' GLY . 23.4 p -157.06 116.21 3.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.513 0.772 . . . . 74.45 110.386 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.65 151.42 42.7 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.501 1.125 . . . . 74.4 110.325 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 101.79 1.51 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.56 1.821 . . . . 72.21 111.047 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.768 HD11 HG22 ' A' ' 423' ' ' VAL . 0.8 OUTLIER -103.89 158.67 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.484 1.115 . . . . 74.34 109.248 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 422' ' ' ILE . . . . . 0.593 ' N ' HD12 ' A' ' 421' ' ' ILE . 11.4 mt -112.29 107.16 22.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.532 1.145 . . . . 65.01 109.277 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.768 HG22 HD11 ' A' ' 421' ' ' ILE . 20.5 t -75.39 149.6 6.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.472 1.107 . . . . 71.52 109.293 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.663 ' O ' HG23 ' A' ' 355' ' ' VAL . 6.9 t0 -126.73 132.95 24.53 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.498 1.124 . . . . 73.34 109.336 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 163.03 36.21 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.543 1.812 . . . . 71.12 111.039 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' PHE . . . . . 0.597 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 1.1 t80 . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.485 1.116 . . . . 72.34 111.037 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 350' ' ' SER . . . . . 0.459 ' HB3' ' CD1' ' A' ' 422' ' ' ILE . 60.7 m . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 110.026 -0.361 . . . . 73.34 110.026 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -90.68 172.75 8.45 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.533 1.146 . . . . 71.43 109.309 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 352' ' ' HIS . . . . . 0.522 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 27.3 m-70 -132.99 130.93 40.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 1.14 . . . . 73.42 109.653 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 353' ' ' ILE . . . . . 0.612 HD12 ' CD1' ' A' ' 421' ' ' ILE . 61.9 mt -119.0 150.71 21.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 65.54 109.29 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.29 139.12 50.72 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.569 1.168 . . . . 51.54 109.285 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 424' ' ' ASP . 21.9 t -87.74 122.59 39.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.504 1.127 . . . . 65.13 109.281 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.7 p -84.52 140.97 31.08 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.532 1.145 . . . . 72.12 110.391 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 357' ' ' GLN . . . . . 0.456 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 7.1 mt-30 -41.06 -33.66 0.35 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.537 1.148 . . . . 62.43 110.304 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -56.55 -49.1 75.82 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.531 1.144 . . . . 61.02 110.306 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 359' ' ' GLN . . . . . 0.443 ' HB2' HG13 ' A' ' 355' ' ' VAL . 11.0 mm-40 -60.24 -66.76 0.47 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 74.33 110.325 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 360' ' ' TYR . . . . . 0.442 ' O ' ' N ' ' A' ' 364' ' ' CYS . 5.7 t80 -38.89 -41.36 0.74 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.481 1.113 . . . . 71.51 110.985 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -63.63 -54.03 42.22 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.5 1.125 . . . . 75.1 110.301 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.6 tp . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.485 1.116 . . . . 54.31 109.329 179.97 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 364' ' ' CYS . . . . . 0.442 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.9 m . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 108.304 -0.999 . . . . 73.1 108.304 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -65.38 -15.21 62.35 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.485 1.116 . . . . 75.43 110.269 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 2.5 ptp -126.0 2.07 7.28 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.54 1.15 . . . . 72.34 110.979 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 49.96 48.38 38.3 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.492 1.12 . . . . 71.11 111.034 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 6.5 t -115.88 177.99 4.48 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.45 0.735 . . . . 73.24 110.003 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 2.2 p -124.37 135.21 53.14 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.539 1.149 . . . . 74.42 110.373 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.545 ' CD2' HG11 ' A' ' 423' ' ' VAL . 32.5 t80 -64.1 -66.08 0.59 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.126 . . . . 65.13 110.997 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 371' ' ' GLN . . . . . 0.53 HE22 ' HB3' ' A' ' 425' ' ' PRO . 0.9 OUTLIER -43.08 -27.16 0.19 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.499 1.124 . . . . 74.24 110.345 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.933 HD22 ' N ' ' A' ' 373' ' ' CYS . 0.4 OUTLIER -73.18 135.91 44.68 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.539 1.149 . . . . 65.51 109.281 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 373' ' ' CYS . . . . . 0.933 ' N ' HD22 ' A' ' 372' ' ' LEU . 31.6 p -64.13 128.53 36.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.025 -0.989 . . . . 64.35 110.908 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -93.07 29.26 1.9 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.491 1.119 . . . . 73.25 109.279 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 375' ' ' ILE . . . . . 0.653 HG21 ' HB3' ' A' ' 396' ' ' CYS . 35.4 mt -108.29 -60.5 2.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.539 1.149 . . . . 71.32 109.276 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 14.3 p -107.93 -22.36 12.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 52.25 108.278 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.567 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 58.79 46.97 13.35 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.463 1.102 . . . . 75.33 109.306 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -131.64 -44.77 0.98 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.453 1.096 . . . . 63.42 110.275 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -113.24 -179.98 3.8 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.492 1.12 . . . . 64.52 109.283 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -94.63 162.73 13.67 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.458 1.099 . . . . 72.51 109.284 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.44 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 20.3 mttt -65.76 -62.54 1.45 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.461 1.1 . . . . 75.1 109.324 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 382' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 420' ' ' PRO . 4.1 t70 60.17 20.34 9.67 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.487 1.117 . . . . 61.35 109.314 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.924 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -149.71 176.09 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.483 1.114 . . . . 72.3 109.296 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.437 ' HD2' HD11 ' A' ' 353' ' ' ILE . 17.5 tttm -159.13 156.39 28.98 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.478 1.111 . . . . 71.42 109.27 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.855 HG22 ' SG ' ' A' ' 388' ' ' CYS . 11.5 mm -122.67 144.16 33.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.51 1.132 . . . . 74.42 109.277 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.537 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.0 OUTLIER -137.68 162.34 55.18 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.554 1.159 . . . . 75.11 110.283 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.537 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.99 -12.46 23.95 Favored 'Cis proline' 0 C--N 1.36 1.153 0 C-N-CA 120.983 -2.507 . . . . 70.11 110.98 -0.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 388' ' ' CYS . . . . . 0.855 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.34 -71.72 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.011 -0.995 . . . . 73.33 110.925 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 389' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.0 16.86 6.57 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.545 1.153 . . . . 73.15 110.981 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.564 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 20.0 m80 -74.46 146.41 42.82 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.483 0.755 . . . . 63.33 109.622 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.814 HD22 ' N ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -116.85 158.2 24.35 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.527 1.142 . . . . 65.14 109.301 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.924 ' O ' HG12 ' A' ' 383' ' ' VAL . 14.2 ptp -173.45 173.37 3.49 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.507 1.129 . . . . 71.42 111.032 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 4.7 p -97.33 119.13 35.29 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.489 1.118 . . . . 74.21 108.309 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 4.5 m -47.05 -41.04 16.09 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.543 1.152 . . . . 64.1 110.378 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.5 p -55.42 -43.12 75.02 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 73.43 110.028 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 396' ' ' CYS . . . . . 0.653 ' HB3' HG21 ' A' ' 375' ' ' ILE . 4.9 m -70.17 -44.32 69.02 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.133 . . . . 55.11 108.32 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 397' ' ' LEU . . . . . 0.432 HD13 ' C ' ' A' ' 397' ' ' LEU . 1.6 tm? -44.97 -47.84 11.41 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.529 1.143 . . . . 75.32 109.27 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 3.2 m -55.75 -35.24 65.97 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.464 1.103 . . . . 73.15 110.388 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 399' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -66.93 -23.45 65.97 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.127 . . . . 65.4 109.271 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 400' ' ' TRP . . . . . 0.414 ' O ' ' HB2' ' A' ' 404' ' ' ASP . 7.7 t-105 -85.91 -58.69 2.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 73.54 107.985 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.51 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 5.5 mm-40 -62.45 -9.84 9.73 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.564 1.165 . . . . 75.51 110.314 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 401' ' ' GLN . 1.0 OUTLIER -37.14 -63.9 0.4 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.428 1.08 . . . . 75.2 110.311 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 6.2 p -121.98 -25.04 5.04 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.505 1.128 . . . . 74.34 109.987 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 404' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 400' ' ' TRP . 3.1 m-20 -82.33 -92.52 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 61.13 109.289 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.51 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 75.53 32.19 55.17 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.516 1.135 . . . . 70.53 111.006 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -89.35 75.56 7.68 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.473 0.749 . . . . 73.51 110.275 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 57.34 -161.58 8.75 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.471 1.107 . . . . 40.0 110.986 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 408' ' ' CYS . . . . . 0.681 ' SG ' HG21 ' A' ' 385' ' ' ILE . 6.8 t -58.02 130.03 82.81 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 108.291 -1.003 . . . . 72.42 108.291 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -0.16 9.63 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.449 1.763 . . . . 65.4 110.994 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 410' ' ' PHE . . . . . 0.564 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 3.8 m-85 -97.64 -41.46 8.11 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.492 1.12 . . . . 60.15 111.004 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 411' ' ' CYS . . . . . 0.482 ' HG ' ' CE1' ' A' ' 390' ' ' HIS . 0.1 OUTLIER -111.19 8.75 21.73 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.537 1.148 . . . . 54.31 108.322 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 412' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 408' ' ' CYS . 12.7 tpp85 38.44 30.35 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.462 1.101 . . . . 32.4 110.275 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 413' ' ' CYS . . . . . 0.442 ' N ' ' C ' ' A' ' 411' ' ' CYS . 1.2 m -124.97 160.77 28.18 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.534 1.146 . . . . 74.01 108.335 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -55.79 149.06 15.29 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.516 1.135 . . . . 63.34 110.276 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.659 HG23 HG23 ' A' ' 385' ' ' ILE . 1.7 mt -94.06 146.35 6.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.544 1.152 . . . . 75.5 109.28 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.93 -49.11 3.18 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.523 1.139 . . . . 74.02 109.305 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 417' ' ' GLY . . . . . 0.419 ' C ' ' CG2' ' A' ' 418' ' ' THR . . . -129.19 139.24 10.82 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.532 1.145 . . . . 53.35 111.015 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 418' ' ' THR . . . . . 0.658 ' CG2' HG21 ' A' ' 415' ' ' ILE . 50.7 p -151.84 141.21 21.52 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.503 0.766 . . . . 73.14 110.369 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -170.25 149.66 3.28 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.466 1.104 . . . . 73.23 110.325 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 382' ' ' ASP . 18.3 Cg_endo -75.01 102.24 1.57 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.505 1.792 . . . . 73.33 111.013 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.735 HD11 HG22 ' A' ' 423' ' ' VAL . 0.9 OUTLIER -103.86 162.76 4.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.559 1.162 . . . . 63.15 109.315 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 422' ' ' ILE . . . . . 0.568 ' N ' HD12 ' A' ' 421' ' ' ILE . 3.3 mp -113.27 106.41 20.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 71.33 109.322 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.735 HG22 HD11 ' A' ' 421' ' ' ILE . 40.5 t -76.95 144.65 11.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.482 1.114 . . . . 73.04 109.307 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.774 ' O ' HG23 ' A' ' 355' ' ' VAL . 1.1 m-20 -130.72 143.68 50.34 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.501 1.125 . . . . 65.31 109.323 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 425' ' ' PRO . . . . . 0.53 ' HB3' HE22 ' A' ' 371' ' ' GLN . 18.1 Cg_endo -75.02 172.46 16.33 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.51 1.795 . . . . 62.02 110.992 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 426' ' ' PHE . . . . . 0.456 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 7.5 t80 . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.502 1.126 . . . . 73.12 110.958 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 350' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 64.8 m . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 109.944 -0.391 . . . . 40.15 109.944 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 351' ' ' ASP . . . . . 0.497 ' CG ' HG22 ' A' ' 421' ' ' ILE . 0.1 OUTLIER -84.55 176.64 8.49 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.507 1.129 . . . . 71.24 109.308 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -134.62 137.65 43.85 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.529 1.143 . . . . 72.24 109.567 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 2.1 mm -117.45 155.54 19.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.511 1.132 . . . . 64.4 109.276 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.09 137.54 53.5 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.459 1.1 . . . . 73.51 109.289 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 424' ' ' ASP . 23.5 t -96.81 140.23 17.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.521 1.138 . . . . 73.11 109.254 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 22.0 p -107.31 154.14 21.72 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.54 1.15 . . . . 72.11 110.404 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 357' ' ' GLN . . . . . 0.557 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 12.4 mt-30 -49.92 -44.21 50.16 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.517 1.136 . . . . 74.41 110.31 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -45.13 -38.13 4.92 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.455 1.097 . . . . 75.12 110.283 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -74.22 -59.41 2.74 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.444 1.09 . . . . 75.33 110.304 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 360' ' ' TYR . . . . . 0.4 ' O ' ' N ' ' A' ' 364' ' ' CYS . 8.8 t80 -43.48 -55.46 4.19 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.488 1.117 . . . . 73.41 111.035 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -55.33 -37.69 67.75 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.539 1.149 . . . . 70.2 110.325 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.472 HD22 ' HA ' ' A' ' 362' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.48 1.113 . . . . 70.31 109.309 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 364' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 360' ' ' TYR . 3.0 m . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 108.344 -0.984 . . . . 73.4 108.344 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -71.74 -20.61 61.87 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.486 1.116 . . . . 64.51 110.326 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -124.06 6.13 8.58 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.443 1.09 . . . . 52.22 110.993 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 45.27 52.91 8.21 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.47 1.106 . . . . 62.12 110.985 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 10.6 t -119.91 -174.83 2.84 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.522 0.778 . . . . 52.34 110.011 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 5.6 p -127.87 133.66 49.35 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.496 1.123 . . . . 74.32 110.42 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -64.33 -63.95 1.01 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.466 1.104 . . . . 65.2 110.997 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 371' ' ' GLN . . . . . 0.556 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -44.1 -26.85 0.33 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.564 1.165 . . . . 65.32 110.301 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.653 HD11 ' HA ' ' A' ' 377' ' ' ALA . 2.0 tm? -78.81 141.82 37.43 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.496 1.123 . . . . 72.01 109.279 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 373' ' ' CYS . . . . . 0.623 ' O ' HD13 ' A' ' 372' ' ' LEU . 15.1 t -75.63 150.99 37.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.967 -1.015 . . . . 72.44 110.89 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -110.9 23.7 13.84 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.534 1.146 . . . . 75.03 109.282 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 12.0 mt -108.12 -50.81 7.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 75.42 109.265 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 376' ' ' CYS . . . . . 1.011 ' SG ' ' CB ' ' A' ' 396' ' ' CYS . 1.6 m -107.52 -42.55 4.75 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.524 1.14 . . . . 75.55 108.283 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.653 ' HA ' HD11 ' A' ' 372' ' ' LEU . . . 72.09 47.43 0.3 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.533 1.146 . . . . 74.25 109.306 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -132.25 -66.56 0.69 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.517 1.136 . . . . 61.01 110.321 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -99.49 159.73 14.81 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.495 1.122 . . . . 64.3 109.304 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -73.14 152.05 41.31 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.506 1.129 . . . . 73.31 109.274 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.465 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 23.5 mttt -49.88 -62.51 1.52 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.476 1.11 . . . . 71.32 109.284 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 382' ' ' ASP . . . . . 0.406 ' HA ' ' O ' ' A' ' 421' ' ' ILE . 40.5 m-20 59.73 24.96 13.9 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.472 1.108 . . . . 75.14 109.253 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.93 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -156.08 172.83 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.462 1.101 . . . . 72.42 109.289 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.451 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 48.5 tttp -155.67 136.58 13.61 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.491 1.119 . . . . 71.35 109.293 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.72 HG21 ' SG ' ' A' ' 408' ' ' CYS . 15.2 mm -102.18 137.3 30.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.467 1.104 . . . . 73.24 109.317 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.521 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.0 OUTLIER -138.02 161.31 60.4 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.5 1.125 . . . . 71.25 110.298 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.521 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.97 -7.17 22.95 Favored 'Cis proline' 0 C--N 1.36 1.136 0 C-N-CA 120.982 -2.508 . . . . 74.12 111.034 -0.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 388' ' ' CYS . . . . . 0.54 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 50.7 t -36.8 -73.89 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.967 -1.015 . . . . 64.1 110.932 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 389' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.32 15.52 7.05 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.544 1.152 . . . . 72.4 110.987 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.54 ' CG ' ' SG ' ' A' ' 388' ' ' CYS . 68.3 m170 -86.7 126.07 34.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.538 0.787 . . . . 74.01 109.605 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.703 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -96.11 158.83 15.26 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.475 1.109 . . . . 62.23 109.272 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.93 ' O ' HG12 ' A' ' 383' ' ' VAL . 20.4 ptp -172.78 175.87 3.27 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 73.24 110.996 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 393' ' ' CYS . . . . . 0.818 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 2.3 p -99.64 114.75 28.02 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.478 1.111 . . . . 70.03 108.293 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 29.2 m -46.54 -24.81 0.58 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.492 1.12 . . . . 72.23 110.448 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.4 p -67.11 -42.49 84.43 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.102 . . . . 72.42 109.99 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' CYS . . . . . 1.011 ' CB ' ' SG ' ' A' ' 376' ' ' CYS . 76.1 m -80.74 -49.83 10.66 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.507 1.129 . . . . 64.41 108.279 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 397' ' ' LEU . . . . . 0.778 HD12 ' SD ' ' A' ' 392' ' ' MET . 2.7 tt -45.62 -48.3 14.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.116 . . . . 73.0 109.315 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.11 -34.77 61.09 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.533 1.145 . . . . 64.52 110.398 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 399' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -62.83 -27.11 69.1 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.436 1.085 . . . . 73.35 109.275 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 400' ' ' TRP . . . . . 0.52 ' CD2' ' HB3' ' A' ' 409' ' ' PRO . 3.7 t-105 -79.59 -53.15 7.13 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.518 1.136 . . . . 73.4 108.019 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.51 HE21 HD21 ' A' ' 397' ' ' LEU . 7.1 mm-40 -62.13 -10.02 9.2 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.49 1.119 . . . . 75.42 110.318 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 401' ' ' GLN . 5.3 mm-40 -37.08 -63.59 0.42 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.103 . . . . 73.44 110.293 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 18.2 t -121.54 -24.58 5.32 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.525 1.14 . . . . 73.22 110.015 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 404' ' ' ASP . . . . . 0.46 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 3.1 m-20 -83.88 -94.76 0.06 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.492 1.12 . . . . 70.21 109.281 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.498 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 73.93 32.59 58.65 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.504 1.128 . . . . 44.01 111.022 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -89.02 63.18 6.6 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.541 0.789 . . . . 75.35 110.304 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 68.52 -162.59 50.03 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.52 1.138 . . . . 64.12 110.978 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 408' ' ' CYS . . . . . 0.72 ' SG ' HG21 ' A' ' 385' ' ' ILE . 3.2 t -56.56 122.86 53.48 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.313 -0.995 . . . . 50.41 108.313 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.52 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.3 Cg_endo -74.98 -1.87 11.79 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.497 1.788 . . . . 61.24 111.017 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 410' ' ' PHE . . . . . 0.55 ' CD2' ' HE2' ' A' ' 392' ' ' MET . 2.6 m-85 -89.16 -41.3 12.34 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 73.0 111.031 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 411' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' A' ' 412' ' ' ARG . 0.7 OUTLIER -117.56 11.86 13.91 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.527 1.142 . . . . 44.11 108.3 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 412' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 411' ' ' CYS . 14.5 tpp85 38.53 46.14 0.94 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.517 1.136 . . . . 55.23 110.294 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 4.1 t -131.04 150.44 52.15 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.499 1.124 . . . . 61.1 108.297 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -58.07 152.76 15.99 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.489 1.118 . . . . 75.42 110.329 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.702 HD13 HD12 ' A' ' 385' ' ' ILE . 2.2 mt -107.2 154.81 8.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.457 1.098 . . . . 63.04 109.318 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -119.56 -41.44 2.7 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.478 1.111 . . . . 64.04 109.334 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 417' ' ' GLY . . . . . 0.477 ' C ' HG23 ' A' ' 418' ' ' THR . . . -119.0 127.73 7.35 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.506 1.129 . . . . 73.1 110.987 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 418' ' ' THR . . . . . 0.559 ' CG2' HG21 ' A' ' 415' ' ' ILE . 42.2 p -154.26 125.09 7.15 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.526 0.78 . . . . 64.03 110.356 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -155.4 151.97 23.68 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.484 1.115 . . . . 73.33 110.287 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.451 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.3 Cg_endo -74.99 100.32 1.35 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.501 1.79 . . . . 63.42 111.014 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.75 HD12 ' N ' ' A' ' 422' ' ' ILE . 1.0 OUTLIER -107.18 171.09 2.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 124.512 1.132 . . . . 71.51 109.296 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 422' ' ' ILE . . . . . 0.75 ' N ' HD12 ' A' ' 421' ' ' ILE . 6.2 mm -121.22 109.92 26.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 73.13 109.3 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.701 HG22 HD11 ' A' ' 421' ' ' ILE . 2.5 t -75.86 140.38 17.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 74.03 109.317 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.742 ' O ' HG23 ' A' ' 355' ' ' VAL . 44.9 m-20 -130.19 143.79 50.57 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.516 1.135 . . . . 72.11 109.282 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 164.97 32.28 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.439 1.757 . . . . 72.31 111.02 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 426' ' ' PHE . . . . . 0.557 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 19.3 t80 . . . . . 0 C--N 1.324 -0.506 0 O-C-N 124.503 1.127 . . . . 74.4 111.028 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 350' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 67.0 m . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.983 -0.377 . . . . 64.02 109.983 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 351' ' ' ASP . . . . . 0.55 ' HB2' HG22 ' A' ' 421' ' ' ILE . 1.3 m-20 -77.12 -177.95 4.77 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.541 1.151 . . . . 63.45 109.324 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -137.41 125.94 23.59 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 73.32 109.586 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 2.2 mm -118.04 111.88 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.51 1.131 . . . . 64.24 109.262 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.31 149.84 28.76 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.459 1.099 . . . . 75.12 109.3 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 424' ' ' ASP . 13.1 t -96.19 136.54 26.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.534 1.146 . . . . 50.14 109.315 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 11.6 p -95.21 143.16 26.84 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.514 1.134 . . . . 64.11 110.425 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 357' ' ' GLN . . . . . 0.508 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 12.0 mt-30 -42.4 -43.4 3.56 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.156 . . . . 52.52 110.3 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -46.8 -50.14 18.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.469 1.106 . . . . 74.14 110.245 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 359' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 362' ' ' LEU . 9.9 mm100 -60.09 -66.79 0.46 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.523 1.139 . . . . 74.32 110.285 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -38.25 -39.23 0.41 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 74.15 110.985 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -70.91 -47.38 59.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.494 1.121 . . . . 71.11 110.253 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.791 ' O ' HD23 ' A' ' 362' ' ' LEU . 4.9 tt . . . . . 0 C--N 1.326 -0.453 0 O-C-N 124.456 1.098 . . . . 73.45 109.293 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 108.308 -0.997 . . . . 72.02 108.308 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -66.68 -18.72 65.52 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.462 1.102 . . . . 72.13 110.338 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -126.58 8.6 7.02 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 74.44 110.959 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 42.74 54.61 4.95 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.538 1.149 . . . . 63.13 111.007 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 62.2 m -121.25 179.0 4.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.523 0.778 . . . . 72.32 110.008 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 2.3 p -124.81 131.38 53.45 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.489 1.118 . . . . 62.21 110.44 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.533 ' CD2' HG11 ' A' ' 423' ' ' VAL . 34.9 t80 -60.7 -65.1 0.74 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.472 1.108 . . . . 73.33 111.025 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 371' ' ' GLN . . . . . 0.436 HE22 ' HB3' ' A' ' 425' ' ' PRO . 0.7 OUTLIER -43.54 -26.93 0.25 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.522 1.138 . . . . 73.43 110.227 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.413 ' N ' ' C ' ' A' ' 370' ' ' PHE . 0.0 OUTLIER -71.65 123.28 22.17 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.505 1.128 . . . . 61.12 109.285 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 30.4 p -55.07 132.51 47.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.006 -0.997 . . . . 41.32 110.94 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.414 ' HZ1' ' HA ' ' A' ' 370' ' ' PHE . 29.8 mmtm -92.93 32.2 1.3 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.465 1.103 . . . . 72.13 109.284 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 5.5 mt -113.35 -60.46 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.543 1.152 . . . . 62.01 109.315 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 376' ' ' CYS . . . . . 0.823 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 0.9 OUTLIER -108.28 -20.87 12.99 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 75.34 108.294 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.407 ' HA ' HD22 ' A' ' 372' ' ' LEU . . . 55.3 41.12 31.55 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.503 1.127 . . . . 54.11 109.308 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -128.38 -44.71 1.39 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.436 1.085 . . . . 74.31 110.324 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -110.21 174.15 6.0 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 75.15 109.293 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -89.03 162.09 16.21 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.517 1.135 . . . . 70.34 109.323 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 392' ' ' MET . 21.9 mttt -65.21 -55.47 18.31 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.132 . . . . 70.23 109.292 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 382' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 381' ' ' LYS . 1.8 p30 50.62 25.58 2.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.462 1.101 . . . . 72.11 109.259 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.891 HG12 ' O ' ' A' ' 392' ' ' MET . 0.3 OUTLIER -154.08 174.76 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.478 1.111 . . . . 74.51 109.263 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 21.1 tttm -158.67 155.77 28.75 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.464 1.102 . . . . 74.31 109.326 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.864 HG22 ' SG ' ' A' ' 388' ' ' CYS . 11.6 mm -121.69 143.78 33.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 73.13 109.314 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.542 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 5.3 mt-10 -137.6 162.49 54.44 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.443 1.089 . . . . 74.14 110.287 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.542 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.99 -12.29 23.98 Favored 'Cis proline' 0 C--N 1.361 1.211 0 C-N-CA 120.977 -2.51 . . . . 73.33 111.017 -0.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 388' ' ' CYS . . . . . 0.864 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.48 -71.81 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.953 -1.021 . . . . 74.41 110.927 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 389' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 115.73 18.58 6.0 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.533 1.145 . . . . 74.4 111.028 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.584 ' CE1' ' HB2' ' A' ' 388' ' ' CYS . 20.6 m80 -76.56 145.52 38.96 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.524 0.779 . . . . 72.2 109.58 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.809 HD22 ' N ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -117.3 155.47 29.47 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.477 1.11 . . . . 55.01 109.273 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.891 ' O ' HG12 ' A' ' 383' ' ' VAL . 18.7 ptp -172.14 172.85 4.48 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 72.41 111.016 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 4.5 p -91.69 115.3 27.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.444 1.09 . . . . 73.44 108.295 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 397' ' ' LEU . 27.3 m -47.83 -57.54 5.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.514 1.134 . . . . 62.23 110.401 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.9 t -45.56 -26.11 0.55 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.534 1.146 . . . . 71.44 109.976 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 396' ' ' CYS . . . . . 0.823 ' SG ' ' SG ' ' A' ' 376' ' ' CYS . 2.2 m -88.01 -41.33 13.19 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.533 1.146 . . . . 54.44 108.288 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 397' ' ' LEU . . . . . 0.743 ' O ' HD23 ' A' ' 397' ' ' LEU . 3.4 tt -51.61 -45.79 63.35 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.458 1.098 . . . . 74.3 109.306 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.54 -35.91 61.23 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.551 1.157 . . . . 71.04 110.428 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 399' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -62.05 -27.87 69.19 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.467 1.105 . . . . 72.11 109.325 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 400' ' ' TRP . . . . . 0.579 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 5.1 t-105 -79.38 -52.42 8.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.026 -1.101 . . . . 74.25 108.026 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.514 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 10.0 mm-40 -62.99 -9.78 11.28 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 1.106 . . . . 65.45 110.291 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 401' ' ' GLN . 9.8 mm-40 -37.05 -63.78 0.4 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.44 1.088 . . . . 54.42 110.298 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 6.6 t -123.61 -24.8 4.46 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.481 1.113 . . . . 74.41 109.972 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 404' ' ' ASP . . . . . 0.579 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 0.9 OUTLIER -81.61 -90.18 0.07 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.456 1.098 . . . . 74.04 109.295 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.514 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 67.51 32.65 79.4 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.493 1.121 . . . . 70.32 111.037 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -91.74 66.93 5.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 0.772 . . . . 65.42 110.331 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 70.04 -161.21 53.16 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.497 1.123 . . . . 33.4 111.041 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 408' ' ' CYS . . . . . 0.688 ' SG ' HG21 ' A' ' 385' ' ' ILE . 7.1 t -62.45 130.68 93.52 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.314 -0.995 . . . . 64.12 108.314 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.94 -1.77 11.64 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.504 1.792 . . . . 61.45 111.003 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 410' ' ' PHE . . . . . 0.479 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 3.2 m-85 -95.63 -41.32 8.96 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.529 1.143 . . . . 72.34 110.982 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 411' ' ' CYS . . . . . 0.485 ' HG ' ' CE1' ' A' ' 390' ' ' HIS . 0.1 OUTLIER -111.08 8.59 21.86 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 75.23 108.277 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 412' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 408' ' ' CYS . 5.7 tpt85 38.39 30.71 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.488 1.117 . . . . 72.45 110.318 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 413' ' ' CYS . . . . . 0.441 ' N ' ' O ' ' A' ' 411' ' ' CYS . 42.1 t -127.77 151.1 49.44 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.512 1.133 . . . . 75.0 108.326 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -49.81 151.1 1.9 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.46 1.1 . . . . 75.15 110.292 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.699 HG21 ' CG2' ' A' ' 418' ' ' THR . 1.9 mt -99.38 150.43 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.484 1.115 . . . . 73.33 109.355 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.459 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 15.2 mmtt -110.51 -45.37 3.54 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.515 1.134 . . . . 64.42 109.299 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 417' ' ' GLY . . . . . 0.448 ' C ' HG23 ' A' ' 418' ' ' THR . . . -129.07 135.0 8.22 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.498 1.124 . . . . 53.24 110.987 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 418' ' ' THR . . . . . 0.699 ' CG2' HG21 ' A' ' 415' ' ' ILE . 80.9 p -152.47 130.53 11.85 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.534 0.785 . . . . 73.44 110.421 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -158.26 153.36 21.6 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.534 1.146 . . . . 65.14 110.263 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.44 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.2 Cg_endo -75.01 102.64 1.61 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.498 1.788 . . . . 73.1 110.977 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.68 HD12 ' N ' ' A' ' 422' ' ' ILE . 1.0 OUTLIER -103.85 167.73 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.47 1.106 . . . . 73.55 109.304 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 422' ' ' ILE . . . . . 0.68 ' N ' HD12 ' A' ' 421' ' ' ILE . 6.0 mm -118.9 109.65 27.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.453 1.096 . . . . 75.42 109.277 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.664 HG22 HD11 ' A' ' 421' ' ' ILE . 23.7 t -79.74 144.35 10.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.495 1.122 . . . . 75.13 109.261 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.749 ' O ' HG23 ' A' ' 355' ' ' VAL . 4.1 m-20 -131.4 143.5 49.5 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.437 1.086 . . . . 71.44 109.299 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 425' ' ' PRO . . . . . 0.436 ' HB3' HE22 ' A' ' 371' ' ' GLN . 18.3 Cg_endo -75.01 160.47 40.09 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.467 1.772 . . . . 71.4 111.005 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 426' ' ' PHE . . . . . 0.508 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 3.3 t80 . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.494 1.121 . . . . 73.3 111.013 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 44.6 m . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 109.973 -0.381 . . . . 75.23 109.973 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 351' ' ' ASP . . . . . 0.551 ' HB2' HG22 ' A' ' 421' ' ' ILE . 13.3 m-20 -88.77 162.7 16.08 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.522 1.139 . . . . 71.1 109.295 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 352' ' ' HIS . . . . . 0.426 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 14.2 m-70 -126.18 138.64 53.67 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.488 1.117 . . . . 75.44 109.579 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 21.9 mt -121.72 137.1 56.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.47 1.106 . . . . 74.32 109.298 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -107.93 123.55 48.79 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.513 1.133 . . . . 71.42 109.345 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 424' ' ' ASP . 4.4 t -72.42 156.6 6.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.456 1.097 . . . . 72.03 109.29 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 359' ' ' GLN . 2.8 p -124.04 145.29 49.32 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.527 1.142 . . . . 62.05 110.414 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 357' ' ' GLN . . . . . 0.518 ' HG2' ' CE2' ' A' ' 426' ' ' PHE . 10.7 mt-30 -40.86 -46.75 2.81 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.47 1.106 . . . . 72.11 110.305 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -50.16 -45.07 53.03 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 1.139 . . . . 64.41 110.299 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 359' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 356' ' ' THR . 70.4 mt-30 -64.28 -66.55 0.53 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.521 1.138 . . . . 75.35 110.309 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 360' ' ' TYR . . . . . 0.421 ' O ' ' N ' ' A' ' 364' ' ' CYS . 2.4 t80 -41.47 -39.12 1.43 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.562 1.164 . . . . 73.42 110.987 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -66.67 -54.11 26.66 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.522 1.139 . . . . 72.31 110.278 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.8 tp . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.562 1.163 . . . . 72.54 109.281 179.98 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 364' ' ' CYS . . . . . 0.421 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 108.293 -1.002 . . . . 71.12 108.293 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.84 -2.73 44.78 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 64.22 110.28 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 8.1 mmt -105.88 -34.91 7.49 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.518 1.137 . . . . 72.3 111.026 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 100.79 16.88 24.98 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.461 1.101 . . . . 54.45 110.998 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 7.0 m -142.84 172.57 12.52 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.521 0.777 . . . . 54.23 110.019 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 11.6 p -98.9 -175.19 2.97 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.532 1.145 . . . . 55.13 110.411 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.533 ' CD2' HG11 ' A' ' 423' ' ' VAL . 27.6 t80 -83.55 -67.18 0.81 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.539 1.149 . . . . 70.01 111.02 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 371' ' ' GLN . . . . . 0.547 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -39.41 -29.76 0.05 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.499 1.125 . . . . 61.25 110.275 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.427 ' N ' ' C ' ' A' ' 370' ' ' PHE . 0.0 OUTLIER -69.97 115.43 9.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.508 1.13 . . . . 70.41 109.322 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 25.3 p -47.48 149.82 1.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.99 -1.005 . . . . 73.34 110.9 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -106.08 24.14 12.9 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 70.43 109.307 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 375' ' ' ILE . . . . . 0.499 HD11 ' HE1' ' A' ' 410' ' ' PHE . 14.6 mt -100.73 -61.13 2.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 72.1 109.271 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 26.9 p -107.92 -22.41 12.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 65.35 108.274 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 61.89 41.39 11.53 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.109 . . . . 71.24 109.294 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -134.64 -45.93 0.74 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.481 1.113 . . . . 75.33 110.249 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -101.41 168.28 9.62 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.538 1.149 . . . . 72.23 109.314 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.82 157.27 17.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.564 1.165 . . . . 72.14 109.296 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 392' ' ' MET . 0.7 OUTLIER -70.22 -62.1 1.52 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.442 1.089 . . . . 72.33 109.311 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 382' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 421' ' ' ILE . 1.3 p30 51.86 21.85 1.57 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.509 1.131 . . . . 74.45 109.306 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.869 HG12 ' O ' ' A' ' 392' ' ' MET . 0.3 OUTLIER -152.75 154.69 7.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.122 . . . . 72.3 109.24 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -141.73 153.72 44.81 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 65.33 109.292 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.887 HG22 ' SG ' ' A' ' 388' ' ' CYS . 22.8 mm -113.85 138.71 42.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.514 1.134 . . . . 72.0 109.275 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.571 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 1.8 mt-10 -129.73 163.32 47.76 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.472 1.108 . . . . 63.31 110.278 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.571 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.98 -18.56 18.59 Favored 'Cis proline' 0 C--N 1.36 1.158 0 C-N-CA 120.975 -2.51 . . . . 53.25 111.022 -0.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 388' ' ' CYS . . . . . 0.887 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -35.61 -91.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.991 -1.004 . . . . 64.03 110.899 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 136.22 44.24 0.1 OUTLIER Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.499 1.124 . . . . 73.21 110.995 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 19.6 m170 -104.37 114.12 28.14 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.461 0.742 . . . . 64.55 109.648 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 391' ' ' LEU . 5.9 mp -84.72 169.73 13.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.123 . . . . 73.45 109.311 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.869 ' O ' HG12 ' A' ' 383' ' ' VAL . 17.2 ptp -179.76 165.6 1.3 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.54 1.15 . . . . 65.14 111.01 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 393' ' ' CYS . . . . . 1.239 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 4.8 p -90.78 115.43 27.84 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.493 1.121 . . . . 64.5 108.301 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 20.7 m -38.72 -59.45 0.94 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.46 1.1 . . . . 53.44 110.4 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 6.7 m -42.24 -41.97 2.91 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.533 1.146 . . . . 72.1 109.983 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 396' ' ' CYS . . . . . 1.239 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 3.6 m -68.86 -56.68 7.17 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.463 1.102 . . . . 75.45 108.34 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 397' ' ' LEU . . . . . 0.716 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -40.95 -36.02 0.6 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.503 1.127 . . . . 73.13 109.283 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 22.7 m -62.61 -49.44 75.21 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 72.14 110.394 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 399' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -54.33 -22.45 12.15 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.475 1.109 . . . . 35.0 109.313 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 400' ' ' TRP . . . . . 0.606 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 11.8 t-105 -85.44 -64.9 1.08 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.483 1.115 . . . . 73.31 108.01 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.502 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 12.5 mm-40 -52.34 -17.5 1.19 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.478 1.111 . . . . 63.21 110.312 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 401' ' ' GLN . 7.5 mt-10 -37.02 -63.31 0.43 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.481 1.113 . . . . 74.32 110.332 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 10.3 t -121.65 -24.5 5.3 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.5 1.125 . . . . 63.15 110.006 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 404' ' ' ASP . . . . . 0.606 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 19.5 m-20 -82.34 -93.78 0.06 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.501 1.125 . . . . 75.45 109.293 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.502 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 68.1 27.63 73.63 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.477 1.11 . . . . 53.12 111.03 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -88.68 67.04 8.3 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.539 0.788 . . . . 64.3 110.263 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 67.87 -162.7 48.17 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.537 1.148 . . . . 73.0 110.993 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 408' ' ' CYS . . . . . 0.67 ' SG ' HG21 ' A' ' 385' ' ' ILE . 5.6 t -59.11 125.76 79.42 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 108.324 -0.991 . . . . 63.51 108.324 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.403 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.3 Cg_endo -74.97 -0.28 9.76 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.48 1.779 . . . . 62.04 111.012 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 410' ' ' PHE . . . . . 0.544 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 5.4 m-85 -95.85 -41.64 8.72 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.48 1.112 . . . . 70.33 110.996 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 411' ' ' CYS . . . . . 0.481 ' HG ' ' CE1' ' A' ' 390' ' ' HIS . 0.4 OUTLIER -112.8 10.43 19.16 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.525 1.14 . . . . 75.33 108.333 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 412' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 411' ' ' CYS . 27.5 mmm-85 38.5 31.75 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.448 1.092 . . . . 75.51 110.291 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 413' ' ' CYS . . . . . 0.42 ' N ' ' O ' ' A' ' 411' ' ' CYS . 10.5 t -125.09 146.36 49.49 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.419 1.074 . . . . 65.33 108.289 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -46.42 155.74 0.21 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.533 1.146 . . . . 75.4 110.351 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.705 HG23 HG23 ' A' ' 385' ' ' ILE . 2.3 mt -102.44 156.91 4.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.449 1.093 . . . . 75.43 109.313 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.409 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 10.3 mmtt -120.28 -43.48 2.52 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.471 1.107 . . . . 70.15 109.297 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 417' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 418' ' ' THR . . . -126.78 140.54 12.02 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.486 1.116 . . . . 63.02 111.001 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 418' ' ' THR . . . . . 0.595 ' CG2' HG21 ' A' ' 415' ' ' ILE . 17.3 p -157.53 116.7 3.28 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.46 0.741 . . . . 61.44 110.407 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.423 ' OE1' ' N ' ' A' ' 419' ' ' GLU . 23.3 pm0 -139.82 150.5 62.97 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.537 1.148 . . . . 72.43 110.313 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.99 102.34 1.58 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.504 1.791 . . . . 73.41 111.005 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.845 HD12 ' N ' ' A' ' 422' ' ' ILE . 1.3 pp -103.85 -178.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.535 1.147 . . . . 65.51 109.258 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 422' ' ' ILE . . . . . 0.845 ' N ' HD12 ' A' ' 421' ' ' ILE . 15.2 mt -144.64 115.49 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 64.2 109.305 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.533 HG11 ' CD2' ' A' ' 370' ' ' PHE . 38.9 t -86.45 144.89 8.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.51 1.131 . . . . 73.5 109.326 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.642 ' O ' HG23 ' A' ' 355' ' ' VAL . 5.1 t70 -131.31 143.64 50.14 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.456 1.098 . . . . 74.12 109.345 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 425' ' ' PRO . . . . . 0.415 ' CD ' ' OE1' ' A' ' 371' ' ' GLN . 18.2 Cg_endo -75.04 170.67 19.91 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.475 1.776 . . . . 61.11 110.963 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 426' ' ' PHE . . . . . 0.518 ' CE2' ' HG2' ' A' ' 357' ' ' GLN . 6.5 t80 . . . . . 0 C--N 1.325 -0.468 0 O-C-N 124.503 1.127 . . . . 72.22 111.013 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 110.061 -0.348 . . . . 61.12 110.061 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -96.59 179.63 4.93 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.5 1.125 . . . . 73.32 109.292 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 352' ' ' HIS . . . . . 0.489 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 29.1 m-70 -134.2 135.44 43.03 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.48 1.113 . . . . 54.45 109.587 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 353' ' ' ILE . . . . . 0.504 HG13 HD13 ' A' ' 421' ' ' ILE . 11.2 mt -116.21 149.14 18.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 75.24 109.262 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.79 137.29 52.84 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 71.22 109.326 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.487 HG22 ' CD2' ' A' ' 370' ' ' PHE . 5.0 t -89.03 141.62 14.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.472 1.107 . . . . 75.12 109.31 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.414 ' OG1' ' CG ' ' A' ' 359' ' ' GLN . 16.6 p -91.55 135.98 33.46 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.486 1.117 . . . . 70.31 110.371 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 357' ' ' GLN . . . . . 0.696 ' CG ' ' CE1' ' A' ' 426' ' ' PHE . 4.4 mt-30 -41.13 -33.15 0.32 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.523 1.139 . . . . 75.11 110.311 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 358' ' ' GLU . . . . . 0.449 ' CG ' ' N ' ' A' ' 359' ' ' GLN . 13.5 pt-20 -63.56 -50.41 69.59 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.515 1.134 . . . . 72.1 110.324 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 359' ' ' GLN . . . . . 0.449 ' N ' ' CG ' ' A' ' 358' ' ' GLU . 9.4 mm100 -56.57 -66.72 0.39 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.453 1.096 . . . . 72.21 110.329 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 360' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 364' ' ' CYS . 10.1 t80 -38.37 -51.94 1.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.522 1.139 . . . . 73.41 110.961 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -58.28 -60.96 2.95 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.493 1.121 . . . . 65.44 110.275 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 6.0 mt . . . . . 0 C--N 1.324 -0.514 0 O-C-N 124.514 1.134 . . . . 72.34 109.271 179.99 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 364' ' ' CYS . . . . . 0.404 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.5 m . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 108.275 -1.009 . . . . 72.31 108.275 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -73.54 -3.74 29.66 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.511 1.132 . . . . 74.11 110.297 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 8.0 mmt -114.38 -33.5 5.59 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.527 1.142 . . . . 63.35 110.995 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.14 35.52 3.14 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.499 1.125 . . . . 62.03 110.994 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 24.0 m -148.76 161.16 42.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 0.771 . . . . 74.42 109.965 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.4 ' OG1' ' CB ' ' A' ' 372' ' ' LEU . 11.5 p -96.48 178.93 5.18 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.506 1.129 . . . . 64.24 110.364 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.487 ' CD2' HG22 ' A' ' 355' ' ' VAL . 50.1 t80 -85.03 -58.91 2.5 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 70.34 110.992 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 371' ' ' GLN . . . . . 0.449 ' CB ' ' HB ' ' A' ' 423' ' ' VAL . 0.1 OUTLIER -54.66 -19.37 5.99 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.49 1.119 . . . . 70.33 110.254 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.797 HD22 ' N ' ' A' ' 373' ' ' CYS . 1.2 tm? -73.15 135.5 44.69 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.503 1.127 . . . . 71.21 109.307 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 373' ' ' CYS . . . . . 0.797 ' N ' HD22 ' A' ' 372' ' ' LEU . 7.6 t -72.2 132.37 44.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.987 -1.006 . . . . 72.51 110.901 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.439 ' NZ ' ' O ' ' A' ' 372' ' ' LEU . 12.5 mmtm -90.19 17.12 7.41 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.51 1.131 . . . . 52.45 109.289 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 375' ' ' ILE . . . . . 0.888 HD11 ' CE1' ' A' ' 410' ' ' PHE . 83.0 mt -102.45 -41.62 7.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.505 1.128 . . . . 71.25 109.328 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 376' ' ' CYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 377' ' ' ALA . 0.0 OUTLIER -115.6 -44.49 2.96 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.534 1.146 . . . . 64.31 108.317 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.762 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 70.23 37.96 1.54 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.477 1.111 . . . . 63.03 109.299 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -131.63 -44.48 0.99 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.483 1.114 . . . . 72.44 110.311 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -107.38 172.79 6.63 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.453 1.096 . . . . 42.25 109.34 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -95.52 147.58 23.4 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.512 1.132 . . . . 73.31 109.274 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.465 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 27.4 mttt -55.41 -62.53 1.62 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 72.33 109.3 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 57.89 28.25 15.81 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 63.43 109.284 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.897 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -158.38 175.83 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.515 1.134 . . . . 61.5 109.293 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.456 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 72.6 tttt -157.83 149.34 21.62 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.502 1.126 . . . . 65.41 109.314 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.691 HG13 ' HE3' ' A' ' 392' ' ' MET . 2.6 mm -114.13 138.16 44.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.115 . . . . 75.34 109.328 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.513 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.2 OUTLIER -138.04 160.86 62.68 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.544 1.153 . . . . 74.34 110.303 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.513 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.98 -8.91 23.79 Favored 'Cis proline' 0 C--N 1.36 1.163 0 C-N-CA 120.979 -2.509 . . . . 72.11 111.012 -0.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 388' ' ' CYS . . . . . 0.539 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 17.5 t -36.84 -75.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.956 -1.02 . . . . 62.11 110.912 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 389' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 120.62 7.41 8.9 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.532 1.145 . . . . 72.21 111.015 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.539 ' CG ' ' SG ' ' A' ' 388' ' ' CYS . 56.6 m170 -77.0 131.78 38.63 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.524 0.779 . . . . 74.21 109.612 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.615 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -102.48 168.09 9.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.447 1.092 . . . . 72.15 109.317 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.897 ' O ' HG12 ' A' ' 383' ' ' VAL . 17.3 ptp -179.25 173.84 1.09 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.51 1.131 . . . . 74.42 111.006 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 393' ' ' CYS . . . . . 0.418 ' O ' ' N ' ' A' ' 396' ' ' CYS . 1.7 p -102.66 117.69 35.21 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 63.45 108.281 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 397' ' ' LEU . 2.5 m -38.7 -60.11 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.484 1.115 . . . . 70.53 110.441 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.8 m -39.3 -41.64 0.93 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.505 1.128 . . . . 44.15 110.042 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' CYS . . . . . 0.495 ' SG ' HG21 ' A' ' 375' ' ' ILE . 38.3 t -73.9 -49.85 22.94 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.471 1.107 . . . . 44.12 108.284 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 397' ' ' LEU . . . . . 0.436 ' CD1' ' HG3' ' A' ' 401' ' ' GLN . 1.5 tm? -42.61 -51.03 5.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.469 1.106 . . . . 73.01 109.328 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 398' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 402' ' ' GLU . 1.2 m -53.89 -42.05 68.25 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.509 1.131 . . . . 52.43 110.411 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 399' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -57.98 -26.59 62.53 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.505 1.128 . . . . 63.22 109.276 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 400' ' ' TRP . . . . . 0.601 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 10.5 t-105 -85.42 -62.58 1.5 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.52 1.137 . . . . 72.35 108.023 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.501 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 8.3 mm-40 -55.94 -14.37 2.46 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 1.122 . . . . 72.54 110.284 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 398' ' ' THR . 2.9 mm-40 -37.12 -63.36 0.44 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 71.13 110.32 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 22.7 t -121.4 -24.59 5.38 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.508 1.13 . . . . 42.42 109.995 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 404' ' ' ASP . . . . . 0.601 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 6.9 m-20 -82.51 -94.05 0.06 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.475 1.109 . . . . 53.31 109.326 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.501 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 72.42 31.04 63.73 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.475 1.109 . . . . 50.22 110.993 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -88.65 54.13 2.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 0.765 . . . . 74.4 110.272 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 72.02 -163.88 54.39 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.541 1.151 . . . . 33.11 111.024 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 408' ' ' CYS . . . . . 0.455 ' O ' ' N ' ' A' ' 412' ' ' ARG . 3.7 t -56.05 121.3 40.23 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.31 -0.996 . . . . 63.44 108.31 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 0.69 8.62 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.492 1.785 . . . . 71.31 110.998 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 410' ' ' PHE . . . . . 0.888 ' CE1' HD11 ' A' ' 375' ' ' ILE . 24.3 m-85 -90.24 -36.34 14.79 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.518 1.136 . . . . 72.2 111.046 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 411' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.13 13.69 6.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 73.4 108.31 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 412' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 408' ' ' CYS . 14.8 tpp85 38.61 48.82 1.34 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.541 1.151 . . . . 73.02 110.347 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 1.2 m -125.89 150.92 47.55 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.468 1.105 . . . . 51.43 108.281 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 414' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 415' ' ' ILE . 5.1 tt0 -59.29 147.62 35.15 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.486 1.117 . . . . 71.01 110.271 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.605 HG21 HG21 ' A' ' 418' ' ' THR . 1.2 mt -89.04 149.11 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.484 1.115 . . . . 62.02 109.283 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.74 -49.82 2.63 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 74.22 109.324 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -140.58 131.89 5.2 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 124.498 1.124 . . . . 74.13 110.993 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 418' ' ' THR . . . . . 0.605 HG21 HG21 ' A' ' 415' ' ' ILE . 1.5 p -147.56 117.89 7.38 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.571 0.807 . . . . 64.12 110.434 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.433 ' O ' HG23 ' A' ' 421' ' ' ILE . 20.5 pt-20 -128.08 150.83 74.85 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.459 1.099 . . . . 70.21 110.309 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 98.51 1.17 Allowed 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.467 1.772 . . . . 65.41 110.994 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.817 HD11 HG22 ' A' ' 423' ' ' VAL . 0.7 OUTLIER -107.45 154.88 8.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.5 1.125 . . . . 71.23 109.292 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 422' ' ' ILE . . . . . 0.489 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 4.0 mp -110.67 105.39 18.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.502 1.126 . . . . 74.33 109.306 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.817 HG22 HD11 ' A' ' 421' ' ' ILE . 38.9 t -77.1 145.62 9.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.488 1.118 . . . . 74.5 109.294 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.445 ' O ' HG23 ' A' ' 355' ' ' VAL . 4.5 m-20 -130.54 143.53 49.67 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.491 1.119 . . . . 75.53 109.283 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 161.63 38.46 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.516 1.798 . . . . 62.4 110.997 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 426' ' ' PHE . . . . . 0.696 ' CE1' ' CG ' ' A' ' 357' ' ' GLN . 3.5 t80 . . . . . 0 C--N 1.326 -0.453 0 O-C-N 124.509 1.131 . . . . 73.14 111.004 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 109.964 -0.384 . . . . 70.02 109.964 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -99.67 169.24 9.41 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.511 1.132 . . . . 63.22 109.259 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 352' ' ' HIS . . . . . 0.506 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 38.4 m-70 -136.3 125.15 24.05 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 72.22 109.629 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 353' ' ' ILE . . . . . 0.552 HG13 HD13 ' A' ' 421' ' ' ILE . 7.7 mt -105.47 149.76 8.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.521 1.138 . . . . 64.34 109.322 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 13.0 tptp -123.27 123.32 40.49 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.458 1.099 . . . . 73.33 109.3 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 424' ' ' ASP . 55.2 t -79.71 148.87 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.487 1.117 . . . . 74.01 109.298 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 40.2 p -114.2 -178.47 3.38 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.493 1.121 . . . . 74.35 110.385 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 357' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -72.81 -36.7 67.59 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 54.34 110.336 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -54.94 -35.33 64.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.537 1.148 . . . . 75.23 110.322 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -79.6 -66.73 0.83 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 1.135 . . . . 75.15 110.306 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 360' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 364' ' ' CYS . 12.3 t80 -38.2 -43.23 0.75 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.499 1.124 . . . . 64.01 111.004 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -61.48 -54.15 47.17 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.464 1.103 . . . . 75.35 110.266 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.4 tt . . . . . 0 C--N 1.325 -0.466 0 O-C-N 124.485 1.116 . . . . 70.13 109.267 -179.952 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 364' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 360' ' ' TYR . 3.3 m . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 108.255 -1.017 . . . . 61.33 108.255 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -71.79 -16.09 62.17 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.535 1.147 . . . . 64.41 110.29 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.94 2.6 6.59 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.461 1.101 . . . . 74.14 110.973 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 50.79 58.69 8.92 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.522 1.139 . . . . 72.34 111.019 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 84.5 p -129.36 177.99 6.78 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 0.757 . . . . 54.35 109.969 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 2.3 p -126.03 142.11 51.67 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.479 1.112 . . . . 64.01 110.388 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.615 ' CZ ' ' CD1' ' A' ' 391' ' ' LEU . 54.1 t80 -66.22 -67.96 0.41 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.485 1.116 . . . . 73.33 111.056 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 371' ' ' GLN . . . . . 0.514 HE22 ' HB3' ' A' ' 425' ' ' PRO . 1.0 OUTLIER -41.32 -31.8 0.26 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.453 1.096 . . . . 70.3 110.295 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.921 HD22 ' N ' ' A' ' 373' ' ' CYS . 0.5 OUTLIER -67.07 136.39 55.13 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.436 1.085 . . . . 64.42 109.293 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 373' ' ' CYS . . . . . 0.921 ' N ' HD22 ' A' ' 372' ' ' LEU . 19.3 p -72.17 129.61 38.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.004 -0.998 . . . . 70.02 110.925 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -90.99 18.35 6.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.453 1.096 . . . . 73.1 109.334 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 375' ' ' ILE . . . . . 0.696 HD11 ' HE1' ' A' ' 410' ' ' PHE . 12.1 mt -92.13 -60.45 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.485 1.116 . . . . 73.14 109.282 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 23.9 p -107.68 -24.04 11.88 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.472 1.108 . . . . 63.21 108.284 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.489 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 60.93 43.24 11.91 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.462 1.102 . . . . 45.1 109.315 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -127.75 -43.65 1.54 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.522 1.139 . . . . 73.24 110.307 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 39.0 m-20 -119.7 177.7 4.85 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.452 1.095 . . . . 74.13 109.349 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -88.3 169.41 11.86 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 73.51 109.303 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.426 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 24.5 mttt -70.55 -62.07 1.53 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.499 1.124 . . . . 63.12 109.312 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 59.92 25.05 14.17 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 63.23 109.301 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.842 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -160.8 155.34 3.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 54.23 109.293 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.854 ' HE3' HD21 ' A' ' 391' ' ' LEU . 4.1 ttmt -139.29 137.32 35.75 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.516 1.135 . . . . 65.51 109.274 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.718 HG23 ' CG2' ' A' ' 415' ' ' ILE . 20.2 mm -97.99 139.57 19.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.523 1.139 . . . . 74.25 109.284 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.524 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.0 OUTLIER -138.0 161.39 60.0 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.46 1.1 . . . . 72.04 110.28 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.524 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.0 -8.94 23.86 Favored 'Cis proline' 0 C--N 1.36 1.147 0 C-N-CA 121.021 -2.491 . . . . 74.24 111.017 -0.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 388' ' ' CYS . . . . . 0.544 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 31.3 t -36.55 -72.89 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.951 -1.022 . . . . 70.14 110.926 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 389' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 115.58 18.28 6.19 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.485 1.115 . . . . 75.01 111.004 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.544 ' CG ' ' SG ' ' A' ' 388' ' ' CYS . 61.7 m170 -87.77 129.3 35.22 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.518 0.775 . . . . 65.13 109.546 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.854 HD21 ' HE3' ' A' ' 384' ' ' LYS . 0.8 OUTLIER -96.1 160.31 14.51 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.459 1.099 . . . . 72.11 109.262 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.842 ' O ' HG12 ' A' ' 383' ' ' VAL . 15.5 ptp -170.52 173.44 5.53 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.477 1.111 . . . . 73.33 111.019 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 393' ' ' CYS . . . . . 1.131 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 5.0 p -99.15 115.0 28.04 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.483 1.115 . . . . 74.52 108.333 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 17.4 m -42.0 -59.7 1.65 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.496 1.123 . . . . 75.31 110.425 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 10.6 t -41.62 -36.58 0.97 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.478 1.111 . . . . 63.35 109.985 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 396' ' ' CYS . . . . . 1.131 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 2.3 m -75.88 -54.93 6.14 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.467 1.105 . . . . 60.23 108.281 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 397' ' ' LEU . . . . . 0.734 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.3 OUTLIER -41.34 -35.19 0.61 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.128 . . . . 75.21 109.28 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 398' ' ' THR . . . . . 0.414 ' N ' HD13 ' A' ' 397' ' ' LEU . 83.2 m -62.05 -49.76 74.7 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.512 1.133 . . . . 53.24 110.431 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 399' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -55.16 -22.16 16.13 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.473 1.108 . . . . 72.43 109.349 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 400' ' ' TRP . . . . . 0.602 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 16.3 t-105 -84.6 -65.16 1.04 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.516 1.135 . . . . 64.45 108.048 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.51 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 38.3 mm-40 -49.18 -20.81 0.65 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.544 1.152 . . . . 51.2 110.304 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 401' ' ' GLN . 10.4 mt-10 -37.47 -63.53 0.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.479 1.112 . . . . 75.44 110.345 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 3.3 m -122.41 -24.22 5.05 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.497 1.123 . . . . 71.13 109.97 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 404' ' ' ASP . . . . . 0.602 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 16.9 m-20 -83.54 -95.17 0.06 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.51 1.131 . . . . 74.44 109.253 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.51 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 67.92 23.22 74.29 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.479 1.112 . . . . 61.22 111.01 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -81.51 58.11 3.56 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.556 0.797 . . . . 75.23 110.326 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 69.95 -160.74 53.18 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.503 1.127 . . . . 70.45 111.023 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 408' ' ' CYS . . . . . 0.616 ' SG ' HG21 ' A' ' 385' ' ' ILE . 4.7 t -56.3 120.3 34.23 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.267 -1.012 . . . . 64.54 108.267 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.412 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.2 Cg_endo -74.95 0.43 8.89 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.454 1.765 . . . . 74.33 110.978 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 410' ' ' PHE . . . . . 0.696 ' HE1' HD11 ' A' ' 375' ' ' ILE . 3.6 m-30 -93.8 -37.23 11.88 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.485 1.116 . . . . 74.03 111.0 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 411' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -123.26 13.49 9.61 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.49 1.119 . . . . 64.45 108.321 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 412' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 408' ' ' CYS . 11.4 mmt85 38.43 40.45 0.37 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 74.54 110.285 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 16.0 t -126.66 140.1 52.66 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.49 1.119 . . . . 73.43 108.301 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -45.32 154.25 0.18 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.467 1.104 . . . . 54.33 110.228 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.718 ' CG2' HG23 ' A' ' 385' ' ' ILE . 2.7 mt -109.8 157.19 10.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.48 1.113 . . . . 61.43 109.327 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -129.9 -46.6 1.14 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.492 1.12 . . . . 73.52 109.259 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 417' ' ' GLY . . . . . 0.555 ' O ' HG23 ' A' ' 418' ' ' THR . . . -107.22 127.14 8.68 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.53 1.144 . . . . 45.14 110.964 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 418' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 417' ' ' GLY . 17.5 p -157.47 128.65 6.73 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 0.76 . . . . 71.54 110.395 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.644 ' OE2' HG22 ' A' ' 421' ' ' ILE . 0.0 OUTLIER -160.02 166.39 15.96 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.466 1.104 . . . . 73.11 110.283 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 101.85 1.52 Allowed 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.541 1.811 . . . . 71.3 110.984 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.913 HD12 ' N ' ' A' ' 422' ' ' ILE . 0.6 OUTLIER -103.89 170.18 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.146 . . . . 73.44 109.313 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 422' ' ' ILE . . . . . 0.913 ' N ' HD12 ' A' ' 421' ' ' ILE . 5.9 mt -137.8 107.63 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.448 1.093 . . . . 71.32 109.284 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.652 ' CG2' HD11 ' A' ' 421' ' ' ILE . 30.7 t -78.16 147.42 7.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.436 1.085 . . . . 70.34 109.264 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.678 ' O ' HG23 ' A' ' 355' ' ' VAL . 5.9 m-20 -129.68 143.72 50.09 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.478 1.112 . . . . 61.12 109.292 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 425' ' ' PRO . . . . . 0.514 ' HB3' HE22 ' A' ' 371' ' ' GLN . 18.3 Cg_endo -75.05 173.42 14.55 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.489 1.784 . . . . 74.4 111.007 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 15.5 t80 . . . . . 0 C--N 1.324 -0.503 0 O-C-N 124.556 1.16 . . . . 74.22 111.023 179.994 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 350' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 64.5 m . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 110.007 -0.368 . . . . 61.23 110.007 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 351' ' ' ASP . . . . . 0.485 ' CG ' HG22 ' A' ' 421' ' ' ILE . 0.3 OUTLIER -79.91 168.41 19.27 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.502 1.126 . . . . 63.13 109.312 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 352' ' ' HIS . . . . . 0.519 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 26.3 m-70 -132.94 135.85 45.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 64.2 109.578 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 3.3 mm -113.78 153.34 15.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.545 1.153 . . . . 62.03 109.308 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.413 ' CD ' ' O ' ' A' ' 355' ' ' VAL . 0.8 OUTLIER -114.31 136.24 53.19 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.471 1.107 . . . . 74.33 109.298 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 424' ' ' ASP . 5.7 t -98.77 163.74 2.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.539 1.149 . . . . 43.13 109.342 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.494 ' N ' ' CG1' ' A' ' 355' ' ' VAL . 2.4 p -125.63 179.68 5.04 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.536 1.147 . . . . 64.53 110.438 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 357' ' ' GLN . . . . . 0.564 ' HG3' ' CZ ' ' A' ' 426' ' ' PHE . 13.0 mt-30 -75.38 -37.54 60.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.545 1.153 . . . . 71.31 110.281 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -60.88 -31.19 70.66 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.502 1.126 . . . . 65.31 110.305 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 359' ' ' GLN . . . . . 0.438 ' NE2' ' OG1' ' A' ' 356' ' ' THR . 62.3 mt-30 -74.2 -66.92 0.66 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.5 1.125 . . . . 72.12 110.293 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -47.07 -34.95 6.33 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.531 1.144 . . . . 63.15 111.031 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -73.53 -57.54 3.93 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.439 1.087 . . . . 73.22 110.273 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.669 ' O ' HD23 ' A' ' 362' ' ' LEU . 7.0 tt . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.555 1.159 . . . . 72.12 109.28 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 108.268 -1.012 . . . . 54.03 108.268 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -75.56 -3.93 37.01 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.5 1.125 . . . . 70.32 110.293 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 19.4 mtm -111.38 -33.91 6.27 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.504 1.127 . . . . 72.1 110.98 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 99.66 13.97 36.2 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.485 1.116 . . . . 73.43 111.028 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 66.1 m -120.86 -176.43 3.25 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.505 0.767 . . . . 75.31 109.99 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.813 HG22 ' NE2' ' A' ' 371' ' ' GLN . 1.9 m -115.81 161.54 18.6 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.463 1.102 . . . . 62.04 110.4 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.489 ' CD2' HG22 ' A' ' 355' ' ' VAL . 89.1 t80 -64.39 -68.76 0.33 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.138 . . . . 74.5 110.981 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 371' ' ' GLN . . . . . 0.813 ' NE2' HG22 ' A' ' 369' ' ' THR . 0.1 OUTLIER -46.69 -34.1 4.83 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.52 1.138 . . . . 71.24 110.268 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.709 HD13 ' O ' ' A' ' 373' ' ' CYS . 2.3 tm? -60.49 141.13 56.86 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 75.3 109.332 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 373' ' ' CYS . . . . . 0.709 ' O ' HD13 ' A' ' 372' ' ' LEU . 24.0 p -72.13 159.95 33.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.03 -0.986 . . . . 74.12 110.882 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -117.17 28.54 8.43 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.523 1.14 . . . . 71.12 109.314 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 375' ' ' ILE . . . . . 0.614 HD11 ' HE1' ' A' ' 410' ' ' PHE . 11.5 mt -112.72 -59.64 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.453 1.096 . . . . 63.24 109.329 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 2.0 m -105.05 -14.85 15.27 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.484 1.115 . . . . 51.11 108.334 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.59 ' HA ' HD11 ' A' ' 372' ' ' LEU . . . 52.14 44.98 29.16 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.505 1.128 . . . . 73.1 109.311 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -131.6 -61.93 0.88 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 70.15 110.298 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -95.18 162.88 13.52 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 70.23 109.313 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -85.42 167.89 15.1 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.514 1.134 . . . . 73.34 109.305 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.515 ' HZ3' HD13 ' A' ' 391' ' ' LEU . 0.7 OUTLIER -70.17 -61.05 1.93 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.117 . . . . 73.32 109.282 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 382' ' ' ASP . . . . . 0.406 ' CG ' ' C ' ' A' ' 381' ' ' LYS . 0.2 OUTLIER 47.51 25.04 0.57 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 72.45 109.278 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.864 HG12 ' O ' ' A' ' 392' ' ' MET . 0.3 OUTLIER -150.91 170.17 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.528 1.143 . . . . 72.32 109.274 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 22.9 tttm -155.29 147.03 23.23 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.454 1.096 . . . . 73.54 109.274 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.823 HD12 HD13 ' A' ' 415' ' ' ILE . 20.6 mm -108.97 135.06 48.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.504 1.127 . . . . 72.43 109.29 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.515 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.8 mt-10 -137.76 161.11 62.01 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.448 1.093 . . . . 74.1 110.326 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.515 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.99 -5.63 21.6 Favored 'Cis proline' 0 C--N 1.36 1.155 0 C-N-CA 120.985 -2.506 . . . . 61.4 110.979 0.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 388' ' ' CYS . . . . . 0.541 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 17.6 t -37.99 -78.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.008 -0.996 . . . . 55.02 110.892 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 389' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 119.23 36.46 0.86 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.485 1.115 . . . . 71.13 110.965 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.541 ' CG ' ' SG ' ' A' ' 388' ' ' CYS . 63.3 m170 -108.5 129.73 55.28 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.52 0.777 . . . . 55.31 109.543 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.515 HD13 ' HZ3' ' A' ' 381' ' ' LYS . 0.8 OUTLIER -98.66 160.41 14.29 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.471 1.107 . . . . 72.4 109.307 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.864 ' O ' HG12 ' A' ' 383' ' ' VAL . 20.5 ptp -177.99 170.9 1.82 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.544 1.152 . . . . 62.34 110.999 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 5.0 p -89.83 114.78 26.58 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.463 1.102 . . . . 64.34 108.296 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 397' ' ' LEU . 3.4 m -46.98 -55.53 7.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.48 1.113 . . . . 73.21 110.447 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 71.5 m -46.41 -29.29 1.64 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 61.02 110.047 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 396' ' ' CYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 399' ' ' ALA . 1.9 m -86.19 -37.92 18.2 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.565 1.166 . . . . 71.12 108.266 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 397' ' ' LEU . . . . . 0.74 ' O ' HD23 ' A' ' 397' ' ' LEU . 3.0 tt -53.88 -47.05 71.46 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.534 1.146 . . . . 63.44 109.338 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.09 -35.28 61.93 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 1.114 . . . . 73.13 110.409 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 399' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -63.01 -26.49 68.88 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.515 1.135 . . . . 64.1 109.305 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 400' ' ' TRP . . . . . 0.492 ' CD2' ' HB3' ' A' ' 409' ' ' PRO . 3.7 t-105 -80.85 -52.87 7.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.97 -1.122 . . . . 74.44 107.97 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.509 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.2 mm-40 -61.74 -10.28 8.41 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.512 1.132 . . . . 65.03 110.339 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 401' ' ' GLN . 37.7 mt-10 -37.23 -63.7 0.42 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.531 1.145 . . . . 65.44 110.287 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.8 m -123.12 -24.88 4.62 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.487 1.117 . . . . 73.34 109.985 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 404' ' ' ASP . . . . . 0.491 ' OD2' ' CH2' ' A' ' 400' ' ' TRP . 0.6 OUTLIER -81.71 -90.9 0.07 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.486 1.116 . . . . 65.22 109.283 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.509 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 69.41 32.51 71.79 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.461 1.101 . . . . 54.4 111.02 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -91.11 64.85 5.4 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.503 0.766 . . . . 74.2 110.295 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 66.07 -156.41 49.96 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.528 1.143 . . . . 74.01 111.006 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 408' ' ' CYS . . . . . 0.754 ' SG ' HG21 ' A' ' 385' ' ' ILE . 5.4 t -57.39 127.22 76.78 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 108.267 -1.012 . . . . 71.32 108.267 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.617 ' HD2' ' HE1' ' A' ' 392' ' ' MET . 18.3 Cg_endo -75.04 0.33 9.05 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.506 1.793 . . . . 75.31 110.99 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 410' ' ' PHE . . . . . 0.614 ' HE1' HD11 ' A' ' 375' ' ' ILE . 3.3 m-85 -93.59 -39.49 10.8 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.54 1.15 . . . . 74.01 110.991 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 411' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.5 OUTLIER -119.8 12.47 12.14 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.505 1.128 . . . . 72.43 108.254 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 412' ' ' ARG . . . . . 0.442 ' HD2' ' CH2' ' A' ' 400' ' ' TRP . 37.4 mmm-85 38.5 31.73 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.509 1.131 . . . . 72.51 110.274 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 413' ' ' CYS . . . . . 0.422 ' N ' ' O ' ' A' ' 411' ' ' CYS . 42.8 t -114.74 151.12 34.24 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.513 1.133 . . . . 75.32 108.255 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -55.16 149.1 12.93 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.516 1.135 . . . . 74.02 110.335 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.823 HD13 HD12 ' A' ' 385' ' ' ILE . 4.0 mt -107.24 157.2 7.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.546 1.154 . . . . 73.14 109.294 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -126.64 -46.78 1.57 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.48 1.113 . . . . 72.14 109.275 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 417' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 418' ' ' THR . . . -107.32 127.08 8.64 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.535 1.147 . . . . 42.44 110.97 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 418' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 417' ' ' GLY . 17.1 p -157.57 117.79 3.44 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.48 0.753 . . . . 75.33 110.413 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -143.6 150.59 51.27 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.521 1.138 . . . . 73.14 110.273 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.49 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.3 Cg_endo -75.06 102.47 1.59 Allowed 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.475 1.776 . . . . 74.21 110.972 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.673 HD12 ' N ' ' A' ' 422' ' ' ILE . 1.2 pp -103.88 172.05 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.466 1.104 . . . . 71.43 109.267 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 422' ' ' ILE . . . . . 0.673 ' N ' HD12 ' A' ' 421' ' ' ILE . 19.5 mm -130.83 115.14 29.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.512 1.133 . . . . 72.24 109.266 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.418 ' CG2' HD11 ' A' ' 421' ' ' ILE . 18.9 t -84.68 141.67 14.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.488 1.118 . . . . 74.13 109.326 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.577 ' O ' HG23 ' A' ' 355' ' ' VAL . 1.0 OUTLIER -128.61 143.44 48.43 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.506 1.129 . . . . 74.23 109.327 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.04 174.44 12.79 Favored 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.5 1.789 . . . . 73.2 110.974 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 426' ' ' PHE . . . . . 0.564 ' CZ ' ' HG3' ' A' ' 357' ' ' GLN . 10.1 t80 . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.489 1.118 . . . . 73.03 111.037 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.979 -0.378 . . . . 73.41 109.979 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -93.48 -178.88 4.87 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 1.12 . . . . 65.23 109.306 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 352' ' ' HIS . . . . . 0.531 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 30.8 m-70 -139.31 145.96 39.74 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.469 1.105 . . . . 61.44 109.58 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 96.5 mt -133.71 142.6 41.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.528 1.142 . . . . 71.12 109.33 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.84 148.2 29.87 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.503 1.127 . . . . 65.0 109.258 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 424' ' ' ASP . 51.8 t -112.99 164.18 9.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.499 1.124 . . . . 63.01 109.331 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.464 ' N ' HG12 ' A' ' 355' ' ' VAL . 2.5 p -124.17 171.92 9.45 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.51 1.131 . . . . 71.23 110.441 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 357' ' ' GLN . . . . . 0.545 ' HG3' ' CZ ' ' A' ' 426' ' ' PHE . 14.9 mt-30 -66.32 -35.88 81.51 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.514 1.134 . . . . 71.05 110.28 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -55.94 -47.62 77.23 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.51 1.131 . . . . 74.24 110.351 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -59.48 -58.67 7.57 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.477 1.11 . . . . 65.04 110.305 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 360' ' ' TYR . . . . . 0.438 ' O ' ' N ' ' A' ' 364' ' ' CYS . 13.1 t80 -55.0 -33.12 62.31 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.486 1.116 . . . . 71.33 110.992 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -60.73 -47.71 85.09 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.466 1.104 . . . . 62.52 110.247 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.427 ' N ' ' CD1' ' A' ' 362' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.325 -0.461 0 O-C-N 124.493 1.12 . . . . 41.44 109.309 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 364' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 108.287 -1.005 . . . . 73.02 108.287 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -77.64 -4.65 47.09 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.485 1.115 . . . . 73.43 110.312 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 19.8 ptp -116.44 -32.24 5.32 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.47 1.106 . . . . 74.21 110.978 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.62 40.37 3.65 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.566 1.166 . . . . 43.42 111.01 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 68.5 m -145.1 171.84 13.93 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.539 0.788 . . . . 61.11 109.987 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.807 HG22 ' NE2' ' A' ' 371' ' ' GLN . 1.8 m -115.07 162.71 16.64 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.547 1.155 . . . . 43.22 110.37 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -66.46 -68.53 0.37 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 63.12 111.004 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 371' ' ' GLN . . . . . 0.807 ' NE2' HG22 ' A' ' 369' ' ' THR . 0.2 OUTLIER -46.05 -26.82 0.8 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.493 1.121 . . . . 74.23 110.29 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.939 HD22 ' N ' ' A' ' 373' ' ' CYS . 0.4 OUTLIER -71.18 135.74 47.73 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.501 1.126 . . . . 70.15 109.298 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 373' ' ' CYS . . . . . 0.939 ' N ' HD22 ' A' ' 372' ' ' LEU . 12.3 p -67.19 134.23 51.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.018 -0.992 . . . . 62.15 110.928 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -92.41 34.5 1.05 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.565 1.166 . . . . 74.52 109.312 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 49.8 mt -112.6 -60.35 2.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.545 1.153 . . . . 71.43 109.292 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -109.04 -18.31 13.69 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.484 1.115 . . . . 63.22 108.298 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.761 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 52.57 52.86 13.25 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.485 1.116 . . . . 63.32 109.328 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -135.19 -49.41 0.73 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.504 1.128 . . . . 75.42 110.326 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -111.89 165.36 12.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.531 1.144 . . . . 75.43 109.305 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -79.89 163.01 24.68 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 63.32 109.28 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.462 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 22.5 mttt -70.13 -62.6 1.32 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.475 1.109 . . . . 73.01 109.286 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 26.5 t0 60.25 23.74 13.14 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.541 1.151 . . . . 73.42 109.291 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.916 HG12 ' O ' ' A' ' 392' ' ' MET . 0.4 OUTLIER -153.4 176.12 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.463 1.102 . . . . 45.41 109.312 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -157.91 154.66 28.25 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.475 1.109 . . . . 71.11 109.296 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.804 HG22 ' SG ' ' A' ' 388' ' ' CYS . 11.6 mm -122.04 142.48 38.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.455 1.097 . . . . 73.14 109.321 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.557 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.1 mt-10 -136.9 162.91 53.1 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.467 1.104 . . . . 64.5 110.29 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.557 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.02 -13.47 23.65 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 120.97 -2.513 . . . . 70.24 110.999 -0.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 388' ' ' CYS . . . . . 0.804 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.12 -71.53 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.978 -1.01 . . . . 52.25 110.911 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 389' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.97 16.38 6.28 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.497 1.123 . . . . 74.32 110.985 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.566 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 44.2 m-70 -73.48 145.16 45.87 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 0.763 . . . . 53.43 109.568 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.814 HD22 ' N ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -117.37 156.57 27.66 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.126 . . . . 75.34 109.345 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.916 ' O ' HG12 ' A' ' 383' ' ' VAL . 12.3 ptp -173.9 173.93 3.14 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.512 1.133 . . . . 73.3 110.999 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 393' ' ' CYS . . . . . 1.127 ' SG ' ' CB ' ' A' ' 396' ' ' CYS . 5.3 p -91.39 137.45 32.35 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.446 1.091 . . . . 63.23 108.286 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 98.4 m -65.81 -31.54 72.56 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.466 1.104 . . . . 53.21 110.386 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 60.9 m -72.46 -58.2 3.57 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.523 1.139 . . . . 75.04 109.99 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 396' ' ' CYS . . . . . 1.127 ' CB ' ' SG ' ' A' ' 393' ' ' CYS . 1.9 p -55.87 -42.84 76.49 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.508 1.13 . . . . 54.41 108.285 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 397' ' ' LEU . . . . . 0.74 HD22 ' O ' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -45.12 -44.02 10.22 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.519 1.137 . . . . 72.11 109.311 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 398' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 402' ' ' GLU . 86.2 m -54.61 -38.47 66.83 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.527 1.142 . . . . 71.2 110.414 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 399' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -55.35 -26.91 43.8 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.46 1.1 . . . . 74.15 109.299 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 400' ' ' TRP . . . . . 0.602 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 8.1 t-105 -85.0 -60.91 1.9 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.985 -1.117 . . . . 72.12 107.985 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.496 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 7.3 mm-40 -56.69 -13.75 2.72 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.482 1.114 . . . . 74.22 110.265 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 398' ' ' THR . 3.6 mm-40 -37.14 -63.41 0.43 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.506 1.129 . . . . 70.44 110.303 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 5.2 t -121.23 -24.62 5.44 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.567 1.167 . . . . 73.52 109.938 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 404' ' ' ASP . . . . . 0.602 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 17.1 m-20 -82.87 -94.54 0.06 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.457 1.098 . . . . 73.1 109.296 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.496 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 73.17 29.72 64.07 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.46 1.1 . . . . 62.44 110.97 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -88.07 66.09 8.44 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.513 0.773 . . . . 73.24 110.308 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 68.45 -160.03 51.6 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.479 1.112 . . . . 63.23 111.018 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 408' ' ' CYS . . . . . 0.696 ' SG ' HG21 ' A' ' 385' ' ' ILE . 7.5 t -59.98 131.79 89.44 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 108.282 -1.007 . . . . 74.02 108.282 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -0.07 9.53 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.547 1.814 . . . . 53.33 110.988 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 410' ' ' PHE . . . . . 0.566 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 8.4 m-85 -95.11 -43.02 8.3 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 72.32 111.002 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 411' ' ' CYS . . . . . 0.445 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.5 OUTLIER -111.67 9.18 20.98 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.518 1.136 . . . . 73.25 108.285 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 412' ' ' ARG . . . . . . . . . . . . . 39.8 mmm-85 38.58 30.24 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.478 1.111 . . . . 70.33 110.253 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 413' ' ' CYS . . . . . 0.445 ' N ' ' O ' ' A' ' 411' ' ' CYS . 24.2 t -127.46 146.15 50.59 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.463 1.102 . . . . 75.02 108.287 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -42.58 152.13 0.1 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 72.44 110.296 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.731 HG23 HG23 ' A' ' 385' ' ' ILE . 2.1 mt -98.86 148.67 5.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.493 1.121 . . . . 64.14 109.303 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -112.29 -48.42 3.03 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.504 1.128 . . . . 74.43 109.331 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 417' ' ' GLY . . . . . 0.45 ' C ' HG23 ' A' ' 418' ' ' THR . . . -116.51 129.04 8.23 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.489 1.118 . . . . 61.33 110.979 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 418' ' ' THR . . . . . 0.604 ' CG2' HG21 ' A' ' 415' ' ' ILE . 82.0 p -152.82 138.95 18.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.492 0.76 . . . . 71.14 110.386 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.41 ' O ' HG23 ' A' ' 421' ' ' ILE . 1.1 pm0 -167.14 150.84 6.26 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.499 1.124 . . . . 74.33 110.309 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 101.08 1.43 Allowed 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.451 1.764 . . . . 74.02 110.977 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.732 HD11 HG22 ' A' ' 423' ' ' VAL . 0.6 OUTLIER -105.32 157.55 6.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 72.43 109.303 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 422' ' ' ILE . . . . . 0.672 ' N ' HD12 ' A' ' 421' ' ' ILE . 13.2 mt -114.82 105.39 18.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.529 1.143 . . . . 71.21 109.3 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.732 HG22 HD11 ' A' ' 421' ' ' ILE . 42.5 t -75.18 146.8 8.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.447 1.092 . . . . 75.13 109.267 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.7 ' O ' HG23 ' A' ' 355' ' ' VAL . 1.1 m-20 -128.73 133.59 25.36 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.462 1.101 . . . . 62.2 109.297 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 425' ' ' PRO . . . . . 0.491 ' CD ' ' OE1' ' A' ' 371' ' ' GLN . 18.2 Cg_endo -74.96 169.71 22.03 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.513 1.796 . . . . 74.52 110.961 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 426' ' ' PHE . . . . . 0.545 ' CZ ' ' HG3' ' A' ' 357' ' ' GLN . 5.1 t80 . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.449 1.093 . . . . 72.11 111.012 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 350' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 70.5 m . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 109.997 -0.371 . . . . 65.03 109.997 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -83.59 178.39 8.01 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.511 1.132 . . . . 73.11 109.327 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 352' ' ' HIS . . . . . 0.537 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 37.6 m-70 -141.97 134.73 28.52 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.534 1.146 . . . . 63.25 109.609 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 23.4 mt -124.86 158.7 32.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.529 1.143 . . . . 60.11 109.302 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 354' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 355' ' ' VAL . 0.3 OUTLIER -124.12 150.51 44.99 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.492 1.12 . . . . 72.42 109.312 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 424' ' ' ASP . 70.3 t -109.09 146.96 14.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.539 1.149 . . . . 62.31 109.293 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 58.1 p -117.96 -173.16 2.39 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.464 1.103 . . . . 75.2 110.369 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 357' ' ' GLN . . . . . 0.4 ' HG2' ' CE1' ' A' ' 426' ' ' PHE . 4.6 mm100 -77.52 -35.04 53.81 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.508 1.13 . . . . 74.11 110.285 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 358' ' ' GLU . . . . . 0.764 ' O ' HD12 ' A' ' 362' ' ' LEU . 4.7 pt-20 -60.27 -31.4 70.19 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.102 . . . . 73.53 110.281 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 359' ' ' GLN . . . . . 0.421 ' OE1' ' CE2' ' A' ' 370' ' ' PHE . 73.3 mt-30 -77.34 -63.42 1.38 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.46 1.1 . . . . 74.41 110.287 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -39.07 -42.87 0.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.518 1.136 . . . . 74.13 111.036 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -61.2 -53.87 51.49 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.482 1.114 . . . . 72.43 110.28 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.764 HD12 ' O ' ' A' ' 358' ' ' GLU . 3.7 mt . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.125 . . . . 64.14 109.33 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 108.318 -0.993 . . . . 64.31 108.318 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.21 -65.82 0.5 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.487 1.117 . . . . 73.24 110.301 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 23.2 ptp -55.23 -34.2 63.77 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.425 1.078 . . . . 74.25 110.975 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 88.92 50.01 3.41 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.488 1.118 . . . . 54.53 110.988 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 368' ' ' SER . . . . . 0.505 ' HB3' HD12 ' A' ' 372' ' ' LEU . 3.6 m -145.58 179.39 7.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.508 0.77 . . . . 60.42 109.963 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.775 HG22 ' NE2' ' A' ' 371' ' ' GLN . 2.0 m -118.42 161.11 20.52 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.508 1.13 . . . . 71.2 110.383 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.426 ' HD1' HG11 ' A' ' 423' ' ' VAL . 2.7 t80 -59.31 -64.51 0.92 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.507 1.129 . . . . 74.54 111.028 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 371' ' ' GLN . . . . . 0.775 ' NE2' HG22 ' A' ' 369' ' ' THR . 0.2 OUTLIER -60.7 -29.52 69.38 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.488 1.117 . . . . 61.12 110.325 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.791 HD22 ' N ' ' A' ' 373' ' ' CYS . 1.2 tm? -60.93 135.61 57.84 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 74.32 109.337 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 373' ' ' CYS . . . . . 0.791 ' N ' HD22 ' A' ' 372' ' ' LEU . 32.1 p -77.9 136.01 37.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.02 -0.991 . . . . 72.14 110.884 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.536 ' N ' ' CD ' ' A' ' 374' ' ' LYS . 0.2 OUTLIER -92.66 26.45 2.68 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.514 1.134 . . . . 62.4 109.306 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 7.0 mt -107.79 -56.67 4.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.495 1.122 . . . . 70.31 109.268 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 14.2 m -108.28 -21.73 12.64 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.513 1.133 . . . . 41.5 108.354 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.627 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 57.71 38.01 27.41 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.511 1.132 . . . . 74.43 109.298 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -129.57 -43.92 1.24 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.448 1.093 . . . . 64.5 110.274 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -108.81 -172.96 2.16 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 72.24 109.287 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.15 175.47 6.28 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.528 1.142 . . . . 74.1 109.332 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.663 ' HZ2' HD12 ' A' ' 391' ' ' LEU . 16.8 mttt -78.59 -50.79 10.92 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 64.41 109.301 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 382' ' ' ASP . . . . . 0.406 ' CG ' ' C ' ' A' ' 381' ' ' LYS . 0.1 OUTLIER 47.65 26.61 0.88 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.473 1.108 . . . . 71.14 109.261 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.886 HG12 ' O ' ' A' ' 392' ' ' MET . 0.3 OUTLIER -156.13 176.1 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.481 1.113 . . . . 62.51 109.274 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -160.52 157.33 27.29 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.522 1.139 . . . . 72.24 109.29 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.864 HG22 ' SG ' ' A' ' 388' ' ' CYS . 11.6 mm -123.82 143.76 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.542 1.152 . . . . 64.5 109.301 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.54 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 7.0 mt-10 -137.72 162.39 54.82 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.575 1.172 . . . . 74.25 110.282 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.54 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.95 -12.49 23.85 Favored 'Cis proline' 0 C--N 1.36 1.163 0 C-N-CA 120.981 -2.508 . . . . 44.15 111.026 -0.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 388' ' ' CYS . . . . . 0.864 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.41 -71.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.983 -1.008 . . . . 75.23 110.914 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 389' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.49 15.9 6.77 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.441 1.088 . . . . 51.44 110.946 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.567 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 21.4 m80 -73.07 148.0 44.46 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.522 0.777 . . . . 73.11 109.591 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.663 HD12 ' HZ2' ' A' ' 381' ' ' LYS . 1.3 mt -119.47 158.14 26.85 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.518 1.136 . . . . 73.1 109.302 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.886 ' O ' HG12 ' A' ' 383' ' ' VAL . 12.6 ptp -174.41 172.18 3.23 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.524 1.14 . . . . 74.02 111.016 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 393' ' ' CYS . . . . . 1.064 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 7.2 p -89.69 118.07 29.03 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.497 1.123 . . . . 71.2 108.275 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 73.4 m -52.51 -45.13 66.13 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.529 1.143 . . . . 74.03 110.374 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 37.2 m -55.69 -29.51 59.51 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.468 1.105 . . . . 62.31 109.971 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 396' ' ' CYS . . . . . 1.064 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 2.5 m -81.15 -47.51 13.37 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.452 1.095 . . . . 62.54 108.25 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 397' ' ' LEU . . . . . 0.719 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.5 OUTLIER -41.49 -36.09 0.82 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 74.34 109.327 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 398' ' ' THR . . . . . 0.486 ' CG2' ' N ' ' A' ' 399' ' ' ALA . 0.5 OUTLIER -61.17 -52.54 64.41 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.43 1.081 . . . . 75.14 110.38 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 399' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 398' ' ' THR . . . -51.44 -23.23 3.68 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.543 1.152 . . . . 71.32 109.285 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 400' ' ' TRP . . . . . 0.607 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 8.9 t-105 -84.44 -64.91 1.08 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.534 1.146 . . . . 74.1 108.034 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.494 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.7 mm-40 -52.34 -17.37 1.14 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.487 1.117 . . . . 74.1 110.316 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 401' ' ' GLN . 7.0 mm-40 -37.18 -63.41 0.43 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 74.2 110.29 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.6 m -120.39 -24.56 5.84 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.515 1.134 . . . . 50.3 110.006 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 404' ' ' ASP . . . . . 0.607 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 8.2 m-20 -82.25 -94.92 0.05 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 64.52 109.327 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.494 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 70.5 28.73 70.69 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.475 1.11 . . . . 44.43 111.036 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -90.17 68.19 7.02 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.465 0.744 . . . . 72.21 110.297 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 65.34 -163.81 38.32 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.517 1.136 . . . . 73.41 111.01 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 408' ' ' CYS . . . . . 0.699 ' SG ' HG21 ' A' ' 385' ' ' ILE . 6.3 t -58.21 129.27 82.98 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 108.363 -0.977 . . . . 71.44 108.363 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 -3.57 14.12 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.489 1.784 . . . . 75.3 111.042 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 410' ' ' PHE . . . . . 0.567 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 4.5 m-85 -92.91 -41.48 10.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.119 . . . . 72.34 111.01 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 411' ' ' CYS . . . . . 0.493 ' HG ' ' CE1' ' A' ' 390' ' ' HIS . 0.1 OUTLIER -111.01 9.02 22.14 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.123 . . . . 71.03 108.285 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 412' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 408' ' ' CYS . 9.1 mmt85 38.56 30.23 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.555 1.159 . . . . 73.51 110.333 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 413' ' ' CYS . . . . . 0.442 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.3 m -125.55 163.01 23.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.531 1.144 . . . . 72.33 108.289 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -59.02 146.99 36.3 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.435 1.085 . . . . 75.42 110.275 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.638 HG23 HG23 ' A' ' 385' ' ' ILE . 1.4 mt -93.06 153.41 3.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.477 1.111 . . . . 62.31 109.278 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.11 -46.33 3.01 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.526 1.141 . . . . 63.51 109.258 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 417' ' ' GLY . . . . . 0.554 ' O ' HG23 ' A' ' 418' ' ' THR . . . -131.11 144.73 16.28 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.501 1.125 . . . . 23.35 110.985 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 418' ' ' THR . . . . . 0.618 ' CG2' HG21 ' A' ' 415' ' ' ILE . 17.6 p -157.59 116.26 3.2 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.512 0.772 . . . . 75.3 110.428 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -136.32 149.21 67.13 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.509 1.131 . . . . 71.03 110.314 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.491 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.3 Cg_endo -74.97 102.46 1.59 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.492 1.785 . . . . 73.24 111.0 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.799 HD11 HG22 ' A' ' 423' ' ' VAL . 0.6 OUTLIER -103.83 158.9 5.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.46 1.1 . . . . 75.33 109.244 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 422' ' ' ILE . . . . . 0.696 ' N ' HD12 ' A' ' 421' ' ' ILE . 11.2 mt -118.61 105.39 17.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.482 1.114 . . . . 73.54 109.311 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.799 HG22 HD11 ' A' ' 421' ' ' ILE . 21.5 t -76.78 149.25 6.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.502 1.127 . . . . 64.0 109.293 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.865 ' O ' HG23 ' A' ' 355' ' ' VAL . 9.2 m-20 -127.64 143.33 47.1 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.494 1.121 . . . . 73.24 109.32 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 179.25 6.26 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.488 1.783 . . . . 63.33 111.032 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 426' ' ' PHE . . . . . 0.4 ' CE1' ' HG2' ' A' ' 357' ' ' GLN . 10.5 t80 . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.499 1.125 . . . . 74.14 111.011 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 350' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 29.6 p . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 110.03 -0.359 . . . . 74.41 110.03 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.14 175.08 10.97 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.501 1.126 . . . . 75.22 109.347 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -136.6 138.86 41.65 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 70.13 109.582 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 52.7 mt -121.73 158.75 24.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.525 1.141 . . . . 72.33 109.323 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -123.2 139.61 53.87 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.476 1.11 . . . . 62.2 109.269 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 424' ' ' ASP . 24.6 t -99.49 144.23 12.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.494 1.121 . . . . 71.42 109.318 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.9 p -110.19 153.02 25.35 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.505 1.128 . . . . 64.1 110.386 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 357' ' ' GLN . . . . . 0.464 ' HG3' ' CE1' ' A' ' 426' ' ' PHE . 24.7 mt-30 -43.35 -52.04 6.08 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.481 1.113 . . . . 74.21 110.284 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -43.85 -49.83 8.11 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 72.1 110.297 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 359' ' ' GLN . . . . . 0.485 ' OE1' ' CD1' ' A' ' 370' ' ' PHE . 18.2 mt-30 -59.62 -32.8 70.76 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.49 1.119 . . . . 74.4 110.274 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 360' ' ' TYR . . . . . 0.443 ' O ' ' N ' ' A' ' 364' ' ' CYS . 3.7 t80 -71.02 -62.07 1.53 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.537 1.148 . . . . 74.21 111.016 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -53.67 -53.69 48.38 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.535 1.147 . . . . 74.43 110.28 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.508 1.13 . . . . 72.14 109.244 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 364' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 108.319 -0.993 . . . . 75.52 108.319 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -73.96 -13.64 60.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.462 1.101 . . . . 73.42 110.286 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 12.0 ptp -121.49 -0.98 9.66 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.493 1.12 . . . . 70.33 111.02 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 57.0 43.79 93.07 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.434 1.084 . . . . 65.41 110.966 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 3.6 p -132.85 173.96 10.83 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.438 0.728 . . . . 74.22 109.967 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.764 HG22 HE21 ' A' ' 371' ' ' GLN . 2.2 m -116.94 161.57 19.15 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.484 1.115 . . . . 74.03 110.383 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.564 ' CD2' HG22 ' A' ' 355' ' ' VAL . 78.2 t80 -64.02 -68.63 0.33 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.519 1.137 . . . . 72.23 110.982 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 371' ' ' GLN . . . . . 0.764 HE21 HG22 ' A' ' 369' ' ' THR . 0.0 OUTLIER -44.31 -35.82 2.5 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.541 1.15 . . . . 73.34 110.31 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.747 HD13 ' N ' ' A' ' 373' ' ' CYS . 1.8 tm? -50.93 140.85 14.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.484 1.115 . . . . 75.34 109.247 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 373' ' ' CYS . . . . . 0.747 ' N ' HD13 ' A' ' 372' ' ' LEU . 19.7 p -85.42 147.08 26.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.97 -1.014 . . . . 63.44 110.913 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.557 ' N ' ' CD ' ' A' ' 374' ' ' LYS . 0.7 OUTLIER -99.54 17.44 20.41 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 63.12 109.29 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 5.9 mt -94.5 -61.69 2.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.458 1.099 . . . . 70.02 109.3 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 376' ' ' CYS . . . . . 0.656 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 2.6 m -102.67 -24.65 13.74 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.532 1.145 . . . . 72.22 108.273 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.682 ' HA ' HD11 ' A' ' 372' ' ' LEU . . . 63.04 46.42 4.73 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.478 1.111 . . . . 74.3 109.323 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -139.53 -49.58 0.49 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.548 1.155 . . . . 74.3 110.279 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 379' ' ' ASN . . . . . 0.429 ' O ' HD22 ' A' ' 372' ' ' LEU . 4.3 m-20 -104.91 174.35 5.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 72.33 109.333 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -85.86 173.18 10.19 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.542 1.151 . . . . 72.2 109.292 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 392' ' ' MET . 15.3 mttt -79.33 -54.86 5.53 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.515 1.134 . . . . 72.32 109.265 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 382' ' ' ASP . . . . . 0.401 ' OD2' ' O ' ' A' ' 381' ' ' LYS . 1.2 p30 51.87 26.78 3.8 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.478 1.111 . . . . 73.15 109.267 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 383' ' ' VAL . . . . . 0.914 HG12 ' O ' ' A' ' 392' ' ' MET . 0.4 OUTLIER -156.03 175.4 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.116 . . . . 54.42 109.35 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.417 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 62.5 tttt -158.53 151.81 22.87 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.503 1.127 . . . . 61.44 109.293 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.822 HG21 ' SG ' ' A' ' 408' ' ' CYS . 24.7 mm -115.28 133.59 61.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.126 . . . . 72.03 109.337 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.522 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 5.9 mt-10 -137.67 161.11 62.13 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.534 1.146 . . . . 73.12 110.286 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.522 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.4 Cg_endo -75.01 -5.2 21.25 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 121.034 -2.486 . . . . 73.23 111.004 -0.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 32.6 t -37.99 -78.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.0 -1.0 . . . . 71.51 110.946 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 389' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 119.53 36.51 0.84 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.483 1.114 . . . . 50.24 111.002 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.551 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 51.0 m170 -108.5 131.9 54.36 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.491 0.759 . . . . 73.3 109.581 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.71 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -99.87 158.55 15.72 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.486 1.116 . . . . 72.13 109.303 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 392' ' ' MET . . . . . 0.914 ' O ' HG12 ' A' ' 383' ' ' VAL . 17.1 ptp -172.6 174.42 3.74 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.473 1.108 . . . . 73.45 111.04 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 393' ' ' CYS . . . . . 1.176 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 28.1 p -97.53 115.55 28.06 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.469 1.106 . . . . 72.53 108.296 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 3.8 m -44.61 -58.99 2.69 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 75.33 110.364 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 29.6 m -41.11 -36.59 0.73 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.527 1.142 . . . . 62.24 109.989 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 396' ' ' CYS . . . . . 1.176 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 2.5 m -76.76 -50.42 13.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.477 1.11 . . . . 51.4 108.257 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 397' ' ' LEU . . . . . 0.695 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.3 OUTLIER -43.0 -35.69 1.32 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.492 1.12 . . . . 74.21 109.282 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 53.4 m -63.01 -45.31 92.98 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.481 1.113 . . . . 63.24 110.447 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 399' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -57.65 -21.72 41.43 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.451 1.094 . . . . 63.0 109.309 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 400' ' ' TRP . . . . . 0.588 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 14.7 t-105 -86.09 -65.21 1.04 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.496 1.123 . . . . 73.34 107.98 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.503 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 40.1 mm-40 -48.83 -20.96 0.55 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.479 1.112 . . . . 73.04 110.288 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 401' ' ' GLN . 7.3 mt-10 -37.64 -63.65 0.44 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.538 1.149 . . . . 74.52 110.276 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 23.0 t -122.41 -24.45 5.0 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.477 1.111 . . . . 74.44 109.98 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 404' ' ' ASP . . . . . 0.588 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 3.0 m-20 -82.85 -94.42 0.06 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.512 1.133 . . . . 75.41 109.311 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.503 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 67.29 21.37 72.1 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.435 1.084 . . . . 53.44 110.965 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -81.0 62.46 4.99 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 0.767 . . . . 62.1 110.287 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 68.15 -163.46 48.2 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.536 1.147 . . . . 70.11 111.002 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 408' ' ' CYS . . . . . 0.822 ' SG ' HG21 ' A' ' 385' ' ' ILE . 2.3 t -56.12 121.45 41.56 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.303 -0.999 . . . . 73.24 108.303 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.447 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.3 Cg_endo -75.03 0.65 8.67 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.53 1.805 . . . . 73.25 110.965 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 410' ' ' PHE . . . . . 0.551 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 2.7 m-85 -92.49 -37.99 12.21 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 74.3 111.047 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 411' ' ' CYS . . . . . 0.435 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.8 OUTLIER -126.02 17.13 7.89 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.475 1.109 . . . . 73.12 108.335 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 412' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 408' ' ' CYS . 47.5 mmm-85 38.43 30.99 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.526 1.141 . . . . 73.01 110.302 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 413' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 411' ' ' CYS . 15.2 t -115.35 139.15 50.24 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 63.04 108.302 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -45.8 158.97 0.08 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.443 1.09 . . . . 64.24 110.344 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.741 HG23 HG23 ' A' ' 385' ' ' ILE . 2.2 mt -114.45 157.24 15.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.448 1.093 . . . . 74.21 109.309 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -128.98 -47.79 1.23 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.514 1.134 . . . . 63.41 109.295 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 417' ' ' GLY . . . . . 0.553 ' O ' HG23 ' A' ' 418' ' ' THR . . . -108.76 127.9 8.8 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.541 1.15 . . . . 60.1 111.031 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 418' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 417' ' ' GLY . 17.5 p -157.51 116.74 3.29 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.502 0.766 . . . . 75.53 110.357 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -140.61 151.29 63.08 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.115 . . . . 71.54 110.296 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.2 Cg_endo -75.05 101.64 1.5 Allowed 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.485 1.781 . . . . 71.22 110.979 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.803 HD11 HG22 ' A' ' 423' ' ' VAL . 0.7 OUTLIER -105.71 167.58 3.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.441 1.088 . . . . 74.31 109.335 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 422' ' ' ILE . . . . . 0.782 ' N ' HD12 ' A' ' 421' ' ' ILE . 12.7 mt -126.52 106.32 15.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.505 1.128 . . . . 72.0 109.293 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.803 HG22 HD11 ' A' ' 421' ' ' ILE . 15.4 t -78.89 145.74 9.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.479 1.112 . . . . 60.32 109.284 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.66 ' O ' HG23 ' A' ' 355' ' ' VAL . 73.0 m-20 -128.38 143.68 49.1 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 64.55 109.302 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 425' ' ' PRO . . . . . 0.438 ' N ' ' OE1' ' A' ' 371' ' ' GLN . 18.1 Cg_endo -75.01 175.65 10.97 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.559 1.82 . . . . 75.14 110.999 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 426' ' ' PHE . . . . . 0.464 ' CE1' ' HG3' ' A' ' 357' ' ' GLN . 39.8 t80 . . . . . 0 C--N 1.324 -0.507 0 O-C-N 124.505 1.128 . . . . 75.32 111.015 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.999 0 N-CA-C 111.012 -0.835 . . . . 32.51 111.012 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 177.87 7.99 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.497 1.788 . . . . 44.11 111.002 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 7.0 m80 70.77 47.33 0.46 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.48 1.113 . . . . 72.42 109.631 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -46.07 -75.34 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 74.52 111.039 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -57.6 178.47 1.1 Allowed Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.526 1.141 . . . . 71.44 110.984 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 29.0 t -91.46 135.25 33.98 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.472 0.748 . . . . 65.14 110.016 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 351' ' ' ASP . . . . . 0.727 ' HB2' HG22 ' A' ' 421' ' ' ILE . 10.8 m-20 -78.54 174.45 11.34 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.429 1.081 . . . . 72.13 109.266 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 352' ' ' HIS . . . . . 0.459 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 28.2 m-70 -131.43 126.46 35.17 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.478 1.111 . . . . 64.23 109.597 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.475 HD11 ' HD2' ' A' ' 384' ' ' LYS . 9.0 mt -111.34 149.16 14.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.481 1.113 . . . . 44.52 109.302 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 32.1 tptt -112.77 133.25 54.86 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.468 1.105 . . . . 72.03 109.353 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 424' ' ' ASP . 40.0 t -87.75 149.53 4.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 71.53 109.33 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 5.9 p -114.15 149.19 36.02 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 72.04 110.413 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' GLN . . . . . 0.556 ' CG ' ' CE1' ' A' ' 426' ' ' PHE . 27.6 mt-30 -50.15 -34.33 21.99 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.479 1.112 . . . . 72.32 110.344 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -56.34 -52.53 64.2 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.497 1.123 . . . . 74.44 110.294 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' GLN . . . . . 0.463 ' OE1' HG13 ' A' ' 355' ' ' VAL . 35.3 mt-30 -55.8 -67.18 0.31 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.521 1.138 . . . . 64.53 110.329 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 364' ' ' CYS . 1.2 t80 -44.25 -45.77 8.71 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.473 1.108 . . . . 72.53 111.021 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -61.61 -42.67 99.2 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.499 1.124 . . . . 72.13 110.314 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 7.8 mt -61.12 -49.4 77.43 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.472 1.107 . . . . 50.02 109.257 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' PTR . . . . . 0.569 ' HE2' ' HZ3' ' A' ' 374' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.6 m -64.9 -36.48 84.5 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.488 1.117 . . . . 61.45 108.345 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -68.67 -7.79 36.55 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.476 1.11 . . . . 75.15 110.316 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 7.4 mmt -106.2 -35.01 7.33 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.501 1.126 . . . . 74.35 111.015 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 90.55 46.97 3.87 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.54 1.15 . . . . 72.13 110.977 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 8.3 t -142.95 -174.63 4.23 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.489 0.758 . . . . 72.53 109.978 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.437 ' O ' ' NZ ' ' A' ' 374' ' ' LYS . 2.0 p -126.47 140.89 52.12 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.492 1.12 . . . . 44.13 110.422 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.445 ' O ' ' N ' ' A' ' 372' ' ' LEU . 76.0 t80 -56.18 -70.96 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.522 1.139 . . . . 74.43 111.027 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.552 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -38.52 -30.44 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 63.22 110.27 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 370' ' ' PHE . 0.0 OUTLIER -71.46 122.78 21.02 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.506 1.129 . . . . 72.14 109.327 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 14.8 p -59.13 134.8 57.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.035 -0.984 . . . . 61.14 110.919 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.569 ' HZ3' ' HE2' ' A' ' 363' ' ' PTR . 23.0 mmtm -97.31 32.35 2.24 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.47 1.106 . . . . 71.35 109.33 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 2.7 mt -113.42 -59.62 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.116 . . . . 74.31 109.29 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 20.7 p -108.27 -13.92 14.8 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 64.4 108.293 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 47.66 41.83 14.28 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.482 1.114 . . . . 75.12 109.32 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -122.92 -41.02 2.37 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.128 . . . . 71.1 110.28 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.58 170.75 11.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.512 1.133 . . . . 74.32 109.313 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -76.72 175.47 9.35 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 74.24 109.33 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.455 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 21.9 mttt -73.78 -62.38 1.51 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.486 1.116 . . . . 64.1 109.314 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 59.91 25.93 15.12 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.478 1.112 . . . . 64.11 109.315 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.909 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -158.01 171.8 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.502 1.127 . . . . 64.24 109.292 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.475 ' HD2' HD11 ' A' ' 353' ' ' ILE . 40.4 tttp -155.21 142.05 19.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.47 1.106 . . . . 71.15 109.303 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.84 HD12 HD13 ' A' ' 415' ' ' ILE . 21.7 mm -105.22 133.93 48.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.479 1.112 . . . . 71.13 109.297 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.511 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.1 mt-10 -137.84 161.19 61.39 Favored Pre-proline 0 C--N 1.324 -0.532 0 O-C-N 124.531 1.144 . . . . 72.43 110.293 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.511 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.02 -5.82 21.88 Favored 'Cis proline' 0 C--N 1.361 1.197 0 C-N-CA 120.982 -2.507 . . . . 75.11 111.035 0.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 388' ' ' CYS . . . . . 0.432 ' SG ' ' ND1' ' A' ' 390' ' ' HIS . 43.1 t -37.43 -76.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.017 -0.992 . . . . 73.41 110.905 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 389' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 118.22 34.79 1.08 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.499 1.124 . . . . 64.42 111.018 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.432 ' ND1' ' SG ' ' A' ' 388' ' ' CYS . 46.1 m170 -105.79 130.82 53.7 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.529 0.782 . . . . 72.21 109.569 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.697 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -101.06 156.73 17.24 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 74.22 109.257 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.909 ' O ' HG12 ' A' ' 383' ' ' VAL . 19.8 ptp -173.64 176.19 2.79 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.517 1.136 . . . . 60.35 110.98 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 7.3 p -94.04 114.93 27.19 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.508 1.13 . . . . 64.41 108.276 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 397' ' ' LEU . 94.6 m -48.43 -56.6 7.79 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.539 1.149 . . . . 54.44 110.422 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.5 t -45.82 -25.96 0.6 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 74.32 109.944 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' CYS . . . . . 0.576 ' O ' ' HB3' ' A' ' 399' ' ' ALA . 1.8 m -87.63 -42.53 12.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.478 1.111 . . . . 64.24 108.322 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.619 HD13 ' C ' ' A' ' 397' ' ' LEU . 1.0 OUTLIER -48.0 -54.55 12.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 71.22 109.31 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 398' ' ' THR . . . . . 0.552 ' N ' HD13 ' A' ' 397' ' ' LEU . 61.6 m -45.63 -36.48 4.84 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.465 1.103 . . . . 70.32 110.438 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 399' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -63.06 -39.61 95.22 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.513 1.133 . . . . 55.44 109.272 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 400' ' ' TRP . . . . . 0.507 ' CD2' ' HB3' ' A' ' 409' ' ' PRO . 2.1 t-105 -69.2 -52.61 26.11 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.496 1.123 . . . . 74.02 108.01 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -62.68 -16.3 56.52 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.546 1.154 . . . . 70.53 110.339 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -86.78 -11.4 51.1 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.448 1.092 . . . . 70.41 110.268 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.4 t -111.9 -23.0 10.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 71.22 109.985 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 404' ' ' ASP . 8.7 t0 -153.19 -88.46 0.05 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.483 1.115 . . . . 71.43 109.307 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 108.3 32.62 3.17 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.493 1.121 . . . . 64.54 111.004 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' GLN . . . . . 0.433 ' O ' ' CG ' ' A' ' 406' ' ' GLN . 3.1 tt0 -91.27 79.28 5.69 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.514 0.773 . . . . 72.22 110.286 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 43.91 -159.06 0.12 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.53 1.144 . . . . 73.14 111.013 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' CYS . . . . . 0.633 ' SG ' HG21 ' A' ' 385' ' ' ILE . 4.9 t -56.38 125.61 66.37 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 108.319 -0.993 . . . . 75.32 108.319 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.507 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.2 Cg_endo -74.98 -2.48 12.59 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.48 1.779 . . . . 74.3 110.968 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 410' ' ' PHE . . . . . 0.565 ' CE1' ' HE2' ' A' ' 392' ' ' MET . 6.7 m-85 -89.12 -37.93 14.71 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.466 1.104 . . . . 73.51 110.975 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 411' ' ' CYS . . . . . . . . . . . . . 1.2 p -121.17 10.37 10.66 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.492 1.12 . . . . 62.23 108.286 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 408' ' ' CYS . 49.1 mmm-85 38.68 49.94 1.54 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.507 1.129 . . . . 63.2 110.343 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 41.8 t -138.14 148.84 45.33 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.511 1.132 . . . . 53.24 108.328 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -52.2 159.0 1.01 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.561 1.163 . . . . 65.15 110.273 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.84 HD13 HD12 ' A' ' 385' ' ' ILE . 2.3 mt -113.83 147.36 17.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.429 1.081 . . . . 71.34 109.293 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -114.85 -44.31 3.06 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.138 . . . . 73.22 109.312 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.502 ' C ' HG23 ' A' ' 418' ' ' THR . . . -111.77 127.78 8.29 Favored Glycine 0 CA--C 1.531 1.053 0 O-C-N 124.537 1.148 . . . . 72.44 110.984 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 418' ' ' THR . . . . . 0.502 HG23 ' C ' ' A' ' 417' ' ' GLY . 38.8 p -156.15 136.26 12.86 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.547 0.792 . . . . 54.5 110.405 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -171.98 156.13 3.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.495 1.122 . . . . 72.43 110.304 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.439 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.5 Cg_endo -74.94 101.87 1.52 Allowed 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.445 1.761 . . . . 73.4 111.011 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.739 ' C ' HD12 ' A' ' 421' ' ' ILE . 1.1 pp -103.93 167.69 2.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.496 1.123 . . . . 74.14 109.326 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 422' ' ' ILE . . . . . 0.554 ' N ' HD12 ' A' ' 421' ' ' ILE . 10.4 mm -113.97 112.22 39.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.53 1.144 . . . . 72.42 109.252 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.631 HG22 HD11 ' A' ' 421' ' ' ILE . 2.2 t -77.43 136.68 23.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.473 1.108 . . . . 72.34 109.27 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.539 ' O ' HG23 ' A' ' 355' ' ' VAL . 10.3 m-20 -131.33 131.85 23.26 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.477 1.111 . . . . 74.45 109.282 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 176.96 9.22 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.467 1.772 . . . . 53.11 110.999 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' PHE . . . . . 0.556 ' CE1' ' CG ' ' A' ' 357' ' ' GLN . 19.6 t80 . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.489 1.118 . . . . 71.45 111.052 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.956 0 N-CA-C 111.027 -0.829 . . . . 64.34 111.027 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 178.61 7.03 Favored 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.45 1.763 . . . . 63.22 110.966 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -74.82 -175.0 2.35 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.507 1.129 . . . . 72.42 109.586 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 4.6 ttp -119.01 177.13 4.98 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.498 1.124 . . . . 53.54 111.03 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 109.24 154.31 15.75 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.486 1.117 . . . . 40.21 111.002 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 69.8 m -74.91 124.75 27.48 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.484 0.756 . . . . 74.11 110.045 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 351' ' ' ASP . . . . . 0.428 ' H ' HG22 ' A' ' 421' ' ' ILE . 2.5 t70 -91.31 169.46 10.79 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 74.33 109.29 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -124.71 114.52 19.41 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.547 1.154 . . . . 74.33 109.629 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.845 HD13 HD13 ' A' ' 421' ' ' ILE . 1.6 mp -102.96 142.68 16.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.469 1.106 . . . . 74.52 109.309 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.402 ' NZ ' ' OD2' ' A' ' 424' ' ' ASP . 17.6 tppt? -124.91 117.93 25.16 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.465 1.103 . . . . 72.44 109.289 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 424' ' ' ASP . 61.9 t -66.25 154.8 7.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.492 1.12 . . . . 73.12 109.315 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 15.0 p -126.25 161.35 27.94 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.509 1.13 . . . . 72.34 110.43 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -56.05 -38.69 70.94 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.509 1.131 . . . . 73.34 110.332 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.14 -32.15 54.39 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.481 1.113 . . . . 75.24 110.29 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -83.79 -66.89 0.84 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.546 1.154 . . . . 74.4 110.281 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -41.89 -35.9 0.94 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.568 1.168 . . . . 74.34 111.039 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -66.41 -62.51 1.43 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.507 1.129 . . . . 73.5 110.281 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 9.8 tt -52.24 -30.53 28.02 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.462 1.101 . . . . 65.22 109.326 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' PTR . . . . . 0.416 ' CE1' ' O2P' ' A' ' 363' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.8 m -67.08 -24.16 65.93 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.465 1.103 . . . . 53.43 108.314 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.25 -21.13 62.15 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 64.22 110.305 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 2.0 mtm -103.33 -28.2 11.99 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 71.4 111.016 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 87.68 40.15 6.87 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.479 1.112 . . . . 61.41 110.954 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 20.8 t -139.22 177.73 7.69 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.502 0.766 . . . . 71.51 109.969 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 12.7 p -113.4 179.53 3.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 73.41 110.402 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.458 ' CD2' HG11 ' A' ' 423' ' ' VAL . 43.9 t80 -85.17 -65.97 0.95 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.555 1.159 . . . . 73.22 111.039 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.677 HE22 ' HB3' ' A' ' 425' ' ' PRO . 0.5 OUTLIER -40.0 -31.72 0.13 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.522 1.139 . . . . 75.12 110.319 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.706 HD22 ' N ' ' A' ' 373' ' ' CYS . 1.5 tm? -66.89 136.73 55.84 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.525 1.141 . . . . 71.22 109.259 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 373' ' ' CYS . . . . . 0.706 ' N ' HD22 ' A' ' 372' ' ' LEU . 13.2 t -79.47 130.18 35.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.965 -1.016 . . . . 72.52 110.931 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.442 ' NZ ' ' O ' ' A' ' 372' ' ' LEU . 10.8 mmtm -87.31 11.31 14.66 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.539 1.15 . . . . 74.32 109.305 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 3.9 mt -102.83 -40.5 6.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.464 1.103 . . . . 75.52 109.262 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 86.1 m -110.21 -35.63 6.04 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.494 1.121 . . . . 53.04 108.321 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.649 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 55.87 35.9 26.31 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.514 1.134 . . . . 72.24 109.327 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -131.79 -44.74 0.97 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.465 1.103 . . . . 74.1 110.314 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -113.69 -176.54 2.92 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.511 1.132 . . . . 74.32 109.32 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -97.66 158.93 15.23 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.502 1.126 . . . . 72.2 109.319 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.415 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 23.9 mttt -59.48 -62.46 1.86 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.47 1.106 . . . . 74.52 109.303 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 13.6 t70 59.54 27.0 16.08 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.459 1.099 . . . . 72.43 109.312 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.895 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -157.84 173.43 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.536 1.147 . . . . 52.32 109.29 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 23.5 tttp -156.68 137.39 13.28 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.469 1.105 . . . . 74.23 109.27 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.824 HG23 HG23 ' A' ' 415' ' ' ILE . 10.4 mm -101.02 132.32 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 63.24 109.341 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.51 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 7.9 mt-10 -137.8 161.16 61.62 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 75.51 110.314 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.51 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.94 -4.73 20.57 Favored 'Cis proline' 0 C--N 1.36 1.159 0 C-N-CA 121.004 -2.498 . . . . 73.52 111.035 -0.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 388' ' ' CYS . . . . . 0.502 ' SG ' ' CE1' ' A' ' 390' ' ' HIS . 44.1 t -37.45 -76.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.96 -1.018 . . . . 73.32 110.907 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 118.15 34.65 1.1 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.512 1.132 . . . . 73.42 111.0 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.502 ' CE1' ' SG ' ' A' ' 388' ' ' CYS . 66.4 m170 -108.6 127.88 54.34 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.509 0.77 . . . . 72.34 109.594 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.717 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -97.46 157.86 15.78 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.463 1.102 . . . . 71.51 109.353 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.895 ' O ' HG12 ' A' ' 383' ' ' VAL . 19.5 ptp -174.37 175.38 2.62 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.452 1.095 . . . . 74.34 110.991 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 23.4 p -97.91 115.51 28.26 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.527 1.142 . . . . 70.53 108.29 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 396' ' ' CYS . 85.5 m -46.15 -60.0 2.55 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.53 1.144 . . . . 72.33 110.415 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 8.1 m -39.91 -29.7 0.07 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.471 1.107 . . . . 74.05 109.956 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' CYS . . . . . 0.524 ' O ' ' HB3' ' A' ' 399' ' ' ALA . 2.8 m -85.44 -53.88 4.92 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.524 1.14 . . . . 73.34 108.296 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.615 ' O ' HD23 ' A' ' 397' ' ' LEU . 2.1 tt -43.01 -55.4 3.81 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.513 1.133 . . . . 72.44 109.319 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 61.3 m -45.56 -38.14 6.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.508 1.13 . . . . 74.2 110.413 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -64.22 -38.49 91.24 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.121 . . . . 71.1 109.313 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' TRP . . . . . 0.449 ' N ' ' O ' ' A' ' 397' ' ' LEU . 2.8 t-105 -63.35 -47.12 83.47 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.549 1.156 . . . . 73.51 107.986 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -58.65 -35.72 73.0 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.482 1.114 . . . . 74.33 110.25 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -74.36 -2.74 26.58 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.512 1.133 . . . . 75.11 110.268 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 29.4 t -113.73 -23.13 9.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 1.131 . . . . 71.11 109.956 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.16 -78.34 0.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.452 1.095 . . . . 74.41 109.259 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 100.1 32.86 5.41 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.473 1.108 . . . . 33.55 110.988 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -93.94 76.51 4.16 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.478 0.752 . . . . 73.53 110.29 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 44.41 -157.68 0.18 Allowed Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.522 1.139 . . . . 53.52 111.026 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' CYS . . . . . 0.514 ' SG ' HG21 ' A' ' 385' ' ' ILE . 5.3 t -56.14 127.01 69.22 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.323 -0.991 . . . . 63.54 108.323 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 0.63 8.69 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.511 1.795 . . . . 74.31 110.986 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' PHE . . . . . 0.432 ' CD2' ' HE2' ' A' ' 392' ' ' MET . 15.8 m-85 -94.76 -36.5 11.68 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.455 1.097 . . . . 75.21 110.984 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 411' ' ' CYS . . . . . 0.449 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.8 OUTLIER -122.83 12.63 9.82 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.464 1.103 . . . . 75.31 108.335 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 412' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 408' ' ' CYS . 1.6 tpt180 38.19 30.75 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.513 1.133 . . . . 73.32 110.313 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 413' ' ' CYS . . . . . 0.449 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.7 m -113.82 150.5 33.43 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.523 1.139 . . . . 44.21 108.278 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -55.96 149.24 15.6 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.437 1.086 . . . . 70.35 110.299 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.824 HG23 HG23 ' A' ' 385' ' ' ILE . 2.1 mt -99.02 136.29 30.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.499 1.124 . . . . 55.0 109.308 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -114.67 -54.72 2.55 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.499 1.124 . . . . 72.24 109.286 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.55 ' O ' HG23 ' A' ' 418' ' ' THR . . . -95.89 127.78 9.29 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.467 1.104 . . . . 73.52 110.956 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 418' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 417' ' ' GLY . 18.2 p -157.47 137.01 12.09 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.541 0.789 . . . . 61.33 110.367 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -172.18 155.97 3.67 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.407 1.067 . . . . 74.24 110.348 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.431 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.4 Cg_endo -75.04 102.82 1.64 Allowed 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.458 1.768 . . . . 74.51 110.974 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.845 HD13 HD13 ' A' ' 353' ' ' ILE . 0.7 OUTLIER -103.82 155.27 5.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.491 1.119 . . . . 65.5 109.301 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 422' ' ' ILE . . . . . 0.574 ' N ' HD12 ' A' ' 421' ' ' ILE . 17.1 mt -108.0 108.49 25.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.545 1.153 . . . . 75.12 109.261 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.773 HG22 HD11 ' A' ' 421' ' ' ILE . 14.6 t -76.57 146.42 8.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.489 1.118 . . . . 72.24 109.25 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.453 ' O ' HG23 ' A' ' 355' ' ' VAL . 3.0 t70 -127.98 127.97 23.83 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.536 1.147 . . . . 75.12 109.336 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 425' ' ' PRO . . . . . 0.677 ' HB3' HE22 ' A' ' 371' ' ' GLN . 18.3 Cg_endo -74.99 179.52 6.0 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.535 1.808 . . . . 71.21 110.983 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 76.9 t80 . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.461 1.1 . . . . 72.13 111.047 179.939 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.021 0 N-CA-C 111.009 -0.836 . . . . 71.33 111.009 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.04 178.19 7.61 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.521 1.801 . . . . 70.33 110.996 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -100.56 148.57 24.65 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.468 1.105 . . . . 74.23 109.56 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -122.27 1.8 9.69 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.51 1.131 . . . . 73.22 111.012 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -94.77 23.82 30.99 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.516 1.135 . . . . 52.15 110.992 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 4.3 m -143.46 136.46 27.73 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.529 0.782 . . . . 73.15 109.951 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -90.64 179.83 5.72 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.483 1.114 . . . . 72.13 109.296 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' HIS . . . . . 0.461 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 61.2 m-70 -138.23 150.17 46.46 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 73.03 109.595 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 17.2 mt -136.55 156.68 36.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.496 1.122 . . . . 74.14 109.308 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 12.0 tptm -117.92 152.66 34.98 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.464 1.102 . . . . 62.41 109.322 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 424' ' ' ASP . 32.1 t -109.09 156.72 9.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.454 1.096 . . . . 73.55 109.337 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 12.3 p -122.7 152.87 40.13 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.507 1.13 . . . . 63.32 110.402 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' GLN . . . . . 0.546 ' HG2' ' CE2' ' A' ' 426' ' ' PHE . 1.7 mm100 -45.84 -53.36 9.84 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.475 1.109 . . . . 72.31 110.325 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -43.55 -40.27 3.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.537 1.148 . . . . 73.04 110.308 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -70.89 -66.49 0.6 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.486 1.116 . . . . 72.53 110.282 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 364' ' ' CYS . 7.4 t80 -45.07 -63.77 0.86 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 73.22 110.997 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -45.34 -52.28 10.05 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.52 1.137 . . . . 71.54 110.267 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.3 tt -55.18 -33.46 63.02 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.548 1.155 . . . . 74.51 109.312 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' PTR . . . . . 0.608 ' CD1' ' HZ1' ' A' ' 374' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' CYS . . . . . 0.449 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.9 m -66.79 -21.89 66.04 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.515 1.134 . . . . 71.51 108.283 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -79.51 -2.71 43.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.545 1.153 . . . . 74.11 110.277 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 8.3 mmt -108.3 -34.82 6.7 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.54 1.15 . . . . 64.51 110.982 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.02 4.61 41.63 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.479 1.112 . . . . 63.0 110.968 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 1.2 m -127.92 -176.2 3.71 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.529 0.782 . . . . 44.43 109.992 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.434 ' O ' ' CE ' ' A' ' 374' ' ' LYS . 15.1 p -114.29 -179.34 3.6 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.518 1.136 . . . . 75.04 110.394 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.495 ' HA ' ' CE1' ' A' ' 363' ' ' PTR . 62.7 t80 -78.49 -67.63 0.72 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 1.12 . . . . 75.11 110.979 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.556 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -38.89 -29.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.538 1.149 . . . . 73.4 110.3 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.907 HD22 ' N ' ' A' ' 373' ' ' CYS . 0.5 OUTLIER -72.56 136.54 45.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.547 1.154 . . . . 74.21 109.273 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 373' ' ' CYS . . . . . 0.907 ' N ' HD22 ' A' ' 372' ' ' LEU . 11.5 t -70.97 133.54 46.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.004 -0.998 . . . . 63.42 110.928 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.608 ' HZ1' ' CD1' ' A' ' 363' ' ' PTR . 29.8 mmtp -93.9 24.39 4.25 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.547 1.154 . . . . 71.3 109.285 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 0.612 HD11 ' CE1' ' A' ' 410' ' ' PHE . 36.3 mt -107.38 -56.17 4.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.498 1.124 . . . . 75.31 109.308 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 1.8 m -104.75 -23.15 13.09 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.482 1.114 . . . . 61.13 108.309 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.639 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 50.61 39.77 22.2 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.516 1.135 . . . . 62.54 109.302 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -124.57 -42.13 2.1 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.13 . . . . 73.52 110.271 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -123.62 171.0 9.88 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.52 1.138 . . . . 72.21 109.303 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -81.35 164.59 22.04 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.484 1.115 . . . . 64.13 109.302 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.458 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 20.0 mttt -67.75 -62.47 1.4 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.55 1.156 . . . . 74.34 109.292 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 1.9 t70 59.29 24.55 13.06 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.546 1.154 . . . . 63.23 109.283 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.923 HG12 ' O ' ' A' ' 392' ' ' MET . 0.6 OUTLIER -155.42 171.01 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.478 1.111 . . . . 75.22 109.305 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -154.19 147.25 24.61 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.462 1.101 . . . . 70.31 109.307 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.811 HG21 ' SG ' ' A' ' 408' ' ' CYS . 22.8 mm -110.4 134.33 52.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.477 1.11 . . . . 74.34 109.285 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.513 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 9.8 mt-10 -137.65 160.97 62.93 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.546 1.154 . . . . 60.5 110.276 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.513 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.5 Cg_endo -74.97 -5.13 21.03 Favored 'Cis proline' 0 C--N 1.36 1.14 0 C-N-CA 121.003 -2.499 . . . . 63.45 111.056 -0.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 388' ' ' CYS . . . . . 0.594 ' SG ' ' CE1' ' A' ' 390' ' ' HIS . 43.0 t -38.11 -79.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.964 -1.016 . . . . 64.33 110.942 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 119.92 36.98 0.79 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.485 1.115 . . . . 62.03 111.012 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.594 ' CE1' ' SG ' ' A' ' 388' ' ' CYS . 65.6 m170 -108.45 130.89 55.23 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 0.76 . . . . 74.32 109.6 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.708 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -98.43 157.48 16.18 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.133 . . . . 73.11 109.28 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.923 ' O ' HG12 ' A' ' 383' ' ' VAL . 15.5 ptp -171.81 174.38 4.24 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.509 1.13 . . . . 74.33 111.036 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 26.3 p -98.13 115.98 29.4 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.531 1.145 . . . . 72.35 108.291 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 26.2 m -42.12 -59.37 1.79 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.559 1.162 . . . . 61.11 110.421 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.7 t -42.82 -37.09 1.68 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.553 1.158 . . . . 64.24 109.983 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 3.5 m -73.69 -53.6 10.02 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.542 1.151 . . . . 52.2 108.297 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.748 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.8 OUTLIER -43.89 -37.18 2.71 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.536 1.147 . . . . 43.22 109.265 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 53.1 m -61.14 -46.07 92.07 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.514 1.134 . . . . 74.23 110.406 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -59.97 -19.88 54.59 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.498 1.124 . . . . 61.5 109.33 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' TRP . . . . . 0.605 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 9.7 t-105 -85.75 -64.94 1.07 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.5 1.125 . . . . 71.04 108.022 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.495 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 10.3 mm-40 -52.44 -17.18 1.1 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.457 1.098 . . . . 73.44 110.313 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 401' ' ' GLN . 2.3 mm-40 -37.19 -63.31 0.44 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.516 1.135 . . . . 63.41 110.281 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 2.5 m -121.0 -24.57 5.55 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.512 1.133 . . . . 54.5 110.004 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' ASP . . . . . 0.605 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 13.2 m-20 -82.05 -94.25 0.05 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.45 1.094 . . . . 73.0 109.298 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.495 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 69.18 30.89 71.67 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 124.5 1.125 . . . . 72.5 111.002 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -90.66 57.34 3.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.569 0.805 . . . . 60.41 110.326 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 69.27 -160.54 52.65 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.472 1.108 . . . . 35.54 110.971 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' CYS . . . . . 0.811 ' SG ' HG21 ' A' ' 385' ' ' ILE . 1.4 t -56.53 121.74 45.64 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 108.282 -1.007 . . . . 74.5 108.282 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.405 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.0 Cg_endo -75.07 0.3 9.1 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.538 1.809 . . . . 73.15 110.969 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' PHE . . . . . 0.612 ' CE1' HD11 ' A' ' 375' ' ' ILE . 10.8 m-85 -89.35 -38.83 13.86 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 62.23 111.0 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 411' ' ' CYS . . . . . 0.402 ' O ' ' C ' ' A' ' 412' ' ' ARG . 0.7 OUTLIER -126.49 15.85 7.64 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 73.2 108.322 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 412' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 408' ' ' CYS . 0.4 OUTLIER 38.71 41.27 0.48 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.561 1.163 . . . . 63.52 110.279 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 14.9 t -124.19 140.48 52.93 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 51.12 108.316 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -47.63 157.44 0.24 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.543 1.152 . . . . 62.45 110.307 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.761 HD13 HD12 ' A' ' 385' ' ' ILE . 2.3 mt -111.75 155.12 13.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.442 1.089 . . . . 75.25 109.319 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -120.91 -46.11 2.35 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.499 1.124 . . . . 72.21 109.308 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.52 ' O ' HG23 ' A' ' 418' ' ' THR . . . -115.55 132.73 10.47 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.525 1.14 . . . . 45.3 110.967 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 418' ' ' THR . . . . . 0.546 ' CG2' HG21 ' A' ' 415' ' ' ILE . 21.0 p -157.23 117.37 3.48 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.443 0.731 . . . . 60.51 110.397 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.401 ' O ' HG23 ' A' ' 421' ' ' ILE . 1.9 pm0 -144.82 151.55 49.82 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.51 1.131 . . . . 74.53 110.291 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 100.82 1.4 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.502 1.791 . . . . 64.04 110.995 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.875 HD11 HG22 ' A' ' 423' ' ' VAL . 0.7 OUTLIER -104.68 169.51 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.502 1.126 . . . . 75.1 109.312 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 422' ' ' ILE . . . . . 0.815 ' N ' HD12 ' A' ' 421' ' ' ILE . 9.7 mt -124.95 105.43 15.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.518 1.136 . . . . 53.42 109.304 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.875 HG22 HD11 ' A' ' 421' ' ' ILE . 11.2 t -78.51 142.29 14.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.472 1.107 . . . . 63.41 109.301 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.544 ' O ' HG23 ' A' ' 355' ' ' VAL . 0.8 OUTLIER -127.92 143.7 48.72 Favored Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.486 1.116 . . . . 74.13 109.324 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 176.44 9.92 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.451 1.764 . . . . 71.31 110.983 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' PHE . . . . . 0.546 ' CE2' ' HG2' ' A' ' 357' ' ' GLN . 3.3 t80 . . . . . 0 C--N 1.325 -0.48 0 O-C-N 124.55 1.156 . . . . 50.13 111.04 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.969 0 N-CA-C 111.036 -0.826 . . . . 24.23 111.036 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 178.59 7.06 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.464 1.77 . . . . 74.34 111.015 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -115.04 112.7 23.03 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 1.136 . . . . 75.3 109.628 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 11.3 mmt -92.51 20.64 6.06 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.554 1.159 . . . . 61.22 111.03 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -142.94 20.36 2.33 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.527 1.142 . . . . 70.21 110.958 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 63.8 m -142.7 140.43 31.52 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.534 0.785 . . . . 55.41 109.998 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -96.3 -174.33 3.04 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.527 1.142 . . . . 61.11 109.318 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' HIS . . . . . 0.518 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 31.3 m-70 -138.99 140.66 38.25 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.461 1.101 . . . . 72.34 109.55 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 3.9 mm -122.07 156.19 26.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.503 1.127 . . . . 73.43 109.336 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -122.28 138.86 54.36 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.526 1.141 . . . . 65.21 109.322 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 424' ' ' ASP . 37.3 t -97.58 148.92 5.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.49 1.119 . . . . 72.22 109.347 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.6 p -108.55 141.86 39.83 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.547 1.154 . . . . 65.44 110.392 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' GLN . . . . . 0.538 ' HG2' ' CE2' ' A' ' 426' ' ' PHE . 4.9 mt-30 -39.66 -32.98 0.16 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.483 1.114 . . . . 72.01 110.32 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -57.05 -53.51 57.28 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.499 1.125 . . . . 53.51 110.322 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' GLN . . . . . 0.466 ' HB2' HG13 ' A' ' 355' ' ' VAL . 5.8 mt-30 -66.07 -22.67 66.42 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.546 1.154 . . . . 64.0 110.331 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -86.82 -23.73 25.24 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.492 1.12 . . . . 75.24 111.03 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 357' ' ' GLN . 4.6 mm-40 -84.41 -50.27 7.94 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.519 1.137 . . . . 72.43 110.235 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.468 ' CD1' ' N ' ' A' ' 362' ' ' LEU . 0.2 OUTLIER -59.97 -41.04 91.1 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.515 1.134 . . . . 72.04 109.288 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 363' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -53.26 60.23 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.119 . . . . 32.55 108.284 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -43.35 -68.31 0.21 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.514 1.134 . . . . 73.43 110.326 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 21.7 ptp -56.65 -31.12 64.06 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.53 1.144 . . . . 73.35 111.001 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 82.42 50.9 4.57 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.533 1.145 . . . . 53.13 111.015 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 1.5 t -126.29 -179.24 4.64 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.477 0.751 . . . . 75.52 110.026 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 2.8 p -129.1 140.46 51.56 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.521 1.138 . . . . 72.32 110.365 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.529 ' CE2' HG11 ' A' ' 423' ' ' VAL . 60.8 t80 -64.52 -68.2 0.37 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.451 1.094 . . . . 74.04 111.035 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.696 HE22 ' HB3' ' A' ' 425' ' ' PRO . 0.8 OUTLIER -39.44 -30.02 0.06 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.124 . . . . 61.0 110.327 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.926 HD22 ' N ' ' A' ' 373' ' ' CYS . 0.4 OUTLIER -73.4 136.14 44.3 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.489 1.118 . . . . 74.02 109.339 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 373' ' ' CYS . . . . . 0.926 ' N ' HD22 ' A' ' 372' ' ' LEU . 26.9 p -67.88 131.85 46.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.015 -0.993 . . . . 34.51 110.926 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -93.21 29.57 1.87 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 65.04 109.328 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 0.776 HD11 ' HE1' ' A' ' 410' ' ' PHE . 17.1 mt -107.65 -59.78 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.469 1.106 . . . . 71.04 109.315 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 3.7 m -107.71 -23.17 12.21 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.516 1.135 . . . . 65.22 108.279 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.668 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 56.81 42.55 26.43 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 63.03 109.321 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -124.17 -42.45 2.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.516 1.135 . . . . 63.12 110.296 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -121.89 170.57 9.66 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.553 1.158 . . . . 61.14 109.309 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 17.3 p30 -83.24 162.1 21.29 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.472 1.108 . . . . 73.12 109.294 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 392' ' ' MET . 24.1 mttt -64.37 -55.57 20.25 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.489 1.118 . . . . 71.3 109.298 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 1.1 p30 52.22 25.71 3.51 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 74.44 109.308 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.869 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -153.21 176.09 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.53 1.143 . . . . 74.13 109.286 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.412 ' H ' HG22 ' A' ' 383' ' ' VAL . 79.0 tttt -160.94 142.23 11.83 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.448 1.093 . . . . 63.22 109.294 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.825 HD13 HG22 ' A' ' 418' ' ' THR . 10.4 mm -108.12 138.58 34.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 124.554 1.159 . . . . 72.23 109.308 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.518 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.1 OUTLIER -138.06 161.39 59.9 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.511 1.132 . . . . 64.12 110.27 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.518 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.98 -7.16 22.99 Favored 'Cis proline' 0 C--N 1.36 1.158 0 C-N-CA 120.983 -2.507 . . . . 75.21 111.024 -0.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 388' ' ' CYS . . . . . 0.442 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 41.2 t -36.83 -73.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.002 -0.999 . . . . 71.22 110.919 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 115.95 16.5 6.78 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.478 1.111 . . . . 73.2 111.043 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.513 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 49.6 m170 -86.85 131.42 34.12 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.525 0.779 . . . . 72.32 109.623 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.676 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -100.78 161.8 13.35 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.506 1.129 . . . . 74.3 109.285 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.869 ' O ' HG12 ' A' ' 383' ' ' VAL . 18.6 ptp -174.72 174.83 2.55 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.508 1.13 . . . . 64.03 110.973 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 7.0 p -96.55 119.56 35.25 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.521 1.138 . . . . 75.12 108.289 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 44.1 m -44.01 -59.22 2.4 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.486 1.117 . . . . 74.21 110.365 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 14.6 m -43.41 -34.2 1.23 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.499 1.124 . . . . 61.44 109.999 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' CYS . . . . . 0.435 ' O ' ' N ' ' A' ' 399' ' ' ALA . 1.8 m -76.1 -57.81 3.65 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.531 1.144 . . . . 65.11 108.34 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.667 HD13 ' C ' ' A' ' 397' ' ' LEU . 1.2 tm? -41.96 -39.03 1.75 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.452 1.095 . . . . 53.33 109.242 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 2.8 m -60.59 -46.52 89.93 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.509 1.131 . . . . 71.55 110.418 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -58.8 -20.65 52.0 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.142 . . . . 73.2 109.293 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 400' ' ' TRP . . . . . 0.607 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 7.7 t-105 -85.94 -64.92 1.07 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.526 1.141 . . . . 72.13 108.005 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.491 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.1 mm-40 -52.23 -17.4 1.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.498 1.124 . . . . 62.12 110.297 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 401' ' ' GLN . 2.3 mm-40 -37.14 -63.36 0.44 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.525 1.14 . . . . 74.2 110.26 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.6 m -120.82 -24.65 5.61 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.482 1.114 . . . . 73.11 110.01 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' ASP . . . . . 0.607 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 12.2 m-20 -81.58 -93.86 0.05 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.516 1.135 . . . . 75.23 109.312 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.491 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 69.93 29.67 70.69 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.485 1.115 . . . . 52.0 111.009 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -92.02 68.13 5.22 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.528 0.781 . . . . 74.12 110.312 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 63.34 -167.01 24.37 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 124.502 1.126 . . . . 50.01 111.005 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' CYS . . . . . 0.663 ' SG ' HG21 ' A' ' 385' ' ' ILE . 2.0 t -56.21 123.22 53.61 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 108.307 -0.997 . . . . 52.32 108.307 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.421 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.2 Cg_endo -74.99 0.3 9.07 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.451 1.763 . . . . 63.21 110.986 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 410' ' ' PHE . . . . . 0.776 ' HE1' HD11 ' A' ' 375' ' ' ILE . 3.3 m-30 -91.38 -40.77 11.26 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.478 1.111 . . . . 65.44 110.986 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 411' ' ' CYS . . . . . 0.442 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.8 OUTLIER -122.36 16.19 10.54 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.533 1.145 . . . . 74.12 108.267 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 412' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 408' ' ' CYS . 5.3 tpt180 38.6 30.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.54 1.15 . . . . 74.54 110.32 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' CYS . . . . . 0.442 ' N ' ' O ' ' A' ' 411' ' ' CYS . 6.9 t -111.97 142.65 44.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 63.13 108.265 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 414' ' ' GLU . . . . . 0.445 ' CG ' ' N ' ' A' ' 415' ' ' ILE . 24.7 tt0 -50.9 158.88 0.63 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.462 1.101 . . . . 74.55 110.34 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.766 HD13 HD12 ' A' ' 385' ' ' ILE . 2.3 mt -110.44 157.33 11.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.478 1.112 . . . . 72.32 109.244 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -119.91 -44.56 2.51 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.48 1.112 . . . . 64.34 109.303 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.6 ' O ' HG23 ' A' ' 418' ' ' THR . . . -134.72 146.55 18.55 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.549 1.156 . . . . 61.05 110.964 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 418' ' ' THR . . . . . 0.825 HG22 HD13 ' A' ' 385' ' ' ILE . 2.3 p -157.52 117.68 3.44 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.533 0.784 . . . . 73.15 110.394 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -138.17 151.27 69.42 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.51 1.131 . . . . 74.33 110.346 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 101.68 1.5 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.51 1.795 . . . . 72.3 111.0 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.835 HD11 HG22 ' A' ' 423' ' ' VAL . 0.8 OUTLIER -104.14 155.72 5.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.488 1.117 . . . . 74.5 109.247 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 422' ' ' ILE . . . . . 0.532 ' N ' HD12 ' A' ' 421' ' ' ILE . 17.0 mt -107.01 105.41 18.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.502 1.126 . . . . 75.13 109.281 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.835 HG22 HD11 ' A' ' 421' ' ' ILE . 38.2 t -76.86 146.98 7.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 54.14 109.247 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.681 ' O ' HG23 ' A' ' 355' ' ' VAL . 0.8 OUTLIER -130.08 143.66 50.01 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.461 1.101 . . . . 54.41 109.237 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 425' ' ' PRO . . . . . 0.696 ' HB3' HE22 ' A' ' 371' ' ' GLN . 18.4 Cg_endo -75.02 170.35 20.61 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.497 1.788 . . . . 73.33 111.001 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 426' ' ' PHE . . . . . 0.538 ' CE2' ' HG2' ' A' ' 357' ' ' GLN . 3.3 t80 . . . . . 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 73.41 111.006 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.99 0 N-CA-C 111.006 -0.838 . . . . 64.0 111.006 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 178.61 7.04 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.557 1.819 . . . . 73.2 111.026 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -119.7 125.39 48.55 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.504 1.127 . . . . 61.43 109.626 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 26.9 tpp -105.62 91.78 3.9 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.531 1.145 . . . . 63.51 111.018 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -125.52 55.69 0.72 Allowed Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.502 1.126 . . . . 34.44 110.977 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 3.0 p -132.7 139.33 47.6 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.48 0.753 . . . . 75.24 110.037 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -97.46 176.85 5.72 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.466 1.104 . . . . 75.21 109.323 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' HIS . . . . . 0.439 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 42.5 m-70 -136.47 134.57 37.78 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.498 1.124 . . . . 63.31 109.604 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 67.0 mt -114.69 135.87 53.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.517 1.135 . . . . 65.21 109.302 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -107.84 118.94 38.06 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.473 1.108 . . . . 64.21 109.282 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.464 ' O ' ' CD2' ' A' ' 426' ' ' PHE . 8.6 t -64.33 140.55 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.539 1.149 . . . . 62.31 109.317 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.44 ' OG1' ' CG ' ' A' ' 359' ' ' GLN . 27.0 p -91.85 156.55 17.42 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 70.1 110.365 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 357' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -57.99 -32.5 67.95 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.454 1.096 . . . . 73.13 110.321 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' GLU . . . . . 0.462 ' CG ' ' N ' ' A' ' 359' ' ' GLN . 18.0 pt-20 -66.05 -47.48 74.2 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.517 1.136 . . . . 74.45 110.305 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' GLN . . . . . 0.462 ' N ' ' CG ' ' A' ' 358' ' ' GLU . 11.9 mm-40 -60.73 -52.77 63.69 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.518 1.136 . . . . 43.22 110.313 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -51.15 -60.63 2.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.527 1.142 . . . . 71.34 111.031 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -58.52 -36.76 74.34 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.491 1.119 . . . . 74.4 110.334 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.0 tp -61.53 -39.51 91.31 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.505 1.128 . . . . 64.14 109.289 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' PTR . . . . . 0.403 ' HD1' ' N ' ' A' ' 363' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 2.1 m -62.01 -41.27 97.9 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.529 1.143 . . . . 60.32 108.258 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -59.25 -17.64 30.2 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.5 1.125 . . . . 74.05 110.291 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 5.0 mtt -109.0 -16.18 14.19 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.487 1.117 . . . . 71.2 110.991 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 65.5 40.25 96.07 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.486 1.116 . . . . 74.43 111.006 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 16.1 m -125.13 -175.34 3.28 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.446 0.733 . . . . 73.0 109.971 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 2.3 p -128.22 136.36 50.95 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.456 1.098 . . . . 75.24 110.451 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.503 ' CZ ' HD12 ' A' ' 391' ' ' LEU . 73.7 t80 -60.58 -68.42 0.3 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.5 1.125 . . . . 75.14 111.002 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.407 ' HB3' ' CG1' ' A' ' 423' ' ' VAL . 0.9 OUTLIER -40.09 -29.23 0.07 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 71.35 110.255 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.416 ' N ' ' C ' ' A' ' 370' ' ' PHE . 0.0 OUTLIER -69.48 115.01 8.25 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.127 . . . . 55.43 109.344 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 30.3 p -45.96 145.87 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.009 -0.996 . . . . 73.32 110.937 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -105.53 31.6 4.86 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.512 1.133 . . . . 62.1 109.31 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 0.57 HG21 ' HB3' ' A' ' 396' ' ' CYS . 46.4 mt -112.42 -58.39 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.51 1.131 . . . . 72.45 109.282 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 5.3 p -107.98 -21.81 12.67 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.479 1.112 . . . . 73.14 108.312 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 56.46 41.51 28.69 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.524 1.14 . . . . 52.31 109.336 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -126.16 -49.06 1.58 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.463 1.102 . . . . 73.22 110.329 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 49.4 m-20 -109.4 167.92 9.77 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.543 1.152 . . . . 63.25 109.323 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 16.6 p30 -84.6 162.66 19.7 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.486 1.116 . . . . 73.33 109.276 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 392' ' ' MET . 22.7 mttt -63.07 -62.4 1.73 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.469 1.106 . . . . 74.13 109.294 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 58.45 25.04 12.48 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.513 1.133 . . . . 74.15 109.262 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.892 HG12 ' O ' ' A' ' 392' ' ' MET . 0.7 OUTLIER -154.85 170.64 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 71.32 109.268 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -154.61 144.45 21.66 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.484 1.115 . . . . 71.35 109.314 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.808 HG21 ' SG ' ' A' ' 408' ' ' CYS . 11.1 mm -107.79 133.66 51.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.505 1.128 . . . . 73.24 109.293 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.517 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 10.5 mt-10 -137.67 160.98 62.86 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 62.14 110.297 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.517 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -75.07 -5.19 21.46 Favored 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 120.995 -2.502 . . . . 63.14 110.995 0.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 388' ' ' CYS . . . . . 0.512 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 16.5 t -38.13 -79.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.985 -1.007 . . . . 74.54 110.92 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 119.64 36.58 0.83 Allowed Glycine 0 CA--C 1.531 1.068 0 O-C-N 124.537 1.148 . . . . 60.35 110.965 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.559 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 67.4 m170 -108.54 127.14 53.68 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.545 0.791 . . . . 74.12 109.596 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.503 HD12 ' CZ ' ' A' ' 370' ' ' PHE . 1.8 mt -95.65 157.27 15.97 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.507 1.13 . . . . 72.33 109.297 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.892 ' O ' HG12 ' A' ' 383' ' ' VAL . 14.2 ptp -171.17 174.57 4.57 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.492 1.12 . . . . 74.5 111.001 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 393' ' ' CYS . . . . . 0.438 ' O ' ' N ' ' A' ' 396' ' ' CYS . 2.8 p -97.85 120.82 38.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.562 1.164 . . . . 73.23 108.289 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 48.8 m -41.11 -59.17 1.56 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.501 1.126 . . . . 62.54 110.339 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 2.7 t -49.3 -36.24 20.32 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.518 1.136 . . . . 63.23 109.999 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' CYS . . . . . 0.57 ' HB3' HG21 ' A' ' 375' ' ' ILE . 2.2 m -71.06 -38.17 72.51 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.461 1.101 . . . . 73.24 108.3 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.698 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -65.03 -36.57 84.8 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.511 1.132 . . . . 63.31 109.32 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 45.8 m -61.96 -45.47 93.51 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.54 1.15 . . . . 51.41 110.392 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -56.77 -23.87 46.14 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.496 1.123 . . . . 55.42 109.304 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' TRP . . . . . 0.601 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 15.8 t-105 -85.13 -65.22 1.03 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.498 1.124 . . . . 72.14 108.023 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.506 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 39.8 mm-40 -48.94 -20.85 0.56 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.53 1.144 . . . . 74.24 110.349 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 401' ' ' GLN . 2.7 mm-40 -37.45 -63.66 0.43 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.123 . . . . 74.32 110.347 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 42.6 t -122.77 -24.46 4.84 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 74.03 110.006 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 404' ' ' ASP . . . . . 0.601 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 18.6 m-20 -82.42 -93.67 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.503 1.127 . . . . 71.05 109.326 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.506 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 66.8 21.74 71.43 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 124.493 1.121 . . . . 74.31 110.991 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -80.34 59.72 3.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.476 0.75 . . . . 64.14 110.337 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 71.67 -165.58 53.6 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.481 1.113 . . . . 55.11 110.99 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' CYS . . . . . 0.808 ' SG ' HG21 ' A' ' 385' ' ' ILE . 1.8 t -56.2 120.9 38.24 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.296 -1.001 . . . . 73.31 108.296 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.427 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.3 Cg_endo -75.04 -0.01 9.47 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.496 1.787 . . . . 64.54 111.015 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 410' ' ' PHE . . . . . 0.559 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 3.5 m-85 -91.51 -37.01 13.4 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.46 1.1 . . . . 72.33 111.014 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 411' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.6 OUTLIER -127.38 17.33 7.06 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.106 . . . . 63.32 108.253 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 412' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 408' ' ' CYS . 6.3 tpp180 38.69 30.12 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.505 1.128 . . . . 75.54 110.279 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 411' ' ' CYS . 51.1 t -114.41 138.72 50.21 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.545 1.153 . . . . 64.34 108.325 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 414' ' ' GLU . . . . . 0.444 ' CG ' ' N ' ' A' ' 415' ' ' ILE . 34.1 tt0 -45.11 159.0 0.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 1.113 . . . . 74.14 110.317 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.704 HG23 HG23 ' A' ' 385' ' ' ILE . 2.3 mt -113.22 157.04 14.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 72.44 109.271 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 10.4 mttm -132.3 -47.17 0.91 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.53 1.144 . . . . 74.52 109.286 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.526 ' O ' HG23 ' A' ' 418' ' ' THR . . . -109.51 130.78 10.15 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.493 1.121 . . . . 71.53 111.015 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 418' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 417' ' ' GLY . 20.8 p -157.2 118.5 3.68 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.492 0.76 . . . . 51.55 110.409 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -141.57 151.44 60.55 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.539 1.149 . . . . 52.41 110.28 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.03 101.3 1.45 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.474 1.776 . . . . 65.11 110.988 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.898 HD12 ' N ' ' A' ' 422' ' ' ILE . 1.1 pp -105.94 178.19 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.463 1.102 . . . . 64.35 109.253 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 422' ' ' ILE . . . . . 0.898 ' N ' HD12 ' A' ' 421' ' ' ILE . 6.1 mt -139.69 111.81 5.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.502 1.126 . . . . 72.53 109.292 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.566 ' CG2' HD11 ' A' ' 421' ' ' ILE . 18.5 t -84.04 142.71 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.477 1.111 . . . . 74.43 109.304 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -131.1 143.73 50.62 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 50.42 109.309 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 174.98 11.86 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.489 1.784 . . . . 73.4 110.956 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' PHE . . . . . 0.464 ' CD2' ' O ' ' A' ' 355' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.521 1.138 . . . . 75.15 111.004 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.028 0 N-CA-C 111.027 -0.829 . . . . 65.43 111.027 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 178.31 7.44 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.536 1.809 . . . . 54.45 110.992 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -174.49 150.19 1.38 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.537 1.148 . . . . 73.33 109.57 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 39.7 mtp -154.19 133.63 12.72 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.464 1.102 . . . . 72.24 111.014 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 97.94 50.34 1.64 Allowed Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.527 1.142 . . . . 61.23 111.008 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 69.9 m -143.37 154.28 43.57 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.502 0.766 . . . . 73.32 109.973 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' ASP . . . . . 0.566 ' HB2' HG22 ' A' ' 421' ' ' ILE . 11.4 m-20 -98.43 171.99 7.81 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.476 1.11 . . . . 74.5 109.281 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 352' ' ' HIS . . . . . 0.416 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 22.4 m-70 -130.37 126.59 37.48 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.474 1.109 . . . . 73.11 109.581 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.518 HG13 HD13 ' A' ' 421' ' ' ILE . 48.0 mt -115.76 127.39 73.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.486 1.116 . . . . 72.33 109.326 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 8.4 tptp -105.58 118.85 37.64 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.544 1.152 . . . . 65.21 109.304 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 424' ' ' ASP . 48.5 t -59.39 164.03 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.528 1.142 . . . . 71.0 109.288 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.455 ' N ' ' CG1' ' A' ' 355' ' ' VAL . 3.0 p -122.89 146.12 47.86 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.506 1.129 . . . . 63.13 110.37 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 357' ' ' GLN . . . . . 0.577 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 16.5 mt-30 -42.46 -53.72 4.17 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 71.23 110.288 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -39.95 -41.22 1.15 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.468 1.105 . . . . 62.03 110.327 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -67.06 -66.84 0.51 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.475 1.109 . . . . 61.04 110.305 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' TYR . . . . . 0.431 ' O ' ' N ' ' A' ' 364' ' ' CYS . 8.4 t80 -40.61 -52.22 2.9 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.434 1.084 . . . . 65.51 110.991 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -55.4 -44.02 75.76 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.493 1.12 . . . . 72.12 110.273 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.1 tt -63.12 -34.24 77.19 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.481 1.113 . . . . 63.53 109.331 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' PTR . . . . . 0.438 ' O ' ' N ' ' A' ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m -65.59 -34.27 77.86 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.508 1.13 . . . . 54.31 108.327 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -62.29 -18.62 61.79 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.472 1.107 . . . . 52.22 110.29 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -128.4 8.52 5.98 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.473 1.108 . . . . 73.15 110.995 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 367' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 363' ' ' PTR . . . 38.04 63.61 0.89 Allowed Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.521 1.138 . . . . 71.5 111.042 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 64.1 p -132.09 -174.03 3.32 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.463 0.743 . . . . 71.14 110.009 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.484 ' O ' ' CE ' ' A' ' 374' ' ' LYS . 33.7 p -126.47 146.53 50.06 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.535 1.147 . . . . 62.03 110.388 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.456 ' CE2' HG11 ' A' ' 423' ' ' VAL . 31.8 t80 -77.23 -63.83 1.28 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.489 1.118 . . . . 62.4 111.003 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.563 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -40.71 -28.78 0.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.489 1.118 . . . . 70.4 110.323 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.721 HD11 ' HA ' ' A' ' 377' ' ' ALA . 3.0 tm? -67.3 139.91 57.29 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.116 . . . . 65.44 109.283 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 373' ' ' CYS . . . . . 0.72 ' N ' HD13 ' A' ' 372' ' ' LEU . 1.9 t -76.16 126.17 30.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.016 -0.993 . . . . 75.3 110.925 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.484 ' CE ' ' O ' ' A' ' 369' ' ' THR . 12.9 mmtm -91.06 18.51 6.69 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.527 1.142 . . . . 53.24 109.297 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 20.3 mt -99.17 -51.61 9.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.457 1.098 . . . . 65.53 109.306 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.54 -30.3 8.32 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.512 1.132 . . . . 60.31 108.305 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.721 ' HA ' HD11 ' A' ' 372' ' ' LEU . . . 65.82 43.69 3.05 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.545 1.153 . . . . 74.05 109.279 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -136.29 -61.89 0.68 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.53 1.144 . . . . 73.24 110.301 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -96.88 161.43 13.85 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.471 1.107 . . . . 72.11 109.298 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 37.4 p30 -81.14 160.73 24.33 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.517 1.136 . . . . 74.21 109.314 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.461 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 23.4 mttt -65.01 -62.49 1.52 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.49 1.119 . . . . 73.1 109.308 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 9.7 t70 60.07 27.05 16.44 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.501 1.126 . . . . 73.32 109.309 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.922 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -157.94 175.26 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.442 1.089 . . . . 72.35 109.313 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.424 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 17.0 tttp -159.4 140.86 13.02 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.481 1.113 . . . . 75.42 109.316 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 1.059 HD12 HD13 ' A' ' 415' ' ' ILE . 24.6 mm -104.91 132.74 50.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.511 1.132 . . . . 71.13 109.268 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.511 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 10.8 mt-10 -137.79 161.08 62.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 74.31 110.312 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.511 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -75.01 -4.65 20.7 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 121.012 -2.495 . . . . 61.45 110.989 0.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 388' ' ' CYS . . . . . 0.523 ' SG ' ' CD2' ' A' ' 390' ' ' HIS . 25.2 t -37.6 -77.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.986 -1.007 . . . . 52.34 110.939 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 389' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 118.72 35.45 0.98 Allowed Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.566 1.166 . . . . 45.52 111.01 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.523 ' CD2' ' SG ' ' A' ' 388' ' ' CYS . 51.7 m170 -108.51 126.89 53.43 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.504 0.767 . . . . 71.22 109.579 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.71 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -97.56 157.53 15.97 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.465 1.103 . . . . 74.31 109.306 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.922 ' O ' HG12 ' A' ' 383' ' ' VAL . 11.4 ptp -173.81 173.71 3.23 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.492 1.12 . . . . 71.25 110.99 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 19.4 p -90.39 140.88 29.29 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 73.4 108.303 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 48.4 m -61.93 -43.35 99.03 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.433 1.083 . . . . 75.31 110.394 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 23.3 t -55.37 -64.54 0.81 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.459 1.099 . . . . 74.23 110.021 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' CYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 399' ' ' ALA . 1.6 p -50.24 -51.38 45.02 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.518 1.136 . . . . 65.01 108.323 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.447 HD13 ' C ' ' A' ' 397' ' ' LEU . 1.3 tm? -45.13 -49.53 11.8 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.496 1.123 . . . . 75.22 109.292 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 76.5 m -54.59 -38.63 66.97 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.509 1.131 . . . . 75.54 110.427 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -60.71 -25.13 66.2 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.461 1.1 . . . . 75.21 109.375 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 400' ' ' TRP . . . . . 0.602 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 10.7 t-105 -85.7 -62.75 1.45 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.498 1.124 . . . . 70.04 108.02 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.49 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 8.2 mm-40 -55.98 -14.34 2.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.545 1.153 . . . . 63.32 110.323 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 401' ' ' GLN . 0.6 OUTLIER -37.23 -63.29 0.44 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.495 1.122 . . . . 60.42 110.302 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 7.8 t -121.13 -24.58 5.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.499 1.124 . . . . 61.32 109.968 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' ASP . . . . . 0.602 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 8.7 m-20 -83.0 -94.86 0.06 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.484 1.115 . . . . 74.02 109.327 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.49 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 73.3 28.99 64.94 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.469 1.106 . . . . 72.23 111.01 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -90.91 70.36 6.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.446 0.733 . . . . 70.53 110.307 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 66.58 -169.03 34.31 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.559 1.162 . . . . 54.33 110.993 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' CYS . . . . . 0.464 ' HB2' HG21 ' A' ' 385' ' ' ILE . 6.0 t -56.55 131.55 77.21 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.329 -0.989 . . . . 63.14 108.329 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 0.34 9.05 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.475 1.776 . . . . 74.31 110.958 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -93.66 -55.63 3.19 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.462 1.101 . . . . 51.31 110.969 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' CYS . . . . . 0.451 ' O ' ' N ' ' A' ' 413' ' ' CYS . 2.6 p -98.56 10.07 41.8 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.558 1.161 . . . . 61.01 108.319 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 412' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 411' ' ' CYS . 3.4 tpt85 38.59 30.19 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.475 1.11 . . . . 63.01 110.325 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' CYS . . . . . 0.451 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.5 m -115.48 154.24 29.67 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.489 1.118 . . . . 54.41 108.309 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -59.35 156.6 12.43 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.531 1.144 . . . . 75.45 110.284 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 1.059 HD13 HD12 ' A' ' 385' ' ' ILE . 5.6 mt -115.48 157.1 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 61.03 109.345 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.405 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 5.9 mmtp -120.26 -44.5 2.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.529 1.143 . . . . 75.24 109.269 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.506 ' C ' HG23 ' A' ' 418' ' ' THR . . . -112.44 127.78 8.19 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.461 1.1 . . . . 63.42 111.009 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 418' ' ' THR . . . . . 0.543 ' CG2' HG21 ' A' ' 415' ' ' ILE . 34.9 p -156.56 125.51 5.97 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.531 0.783 . . . . 71.13 110.419 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 421' ' ' ILE . 4.4 pt-20 -158.06 151.43 18.94 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.484 1.115 . . . . 61.42 110.3 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 99.17 1.23 Allowed 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.551 1.817 . . . . 73.32 111.031 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.877 HD11 HG22 ' A' ' 423' ' ' VAL . 0.8 OUTLIER -104.38 163.93 3.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.48 1.113 . . . . 71.45 109.341 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 422' ' ' ILE . . . . . 0.717 ' N ' HD12 ' A' ' 421' ' ' ILE . 3.3 mp -113.18 105.44 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.496 1.123 . . . . 74.23 109.301 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.877 HG22 HD11 ' A' ' 421' ' ' ILE . 12.9 t -78.22 140.19 17.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.465 1.103 . . . . 65.12 109.307 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.767 ' O ' HG23 ' A' ' 355' ' ' VAL . 23.6 m-20 -130.2 143.72 50.32 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.519 1.137 . . . . 70.14 109.309 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 160.29 40.29 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.493 1.786 . . . . 63.24 110.96 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' PHE . . . . . 0.577 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 26.4 t80 . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.481 1.113 . . . . 64.32 111.033 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.994 0 N-CA-C 111.024 -0.83 . . . . 41.55 111.024 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.92 178.65 6.96 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.446 1.761 . . . . 74.52 111.02 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -95.61 -177.05 3.94 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.456 1.098 . . . . 74.3 109.587 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 7.4 mmt -109.86 19.23 19.31 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.127 . . . . 74.34 111.001 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -97.45 -16.96 32.74 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.48 1.113 . . . . 73.52 110.991 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 3.2 p -77.86 137.08 38.19 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.521 0.777 . . . . 63.42 109.967 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -87.22 -177.28 5.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.463 1.102 . . . . 74.21 109.263 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' HIS . . . . . 0.543 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 25.0 m-70 -138.3 149.9 46.12 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.509 1.13 . . . . 71.3 109.588 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.47 HG13 HD13 ' A' ' 421' ' ' ILE . 7.7 mt -136.11 158.65 38.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.564 1.165 . . . . 63.23 109.266 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.411 ' N ' ' CG2' ' A' ' 353' ' ' ILE . 0.1 OUTLIER -123.38 152.74 41.23 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.461 1.1 . . . . 64.31 109.317 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.667 HG22 ' CD2' ' A' ' 370' ' ' PHE . 9.2 t -107.94 162.05 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 71.31 109.288 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.466 ' N ' ' CG1' ' A' ' 355' ' ' VAL . 13.1 p -112.95 158.7 19.91 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.499 1.124 . . . . 71.43 110.43 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 357' ' ' GLN . . . . . 0.525 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 11.5 mt-30 -59.87 -45.7 91.66 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.54 1.15 . . . . 71.32 110.341 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -49.25 -44.92 44.08 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.495 1.122 . . . . 71.14 110.299 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -66.42 -43.49 85.57 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.445 1.091 . . . . 54.34 110.311 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -58.26 -27.22 63.81 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.453 1.095 . . . . 73.51 110.953 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -89.58 -40.39 12.64 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.527 1.142 . . . . 72.2 110.358 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.994 ' O ' HD12 ' A' ' 362' ' ' LEU . 0.5 OUTLIER -63.87 -32.82 74.47 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.127 . . . . 65.14 109.3 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 363' ' ' PTR . . . . . 0.597 ' CE1' ' NZ ' ' A' ' 374' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.64 -54.87 37.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.517 1.135 . . . . 63.12 108.287 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -41.55 -66.68 0.32 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.546 1.154 . . . . 72.04 110.264 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' MET . . . . . 0.41 ' CG ' ' O ' ' A' ' 363' ' ' PTR . 19.1 ptp -53.73 -34.49 59.09 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.486 1.116 . . . . 71.32 111.001 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 88.45 50.21 3.45 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.429 1.081 . . . . 61.35 110.953 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 3.3 m -146.21 179.05 7.77 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.498 0.763 . . . . 70.35 109.989 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.772 HG22 ' NE2' ' A' ' 371' ' ' GLN . 2.3 m -117.89 160.66 21.04 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.528 1.143 . . . . 74.12 110.395 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.667 ' CD2' HG22 ' A' ' 355' ' ' VAL . 64.3 t80 -62.59 -68.67 0.31 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.53 1.144 . . . . 61.53 111.015 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.772 ' NE2' HG22 ' A' ' 369' ' ' THR . 0.1 OUTLIER -47.33 -24.95 0.87 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.529 1.143 . . . . 73.23 110.283 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.418 ' CD2' ' HA ' ' A' ' 377' ' ' ALA . 0.0 OUTLIER -69.75 117.7 11.67 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 44.53 109.236 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 25.1 t -52.22 145.24 11.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.947 -1.024 . . . . 64.14 110.89 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.597 ' NZ ' ' CE1' ' A' ' 363' ' ' PTR . 25.5 mmtp -103.36 24.26 11.25 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.463 1.102 . . . . 42.32 109.267 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 0.743 HD11 ' HE1' ' A' ' 410' ' ' PHE . 52.8 mt -111.47 -49.29 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.451 1.094 . . . . 62.24 109.316 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 3.5 m -109.04 -32.65 7.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.501 1.126 . . . . 34.32 108.285 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.418 ' HA ' ' CD2' ' A' ' 372' ' ' LEU . . . 61.03 28.21 18.0 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.499 1.124 . . . . 33.2 109.322 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -121.83 -40.32 2.54 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.497 1.123 . . . . 53.3 110.28 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -115.53 169.65 9.02 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.514 1.134 . . . . 74.5 109.294 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -87.52 166.19 14.94 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 72.45 109.354 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.454 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 19.2 mttt -67.12 -62.53 1.38 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.476 1.11 . . . . 65.41 109.268 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 4.8 t0 60.56 20.89 10.71 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.452 1.095 . . . . 75.32 109.281 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.928 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -151.19 175.42 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.539 1.149 . . . . 61.25 109.285 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.416 ' H ' HG22 ' A' ' 383' ' ' VAL . 20.8 tttm -158.13 156.66 31.32 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.492 1.12 . . . . 64.03 109.318 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.859 HG22 ' SG ' ' A' ' 388' ' ' CYS . 11.8 mm -122.72 144.3 32.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.562 1.164 . . . . 54.31 109.331 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.536 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.4 mt-10 -137.74 162.4 54.72 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.501 1.125 . . . . 61.03 110.282 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.536 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.03 -12.15 24.12 Favored 'Cis proline' 0 C--N 1.36 1.172 0 C-N-CA 121.032 -2.487 . . . . 42.44 110.986 0.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 388' ' ' CYS . . . . . 0.859 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.63 -71.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.04 -0.982 . . . . 72.33 110.881 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 389' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 115.77 18.15 6.16 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.492 1.12 . . . . 72.45 111.022 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.529 ' CE1' ' HB2' ' A' ' 388' ' ' CYS . 20.0 m170 -75.58 147.13 39.88 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.529 0.782 . . . . 74.24 109.565 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.813 HD22 ' N ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -117.3 156.47 27.75 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.132 . . . . 65.3 109.308 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.928 ' O ' HG12 ' A' ' 383' ' ' VAL . 18.8 ptp -172.01 173.54 4.36 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.502 1.126 . . . . 75.23 110.958 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 26.1 p -95.18 126.08 40.26 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.471 1.107 . . . . 70.34 108.278 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 6.4 m -54.12 -56.25 19.86 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.508 1.13 . . . . 74.04 110.381 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.6 t -43.61 -30.71 0.64 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.546 1.153 . . . . 42.32 109.988 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 2.5 m -80.79 -52.32 7.64 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.544 1.153 . . . . 63.12 108.287 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.683 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.7 OUTLIER -43.56 -37.91 2.72 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.452 1.095 . . . . 74.31 109.326 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 1.1 m -60.75 -46.8 89.07 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.482 1.114 . . . . 74.41 110.413 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -58.12 -21.94 48.68 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.482 1.114 . . . . 71.24 109.308 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' TRP . . . . . 0.608 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 8.9 t-105 -84.77 -64.88 1.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.523 1.139 . . . . 75.1 108.006 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.497 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.6 mm-40 -52.77 -16.99 1.13 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.472 1.107 . . . . 74.12 110.319 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 401' ' ' GLN . 5.8 mm-40 -37.09 -63.42 0.43 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.492 1.12 . . . . 73.14 110.303 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 2.8 m -120.61 -24.51 5.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.496 1.122 . . . . 72.21 109.995 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' ASP . . . . . 0.608 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 16.6 m-20 -82.09 -94.51 0.05 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.114 . . . . 70.13 109.282 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.497 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 70.5 29.96 69.38 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.488 1.117 . . . . 43.41 110.981 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -91.71 68.0 5.48 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.567 0.804 . . . . 75.44 110.279 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 66.0 -166.46 36.55 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.471 1.107 . . . . 64.1 110.976 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' CYS . . . . . 0.693 ' SG ' HG21 ' A' ' 385' ' ' ILE . 6.5 t -57.31 128.9 79.37 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 108.324 -0.991 . . . . 65.54 108.324 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 0.3 9.07 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.511 1.795 . . . . 71.25 110.958 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' PHE . . . . . 0.743 ' HE1' HD11 ' A' ' 375' ' ' ILE . 3.2 m-85 -97.91 -41.54 7.96 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.505 1.128 . . . . 74.34 111.019 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 411' ' ' CYS . . . . . 0.444 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.1 OUTLIER -111.32 8.98 21.58 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.522 1.138 . . . . 61.04 108.284 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 412' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 408' ' ' CYS . 8.0 tpp85 38.49 30.28 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.546 1.154 . . . . 72.23 110.294 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 413' ' ' CYS . . . . . 0.444 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.3 m -123.09 164.85 17.83 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.501 1.126 . . . . 74.3 108.265 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -63.07 145.08 56.23 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.494 1.121 . . . . 71.12 110.281 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.739 HG23 HG23 ' A' ' 385' ' ' ILE . 1.6 mt -94.92 147.01 6.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.522 1.139 . . . . 61.52 109.304 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -117.26 -43.78 2.82 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.489 1.118 . . . . 75.12 109.305 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.453 ' C ' HG23 ' A' ' 418' ' ' THR . . . -119.21 130.0 8.34 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.452 1.095 . . . . 75.33 110.976 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 418' ' ' THR . . . . . 0.578 ' CG2' HG21 ' A' ' 415' ' ' ILE . 80.6 p -152.69 138.86 18.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.477 0.751 . . . . 62.22 110.359 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -171.86 151.12 2.69 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.458 1.099 . . . . 74.05 110.275 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.08 101.66 1.5 Allowed 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.518 1.799 . . . . 63.0 110.981 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.793 HD11 HG22 ' A' ' 423' ' ' VAL . 0.8 OUTLIER -104.18 159.42 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.444 1.09 . . . . 73.15 109.289 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 422' ' ' ILE . . . . . 0.543 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 8.1 mt -111.47 105.51 18.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.488 1.118 . . . . 45.11 109.27 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.793 HG22 HD11 ' A' ' 421' ' ' ILE . 39.5 t -76.97 146.78 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.509 1.131 . . . . 73.0 109.322 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.514 ' O ' HG23 ' A' ' 355' ' ' VAL . 9.3 m-20 -129.49 143.87 50.63 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.478 1.111 . . . . 60.41 109.34 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.96 174.05 13.45 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.492 1.785 . . . . 72.1 110.993 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' PHE . . . . . 0.525 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 4.8 t80 . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.118 . . . . 74.4 111.058 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.966 0 N-CA-C 111.018 -0.833 . . . . 74.41 111.018 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 178.39 7.33 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.502 1.791 . . . . 64.12 110.958 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -78.63 129.13 34.41 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.479 1.112 . . . . 61.44 109.612 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 18.9 mtt -118.97 -47.64 2.49 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.486 1.116 . . . . 75.14 111.044 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 125.6 -21.11 6.39 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.496 1.123 . . . . 25.0 110.983 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 67.0 m -51.99 148.95 5.45 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.484 0.755 . . . . 63.04 109.966 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -94.22 -174.75 3.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.488 1.117 . . . . 72.24 109.28 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' HIS . . . . . 0.568 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 28.9 m-70 -140.15 141.55 36.04 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.551 1.157 . . . . 74.35 109.578 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' A' ' 354' ' ' LYS . 3.7 mm -128.2 158.46 40.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.445 1.091 . . . . 64.04 109.293 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.404 ' N ' ' CG2' ' A' ' 353' ' ' ILE . 0.0 OUTLIER -117.91 153.66 33.21 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.498 1.124 . . . . 74.02 109.304 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 424' ' ' ASP . 14.3 t -105.44 149.12 9.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.115 . . . . 75.2 109.272 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 19.8 p -117.2 176.9 4.93 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.485 1.116 . . . . 72.35 110.395 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -74.49 -33.85 62.94 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.497 1.123 . . . . 73.22 110.292 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' GLU . . . . . 0.41 ' CG ' ' N ' ' A' ' 359' ' ' GLN . 15.3 pt-20 -57.98 -47.64 82.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.474 1.109 . . . . 75.22 110.305 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 359' ' ' GLN . . . . . 0.41 ' N ' ' CG ' ' A' ' 358' ' ' GLU . 29.1 mm-40 -60.9 -66.65 0.5 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 74.14 110.297 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 360' ' ' TYR . . . . . 0.41 ' O ' ' N ' ' A' ' 364' ' ' CYS . 4.9 t80 -44.02 -42.9 6.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 75.11 110.995 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -65.71 -42.38 91.19 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.453 1.096 . . . . 73.13 110.263 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.7 tp -62.03 -39.36 92.06 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.47 1.106 . . . . 64.11 109.338 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 364' ' ' CYS . . . . . 0.41 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.7 m -63.27 -21.93 66.55 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.491 1.119 . . . . 71.25 108.302 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -75.47 -29.28 59.55 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.525 1.141 . . . . 62.2 110.305 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' MET . . . . . 0.405 ' SD ' ' N ' ' A' ' 366' ' ' MET . 0.0 OUTLIER -113.49 21.02 15.55 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.514 1.134 . . . . 53.42 110.979 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 37.78 47.71 1.8 Allowed Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.448 1.093 . . . . 75.14 110.987 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 31.6 m -121.42 152.84 38.61 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.504 0.767 . . . . 62.42 109.989 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.527 HG22 ' OE1' ' A' ' 371' ' ' GLN . 2.2 m -98.51 159.77 14.72 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 72.24 110.369 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.535 ' CD1' HG11 ' A' ' 423' ' ' VAL . 5.9 t80 -66.34 -65.66 0.65 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.483 1.114 . . . . 74.53 110.981 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.527 ' OE1' HG22 ' A' ' 369' ' ' THR . 0.0 OUTLIER -53.34 -32.8 50.85 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.128 . . . . 64.44 110.322 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.883 HD22 ' N ' ' A' ' 373' ' ' CYS . 0.7 OUTLIER -58.67 135.87 57.52 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.507 1.129 . . . . 65.13 109.278 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 373' ' ' CYS . . . . . 0.883 ' N ' HD22 ' A' ' 372' ' ' LEU . 16.4 t -76.68 135.91 39.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.965 -1.016 . . . . 74.43 110.896 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.402 ' HD2' ' N ' ' A' ' 374' ' ' LYS . 0.6 OUTLIER -92.94 22.17 5.13 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.506 1.129 . . . . 73.45 109.317 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 5.0 mt -110.68 -52.18 6.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.524 1.14 . . . . 61.54 109.33 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 7.5 m -102.75 -27.04 12.93 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.485 1.116 . . . . 45.04 108.313 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.704 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 55.52 29.05 12.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.464 1.103 . . . . 54.01 109.327 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -122.45 -40.86 2.43 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.468 1.105 . . . . 74.45 110.31 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -119.06 -179.94 3.98 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.463 1.102 . . . . 65.3 109.348 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -89.55 171.76 9.46 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.52 1.137 . . . . 73.12 109.327 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.449 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 11.6 mttt -79.14 -62.49 1.68 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 74.42 109.284 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 15.7 t0 62.4 22.2 13.07 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.464 1.102 . . . . 74.15 109.324 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.872 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -158.25 172.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.488 1.117 . . . . 71.5 109.298 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.404 ' CE ' ' HA2' ' A' ' 389' ' ' GLY . 76.4 tttt -156.74 159.5 38.39 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.464 1.102 . . . . 74.24 109.312 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.886 HG22 ' SG ' ' A' ' 388' ' ' CYS . 18.1 mm -117.21 139.92 42.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.522 1.138 . . . . 70.25 109.298 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.534 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.9 mt-10 -130.61 162.26 55.93 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.446 1.091 . . . . 64.43 110.271 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.534 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.4 Cg_endo -74.93 -14.72 22.76 Favored 'Cis proline' 0 C--N 1.36 1.157 0 C-N-CA 121.034 -2.486 . . . . 63.41 110.986 -0.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 388' ' ' CYS . . . . . 0.886 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.82 -87.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.047 -0.979 . . . . 55.4 110.915 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 389' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 130.91 42.9 0.19 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.467 1.104 . . . . 41.33 111.027 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.499 ' C ' HD13 ' A' ' 391' ' ' LEU . 27.8 m170 -97.45 131.49 44.04 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.49 0.759 . . . . 73.44 109.643 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.697 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -100.21 151.83 20.99 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.462 1.102 . . . . 70.11 109.309 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.872 ' O ' HG12 ' A' ' 383' ' ' VAL . 16.8 ptp -167.61 170.74 10.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.536 1.147 . . . . 75.22 110.933 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 26.1 p -97.14 115.28 27.25 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.452 1.095 . . . . 74.21 108.334 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 24.3 m -39.71 -58.69 1.28 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.552 1.157 . . . . 34.54 110.389 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.4 t -42.64 -43.61 3.91 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.513 1.133 . . . . 53.25 110.004 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' CYS . . . . . 0.401 ' O ' ' N ' ' A' ' 399' ' ' ALA . 3.6 m -67.52 -55.2 14.44 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.474 1.109 . . . . 61.34 108.293 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.749 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -44.15 -36.26 2.55 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.476 1.11 . . . . 73.31 109.308 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 17.5 m -61.35 -46.06 91.79 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 71.5 110.436 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -56.89 -22.6 38.46 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.458 1.098 . . . . 75.04 109.302 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 400' ' ' TRP . . . . . 0.605 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 9.1 t-105 -85.56 -64.77 1.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.982 -1.118 . . . . 73.02 107.982 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.497 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 10.1 mm-40 -52.94 -16.88 1.16 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 72.24 110.316 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 401' ' ' GLN . 5.1 mt-10 -37.16 -63.29 0.44 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.489 1.118 . . . . 73.23 110.323 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 5.4 t -120.51 -24.46 5.81 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.443 1.089 . . . . 53.53 109.986 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' ASP . . . . . 0.605 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 4.6 m-20 -82.62 -95.08 0.05 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.478 1.111 . . . . 65.34 109.288 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.497 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 70.57 32.45 67.6 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.57 1.169 . . . . 62.52 110.992 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -92.02 66.94 5.06 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 0.773 . . . . 74.23 110.344 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 66.19 -161.89 44.1 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.532 1.145 . . . . 64.55 111.05 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' CYS . . . . . 0.673 ' SG ' HG21 ' A' ' 385' ' ' ILE . 5.5 t -60.21 126.25 83.58 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 108.332 -0.988 . . . . 74.12 108.332 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.06 -1.56 11.39 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.518 1.799 . . . . 65.04 110.998 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -94.9 -42.19 8.8 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 1.136 . . . . 65.32 111.001 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' CYS . . . . . 0.445 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.2 OUTLIER -111.79 10.45 20.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.135 . . . . 52.31 108.265 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 412' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 408' ' ' CYS . 4.8 tpt180 38.48 30.35 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.534 1.146 . . . . 75.34 110.316 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 413' ' ' CYS . . . . . 0.445 ' N ' ' O ' ' A' ' 411' ' ' CYS . 16.0 t -125.3 145.65 49.92 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.487 1.117 . . . . 74.53 108.311 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -46.59 152.67 0.44 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.552 1.158 . . . . 73.32 110.292 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.798 HG23 HG23 ' A' ' 385' ' ' ILE . 2.1 mt -100.54 153.11 4.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.463 1.102 . . . . 63.4 109.323 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.468 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 5.1 mmtt -113.98 -46.24 3.02 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 74.25 109.273 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.457 ' C ' HG23 ' A' ' 418' ' ' THR . . . -121.5 129.66 7.81 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.466 1.103 . . . . 72.45 111.03 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 418' ' ' THR . . . . . 0.647 ' CG2' HG21 ' A' ' 415' ' ' ILE . 82.8 p -152.96 136.17 15.7 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.473 0.749 . . . . 64.5 110.378 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 13.4 pm0 -168.1 150.54 5.27 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.534 1.146 . . . . 63.32 110.327 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.4 Cg_endo -74.95 102.11 1.55 Allowed 'Trans proline' 0 C--N 1.359 1.11 0 O-C-N 124.514 1.797 . . . . 74.25 111.052 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.885 HD11 HG22 ' A' ' 423' ' ' VAL . 0.7 OUTLIER -103.9 156.4 5.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.475 1.11 . . . . 70.2 109.308 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 422' ' ' ILE . . . . . 0.568 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 14.2 mt -110.39 105.9 19.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.501 1.125 . . . . 74.33 109.293 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.885 HG22 HD11 ' A' ' 421' ' ' ILE . 18.7 t -77.79 146.74 7.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.493 1.12 . . . . 73.15 109.302 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.639 ' O ' HG23 ' A' ' 355' ' ' VAL . 76.0 m-20 -129.2 143.55 49.28 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.504 1.127 . . . . 64.13 109.299 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 174.03 13.5 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.529 1.805 . . . . 64.03 111.018 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' PHE . . . . . 0.483 ' CD1' ' C ' ' A' ' 426' ' ' PHE . 2.8 t80 . . . . . 0 C--N 1.325 -0.491 0 O-C-N 124.482 1.114 . . . . 73.53 111.01 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.019 0 N-CA-C 111.009 -0.836 . . . . 72.13 111.009 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 178.68 6.94 Favored 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.54 1.81 . . . . 71.22 111.005 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -69.33 -174.6 0.68 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.449 1.093 . . . . 71.34 109.626 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 6.0 ptt? -130.98 6.31 4.6 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.499 1.124 . . . . 71.04 111.031 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -90.54 -10.56 63.39 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.502 1.126 . . . . 62.21 111.02 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 2.3 p -87.36 144.43 26.77 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.473 0.749 . . . . 73.3 109.993 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -91.28 -178.09 5.04 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.539 1.149 . . . . 74.01 109.297 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' HIS . . . . . 0.534 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 25.9 m-70 -138.95 140.87 38.41 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.53 1.143 . . . . 53.13 109.608 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.454 HG13 HD13 ' A' ' 421' ' ' ILE . 35.8 mt -130.16 136.02 59.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.125 . . . . 74.41 109.311 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -103.37 129.93 50.56 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.471 1.107 . . . . 72.11 109.319 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 424' ' ' ASP . 12.7 t -77.56 157.62 5.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 75.1 109.328 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.5 p -122.25 148.81 44.54 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.505 1.128 . . . . 62.32 110.398 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' GLN . . . . . 0.618 ' CG ' ' CE2' ' A' ' 426' ' ' PHE . 3.1 mt-30 -47.52 -38.44 14.06 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.133 . . . . 72.01 110.29 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -58.28 -37.1 74.32 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.511 1.132 . . . . 71.02 110.296 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -74.56 -66.74 0.7 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.52 1.138 . . . . 44.44 110.292 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' TYR . . . . . 0.42 ' O ' ' N ' ' A' ' 364' ' ' CYS . 7.0 t80 -40.98 -62.07 0.88 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.553 1.158 . . . . 75.51 111.056 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -48.84 -48.83 41.47 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.535 1.147 . . . . 73.41 110.303 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 9.9 tt -58.62 -32.4 68.99 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.493 1.121 . . . . 35.01 109.313 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' PTR . . . . . 0.657 ' CD1' ' HZ1' ' A' ' 374' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' CYS . . . . . 0.42 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m -67.5 -27.33 66.91 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.55 1.156 . . . . 71.31 108.318 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -77.23 -8.24 57.25 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.493 1.121 . . . . 52.22 110.342 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 8.0 mmt -102.61 -29.93 11.25 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.528 1.143 . . . . 55.41 111.003 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 89.93 30.01 14.04 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.498 1.124 . . . . 54.21 110.997 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 1.1 p -144.66 -175.01 4.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.469 0.746 . . . . 71.32 109.991 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.416 ' O ' ' CE ' ' A' ' 374' ' ' LYS . 11.7 p -118.79 167.32 11.81 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.452 1.095 . . . . 72.3 110.395 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.574 ' CD2' HG11 ' A' ' 423' ' ' VAL . 38.2 t80 -71.2 -65.37 0.75 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 63.41 110.999 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.542 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.3 OUTLIER -43.67 -27.2 0.29 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 51.14 110.335 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.901 HD22 ' N ' ' A' ' 373' ' ' CYS . 0.5 OUTLIER -74.16 136.08 42.86 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.472 1.108 . . . . 71.01 109.309 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 373' ' ' CYS . . . . . 0.901 ' N ' HD22 ' A' ' 372' ' ' LEU . 32.1 p -68.48 130.75 43.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.008 -0.996 . . . . 71.55 110.878 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.657 ' HZ1' ' CD1' ' A' ' 363' ' ' PTR . 28.8 mmtp -92.97 31.46 1.41 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.488 1.118 . . . . 75.21 109.337 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 0.655 HD11 ' HE1' ' A' ' 410' ' ' PHE . 18.8 mt -112.31 -59.74 3.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.509 1.13 . . . . 34.52 109.276 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 4.0 m -107.41 -22.01 12.72 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.471 1.107 . . . . 54.24 108.312 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.703 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 54.76 40.3 31.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.511 1.132 . . . . 64.31 109.335 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -121.51 -40.28 2.58 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.499 1.125 . . . . 74.33 110.322 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -124.03 179.18 4.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.527 1.142 . . . . 71.3 109.278 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -89.45 165.84 14.07 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.557 1.161 . . . . 72.44 109.307 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.467 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 17.2 mttt -66.49 -62.63 1.36 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.561 1.163 . . . . 75.22 109.28 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 33.9 t0 59.91 22.71 11.74 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.51 1.131 . . . . 52.11 109.301 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.901 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -156.75 174.62 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.524 1.14 . . . . 53.13 109.29 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.405 ' CG ' ' N ' ' A' ' 385' ' ' ILE . 47.1 tttt -158.44 158.48 34.23 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.442 1.089 . . . . 64.22 109.311 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.831 HG22 ' SG ' ' A' ' 388' ' ' CYS . 14.8 mm -118.32 144.75 25.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.521 1.138 . . . . 74.03 109.268 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.537 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.0 mt-10 -136.86 162.35 56.36 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.435 1.084 . . . . 74.03 110.291 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.537 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.04 -13.69 23.59 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 121.023 -2.491 . . . . 75.32 111.02 0.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 388' ' ' CYS . . . . . 0.831 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.8 -84.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.953 -1.021 . . . . 45.52 110.892 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 128.36 41.99 0.26 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.507 1.129 . . . . 73.55 110.964 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.52 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 27.2 m80 -97.55 137.9 35.78 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.526 0.78 . . . . 72.41 109.56 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.706 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -106.64 150.82 25.83 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.501 1.126 . . . . 62.02 109.286 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.901 ' O ' HG12 ' A' ' 383' ' ' VAL . 16.3 ptp -167.48 166.33 14.33 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.467 1.104 . . . . 44.15 111.011 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 8.8 p -90.9 124.54 35.27 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 1.128 . . . . 61.5 108.254 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 10.6 m -47.93 -56.85 6.64 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.5 1.125 . . . . 52.32 110.39 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 4.1 m -44.94 -27.15 0.5 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.521 1.138 . . . . 72.55 110.019 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' CYS . . . . . 0.442 ' O ' ' HB3' ' A' ' 399' ' ' ALA . 1.9 m -83.26 -51.61 7.3 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.495 1.122 . . . . 72.35 108.346 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.661 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -40.97 -52.25 3.14 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.532 1.145 . . . . 75.55 109.292 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 398' ' ' THR . . . . . 0.63 ' N ' HD13 ' A' ' 397' ' ' LEU . 2.7 m -53.04 -43.11 66.36 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.525 1.141 . . . . 71.22 110.416 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 399' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -57.19 -26.13 60.14 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.538 1.149 . . . . 73.45 109.329 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 400' ' ' TRP . . . . . 0.596 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 10.3 t-105 -85.62 -62.52 1.51 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.998 -1.112 . . . . 70.23 107.998 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.499 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.4 mm-40 -56.13 -14.15 2.5 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.514 1.134 . . . . 64.14 110.342 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 398' ' ' THR . 3.0 mm-40 -37.12 -63.39 0.43 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.488 1.118 . . . . 75.32 110.292 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.4 t -121.3 -24.61 5.42 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.543 1.152 . . . . 75.22 109.978 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' ASP . . . . . 0.596 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 15.0 m-20 -82.63 -94.28 0.06 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.458 1.098 . . . . 74.3 109.334 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.499 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 72.56 30.23 64.59 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.516 1.135 . . . . 63.51 111.002 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 406' ' ' GLN . . . . . 0.531 ' NE2' ' C ' ' A' ' 406' ' ' GLN . 0.0 OUTLIER -91.36 71.37 6.09 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.508 0.769 . . . . 74.4 110.322 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 61.74 -167.81 14.58 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.547 1.154 . . . . 72.22 111.011 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' CYS . . . . . 0.657 ' SG ' HG21 ' A' ' 385' ' ' ILE . 5.7 t -56.26 125.99 66.77 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 108.29 -1.004 . . . . 75.25 108.29 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.94 0.17 9.2 Favored 'Trans proline' 0 C--N 1.359 1.104 0 O-C-N 124.521 1.801 . . . . 74.52 111.003 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' PHE . . . . . 0.655 ' HE1' HD11 ' A' ' 375' ' ' ILE . 3.6 m-85 -94.67 -55.78 3.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.107 . . . . 72.52 111.027 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 411' ' ' CYS . . . . . 0.436 ' O ' ' N ' ' A' ' 413' ' ' CYS . 2.4 p -98.95 12.86 34.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 62.23 108.293 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 412' ' ' ARG . . . . . . . . . . . . . 14.2 mmm-85 38.55 30.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.476 1.11 . . . . 61.42 110.288 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 413' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.3 m -119.76 163.22 17.79 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.53 1.144 . . . . 75.21 108.332 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.31 154.8 34.15 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.525 1.141 . . . . 74.41 110.293 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.749 HG23 HG23 ' A' ' 385' ' ' ILE . 1.9 mt -104.61 143.49 16.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.438 1.087 . . . . 64.33 109.279 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.451 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 3.5 mmtp -109.85 -46.37 3.5 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.559 1.162 . . . . 53.12 109.321 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.479 ' C ' HG23 ' A' ' 418' ' ' THR . . . -124.36 139.66 12.05 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.541 1.151 . . . . 73.12 110.994 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 418' ' ' THR . . . . . 0.598 ' CG2' HG21 ' A' ' 415' ' ' ILE . 72.3 p -153.92 126.43 8.07 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.517 0.775 . . . . 63.41 110.359 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.21 151.12 23.65 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.489 1.118 . . . . 73.13 110.332 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.96 102.11 1.55 Allowed 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.514 1.797 . . . . 72.03 111.037 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.883 HD11 HG22 ' A' ' 423' ' ' VAL . 0.7 OUTLIER -103.87 155.03 5.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.131 . . . . 71.34 109.29 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 422' ' ' ILE . . . . . 0.541 ' N ' HD12 ' A' ' 421' ' ' ILE . 19.4 mt -109.37 105.99 19.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.567 1.167 . . . . 73.43 109.307 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.883 HG22 HD11 ' A' ' 421' ' ' ILE . 17.1 t -76.23 146.94 8.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.434 1.084 . . . . 74.34 109.265 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.768 ' O ' HG23 ' A' ' 355' ' ' VAL . 1.8 t70 -128.68 143.5 48.7 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.523 1.139 . . . . 73.11 109.352 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 176.19 10.22 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.481 1.779 . . . . 63.3 111.053 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' PHE . . . . . 0.618 ' CE2' ' CG ' ' A' ' 357' ' ' GLN . 5.9 t80 . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.542 1.151 . . . . 74.51 111.042 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.005 0 N-CA-C 110.995 -0.842 . . . . 62.22 110.995 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 178.73 6.88 Favored 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.496 1.788 . . . . 75.21 111.056 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -136.83 124.02 21.76 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.551 1.157 . . . . 73.01 109.61 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 55.4 tpp -151.07 144.99 25.19 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.5 1.125 . . . . 44.33 110.966 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -88.54 67.72 2.99 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.51 1.131 . . . . 70.25 111.032 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.7 p -122.95 134.46 54.34 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.481 0.754 . . . . 74.42 110.043 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -87.89 -175.07 4.99 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.514 1.134 . . . . 73.51 109.28 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' HIS . . . . . 0.547 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 39.0 m-70 -142.05 146.93 36.04 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.517 1.136 . . . . 73.13 109.627 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 58.4 mt -130.83 158.63 43.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.484 1.115 . . . . 62.42 109.247 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -128.36 134.03 48.77 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.547 1.154 . . . . 72.25 109.3 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 424' ' ' ASP . 43.8 t -95.28 164.29 2.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.487 1.117 . . . . 72.23 109.274 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.468 ' N ' ' CG1' ' A' ' 355' ' ' VAL . 71.2 p -125.69 157.39 37.45 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.542 1.151 . . . . 63.33 110.406 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 357' ' ' GLN . . . . . 0.597 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 20.4 mt-30 -53.9 -46.29 71.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.469 1.105 . . . . 72.33 110.275 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -44.04 -30.46 0.74 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.504 1.127 . . . . 75.1 110.339 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' GLN . . . . . 0.529 ' OE1' ' CD1' ' A' ' 370' ' ' PHE . 58.8 mt-30 -83.58 -66.86 0.84 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.471 1.107 . . . . 42.43 110.287 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 360' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 364' ' ' CYS . 3.9 t80 -38.15 -38.56 0.34 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.499 1.124 . . . . 64.33 110.999 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -63.71 -52.36 60.86 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.431 1.082 . . . . 63.55 110.292 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 2.1 tp -61.59 -32.11 72.2 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.442 1.089 . . . . 55.43 109.287 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' PTR . . . . . 0.501 ' CE2' ' HA ' ' A' ' 370' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m -72.92 -21.68 60.86 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.531 1.145 . . . . 52.44 108.317 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -75.14 -51.95 12.16 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.461 1.101 . . . . 71.41 110.306 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 24.3 ptp -68.06 -15.14 63.47 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.506 1.128 . . . . 71.41 111.0 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 75.04 34.65 51.88 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.482 1.114 . . . . 54.22 111.012 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.1 -178.03 4.91 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 0.759 . . . . 64.24 110.026 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.823 HG22 ' NE2' ' A' ' 371' ' ' GLN . 2.0 m -117.35 161.22 19.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.132 . . . . 72.05 110.424 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.529 ' CD1' ' OE1' ' A' ' 359' ' ' GLN . 67.2 t80 -62.51 -69.39 0.26 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.51 1.131 . . . . 74.43 110.954 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.823 ' NE2' HG22 ' A' ' 369' ' ' THR . 0.2 OUTLIER -44.95 -25.9 0.36 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.533 1.146 . . . . 73.31 110.295 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.511 HD22 ' HA ' ' A' ' 377' ' ' ALA . 0.2 OUTLIER -62.26 132.32 52.32 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.479 1.112 . . . . 71.35 109.263 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 5.1 t -68.32 124.43 23.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.954 -1.021 . . . . 73.11 110.893 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.611 ' HB3' ' HZ3' ' A' ' 374' ' ' LYS . 1.4 mmmm -90.88 18.46 6.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.517 1.136 . . . . 72.33 109.294 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 1.011 HD11 ' CZ ' ' A' ' 410' ' ' PHE . 64.2 mt -109.81 -25.7 3.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.524 1.14 . . . . 64.35 109.283 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 376' ' ' CYS . . . . . 0.54 ' O ' ' HB3' ' A' ' 377' ' ' ALA . 5.8 p -132.28 -48.66 0.92 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.131 . . . . 65.44 108.31 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 376' ' ' CYS . . . 73.79 44.54 0.27 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.459 1.1 . . . . 75.2 109.318 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -123.68 -42.27 2.21 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.497 1.123 . . . . 75.14 110.297 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -133.82 176.83 8.21 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.509 1.131 . . . . 74.5 109.316 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -84.96 149.53 25.56 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.499 1.124 . . . . 75.33 109.264 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 392' ' ' MET . 22.1 mttt -51.83 -55.9 17.22 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.455 1.097 . . . . 52.52 109.313 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 1.1 p30 52.28 25.45 3.4 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.511 1.132 . . . . 61.52 109.301 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.895 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -153.92 176.09 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.475 1.109 . . . . 71.22 109.343 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.601 ' HE3' HD11 ' A' ' 391' ' ' LEU . 8.9 ttmt -158.46 148.26 19.63 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.498 1.124 . . . . 74.2 109.347 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.738 HD12 HD13 ' A' ' 415' ' ' ILE . 16.8 mm -112.16 141.25 28.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.53 1.144 . . . . 73.32 109.283 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.523 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.2 mt-10 -138.14 161.34 60.02 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.498 1.124 . . . . 73.5 110.331 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.523 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.99 -9.76 24.02 Favored 'Cis proline' 0 C--N 1.36 1.144 0 C-N-CA 121.006 -2.498 . . . . 74.02 111.031 0.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 388' ' ' CYS . . . . . 0.446 ' SG ' ' ND1' ' A' ' 390' ' ' HIS . 4.2 t -36.68 -72.96 0.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.965 -1.016 . . . . 73.35 110.936 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.34 15.72 6.94 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.47 1.106 . . . . 73.32 111.018 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.446 ' ND1' ' SG ' ' A' ' 388' ' ' CYS . 16.6 m170 -82.08 135.94 35.26 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 0.767 . . . . 73.34 109.627 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.678 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -102.63 160.1 14.87 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.537 1.148 . . . . 73.11 109.327 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.895 ' O ' HG12 ' A' ' 383' ' ' VAL . 15.2 ptp -173.07 175.31 3.25 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 1.131 . . . . 74.14 111.016 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 393' ' ' CYS . . . . . 0.424 ' O ' ' N ' ' A' ' 396' ' ' CYS . 20.0 p -96.94 114.92 26.58 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.55 1.156 . . . . 62.13 108.307 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 28.6 m -38.85 -59.8 0.92 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.49 1.119 . . . . 64.1 110.4 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.3 p -43.27 -42.46 4.41 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.509 1.13 . . . . 61.32 109.976 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' CYS . . . . . 0.424 ' N ' ' O ' ' A' ' 393' ' ' CYS . 2.8 m -67.8 -51.39 49.37 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.456 1.098 . . . . 72.3 108.312 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.688 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -45.67 -46.51 14.74 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.5 1.125 . . . . 71.24 109.319 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 398' ' ' THR . . . . . 0.559 ' N ' HD13 ' A' ' 397' ' ' LEU . 1.1 m -56.67 -35.55 68.54 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 74.14 110.434 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 399' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -69.08 -21.13 64.08 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.522 1.139 . . . . 62.25 109.283 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 400' ' ' TRP . . . . . 0.602 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 8.9 t-105 -85.71 -61.29 1.79 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.506 1.129 . . . . 63.12 108.025 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.501 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 8.6 mm-40 -56.2 -14.24 2.63 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.121 . . . . 63.31 110.34 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 401' ' ' GLN . 1.0 OUTLIER -37.14 -63.36 0.44 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.513 1.133 . . . . 74.23 110.277 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.5 m -121.08 -24.57 5.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.102 . . . . 75.43 109.959 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' ASP . . . . . 0.602 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 3.1 m-20 -83.21 -95.09 0.06 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 70.51 109.341 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.501 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 73.96 27.6 66.32 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.548 1.155 . . . . 61.32 111.001 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -89.37 67.83 7.82 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.497 0.763 . . . . 75.31 110.279 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 61.86 -163.25 24.9 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.546 1.154 . . . . 71.25 110.989 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' CYS . . . . . 0.424 ' SG ' HG21 ' A' ' 385' ' ' ILE . 4.9 t -56.23 127.6 70.98 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 108.325 -0.991 . . . . 54.23 108.325 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 0.3 9.06 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.452 1.764 . . . . 65.13 111.014 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' PHE . . . . . 1.011 ' CZ ' HD11 ' A' ' 375' ' ' ILE . 9.1 m-85 -93.37 -48.15 6.55 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.56 1.162 . . . . 71.21 111.016 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 411' ' ' CYS . . . . . 0.44 ' O ' ' N ' ' A' ' 413' ' ' CYS . 1.1 p -109.35 13.06 24.4 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.535 1.147 . . . . 74.51 108.312 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 412' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 38.48 30.46 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.471 1.107 . . . . 74.03 110.282 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' CYS . . . . . 0.44 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.6 m -113.31 155.06 25.82 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.587 1.179 . . . . 72.35 108.296 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -59.25 158.95 8.3 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.451 1.094 . . . . 63.12 110.307 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.738 HD13 HD12 ' A' ' 385' ' ' ILE . 7.2 mt -114.31 156.86 15.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.518 1.136 . . . . 54.43 109.329 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.428 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 20.3 mmtt -125.63 -46.72 1.72 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 73.24 109.305 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 418' ' ' THR . . . -111.28 133.56 11.59 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.494 1.122 . . . . 72.52 111.008 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 418' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 417' ' ' GLY . 23.4 p -157.06 116.21 3.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.513 0.772 . . . . 74.45 110.386 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.65 151.42 42.7 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.501 1.125 . . . . 74.4 110.325 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 101.79 1.51 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.56 1.821 . . . . 72.21 111.047 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.768 HD11 HG22 ' A' ' 423' ' ' VAL . 0.8 OUTLIER -103.89 158.67 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.484 1.115 . . . . 74.34 109.248 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 422' ' ' ILE . . . . . 0.593 ' N ' HD12 ' A' ' 421' ' ' ILE . 11.4 mt -112.29 107.16 22.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.532 1.145 . . . . 65.01 109.277 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.768 HG22 HD11 ' A' ' 421' ' ' ILE . 20.5 t -75.39 149.6 6.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.472 1.107 . . . . 71.52 109.293 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.663 ' O ' HG23 ' A' ' 355' ' ' VAL . 6.9 t0 -126.73 132.95 24.53 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.498 1.124 . . . . 73.34 109.336 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 163.03 36.21 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.543 1.812 . . . . 71.12 111.039 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' PHE . . . . . 0.597 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 1.1 t80 . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.485 1.116 . . . . 72.34 111.037 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.028 0 N-CA-C 111.002 -0.839 . . . . 55.11 111.002 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 178.59 7.05 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.501 1.79 . . . . 73.43 110.998 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -111.39 121.37 45.04 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 1.135 . . . . 70.34 109.621 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 6.9 mtt -91.15 134.21 34.72 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.473 1.108 . . . . 70.24 110.991 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 152.21 -51.29 0.5 Allowed Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.484 1.115 . . . . 52.24 111.022 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 350' ' ' SER . . . . . 0.459 ' HB3' ' CD1' ' A' ' 422' ' ' ILE . 60.7 m -64.95 140.48 58.87 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.497 0.763 . . . . 73.34 110.026 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -90.68 172.75 8.45 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.533 1.146 . . . . 71.43 109.309 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' HIS . . . . . 0.522 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 27.3 m-70 -132.99 130.93 40.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 1.14 . . . . 73.42 109.653 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.612 HD12 ' CD1' ' A' ' 421' ' ' ILE . 61.9 mt -119.0 150.71 21.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 65.54 109.29 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.29 139.12 50.72 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.569 1.168 . . . . 51.54 109.285 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 424' ' ' ASP . 21.9 t -87.74 122.59 39.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.504 1.127 . . . . 65.13 109.281 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.7 p -84.52 140.97 31.08 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.532 1.145 . . . . 72.12 110.391 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 357' ' ' GLN . . . . . 0.456 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 7.1 mt-30 -41.06 -33.66 0.35 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.537 1.148 . . . . 62.43 110.304 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -56.55 -49.1 75.82 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.531 1.144 . . . . 61.02 110.306 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' GLN . . . . . 0.443 ' HB2' HG13 ' A' ' 355' ' ' VAL . 11.0 mm-40 -60.24 -66.76 0.47 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 74.33 110.325 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 360' ' ' TYR . . . . . 0.442 ' O ' ' N ' ' A' ' 364' ' ' CYS . 5.7 t80 -38.89 -41.36 0.74 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.481 1.113 . . . . 71.51 110.985 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -63.63 -54.03 42.22 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.5 1.125 . . . . 75.1 110.301 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.6 tp -56.26 -33.83 65.82 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.485 1.116 . . . . 54.31 109.329 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 363' ' ' PTR . . . . . 0.411 ' N ' ' HD1' ' A' ' 363' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 364' ' ' CYS . . . . . 0.442 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.9 m -70.15 -32.36 70.3 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.523 1.14 . . . . 73.1 108.304 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -65.38 -15.21 62.35 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.485 1.116 . . . . 75.43 110.269 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 2.5 ptp -126.0 2.07 7.28 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.54 1.15 . . . . 72.34 110.979 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 49.96 48.38 38.3 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.492 1.12 . . . . 71.11 111.034 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 6.5 t -115.88 177.99 4.48 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.45 0.735 . . . . 73.24 110.003 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 2.2 p -124.37 135.21 53.14 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.539 1.149 . . . . 74.42 110.373 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.545 ' CD2' HG11 ' A' ' 423' ' ' VAL . 32.5 t80 -64.1 -66.08 0.59 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.126 . . . . 65.13 110.997 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.53 HE22 ' HB3' ' A' ' 425' ' ' PRO . 0.9 OUTLIER -43.08 -27.16 0.19 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.499 1.124 . . . . 74.24 110.345 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.933 HD22 ' N ' ' A' ' 373' ' ' CYS . 0.4 OUTLIER -73.18 135.91 44.68 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.539 1.149 . . . . 65.51 109.281 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 373' ' ' CYS . . . . . 0.933 ' N ' HD22 ' A' ' 372' ' ' LEU . 31.6 p -64.13 128.53 36.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.025 -0.989 . . . . 64.35 110.908 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.4 ' HZ1' ' CD2' ' A' ' 363' ' ' PTR . 25.5 mmtp -93.07 29.26 1.9 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.491 1.119 . . . . 73.25 109.279 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 0.653 HG21 ' HB3' ' A' ' 396' ' ' CYS . 35.4 mt -108.29 -60.5 2.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.539 1.149 . . . . 71.32 109.276 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 14.3 p -107.93 -22.36 12.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 52.25 108.278 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.567 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 58.79 46.97 13.35 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.463 1.102 . . . . 75.33 109.306 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -131.64 -44.77 0.98 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.453 1.096 . . . . 63.42 110.275 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -113.24 -179.98 3.8 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.492 1.12 . . . . 64.52 109.283 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -94.63 162.73 13.67 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.458 1.099 . . . . 72.51 109.284 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.44 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 20.3 mttt -65.76 -62.54 1.45 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.461 1.1 . . . . 75.1 109.324 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 382' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 420' ' ' PRO . 4.1 t70 60.17 20.34 9.67 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.487 1.117 . . . . 61.35 109.314 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.924 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -149.71 176.09 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.483 1.114 . . . . 72.3 109.296 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.437 ' HD2' HD11 ' A' ' 353' ' ' ILE . 17.5 tttm -159.13 156.39 28.98 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.478 1.111 . . . . 71.42 109.27 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.855 HG22 ' SG ' ' A' ' 388' ' ' CYS . 11.5 mm -122.67 144.16 33.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.51 1.132 . . . . 74.42 109.277 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.537 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.0 OUTLIER -137.68 162.34 55.18 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.554 1.159 . . . . 75.11 110.283 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.537 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.99 -12.46 23.95 Favored 'Cis proline' 0 C--N 1.36 1.153 0 C-N-CA 120.983 -2.507 . . . . 70.11 110.98 -0.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 388' ' ' CYS . . . . . 0.855 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.34 -71.72 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.011 -0.995 . . . . 73.33 110.925 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 389' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.0 16.86 6.57 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.545 1.153 . . . . 73.15 110.981 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.564 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 20.0 m80 -74.46 146.41 42.82 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.483 0.755 . . . . 63.33 109.622 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.814 HD22 ' N ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -116.85 158.2 24.35 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.527 1.142 . . . . 65.14 109.301 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.924 ' O ' HG12 ' A' ' 383' ' ' VAL . 14.2 ptp -173.45 173.37 3.49 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.507 1.129 . . . . 71.42 111.032 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 4.7 p -97.33 119.13 35.29 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.489 1.118 . . . . 74.21 108.309 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 4.5 m -47.05 -41.04 16.09 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.543 1.152 . . . . 64.1 110.378 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.5 p -55.42 -43.12 75.02 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 73.43 110.028 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' CYS . . . . . 0.653 ' HB3' HG21 ' A' ' 375' ' ' ILE . 4.9 m -70.17 -44.32 69.02 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.133 . . . . 55.11 108.32 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.432 HD13 ' C ' ' A' ' 397' ' ' LEU . 1.6 tm? -44.97 -47.84 11.41 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.529 1.143 . . . . 75.32 109.27 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 3.2 m -55.75 -35.24 65.97 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.464 1.103 . . . . 73.15 110.388 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -66.93 -23.45 65.97 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.127 . . . . 65.4 109.271 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 400' ' ' TRP . . . . . 0.414 ' O ' ' HB2' ' A' ' 404' ' ' ASP . 7.7 t-105 -85.91 -58.69 2.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 73.54 107.985 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.51 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 5.5 mm-40 -62.45 -9.84 9.73 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.564 1.165 . . . . 75.51 110.314 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 401' ' ' GLN . 1.0 OUTLIER -37.14 -63.9 0.4 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.428 1.08 . . . . 75.2 110.311 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 6.2 p -121.98 -25.04 5.04 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.505 1.128 . . . . 74.34 109.987 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 400' ' ' TRP . 3.1 m-20 -82.33 -92.52 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 61.13 109.289 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.51 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 75.53 32.19 55.17 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.516 1.135 . . . . 70.53 111.006 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -89.35 75.56 7.68 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.473 0.749 . . . . 73.51 110.275 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 57.34 -161.58 8.75 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.471 1.107 . . . . 40.0 110.986 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' CYS . . . . . 0.681 ' SG ' HG21 ' A' ' 385' ' ' ILE . 6.8 t -58.02 130.03 82.81 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 108.291 -1.003 . . . . 72.42 108.291 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -0.16 9.63 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.449 1.763 . . . . 65.4 110.994 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' PHE . . . . . 0.564 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 3.8 m-85 -97.64 -41.46 8.11 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.492 1.12 . . . . 60.15 111.004 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 411' ' ' CYS . . . . . 0.442 ' C ' ' N ' ' A' ' 413' ' ' CYS . 0.1 OUTLIER -111.19 8.75 21.73 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.537 1.148 . . . . 54.31 108.322 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 412' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 408' ' ' CYS . 12.7 tpp85 38.44 30.35 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.462 1.101 . . . . 32.4 110.275 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 413' ' ' CYS . . . . . 0.442 ' N ' ' C ' ' A' ' 411' ' ' CYS . 1.2 m -124.97 160.77 28.18 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.534 1.146 . . . . 74.01 108.335 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -55.79 149.06 15.29 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.516 1.135 . . . . 63.34 110.276 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.659 HG23 HG23 ' A' ' 385' ' ' ILE . 1.7 mt -94.06 146.35 6.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.544 1.152 . . . . 75.5 109.28 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.93 -49.11 3.18 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.523 1.139 . . . . 74.02 109.305 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.419 ' C ' ' CG2' ' A' ' 418' ' ' THR . . . -129.19 139.24 10.82 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.532 1.145 . . . . 53.35 111.015 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 418' ' ' THR . . . . . 0.658 ' CG2' HG21 ' A' ' 415' ' ' ILE . 50.7 p -151.84 141.21 21.52 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.503 0.766 . . . . 73.14 110.369 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -170.25 149.66 3.28 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.466 1.104 . . . . 73.23 110.325 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 382' ' ' ASP . 18.3 Cg_endo -75.01 102.24 1.57 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.505 1.792 . . . . 73.33 111.013 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.735 HD11 HG22 ' A' ' 423' ' ' VAL . 0.9 OUTLIER -103.86 162.76 4.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.559 1.162 . . . . 63.15 109.315 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 422' ' ' ILE . . . . . 0.568 ' N ' HD12 ' A' ' 421' ' ' ILE . 3.3 mp -113.27 106.41 20.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 71.33 109.322 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.735 HG22 HD11 ' A' ' 421' ' ' ILE . 40.5 t -76.95 144.65 11.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.482 1.114 . . . . 73.04 109.307 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.774 ' O ' HG23 ' A' ' 355' ' ' VAL . 1.1 m-20 -130.72 143.68 50.34 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.501 1.125 . . . . 65.31 109.323 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 425' ' ' PRO . . . . . 0.53 ' HB3' HE22 ' A' ' 371' ' ' GLN . 18.1 Cg_endo -75.02 172.46 16.33 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.51 1.795 . . . . 62.02 110.992 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 426' ' ' PHE . . . . . 0.456 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 7.5 t80 . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.502 1.126 . . . . 73.12 110.958 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.97 0 N-CA-C 111.024 -0.83 . . . . 35.34 111.024 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 178.65 6.99 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.523 1.802 . . . . 74.44 111.03 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -152.58 153.46 33.43 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.538 1.149 . . . . 44.34 109.608 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 29.7 ttp -103.2 -67.42 0.88 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.51 1.131 . . . . 73.14 110.983 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -155.29 99.08 0.18 Allowed Glycine 0 CA--C 1.531 1.053 0 O-C-N 124.488 1.118 . . . . 51.14 111.002 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 350' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 64.8 m -143.38 153.28 42.54 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.55 0.794 . . . . 40.15 109.944 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 351' ' ' ASP . . . . . 0.497 ' CG ' HG22 ' A' ' 421' ' ' ILE . 0.1 OUTLIER -84.55 176.64 8.49 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.507 1.129 . . . . 71.24 109.308 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -134.62 137.65 43.85 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.529 1.143 . . . . 72.24 109.567 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 2.1 mm -117.45 155.54 19.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.511 1.132 . . . . 64.4 109.276 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.09 137.54 53.5 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.459 1.1 . . . . 73.51 109.289 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 424' ' ' ASP . 23.5 t -96.81 140.23 17.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.521 1.138 . . . . 73.11 109.254 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 22.0 p -107.31 154.14 21.72 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.54 1.15 . . . . 72.11 110.404 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 357' ' ' GLN . . . . . 0.557 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 12.4 mt-30 -49.92 -44.21 50.16 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.517 1.136 . . . . 74.41 110.31 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -45.13 -38.13 4.92 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.455 1.097 . . . . 75.12 110.283 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -74.22 -59.41 2.74 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.444 1.09 . . . . 75.33 110.304 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -43.48 -55.46 4.19 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.488 1.117 . . . . 73.41 111.035 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -55.33 -37.69 67.75 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.539 1.149 . . . . 70.2 110.325 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.472 HD22 ' HA ' ' A' ' 362' ' ' LEU . 1.0 OUTLIER -63.29 -38.4 91.02 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.48 1.113 . . . . 70.31 109.309 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 363' ' ' PTR . . . . . 0.458 ' CE1' ' HA ' ' A' ' 370' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 3.0 m -66.7 -25.61 66.62 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.472 1.108 . . . . 73.4 108.344 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -71.74 -20.61 61.87 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.486 1.116 . . . . 64.51 110.326 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -124.06 6.13 8.58 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.443 1.09 . . . . 52.22 110.993 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 367' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 363' ' ' PTR . . . 45.27 52.91 8.21 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.47 1.106 . . . . 62.12 110.985 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 10.6 t -119.91 -174.83 2.84 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.522 0.778 . . . . 52.34 110.011 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 5.6 p -127.87 133.66 49.35 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.496 1.123 . . . . 74.32 110.42 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.458 ' HA ' ' CE1' ' A' ' 363' ' ' PTR . 68.0 t80 -64.33 -63.95 1.01 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.466 1.104 . . . . 65.2 110.997 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.556 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -44.1 -26.85 0.33 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.564 1.165 . . . . 65.32 110.301 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.653 HD11 ' HA ' ' A' ' 377' ' ' ALA . 2.0 tm? -78.81 141.82 37.43 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.496 1.123 . . . . 72.01 109.279 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 373' ' ' CYS . . . . . 0.623 ' O ' HD13 ' A' ' 372' ' ' LEU . 15.1 t -75.63 150.99 37.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.967 -1.015 . . . . 72.44 110.89 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -110.9 23.7 13.84 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.534 1.146 . . . . 75.03 109.282 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 12.0 mt -108.12 -50.81 7.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 75.42 109.265 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 376' ' ' CYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 377' ' ' ALA . 1.6 m -107.52 -42.55 4.75 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.524 1.14 . . . . 75.55 108.283 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.653 ' HA ' HD11 ' A' ' 372' ' ' LEU . . . 72.09 47.43 0.3 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.533 1.146 . . . . 74.25 109.306 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -132.25 -66.56 0.69 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.517 1.136 . . . . 61.01 110.321 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -99.49 159.73 14.81 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.495 1.122 . . . . 64.3 109.304 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -73.14 152.05 41.31 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.506 1.129 . . . . 73.31 109.274 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.465 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 23.5 mttt -49.88 -62.51 1.52 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.476 1.11 . . . . 71.32 109.284 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 382' ' ' ASP . . . . . 0.406 ' HA ' ' O ' ' A' ' 421' ' ' ILE . 40.5 m-20 59.73 24.96 13.9 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.472 1.108 . . . . 75.14 109.253 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.93 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -156.08 172.83 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.462 1.101 . . . . 72.42 109.289 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.451 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 48.5 tttp -155.67 136.58 13.61 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.491 1.119 . . . . 71.35 109.293 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.72 HG21 ' SG ' ' A' ' 408' ' ' CYS . 15.2 mm -102.18 137.3 30.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.467 1.104 . . . . 73.24 109.317 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.521 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.0 OUTLIER -138.02 161.31 60.4 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.5 1.125 . . . . 71.25 110.298 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.521 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.97 -7.17 22.95 Favored 'Cis proline' 0 C--N 1.36 1.136 0 C-N-CA 120.982 -2.508 . . . . 74.12 111.034 -0.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 388' ' ' CYS . . . . . 0.54 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 50.7 t -36.8 -73.89 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.967 -1.015 . . . . 64.1 110.932 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 389' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.32 15.52 7.05 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.544 1.152 . . . . 72.4 110.987 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.54 ' CG ' ' SG ' ' A' ' 388' ' ' CYS . 68.3 m170 -86.7 126.07 34.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.538 0.787 . . . . 74.01 109.605 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.703 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -96.11 158.83 15.26 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.475 1.109 . . . . 62.23 109.272 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.93 ' O ' HG12 ' A' ' 383' ' ' VAL . 20.4 ptp -172.78 175.87 3.27 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 73.24 110.996 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 2.3 p -99.64 114.75 28.02 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.478 1.111 . . . . 70.03 108.293 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 29.2 m -46.54 -24.81 0.58 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.492 1.12 . . . . 72.23 110.448 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.4 p -67.11 -42.49 84.43 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.102 . . . . 72.42 109.99 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' CYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 399' ' ' ALA . 76.1 m -80.74 -49.83 10.66 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.507 1.129 . . . . 64.41 108.279 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.778 HD12 ' SD ' ' A' ' 392' ' ' MET . 2.7 tt -45.62 -48.3 14.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.116 . . . . 73.0 109.315 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.11 -34.77 61.09 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.533 1.145 . . . . 64.52 110.398 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 399' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -62.83 -27.11 69.1 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.436 1.085 . . . . 73.35 109.275 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 400' ' ' TRP . . . . . 0.52 ' CD2' ' HB3' ' A' ' 409' ' ' PRO . 3.7 t-105 -79.59 -53.15 7.13 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.518 1.136 . . . . 73.4 108.019 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.51 HE21 HD21 ' A' ' 397' ' ' LEU . 7.1 mm-40 -62.13 -10.02 9.2 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.49 1.119 . . . . 75.42 110.318 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 401' ' ' GLN . 5.3 mm-40 -37.08 -63.59 0.42 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.103 . . . . 73.44 110.293 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 18.2 t -121.54 -24.58 5.32 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.525 1.14 . . . . 73.22 110.015 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' ASP . . . . . 0.46 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 3.1 m-20 -83.88 -94.76 0.06 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.492 1.12 . . . . 70.21 109.281 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.498 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 73.93 32.59 58.65 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.504 1.128 . . . . 44.01 111.022 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -89.02 63.18 6.6 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.541 0.789 . . . . 75.35 110.304 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 68.52 -162.59 50.03 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.52 1.138 . . . . 64.12 110.978 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' CYS . . . . . 0.72 ' SG ' HG21 ' A' ' 385' ' ' ILE . 3.2 t -56.56 122.86 53.48 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.313 -0.995 . . . . 50.41 108.313 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.52 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.3 Cg_endo -74.98 -1.87 11.79 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.497 1.788 . . . . 61.24 111.017 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 410' ' ' PHE . . . . . 0.55 ' CD2' ' HE2' ' A' ' 392' ' ' MET . 2.6 m-85 -89.16 -41.3 12.34 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 73.0 111.031 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 411' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' A' ' 412' ' ' ARG . 0.7 OUTLIER -117.56 11.86 13.91 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.527 1.142 . . . . 44.11 108.3 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 412' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 411' ' ' CYS . 14.5 tpp85 38.53 46.14 0.94 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.517 1.136 . . . . 55.23 110.294 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 4.1 t -131.04 150.44 52.15 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.499 1.124 . . . . 61.1 108.297 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -58.07 152.76 15.99 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.489 1.118 . . . . 75.42 110.329 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.702 HD13 HD12 ' A' ' 385' ' ' ILE . 2.2 mt -107.2 154.81 8.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.457 1.098 . . . . 63.04 109.318 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -119.56 -41.44 2.7 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.478 1.111 . . . . 64.04 109.334 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.477 ' C ' HG23 ' A' ' 418' ' ' THR . . . -119.0 127.73 7.35 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.506 1.129 . . . . 73.1 110.987 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 418' ' ' THR . . . . . 0.559 ' CG2' HG21 ' A' ' 415' ' ' ILE . 42.2 p -154.26 125.09 7.15 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.526 0.78 . . . . 64.03 110.356 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -155.4 151.97 23.68 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.484 1.115 . . . . 73.33 110.287 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.451 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.3 Cg_endo -74.99 100.32 1.35 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.501 1.79 . . . . 63.42 111.014 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.75 HD12 ' N ' ' A' ' 422' ' ' ILE . 1.0 OUTLIER -107.18 171.09 2.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 124.512 1.132 . . . . 71.51 109.296 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 422' ' ' ILE . . . . . 0.75 ' N ' HD12 ' A' ' 421' ' ' ILE . 6.2 mm -121.22 109.92 26.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 73.13 109.3 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.701 HG22 HD11 ' A' ' 421' ' ' ILE . 2.5 t -75.86 140.38 17.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 74.03 109.317 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.742 ' O ' HG23 ' A' ' 355' ' ' VAL . 44.9 m-20 -130.19 143.79 50.57 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.516 1.135 . . . . 72.11 109.282 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 164.97 32.28 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.439 1.757 . . . . 72.31 111.02 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' PHE . . . . . 0.557 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 19.3 t80 . . . . . 0 C--N 1.324 -0.506 0 O-C-N 124.503 1.127 . . . . 74.4 111.028 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.011 0 N-CA-C 110.984 -0.846 . . . . 75.51 110.984 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.96 178.26 7.48 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.538 1.81 . . . . 74.51 111.033 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.26 167.24 13.47 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.505 1.128 . . . . 64.14 109.586 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 348' ' ' MET . . . . . 0.418 ' N ' ' SD ' ' A' ' 348' ' ' MET . 0.0 OUTLIER -119.58 122.91 42.64 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.483 1.115 . . . . 72.41 110.985 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -120.56 47.89 0.99 Allowed Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.53 1.144 . . . . 72.21 110.973 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 350' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 67.0 m -58.9 134.3 56.8 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.473 0.749 . . . . 64.02 109.983 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 351' ' ' ASP . . . . . 0.55 ' HB2' HG22 ' A' ' 421' ' ' ILE . 1.3 m-20 -77.12 -177.95 4.77 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.541 1.151 . . . . 63.45 109.324 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -137.41 125.94 23.59 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 73.32 109.586 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 2.2 mm -118.04 111.88 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.51 1.131 . . . . 64.24 109.262 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.31 149.84 28.76 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.459 1.099 . . . . 75.12 109.3 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 424' ' ' ASP . 13.1 t -96.19 136.54 26.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.534 1.146 . . . . 50.14 109.315 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 11.6 p -95.21 143.16 26.84 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.514 1.134 . . . . 64.11 110.425 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 357' ' ' GLN . . . . . 0.508 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 12.0 mt-30 -42.4 -43.4 3.56 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.156 . . . . 52.52 110.3 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -46.8 -50.14 18.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.469 1.106 . . . . 74.14 110.245 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 359' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 362' ' ' LEU . 9.9 mm100 -60.09 -66.79 0.46 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.523 1.139 . . . . 74.32 110.285 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -38.25 -39.23 0.41 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 74.15 110.985 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -70.91 -47.38 59.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.494 1.121 . . . . 71.11 110.253 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.791 ' O ' HD23 ' A' ' 362' ' ' LEU . 4.9 tt -58.05 -33.57 69.15 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.456 1.098 . . . . 73.45 109.293 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 363' ' ' PTR . . . . . 0.452 ' CE1' ' O2P' ' A' ' 363' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 2.4 m -64.18 -29.61 70.71 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.504 1.127 . . . . 72.02 108.308 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -66.68 -18.72 65.52 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.462 1.102 . . . . 72.13 110.338 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -126.58 8.6 7.02 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 74.44 110.959 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 42.74 54.61 4.95 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.538 1.149 . . . . 63.13 111.007 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 62.2 m -121.25 179.0 4.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.523 0.778 . . . . 72.32 110.008 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 2.3 p -124.81 131.38 53.45 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.489 1.118 . . . . 62.21 110.44 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.533 ' CD2' HG11 ' A' ' 423' ' ' VAL . 34.9 t80 -60.7 -65.1 0.74 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.472 1.108 . . . . 73.33 111.025 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.436 HE22 ' HB3' ' A' ' 425' ' ' PRO . 0.7 OUTLIER -43.54 -26.93 0.25 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.522 1.138 . . . . 73.43 110.227 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.413 ' N ' ' C ' ' A' ' 370' ' ' PHE . 0.0 OUTLIER -71.65 123.28 22.17 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.505 1.128 . . . . 61.12 109.285 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 30.4 p -55.07 132.51 47.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.006 -0.997 . . . . 41.32 110.94 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.414 ' HZ1' ' HA ' ' A' ' 370' ' ' PHE . 29.8 mmtm -92.93 32.2 1.3 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.465 1.103 . . . . 72.13 109.284 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 5.5 mt -113.35 -60.46 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.543 1.152 . . . . 62.01 109.315 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -108.28 -20.87 12.99 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 75.34 108.294 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.407 ' HA ' HD22 ' A' ' 372' ' ' LEU . . . 55.3 41.12 31.55 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.503 1.127 . . . . 54.11 109.308 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -128.38 -44.71 1.39 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.436 1.085 . . . . 74.31 110.324 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -110.21 174.15 6.0 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 75.15 109.293 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -89.03 162.09 16.21 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.517 1.135 . . . . 70.34 109.323 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 392' ' ' MET . 21.9 mttt -65.21 -55.47 18.31 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.132 . . . . 70.23 109.292 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 382' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 381' ' ' LYS . 1.8 p30 50.62 25.58 2.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.462 1.101 . . . . 72.11 109.259 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.891 HG12 ' O ' ' A' ' 392' ' ' MET . 0.3 OUTLIER -154.08 174.76 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.478 1.111 . . . . 74.51 109.263 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 21.1 tttm -158.67 155.77 28.75 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.464 1.102 . . . . 74.31 109.326 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.864 HG22 ' SG ' ' A' ' 388' ' ' CYS . 11.6 mm -121.69 143.78 33.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 73.13 109.314 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.542 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 5.3 mt-10 -137.6 162.49 54.44 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.443 1.089 . . . . 74.14 110.287 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.542 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.99 -12.29 23.98 Favored 'Cis proline' 0 C--N 1.361 1.211 0 C-N-CA 120.977 -2.51 . . . . 73.33 111.017 -0.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 388' ' ' CYS . . . . . 0.864 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.48 -71.81 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.953 -1.021 . . . . 74.41 110.927 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 389' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 115.73 18.58 6.0 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.533 1.145 . . . . 74.4 111.028 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.584 ' CE1' ' HB2' ' A' ' 388' ' ' CYS . 20.6 m80 -76.56 145.52 38.96 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.524 0.779 . . . . 72.2 109.58 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.809 HD22 ' N ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -117.3 155.47 29.47 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.477 1.11 . . . . 55.01 109.273 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.891 ' O ' HG12 ' A' ' 383' ' ' VAL . 18.7 ptp -172.14 172.85 4.48 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 72.41 111.016 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 4.5 p -91.69 115.3 27.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.444 1.09 . . . . 73.44 108.295 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 397' ' ' LEU . 27.3 m -47.83 -57.54 5.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.514 1.134 . . . . 62.23 110.401 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.9 t -45.56 -26.11 0.55 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.534 1.146 . . . . 71.44 109.976 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' CYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 399' ' ' ALA . 2.2 m -88.01 -41.33 13.19 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.533 1.146 . . . . 54.44 108.288 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.743 ' O ' HD23 ' A' ' 397' ' ' LEU . 3.4 tt -51.61 -45.79 63.35 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.458 1.098 . . . . 74.3 109.306 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.54 -35.91 61.23 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.551 1.157 . . . . 71.04 110.428 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 399' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -62.05 -27.87 69.19 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.467 1.105 . . . . 72.11 109.325 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 400' ' ' TRP . . . . . 0.579 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 5.1 t-105 -79.38 -52.42 8.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.026 -1.101 . . . . 74.25 108.026 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.514 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 10.0 mm-40 -62.99 -9.78 11.28 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 1.106 . . . . 65.45 110.291 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 401' ' ' GLN . 9.8 mm-40 -37.05 -63.78 0.4 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.44 1.088 . . . . 54.42 110.298 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 6.6 t -123.61 -24.8 4.46 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.481 1.113 . . . . 74.41 109.972 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 404' ' ' ASP . . . . . 0.579 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 0.9 OUTLIER -81.61 -90.18 0.07 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.456 1.098 . . . . 74.04 109.295 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.514 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 67.51 32.65 79.4 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.493 1.121 . . . . 70.32 111.037 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -91.74 66.93 5.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 0.772 . . . . 65.42 110.331 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 70.04 -161.21 53.16 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.497 1.123 . . . . 33.4 111.041 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' CYS . . . . . 0.688 ' SG ' HG21 ' A' ' 385' ' ' ILE . 7.1 t -62.45 130.68 93.52 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.314 -0.995 . . . . 64.12 108.314 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.94 -1.77 11.64 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.504 1.792 . . . . 61.45 111.003 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 410' ' ' PHE . . . . . 0.479 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 3.2 m-85 -95.63 -41.32 8.96 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.529 1.143 . . . . 72.34 110.982 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 411' ' ' CYS . . . . . 0.452 ' SG ' ' CE1' ' A' ' 390' ' ' HIS . 0.1 OUTLIER -111.08 8.59 21.86 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 75.23 108.277 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 412' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 408' ' ' CYS . 5.7 tpt85 38.39 30.71 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.488 1.117 . . . . 72.45 110.318 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 413' ' ' CYS . . . . . 0.441 ' N ' ' O ' ' A' ' 411' ' ' CYS . 42.1 t -127.77 151.1 49.44 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.512 1.133 . . . . 75.0 108.326 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -49.81 151.1 1.9 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.46 1.1 . . . . 75.15 110.292 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.699 HG21 ' CG2' ' A' ' 418' ' ' THR . 1.9 mt -99.38 150.43 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.484 1.115 . . . . 73.33 109.355 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.459 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 15.2 mmtt -110.51 -45.37 3.54 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.515 1.134 . . . . 64.42 109.299 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.448 ' C ' HG23 ' A' ' 418' ' ' THR . . . -129.07 135.0 8.22 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.498 1.124 . . . . 53.24 110.987 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 418' ' ' THR . . . . . 0.699 ' CG2' HG21 ' A' ' 415' ' ' ILE . 80.9 p -152.47 130.53 11.85 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.534 0.785 . . . . 73.44 110.421 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -158.26 153.36 21.6 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.534 1.146 . . . . 65.14 110.263 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.44 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.2 Cg_endo -75.01 102.64 1.61 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.498 1.788 . . . . 73.1 110.977 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.68 HD12 ' N ' ' A' ' 422' ' ' ILE . 1.0 OUTLIER -103.85 167.73 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.47 1.106 . . . . 73.55 109.304 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 422' ' ' ILE . . . . . 0.68 ' N ' HD12 ' A' ' 421' ' ' ILE . 6.0 mm -118.9 109.65 27.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.453 1.096 . . . . 75.42 109.277 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.664 HG22 HD11 ' A' ' 421' ' ' ILE . 23.7 t -79.74 144.35 10.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.495 1.122 . . . . 75.13 109.261 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.749 ' O ' HG23 ' A' ' 355' ' ' VAL . 4.1 m-20 -131.4 143.5 49.5 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.437 1.086 . . . . 71.44 109.299 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 425' ' ' PRO . . . . . 0.436 ' HB3' HE22 ' A' ' 371' ' ' GLN . 18.3 Cg_endo -75.01 160.47 40.09 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.467 1.772 . . . . 71.4 111.005 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 426' ' ' PHE . . . . . 0.508 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 3.3 t80 . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.494 1.121 . . . . 73.3 111.013 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.031 0 N-CA-C 110.994 -0.842 . . . . 24.54 110.994 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 178.16 7.63 Favored 'Trans proline' 0 C--N 1.359 1.115 0 O-C-N 124.558 1.82 . . . . 71.15 111.004 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 48.0 54.43 10.08 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.483 1.114 . . . . 72.34 109.59 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 8.0 ttp -61.42 97.81 0.07 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.524 1.14 . . . . 73.5 111.047 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -173.47 152.82 16.31 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.506 1.129 . . . . 42.42 110.975 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 44.6 m -90.32 134.23 34.45 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.519 0.776 . . . . 75.23 109.973 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 351' ' ' ASP . . . . . 0.551 ' HB2' HG22 ' A' ' 421' ' ' ILE . 13.3 m-20 -88.77 162.7 16.08 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.522 1.139 . . . . 71.1 109.295 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 352' ' ' HIS . . . . . 0.426 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 14.2 m-70 -126.18 138.64 53.67 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.488 1.117 . . . . 75.44 109.579 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 21.9 mt -121.72 137.1 56.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.47 1.106 . . . . 74.32 109.298 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -107.93 123.55 48.79 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.513 1.133 . . . . 71.42 109.345 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 424' ' ' ASP . 4.4 t -72.42 156.6 6.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.456 1.097 . . . . 72.03 109.29 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 359' ' ' GLN . 2.8 p -124.04 145.29 49.32 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.527 1.142 . . . . 62.05 110.414 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 357' ' ' GLN . . . . . 0.518 ' HG2' ' CE2' ' A' ' 426' ' ' PHE . 10.7 mt-30 -40.86 -46.75 2.81 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.47 1.106 . . . . 72.11 110.305 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -50.16 -45.07 53.03 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 1.139 . . . . 64.41 110.299 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 359' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 356' ' ' THR . 70.4 mt-30 -64.28 -66.55 0.53 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.521 1.138 . . . . 75.35 110.309 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 360' ' ' TYR . . . . . 0.421 ' O ' ' N ' ' A' ' 364' ' ' CYS . 2.4 t80 -41.47 -39.12 1.43 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.562 1.164 . . . . 73.42 110.987 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -66.67 -54.11 26.66 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.522 1.139 . . . . 72.31 110.278 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.8 tp -54.89 -34.33 62.91 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.562 1.163 . . . . 72.54 109.281 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' PTR . . . . . 0.534 ' HD1' ' HZ1' ' A' ' 374' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' CYS . . . . . 0.421 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m -63.99 -25.25 68.04 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.435 1.085 . . . . 71.12 108.293 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.84 -2.73 44.78 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 64.22 110.28 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 8.1 mmt -105.88 -34.91 7.49 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.518 1.137 . . . . 72.3 111.026 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 100.79 16.88 24.98 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.461 1.101 . . . . 54.45 110.998 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 7.0 m -142.84 172.57 12.52 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.521 0.777 . . . . 54.23 110.019 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 11.6 p -98.9 -175.19 2.97 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.532 1.145 . . . . 55.13 110.411 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.533 ' CD2' HG11 ' A' ' 423' ' ' VAL . 27.6 t80 -83.55 -67.18 0.81 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.539 1.149 . . . . 70.01 111.02 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.547 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -39.41 -29.76 0.05 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.499 1.125 . . . . 61.25 110.275 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.427 ' N ' ' C ' ' A' ' 370' ' ' PHE . 0.0 OUTLIER -69.97 115.43 9.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.508 1.13 . . . . 70.41 109.322 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 25.3 p -47.48 149.82 1.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.99 -1.005 . . . . 73.34 110.9 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.534 ' HZ1' ' HD1' ' A' ' 363' ' ' PTR . 24.5 mmtp -106.08 24.14 12.9 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 70.43 109.307 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 0.499 HD11 ' HE1' ' A' ' 410' ' ' PHE . 14.6 mt -100.73 -61.13 2.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 72.1 109.271 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 26.9 p -107.92 -22.41 12.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 65.35 108.274 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 61.89 41.39 11.53 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.109 . . . . 71.24 109.294 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -134.64 -45.93 0.74 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.481 1.113 . . . . 75.33 110.249 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -101.41 168.28 9.62 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.538 1.149 . . . . 72.23 109.314 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.82 157.27 17.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.564 1.165 . . . . 72.14 109.296 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 392' ' ' MET . 0.7 OUTLIER -70.22 -62.1 1.52 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.442 1.089 . . . . 72.33 109.311 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 382' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 421' ' ' ILE . 1.3 p30 51.86 21.85 1.57 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.509 1.131 . . . . 74.45 109.306 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.869 HG12 ' O ' ' A' ' 392' ' ' MET . 0.3 OUTLIER -152.75 154.69 7.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.122 . . . . 72.3 109.24 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -141.73 153.72 44.81 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 65.33 109.292 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.887 HG22 ' SG ' ' A' ' 388' ' ' CYS . 22.8 mm -113.85 138.71 42.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.514 1.134 . . . . 72.0 109.275 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.571 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 1.8 mt-10 -129.73 163.32 47.76 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.472 1.108 . . . . 63.31 110.278 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.571 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.98 -18.56 18.59 Favored 'Cis proline' 0 C--N 1.36 1.158 0 C-N-CA 120.975 -2.51 . . . . 53.25 111.022 -0.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 388' ' ' CYS . . . . . 0.887 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -35.61 -91.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.991 -1.004 . . . . 64.03 110.899 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 136.22 44.24 0.1 OUTLIER Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.499 1.124 . . . . 73.21 110.995 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 19.6 m170 -104.37 114.12 28.14 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.461 0.742 . . . . 64.55 109.648 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 391' ' ' LEU . 5.9 mp -84.72 169.73 13.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.123 . . . . 73.45 109.311 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.869 ' O ' HG12 ' A' ' 383' ' ' VAL . 17.2 ptp -179.76 165.6 1.3 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.54 1.15 . . . . 65.14 111.01 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 393' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 396' ' ' CYS . 4.8 p -90.78 115.43 27.84 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.493 1.121 . . . . 64.5 108.301 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 20.7 m -38.72 -59.45 0.94 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.46 1.1 . . . . 53.44 110.4 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 6.7 m -42.24 -41.97 2.91 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.533 1.146 . . . . 72.1 109.983 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' CYS . . . . . 0.445 ' O ' ' N ' ' A' ' 399' ' ' ALA . 3.6 m -68.86 -56.68 7.17 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.463 1.102 . . . . 75.45 108.34 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.716 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -40.95 -36.02 0.6 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.503 1.127 . . . . 73.13 109.283 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 22.7 m -62.61 -49.44 75.21 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 72.14 110.394 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -54.33 -22.45 12.15 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.475 1.109 . . . . 35.0 109.313 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 400' ' ' TRP . . . . . 0.606 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 11.8 t-105 -85.44 -64.9 1.08 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.483 1.115 . . . . 73.31 108.01 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.502 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 12.5 mm-40 -52.34 -17.5 1.19 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.478 1.111 . . . . 63.21 110.312 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 401' ' ' GLN . 7.5 mt-10 -37.02 -63.31 0.43 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.481 1.113 . . . . 74.32 110.332 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 10.3 t -121.65 -24.5 5.3 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.5 1.125 . . . . 63.15 110.006 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 404' ' ' ASP . . . . . 0.606 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 19.5 m-20 -82.34 -93.78 0.06 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.501 1.125 . . . . 75.45 109.293 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.502 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 68.1 27.63 73.63 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.477 1.11 . . . . 53.12 111.03 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -88.68 67.04 8.3 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.539 0.788 . . . . 64.3 110.263 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 67.87 -162.7 48.17 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.537 1.148 . . . . 73.0 110.993 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' CYS . . . . . 0.67 ' SG ' HG21 ' A' ' 385' ' ' ILE . 5.6 t -59.11 125.76 79.42 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 108.324 -0.991 . . . . 63.51 108.324 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.403 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.3 Cg_endo -74.97 -0.28 9.76 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.48 1.779 . . . . 62.04 111.012 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 410' ' ' PHE . . . . . 0.544 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 5.4 m-85 -95.85 -41.64 8.72 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.48 1.112 . . . . 70.33 110.996 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 411' ' ' CYS . . . . . 0.447 ' SG ' ' ND1' ' A' ' 390' ' ' HIS . 0.4 OUTLIER -112.8 10.43 19.16 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.525 1.14 . . . . 75.33 108.333 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 412' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 411' ' ' CYS . 27.5 mmm-85 38.5 31.75 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.448 1.092 . . . . 75.51 110.291 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 413' ' ' CYS . . . . . 0.42 ' N ' ' O ' ' A' ' 411' ' ' CYS . 10.5 t -125.09 146.36 49.49 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.419 1.074 . . . . 65.33 108.289 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -46.42 155.74 0.21 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.533 1.146 . . . . 75.4 110.351 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.705 HG23 HG23 ' A' ' 385' ' ' ILE . 2.3 mt -102.44 156.91 4.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.449 1.093 . . . . 75.43 109.313 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.409 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 10.3 mmtt -120.28 -43.48 2.52 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.471 1.107 . . . . 70.15 109.297 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 418' ' ' THR . . . -126.78 140.54 12.02 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.486 1.116 . . . . 63.02 111.001 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 418' ' ' THR . . . . . 0.595 ' CG2' HG21 ' A' ' 415' ' ' ILE . 17.3 p -157.53 116.7 3.28 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.46 0.741 . . . . 61.44 110.407 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.423 ' OE1' ' N ' ' A' ' 419' ' ' GLU . 23.3 pm0 -139.82 150.5 62.97 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.537 1.148 . . . . 72.43 110.313 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.99 102.34 1.58 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.504 1.791 . . . . 73.41 111.005 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.845 HD12 ' N ' ' A' ' 422' ' ' ILE . 1.3 pp -103.85 -178.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.535 1.147 . . . . 65.51 109.258 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 422' ' ' ILE . . . . . 0.845 ' N ' HD12 ' A' ' 421' ' ' ILE . 15.2 mt -144.64 115.49 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 64.2 109.305 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.533 HG11 ' CD2' ' A' ' 370' ' ' PHE . 38.9 t -86.45 144.89 8.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.51 1.131 . . . . 73.5 109.326 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.642 ' O ' HG23 ' A' ' 355' ' ' VAL . 5.1 t70 -131.31 143.64 50.14 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.456 1.098 . . . . 74.12 109.345 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 425' ' ' PRO . . . . . 0.415 ' CD ' ' OE1' ' A' ' 371' ' ' GLN . 18.2 Cg_endo -75.04 170.67 19.91 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.475 1.776 . . . . 61.11 110.963 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 426' ' ' PHE . . . . . 0.518 ' CE2' ' HG2' ' A' ' 357' ' ' GLN . 6.5 t80 . . . . . 0 C--N 1.325 -0.468 0 O-C-N 124.503 1.127 . . . . 72.22 111.013 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.972 0 N-CA-C 111.016 -0.833 . . . . 63.11 111.016 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 178.7 6.91 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.519 1.8 . . . . 72.32 111.035 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -72.42 82.46 1.07 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 71.43 109.554 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 12.8 mmt -56.57 129.43 40.85 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.53 1.144 . . . . 74.4 110.983 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 163.66 43.06 0.02 OUTLIER Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.512 1.133 . . . . 54.21 111.01 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 2.6 p -118.45 132.07 56.25 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.467 0.746 . . . . 61.12 110.061 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -96.59 179.63 4.93 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.5 1.125 . . . . 73.32 109.292 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' HIS . . . . . 0.489 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 29.1 m-70 -134.2 135.44 43.03 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.48 1.113 . . . . 54.45 109.587 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.504 HG13 HD13 ' A' ' 421' ' ' ILE . 11.2 mt -116.21 149.14 18.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 75.24 109.262 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.79 137.29 52.84 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 71.22 109.326 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.487 HG22 ' CD2' ' A' ' 370' ' ' PHE . 5.0 t -89.03 141.62 14.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.472 1.107 . . . . 75.12 109.31 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.414 ' OG1' ' CG ' ' A' ' 359' ' ' GLN . 16.6 p -91.55 135.98 33.46 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.486 1.117 . . . . 70.31 110.371 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 357' ' ' GLN . . . . . 0.696 ' CG ' ' CE1' ' A' ' 426' ' ' PHE . 4.4 mt-30 -41.13 -33.15 0.32 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.523 1.139 . . . . 75.11 110.311 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 358' ' ' GLU . . . . . 0.449 ' CG ' ' N ' ' A' ' 359' ' ' GLN . 13.5 pt-20 -63.56 -50.41 69.59 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.515 1.134 . . . . 72.1 110.324 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 359' ' ' GLN . . . . . 0.449 ' N ' ' CG ' ' A' ' 358' ' ' GLU . 9.4 mm100 -56.57 -66.72 0.39 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.453 1.096 . . . . 72.21 110.329 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 360' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 364' ' ' CYS . 10.1 t80 -38.37 -51.94 1.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.522 1.139 . . . . 73.41 110.961 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -58.28 -60.96 2.95 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.493 1.121 . . . . 65.44 110.275 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 6.0 mt -45.47 -63.9 0.85 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.514 1.134 . . . . 72.34 109.271 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 363' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 364' ' ' CYS . . . . . 0.404 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.5 m -69.06 -23.29 64.02 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.472 1.108 . . . . 72.31 108.275 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -73.54 -3.74 29.66 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.511 1.132 . . . . 74.11 110.297 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 8.0 mmt -114.38 -33.5 5.59 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.527 1.142 . . . . 63.35 110.995 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.14 35.52 3.14 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.499 1.125 . . . . 62.03 110.994 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 24.0 m -148.76 161.16 42.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 0.771 . . . . 74.42 109.965 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.4 ' OG1' ' CB ' ' A' ' 372' ' ' LEU . 11.5 p -96.48 178.93 5.18 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.506 1.129 . . . . 64.24 110.364 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.487 ' CD2' HG22 ' A' ' 355' ' ' VAL . 50.1 t80 -85.03 -58.91 2.5 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 70.34 110.992 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.449 ' CB ' ' HB ' ' A' ' 423' ' ' VAL . 0.1 OUTLIER -54.66 -19.37 5.99 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.49 1.119 . . . . 70.33 110.254 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.797 HD22 ' N ' ' A' ' 373' ' ' CYS . 1.2 tm? -73.15 135.5 44.69 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.503 1.127 . . . . 71.21 109.307 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 373' ' ' CYS . . . . . 0.797 ' N ' HD22 ' A' ' 372' ' ' LEU . 7.6 t -72.2 132.37 44.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.987 -1.006 . . . . 72.51 110.901 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.439 ' NZ ' ' O ' ' A' ' 372' ' ' LEU . 12.5 mmtm -90.19 17.12 7.41 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.51 1.131 . . . . 52.45 109.289 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 0.888 HD11 ' CE1' ' A' ' 410' ' ' PHE . 83.0 mt -102.45 -41.62 7.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.505 1.128 . . . . 71.25 109.328 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 376' ' ' CYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 377' ' ' ALA . 0.0 OUTLIER -115.6 -44.49 2.96 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.534 1.146 . . . . 64.31 108.317 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.762 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 70.23 37.96 1.54 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.477 1.111 . . . . 63.03 109.299 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -131.63 -44.48 0.99 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.483 1.114 . . . . 72.44 110.311 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -107.38 172.79 6.63 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.453 1.096 . . . . 42.25 109.34 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -95.52 147.58 23.4 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.512 1.132 . . . . 73.31 109.274 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.465 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 27.4 mttt -55.41 -62.53 1.62 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 72.33 109.3 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 57.89 28.25 15.81 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 63.43 109.284 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.897 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -158.38 175.83 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.515 1.134 . . . . 61.5 109.293 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.456 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 72.6 tttt -157.83 149.34 21.62 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.502 1.126 . . . . 65.41 109.314 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.691 HG13 ' HE3' ' A' ' 392' ' ' MET . 2.6 mm -114.13 138.16 44.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.115 . . . . 75.34 109.328 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.513 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.2 OUTLIER -138.04 160.86 62.68 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.544 1.153 . . . . 74.34 110.303 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.513 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.98 -8.91 23.79 Favored 'Cis proline' 0 C--N 1.36 1.163 0 C-N-CA 120.979 -2.509 . . . . 72.11 111.012 -0.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 388' ' ' CYS . . . . . 0.539 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 17.5 t -36.84 -75.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.956 -1.02 . . . . 62.11 110.912 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 389' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 120.62 7.41 8.9 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.532 1.145 . . . . 72.21 111.015 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.539 ' CG ' ' SG ' ' A' ' 388' ' ' CYS . 56.6 m170 -77.0 131.78 38.63 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.524 0.779 . . . . 74.21 109.612 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.615 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -102.48 168.09 9.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.447 1.092 . . . . 72.15 109.317 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.897 ' O ' HG12 ' A' ' 383' ' ' VAL . 17.3 ptp -179.25 173.84 1.09 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.51 1.131 . . . . 74.42 111.006 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 393' ' ' CYS . . . . . 0.418 ' O ' ' N ' ' A' ' 396' ' ' CYS . 1.7 p -102.66 117.69 35.21 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 63.45 108.281 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 397' ' ' LEU . 2.5 m -38.7 -60.11 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.484 1.115 . . . . 70.53 110.441 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.8 m -39.3 -41.64 0.93 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.505 1.128 . . . . 44.15 110.042 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' CYS . . . . . 0.495 ' SG ' HG21 ' A' ' 375' ' ' ILE . 38.3 t -73.9 -49.85 22.94 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.471 1.107 . . . . 44.12 108.284 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.436 ' CD1' ' HG3' ' A' ' 401' ' ' GLN . 1.5 tm? -42.61 -51.03 5.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.469 1.106 . . . . 73.01 109.328 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 398' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 402' ' ' GLU . 1.2 m -53.89 -42.05 68.25 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.509 1.131 . . . . 52.43 110.411 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 399' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -57.98 -26.59 62.53 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.505 1.128 . . . . 63.22 109.276 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 400' ' ' TRP . . . . . 0.601 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 10.5 t-105 -85.42 -62.58 1.5 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.52 1.137 . . . . 72.35 108.023 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.501 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 8.3 mm-40 -55.94 -14.37 2.46 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 1.122 . . . . 72.54 110.284 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 398' ' ' THR . 2.9 mm-40 -37.12 -63.36 0.44 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 71.13 110.32 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 22.7 t -121.4 -24.59 5.38 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.508 1.13 . . . . 42.42 109.995 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' ASP . . . . . 0.601 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 6.9 m-20 -82.51 -94.05 0.06 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.475 1.109 . . . . 53.31 109.326 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.501 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 72.42 31.04 63.73 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.475 1.109 . . . . 50.22 110.993 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -88.65 54.13 2.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 0.765 . . . . 74.4 110.272 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 72.02 -163.88 54.39 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.541 1.151 . . . . 33.11 111.024 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' CYS . . . . . 0.455 ' O ' ' N ' ' A' ' 412' ' ' ARG . 3.7 t -56.05 121.3 40.23 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.31 -0.996 . . . . 63.44 108.31 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 0.69 8.62 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.492 1.785 . . . . 71.31 110.998 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' PHE . . . . . 0.888 ' CE1' HD11 ' A' ' 375' ' ' ILE . 24.3 m-85 -90.24 -36.34 14.79 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.518 1.136 . . . . 72.2 111.046 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 411' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.13 13.69 6.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 73.4 108.31 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 412' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 408' ' ' CYS . 14.8 tpp85 38.61 48.82 1.34 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.541 1.151 . . . . 73.02 110.347 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 1.2 m -125.89 150.92 47.55 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.468 1.105 . . . . 51.43 108.281 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 414' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 415' ' ' ILE . 5.1 tt0 -59.29 147.62 35.15 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.486 1.117 . . . . 71.01 110.271 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.605 HG21 HG21 ' A' ' 418' ' ' THR . 1.2 mt -89.04 149.11 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.484 1.115 . . . . 62.02 109.283 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.74 -49.82 2.63 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 74.22 109.324 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -140.58 131.89 5.2 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 124.498 1.124 . . . . 74.13 110.993 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' THR . . . . . 0.605 HG21 HG21 ' A' ' 415' ' ' ILE . 1.5 p -147.56 117.89 7.38 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.571 0.807 . . . . 64.12 110.434 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.433 ' O ' HG23 ' A' ' 421' ' ' ILE . 20.5 pt-20 -128.08 150.83 74.85 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.459 1.099 . . . . 70.21 110.309 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 98.51 1.17 Allowed 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.467 1.772 . . . . 65.41 110.994 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.817 HD11 HG22 ' A' ' 423' ' ' VAL . 0.7 OUTLIER -107.45 154.88 8.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.5 1.125 . . . . 71.23 109.292 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 422' ' ' ILE . . . . . 0.489 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 4.0 mp -110.67 105.39 18.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.502 1.126 . . . . 74.33 109.306 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.817 HG22 HD11 ' A' ' 421' ' ' ILE . 38.9 t -77.1 145.62 9.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.488 1.118 . . . . 74.5 109.294 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.445 ' O ' HG23 ' A' ' 355' ' ' VAL . 4.5 m-20 -130.54 143.53 49.67 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.491 1.119 . . . . 75.53 109.283 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 161.63 38.46 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.516 1.798 . . . . 62.4 110.997 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' PHE . . . . . 0.696 ' CE1' ' CG ' ' A' ' 357' ' ' GLN . 3.5 t80 . . . . . 0 C--N 1.326 -0.453 0 O-C-N 124.509 1.131 . . . . 73.14 111.004 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.028 0 N-CA-C 111.022 -0.831 . . . . 43.42 111.022 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 178.66 6.97 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.503 1.791 . . . . 65.14 111.008 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 8.5 m170 62.51 25.6 15.25 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.512 1.133 . . . . 73.13 109.635 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 14.4 ptm -90.68 17.01 8.1 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.481 1.113 . . . . 72.34 111.04 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -83.48 69.52 3.35 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.473 1.108 . . . . 65.12 111.008 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 16.2 m -49.14 145.39 4.26 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.443 0.731 . . . . 70.02 109.964 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -99.67 169.24 9.41 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.511 1.132 . . . . 63.22 109.259 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 352' ' ' HIS . . . . . 0.506 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 38.4 m-70 -136.3 125.15 24.05 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 72.22 109.629 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.552 HG13 HD13 ' A' ' 421' ' ' ILE . 7.7 mt -105.47 149.76 8.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.521 1.138 . . . . 64.34 109.322 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 13.0 tptp -123.27 123.32 40.49 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.458 1.099 . . . . 73.33 109.3 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 424' ' ' ASP . 55.2 t -79.71 148.87 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.487 1.117 . . . . 74.01 109.298 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 40.2 p -114.2 -178.47 3.38 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.493 1.121 . . . . 74.35 110.385 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 357' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -72.81 -36.7 67.59 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 54.34 110.336 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -54.94 -35.33 64.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.537 1.148 . . . . 75.23 110.322 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -79.6 -66.73 0.83 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 1.135 . . . . 75.15 110.306 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 360' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 364' ' ' CYS . 12.3 t80 -38.2 -43.23 0.75 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.499 1.124 . . . . 64.01 111.004 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -61.48 -54.15 47.17 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.464 1.103 . . . . 75.35 110.266 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.4 tt -55.36 -35.75 65.59 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.485 1.116 . . . . 70.13 109.267 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 363' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 364' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 360' ' ' TYR . 3.3 m -71.65 -25.6 62.2 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.463 1.102 . . . . 61.33 108.255 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -71.79 -16.09 62.17 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.535 1.147 . . . . 64.41 110.29 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.94 2.6 6.59 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.461 1.101 . . . . 74.14 110.973 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 50.79 58.69 8.92 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.522 1.139 . . . . 72.34 111.019 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 84.5 p -129.36 177.99 6.78 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 0.757 . . . . 54.35 109.969 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 2.3 p -126.03 142.11 51.67 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.479 1.112 . . . . 64.01 110.388 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.615 ' CZ ' ' CD1' ' A' ' 391' ' ' LEU . 54.1 t80 -66.22 -67.96 0.41 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.485 1.116 . . . . 73.33 111.056 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.514 HE22 ' HB3' ' A' ' 425' ' ' PRO . 1.0 OUTLIER -41.32 -31.8 0.26 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.453 1.096 . . . . 70.3 110.295 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.921 HD22 ' N ' ' A' ' 373' ' ' CYS . 0.5 OUTLIER -67.07 136.39 55.13 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.436 1.085 . . . . 64.42 109.293 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 373' ' ' CYS . . . . . 0.921 ' N ' HD22 ' A' ' 372' ' ' LEU . 19.3 p -72.17 129.61 38.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.004 -0.998 . . . . 70.02 110.925 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -90.99 18.35 6.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.453 1.096 . . . . 73.1 109.334 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 0.696 HD11 ' HE1' ' A' ' 410' ' ' PHE . 12.1 mt -92.13 -60.45 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.485 1.116 . . . . 73.14 109.282 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 23.9 p -107.68 -24.04 11.88 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.472 1.108 . . . . 63.21 108.284 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.489 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 60.93 43.24 11.91 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.462 1.102 . . . . 45.1 109.315 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -127.75 -43.65 1.54 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.522 1.139 . . . . 73.24 110.307 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 39.0 m-20 -119.7 177.7 4.85 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.452 1.095 . . . . 74.13 109.349 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -88.3 169.41 11.86 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 73.51 109.303 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.426 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 24.5 mttt -70.55 -62.07 1.53 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.499 1.124 . . . . 63.12 109.312 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 59.92 25.05 14.17 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 63.23 109.301 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.842 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -160.8 155.34 3.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 54.23 109.293 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.854 ' HE3' HD21 ' A' ' 391' ' ' LEU . 4.1 ttmt -139.29 137.32 35.75 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.516 1.135 . . . . 65.51 109.274 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.718 HG23 ' CG2' ' A' ' 415' ' ' ILE . 20.2 mm -97.99 139.57 19.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.523 1.139 . . . . 74.25 109.284 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.524 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.0 OUTLIER -138.0 161.39 60.0 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.46 1.1 . . . . 72.04 110.28 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.524 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.0 -8.94 23.86 Favored 'Cis proline' 0 C--N 1.36 1.147 0 C-N-CA 121.021 -2.491 . . . . 74.24 111.017 -0.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 388' ' ' CYS . . . . . 0.544 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 31.3 t -36.55 -72.89 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.951 -1.022 . . . . 70.14 110.926 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 389' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 115.58 18.28 6.19 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.485 1.115 . . . . 75.01 111.004 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.544 ' CG ' ' SG ' ' A' ' 388' ' ' CYS . 61.7 m170 -87.77 129.3 35.22 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.518 0.775 . . . . 65.13 109.546 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.854 HD21 ' HE3' ' A' ' 384' ' ' LYS . 0.8 OUTLIER -96.1 160.31 14.51 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.459 1.099 . . . . 72.11 109.262 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.842 ' O ' HG12 ' A' ' 383' ' ' VAL . 15.5 ptp -170.52 173.44 5.53 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.477 1.111 . . . . 73.33 111.019 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 5.0 p -99.15 115.0 28.04 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.483 1.115 . . . . 74.52 108.333 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 17.4 m -42.0 -59.7 1.65 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.496 1.123 . . . . 75.31 110.425 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 10.6 t -41.62 -36.58 0.97 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.478 1.111 . . . . 63.35 109.985 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' CYS . . . . . 0.455 ' HB3' HG21 ' A' ' 375' ' ' ILE . 2.3 m -75.88 -54.93 6.14 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.467 1.105 . . . . 60.23 108.281 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.734 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.3 OUTLIER -41.34 -35.19 0.61 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.128 . . . . 75.21 109.28 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 398' ' ' THR . . . . . 0.414 ' N ' HD13 ' A' ' 397' ' ' LEU . 83.2 m -62.05 -49.76 74.7 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.512 1.133 . . . . 53.24 110.431 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 399' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -55.16 -22.16 16.13 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.473 1.108 . . . . 72.43 109.349 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 400' ' ' TRP . . . . . 0.602 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 16.3 t-105 -84.6 -65.16 1.04 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.516 1.135 . . . . 64.45 108.048 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.51 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 38.3 mm-40 -49.18 -20.81 0.65 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.544 1.152 . . . . 51.2 110.304 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 401' ' ' GLN . 10.4 mt-10 -37.47 -63.53 0.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.479 1.112 . . . . 75.44 110.345 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 3.3 m -122.41 -24.22 5.05 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.497 1.123 . . . . 71.13 109.97 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 404' ' ' ASP . . . . . 0.602 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 16.9 m-20 -83.54 -95.17 0.06 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.51 1.131 . . . . 74.44 109.253 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.51 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 67.92 23.22 74.29 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.479 1.112 . . . . 61.22 111.01 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -81.51 58.11 3.56 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.556 0.797 . . . . 75.23 110.326 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 69.95 -160.74 53.18 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.503 1.127 . . . . 70.45 111.023 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' CYS . . . . . 0.616 ' SG ' HG21 ' A' ' 385' ' ' ILE . 4.7 t -56.3 120.3 34.23 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.267 -1.012 . . . . 64.54 108.267 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.412 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.2 Cg_endo -74.95 0.43 8.89 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.454 1.765 . . . . 74.33 110.978 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 410' ' ' PHE . . . . . 0.696 ' HE1' HD11 ' A' ' 375' ' ' ILE . 3.6 m-30 -93.8 -37.23 11.88 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.485 1.116 . . . . 74.03 111.0 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 411' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -123.26 13.49 9.61 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.49 1.119 . . . . 64.45 108.321 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 412' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 408' ' ' CYS . 11.4 mmt85 38.43 40.45 0.37 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 74.54 110.285 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 16.0 t -126.66 140.1 52.66 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.49 1.119 . . . . 73.43 108.301 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -45.32 154.25 0.18 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.467 1.104 . . . . 54.33 110.228 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.718 ' CG2' HG23 ' A' ' 385' ' ' ILE . 2.7 mt -109.8 157.19 10.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.48 1.113 . . . . 61.43 109.327 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -129.9 -46.6 1.14 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.492 1.12 . . . . 73.52 109.259 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.555 ' O ' HG23 ' A' ' 418' ' ' THR . . . -107.22 127.14 8.68 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.53 1.144 . . . . 45.14 110.964 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 418' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 417' ' ' GLY . 17.5 p -157.47 128.65 6.73 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 0.76 . . . . 71.54 110.395 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.644 ' OE2' HG22 ' A' ' 421' ' ' ILE . 0.0 OUTLIER -160.02 166.39 15.96 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.466 1.104 . . . . 73.11 110.283 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 101.85 1.52 Allowed 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.541 1.811 . . . . 71.3 110.984 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.913 HD12 ' N ' ' A' ' 422' ' ' ILE . 0.6 OUTLIER -103.89 170.18 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.146 . . . . 73.44 109.313 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 422' ' ' ILE . . . . . 0.913 ' N ' HD12 ' A' ' 421' ' ' ILE . 5.9 mt -137.8 107.63 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.448 1.093 . . . . 71.32 109.284 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.652 ' CG2' HD11 ' A' ' 421' ' ' ILE . 30.7 t -78.16 147.42 7.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.436 1.085 . . . . 70.34 109.264 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.678 ' O ' HG23 ' A' ' 355' ' ' VAL . 5.9 m-20 -129.68 143.72 50.09 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.478 1.112 . . . . 61.12 109.292 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 425' ' ' PRO . . . . . 0.514 ' HB3' HE22 ' A' ' 371' ' ' GLN . 18.3 Cg_endo -75.05 173.42 14.55 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.489 1.784 . . . . 74.4 111.007 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 15.5 t80 . . . . . 0 C--N 1.324 -0.503 0 O-C-N 124.556 1.16 . . . . 74.22 111.023 179.994 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.01 0 N-CA-C 111.02 -0.832 . . . . 55.12 111.02 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 178.72 6.88 Favored 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.56 1.821 . . . . 71.44 110.985 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -98.22 177.14 5.48 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.46 1.1 . . . . 62.41 109.551 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 348' ' ' MET . . . . . 0.41 ' N ' ' SD ' ' A' ' 348' ' ' MET . 1.9 mpt? -123.73 140.66 52.77 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.53 1.144 . . . . 73.44 110.98 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 107.3 -5.68 35.96 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.451 1.094 . . . . 74.13 110.997 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 350' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 64.5 m -113.13 144.36 42.78 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.457 0.739 . . . . 61.23 110.007 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 351' ' ' ASP . . . . . 0.485 ' CG ' HG22 ' A' ' 421' ' ' ILE . 0.3 OUTLIER -79.91 168.41 19.27 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.502 1.126 . . . . 63.13 109.312 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 352' ' ' HIS . . . . . 0.519 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 26.3 m-70 -132.94 135.85 45.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 64.2 109.578 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 3.3 mm -113.78 153.34 15.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.545 1.153 . . . . 62.03 109.308 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.413 ' CD ' ' O ' ' A' ' 355' ' ' VAL . 0.8 OUTLIER -114.31 136.24 53.19 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.471 1.107 . . . . 74.33 109.298 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 424' ' ' ASP . 5.7 t -98.77 163.74 2.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.539 1.149 . . . . 43.13 109.342 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.494 ' N ' ' CG1' ' A' ' 355' ' ' VAL . 2.4 p -125.63 179.68 5.04 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.536 1.147 . . . . 64.53 110.438 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 357' ' ' GLN . . . . . 0.564 ' HG3' ' CZ ' ' A' ' 426' ' ' PHE . 13.0 mt-30 -75.38 -37.54 60.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.545 1.153 . . . . 71.31 110.281 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -60.88 -31.19 70.66 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.502 1.126 . . . . 65.31 110.305 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 359' ' ' GLN . . . . . 0.438 ' NE2' ' OG1' ' A' ' 356' ' ' THR . 62.3 mt-30 -74.2 -66.92 0.66 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.5 1.125 . . . . 72.12 110.293 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -47.07 -34.95 6.33 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.531 1.144 . . . . 63.15 111.031 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -73.53 -57.54 3.93 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.439 1.087 . . . . 73.22 110.273 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.669 ' O ' HD23 ' A' ' 362' ' ' LEU . 7.0 tt -51.15 -32.3 22.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.555 1.159 . . . . 72.12 109.28 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 363' ' ' PTR . . . . . 0.752 ' CD2' ' HZ1' ' A' ' 374' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.8 m -66.68 -24.35 66.26 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.523 1.14 . . . . 54.03 108.268 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -75.56 -3.93 37.01 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.5 1.125 . . . . 70.32 110.293 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 19.4 mtm -111.38 -33.91 6.27 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.504 1.127 . . . . 72.1 110.98 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 99.66 13.97 36.2 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.485 1.116 . . . . 73.43 111.028 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 66.1 m -120.86 -176.43 3.25 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.505 0.767 . . . . 75.31 109.99 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.813 HG22 ' NE2' ' A' ' 371' ' ' GLN . 1.9 m -115.81 161.54 18.6 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.463 1.102 . . . . 62.04 110.4 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.489 ' CD2' HG22 ' A' ' 355' ' ' VAL . 89.1 t80 -64.39 -68.76 0.33 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.138 . . . . 74.5 110.981 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.813 ' NE2' HG22 ' A' ' 369' ' ' THR . 0.1 OUTLIER -46.69 -34.1 4.83 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.52 1.138 . . . . 71.24 110.268 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.709 HD13 ' O ' ' A' ' 373' ' ' CYS . 2.3 tm? -60.49 141.13 56.86 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 75.3 109.332 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 373' ' ' CYS . . . . . 0.709 ' O ' HD13 ' A' ' 372' ' ' LEU . 24.0 p -72.13 159.95 33.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.03 -0.986 . . . . 74.12 110.882 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.752 ' HZ1' ' CD2' ' A' ' 363' ' ' PTR . 21.8 mmtp -117.17 28.54 8.43 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.523 1.14 . . . . 71.12 109.314 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 0.614 HD11 ' HE1' ' A' ' 410' ' ' PHE . 11.5 mt -112.72 -59.64 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.453 1.096 . . . . 63.24 109.329 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 2.0 m -105.05 -14.85 15.27 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.484 1.115 . . . . 51.11 108.334 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.59 ' HA ' HD11 ' A' ' 372' ' ' LEU . . . 52.14 44.98 29.16 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.505 1.128 . . . . 73.1 109.311 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -131.6 -61.93 0.88 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 70.15 110.298 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -95.18 162.88 13.52 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 70.23 109.313 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -85.42 167.89 15.1 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.514 1.134 . . . . 73.34 109.305 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.514 ' HZ1' HD12 ' A' ' 391' ' ' LEU . 0.7 OUTLIER -70.17 -61.05 1.93 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.117 . . . . 73.32 109.282 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 382' ' ' ASP . . . . . 0.406 ' CG ' ' C ' ' A' ' 381' ' ' LYS . 0.2 OUTLIER 47.51 25.04 0.57 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 72.45 109.278 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.864 HG12 ' O ' ' A' ' 392' ' ' MET . 0.3 OUTLIER -150.91 170.17 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.528 1.143 . . . . 72.32 109.274 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 22.9 tttm -155.29 147.03 23.23 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.454 1.096 . . . . 73.54 109.274 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.823 HD12 HD13 ' A' ' 415' ' ' ILE . 20.6 mm -108.97 135.06 48.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.504 1.127 . . . . 72.43 109.29 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.515 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.8 mt-10 -137.76 161.11 62.01 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.448 1.093 . . . . 74.1 110.326 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.515 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.99 -5.63 21.6 Favored 'Cis proline' 0 C--N 1.36 1.155 0 C-N-CA 120.985 -2.506 . . . . 61.4 110.979 0.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 388' ' ' CYS . . . . . 0.541 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 17.6 t -37.99 -78.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.008 -0.996 . . . . 55.02 110.892 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 389' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 119.23 36.46 0.86 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.485 1.115 . . . . 71.13 110.965 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.541 ' CG ' ' SG ' ' A' ' 388' ' ' CYS . 63.3 m170 -108.5 129.73 55.28 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.52 0.777 . . . . 55.31 109.543 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.514 HD12 ' HZ1' ' A' ' 381' ' ' LYS . 0.8 OUTLIER -98.66 160.41 14.29 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.471 1.107 . . . . 72.4 109.307 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.864 ' O ' HG12 ' A' ' 383' ' ' VAL . 20.5 ptp -177.99 170.9 1.82 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.544 1.152 . . . . 62.34 110.999 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 5.0 p -89.83 114.78 26.58 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.463 1.102 . . . . 64.34 108.296 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 397' ' ' LEU . 3.4 m -46.98 -55.53 7.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.48 1.113 . . . . 73.21 110.447 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 71.5 m -46.41 -29.29 1.64 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 61.02 110.047 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' CYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 399' ' ' ALA . 1.9 m -86.19 -37.92 18.2 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.565 1.166 . . . . 71.12 108.266 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.74 ' O ' HD23 ' A' ' 397' ' ' LEU . 3.0 tt -53.88 -47.05 71.46 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.534 1.146 . . . . 63.44 109.338 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.09 -35.28 61.93 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 1.114 . . . . 73.13 110.409 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 399' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -63.01 -26.49 68.88 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.515 1.135 . . . . 64.1 109.305 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 400' ' ' TRP . . . . . 0.492 ' CD2' ' HB3' ' A' ' 409' ' ' PRO . 3.7 t-105 -80.85 -52.87 7.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.97 -1.122 . . . . 74.44 107.97 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.509 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.2 mm-40 -61.74 -10.28 8.41 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.512 1.132 . . . . 65.03 110.339 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 401' ' ' GLN . 37.7 mt-10 -37.23 -63.7 0.42 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.531 1.145 . . . . 65.44 110.287 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.8 m -123.12 -24.88 4.62 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.487 1.117 . . . . 73.34 109.985 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 404' ' ' ASP . . . . . 0.491 ' OD2' ' CH2' ' A' ' 400' ' ' TRP . 0.6 OUTLIER -81.71 -90.9 0.07 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.486 1.116 . . . . 65.22 109.283 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.509 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 69.41 32.51 71.79 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.461 1.101 . . . . 54.4 111.02 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -91.11 64.85 5.4 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.503 0.766 . . . . 74.2 110.295 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 66.07 -156.41 49.96 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.528 1.143 . . . . 74.01 111.006 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' CYS . . . . . 0.754 ' SG ' HG21 ' A' ' 385' ' ' ILE . 5.4 t -57.39 127.22 76.78 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 108.267 -1.012 . . . . 71.32 108.267 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.552 ' HD2' ' HE1' ' A' ' 392' ' ' MET . 18.3 Cg_endo -75.04 0.33 9.05 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.506 1.793 . . . . 75.31 110.99 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 410' ' ' PHE . . . . . 0.614 ' HE1' HD11 ' A' ' 375' ' ' ILE . 3.3 m-85 -93.59 -39.49 10.8 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.54 1.15 . . . . 74.01 110.991 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 411' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.5 OUTLIER -119.8 12.47 12.14 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.505 1.128 . . . . 72.43 108.254 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 412' ' ' ARG . . . . . 0.442 ' HD2' ' CH2' ' A' ' 400' ' ' TRP . 37.4 mmm-85 38.5 31.73 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.509 1.131 . . . . 72.51 110.274 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 413' ' ' CYS . . . . . 0.422 ' N ' ' O ' ' A' ' 411' ' ' CYS . 42.8 t -114.74 151.12 34.24 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.513 1.133 . . . . 75.32 108.255 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -55.16 149.1 12.93 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.516 1.135 . . . . 74.02 110.335 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.823 HD13 HD12 ' A' ' 385' ' ' ILE . 4.0 mt -107.24 157.2 7.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.546 1.154 . . . . 73.14 109.294 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -126.64 -46.78 1.57 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.48 1.113 . . . . 72.14 109.275 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 418' ' ' THR . . . -107.32 127.08 8.64 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.535 1.147 . . . . 42.44 110.97 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 418' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 417' ' ' GLY . 17.1 p -157.57 117.79 3.44 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.48 0.753 . . . . 75.33 110.413 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -143.6 150.59 51.27 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.521 1.138 . . . . 73.14 110.273 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.49 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.3 Cg_endo -75.06 102.47 1.59 Allowed 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.475 1.776 . . . . 74.21 110.972 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.673 HD12 ' N ' ' A' ' 422' ' ' ILE . 1.2 pp -103.88 172.05 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.466 1.104 . . . . 71.43 109.267 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 422' ' ' ILE . . . . . 0.673 ' N ' HD12 ' A' ' 421' ' ' ILE . 19.5 mm -130.83 115.14 29.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.512 1.133 . . . . 72.24 109.266 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.418 ' CG2' HD11 ' A' ' 421' ' ' ILE . 18.9 t -84.68 141.67 14.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.488 1.118 . . . . 74.13 109.326 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.577 ' O ' HG23 ' A' ' 355' ' ' VAL . 1.0 OUTLIER -128.61 143.44 48.43 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.506 1.129 . . . . 74.23 109.327 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.04 174.44 12.79 Favored 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.5 1.789 . . . . 73.2 110.974 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 426' ' ' PHE . . . . . 0.564 ' CZ ' ' HG3' ' A' ' 357' ' ' GLN . 10.1 t80 . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.489 1.118 . . . . 73.03 111.037 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.035 0 N-CA-C 110.964 -0.854 . . . . 73.32 110.964 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 178.71 6.9 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.513 1.796 . . . . 60.15 111.028 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.54 146.37 41.83 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.451 1.094 . . . . 72.5 109.596 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 348' ' ' MET . . . . . 0.45 ' N ' ' SD ' ' A' ' 348' ' ' MET . 0.0 OUTLIER -44.93 167.34 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.524 1.14 . . . . 63.25 110.978 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -59.48 108.51 1.7 Allowed Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.504 1.128 . . . . 71.21 111.006 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 5.7 p -142.73 143.47 32.27 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.496 0.763 . . . . 73.41 109.979 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -93.48 -178.88 4.87 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 1.12 . . . . 65.23 109.306 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' HIS . . . . . 0.531 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 30.8 m-70 -139.31 145.96 39.74 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.469 1.105 . . . . 61.44 109.58 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 96.5 mt -133.71 142.6 41.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.528 1.142 . . . . 71.12 109.33 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.84 148.2 29.87 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.503 1.127 . . . . 65.0 109.258 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 424' ' ' ASP . 51.8 t -112.99 164.18 9.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.499 1.124 . . . . 63.01 109.331 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.464 ' N ' HG12 ' A' ' 355' ' ' VAL . 2.5 p -124.17 171.92 9.45 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.51 1.131 . . . . 71.23 110.441 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 357' ' ' GLN . . . . . 0.545 ' HG3' ' CZ ' ' A' ' 426' ' ' PHE . 14.9 mt-30 -66.32 -35.88 81.51 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.514 1.134 . . . . 71.05 110.28 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -55.94 -47.62 77.23 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.51 1.131 . . . . 74.24 110.351 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -59.48 -58.67 7.57 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.477 1.11 . . . . 65.04 110.305 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 360' ' ' TYR . . . . . 0.438 ' O ' ' N ' ' A' ' 364' ' ' CYS . 13.1 t80 -55.0 -33.12 62.31 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.486 1.116 . . . . 71.33 110.992 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -60.73 -47.71 85.09 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.466 1.104 . . . . 62.52 110.247 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.427 ' N ' ' CD1' ' A' ' 362' ' ' LEU . 0.4 OUTLIER -70.44 -44.84 67.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.493 1.12 . . . . 41.44 109.309 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 363' ' ' PTR . . . . . 0.434 ' CD2' ' HZ1' ' A' ' 374' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 364' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m -84.27 -21.57 31.06 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.456 1.097 . . . . 73.02 108.287 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -77.64 -4.65 47.09 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.485 1.115 . . . . 73.43 110.312 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' MET . . . . . 0.427 ' CG ' ' O ' ' A' ' 363' ' ' PTR . 19.8 ptp -116.44 -32.24 5.32 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.47 1.106 . . . . 74.21 110.978 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.62 40.37 3.65 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.566 1.166 . . . . 43.42 111.01 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 68.5 m -145.1 171.84 13.93 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.539 0.788 . . . . 61.11 109.987 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.807 HG22 ' NE2' ' A' ' 371' ' ' GLN . 1.8 m -115.07 162.71 16.64 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.547 1.155 . . . . 43.22 110.37 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.416 ' HA ' ' CE2' ' A' ' 363' ' ' PTR . 43.7 t80 -66.46 -68.53 0.37 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 63.12 111.004 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.807 ' NE2' HG22 ' A' ' 369' ' ' THR . 0.2 OUTLIER -46.05 -26.82 0.8 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.493 1.121 . . . . 74.23 110.29 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.939 HD22 ' N ' ' A' ' 373' ' ' CYS . 0.4 OUTLIER -71.18 135.74 47.73 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.501 1.126 . . . . 70.15 109.298 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 373' ' ' CYS . . . . . 0.939 ' N ' HD22 ' A' ' 372' ' ' LEU . 12.3 p -67.19 134.23 51.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.018 -0.992 . . . . 62.15 110.928 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.434 ' HZ1' ' CD2' ' A' ' 363' ' ' PTR . 28.8 mmtp -92.41 34.5 1.05 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.565 1.166 . . . . 74.52 109.312 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 49.8 mt -112.6 -60.35 2.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.545 1.153 . . . . 71.43 109.292 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -109.04 -18.31 13.69 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.484 1.115 . . . . 63.22 108.298 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.761 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 52.57 52.86 13.25 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.485 1.116 . . . . 63.32 109.328 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -135.19 -49.41 0.73 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.504 1.128 . . . . 75.42 110.326 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -111.89 165.36 12.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.531 1.144 . . . . 75.43 109.305 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -79.89 163.01 24.68 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 63.32 109.28 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.462 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 22.5 mttt -70.13 -62.6 1.32 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.475 1.109 . . . . 73.01 109.286 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 26.5 t0 60.25 23.74 13.14 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.541 1.151 . . . . 73.42 109.291 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.916 HG12 ' O ' ' A' ' 392' ' ' MET . 0.4 OUTLIER -153.4 176.12 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.463 1.102 . . . . 45.41 109.312 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -157.91 154.66 28.25 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.475 1.109 . . . . 71.11 109.296 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.804 HG22 ' SG ' ' A' ' 388' ' ' CYS . 11.6 mm -122.04 142.48 38.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.455 1.097 . . . . 73.14 109.321 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.557 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.1 mt-10 -136.9 162.91 53.1 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.467 1.104 . . . . 64.5 110.29 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.557 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.02 -13.47 23.65 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 120.97 -2.513 . . . . 70.24 110.999 -0.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 388' ' ' CYS . . . . . 0.804 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.12 -71.53 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.978 -1.01 . . . . 52.25 110.911 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 389' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.97 16.38 6.28 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.497 1.123 . . . . 74.32 110.985 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.568 ' CE1' ' HB2' ' A' ' 388' ' ' CYS . 20.9 m80 -73.48 145.16 45.87 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 0.763 . . . . 53.43 109.568 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.814 HD22 ' N ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -117.37 156.57 27.66 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.126 . . . . 75.34 109.345 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.916 ' O ' HG12 ' A' ' 383' ' ' VAL . 12.3 ptp -173.9 173.93 3.14 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.512 1.133 . . . . 73.3 110.999 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 5.3 p -91.39 137.45 32.35 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.446 1.091 . . . . 63.23 108.286 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 98.4 m -65.81 -31.54 72.56 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.466 1.104 . . . . 53.21 110.386 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 60.9 m -72.46 -58.2 3.57 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.523 1.139 . . . . 75.04 109.99 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' CYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 399' ' ' ALA . 1.9 p -55.87 -42.84 76.49 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.508 1.13 . . . . 54.41 108.285 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.74 HD22 ' O ' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -45.12 -44.02 10.22 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.519 1.137 . . . . 72.11 109.311 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 398' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 402' ' ' GLU . 86.2 m -54.61 -38.47 66.83 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.527 1.142 . . . . 71.2 110.414 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 399' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -55.35 -26.91 43.8 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.46 1.1 . . . . 74.15 109.299 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 400' ' ' TRP . . . . . 0.602 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 8.1 t-105 -85.0 -60.91 1.9 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.985 -1.117 . . . . 72.12 107.985 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.496 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 7.3 mm-40 -56.69 -13.75 2.72 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.482 1.114 . . . . 74.22 110.265 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 398' ' ' THR . 3.6 mm-40 -37.14 -63.41 0.43 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.506 1.129 . . . . 70.44 110.303 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 5.2 t -121.23 -24.62 5.44 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.567 1.167 . . . . 73.52 109.938 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 404' ' ' ASP . . . . . 0.602 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 17.1 m-20 -82.87 -94.54 0.06 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.457 1.098 . . . . 73.1 109.296 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.496 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 73.17 29.72 64.07 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.46 1.1 . . . . 62.44 110.97 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -88.07 66.09 8.44 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.513 0.773 . . . . 73.24 110.308 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 68.45 -160.03 51.6 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.479 1.112 . . . . 63.23 111.018 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 408' ' ' CYS . . . . . 0.696 ' SG ' HG21 ' A' ' 385' ' ' ILE . 7.5 t -59.98 131.79 89.44 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 108.282 -1.007 . . . . 74.02 108.282 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -0.07 9.53 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.547 1.814 . . . . 53.33 110.988 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' PHE . . . . . 0.568 ' CD1' ' HE1' ' A' ' 392' ' ' MET . 8.4 m-85 -95.11 -43.02 8.3 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 72.32 111.002 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 411' ' ' CYS . . . . . 0.445 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.5 OUTLIER -111.67 9.18 20.98 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.518 1.136 . . . . 73.25 108.285 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 412' ' ' ARG . . . . . . . . . . . . . 39.8 mmm-85 38.58 30.24 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.478 1.111 . . . . 70.33 110.253 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 413' ' ' CYS . . . . . 0.445 ' N ' ' O ' ' A' ' 411' ' ' CYS . 24.2 t -127.46 146.15 50.59 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.463 1.102 . . . . 75.02 108.287 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -42.58 152.13 0.1 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 72.44 110.296 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.731 HG23 HG23 ' A' ' 385' ' ' ILE . 2.1 mt -98.86 148.67 5.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.493 1.121 . . . . 64.14 109.303 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -112.29 -48.42 3.03 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.504 1.128 . . . . 74.43 109.331 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.45 ' C ' HG23 ' A' ' 418' ' ' THR . . . -116.51 129.04 8.23 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.489 1.118 . . . . 61.33 110.979 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 418' ' ' THR . . . . . 0.604 ' CG2' HG21 ' A' ' 415' ' ' ILE . 82.0 p -152.82 138.95 18.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.492 0.76 . . . . 71.14 110.386 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.41 ' O ' HG23 ' A' ' 421' ' ' ILE . 1.1 pm0 -167.14 150.84 6.26 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.499 1.124 . . . . 74.33 110.309 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 101.08 1.43 Allowed 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.451 1.764 . . . . 74.02 110.977 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.732 HD11 HG22 ' A' ' 423' ' ' VAL . 0.6 OUTLIER -105.32 157.55 6.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 72.43 109.303 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 422' ' ' ILE . . . . . 0.672 ' N ' HD12 ' A' ' 421' ' ' ILE . 13.2 mt -114.82 105.39 18.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.529 1.143 . . . . 71.21 109.3 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.732 HG22 HD11 ' A' ' 421' ' ' ILE . 42.5 t -75.18 146.8 8.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.447 1.092 . . . . 75.13 109.267 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.7 ' O ' HG23 ' A' ' 355' ' ' VAL . 1.1 m-20 -128.73 133.59 25.36 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.462 1.101 . . . . 62.2 109.297 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 425' ' ' PRO . . . . . 0.491 ' CD ' ' OE1' ' A' ' 371' ' ' GLN . 18.2 Cg_endo -74.96 169.71 22.03 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.513 1.796 . . . . 74.52 110.961 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 426' ' ' PHE . . . . . 0.545 ' CZ ' ' HG3' ' A' ' 357' ' ' GLN . 5.1 t80 . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.449 1.093 . . . . 72.11 111.012 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.003 0 N-CA-C 111.006 -0.838 . . . . 30.24 111.006 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 178.58 7.07 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.475 1.776 . . . . 54.0 110.979 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.401 ' C ' ' SD ' ' A' ' 348' ' ' MET . 2.5 m-70 -125.75 69.65 1.19 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.444 1.09 . . . . 71.43 109.601 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 348' ' ' MET . . . . . 0.401 ' SD ' ' C ' ' A' ' 347' ' ' HIS . 3.0 mpp? -150.37 157.25 42.84 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.504 1.127 . . . . 75.5 110.985 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 43.46 52.52 6.23 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.538 1.149 . . . . 63.23 110.996 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 350' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 70.5 m -143.67 144.71 31.99 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.44 0.729 . . . . 65.03 109.997 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -83.59 178.39 8.01 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.511 1.132 . . . . 73.11 109.327 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' HIS . . . . . 0.537 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 37.6 m-70 -141.97 134.73 28.52 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.534 1.146 . . . . 63.25 109.609 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 23.4 mt -124.86 158.7 32.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.529 1.143 . . . . 60.11 109.302 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 355' ' ' VAL . 0.3 OUTLIER -124.12 150.51 44.99 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.492 1.12 . . . . 72.42 109.312 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 424' ' ' ASP . 70.3 t -109.09 146.96 14.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.539 1.149 . . . . 62.31 109.293 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 58.1 p -117.96 -173.16 2.39 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.464 1.103 . . . . 75.2 110.369 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 357' ' ' GLN . . . . . 0.4 ' HG2' ' CE1' ' A' ' 426' ' ' PHE . 4.6 mm100 -77.52 -35.04 53.81 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.508 1.13 . . . . 74.11 110.285 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 358' ' ' GLU . . . . . 0.764 ' O ' HD12 ' A' ' 362' ' ' LEU . 4.7 pt-20 -60.27 -31.4 70.19 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.102 . . . . 73.53 110.281 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 359' ' ' GLN . . . . . 0.421 ' OE1' ' CE2' ' A' ' 370' ' ' PHE . 73.3 mt-30 -77.34 -63.42 1.38 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.46 1.1 . . . . 74.41 110.287 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -39.07 -42.87 0.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.518 1.136 . . . . 74.13 111.036 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -61.2 -53.87 51.49 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.482 1.114 . . . . 72.43 110.28 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.764 HD12 ' O ' ' A' ' 358' ' ' GLU . 3.7 mt -55.46 -54.5 43.12 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.125 . . . . 64.14 109.33 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 363' ' ' PTR . . . . . 0.469 ' HE1' ' CE ' ' A' ' 374' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -48.22 82.66 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.498 1.124 . . . . 64.31 108.318 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.21 -65.82 0.5 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.487 1.117 . . . . 73.24 110.301 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 23.2 ptp -55.23 -34.2 63.77 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.425 1.078 . . . . 74.25 110.975 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 88.92 50.01 3.41 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.488 1.118 . . . . 54.53 110.988 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' SER . . . . . 0.505 ' HB3' HD12 ' A' ' 372' ' ' LEU . 3.6 m -145.58 179.39 7.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.508 0.77 . . . . 60.42 109.963 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.775 HG22 ' NE2' ' A' ' 371' ' ' GLN . 2.0 m -118.42 161.11 20.52 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.508 1.13 . . . . 71.2 110.383 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.453 ' HA ' ' CE1' ' A' ' 363' ' ' PTR . 2.7 t80 -59.31 -64.51 0.92 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.507 1.129 . . . . 74.54 111.028 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.775 ' NE2' HG22 ' A' ' 369' ' ' THR . 0.2 OUTLIER -60.7 -29.52 69.38 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.488 1.117 . . . . 61.12 110.325 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.791 HD22 ' N ' ' A' ' 373' ' ' CYS . 1.2 tm? -60.93 135.61 57.84 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 74.32 109.337 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 373' ' ' CYS . . . . . 0.791 ' N ' HD22 ' A' ' 372' ' ' LEU . 32.1 p -77.9 136.01 37.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.02 -0.991 . . . . 72.14 110.884 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.536 ' N ' ' CD ' ' A' ' 374' ' ' LYS . 0.2 OUTLIER -92.66 26.45 2.68 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.514 1.134 . . . . 62.4 109.306 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 7.0 mt -107.79 -56.67 4.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.495 1.122 . . . . 70.31 109.268 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 14.2 m -108.28 -21.73 12.64 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.513 1.133 . . . . 41.5 108.354 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.627 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 57.71 38.01 27.41 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.511 1.132 . . . . 74.43 109.298 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -129.57 -43.92 1.24 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.448 1.093 . . . . 64.5 110.274 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -108.81 -172.96 2.16 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 72.24 109.287 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.15 175.47 6.28 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.528 1.142 . . . . 74.1 109.332 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.663 ' HZ2' HD12 ' A' ' 391' ' ' LEU . 16.8 mttt -78.59 -50.79 10.92 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 64.41 109.301 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 382' ' ' ASP . . . . . 0.406 ' CG ' ' C ' ' A' ' 381' ' ' LYS . 0.1 OUTLIER 47.65 26.61 0.88 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.473 1.108 . . . . 71.14 109.261 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.886 HG12 ' O ' ' A' ' 392' ' ' MET . 0.3 OUTLIER -156.13 176.1 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.481 1.113 . . . . 62.51 109.274 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -160.52 157.33 27.29 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.522 1.139 . . . . 72.24 109.29 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.864 HG22 ' SG ' ' A' ' 388' ' ' CYS . 11.6 mm -123.82 143.76 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.542 1.152 . . . . 64.5 109.301 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.54 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 7.0 mt-10 -137.72 162.39 54.82 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.575 1.172 . . . . 74.25 110.282 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.54 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.95 -12.49 23.85 Favored 'Cis proline' 0 C--N 1.36 1.163 0 C-N-CA 120.981 -2.508 . . . . 44.15 111.026 -0.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 388' ' ' CYS . . . . . 0.864 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.41 -71.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.983 -1.008 . . . . 75.23 110.914 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 389' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.49 15.9 6.77 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.441 1.088 . . . . 51.44 110.946 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.567 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 21.4 m80 -73.07 148.0 44.46 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.522 0.777 . . . . 73.11 109.591 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.663 HD12 ' HZ2' ' A' ' 381' ' ' LYS . 1.3 mt -119.47 158.14 26.85 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.518 1.136 . . . . 73.1 109.302 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.886 ' O ' HG12 ' A' ' 383' ' ' VAL . 12.6 ptp -174.41 172.18 3.23 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.524 1.14 . . . . 74.02 111.016 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 7.2 p -89.69 118.07 29.03 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.497 1.123 . . . . 71.2 108.275 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 73.4 m -52.51 -45.13 66.13 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.529 1.143 . . . . 74.03 110.374 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 37.2 m -55.69 -29.51 59.51 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.468 1.105 . . . . 62.31 109.971 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 2.5 m -81.15 -47.51 13.37 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.452 1.095 . . . . 62.54 108.25 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.719 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.5 OUTLIER -41.49 -36.09 0.82 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 74.34 109.327 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 398' ' ' THR . . . . . 0.486 ' CG2' ' N ' ' A' ' 399' ' ' ALA . 0.5 OUTLIER -61.17 -52.54 64.41 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.43 1.081 . . . . 75.14 110.38 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 399' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 398' ' ' THR . . . -51.44 -23.23 3.68 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.543 1.152 . . . . 71.32 109.285 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 400' ' ' TRP . . . . . 0.607 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 8.9 t-105 -84.44 -64.91 1.08 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.534 1.146 . . . . 74.1 108.034 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.494 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.7 mm-40 -52.34 -17.37 1.14 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.487 1.117 . . . . 74.1 110.316 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 401' ' ' GLN . 7.0 mm-40 -37.18 -63.41 0.43 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 74.2 110.29 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.6 m -120.39 -24.56 5.84 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.515 1.134 . . . . 50.3 110.006 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 404' ' ' ASP . . . . . 0.607 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 8.2 m-20 -82.25 -94.92 0.05 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 64.52 109.327 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.494 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 70.5 28.73 70.69 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.475 1.11 . . . . 44.43 111.036 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -90.17 68.19 7.02 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.465 0.744 . . . . 72.21 110.297 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 65.34 -163.81 38.32 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.517 1.136 . . . . 73.41 111.01 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 408' ' ' CYS . . . . . 0.699 ' SG ' HG21 ' A' ' 385' ' ' ILE . 6.3 t -58.21 129.27 82.98 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 108.363 -0.977 . . . . 71.44 108.363 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 -3.57 14.12 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.489 1.784 . . . . 75.3 111.042 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 410' ' ' PHE . . . . . 0.567 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 4.5 m-85 -92.91 -41.48 10.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.119 . . . . 72.34 111.01 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 411' ' ' CYS . . . . . 0.456 ' SG ' ' CE1' ' A' ' 390' ' ' HIS . 0.1 OUTLIER -111.01 9.02 22.14 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.123 . . . . 71.03 108.285 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 412' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 408' ' ' CYS . 9.1 mmt85 38.56 30.23 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.555 1.159 . . . . 73.51 110.333 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 413' ' ' CYS . . . . . 0.442 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.3 m -125.55 163.01 23.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.531 1.144 . . . . 72.33 108.289 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -59.02 146.99 36.3 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.435 1.085 . . . . 75.42 110.275 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.638 HG23 HG23 ' A' ' 385' ' ' ILE . 1.4 mt -93.06 153.41 3.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.477 1.111 . . . . 62.31 109.278 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.11 -46.33 3.01 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.526 1.141 . . . . 63.51 109.258 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.554 ' O ' HG23 ' A' ' 418' ' ' THR . . . -131.11 144.73 16.28 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.501 1.125 . . . . 23.35 110.985 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 418' ' ' THR . . . . . 0.618 ' CG2' HG21 ' A' ' 415' ' ' ILE . 17.6 p -157.59 116.26 3.2 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.512 0.772 . . . . 75.3 110.428 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -136.32 149.21 67.13 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.509 1.131 . . . . 71.03 110.314 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.491 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.3 Cg_endo -74.97 102.46 1.59 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.492 1.785 . . . . 73.24 111.0 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.799 HD11 HG22 ' A' ' 423' ' ' VAL . 0.6 OUTLIER -103.83 158.9 5.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.46 1.1 . . . . 75.33 109.244 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 422' ' ' ILE . . . . . 0.696 ' N ' HD12 ' A' ' 421' ' ' ILE . 11.2 mt -118.61 105.39 17.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.482 1.114 . . . . 73.54 109.311 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.799 HG22 HD11 ' A' ' 421' ' ' ILE . 21.5 t -76.78 149.25 6.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.502 1.127 . . . . 64.0 109.293 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.865 ' O ' HG23 ' A' ' 355' ' ' VAL . 9.2 m-20 -127.64 143.33 47.1 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.494 1.121 . . . . 73.24 109.32 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 179.25 6.26 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.488 1.783 . . . . 63.33 111.032 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 426' ' ' PHE . . . . . 0.4 ' CE1' ' HG2' ' A' ' 357' ' ' GLN . 10.5 t80 . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.499 1.125 . . . . 74.14 111.011 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 345' ' ' GLY . . . . . 0.404 ' N ' ' CD ' ' A' ' 346' ' ' PRO . . . . . . . . 0 CA--C 1.53 1.001 0 N-CA-C 110.99 -0.844 . . . . 74.11 110.99 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 346' ' ' PRO . . . . . 0.523 ' O ' ' CG ' ' A' ' 347' ' ' HIS . 18.4 Cg_endo -74.95 178.65 6.97 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.446 1.761 . . . . 62.11 111.052 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.523 ' CG ' ' O ' ' A' ' 346' ' ' PRO . 54.3 m80 -161.9 124.27 2.92 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.507 1.13 . . . . 70.25 109.576 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 42.9 mtp -145.79 166.12 26.84 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.535 1.147 . . . . 65.1 111.024 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -70.11 -30.81 69.49 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.477 1.11 . . . . 63.13 110.996 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 350' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 29.6 p -40.86 151.46 0.06 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.544 0.791 . . . . 74.41 110.03 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.14 175.08 10.97 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.501 1.126 . . . . 75.22 109.347 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -136.6 138.86 41.65 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 70.13 109.582 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 52.7 mt -121.73 158.75 24.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.525 1.141 . . . . 72.33 109.323 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -123.2 139.61 53.87 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.476 1.11 . . . . 62.2 109.269 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 424' ' ' ASP . 24.6 t -99.49 144.23 12.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.494 1.121 . . . . 71.42 109.318 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.9 p -110.19 153.02 25.35 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.505 1.128 . . . . 64.1 110.386 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 357' ' ' GLN . . . . . 0.464 ' HG3' ' CE1' ' A' ' 426' ' ' PHE . 24.7 mt-30 -43.35 -52.04 6.08 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.481 1.113 . . . . 74.21 110.284 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -43.85 -49.83 8.11 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 72.1 110.297 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 359' ' ' GLN . . . . . 0.546 ' O ' ' CD1' ' A' ' 363' ' ' PTR . 18.2 mt-30 -59.62 -32.8 70.76 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.49 1.119 . . . . 74.4 110.274 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 360' ' ' TYR . . . . . 0.443 ' O ' ' N ' ' A' ' 364' ' ' CYS . 3.7 t80 -71.02 -62.07 1.53 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.537 1.148 . . . . 74.21 111.016 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -53.67 -53.69 48.38 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.535 1.147 . . . . 74.43 110.28 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.62 -34.96 39.91 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.508 1.13 . . . . 72.14 109.244 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 363' ' ' PTR . . . . . 0.546 ' CD1' ' O ' ' A' ' 359' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 364' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m -64.96 -21.76 66.89 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.414 1.071 . . . . 75.52 108.319 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -73.96 -13.64 60.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.462 1.101 . . . . 73.42 110.286 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' MET . . . . . 0.435 ' CG ' ' O ' ' A' ' 363' ' ' PTR . 12.0 ptp -121.49 -0.98 9.66 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.493 1.12 . . . . 70.33 111.02 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 57.0 43.79 93.07 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.434 1.084 . . . . 65.41 110.966 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 3.6 p -132.85 173.96 10.83 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.438 0.728 . . . . 74.22 109.967 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.764 HG22 HE21 ' A' ' 371' ' ' GLN . 2.2 m -116.94 161.57 19.15 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.484 1.115 . . . . 74.03 110.383 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.564 ' CD2' HG22 ' A' ' 355' ' ' VAL . 78.2 t80 -64.02 -68.63 0.33 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.519 1.137 . . . . 72.23 110.982 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 371' ' ' GLN . . . . . 0.764 HE21 HG22 ' A' ' 369' ' ' THR . 0.0 OUTLIER -44.31 -35.82 2.5 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.541 1.15 . . . . 73.34 110.31 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.747 HD13 ' N ' ' A' ' 373' ' ' CYS . 1.8 tm? -50.93 140.85 14.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.484 1.115 . . . . 75.34 109.247 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 373' ' ' CYS . . . . . 0.747 ' N ' HD13 ' A' ' 372' ' ' LEU . 19.7 p -85.42 147.08 26.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.97 -1.014 . . . . 63.44 110.913 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.557 ' N ' ' CD ' ' A' ' 374' ' ' LYS . 0.7 OUTLIER -99.54 17.44 20.41 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 63.12 109.29 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 5.9 mt -94.5 -61.69 2.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.458 1.099 . . . . 70.02 109.3 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 2.6 m -102.67 -24.65 13.74 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.532 1.145 . . . . 72.22 108.273 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.682 ' HA ' HD11 ' A' ' 372' ' ' LEU . . . 63.04 46.42 4.73 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.478 1.111 . . . . 74.3 109.323 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -139.53 -49.58 0.49 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.548 1.155 . . . . 74.3 110.279 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 379' ' ' ASN . . . . . 0.429 ' O ' HD22 ' A' ' 372' ' ' LEU . 4.3 m-20 -104.91 174.35 5.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 72.33 109.333 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -85.86 173.18 10.19 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.542 1.151 . . . . 72.2 109.292 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 392' ' ' MET . 15.3 mttt -79.33 -54.86 5.53 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.515 1.134 . . . . 72.32 109.265 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 382' ' ' ASP . . . . . 0.401 ' OD2' ' O ' ' A' ' 381' ' ' LYS . 1.2 p30 51.87 26.78 3.8 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.478 1.111 . . . . 73.15 109.267 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 383' ' ' VAL . . . . . 0.914 HG12 ' O ' ' A' ' 392' ' ' MET . 0.4 OUTLIER -156.03 175.4 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.116 . . . . 54.42 109.35 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.417 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 62.5 tttt -158.53 151.81 22.87 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.503 1.127 . . . . 61.44 109.293 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.822 HG21 ' SG ' ' A' ' 408' ' ' CYS . 24.7 mm -115.28 133.59 61.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.126 . . . . 72.03 109.337 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.522 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 5.9 mt-10 -137.67 161.11 62.13 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.534 1.146 . . . . 73.12 110.286 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.522 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.4 Cg_endo -75.01 -5.2 21.25 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 121.034 -2.486 . . . . 73.23 111.004 -0.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 32.6 t -37.99 -78.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.0 -1.0 . . . . 71.51 110.946 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 389' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 119.53 36.51 0.84 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.483 1.114 . . . . 50.24 111.002 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.551 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 51.0 m170 -108.5 131.9 54.36 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.491 0.759 . . . . 73.3 109.581 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.71 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -99.87 158.55 15.72 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.486 1.116 . . . . 72.13 109.303 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 392' ' ' MET . . . . . 0.914 ' O ' HG12 ' A' ' 383' ' ' VAL . 17.1 ptp -172.6 174.42 3.74 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.473 1.108 . . . . 73.45 111.04 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 28.1 p -97.53 115.55 28.06 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.469 1.106 . . . . 72.53 108.296 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 3.8 m -44.61 -58.99 2.69 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 75.33 110.364 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 29.6 m -41.11 -36.59 0.73 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.527 1.142 . . . . 62.24 109.989 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 399' ' ' ALA . 2.5 m -76.76 -50.42 13.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.477 1.11 . . . . 51.4 108.257 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.695 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.3 OUTLIER -43.0 -35.69 1.32 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.492 1.12 . . . . 74.21 109.282 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 53.4 m -63.01 -45.31 92.98 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.481 1.113 . . . . 63.24 110.447 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -57.65 -21.72 41.43 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.451 1.094 . . . . 63.0 109.309 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 400' ' ' TRP . . . . . 0.588 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 14.7 t-105 -86.09 -65.21 1.04 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.496 1.123 . . . . 73.34 107.98 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.503 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 40.1 mm-40 -48.83 -20.96 0.55 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.479 1.112 . . . . 73.04 110.288 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 401' ' ' GLN . 7.3 mt-10 -37.64 -63.65 0.44 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.538 1.149 . . . . 74.52 110.276 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 23.0 t -122.41 -24.45 5.0 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.477 1.111 . . . . 74.44 109.98 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' ASP . . . . . 0.588 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 3.0 m-20 -82.85 -94.42 0.06 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.512 1.133 . . . . 75.41 109.311 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.503 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 67.29 21.37 72.1 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.435 1.084 . . . . 53.44 110.965 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -81.0 62.46 4.99 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 0.767 . . . . 62.1 110.287 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 68.15 -163.46 48.2 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.536 1.147 . . . . 70.11 111.002 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' CYS . . . . . 0.822 ' SG ' HG21 ' A' ' 385' ' ' ILE . 2.3 t -56.12 121.45 41.56 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.303 -0.999 . . . . 73.24 108.303 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.447 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.3 Cg_endo -75.03 0.65 8.67 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.53 1.805 . . . . 73.25 110.965 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 410' ' ' PHE . . . . . 0.551 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 2.7 m-85 -92.49 -37.99 12.21 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 74.3 111.047 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 411' ' ' CYS . . . . . 0.435 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.8 OUTLIER -126.02 17.13 7.89 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.475 1.109 . . . . 73.12 108.335 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 412' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 408' ' ' CYS . 47.5 mmm-85 38.43 30.99 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.526 1.141 . . . . 73.01 110.302 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 413' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 411' ' ' CYS . 15.2 t -115.35 139.15 50.24 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 63.04 108.302 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -45.8 158.97 0.08 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.443 1.09 . . . . 64.24 110.344 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.741 HG23 HG23 ' A' ' 385' ' ' ILE . 2.2 mt -114.45 157.24 15.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.448 1.093 . . . . 74.21 109.309 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -128.98 -47.79 1.23 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.514 1.134 . . . . 63.41 109.295 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.553 ' O ' HG23 ' A' ' 418' ' ' THR . . . -108.76 127.9 8.8 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.541 1.15 . . . . 60.1 111.031 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 418' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 417' ' ' GLY . 17.5 p -157.51 116.74 3.29 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.502 0.766 . . . . 75.53 110.357 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -140.61 151.29 63.08 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.115 . . . . 71.54 110.296 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.2 Cg_endo -75.05 101.64 1.5 Allowed 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.485 1.781 . . . . 71.22 110.979 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.803 HD11 HG22 ' A' ' 423' ' ' VAL . 0.7 OUTLIER -105.71 167.58 3.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.441 1.088 . . . . 74.31 109.335 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 422' ' ' ILE . . . . . 0.782 ' N ' HD12 ' A' ' 421' ' ' ILE . 12.7 mt -126.52 106.32 15.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.505 1.128 . . . . 72.0 109.293 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.803 HG22 HD11 ' A' ' 421' ' ' ILE . 15.4 t -78.89 145.74 9.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.479 1.112 . . . . 60.32 109.284 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.66 ' O ' HG23 ' A' ' 355' ' ' VAL . 73.0 m-20 -128.38 143.68 49.1 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 64.55 109.302 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 425' ' ' PRO . . . . . 0.438 ' N ' ' OE1' ' A' ' 371' ' ' GLN . 18.1 Cg_endo -75.01 175.65 10.97 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.559 1.82 . . . . 75.14 110.999 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 426' ' ' PHE . . . . . 0.464 ' CE1' ' HG3' ' A' ' 357' ' ' GLN . 39.8 t80 . . . . . 0 C--N 1.324 -0.507 0 O-C-N 124.505 1.128 . . . . 75.32 111.015 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 29.0 t . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 110.016 -0.364 . . . . 65.14 110.016 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . 0.727 ' HB2' HG22 ' A' ' 421' ' ' ILE . 10.8 m-20 -78.54 174.45 11.34 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.429 1.081 . . . . 72.13 109.266 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . 0.459 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 28.2 m-70 -131.43 126.46 35.17 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.478 1.111 . . . . 64.23 109.597 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . 0.475 HD11 ' HD2' ' A' ' 384' ' ' LYS . 9.0 mt -111.34 149.16 14.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.481 1.113 . . . . 44.52 109.302 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 32.1 tptt -112.77 133.25 54.86 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.468 1.105 . . . . 72.03 109.353 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 424' ' ' ASP . 40.0 t -87.75 149.53 4.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 71.53 109.33 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 5.9 p -114.15 149.19 36.02 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 72.04 110.413 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' GLN . . . . . 0.556 ' CG ' ' CE1' ' A' ' 426' ' ' PHE . 27.6 mt-30 -50.15 -34.33 21.99 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.479 1.112 . . . . 72.32 110.344 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -56.34 -52.53 64.2 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.497 1.123 . . . . 74.44 110.294 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . 0.463 ' OE1' HG13 ' A' ' 355' ' ' VAL . 35.3 mt-30 -55.8 -67.18 0.31 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.521 1.138 . . . . 64.53 110.329 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 364' ' ' CYS . 1.2 t80 -44.25 -45.77 8.71 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.473 1.108 . . . . 72.53 111.021 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -61.61 -42.67 99.2 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.499 1.124 . . . . 72.13 110.314 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 7.8 mt . . . . . 0 C--N 1.325 -0.488 0 O-C-N 124.472 1.107 . . . . 50.02 109.257 -179.969 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.6 m . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 108.345 -0.983 . . . . 61.45 108.345 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -68.67 -7.79 36.55 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.476 1.11 . . . . 75.15 110.316 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 7.4 mmt -106.2 -35.01 7.33 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.501 1.126 . . . . 74.35 111.015 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 90.55 46.97 3.87 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.54 1.15 . . . . 72.13 110.977 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 8.3 t -142.95 -174.63 4.23 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.489 0.758 . . . . 72.53 109.978 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.437 ' O ' ' NZ ' ' A' ' 374' ' ' LYS . 2.0 p -126.47 140.89 52.12 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.492 1.12 . . . . 44.13 110.422 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.445 ' O ' ' N ' ' A' ' 372' ' ' LEU . 76.0 t80 -56.18 -70.96 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.522 1.139 . . . . 74.43 111.027 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' GLN . . . . . 0.552 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -38.52 -30.44 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 63.22 110.27 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 370' ' ' PHE . 0.0 OUTLIER -71.46 122.78 21.02 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.506 1.129 . . . . 72.14 109.327 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . 0.451 ' HG ' ' HG ' ' A' ' 376' ' ' CYS . 14.8 p -59.13 134.8 57.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.035 -0.984 . . . . 61.14 110.919 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.437 ' NZ ' ' O ' ' A' ' 369' ' ' THR . 23.0 mmtm -97.31 32.35 2.24 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.47 1.106 . . . . 71.35 109.33 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 2.7 mt -113.42 -59.62 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.116 . . . . 74.31 109.29 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' CYS . . . . . 0.451 ' HG ' ' HG ' ' A' ' 373' ' ' CYS . 20.7 p -108.27 -13.92 14.8 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 64.4 108.293 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 47.66 41.83 14.28 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.482 1.114 . . . . 75.12 109.32 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -122.92 -41.02 2.37 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.128 . . . . 71.1 110.28 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.58 170.75 11.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.512 1.133 . . . . 74.32 109.313 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -76.72 175.47 9.35 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 74.24 109.33 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.455 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 21.9 mttt -73.78 -62.38 1.51 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.486 1.116 . . . . 64.1 109.314 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 59.91 25.93 15.12 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.478 1.112 . . . . 64.11 109.315 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.909 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -158.01 171.8 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.502 1.127 . . . . 64.24 109.292 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.475 ' HD2' HD11 ' A' ' 353' ' ' ILE . 40.4 tttp -155.21 142.05 19.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.47 1.106 . . . . 71.15 109.303 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.84 HD12 HD13 ' A' ' 415' ' ' ILE . 21.7 mm -105.22 133.93 48.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.479 1.112 . . . . 71.13 109.297 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.511 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.1 mt-10 -137.84 161.19 61.39 Favored Pre-proline 0 C--N 1.324 -0.532 0 O-C-N 124.531 1.144 . . . . 72.43 110.293 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.511 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.02 -5.82 21.88 Favored 'Cis proline' 0 C--N 1.361 1.197 0 C-N-CA 120.982 -2.507 . . . . 75.11 111.035 0.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . 0.432 ' SG ' ' ND1' ' A' ' 390' ' ' HIS . 43.1 t -37.43 -76.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.017 -0.992 . . . . 73.41 110.905 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 118.22 34.79 1.08 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.499 1.124 . . . . 64.42 111.018 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.432 ' ND1' ' SG ' ' A' ' 388' ' ' CYS . 46.1 m170 -105.79 130.82 53.7 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.529 0.782 . . . . 72.21 109.569 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.697 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -101.06 156.73 17.24 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 74.22 109.257 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.909 ' O ' HG12 ' A' ' 383' ' ' VAL . 19.8 ptp -173.64 176.19 2.79 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.517 1.136 . . . . 60.35 110.98 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . 1.22 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 7.3 p -94.04 114.93 27.19 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.508 1.13 . . . . 64.41 108.276 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 397' ' ' LEU . 94.6 m -48.43 -56.6 7.79 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.539 1.149 . . . . 54.44 110.422 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.5 t -45.82 -25.96 0.6 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 74.32 109.944 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . 1.22 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 1.8 m -87.63 -42.53 12.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.478 1.111 . . . . 64.24 108.322 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . 0.619 HD13 ' C ' ' A' ' 397' ' ' LEU . 1.0 OUTLIER -48.0 -54.55 12.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 71.22 109.31 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' THR . . . . . 0.552 ' N ' HD13 ' A' ' 397' ' ' LEU . 61.6 m -45.63 -36.48 4.84 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.465 1.103 . . . . 70.32 110.438 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -63.06 -39.61 95.22 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.513 1.133 . . . . 55.44 109.272 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' TRP . . . . . 0.507 ' CD2' ' HB3' ' A' ' 409' ' ' PRO . 2.1 t-105 -69.2 -52.61 26.11 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.496 1.123 . . . . 74.02 108.01 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -62.68 -16.3 56.52 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.546 1.154 . . . . 70.53 110.339 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -86.78 -11.4 51.1 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.448 1.092 . . . . 70.41 110.268 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.4 t -111.9 -23.0 10.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 71.22 109.985 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 404' ' ' ASP . 8.7 t0 -153.19 -88.46 0.05 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.483 1.115 . . . . 71.43 109.307 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 108.3 32.62 3.17 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.493 1.121 . . . . 64.54 111.004 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.433 ' O ' ' CG ' ' A' ' 406' ' ' GLN . 3.1 tt0 -91.27 79.28 5.69 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.514 0.773 . . . . 72.22 110.286 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 43.91 -159.06 0.12 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.53 1.144 . . . . 73.14 111.013 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . 0.633 ' SG ' HG21 ' A' ' 385' ' ' ILE . 4.9 t -56.38 125.61 66.37 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 108.319 -0.993 . . . . 75.32 108.319 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.507 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.2 Cg_endo -74.98 -2.48 12.59 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.48 1.779 . . . . 74.3 110.968 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . 0.455 ' CE1' ' HE2' ' A' ' 392' ' ' MET . 6.7 m-85 -89.12 -37.93 14.71 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.466 1.104 . . . . 73.51 110.975 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' CYS . . . . . . . . . . . . . 1.2 p -121.17 10.37 10.66 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.492 1.12 . . . . 62.23 108.286 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 408' ' ' CYS . 49.1 mmm-85 38.68 49.94 1.54 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.507 1.129 . . . . 63.2 110.343 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 41.8 t -138.14 148.84 45.33 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.511 1.132 . . . . 53.24 108.328 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -52.2 159.0 1.01 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.561 1.163 . . . . 65.15 110.273 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.84 HD13 HD12 ' A' ' 385' ' ' ILE . 2.3 mt -113.83 147.36 17.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.429 1.081 . . . . 71.34 109.293 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -114.85 -44.31 3.06 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.138 . . . . 73.22 109.312 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . 0.502 ' C ' HG23 ' A' ' 418' ' ' THR . . . -111.77 127.78 8.29 Favored Glycine 0 CA--C 1.531 1.053 0 O-C-N 124.537 1.148 . . . . 72.44 110.984 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . 0.502 HG23 ' C ' ' A' ' 417' ' ' GLY . 38.8 p -156.15 136.26 12.86 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.547 0.792 . . . . 54.5 110.405 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -171.98 156.13 3.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.495 1.122 . . . . 72.43 110.304 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.439 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.5 Cg_endo -74.94 101.87 1.52 Allowed 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.445 1.761 . . . . 73.4 111.011 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.739 ' C ' HD12 ' A' ' 421' ' ' ILE . 1.1 pp -103.93 167.69 2.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.496 1.123 . . . . 74.14 109.326 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . 0.554 ' N ' HD12 ' A' ' 421' ' ' ILE . 10.4 mm -113.97 112.22 39.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.53 1.144 . . . . 72.42 109.252 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.631 HG22 HD11 ' A' ' 421' ' ' ILE . 2.2 t -77.43 136.68 23.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.473 1.108 . . . . 72.34 109.27 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.539 ' O ' HG23 ' A' ' 355' ' ' VAL . 10.3 m-20 -131.33 131.85 23.26 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.477 1.111 . . . . 74.45 109.282 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 176.96 9.22 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.467 1.772 . . . . 53.11 110.999 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . 0.556 ' CE1' ' CG ' ' A' ' 357' ' ' GLN . 19.6 t80 . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.489 1.118 . . . . 71.45 111.052 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 69.8 m . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 110.045 -0.354 . . . . 74.11 110.045 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . 0.428 ' H ' HG22 ' A' ' 421' ' ' ILE . 2.5 t70 -91.31 169.46 10.79 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 74.33 109.29 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -124.71 114.52 19.41 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.547 1.154 . . . . 74.33 109.629 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . 0.845 HD13 HD13 ' A' ' 421' ' ' ILE . 1.6 mp -102.96 142.68 16.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.469 1.106 . . . . 74.52 109.309 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.402 ' NZ ' ' OD2' ' A' ' 424' ' ' ASP . 17.6 tppt? -124.91 117.93 25.16 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.465 1.103 . . . . 72.44 109.289 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 424' ' ' ASP . 61.9 t -66.25 154.8 7.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.492 1.12 . . . . 73.12 109.315 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 15.0 p -126.25 161.35 27.94 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.509 1.13 . . . . 72.34 110.43 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -56.05 -38.69 70.94 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.509 1.131 . . . . 73.34 110.332 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.14 -32.15 54.39 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.481 1.113 . . . . 75.24 110.29 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -83.79 -66.89 0.84 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.546 1.154 . . . . 74.4 110.281 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -41.89 -35.9 0.94 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.568 1.168 . . . . 74.34 111.039 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -66.41 -62.51 1.43 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.507 1.129 . . . . 73.5 110.281 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 9.8 tt . . . . . 0 C--N 1.325 -0.459 0 O-C-N 124.462 1.101 . . . . 65.22 109.326 179.999 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 108.314 -0.995 . . . . 53.43 108.314 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.25 -21.13 62.15 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 64.22 110.305 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 2.0 mtm -103.33 -28.2 11.99 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 71.4 111.016 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 87.68 40.15 6.87 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.479 1.112 . . . . 61.41 110.954 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 20.8 t -139.22 177.73 7.69 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.502 0.766 . . . . 71.51 109.969 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 12.7 p -113.4 179.53 3.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 73.41 110.402 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.458 ' CD2' HG11 ' A' ' 423' ' ' VAL . 43.9 t80 -85.17 -65.97 0.95 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.555 1.159 . . . . 73.22 111.039 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' GLN . . . . . 0.559 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -40.0 -31.72 0.13 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.522 1.139 . . . . 75.12 110.319 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.706 HD22 ' N ' ' A' ' 373' ' ' CYS . 1.5 tm? -66.89 136.73 55.84 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.525 1.141 . . . . 71.22 109.259 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . 0.706 ' N ' HD22 ' A' ' 372' ' ' LEU . 13.2 t -79.47 130.18 35.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.965 -1.016 . . . . 72.52 110.931 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.442 ' NZ ' ' O ' ' A' ' 372' ' ' LEU . 10.8 mmtm -87.31 11.31 14.66 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.539 1.15 . . . . 74.32 109.305 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 3.9 mt -102.83 -40.5 6.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.464 1.103 . . . . 75.52 109.262 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' CYS . . . . . 1.209 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 86.1 m -110.21 -35.63 6.04 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.494 1.121 . . . . 53.04 108.321 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.649 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 55.87 35.9 26.31 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.514 1.134 . . . . 72.24 109.327 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -131.79 -44.74 0.97 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.465 1.103 . . . . 74.1 110.314 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -113.69 -176.54 2.92 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.511 1.132 . . . . 74.32 109.32 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -97.66 158.93 15.23 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.502 1.126 . . . . 72.2 109.319 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.415 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 23.9 mttt -59.48 -62.46 1.86 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.47 1.106 . . . . 74.52 109.303 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 13.6 t70 59.54 27.0 16.08 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.459 1.099 . . . . 72.43 109.312 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.895 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -157.84 173.43 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.536 1.147 . . . . 52.32 109.29 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 23.5 tttp -156.68 137.39 13.28 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.469 1.105 . . . . 74.23 109.27 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.824 HG23 HG23 ' A' ' 415' ' ' ILE . 10.4 mm -101.02 132.32 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 63.24 109.341 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.51 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 7.9 mt-10 -137.8 161.16 61.62 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 75.51 110.314 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.51 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.94 -4.73 20.57 Favored 'Cis proline' 0 C--N 1.36 1.159 0 C-N-CA 121.004 -2.498 . . . . 73.52 111.035 -0.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . 0.502 ' SG ' ' CE1' ' A' ' 390' ' ' HIS . 44.1 t -37.45 -76.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.96 -1.018 . . . . 73.32 110.907 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 118.15 34.65 1.1 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.512 1.132 . . . . 73.42 111.0 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.502 ' CE1' ' SG ' ' A' ' 388' ' ' CYS . 66.4 m170 -108.6 127.88 54.34 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.509 0.77 . . . . 72.34 109.594 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.717 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -97.46 157.86 15.78 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.463 1.102 . . . . 71.51 109.353 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.895 ' O ' HG12 ' A' ' 383' ' ' VAL . 19.5 ptp -174.37 175.38 2.62 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.452 1.095 . . . . 74.34 110.991 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . 1.192 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 23.4 p -97.91 115.51 28.26 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.527 1.142 . . . . 70.53 108.29 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 396' ' ' CYS . 85.5 m -46.15 -60.0 2.55 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.53 1.144 . . . . 72.33 110.415 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 8.1 m -39.91 -29.7 0.07 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.471 1.107 . . . . 74.05 109.956 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . 1.209 ' SG ' ' SG ' ' A' ' 376' ' ' CYS . 2.8 m -85.44 -53.88 4.92 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.524 1.14 . . . . 73.34 108.296 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . 0.615 ' O ' HD23 ' A' ' 397' ' ' LEU . 2.1 tt -43.01 -55.4 3.81 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.513 1.133 . . . . 72.44 109.319 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 61.3 m -45.56 -38.14 6.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.508 1.13 . . . . 74.2 110.413 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -64.22 -38.49 91.24 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.121 . . . . 71.1 109.313 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' TRP . . . . . 0.449 ' N ' ' O ' ' A' ' 397' ' ' LEU . 2.8 t-105 -63.35 -47.12 83.47 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.549 1.156 . . . . 73.51 107.986 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -58.65 -35.72 73.0 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.482 1.114 . . . . 74.33 110.25 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -74.36 -2.74 26.58 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.512 1.133 . . . . 75.11 110.268 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 29.4 t -113.73 -23.13 9.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 1.131 . . . . 71.11 109.956 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.16 -78.34 0.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.452 1.095 . . . . 74.41 109.259 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 100.1 32.86 5.41 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.473 1.108 . . . . 33.55 110.988 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -93.94 76.51 4.16 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.478 0.752 . . . . 73.53 110.29 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 44.41 -157.68 0.18 Allowed Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.522 1.139 . . . . 53.52 111.026 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . 0.514 ' SG ' HG21 ' A' ' 385' ' ' ILE . 5.3 t -56.14 127.01 69.22 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.323 -0.991 . . . . 63.54 108.323 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 0.63 8.69 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.511 1.795 . . . . 74.31 110.986 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . 0.431 ' CD2' ' HE1' ' A' ' 392' ' ' MET . 15.8 m-85 -94.76 -36.5 11.68 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.455 1.097 . . . . 75.21 110.984 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' CYS . . . . . 0.449 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.8 OUTLIER -122.83 12.63 9.82 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.464 1.103 . . . . 75.31 108.335 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 408' ' ' CYS . 1.6 tpt180 38.19 30.75 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.513 1.133 . . . . 73.32 110.313 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' CYS . . . . . 0.449 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.7 m -113.82 150.5 33.43 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.523 1.139 . . . . 44.21 108.278 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -55.96 149.24 15.6 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.437 1.086 . . . . 70.35 110.299 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.824 HG23 HG23 ' A' ' 385' ' ' ILE . 2.1 mt -99.02 136.29 30.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.499 1.124 . . . . 55.0 109.308 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -114.67 -54.72 2.55 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.499 1.124 . . . . 72.24 109.286 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . 0.55 ' O ' HG23 ' A' ' 418' ' ' THR . . . -95.89 127.78 9.29 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.467 1.104 . . . . 73.52 110.956 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 417' ' ' GLY . 18.2 p -157.47 137.01 12.09 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.541 0.789 . . . . 61.33 110.367 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -172.18 155.97 3.67 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.407 1.067 . . . . 74.24 110.348 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.431 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.4 Cg_endo -75.04 102.82 1.64 Allowed 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.458 1.768 . . . . 74.51 110.974 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.845 HD13 HD13 ' A' ' 353' ' ' ILE . 0.7 OUTLIER -103.82 155.27 5.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.491 1.119 . . . . 65.5 109.301 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . 0.574 ' N ' HD12 ' A' ' 421' ' ' ILE . 17.1 mt -108.0 108.49 25.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.545 1.153 . . . . 75.12 109.261 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.773 HG22 HD11 ' A' ' 421' ' ' ILE . 14.6 t -76.57 146.42 8.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.489 1.118 . . . . 72.24 109.25 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.453 ' O ' HG23 ' A' ' 355' ' ' VAL . 3.0 t70 -127.98 127.97 23.83 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.536 1.147 . . . . 75.12 109.336 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 179.52 6.0 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.535 1.808 . . . . 71.21 110.983 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 76.9 t80 . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.461 1.1 . . . . 72.13 111.047 179.939 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 109.951 -0.389 . . . . 73.15 109.951 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -90.64 179.83 5.72 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.483 1.114 . . . . 72.13 109.296 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . 0.461 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 61.2 m-70 -138.23 150.17 46.46 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 73.03 109.595 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 17.2 mt -136.55 156.68 36.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.496 1.122 . . . . 74.14 109.308 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 12.0 tptm -117.92 152.66 34.98 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.464 1.102 . . . . 62.41 109.322 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 424' ' ' ASP . 32.1 t -109.09 156.72 9.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.454 1.096 . . . . 73.55 109.337 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 12.3 p -122.7 152.87 40.13 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.507 1.13 . . . . 63.32 110.402 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' GLN . . . . . 0.546 ' HG2' ' CE2' ' A' ' 426' ' ' PHE . 1.7 mm100 -45.84 -53.36 9.84 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.475 1.109 . . . . 72.31 110.325 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -43.55 -40.27 3.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.537 1.148 . . . . 73.04 110.308 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -70.89 -66.49 0.6 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.486 1.116 . . . . 72.53 110.282 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 364' ' ' CYS . 7.4 t80 -45.07 -63.77 0.86 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 73.22 110.997 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -45.34 -52.28 10.05 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.52 1.137 . . . . 71.54 110.267 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.3 tt . . . . . 0 C--N 1.324 -0.503 0 O-C-N 124.548 1.155 . . . . 74.51 109.312 -179.996 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . 0.449 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.9 m . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 108.283 -1.006 . . . . 71.51 108.283 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -79.51 -2.71 43.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.545 1.153 . . . . 74.11 110.277 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 8.3 mmt -108.3 -34.82 6.7 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.54 1.15 . . . . 64.51 110.982 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.02 4.61 41.63 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.479 1.112 . . . . 63.0 110.968 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 1.2 m -127.92 -176.2 3.71 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.529 0.782 . . . . 44.43 109.992 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.434 ' O ' ' CE ' ' A' ' 374' ' ' LYS . 15.1 p -114.29 -179.34 3.6 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.518 1.136 . . . . 75.04 110.394 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.436 ' C ' ' N ' ' A' ' 372' ' ' LEU . 62.7 t80 -78.49 -67.63 0.72 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 1.12 . . . . 75.11 110.979 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' GLN . . . . . 0.556 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -38.89 -29.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.538 1.149 . . . . 73.4 110.3 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.907 HD22 ' N ' ' A' ' 373' ' ' CYS . 0.5 OUTLIER -72.56 136.54 45.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.547 1.154 . . . . 74.21 109.273 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . 0.907 ' N ' HD22 ' A' ' 372' ' ' LEU . 11.5 t -70.97 133.54 46.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.004 -0.998 . . . . 63.42 110.928 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.434 ' CE ' ' O ' ' A' ' 369' ' ' THR . 29.8 mmtp -93.9 24.39 4.25 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.547 1.154 . . . . 71.3 109.285 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . 0.612 HD11 ' CE1' ' A' ' 410' ' ' PHE . 36.3 mt -107.38 -56.17 4.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.498 1.124 . . . . 75.31 109.308 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' CYS . . . . . 0.951 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 1.8 m -104.75 -23.15 13.09 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.482 1.114 . . . . 61.13 108.309 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.639 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 50.61 39.77 22.2 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.516 1.135 . . . . 62.54 109.302 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -124.57 -42.13 2.1 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.13 . . . . 73.52 110.271 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -123.62 171.0 9.88 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.52 1.138 . . . . 72.21 109.303 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -81.35 164.59 22.04 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.484 1.115 . . . . 64.13 109.302 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.458 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 20.0 mttt -67.75 -62.47 1.4 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.55 1.156 . . . . 74.34 109.292 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 1.9 t70 59.29 24.55 13.06 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.546 1.154 . . . . 63.23 109.283 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.923 HG12 ' O ' ' A' ' 392' ' ' MET . 0.6 OUTLIER -155.42 171.01 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.478 1.111 . . . . 75.22 109.305 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -154.19 147.25 24.61 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.462 1.101 . . . . 70.31 109.307 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.811 HG21 ' SG ' ' A' ' 408' ' ' CYS . 22.8 mm -110.4 134.33 52.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.477 1.11 . . . . 74.34 109.285 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.513 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 9.8 mt-10 -137.65 160.97 62.93 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.546 1.154 . . . . 60.5 110.276 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.513 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.5 Cg_endo -74.97 -5.13 21.03 Favored 'Cis proline' 0 C--N 1.36 1.14 0 C-N-CA 121.003 -2.499 . . . . 63.45 111.056 -0.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . 0.594 ' SG ' ' CE1' ' A' ' 390' ' ' HIS . 43.0 t -38.11 -79.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.964 -1.016 . . . . 64.33 110.942 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 119.92 36.98 0.79 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.485 1.115 . . . . 62.03 111.012 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.594 ' CE1' ' SG ' ' A' ' 388' ' ' CYS . 65.6 m170 -108.45 130.89 55.23 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 0.76 . . . . 74.32 109.6 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.708 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -98.43 157.48 16.18 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.133 . . . . 73.11 109.28 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.923 ' O ' HG12 ' A' ' 383' ' ' VAL . 15.5 ptp -171.81 174.38 4.24 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.509 1.13 . . . . 74.33 111.036 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . 1.142 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 26.3 p -98.13 115.98 29.4 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.531 1.145 . . . . 72.35 108.291 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 26.2 m -42.12 -59.37 1.79 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.559 1.162 . . . . 61.11 110.421 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.7 t -42.82 -37.09 1.68 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.553 1.158 . . . . 64.24 109.983 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . 1.142 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 3.5 m -73.69 -53.6 10.02 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.542 1.151 . . . . 52.2 108.297 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . 0.748 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.8 OUTLIER -43.89 -37.18 2.71 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.536 1.147 . . . . 43.22 109.265 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 53.1 m -61.14 -46.07 92.07 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.514 1.134 . . . . 74.23 110.406 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -59.97 -19.88 54.59 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.498 1.124 . . . . 61.5 109.33 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' TRP . . . . . 0.605 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 9.7 t-105 -85.75 -64.94 1.07 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.5 1.125 . . . . 71.04 108.022 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.495 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 10.3 mm-40 -52.44 -17.18 1.1 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.457 1.098 . . . . 73.44 110.313 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 401' ' ' GLN . 2.3 mm-40 -37.19 -63.31 0.44 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.516 1.135 . . . . 63.41 110.281 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 2.5 m -121.0 -24.57 5.55 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.512 1.133 . . . . 54.5 110.004 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . 0.605 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 13.2 m-20 -82.05 -94.25 0.05 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.45 1.094 . . . . 73.0 109.298 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.495 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 69.18 30.89 71.67 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 124.5 1.125 . . . . 72.5 111.002 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -90.66 57.34 3.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.569 0.805 . . . . 60.41 110.326 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 69.27 -160.54 52.65 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.472 1.108 . . . . 35.54 110.971 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . 0.811 ' SG ' HG21 ' A' ' 385' ' ' ILE . 1.4 t -56.53 121.74 45.64 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 108.282 -1.007 . . . . 74.5 108.282 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.405 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.0 Cg_endo -75.07 0.3 9.1 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.538 1.809 . . . . 73.15 110.969 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . 0.612 ' CE1' HD11 ' A' ' 375' ' ' ILE . 10.8 m-85 -89.35 -38.83 13.86 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 62.23 111.0 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' CYS . . . . . 0.402 ' O ' ' C ' ' A' ' 412' ' ' ARG . 0.7 OUTLIER -126.49 15.85 7.64 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 73.2 108.322 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 408' ' ' CYS . 0.4 OUTLIER 38.71 41.27 0.48 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.561 1.163 . . . . 63.52 110.279 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 14.9 t -124.19 140.48 52.93 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 51.12 108.316 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -47.63 157.44 0.24 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.543 1.152 . . . . 62.45 110.307 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.761 HD13 HD12 ' A' ' 385' ' ' ILE . 2.3 mt -111.75 155.12 13.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.442 1.089 . . . . 75.25 109.319 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -120.91 -46.11 2.35 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.499 1.124 . . . . 72.21 109.308 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . 0.52 ' O ' HG23 ' A' ' 418' ' ' THR . . . -115.55 132.73 10.47 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.525 1.14 . . . . 45.3 110.967 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . 0.546 ' CG2' HG21 ' A' ' 415' ' ' ILE . 21.0 p -157.23 117.37 3.48 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.443 0.731 . . . . 60.51 110.397 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.401 ' O ' HG23 ' A' ' 421' ' ' ILE . 1.9 pm0 -144.82 151.55 49.82 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.51 1.131 . . . . 74.53 110.291 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 100.82 1.4 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.502 1.791 . . . . 64.04 110.995 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.875 HD11 HG22 ' A' ' 423' ' ' VAL . 0.7 OUTLIER -104.68 169.51 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.502 1.126 . . . . 75.1 109.312 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . 0.815 ' N ' HD12 ' A' ' 421' ' ' ILE . 9.7 mt -124.95 105.43 15.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.518 1.136 . . . . 53.42 109.304 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.875 HG22 HD11 ' A' ' 421' ' ' ILE . 11.2 t -78.51 142.29 14.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.472 1.107 . . . . 63.41 109.301 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.544 ' O ' HG23 ' A' ' 355' ' ' VAL . 0.8 OUTLIER -127.92 143.7 48.72 Favored Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.486 1.116 . . . . 74.13 109.324 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 176.44 9.92 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.451 1.764 . . . . 71.31 110.983 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . 0.546 ' CE2' ' HG2' ' A' ' 357' ' ' GLN . 3.3 t80 . . . . . 0 C--N 1.325 -0.48 0 O-C-N 124.55 1.156 . . . . 50.13 111.04 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 63.8 m . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.998 -0.371 . . . . 55.41 109.998 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -96.3 -174.33 3.04 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.527 1.142 . . . . 61.11 109.318 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . 0.518 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 31.3 m-70 -138.99 140.66 38.25 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.461 1.101 . . . . 72.34 109.55 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 3.9 mm -122.07 156.19 26.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.503 1.127 . . . . 73.43 109.336 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -122.28 138.86 54.36 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.526 1.141 . . . . 65.21 109.322 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 424' ' ' ASP . 37.3 t -97.58 148.92 5.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.49 1.119 . . . . 72.22 109.347 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.6 p -108.55 141.86 39.83 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.547 1.154 . . . . 65.44 110.392 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' GLN . . . . . 0.538 ' HG2' ' CE2' ' A' ' 426' ' ' PHE . 4.9 mt-30 -39.66 -32.98 0.16 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.483 1.114 . . . . 72.01 110.32 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -57.05 -53.51 57.28 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.499 1.125 . . . . 53.51 110.322 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . 0.466 ' HB2' HG13 ' A' ' 355' ' ' VAL . 5.8 mt-30 -66.07 -22.67 66.42 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.546 1.154 . . . . 64.0 110.331 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -86.82 -23.73 25.24 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.492 1.12 . . . . 75.24 111.03 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 357' ' ' GLN . 4.6 mm-40 -84.41 -50.27 7.94 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.519 1.137 . . . . 72.43 110.235 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.468 ' CD1' ' N ' ' A' ' 362' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.515 1.134 . . . . 72.04 109.288 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 108.284 -1.006 . . . . 32.55 108.284 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -43.35 -68.31 0.21 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.514 1.134 . . . . 73.43 110.326 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 21.7 ptp -56.65 -31.12 64.06 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.53 1.144 . . . . 73.35 111.001 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 82.42 50.9 4.57 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.533 1.145 . . . . 53.13 111.015 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 1.5 t -126.29 -179.24 4.64 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.477 0.751 . . . . 75.52 110.026 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.435 ' HB ' ' NE2' ' A' ' 371' ' ' GLN . 2.8 p -129.1 140.46 51.56 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.521 1.138 . . . . 72.32 110.365 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.529 ' CE2' HG11 ' A' ' 423' ' ' VAL . 60.8 t80 -64.52 -68.2 0.37 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.451 1.094 . . . . 74.04 111.035 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' GLN . . . . . 0.569 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -39.44 -30.02 0.06 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.124 . . . . 61.0 110.327 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.926 HD22 ' N ' ' A' ' 373' ' ' CYS . 0.4 OUTLIER -73.4 136.14 44.3 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.489 1.118 . . . . 74.02 109.339 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . 0.926 ' N ' HD22 ' A' ' 372' ' ' LEU . 26.9 p -67.88 131.85 46.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.015 -0.993 . . . . 34.51 110.926 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -93.21 29.57 1.87 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 65.04 109.328 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . 0.776 HD11 ' HE1' ' A' ' 410' ' ' PHE . 17.1 mt -107.65 -59.78 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.469 1.106 . . . . 71.04 109.315 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 3.7 m -107.71 -23.17 12.21 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.516 1.135 . . . . 65.22 108.279 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.668 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 56.81 42.55 26.43 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 63.03 109.321 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -124.17 -42.45 2.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.516 1.135 . . . . 63.12 110.296 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -121.89 170.57 9.66 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.553 1.158 . . . . 61.14 109.309 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 17.3 p30 -83.24 162.1 21.29 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.472 1.108 . . . . 73.12 109.294 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 392' ' ' MET . 24.1 mttt -64.37 -55.57 20.25 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.489 1.118 . . . . 71.3 109.298 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 1.1 p30 52.22 25.71 3.51 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 74.44 109.308 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.869 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -153.21 176.09 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.53 1.143 . . . . 74.13 109.286 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.412 ' H ' HG22 ' A' ' 383' ' ' VAL . 79.0 tttt -160.94 142.23 11.83 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.448 1.093 . . . . 63.22 109.294 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.825 HD13 HG22 ' A' ' 418' ' ' THR . 10.4 mm -108.12 138.58 34.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 124.554 1.159 . . . . 72.23 109.308 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.518 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.1 OUTLIER -138.06 161.39 59.9 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.511 1.132 . . . . 64.12 110.27 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.518 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.98 -7.16 22.99 Favored 'Cis proline' 0 C--N 1.36 1.158 0 C-N-CA 120.983 -2.507 . . . . 75.21 111.024 -0.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . 0.442 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 41.2 t -36.83 -73.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.002 -0.999 . . . . 71.22 110.919 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 115.95 16.5 6.78 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.478 1.111 . . . . 73.2 111.043 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.513 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 49.6 m170 -86.85 131.42 34.12 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.525 0.779 . . . . 72.32 109.623 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.676 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -100.78 161.8 13.35 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.506 1.129 . . . . 74.3 109.285 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.869 ' O ' HG12 ' A' ' 383' ' ' VAL . 18.6 ptp -174.72 174.83 2.55 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.508 1.13 . . . . 64.03 110.973 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . 0.97 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 7.0 p -96.55 119.56 35.25 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.521 1.138 . . . . 75.12 108.289 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 44.1 m -44.01 -59.22 2.4 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.486 1.117 . . . . 74.21 110.365 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 14.6 m -43.41 -34.2 1.23 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.499 1.124 . . . . 61.44 109.999 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . 0.97 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 1.8 m -76.1 -57.81 3.65 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.531 1.144 . . . . 65.11 108.34 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . 0.667 HD13 ' C ' ' A' ' 397' ' ' LEU . 1.2 tm? -41.96 -39.03 1.75 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.452 1.095 . . . . 53.33 109.242 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 2.8 m -60.59 -46.52 89.93 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.509 1.131 . . . . 71.55 110.418 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -58.8 -20.65 52.0 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.142 . . . . 73.2 109.293 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' TRP . . . . . 0.607 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 7.7 t-105 -85.94 -64.92 1.07 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.526 1.141 . . . . 72.13 108.005 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.491 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.1 mm-40 -52.23 -17.4 1.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.498 1.124 . . . . 62.12 110.297 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 401' ' ' GLN . 2.3 mm-40 -37.14 -63.36 0.44 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.525 1.14 . . . . 74.2 110.26 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.6 m -120.82 -24.65 5.61 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.482 1.114 . . . . 73.11 110.01 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . 0.607 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 12.2 m-20 -81.58 -93.86 0.05 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.516 1.135 . . . . 75.23 109.312 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.491 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 69.93 29.67 70.69 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.485 1.115 . . . . 52.0 111.009 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -92.02 68.13 5.22 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.528 0.781 . . . . 74.12 110.312 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 63.34 -167.01 24.37 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 124.502 1.126 . . . . 50.01 111.005 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . 0.663 ' SG ' HG21 ' A' ' 385' ' ' ILE . 2.0 t -56.21 123.22 53.61 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 108.307 -0.997 . . . . 52.32 108.307 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.421 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.2 Cg_endo -74.99 0.3 9.07 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.451 1.763 . . . . 63.21 110.986 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . 0.776 ' HE1' HD11 ' A' ' 375' ' ' ILE . 3.3 m-30 -91.38 -40.77 11.26 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.478 1.111 . . . . 65.44 110.986 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' CYS . . . . . 0.442 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.8 OUTLIER -122.36 16.19 10.54 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.533 1.145 . . . . 74.12 108.267 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 408' ' ' CYS . 5.3 tpt180 38.6 30.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.54 1.15 . . . . 74.54 110.32 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' CYS . . . . . 0.442 ' N ' ' O ' ' A' ' 411' ' ' CYS . 6.9 t -111.97 142.65 44.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 63.13 108.265 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . 0.445 ' CG ' ' N ' ' A' ' 415' ' ' ILE . 24.7 tt0 -50.9 158.88 0.63 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.462 1.101 . . . . 74.55 110.34 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.766 HD13 HD12 ' A' ' 385' ' ' ILE . 2.3 mt -110.44 157.33 11.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.478 1.112 . . . . 72.32 109.244 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -119.91 -44.56 2.51 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.48 1.112 . . . . 64.34 109.303 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . 0.6 ' O ' HG23 ' A' ' 418' ' ' THR . . . -134.72 146.55 18.55 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.549 1.156 . . . . 61.05 110.964 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . 0.825 HG22 HD13 ' A' ' 385' ' ' ILE . 2.3 p -157.52 117.68 3.44 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.533 0.784 . . . . 73.15 110.394 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -138.17 151.27 69.42 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.51 1.131 . . . . 74.33 110.346 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 101.68 1.5 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.51 1.795 . . . . 72.3 111.0 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.835 HD11 HG22 ' A' ' 423' ' ' VAL . 0.8 OUTLIER -104.14 155.72 5.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.488 1.117 . . . . 74.5 109.247 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . 0.532 ' N ' HD12 ' A' ' 421' ' ' ILE . 17.0 mt -107.01 105.41 18.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.502 1.126 . . . . 75.13 109.281 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.835 HG22 HD11 ' A' ' 421' ' ' ILE . 38.2 t -76.86 146.98 7.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 54.14 109.247 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.681 ' O ' HG23 ' A' ' 355' ' ' VAL . 0.8 OUTLIER -130.08 143.66 50.01 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.461 1.101 . . . . 54.41 109.237 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 170.35 20.61 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.497 1.788 . . . . 73.33 111.001 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . 0.538 ' CE2' ' HG2' ' A' ' 357' ' ' GLN . 3.3 t80 . . . . . 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 73.41 111.006 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 110.037 -0.357 . . . . 75.24 110.037 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -97.46 176.85 5.72 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.466 1.104 . . . . 75.21 109.323 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . 0.439 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 42.5 m-70 -136.47 134.57 37.78 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.498 1.124 . . . . 63.31 109.604 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 67.0 mt -114.69 135.87 53.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.517 1.135 . . . . 65.21 109.302 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -107.84 118.94 38.06 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.473 1.108 . . . . 64.21 109.282 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.464 ' O ' ' CD2' ' A' ' 426' ' ' PHE . 8.6 t -64.33 140.55 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.539 1.149 . . . . 62.31 109.317 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.44 ' OG1' ' CG ' ' A' ' 359' ' ' GLN . 27.0 p -91.85 156.55 17.42 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 70.1 110.365 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -57.99 -32.5 67.95 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.454 1.096 . . . . 73.13 110.321 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . 0.462 ' CG ' ' N ' ' A' ' 359' ' ' GLN . 18.0 pt-20 -66.05 -47.48 74.2 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.517 1.136 . . . . 74.45 110.305 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . 0.462 ' N ' ' CG ' ' A' ' 358' ' ' GLU . 11.9 mm-40 -60.73 -52.77 63.69 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.518 1.136 . . . . 43.22 110.313 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -51.15 -60.63 2.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.527 1.142 . . . . 71.34 111.031 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -58.52 -36.76 74.34 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.491 1.119 . . . . 74.4 110.334 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.0 tp . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.505 1.128 . . . . 64.14 109.289 -179.997 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 108.258 -1.016 . . . . 60.32 108.258 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -59.25 -17.64 30.2 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.5 1.125 . . . . 74.05 110.291 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 5.0 mtt -109.0 -16.18 14.19 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.487 1.117 . . . . 71.2 110.991 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 65.5 40.25 96.07 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.486 1.116 . . . . 74.43 111.006 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 16.1 m -125.13 -175.34 3.28 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.446 0.733 . . . . 73.0 109.971 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.433 ' HB ' ' NE2' ' A' ' 371' ' ' GLN . 2.3 p -128.22 136.36 50.95 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.456 1.098 . . . . 75.24 110.451 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.503 ' CZ ' HD12 ' A' ' 391' ' ' LEU . 73.7 t80 -60.58 -68.42 0.3 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.5 1.125 . . . . 75.14 111.002 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' GLN . . . . . 0.537 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -40.09 -29.23 0.07 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 71.35 110.255 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.416 ' N ' ' C ' ' A' ' 370' ' ' PHE . 0.0 OUTLIER -69.48 115.01 8.25 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.127 . . . . 55.43 109.344 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 30.3 p -45.96 145.87 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.009 -0.996 . . . . 73.32 110.937 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -105.53 31.6 4.86 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.512 1.133 . . . . 62.1 109.31 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . 0.57 HG21 ' HB3' ' A' ' 396' ' ' CYS . 46.4 mt -112.42 -58.39 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.51 1.131 . . . . 72.45 109.282 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 5.3 p -107.98 -21.81 12.67 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.479 1.112 . . . . 73.14 108.312 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 56.46 41.51 28.69 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.524 1.14 . . . . 52.31 109.336 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -126.16 -49.06 1.58 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.463 1.102 . . . . 73.22 110.329 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 49.4 m-20 -109.4 167.92 9.77 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.543 1.152 . . . . 63.25 109.323 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 16.6 p30 -84.6 162.66 19.7 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.486 1.116 . . . . 73.33 109.276 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 392' ' ' MET . 22.7 mttt -63.07 -62.4 1.73 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.469 1.106 . . . . 74.13 109.294 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 58.45 25.04 12.48 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.513 1.133 . . . . 74.15 109.262 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.892 HG12 ' O ' ' A' ' 392' ' ' MET . 0.7 OUTLIER -154.85 170.64 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 71.32 109.268 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -154.61 144.45 21.66 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.484 1.115 . . . . 71.35 109.314 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.808 HG21 ' SG ' ' A' ' 408' ' ' CYS . 11.1 mm -107.79 133.66 51.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.505 1.128 . . . . 73.24 109.293 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.517 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 10.5 mt-10 -137.67 160.98 62.86 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 62.14 110.297 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.517 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -75.07 -5.19 21.46 Favored 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 120.995 -2.502 . . . . 63.14 110.995 0.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . 0.512 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 16.5 t -38.13 -79.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.985 -1.007 . . . . 74.54 110.92 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 119.64 36.58 0.83 Allowed Glycine 0 CA--C 1.531 1.068 0 O-C-N 124.537 1.148 . . . . 60.35 110.965 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.559 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 67.4 m170 -108.54 127.14 53.68 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.545 0.791 . . . . 74.12 109.596 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.503 HD12 ' CZ ' ' A' ' 370' ' ' PHE . 1.8 mt -95.65 157.27 15.97 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.507 1.13 . . . . 72.33 109.297 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.892 ' O ' HG12 ' A' ' 383' ' ' VAL . 14.2 ptp -171.17 174.57 4.57 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.492 1.12 . . . . 74.5 111.001 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . 1.059 ' SG ' ' CB ' ' A' ' 396' ' ' CYS . 2.8 p -97.85 120.82 38.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.562 1.164 . . . . 73.23 108.289 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 48.8 m -41.11 -59.17 1.56 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.501 1.126 . . . . 62.54 110.339 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 2.7 t -49.3 -36.24 20.32 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.518 1.136 . . . . 63.23 109.999 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . 1.059 ' CB ' ' SG ' ' A' ' 393' ' ' CYS . 2.2 m -71.06 -38.17 72.51 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.461 1.101 . . . . 73.24 108.3 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . 0.698 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -65.03 -36.57 84.8 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.511 1.132 . . . . 63.31 109.32 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 45.8 m -61.96 -45.47 93.51 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.54 1.15 . . . . 51.41 110.392 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -56.77 -23.87 46.14 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.496 1.123 . . . . 55.42 109.304 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' TRP . . . . . 0.601 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 15.8 t-105 -85.13 -65.22 1.03 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.498 1.124 . . . . 72.14 108.023 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.506 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 39.8 mm-40 -48.94 -20.85 0.56 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.53 1.144 . . . . 74.24 110.349 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 401' ' ' GLN . 2.7 mm-40 -37.45 -63.66 0.43 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.123 . . . . 74.32 110.347 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 42.6 t -122.77 -24.46 4.84 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 74.03 110.006 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . 0.601 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 18.6 m-20 -82.42 -93.67 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.503 1.127 . . . . 71.05 109.326 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.506 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 66.8 21.74 71.43 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 124.493 1.121 . . . . 74.31 110.991 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -80.34 59.72 3.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.476 0.75 . . . . 64.14 110.337 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 71.67 -165.58 53.6 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.481 1.113 . . . . 55.11 110.99 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . 0.808 ' SG ' HG21 ' A' ' 385' ' ' ILE . 1.8 t -56.2 120.9 38.24 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.296 -1.001 . . . . 73.31 108.296 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.427 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.3 Cg_endo -75.04 -0.01 9.47 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.496 1.787 . . . . 64.54 111.015 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . 0.559 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 3.5 m-85 -91.51 -37.01 13.4 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.46 1.1 . . . . 72.33 111.014 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' CYS . . . . . 0.456 ' HG ' ' CE1' ' A' ' 390' ' ' HIS . 0.6 OUTLIER -127.38 17.33 7.06 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.106 . . . . 63.32 108.253 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 408' ' ' CYS . 6.3 tpp180 38.69 30.12 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.505 1.128 . . . . 75.54 110.279 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 411' ' ' CYS . 51.1 t -114.41 138.72 50.21 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.545 1.153 . . . . 64.34 108.325 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . 0.444 ' CG ' ' N ' ' A' ' 415' ' ' ILE . 34.1 tt0 -45.11 159.0 0.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 1.113 . . . . 74.14 110.317 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.704 HG23 HG23 ' A' ' 385' ' ' ILE . 2.3 mt -113.22 157.04 14.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 72.44 109.271 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 10.4 mttm -132.3 -47.17 0.91 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.53 1.144 . . . . 74.52 109.286 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . 0.526 ' O ' HG23 ' A' ' 418' ' ' THR . . . -109.51 130.78 10.15 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.493 1.121 . . . . 71.53 111.015 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 417' ' ' GLY . 20.8 p -157.2 118.5 3.68 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.492 0.76 . . . . 51.55 110.409 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -141.57 151.44 60.55 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.539 1.149 . . . . 52.41 110.28 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.03 101.3 1.45 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.474 1.776 . . . . 65.11 110.988 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.898 HD12 ' N ' ' A' ' 422' ' ' ILE . 1.1 pp -105.94 178.19 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.463 1.102 . . . . 64.35 109.253 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . 0.898 ' N ' HD12 ' A' ' 421' ' ' ILE . 6.1 mt -139.69 111.81 5.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.502 1.126 . . . . 72.53 109.292 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.566 ' CG2' HD11 ' A' ' 421' ' ' ILE . 18.5 t -84.04 142.71 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.477 1.111 . . . . 74.43 109.304 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -131.1 143.73 50.62 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 50.42 109.309 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 174.98 11.86 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.489 1.784 . . . . 73.4 110.956 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . 0.464 ' CD2' ' O ' ' A' ' 355' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.521 1.138 . . . . 75.15 111.004 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 69.9 m . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.973 -0.38 . . . . 73.32 109.973 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . 0.566 ' HB2' HG22 ' A' ' 421' ' ' ILE . 11.4 m-20 -98.43 171.99 7.81 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.476 1.11 . . . . 74.5 109.281 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . 0.416 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 22.4 m-70 -130.37 126.59 37.48 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.474 1.109 . . . . 73.11 109.581 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . 0.518 HG13 HD13 ' A' ' 421' ' ' ILE . 48.0 mt -115.76 127.39 73.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.486 1.116 . . . . 72.33 109.326 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 8.4 tptp -105.58 118.85 37.64 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.544 1.152 . . . . 65.21 109.304 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 424' ' ' ASP . 48.5 t -59.39 164.03 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.528 1.142 . . . . 71.0 109.288 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.455 ' N ' ' CG1' ' A' ' 355' ' ' VAL . 3.0 p -122.89 146.12 47.86 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.506 1.129 . . . . 63.13 110.37 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' GLN . . . . . 0.577 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 5.8 mt-30 -42.46 -53.72 4.17 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 71.23 110.288 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -39.95 -41.22 1.15 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.468 1.105 . . . . 62.03 110.327 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -67.06 -66.84 0.51 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.475 1.109 . . . . 61.04 110.305 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . 0.431 ' O ' ' N ' ' A' ' 364' ' ' CYS . 8.4 t80 -40.61 -52.22 2.9 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.434 1.084 . . . . 65.51 110.991 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -55.4 -44.02 75.76 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.493 1.12 . . . . 72.12 110.273 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.1 tt . . . . . 0 C--N 1.325 -0.462 0 O-C-N 124.481 1.113 . . . . 63.53 109.331 -179.997 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 108.327 -0.99 . . . . 54.31 108.327 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -62.29 -18.62 61.79 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.472 1.107 . . . . 52.22 110.29 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -128.4 8.52 5.98 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.473 1.108 . . . . 73.15 110.995 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 38.04 63.61 0.89 Allowed Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.521 1.138 . . . . 71.5 111.042 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 64.1 p -132.09 -174.03 3.32 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.463 0.743 . . . . 71.14 110.009 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.484 ' O ' ' CE ' ' A' ' 374' ' ' LYS . 33.7 p -126.47 146.53 50.06 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.535 1.147 . . . . 62.03 110.388 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.456 ' CE2' HG11 ' A' ' 423' ' ' VAL . 31.8 t80 -77.23 -63.83 1.28 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.489 1.118 . . . . 62.4 111.003 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' GLN . . . . . 0.563 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -40.71 -28.78 0.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.489 1.118 . . . . 70.4 110.323 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.721 HD11 ' HA ' ' A' ' 377' ' ' ALA . 3.0 tm? -67.3 139.91 57.29 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.116 . . . . 65.44 109.283 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . 0.72 ' N ' HD13 ' A' ' 372' ' ' LEU . 1.9 t -76.16 126.17 30.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.016 -0.993 . . . . 75.3 110.925 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.484 ' CE ' ' O ' ' A' ' 369' ' ' THR . 12.9 mmtm -91.06 18.51 6.69 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.527 1.142 . . . . 53.24 109.297 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 20.3 mt -99.17 -51.61 9.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.457 1.098 . . . . 65.53 109.306 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.54 -30.3 8.32 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.512 1.132 . . . . 60.31 108.305 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.721 ' HA ' HD11 ' A' ' 372' ' ' LEU . . . 65.82 43.69 3.05 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.545 1.153 . . . . 74.05 109.279 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -136.29 -61.89 0.68 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.53 1.144 . . . . 73.24 110.301 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -96.88 161.43 13.85 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.471 1.107 . . . . 72.11 109.298 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 37.4 p30 -81.14 160.73 24.33 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.517 1.136 . . . . 74.21 109.314 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.461 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 23.4 mttt -65.01 -62.49 1.52 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.49 1.119 . . . . 73.1 109.308 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 9.7 t70 60.07 27.05 16.44 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.501 1.126 . . . . 73.32 109.309 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.922 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -157.94 175.26 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.442 1.089 . . . . 72.35 109.313 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.424 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 17.0 tttp -159.4 140.86 13.02 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.481 1.113 . . . . 75.42 109.316 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 1.059 HD12 HD13 ' A' ' 415' ' ' ILE . 24.6 mm -104.91 132.74 50.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.511 1.132 . . . . 71.13 109.268 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.511 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 10.8 mt-10 -137.79 161.08 62.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 74.31 110.312 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.511 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -75.01 -4.65 20.7 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 121.012 -2.495 . . . . 61.45 110.989 0.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . 0.523 ' SG ' ' CD2' ' A' ' 390' ' ' HIS . 25.2 t -37.6 -77.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.986 -1.007 . . . . 52.34 110.939 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 118.72 35.45 0.98 Allowed Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.566 1.166 . . . . 45.52 111.01 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.523 ' CD2' ' SG ' ' A' ' 388' ' ' CYS . 51.7 m170 -108.51 126.89 53.43 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.504 0.767 . . . . 71.22 109.579 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.71 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -97.56 157.53 15.97 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.465 1.103 . . . . 74.31 109.306 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.922 ' O ' HG12 ' A' ' 383' ' ' VAL . 11.4 ptp -173.81 173.71 3.23 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.492 1.12 . . . . 71.25 110.99 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . 1.128 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 19.4 p -90.39 140.88 29.29 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 73.4 108.303 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 48.4 m -61.93 -43.35 99.03 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.433 1.083 . . . . 75.31 110.394 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 23.3 t -55.37 -64.54 0.81 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.459 1.099 . . . . 74.23 110.021 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . 1.128 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 1.6 p -50.24 -51.38 45.02 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.518 1.136 . . . . 65.01 108.323 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . 0.447 HD13 ' C ' ' A' ' 397' ' ' LEU . 1.3 tm? -45.13 -49.53 11.8 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.496 1.123 . . . . 75.22 109.292 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 76.5 m -54.59 -38.63 66.97 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.509 1.131 . . . . 75.54 110.427 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -60.71 -25.13 66.2 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.461 1.1 . . . . 75.21 109.375 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' TRP . . . . . 0.602 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 10.7 t-105 -85.7 -62.75 1.45 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.498 1.124 . . . . 70.04 108.02 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.49 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 8.2 mm-40 -55.98 -14.34 2.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.545 1.153 . . . . 63.32 110.323 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 401' ' ' GLN . 0.6 OUTLIER -37.23 -63.29 0.44 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.495 1.122 . . . . 60.42 110.302 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 7.8 t -121.13 -24.58 5.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.499 1.124 . . . . 61.32 109.968 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . 0.602 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 8.7 m-20 -83.0 -94.86 0.06 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.484 1.115 . . . . 74.02 109.327 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.49 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 73.3 28.99 64.94 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.469 1.106 . . . . 72.23 111.01 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -90.91 70.36 6.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.446 0.733 . . . . 70.53 110.307 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 66.58 -169.03 34.31 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.559 1.162 . . . . 54.33 110.993 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . 0.464 ' HB2' HG21 ' A' ' 385' ' ' ILE . 6.0 t -56.55 131.55 77.21 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.329 -0.989 . . . . 63.14 108.329 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 0.34 9.05 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.475 1.776 . . . . 74.31 110.958 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -93.66 -55.63 3.19 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.462 1.101 . . . . 51.31 110.969 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' CYS . . . . . 0.451 ' O ' ' N ' ' A' ' 413' ' ' CYS . 2.6 p -98.56 10.07 41.8 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.558 1.161 . . . . 61.01 108.319 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 411' ' ' CYS . 3.4 tpt85 38.59 30.19 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.475 1.11 . . . . 63.01 110.325 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' CYS . . . . . 0.451 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.5 m -115.48 154.24 29.67 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.489 1.118 . . . . 54.41 108.309 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -59.35 156.6 12.43 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.531 1.144 . . . . 75.45 110.284 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 1.059 HD13 HD12 ' A' ' 385' ' ' ILE . 5.6 mt -115.48 157.1 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 61.03 109.345 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.405 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 5.9 mmtp -120.26 -44.5 2.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.529 1.143 . . . . 75.24 109.269 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . 0.506 ' C ' HG23 ' A' ' 418' ' ' THR . . . -112.44 127.78 8.19 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.461 1.1 . . . . 63.42 111.009 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . 0.543 ' CG2' HG21 ' A' ' 415' ' ' ILE . 34.9 p -156.56 125.51 5.97 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.531 0.783 . . . . 71.13 110.419 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 421' ' ' ILE . 4.4 pt-20 -158.06 151.43 18.94 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.484 1.115 . . . . 61.42 110.3 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 99.17 1.23 Allowed 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.551 1.817 . . . . 73.32 111.031 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.877 HD11 HG22 ' A' ' 423' ' ' VAL . 0.8 OUTLIER -104.38 163.93 3.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.48 1.113 . . . . 71.45 109.341 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . 0.717 ' N ' HD12 ' A' ' 421' ' ' ILE . 3.3 mp -113.18 105.44 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.496 1.123 . . . . 74.23 109.301 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.877 HG22 HD11 ' A' ' 421' ' ' ILE . 12.9 t -78.22 140.19 17.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.465 1.103 . . . . 65.12 109.307 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.767 ' O ' HG23 ' A' ' 355' ' ' VAL . 23.6 m-20 -130.2 143.72 50.32 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.519 1.137 . . . . 70.14 109.309 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 160.29 40.29 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.493 1.786 . . . . 63.24 110.96 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . 0.577 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 26.4 t80 . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.481 1.113 . . . . 64.32 111.033 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 109.967 -0.383 . . . . 63.42 109.967 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -87.22 -177.28 5.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.463 1.102 . . . . 74.21 109.263 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . 0.543 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 25.0 m-70 -138.3 149.9 46.12 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.509 1.13 . . . . 71.3 109.588 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . 0.47 HG13 HD13 ' A' ' 421' ' ' ILE . 7.7 mt -136.11 158.65 38.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.564 1.165 . . . . 63.23 109.266 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.411 ' N ' ' CG2' ' A' ' 353' ' ' ILE . 0.1 OUTLIER -123.38 152.74 41.23 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.461 1.1 . . . . 64.31 109.317 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.667 HG22 ' CD2' ' A' ' 370' ' ' PHE . 9.2 t -107.94 162.05 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 71.31 109.288 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.466 ' N ' ' CG1' ' A' ' 355' ' ' VAL . 13.1 p -112.95 158.7 19.91 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.499 1.124 . . . . 71.43 110.43 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' GLN . . . . . 0.525 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 11.5 mt-30 -59.87 -45.7 91.66 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.54 1.15 . . . . 71.32 110.341 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -49.25 -44.92 44.08 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.495 1.122 . . . . 71.14 110.299 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -66.42 -43.49 85.57 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.445 1.091 . . . . 54.34 110.311 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -58.26 -27.22 63.81 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.453 1.095 . . . . 73.51 110.953 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -89.58 -40.39 12.64 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.527 1.142 . . . . 72.2 110.358 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.994 ' O ' HD12 ' A' ' 362' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.127 . . . . 65.14 109.3 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 108.287 -1.005 . . . . 63.12 108.287 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -41.55 -66.68 0.32 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.546 1.154 . . . . 72.04 110.264 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 19.1 ptp -53.73 -34.49 59.09 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.486 1.116 . . . . 71.32 111.001 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 88.45 50.21 3.45 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.429 1.081 . . . . 61.35 110.953 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 3.3 m -146.21 179.05 7.77 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.498 0.763 . . . . 70.35 109.989 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.772 HG22 ' NE2' ' A' ' 371' ' ' GLN . 2.3 m -117.89 160.66 21.04 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.528 1.143 . . . . 74.12 110.395 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.667 ' CD2' HG22 ' A' ' 355' ' ' VAL . 64.3 t80 -62.59 -68.67 0.31 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.53 1.144 . . . . 61.53 111.015 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' GLN . . . . . 0.772 ' NE2' HG22 ' A' ' 369' ' ' THR . 0.1 OUTLIER -47.33 -24.95 0.87 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.529 1.143 . . . . 73.23 110.283 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.418 ' CD2' ' HA ' ' A' ' 377' ' ' ALA . 0.0 OUTLIER -69.75 117.7 11.67 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 44.53 109.236 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 25.1 t -52.22 145.24 11.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.947 -1.024 . . . . 64.14 110.89 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -103.36 24.26 11.25 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.463 1.102 . . . . 42.32 109.267 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . 0.743 HD11 ' HE1' ' A' ' 410' ' ' PHE . 52.8 mt -111.47 -49.29 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.451 1.094 . . . . 62.24 109.316 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' CYS . . . . . 0.763 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 3.5 m -109.04 -32.65 7.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.501 1.126 . . . . 34.32 108.285 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.418 ' HA ' ' CD2' ' A' ' 372' ' ' LEU . . . 61.03 28.21 18.0 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.499 1.124 . . . . 33.2 109.322 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -121.83 -40.32 2.54 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.497 1.123 . . . . 53.3 110.28 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -115.53 169.65 9.02 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.514 1.134 . . . . 74.5 109.294 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -87.52 166.19 14.94 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 72.45 109.354 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.454 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 19.2 mttt -67.12 -62.53 1.38 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.476 1.11 . . . . 65.41 109.268 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 4.8 t0 60.56 20.89 10.71 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.452 1.095 . . . . 75.32 109.281 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.928 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -151.19 175.42 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.539 1.149 . . . . 61.25 109.285 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.416 ' H ' HG22 ' A' ' 383' ' ' VAL . 20.8 tttm -158.13 156.66 31.32 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.492 1.12 . . . . 64.03 109.318 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.859 HG22 ' SG ' ' A' ' 388' ' ' CYS . 11.8 mm -122.72 144.3 32.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.562 1.164 . . . . 54.31 109.331 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.536 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.4 mt-10 -137.74 162.4 54.72 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.501 1.125 . . . . 61.03 110.282 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.536 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.03 -12.15 24.12 Favored 'Cis proline' 0 C--N 1.36 1.172 0 C-N-CA 121.032 -2.487 . . . . 42.44 110.986 0.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . 0.859 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.63 -71.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.04 -0.982 . . . . 72.33 110.881 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 115.77 18.15 6.16 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.492 1.12 . . . . 72.45 111.022 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.529 ' CE1' ' HB2' ' A' ' 388' ' ' CYS . 20.0 m170 -75.58 147.13 39.88 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.529 0.782 . . . . 74.24 109.565 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.813 HD22 ' N ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -117.3 156.47 27.75 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.132 . . . . 65.3 109.308 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.928 ' O ' HG12 ' A' ' 383' ' ' VAL . 18.8 ptp -172.01 173.54 4.36 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.502 1.126 . . . . 75.23 110.958 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . 1.169 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 26.1 p -95.18 126.08 40.26 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.471 1.107 . . . . 70.34 108.278 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 6.4 m -54.12 -56.25 19.86 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.508 1.13 . . . . 74.04 110.381 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.6 t -43.61 -30.71 0.64 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.546 1.153 . . . . 42.32 109.988 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . 1.169 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 2.5 m -80.79 -52.32 7.64 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.544 1.153 . . . . 63.12 108.287 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . 0.683 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.7 OUTLIER -43.56 -37.91 2.72 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.452 1.095 . . . . 74.31 109.326 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 1.1 m -60.75 -46.8 89.07 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.482 1.114 . . . . 74.41 110.413 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -58.12 -21.94 48.68 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.482 1.114 . . . . 71.24 109.308 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' TRP . . . . . 0.608 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 8.9 t-105 -84.77 -64.88 1.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.523 1.139 . . . . 75.1 108.006 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.497 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.6 mm-40 -52.77 -16.99 1.13 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.472 1.107 . . . . 74.12 110.319 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 401' ' ' GLN . 5.8 mm-40 -37.09 -63.42 0.43 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.492 1.12 . . . . 73.14 110.303 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 2.8 m -120.61 -24.51 5.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.496 1.122 . . . . 72.21 109.995 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . 0.608 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 16.6 m-20 -82.09 -94.51 0.05 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.114 . . . . 70.13 109.282 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.497 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 70.5 29.96 69.38 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.488 1.117 . . . . 43.41 110.981 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -91.71 68.0 5.48 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.567 0.804 . . . . 75.44 110.279 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 66.0 -166.46 36.55 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.471 1.107 . . . . 64.1 110.976 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . 0.693 ' SG ' HG21 ' A' ' 385' ' ' ILE . 6.5 t -57.31 128.9 79.37 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 108.324 -0.991 . . . . 65.54 108.324 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 0.3 9.07 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.511 1.795 . . . . 71.25 110.958 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . 0.743 ' HE1' HD11 ' A' ' 375' ' ' ILE . 3.2 m-85 -97.91 -41.54 7.96 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.505 1.128 . . . . 74.34 111.019 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' CYS . . . . . 0.482 ' HG ' ' CE1' ' A' ' 390' ' ' HIS . 0.1 OUTLIER -111.32 8.98 21.58 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.522 1.138 . . . . 61.04 108.284 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 408' ' ' CYS . 8.0 tpp85 38.49 30.28 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.546 1.154 . . . . 72.23 110.294 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' CYS . . . . . 0.444 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.3 m -123.09 164.85 17.83 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.501 1.126 . . . . 74.3 108.265 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -63.07 145.08 56.23 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.494 1.121 . . . . 71.12 110.281 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.739 HG23 HG23 ' A' ' 385' ' ' ILE . 1.6 mt -94.92 147.01 6.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.522 1.139 . . . . 61.52 109.304 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -117.26 -43.78 2.82 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.489 1.118 . . . . 75.12 109.305 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . 0.453 ' C ' HG23 ' A' ' 418' ' ' THR . . . -119.21 130.0 8.34 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.452 1.095 . . . . 75.33 110.976 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . 0.578 ' CG2' HG21 ' A' ' 415' ' ' ILE . 80.6 p -152.69 138.86 18.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.477 0.751 . . . . 62.22 110.359 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -171.86 151.12 2.69 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.458 1.099 . . . . 74.05 110.275 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.08 101.66 1.5 Allowed 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.518 1.799 . . . . 63.0 110.981 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.793 HD11 HG22 ' A' ' 423' ' ' VAL . 0.8 OUTLIER -104.18 159.42 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.444 1.09 . . . . 73.15 109.289 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . 0.543 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 8.1 mt -111.47 105.51 18.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.488 1.118 . . . . 45.11 109.27 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.793 HG22 HD11 ' A' ' 421' ' ' ILE . 39.5 t -76.97 146.78 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.509 1.131 . . . . 73.0 109.322 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.514 ' O ' HG23 ' A' ' 355' ' ' VAL . 9.3 m-20 -129.49 143.87 50.63 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.478 1.111 . . . . 60.41 109.34 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.96 174.05 13.45 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.492 1.785 . . . . 72.1 110.993 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . 0.525 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 4.8 t80 . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.118 . . . . 74.4 111.058 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 67.0 m . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 109.966 -0.383 . . . . 63.04 109.966 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -94.22 -174.75 3.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.488 1.117 . . . . 72.24 109.28 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . 0.568 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 28.9 m-70 -140.15 141.55 36.04 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.551 1.157 . . . . 74.35 109.578 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' A' ' 354' ' ' LYS . 3.7 mm -128.2 158.46 40.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.445 1.091 . . . . 64.04 109.293 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.404 ' N ' ' CG2' ' A' ' 353' ' ' ILE . 0.0 OUTLIER -117.91 153.66 33.21 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.498 1.124 . . . . 74.02 109.304 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 424' ' ' ASP . 14.3 t -105.44 149.12 9.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.115 . . . . 75.2 109.272 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 19.8 p -117.2 176.9 4.93 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.485 1.116 . . . . 72.35 110.395 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -74.49 -33.85 62.94 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.497 1.123 . . . . 73.22 110.292 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . 0.41 ' CG ' ' N ' ' A' ' 359' ' ' GLN . 15.3 pt-20 -57.98 -47.64 82.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.474 1.109 . . . . 75.22 110.305 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . 0.41 ' N ' ' CG ' ' A' ' 358' ' ' GLU . 29.1 mm-40 -60.9 -66.65 0.5 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 74.14 110.297 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . 0.41 ' O ' ' N ' ' A' ' 364' ' ' CYS . 4.9 t80 -44.02 -42.9 6.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 75.11 110.995 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -65.71 -42.38 91.19 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.453 1.096 . . . . 73.13 110.263 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.7 tp . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.47 1.106 . . . . 64.11 109.338 -179.988 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . 0.41 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.7 m . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 108.302 -0.999 . . . . 71.25 108.302 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -75.47 -29.28 59.55 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.525 1.141 . . . . 62.2 110.305 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' MET . . . . . 0.405 ' SD ' ' N ' ' A' ' 366' ' ' MET . 0.0 OUTLIER -113.49 21.02 15.55 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.514 1.134 . . . . 53.42 110.979 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 37.78 47.71 1.8 Allowed Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.448 1.093 . . . . 75.14 110.987 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 31.6 m -121.42 152.84 38.61 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.504 0.767 . . . . 62.42 109.989 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.791 HG22 HE21 ' A' ' 371' ' ' GLN . 2.2 m -98.51 159.77 14.72 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 72.24 110.369 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.535 ' CD1' HG11 ' A' ' 423' ' ' VAL . 5.9 t80 -66.34 -65.66 0.65 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.483 1.114 . . . . 74.53 110.981 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' GLN . . . . . 0.791 HE21 HG22 ' A' ' 369' ' ' THR . 0.0 OUTLIER -53.34 -32.8 50.85 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.128 . . . . 64.44 110.322 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.883 HD22 ' N ' ' A' ' 373' ' ' CYS . 0.7 OUTLIER -58.67 135.87 57.52 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.507 1.129 . . . . 65.13 109.278 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . 0.883 ' N ' HD22 ' A' ' 372' ' ' LEU . 16.4 t -76.68 135.91 39.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.965 -1.016 . . . . 74.43 110.896 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.402 ' HD2' ' N ' ' A' ' 374' ' ' LYS . 0.6 OUTLIER -92.94 22.17 5.13 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.506 1.129 . . . . 73.45 109.317 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 5.0 mt -110.68 -52.18 6.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.524 1.14 . . . . 61.54 109.33 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' CYS . . . . . 1.171 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 7.5 m -102.75 -27.04 12.93 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.485 1.116 . . . . 45.04 108.313 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.704 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 55.52 29.05 12.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.464 1.103 . . . . 54.01 109.327 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -122.45 -40.86 2.43 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.468 1.105 . . . . 74.45 110.31 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -119.06 -179.94 3.98 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.463 1.102 . . . . 65.3 109.348 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -89.55 171.76 9.46 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.52 1.137 . . . . 73.12 109.327 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.449 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 11.6 mttt -79.14 -62.49 1.68 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 74.42 109.284 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 15.7 t0 62.4 22.2 13.07 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.464 1.102 . . . . 74.15 109.324 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.872 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -158.25 172.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.488 1.117 . . . . 71.5 109.298 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.404 ' CE ' ' HA2' ' A' ' 389' ' ' GLY . 76.4 tttt -156.74 159.5 38.39 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.464 1.102 . . . . 74.24 109.312 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.886 HG22 ' SG ' ' A' ' 388' ' ' CYS . 18.1 mm -117.21 139.92 42.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.522 1.138 . . . . 70.25 109.298 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.534 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.9 mt-10 -130.61 162.26 55.93 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.446 1.091 . . . . 64.43 110.271 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.534 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.4 Cg_endo -74.93 -14.72 22.76 Favored 'Cis proline' 0 C--N 1.36 1.157 0 C-N-CA 121.034 -2.486 . . . . 63.41 110.986 -0.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . 0.886 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.82 -87.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.047 -0.979 . . . . 55.4 110.915 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 130.91 42.9 0.19 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.467 1.104 . . . . 41.33 111.027 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.499 ' C ' HD13 ' A' ' 391' ' ' LEU . 27.8 m170 -97.45 131.49 44.04 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.49 0.759 . . . . 73.44 109.643 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.697 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -100.21 151.83 20.99 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.462 1.102 . . . . 70.11 109.309 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.872 ' O ' HG12 ' A' ' 383' ' ' VAL . 16.8 ptp -167.61 170.74 10.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.536 1.147 . . . . 75.22 110.933 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . 1.208 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 26.1 p -97.14 115.28 27.25 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.452 1.095 . . . . 74.21 108.334 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 24.3 m -39.71 -58.69 1.28 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.552 1.157 . . . . 34.54 110.389 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.4 t -42.64 -43.61 3.91 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.513 1.133 . . . . 53.25 110.004 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . 1.208 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 3.6 m -67.52 -55.2 14.44 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.474 1.109 . . . . 61.34 108.293 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . 0.749 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -44.15 -36.26 2.55 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.476 1.11 . . . . 73.31 109.308 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 17.5 m -61.35 -46.06 91.79 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 71.5 110.436 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -56.89 -22.6 38.46 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.458 1.098 . . . . 75.04 109.302 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' TRP . . . . . 0.605 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 9.1 t-105 -85.56 -64.77 1.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.982 -1.118 . . . . 73.02 107.982 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.497 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 10.1 mm-40 -52.94 -16.88 1.16 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 72.24 110.316 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 401' ' ' GLN . 5.1 mt-10 -37.16 -63.29 0.44 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.489 1.118 . . . . 73.23 110.323 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 5.4 t -120.51 -24.46 5.81 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.443 1.089 . . . . 53.53 109.986 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . 0.605 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 4.6 m-20 -82.62 -95.08 0.05 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.478 1.111 . . . . 65.34 109.288 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.497 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 70.57 32.45 67.6 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.57 1.169 . . . . 62.52 110.992 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -92.02 66.94 5.06 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 0.773 . . . . 74.23 110.344 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 66.19 -161.89 44.1 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.532 1.145 . . . . 64.55 111.05 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . 0.673 ' SG ' HG21 ' A' ' 385' ' ' ILE . 5.5 t -60.21 126.25 83.58 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 108.332 -0.988 . . . . 74.12 108.332 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.06 -1.56 11.39 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.518 1.799 . . . . 65.04 110.998 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -94.9 -42.19 8.8 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 1.136 . . . . 65.32 111.001 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' CYS . . . . . 0.445 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.2 OUTLIER -111.79 10.45 20.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.135 . . . . 52.31 108.265 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 408' ' ' CYS . 4.8 tpt180 38.48 30.35 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.534 1.146 . . . . 75.34 110.316 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' CYS . . . . . 0.445 ' N ' ' O ' ' A' ' 411' ' ' CYS . 16.0 t -125.3 145.65 49.92 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.487 1.117 . . . . 74.53 108.311 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -46.59 152.67 0.44 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.552 1.158 . . . . 73.32 110.292 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.798 HG23 HG23 ' A' ' 385' ' ' ILE . 2.1 mt -100.54 153.11 4.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.463 1.102 . . . . 63.4 109.323 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.468 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 5.1 mmtt -113.98 -46.24 3.02 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 74.25 109.273 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . 0.457 ' C ' HG23 ' A' ' 418' ' ' THR . . . -121.5 129.66 7.81 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.466 1.103 . . . . 72.45 111.03 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . 0.647 ' CG2' HG21 ' A' ' 415' ' ' ILE . 82.8 p -152.96 136.17 15.7 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.473 0.749 . . . . 64.5 110.378 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 13.4 pm0 -168.1 150.54 5.27 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.534 1.146 . . . . 63.32 110.327 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.4 Cg_endo -74.95 102.11 1.55 Allowed 'Trans proline' 0 C--N 1.359 1.11 0 O-C-N 124.514 1.797 . . . . 74.25 111.052 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.885 HD11 HG22 ' A' ' 423' ' ' VAL . 0.7 OUTLIER -103.9 156.4 5.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.475 1.11 . . . . 70.2 109.308 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . 0.568 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 14.2 mt -110.39 105.9 19.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.501 1.125 . . . . 74.33 109.293 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.885 HG22 HD11 ' A' ' 421' ' ' ILE . 18.7 t -77.79 146.74 7.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.493 1.12 . . . . 73.15 109.302 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.639 ' O ' HG23 ' A' ' 355' ' ' VAL . 76.0 m-20 -129.2 143.55 49.28 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.504 1.127 . . . . 64.13 109.299 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 174.03 13.5 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.529 1.805 . . . . 64.03 111.018 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . 0.483 ' CD1' ' C ' ' A' ' 426' ' ' PHE . 2.8 t80 . . . . . 0 C--N 1.325 -0.491 0 O-C-N 124.482 1.114 . . . . 73.53 111.01 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 109.993 -0.373 . . . . 73.3 109.993 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -91.28 -178.09 5.04 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.539 1.149 . . . . 74.01 109.297 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . 0.534 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 25.9 m-70 -138.95 140.87 38.41 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.53 1.143 . . . . 53.13 109.608 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . 0.454 HG13 HD13 ' A' ' 421' ' ' ILE . 35.8 mt -130.16 136.02 59.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.125 . . . . 74.41 109.311 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -103.37 129.93 50.56 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.471 1.107 . . . . 72.11 109.319 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 424' ' ' ASP . 12.7 t -77.56 157.62 5.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 75.1 109.328 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.5 p -122.25 148.81 44.54 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.505 1.128 . . . . 62.32 110.398 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' GLN . . . . . 0.618 ' CG ' ' CE2' ' A' ' 426' ' ' PHE . 3.1 mt-30 -47.52 -38.44 14.06 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.133 . . . . 72.01 110.29 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -58.28 -37.1 74.32 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.511 1.132 . . . . 71.02 110.296 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -74.56 -66.74 0.7 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.52 1.138 . . . . 44.44 110.292 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . 0.42 ' O ' ' N ' ' A' ' 364' ' ' CYS . 7.0 t80 -40.98 -62.07 0.88 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.553 1.158 . . . . 75.51 111.056 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -48.84 -48.83 41.47 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.535 1.147 . . . . 73.41 110.303 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 9.9 tt . . . . . 0 C--N 1.325 -0.468 0 O-C-N 124.493 1.121 . . . . 35.01 109.313 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . 0.42 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 108.318 -0.993 . . . . 71.31 108.318 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -77.23 -8.24 57.25 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.493 1.121 . . . . 52.22 110.342 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 8.0 mmt -102.61 -29.93 11.25 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.528 1.143 . . . . 55.41 111.003 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 89.93 30.01 14.04 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.498 1.124 . . . . 54.21 110.997 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 1.1 p -144.66 -175.01 4.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.469 0.746 . . . . 71.32 109.991 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.416 ' O ' ' CE ' ' A' ' 374' ' ' LYS . 11.7 p -118.79 167.32 11.81 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.452 1.095 . . . . 72.3 110.395 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.574 ' CD2' HG11 ' A' ' 423' ' ' VAL . 38.2 t80 -71.2 -65.37 0.75 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 63.41 110.999 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' GLN . . . . . 0.542 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.3 OUTLIER -43.67 -27.2 0.29 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 51.14 110.335 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.901 HD22 ' N ' ' A' ' 373' ' ' CYS . 0.5 OUTLIER -74.16 136.08 42.86 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.472 1.108 . . . . 71.01 109.309 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . 0.901 ' N ' HD22 ' A' ' 372' ' ' LEU . 32.1 p -68.48 130.75 43.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.008 -0.996 . . . . 71.55 110.878 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.416 ' CE ' ' O ' ' A' ' 369' ' ' THR . 28.8 mmtp -92.97 31.46 1.41 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.488 1.118 . . . . 75.21 109.337 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . 0.655 HD11 ' HE1' ' A' ' 410' ' ' PHE . 18.8 mt -112.31 -59.74 3.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.509 1.13 . . . . 34.52 109.276 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 4.0 m -107.41 -22.01 12.72 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.471 1.107 . . . . 54.24 108.312 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.703 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 54.76 40.3 31.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.511 1.132 . . . . 64.31 109.335 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -121.51 -40.28 2.58 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.499 1.125 . . . . 74.33 110.322 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -124.03 179.18 4.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.527 1.142 . . . . 71.3 109.278 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -89.45 165.84 14.07 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.557 1.161 . . . . 72.44 109.307 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.467 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 17.2 mttt -66.49 -62.63 1.36 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.561 1.163 . . . . 75.22 109.28 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 33.9 t0 59.91 22.71 11.74 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.51 1.131 . . . . 52.11 109.301 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.901 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -156.75 174.62 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.524 1.14 . . . . 53.13 109.29 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.405 ' CG ' ' N ' ' A' ' 385' ' ' ILE . 47.1 tttt -158.44 158.48 34.23 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.442 1.089 . . . . 64.22 109.311 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.831 HG22 ' SG ' ' A' ' 388' ' ' CYS . 14.8 mm -118.32 144.75 25.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.521 1.138 . . . . 74.03 109.268 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.537 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.0 mt-10 -136.86 162.35 56.36 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.435 1.084 . . . . 74.03 110.291 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.537 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.04 -13.69 23.59 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 121.023 -2.491 . . . . 75.32 111.02 0.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . 0.831 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.8 -84.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.953 -1.021 . . . . 45.52 110.892 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 128.36 41.99 0.26 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.507 1.129 . . . . 73.55 110.964 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.52 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 27.2 m80 -97.55 137.9 35.78 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.526 0.78 . . . . 72.41 109.56 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.706 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -106.64 150.82 25.83 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.501 1.126 . . . . 62.02 109.286 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.901 ' O ' HG12 ' A' ' 383' ' ' VAL . 16.3 ptp -167.48 166.33 14.33 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.467 1.104 . . . . 44.15 111.011 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . 1.105 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 8.8 p -90.9 124.54 35.27 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 1.128 . . . . 61.5 108.254 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 10.6 m -47.93 -56.85 6.64 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.5 1.125 . . . . 52.32 110.39 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 4.1 m -44.94 -27.15 0.5 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.521 1.138 . . . . 72.55 110.019 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . 1.105 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 1.9 m -83.26 -51.61 7.3 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.495 1.122 . . . . 72.35 108.346 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . 0.661 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -40.97 -52.25 3.14 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.532 1.145 . . . . 75.55 109.292 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' THR . . . . . 0.63 ' N ' HD13 ' A' ' 397' ' ' LEU . 2.7 m -53.04 -43.11 66.36 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.525 1.141 . . . . 71.22 110.416 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -57.19 -26.13 60.14 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.538 1.149 . . . . 73.45 109.329 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' TRP . . . . . 0.596 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 10.3 t-105 -85.62 -62.52 1.51 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.998 -1.112 . . . . 70.23 107.998 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.499 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.4 mm-40 -56.13 -14.15 2.5 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.514 1.134 . . . . 64.14 110.342 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 398' ' ' THR . 3.0 mm-40 -37.12 -63.39 0.43 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.488 1.118 . . . . 75.32 110.292 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.4 t -121.3 -24.61 5.42 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.543 1.152 . . . . 75.22 109.978 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . 0.596 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 15.0 m-20 -82.63 -94.28 0.06 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.458 1.098 . . . . 74.3 109.334 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.499 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 72.56 30.23 64.59 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.516 1.135 . . . . 63.51 111.002 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.901 HE21 HH21 ' A' ' 412' ' ' ARG . 0.6 OUTLIER -91.36 71.37 6.09 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.508 0.769 . . . . 74.4 110.322 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 61.74 -167.81 14.58 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.547 1.154 . . . . 72.22 111.011 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . 0.657 ' SG ' HG21 ' A' ' 385' ' ' ILE . 5.7 t -56.26 125.99 66.77 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 108.29 -1.004 . . . . 75.25 108.29 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.94 0.17 9.2 Favored 'Trans proline' 0 C--N 1.359 1.104 0 O-C-N 124.521 1.801 . . . . 74.52 111.003 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . 0.655 ' HE1' HD11 ' A' ' 375' ' ' ILE . 3.6 m-85 -94.67 -55.78 3.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.107 . . . . 72.52 111.027 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' CYS . . . . . 0.436 ' O ' ' N ' ' A' ' 413' ' ' CYS . 2.4 p -98.95 12.86 34.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 62.23 108.293 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' ARG . . . . . 0.901 HH21 HE21 ' A' ' 406' ' ' GLN . 14.2 mmm-85 38.55 30.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.476 1.11 . . . . 61.42 110.288 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.3 m -119.76 163.22 17.79 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.53 1.144 . . . . 75.21 108.332 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.31 154.8 34.15 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.525 1.141 . . . . 74.41 110.293 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.749 HG23 HG23 ' A' ' 385' ' ' ILE . 1.9 mt -104.61 143.49 16.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.438 1.087 . . . . 64.33 109.279 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.451 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 3.5 mmtp -109.85 -46.37 3.5 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.559 1.162 . . . . 53.12 109.321 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . 0.479 ' C ' HG23 ' A' ' 418' ' ' THR . . . -124.36 139.66 12.05 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.541 1.151 . . . . 73.12 110.994 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . 0.598 ' CG2' HG21 ' A' ' 415' ' ' ILE . 72.3 p -153.92 126.43 8.07 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.517 0.775 . . . . 63.41 110.359 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.21 151.12 23.65 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.489 1.118 . . . . 73.13 110.332 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.96 102.11 1.55 Allowed 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.514 1.797 . . . . 72.03 111.037 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.883 HD11 HG22 ' A' ' 423' ' ' VAL . 0.7 OUTLIER -103.87 155.03 5.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.131 . . . . 71.34 109.29 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . 0.541 ' N ' HD12 ' A' ' 421' ' ' ILE . 19.4 mt -109.37 105.99 19.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.567 1.167 . . . . 73.43 109.307 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.883 HG22 HD11 ' A' ' 421' ' ' ILE . 17.1 t -76.23 146.94 8.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.434 1.084 . . . . 74.34 109.265 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.768 ' O ' HG23 ' A' ' 355' ' ' VAL . 1.8 t70 -128.68 143.5 48.7 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.523 1.139 . . . . 73.11 109.352 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 176.19 10.22 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.481 1.779 . . . . 63.3 111.053 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . 0.618 ' CE2' ' CG ' ' A' ' 357' ' ' GLN . 5.9 t80 . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.542 1.151 . . . . 74.51 111.042 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 110.043 -0.355 . . . . 74.42 110.043 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -87.89 -175.07 4.99 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.514 1.134 . . . . 73.51 109.28 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . 0.547 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 39.0 m-70 -142.05 146.93 36.04 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.517 1.136 . . . . 73.13 109.627 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 58.4 mt -130.83 158.63 43.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.484 1.115 . . . . 62.42 109.247 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -128.36 134.03 48.77 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.547 1.154 . . . . 72.25 109.3 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 424' ' ' ASP . 43.8 t -95.28 164.29 2.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.487 1.117 . . . . 72.23 109.274 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.468 ' N ' ' CG1' ' A' ' 355' ' ' VAL . 71.2 p -125.69 157.39 37.45 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.542 1.151 . . . . 63.33 110.406 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' GLN . . . . . 0.597 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 7.1 mt-30 -53.9 -46.29 71.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.469 1.105 . . . . 72.33 110.275 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -44.04 -30.46 0.74 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.504 1.127 . . . . 75.1 110.339 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . 0.529 ' OE1' ' CD1' ' A' ' 370' ' ' PHE . 58.8 mt-30 -83.58 -66.86 0.84 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.471 1.107 . . . . 42.43 110.287 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 364' ' ' CYS . 3.9 t80 -38.15 -38.56 0.34 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.499 1.124 . . . . 64.33 110.999 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -63.71 -52.36 60.86 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.431 1.082 . . . . 63.55 110.292 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 2.1 tp . . . . . 0 C--N 1.326 -0.447 0 O-C-N 124.442 1.089 . . . . 55.43 109.287 -179.953 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 108.317 -0.994 . . . . 52.44 108.317 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -75.14 -51.95 12.16 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.461 1.101 . . . . 71.41 110.306 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 24.3 ptp -68.06 -15.14 63.47 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.506 1.128 . . . . 71.41 111.0 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 75.04 34.65 51.88 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.482 1.114 . . . . 54.22 111.012 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.1 -178.03 4.91 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 0.759 . . . . 64.24 110.026 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.823 HG22 ' NE2' ' A' ' 371' ' ' GLN . 2.0 m -117.35 161.22 19.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.132 . . . . 72.05 110.424 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.529 ' CD1' ' OE1' ' A' ' 359' ' ' GLN . 67.2 t80 -62.51 -69.39 0.26 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.51 1.131 . . . . 74.43 110.954 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' GLN . . . . . 0.823 ' NE2' HG22 ' A' ' 369' ' ' THR . 0.2 OUTLIER -44.95 -25.9 0.36 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.533 1.146 . . . . 73.31 110.295 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.511 HD22 ' HA ' ' A' ' 377' ' ' ALA . 0.2 OUTLIER -62.26 132.32 52.32 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.479 1.112 . . . . 71.35 109.263 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 5.1 t -68.32 124.43 23.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.954 -1.021 . . . . 73.11 110.893 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.458 ' HB3' ' HZ3' ' A' ' 374' ' ' LYS . 1.4 mmmm -90.88 18.46 6.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.517 1.136 . . . . 72.33 109.294 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . 1.011 HD11 ' CZ ' ' A' ' 410' ' ' PHE . 64.2 mt -109.81 -25.7 3.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.524 1.14 . . . . 64.35 109.283 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' CYS . . . . . 0.848 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 5.8 p -132.28 -48.66 0.92 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.131 . . . . 65.44 108.31 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 376' ' ' CYS . . . 73.79 44.54 0.27 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.459 1.1 . . . . 75.2 109.318 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -123.68 -42.27 2.21 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.497 1.123 . . . . 75.14 110.297 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -133.82 176.83 8.21 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.509 1.131 . . . . 74.5 109.316 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -84.96 149.53 25.56 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.499 1.124 . . . . 75.33 109.264 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 392' ' ' MET . 22.1 mttt -51.83 -55.9 17.22 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.455 1.097 . . . . 52.52 109.313 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 1.1 p30 52.28 25.45 3.4 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.511 1.132 . . . . 61.52 109.301 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.895 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -153.92 176.09 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.475 1.109 . . . . 71.22 109.343 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.601 ' HE3' HD11 ' A' ' 391' ' ' LEU . 8.9 ttmt -158.46 148.26 19.63 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.498 1.124 . . . . 74.2 109.347 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.738 HD12 HD13 ' A' ' 415' ' ' ILE . 16.8 mm -112.16 141.25 28.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.53 1.144 . . . . 73.32 109.283 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.523 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.2 mt-10 -138.14 161.34 60.02 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.498 1.124 . . . . 73.5 110.331 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.523 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.99 -9.76 24.02 Favored 'Cis proline' 0 C--N 1.36 1.144 0 C-N-CA 121.006 -2.498 . . . . 74.02 111.031 0.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . 0.446 ' SG ' ' ND1' ' A' ' 390' ' ' HIS . 4.2 t -36.68 -72.96 0.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.965 -1.016 . . . . 73.35 110.936 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.34 15.72 6.94 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.47 1.106 . . . . 73.32 111.018 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.446 ' ND1' ' SG ' ' A' ' 388' ' ' CYS . 16.6 m170 -82.08 135.94 35.26 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 0.767 . . . . 73.34 109.627 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.678 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -102.63 160.1 14.87 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.537 1.148 . . . . 73.11 109.327 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.895 ' O ' HG12 ' A' ' 383' ' ' VAL . 15.2 ptp -173.07 175.31 3.25 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 1.131 . . . . 74.14 111.016 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 20.0 p -96.94 114.92 26.58 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.55 1.156 . . . . 62.13 108.307 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 28.6 m -38.85 -59.8 0.92 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.49 1.119 . . . . 64.1 110.4 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.3 p -43.27 -42.46 4.41 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.509 1.13 . . . . 61.32 109.976 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 2.8 m -67.8 -51.39 49.37 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.456 1.098 . . . . 72.3 108.312 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . 0.688 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -45.67 -46.51 14.74 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.5 1.125 . . . . 71.24 109.319 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' THR . . . . . 0.559 ' N ' HD13 ' A' ' 397' ' ' LEU . 1.1 m -56.67 -35.55 68.54 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 74.14 110.434 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -69.08 -21.13 64.08 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.522 1.139 . . . . 62.25 109.283 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' TRP . . . . . 0.602 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 8.9 t-105 -85.71 -61.29 1.79 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.506 1.129 . . . . 63.12 108.025 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.501 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 8.6 mm-40 -56.2 -14.24 2.63 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.121 . . . . 63.31 110.34 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 401' ' ' GLN . 1.0 OUTLIER -37.14 -63.36 0.44 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.513 1.133 . . . . 74.23 110.277 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.5 m -121.08 -24.57 5.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.102 . . . . 75.43 109.959 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . 0.602 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 3.1 m-20 -83.21 -95.09 0.06 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 70.51 109.341 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.501 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 73.96 27.6 66.32 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.548 1.155 . . . . 61.32 111.001 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -89.37 67.83 7.82 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.497 0.763 . . . . 75.31 110.279 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 61.86 -163.25 24.9 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.546 1.154 . . . . 71.25 110.989 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . 0.424 ' SG ' HG21 ' A' ' 385' ' ' ILE . 4.9 t -56.23 127.6 70.98 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 108.325 -0.991 . . . . 54.23 108.325 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 0.3 9.06 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.452 1.764 . . . . 65.13 111.014 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . 1.011 ' CZ ' HD11 ' A' ' 375' ' ' ILE . 9.1 m-85 -93.37 -48.15 6.55 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.56 1.162 . . . . 71.21 111.016 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' CYS . . . . . 0.44 ' O ' ' N ' ' A' ' 413' ' ' CYS . 1.1 p -109.35 13.06 24.4 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.535 1.147 . . . . 74.51 108.312 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 38.48 30.46 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.471 1.107 . . . . 74.03 110.282 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' CYS . . . . . 0.44 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.6 m -113.31 155.06 25.82 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.587 1.179 . . . . 72.35 108.296 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -59.25 158.95 8.3 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.451 1.094 . . . . 63.12 110.307 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.738 HD13 HD12 ' A' ' 385' ' ' ILE . 7.2 mt -114.31 156.86 15.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.518 1.136 . . . . 54.43 109.329 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.428 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 20.3 mmtt -125.63 -46.72 1.72 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 73.24 109.305 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 418' ' ' THR . . . -111.28 133.56 11.59 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.494 1.122 . . . . 72.52 111.008 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 417' ' ' GLY . 23.4 p -157.06 116.21 3.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.513 0.772 . . . . 74.45 110.386 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.65 151.42 42.7 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.501 1.125 . . . . 74.4 110.325 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 101.79 1.51 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.56 1.821 . . . . 72.21 111.047 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.768 HD11 HG22 ' A' ' 423' ' ' VAL . 0.8 OUTLIER -103.89 158.67 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.484 1.115 . . . . 74.34 109.248 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . 0.593 ' N ' HD12 ' A' ' 421' ' ' ILE . 11.4 mt -112.29 107.16 22.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.532 1.145 . . . . 65.01 109.277 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.768 HG22 HD11 ' A' ' 421' ' ' ILE . 20.5 t -75.39 149.6 6.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.472 1.107 . . . . 71.52 109.293 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.663 ' O ' HG23 ' A' ' 355' ' ' VAL . 6.9 t0 -126.73 132.95 24.53 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.498 1.124 . . . . 73.34 109.336 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 163.03 36.21 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.543 1.812 . . . . 71.12 111.039 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . 0.597 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 1.1 t80 . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.485 1.116 . . . . 72.34 111.037 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . 0.459 ' HB3' ' CD1' ' A' ' 422' ' ' ILE . 60.7 m . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 110.026 -0.361 . . . . 73.34 110.026 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -90.68 172.75 8.45 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.533 1.146 . . . . 71.43 109.309 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . 0.522 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 27.3 m-70 -132.99 130.93 40.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 1.14 . . . . 73.42 109.653 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . 0.612 HD12 ' CD1' ' A' ' 421' ' ' ILE . 61.9 mt -119.0 150.71 21.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 65.54 109.29 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.29 139.12 50.72 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.569 1.168 . . . . 51.54 109.285 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 424' ' ' ASP . 21.9 t -87.74 122.59 39.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.504 1.127 . . . . 65.13 109.281 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.7 p -84.52 140.97 31.08 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.532 1.145 . . . . 72.12 110.391 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' GLN . . . . . 0.456 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 7.1 mt-30 -41.06 -33.66 0.35 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.537 1.148 . . . . 62.43 110.304 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -56.55 -49.1 75.82 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.531 1.144 . . . . 61.02 110.306 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . 0.443 ' HB2' HG13 ' A' ' 355' ' ' VAL . 11.0 mm-40 -60.24 -66.76 0.47 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 74.33 110.325 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . 0.442 ' O ' ' N ' ' A' ' 364' ' ' CYS . 5.7 t80 -38.89 -41.36 0.74 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.481 1.113 . . . . 71.51 110.985 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -63.63 -54.03 42.22 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.5 1.125 . . . . 75.1 110.301 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.6 tp . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.485 1.116 . . . . 54.31 109.329 179.97 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . 0.442 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.9 m . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 108.304 -0.999 . . . . 73.1 108.304 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -65.38 -15.21 62.35 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.485 1.116 . . . . 75.43 110.269 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 2.5 ptp -126.0 2.07 7.28 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.54 1.15 . . . . 72.34 110.979 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 49.96 48.38 38.3 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.492 1.12 . . . . 71.11 111.034 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 6.5 t -115.88 177.99 4.48 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.45 0.735 . . . . 73.24 110.003 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 2.2 p -124.37 135.21 53.14 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.539 1.149 . . . . 74.42 110.373 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.545 ' CD2' HG11 ' A' ' 423' ' ' VAL . 32.5 t80 -64.1 -66.08 0.59 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.126 . . . . 65.13 110.997 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' GLN . . . . . 0.581 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.3 OUTLIER -43.08 -27.16 0.19 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.499 1.124 . . . . 74.24 110.345 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.933 HD22 ' N ' ' A' ' 373' ' ' CYS . 0.4 OUTLIER -73.18 135.91 44.68 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.539 1.149 . . . . 65.51 109.281 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . 0.933 ' N ' HD22 ' A' ' 372' ' ' LEU . 31.6 p -64.13 128.53 36.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.025 -0.989 . . . . 64.35 110.908 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -93.07 29.26 1.9 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.491 1.119 . . . . 73.25 109.279 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . 0.653 HG21 ' HB3' ' A' ' 396' ' ' CYS . 35.4 mt -108.29 -60.5 2.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.539 1.149 . . . . 71.32 109.276 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 14.3 p -107.93 -22.36 12.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 52.25 108.278 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.567 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 58.79 46.97 13.35 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.463 1.102 . . . . 75.33 109.306 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -131.64 -44.77 0.98 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.453 1.096 . . . . 63.42 110.275 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -113.24 -179.98 3.8 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.492 1.12 . . . . 64.52 109.283 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -94.63 162.73 13.67 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.458 1.099 . . . . 72.51 109.284 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.44 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 20.3 mttt -65.76 -62.54 1.45 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.461 1.1 . . . . 75.1 109.324 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 420' ' ' PRO . 4.1 t70 60.17 20.34 9.67 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.487 1.117 . . . . 61.35 109.314 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.924 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -149.71 176.09 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.483 1.114 . . . . 72.3 109.296 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.437 ' HD2' HD11 ' A' ' 353' ' ' ILE . 17.5 tttm -159.13 156.39 28.98 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.478 1.111 . . . . 71.42 109.27 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.855 HG22 ' SG ' ' A' ' 388' ' ' CYS . 11.5 mm -122.67 144.16 33.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.51 1.132 . . . . 74.42 109.277 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.537 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.0 OUTLIER -137.68 162.34 55.18 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.554 1.159 . . . . 75.11 110.283 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.537 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.99 -12.46 23.95 Favored 'Cis proline' 0 C--N 1.36 1.153 0 C-N-CA 120.983 -2.507 . . . . 70.11 110.98 -0.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . 0.855 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.34 -71.72 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.011 -0.995 . . . . 73.33 110.925 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.0 16.86 6.57 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.545 1.153 . . . . 73.15 110.981 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.564 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 20.0 m80 -74.46 146.41 42.82 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.483 0.755 . . . . 63.33 109.622 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.814 HD22 ' N ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -116.85 158.2 24.35 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.527 1.142 . . . . 65.14 109.301 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.924 ' O ' HG12 ' A' ' 383' ' ' VAL . 14.2 ptp -173.45 173.37 3.49 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.507 1.129 . . . . 71.42 111.032 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 4.7 p -97.33 119.13 35.29 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.489 1.118 . . . . 74.21 108.309 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 4.5 m -47.05 -41.04 16.09 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.543 1.152 . . . . 64.1 110.378 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.5 p -55.42 -43.12 75.02 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 73.43 110.028 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . 0.653 ' HB3' HG21 ' A' ' 375' ' ' ILE . 4.9 m -70.17 -44.32 69.02 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.133 . . . . 55.11 108.32 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . 0.432 HD13 ' C ' ' A' ' 397' ' ' LEU . 1.6 tm? -44.97 -47.84 11.41 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.529 1.143 . . . . 75.32 109.27 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 3.2 m -55.75 -35.24 65.97 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.464 1.103 . . . . 73.15 110.388 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -66.93 -23.45 65.97 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.127 . . . . 65.4 109.271 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' TRP . . . . . 0.414 ' O ' ' HB2' ' A' ' 404' ' ' ASP . 7.7 t-105 -85.91 -58.69 2.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 73.54 107.985 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.51 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 5.5 mm-40 -62.45 -9.84 9.73 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.564 1.165 . . . . 75.51 110.314 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 401' ' ' GLN . 1.0 OUTLIER -37.14 -63.9 0.4 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.428 1.08 . . . . 75.2 110.311 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 6.2 p -121.98 -25.04 5.04 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.505 1.128 . . . . 74.34 109.987 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 400' ' ' TRP . 3.1 m-20 -82.33 -92.52 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 61.13 109.289 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.51 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 75.53 32.19 55.17 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.516 1.135 . . . . 70.53 111.006 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -89.35 75.56 7.68 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.473 0.749 . . . . 73.51 110.275 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 57.34 -161.58 8.75 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.471 1.107 . . . . 40.0 110.986 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . 0.681 ' SG ' HG21 ' A' ' 385' ' ' ILE . 6.8 t -58.02 130.03 82.81 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 108.291 -1.003 . . . . 72.42 108.291 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -0.16 9.63 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.449 1.763 . . . . 65.4 110.994 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . 0.564 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 3.8 m-85 -97.64 -41.46 8.11 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.492 1.12 . . . . 60.15 111.004 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' CYS . . . . . 0.482 ' HG ' ' CE1' ' A' ' 390' ' ' HIS . 0.1 OUTLIER -111.19 8.75 21.73 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.537 1.148 . . . . 54.31 108.322 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 408' ' ' CYS . 12.7 tpp85 38.44 30.35 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.462 1.101 . . . . 32.4 110.275 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' CYS . . . . . 0.442 ' N ' ' C ' ' A' ' 411' ' ' CYS . 1.2 m -124.97 160.77 28.18 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.534 1.146 . . . . 74.01 108.335 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -55.79 149.06 15.29 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.516 1.135 . . . . 63.34 110.276 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.659 HG23 HG23 ' A' ' 385' ' ' ILE . 1.7 mt -94.06 146.35 6.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.544 1.152 . . . . 75.5 109.28 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.93 -49.11 3.18 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.523 1.139 . . . . 74.02 109.305 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . 0.419 ' C ' ' CG2' ' A' ' 418' ' ' THR . . . -129.19 139.24 10.82 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.532 1.145 . . . . 53.35 111.015 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . 0.658 ' CG2' HG21 ' A' ' 415' ' ' ILE . 50.7 p -151.84 141.21 21.52 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.503 0.766 . . . . 73.14 110.369 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -170.25 149.66 3.28 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.466 1.104 . . . . 73.23 110.325 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 382' ' ' ASP . 18.3 Cg_endo -75.01 102.24 1.57 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.505 1.792 . . . . 73.33 111.013 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.735 HD11 HG22 ' A' ' 423' ' ' VAL . 0.9 OUTLIER -103.86 162.76 4.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.559 1.162 . . . . 63.15 109.315 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . 0.568 ' N ' HD12 ' A' ' 421' ' ' ILE . 3.3 mp -113.27 106.41 20.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 71.33 109.322 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.735 HG22 HD11 ' A' ' 421' ' ' ILE . 40.5 t -76.95 144.65 11.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.482 1.114 . . . . 73.04 109.307 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.774 ' O ' HG23 ' A' ' 355' ' ' VAL . 1.1 m-20 -130.72 143.68 50.34 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.501 1.125 . . . . 65.31 109.323 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 172.46 16.33 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.51 1.795 . . . . 62.02 110.992 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . 0.456 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 7.5 t80 . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.502 1.126 . . . . 73.12 110.958 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 64.8 m . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 109.944 -0.391 . . . . 40.15 109.944 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . 0.497 ' CG ' HG22 ' A' ' 421' ' ' ILE . 0.1 OUTLIER -84.55 176.64 8.49 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.507 1.129 . . . . 71.24 109.308 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -134.62 137.65 43.85 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.529 1.143 . . . . 72.24 109.567 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 2.1 mm -117.45 155.54 19.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.511 1.132 . . . . 64.4 109.276 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.09 137.54 53.5 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.459 1.1 . . . . 73.51 109.289 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 424' ' ' ASP . 23.5 t -96.81 140.23 17.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.521 1.138 . . . . 73.11 109.254 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 22.0 p -107.31 154.14 21.72 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.54 1.15 . . . . 72.11 110.404 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' GLN . . . . . 0.557 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 12.4 mt-30 -49.92 -44.21 50.16 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.517 1.136 . . . . 74.41 110.31 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -45.13 -38.13 4.92 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.455 1.097 . . . . 75.12 110.283 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -74.22 -59.41 2.74 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.444 1.09 . . . . 75.33 110.304 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . 0.4 ' O ' ' N ' ' A' ' 364' ' ' CYS . 8.8 t80 -43.48 -55.46 4.19 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.488 1.117 . . . . 73.41 111.035 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -55.33 -37.69 67.75 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.539 1.149 . . . . 70.2 110.325 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.472 HD22 ' HA ' ' A' ' 362' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.48 1.113 . . . . 70.31 109.309 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 360' ' ' TYR . 3.0 m . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 108.344 -0.984 . . . . 73.4 108.344 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -71.74 -20.61 61.87 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.486 1.116 . . . . 64.51 110.326 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -124.06 6.13 8.58 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.443 1.09 . . . . 52.22 110.993 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 45.27 52.91 8.21 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.47 1.106 . . . . 62.12 110.985 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 10.6 t -119.91 -174.83 2.84 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.522 0.778 . . . . 52.34 110.011 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 5.6 p -127.87 133.66 49.35 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.496 1.123 . . . . 74.32 110.42 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -64.33 -63.95 1.01 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.466 1.104 . . . . 65.2 110.997 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' GLN . . . . . 0.556 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -44.1 -26.85 0.33 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.564 1.165 . . . . 65.32 110.301 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.653 HD11 ' HA ' ' A' ' 377' ' ' ALA . 2.0 tm? -78.81 141.82 37.43 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.496 1.123 . . . . 72.01 109.279 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . 0.623 ' O ' HD13 ' A' ' 372' ' ' LEU . 15.1 t -75.63 150.99 37.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.967 -1.015 . . . . 72.44 110.89 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -110.9 23.7 13.84 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.534 1.146 . . . . 75.03 109.282 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 12.0 mt -108.12 -50.81 7.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 75.42 109.265 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' CYS . . . . . 1.011 ' SG ' ' CB ' ' A' ' 396' ' ' CYS . 1.6 m -107.52 -42.55 4.75 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.524 1.14 . . . . 75.55 108.283 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.653 ' HA ' HD11 ' A' ' 372' ' ' LEU . . . 72.09 47.43 0.3 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.533 1.146 . . . . 74.25 109.306 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -132.25 -66.56 0.69 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.517 1.136 . . . . 61.01 110.321 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -99.49 159.73 14.81 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.495 1.122 . . . . 64.3 109.304 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -73.14 152.05 41.31 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.506 1.129 . . . . 73.31 109.274 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.465 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 23.5 mttt -49.88 -62.51 1.52 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.476 1.11 . . . . 71.32 109.284 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . 0.406 ' HA ' ' O ' ' A' ' 421' ' ' ILE . 40.5 m-20 59.73 24.96 13.9 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.472 1.108 . . . . 75.14 109.253 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.93 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -156.08 172.83 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.462 1.101 . . . . 72.42 109.289 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.451 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 48.5 tttp -155.67 136.58 13.61 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.491 1.119 . . . . 71.35 109.293 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.72 HG21 ' SG ' ' A' ' 408' ' ' CYS . 15.2 mm -102.18 137.3 30.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.467 1.104 . . . . 73.24 109.317 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.521 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.0 OUTLIER -138.02 161.31 60.4 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.5 1.125 . . . . 71.25 110.298 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.521 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.97 -7.17 22.95 Favored 'Cis proline' 0 C--N 1.36 1.136 0 C-N-CA 120.982 -2.508 . . . . 74.12 111.034 -0.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . 0.54 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 50.7 t -36.8 -73.89 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.967 -1.015 . . . . 64.1 110.932 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.32 15.52 7.05 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.544 1.152 . . . . 72.4 110.987 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.54 ' CG ' ' SG ' ' A' ' 388' ' ' CYS . 68.3 m170 -86.7 126.07 34.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.538 0.787 . . . . 74.01 109.605 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.703 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -96.11 158.83 15.26 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.475 1.109 . . . . 62.23 109.272 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.93 ' O ' HG12 ' A' ' 383' ' ' VAL . 20.4 ptp -172.78 175.87 3.27 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 73.24 110.996 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . 0.818 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 2.3 p -99.64 114.75 28.02 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.478 1.111 . . . . 70.03 108.293 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 29.2 m -46.54 -24.81 0.58 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.492 1.12 . . . . 72.23 110.448 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.4 p -67.11 -42.49 84.43 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.102 . . . . 72.42 109.99 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . 1.011 ' CB ' ' SG ' ' A' ' 376' ' ' CYS . 76.1 m -80.74 -49.83 10.66 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.507 1.129 . . . . 64.41 108.279 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . 0.778 HD12 ' SD ' ' A' ' 392' ' ' MET . 2.7 tt -45.62 -48.3 14.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.116 . . . . 73.0 109.315 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.11 -34.77 61.09 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.533 1.145 . . . . 64.52 110.398 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -62.83 -27.11 69.1 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.436 1.085 . . . . 73.35 109.275 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' TRP . . . . . 0.52 ' CD2' ' HB3' ' A' ' 409' ' ' PRO . 3.7 t-105 -79.59 -53.15 7.13 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.518 1.136 . . . . 73.4 108.019 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.51 HE21 HD21 ' A' ' 397' ' ' LEU . 7.1 mm-40 -62.13 -10.02 9.2 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.49 1.119 . . . . 75.42 110.318 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 401' ' ' GLN . 5.3 mm-40 -37.08 -63.59 0.42 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.103 . . . . 73.44 110.293 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 18.2 t -121.54 -24.58 5.32 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.525 1.14 . . . . 73.22 110.015 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . 0.46 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 3.1 m-20 -83.88 -94.76 0.06 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.492 1.12 . . . . 70.21 109.281 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.498 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 73.93 32.59 58.65 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.504 1.128 . . . . 44.01 111.022 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -89.02 63.18 6.6 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.541 0.789 . . . . 75.35 110.304 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 68.52 -162.59 50.03 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.52 1.138 . . . . 64.12 110.978 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . 0.72 ' SG ' HG21 ' A' ' 385' ' ' ILE . 3.2 t -56.56 122.86 53.48 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.313 -0.995 . . . . 50.41 108.313 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.52 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.3 Cg_endo -74.98 -1.87 11.79 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.497 1.788 . . . . 61.24 111.017 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . 0.55 ' CD2' ' HE2' ' A' ' 392' ' ' MET . 2.6 m-85 -89.16 -41.3 12.34 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 73.0 111.031 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' A' ' 412' ' ' ARG . 0.7 OUTLIER -117.56 11.86 13.91 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.527 1.142 . . . . 44.11 108.3 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 411' ' ' CYS . 14.5 tpp85 38.53 46.14 0.94 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.517 1.136 . . . . 55.23 110.294 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 4.1 t -131.04 150.44 52.15 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.499 1.124 . . . . 61.1 108.297 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -58.07 152.76 15.99 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.489 1.118 . . . . 75.42 110.329 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.702 HD13 HD12 ' A' ' 385' ' ' ILE . 2.2 mt -107.2 154.81 8.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.457 1.098 . . . . 63.04 109.318 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -119.56 -41.44 2.7 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.478 1.111 . . . . 64.04 109.334 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . 0.477 ' C ' HG23 ' A' ' 418' ' ' THR . . . -119.0 127.73 7.35 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.506 1.129 . . . . 73.1 110.987 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . 0.559 ' CG2' HG21 ' A' ' 415' ' ' ILE . 42.2 p -154.26 125.09 7.15 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.526 0.78 . . . . 64.03 110.356 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -155.4 151.97 23.68 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.484 1.115 . . . . 73.33 110.287 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.451 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.3 Cg_endo -74.99 100.32 1.35 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.501 1.79 . . . . 63.42 111.014 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.75 HD12 ' N ' ' A' ' 422' ' ' ILE . 1.0 OUTLIER -107.18 171.09 2.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 124.512 1.132 . . . . 71.51 109.296 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . 0.75 ' N ' HD12 ' A' ' 421' ' ' ILE . 6.2 mm -121.22 109.92 26.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 73.13 109.3 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.701 HG22 HD11 ' A' ' 421' ' ' ILE . 2.5 t -75.86 140.38 17.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 74.03 109.317 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.742 ' O ' HG23 ' A' ' 355' ' ' VAL . 44.9 m-20 -130.19 143.79 50.57 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.516 1.135 . . . . 72.11 109.282 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 164.97 32.28 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.439 1.757 . . . . 72.31 111.02 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . 0.557 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 19.3 t80 . . . . . 0 C--N 1.324 -0.506 0 O-C-N 124.503 1.127 . . . . 74.4 111.028 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 67.0 m . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.983 -0.377 . . . . 64.02 109.983 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . 0.55 ' HB2' HG22 ' A' ' 421' ' ' ILE . 1.3 m-20 -77.12 -177.95 4.77 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.541 1.151 . . . . 63.45 109.324 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -137.41 125.94 23.59 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 73.32 109.586 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 2.2 mm -118.04 111.88 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.51 1.131 . . . . 64.24 109.262 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.31 149.84 28.76 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.459 1.099 . . . . 75.12 109.3 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 424' ' ' ASP . 13.1 t -96.19 136.54 26.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.534 1.146 . . . . 50.14 109.315 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 11.6 p -95.21 143.16 26.84 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.514 1.134 . . . . 64.11 110.425 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' GLN . . . . . 0.508 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 12.0 mt-30 -42.4 -43.4 3.56 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.156 . . . . 52.52 110.3 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -46.8 -50.14 18.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.469 1.106 . . . . 74.14 110.245 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 362' ' ' LEU . 9.9 mm100 -60.09 -66.79 0.46 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.523 1.139 . . . . 74.32 110.285 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -38.25 -39.23 0.41 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 74.15 110.985 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -70.91 -47.38 59.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.494 1.121 . . . . 71.11 110.253 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.791 ' O ' HD23 ' A' ' 362' ' ' LEU . 4.9 tt . . . . . 0 C--N 1.326 -0.453 0 O-C-N 124.456 1.098 . . . . 73.45 109.293 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 108.308 -0.997 . . . . 72.02 108.308 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -66.68 -18.72 65.52 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.462 1.102 . . . . 72.13 110.338 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -126.58 8.6 7.02 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 74.44 110.959 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 42.74 54.61 4.95 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.538 1.149 . . . . 63.13 111.007 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 62.2 m -121.25 179.0 4.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.523 0.778 . . . . 72.32 110.008 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 2.3 p -124.81 131.38 53.45 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.489 1.118 . . . . 62.21 110.44 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.533 ' CD2' HG11 ' A' ' 423' ' ' VAL . 34.9 t80 -60.7 -65.1 0.74 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.472 1.108 . . . . 73.33 111.025 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' GLN . . . . . 0.546 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -43.54 -26.93 0.25 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.522 1.138 . . . . 73.43 110.227 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.413 ' N ' ' C ' ' A' ' 370' ' ' PHE . 0.0 OUTLIER -71.65 123.28 22.17 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.505 1.128 . . . . 61.12 109.285 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 30.4 p -55.07 132.51 47.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.006 -0.997 . . . . 41.32 110.94 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.414 ' HZ1' ' HA ' ' A' ' 370' ' ' PHE . 29.8 mmtm -92.93 32.2 1.3 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.465 1.103 . . . . 72.13 109.284 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 5.5 mt -113.35 -60.46 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.543 1.152 . . . . 62.01 109.315 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' CYS . . . . . 0.823 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 0.9 OUTLIER -108.28 -20.87 12.99 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 75.34 108.294 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.407 ' HA ' HD22 ' A' ' 372' ' ' LEU . . . 55.3 41.12 31.55 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.503 1.127 . . . . 54.11 109.308 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -128.38 -44.71 1.39 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.436 1.085 . . . . 74.31 110.324 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -110.21 174.15 6.0 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 75.15 109.293 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -89.03 162.09 16.21 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.517 1.135 . . . . 70.34 109.323 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 392' ' ' MET . 21.9 mttt -65.21 -55.47 18.31 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.132 . . . . 70.23 109.292 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 381' ' ' LYS . 1.8 p30 50.62 25.58 2.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.462 1.101 . . . . 72.11 109.259 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.891 HG12 ' O ' ' A' ' 392' ' ' MET . 0.3 OUTLIER -154.08 174.76 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.478 1.111 . . . . 74.51 109.263 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 21.1 tttm -158.67 155.77 28.75 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.464 1.102 . . . . 74.31 109.326 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.864 HG22 ' SG ' ' A' ' 388' ' ' CYS . 11.6 mm -121.69 143.78 33.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 73.13 109.314 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.542 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 5.3 mt-10 -137.6 162.49 54.44 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.443 1.089 . . . . 74.14 110.287 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.542 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.99 -12.29 23.98 Favored 'Cis proline' 0 C--N 1.361 1.211 0 C-N-CA 120.977 -2.51 . . . . 73.33 111.017 -0.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . 0.864 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.48 -71.81 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.953 -1.021 . . . . 74.41 110.927 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 115.73 18.58 6.0 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.533 1.145 . . . . 74.4 111.028 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.584 ' CE1' ' HB2' ' A' ' 388' ' ' CYS . 20.6 m80 -76.56 145.52 38.96 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.524 0.779 . . . . 72.2 109.58 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.809 HD22 ' N ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -117.3 155.47 29.47 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.477 1.11 . . . . 55.01 109.273 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.891 ' O ' HG12 ' A' ' 383' ' ' VAL . 18.7 ptp -172.14 172.85 4.48 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 72.41 111.016 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 4.5 p -91.69 115.3 27.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.444 1.09 . . . . 73.44 108.295 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 397' ' ' LEU . 27.3 m -47.83 -57.54 5.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.514 1.134 . . . . 62.23 110.401 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.9 t -45.56 -26.11 0.55 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.534 1.146 . . . . 71.44 109.976 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . 0.823 ' SG ' ' SG ' ' A' ' 376' ' ' CYS . 2.2 m -88.01 -41.33 13.19 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.533 1.146 . . . . 54.44 108.288 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . 0.743 ' O ' HD23 ' A' ' 397' ' ' LEU . 3.4 tt -51.61 -45.79 63.35 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.458 1.098 . . . . 74.3 109.306 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.54 -35.91 61.23 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.551 1.157 . . . . 71.04 110.428 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -62.05 -27.87 69.19 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.467 1.105 . . . . 72.11 109.325 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' TRP . . . . . 0.579 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 5.1 t-105 -79.38 -52.42 8.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.026 -1.101 . . . . 74.25 108.026 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.514 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 10.0 mm-40 -62.99 -9.78 11.28 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 1.106 . . . . 65.45 110.291 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 401' ' ' GLN . 9.8 mm-40 -37.05 -63.78 0.4 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.44 1.088 . . . . 54.42 110.298 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 6.6 t -123.61 -24.8 4.46 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.481 1.113 . . . . 74.41 109.972 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . 0.579 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 0.9 OUTLIER -81.61 -90.18 0.07 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.456 1.098 . . . . 74.04 109.295 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.514 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 67.51 32.65 79.4 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.493 1.121 . . . . 70.32 111.037 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -91.74 66.93 5.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 0.772 . . . . 65.42 110.331 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 70.04 -161.21 53.16 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.497 1.123 . . . . 33.4 111.041 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . 0.688 ' SG ' HG21 ' A' ' 385' ' ' ILE . 7.1 t -62.45 130.68 93.52 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.314 -0.995 . . . . 64.12 108.314 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.94 -1.77 11.64 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.504 1.792 . . . . 61.45 111.003 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . 0.479 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 3.2 m-85 -95.63 -41.32 8.96 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.529 1.143 . . . . 72.34 110.982 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' CYS . . . . . 0.485 ' HG ' ' CE1' ' A' ' 390' ' ' HIS . 0.1 OUTLIER -111.08 8.59 21.86 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 75.23 108.277 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 408' ' ' CYS . 5.7 tpt85 38.39 30.71 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.488 1.117 . . . . 72.45 110.318 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' CYS . . . . . 0.441 ' N ' ' O ' ' A' ' 411' ' ' CYS . 42.1 t -127.77 151.1 49.44 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.512 1.133 . . . . 75.0 108.326 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -49.81 151.1 1.9 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.46 1.1 . . . . 75.15 110.292 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.699 HG21 ' CG2' ' A' ' 418' ' ' THR . 1.9 mt -99.38 150.43 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.484 1.115 . . . . 73.33 109.355 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.459 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 15.2 mmtt -110.51 -45.37 3.54 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.515 1.134 . . . . 64.42 109.299 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . 0.448 ' C ' HG23 ' A' ' 418' ' ' THR . . . -129.07 135.0 8.22 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.498 1.124 . . . . 53.24 110.987 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . 0.699 ' CG2' HG21 ' A' ' 415' ' ' ILE . 80.9 p -152.47 130.53 11.85 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.534 0.785 . . . . 73.44 110.421 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -158.26 153.36 21.6 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.534 1.146 . . . . 65.14 110.263 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.44 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.2 Cg_endo -75.01 102.64 1.61 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.498 1.788 . . . . 73.1 110.977 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.68 HD12 ' N ' ' A' ' 422' ' ' ILE . 1.0 OUTLIER -103.85 167.73 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.47 1.106 . . . . 73.55 109.304 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . 0.68 ' N ' HD12 ' A' ' 421' ' ' ILE . 6.0 mm -118.9 109.65 27.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.453 1.096 . . . . 75.42 109.277 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.664 HG22 HD11 ' A' ' 421' ' ' ILE . 23.7 t -79.74 144.35 10.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.495 1.122 . . . . 75.13 109.261 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.749 ' O ' HG23 ' A' ' 355' ' ' VAL . 4.1 m-20 -131.4 143.5 49.5 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.437 1.086 . . . . 71.44 109.299 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 160.47 40.09 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.467 1.772 . . . . 71.4 111.005 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . 0.508 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 3.3 t80 . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.494 1.121 . . . . 73.3 111.013 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 44.6 m . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 109.973 -0.381 . . . . 75.23 109.973 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . 0.551 ' HB2' HG22 ' A' ' 421' ' ' ILE . 13.3 m-20 -88.77 162.7 16.08 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.522 1.139 . . . . 71.1 109.295 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . 0.426 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 14.2 m-70 -126.18 138.64 53.67 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.488 1.117 . . . . 75.44 109.579 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 21.9 mt -121.72 137.1 56.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.47 1.106 . . . . 74.32 109.298 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -107.93 123.55 48.79 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.513 1.133 . . . . 71.42 109.345 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 424' ' ' ASP . 4.4 t -72.42 156.6 6.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.456 1.097 . . . . 72.03 109.29 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 359' ' ' GLN . 2.8 p -124.04 145.29 49.32 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.527 1.142 . . . . 62.05 110.414 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' GLN . . . . . 0.518 ' HG2' ' CE2' ' A' ' 426' ' ' PHE . 10.7 mt-30 -40.86 -46.75 2.81 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.47 1.106 . . . . 72.11 110.305 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -50.16 -45.07 53.03 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 1.139 . . . . 64.41 110.299 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 356' ' ' THR . 70.4 mt-30 -64.28 -66.55 0.53 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.521 1.138 . . . . 75.35 110.309 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . 0.421 ' O ' ' N ' ' A' ' 364' ' ' CYS . 2.4 t80 -41.47 -39.12 1.43 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.562 1.164 . . . . 73.42 110.987 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -66.67 -54.11 26.66 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.522 1.139 . . . . 72.31 110.278 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.8 tp . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.562 1.163 . . . . 72.54 109.281 179.98 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . 0.421 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 108.293 -1.002 . . . . 71.12 108.293 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.84 -2.73 44.78 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 64.22 110.28 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 8.1 mmt -105.88 -34.91 7.49 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.518 1.137 . . . . 72.3 111.026 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 100.79 16.88 24.98 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.461 1.101 . . . . 54.45 110.998 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 7.0 m -142.84 172.57 12.52 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.521 0.777 . . . . 54.23 110.019 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 11.6 p -98.9 -175.19 2.97 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.532 1.145 . . . . 55.13 110.411 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.533 ' CD2' HG11 ' A' ' 423' ' ' VAL . 27.6 t80 -83.55 -67.18 0.81 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.539 1.149 . . . . 70.01 111.02 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' GLN . . . . . 0.547 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -39.41 -29.76 0.05 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.499 1.125 . . . . 61.25 110.275 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.427 ' N ' ' C ' ' A' ' 370' ' ' PHE . 0.0 OUTLIER -69.97 115.43 9.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.508 1.13 . . . . 70.41 109.322 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 25.3 p -47.48 149.82 1.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.99 -1.005 . . . . 73.34 110.9 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -106.08 24.14 12.9 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 70.43 109.307 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . 0.499 HD11 ' HE1' ' A' ' 410' ' ' PHE . 14.6 mt -100.73 -61.13 2.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 72.1 109.271 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 26.9 p -107.92 -22.41 12.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 65.35 108.274 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 61.89 41.39 11.53 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.109 . . . . 71.24 109.294 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -134.64 -45.93 0.74 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.481 1.113 . . . . 75.33 110.249 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -101.41 168.28 9.62 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.538 1.149 . . . . 72.23 109.314 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.82 157.27 17.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.564 1.165 . . . . 72.14 109.296 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 392' ' ' MET . 0.7 OUTLIER -70.22 -62.1 1.52 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.442 1.089 . . . . 72.33 109.311 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 421' ' ' ILE . 1.3 p30 51.86 21.85 1.57 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.509 1.131 . . . . 74.45 109.306 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.869 HG12 ' O ' ' A' ' 392' ' ' MET . 0.3 OUTLIER -152.75 154.69 7.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.122 . . . . 72.3 109.24 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -141.73 153.72 44.81 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 65.33 109.292 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.887 HG22 ' SG ' ' A' ' 388' ' ' CYS . 22.8 mm -113.85 138.71 42.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.514 1.134 . . . . 72.0 109.275 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.571 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 1.8 mt-10 -129.73 163.32 47.76 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.472 1.108 . . . . 63.31 110.278 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.571 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.98 -18.56 18.59 Favored 'Cis proline' 0 C--N 1.36 1.158 0 C-N-CA 120.975 -2.51 . . . . 53.25 111.022 -0.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . 0.887 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -35.61 -91.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.991 -1.004 . . . . 64.03 110.899 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 136.22 44.24 0.1 OUTLIER Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.499 1.124 . . . . 73.21 110.995 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 19.6 m170 -104.37 114.12 28.14 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.461 0.742 . . . . 64.55 109.648 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 391' ' ' LEU . 5.9 mp -84.72 169.73 13.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.123 . . . . 73.45 109.311 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.869 ' O ' HG12 ' A' ' 383' ' ' VAL . 17.2 ptp -179.76 165.6 1.3 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.54 1.15 . . . . 65.14 111.01 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . 1.239 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 4.8 p -90.78 115.43 27.84 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.493 1.121 . . . . 64.5 108.301 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 20.7 m -38.72 -59.45 0.94 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.46 1.1 . . . . 53.44 110.4 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 6.7 m -42.24 -41.97 2.91 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.533 1.146 . . . . 72.1 109.983 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . 1.239 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 3.6 m -68.86 -56.68 7.17 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.463 1.102 . . . . 75.45 108.34 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . 0.716 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -40.95 -36.02 0.6 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.503 1.127 . . . . 73.13 109.283 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 22.7 m -62.61 -49.44 75.21 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 72.14 110.394 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -54.33 -22.45 12.15 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.475 1.109 . . . . 35.0 109.313 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' TRP . . . . . 0.606 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 11.8 t-105 -85.44 -64.9 1.08 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.483 1.115 . . . . 73.31 108.01 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.502 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 12.5 mm-40 -52.34 -17.5 1.19 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.478 1.111 . . . . 63.21 110.312 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 401' ' ' GLN . 7.5 mt-10 -37.02 -63.31 0.43 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.481 1.113 . . . . 74.32 110.332 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 10.3 t -121.65 -24.5 5.3 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.5 1.125 . . . . 63.15 110.006 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . 0.606 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 19.5 m-20 -82.34 -93.78 0.06 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.501 1.125 . . . . 75.45 109.293 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.502 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 68.1 27.63 73.63 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.477 1.11 . . . . 53.12 111.03 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -88.68 67.04 8.3 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.539 0.788 . . . . 64.3 110.263 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 67.87 -162.7 48.17 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.537 1.148 . . . . 73.0 110.993 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . 0.67 ' SG ' HG21 ' A' ' 385' ' ' ILE . 5.6 t -59.11 125.76 79.42 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 108.324 -0.991 . . . . 63.51 108.324 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.403 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.3 Cg_endo -74.97 -0.28 9.76 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.48 1.779 . . . . 62.04 111.012 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . 0.544 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 5.4 m-85 -95.85 -41.64 8.72 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.48 1.112 . . . . 70.33 110.996 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' CYS . . . . . 0.481 ' HG ' ' CE1' ' A' ' 390' ' ' HIS . 0.4 OUTLIER -112.8 10.43 19.16 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.525 1.14 . . . . 75.33 108.333 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 411' ' ' CYS . 27.5 mmm-85 38.5 31.75 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.448 1.092 . . . . 75.51 110.291 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' CYS . . . . . 0.42 ' N ' ' O ' ' A' ' 411' ' ' CYS . 10.5 t -125.09 146.36 49.49 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.419 1.074 . . . . 65.33 108.289 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -46.42 155.74 0.21 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.533 1.146 . . . . 75.4 110.351 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.705 HG23 HG23 ' A' ' 385' ' ' ILE . 2.3 mt -102.44 156.91 4.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.449 1.093 . . . . 75.43 109.313 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.409 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 10.3 mmtt -120.28 -43.48 2.52 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.471 1.107 . . . . 70.15 109.297 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 418' ' ' THR . . . -126.78 140.54 12.02 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.486 1.116 . . . . 63.02 111.001 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . 0.595 ' CG2' HG21 ' A' ' 415' ' ' ILE . 17.3 p -157.53 116.7 3.28 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.46 0.741 . . . . 61.44 110.407 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.423 ' OE1' ' N ' ' A' ' 419' ' ' GLU . 23.3 pm0 -139.82 150.5 62.97 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.537 1.148 . . . . 72.43 110.313 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.99 102.34 1.58 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.504 1.791 . . . . 73.41 111.005 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.845 HD12 ' N ' ' A' ' 422' ' ' ILE . 1.3 pp -103.85 -178.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.535 1.147 . . . . 65.51 109.258 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . 0.845 ' N ' HD12 ' A' ' 421' ' ' ILE . 15.2 mt -144.64 115.49 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 64.2 109.305 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.533 HG11 ' CD2' ' A' ' 370' ' ' PHE . 38.9 t -86.45 144.89 8.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.51 1.131 . . . . 73.5 109.326 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.642 ' O ' HG23 ' A' ' 355' ' ' VAL . 5.1 t70 -131.31 143.64 50.14 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.456 1.098 . . . . 74.12 109.345 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . 0.415 ' CD ' ' OE1' ' A' ' 371' ' ' GLN . 18.2 Cg_endo -75.04 170.67 19.91 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.475 1.776 . . . . 61.11 110.963 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . 0.518 ' CE2' ' HG2' ' A' ' 357' ' ' GLN . 6.5 t80 . . . . . 0 C--N 1.325 -0.468 0 O-C-N 124.503 1.127 . . . . 72.22 111.013 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 110.061 -0.348 . . . . 61.12 110.061 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -96.59 179.63 4.93 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.5 1.125 . . . . 73.32 109.292 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . 0.489 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 29.1 m-70 -134.2 135.44 43.03 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.48 1.113 . . . . 54.45 109.587 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . 0.504 HG13 HD13 ' A' ' 421' ' ' ILE . 11.2 mt -116.21 149.14 18.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 75.24 109.262 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.79 137.29 52.84 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 71.22 109.326 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.487 HG22 ' CD2' ' A' ' 370' ' ' PHE . 5.0 t -89.03 141.62 14.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.472 1.107 . . . . 75.12 109.31 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.414 ' OG1' ' CG ' ' A' ' 359' ' ' GLN . 16.6 p -91.55 135.98 33.46 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.486 1.117 . . . . 70.31 110.371 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' GLN . . . . . 0.696 ' CG ' ' CE1' ' A' ' 426' ' ' PHE . 4.4 mt-30 -41.13 -33.15 0.32 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.523 1.139 . . . . 75.11 110.311 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . 0.449 ' CG ' ' N ' ' A' ' 359' ' ' GLN . 13.5 pt-20 -63.56 -50.41 69.59 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.515 1.134 . . . . 72.1 110.324 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . 0.449 ' N ' ' CG ' ' A' ' 358' ' ' GLU . 9.4 mm100 -56.57 -66.72 0.39 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.453 1.096 . . . . 72.21 110.329 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 364' ' ' CYS . 10.1 t80 -38.37 -51.94 1.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.522 1.139 . . . . 73.41 110.961 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -58.28 -60.96 2.95 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.493 1.121 . . . . 65.44 110.275 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 6.0 mt . . . . . 0 C--N 1.324 -0.514 0 O-C-N 124.514 1.134 . . . . 72.34 109.271 179.99 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . 0.404 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.5 m . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 108.275 -1.009 . . . . 72.31 108.275 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -73.54 -3.74 29.66 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.511 1.132 . . . . 74.11 110.297 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 8.0 mmt -114.38 -33.5 5.59 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.527 1.142 . . . . 63.35 110.995 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.14 35.52 3.14 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.499 1.125 . . . . 62.03 110.994 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 24.0 m -148.76 161.16 42.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 0.771 . . . . 74.42 109.965 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.4 ' OG1' ' CB ' ' A' ' 372' ' ' LEU . 11.5 p -96.48 178.93 5.18 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.506 1.129 . . . . 64.24 110.364 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.487 ' CD2' HG22 ' A' ' 355' ' ' VAL . 50.1 t80 -85.03 -58.91 2.5 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 70.34 110.992 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' GLN . . . . . 0.449 ' CB ' ' HB ' ' A' ' 423' ' ' VAL . 0.1 OUTLIER -54.66 -19.37 5.99 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.49 1.119 . . . . 70.33 110.254 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.797 HD22 ' N ' ' A' ' 373' ' ' CYS . 1.2 tm? -73.15 135.5 44.69 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.503 1.127 . . . . 71.21 109.307 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . 0.797 ' N ' HD22 ' A' ' 372' ' ' LEU . 7.6 t -72.2 132.37 44.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.987 -1.006 . . . . 72.51 110.901 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.439 ' NZ ' ' O ' ' A' ' 372' ' ' LEU . 12.5 mmtm -90.19 17.12 7.41 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.51 1.131 . . . . 52.45 109.289 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . 0.888 HD11 ' CE1' ' A' ' 410' ' ' PHE . 83.0 mt -102.45 -41.62 7.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.505 1.128 . . . . 71.25 109.328 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' CYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 377' ' ' ALA . 0.0 OUTLIER -115.6 -44.49 2.96 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.534 1.146 . . . . 64.31 108.317 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.762 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 70.23 37.96 1.54 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.477 1.111 . . . . 63.03 109.299 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -131.63 -44.48 0.99 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.483 1.114 . . . . 72.44 110.311 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -107.38 172.79 6.63 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.453 1.096 . . . . 42.25 109.34 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -95.52 147.58 23.4 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.512 1.132 . . . . 73.31 109.274 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.465 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 27.4 mttt -55.41 -62.53 1.62 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 72.33 109.3 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 57.89 28.25 15.81 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 63.43 109.284 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.897 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -158.38 175.83 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.515 1.134 . . . . 61.5 109.293 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.456 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 72.6 tttt -157.83 149.34 21.62 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.502 1.126 . . . . 65.41 109.314 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.691 HG13 ' HE3' ' A' ' 392' ' ' MET . 2.6 mm -114.13 138.16 44.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.115 . . . . 75.34 109.328 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.513 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.2 OUTLIER -138.04 160.86 62.68 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.544 1.153 . . . . 74.34 110.303 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.513 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.98 -8.91 23.79 Favored 'Cis proline' 0 C--N 1.36 1.163 0 C-N-CA 120.979 -2.509 . . . . 72.11 111.012 -0.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . 0.539 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 17.5 t -36.84 -75.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.956 -1.02 . . . . 62.11 110.912 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 120.62 7.41 8.9 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.532 1.145 . . . . 72.21 111.015 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.539 ' CG ' ' SG ' ' A' ' 388' ' ' CYS . 56.6 m170 -77.0 131.78 38.63 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.524 0.779 . . . . 74.21 109.612 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.615 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -102.48 168.09 9.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.447 1.092 . . . . 72.15 109.317 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.897 ' O ' HG12 ' A' ' 383' ' ' VAL . 17.3 ptp -179.25 173.84 1.09 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.51 1.131 . . . . 74.42 111.006 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . 0.418 ' O ' ' N ' ' A' ' 396' ' ' CYS . 1.7 p -102.66 117.69 35.21 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 63.45 108.281 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 397' ' ' LEU . 2.5 m -38.7 -60.11 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.484 1.115 . . . . 70.53 110.441 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.8 m -39.3 -41.64 0.93 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.505 1.128 . . . . 44.15 110.042 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . 0.495 ' SG ' HG21 ' A' ' 375' ' ' ILE . 38.3 t -73.9 -49.85 22.94 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.471 1.107 . . . . 44.12 108.284 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . 0.436 ' CD1' ' HG3' ' A' ' 401' ' ' GLN . 1.5 tm? -42.61 -51.03 5.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.469 1.106 . . . . 73.01 109.328 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 402' ' ' GLU . 1.2 m -53.89 -42.05 68.25 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.509 1.131 . . . . 52.43 110.411 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -57.98 -26.59 62.53 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.505 1.128 . . . . 63.22 109.276 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' TRP . . . . . 0.601 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 10.5 t-105 -85.42 -62.58 1.5 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.52 1.137 . . . . 72.35 108.023 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.501 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 8.3 mm-40 -55.94 -14.37 2.46 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 1.122 . . . . 72.54 110.284 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 398' ' ' THR . 2.9 mm-40 -37.12 -63.36 0.44 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 71.13 110.32 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 22.7 t -121.4 -24.59 5.38 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.508 1.13 . . . . 42.42 109.995 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . 0.601 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 6.9 m-20 -82.51 -94.05 0.06 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.475 1.109 . . . . 53.31 109.326 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.501 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 72.42 31.04 63.73 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.475 1.109 . . . . 50.22 110.993 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -88.65 54.13 2.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 0.765 . . . . 74.4 110.272 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 72.02 -163.88 54.39 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.541 1.151 . . . . 33.11 111.024 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . 0.455 ' O ' ' N ' ' A' ' 412' ' ' ARG . 3.7 t -56.05 121.3 40.23 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.31 -0.996 . . . . 63.44 108.31 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 0.69 8.62 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.492 1.785 . . . . 71.31 110.998 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . 0.888 ' CE1' HD11 ' A' ' 375' ' ' ILE . 24.3 m-85 -90.24 -36.34 14.79 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.518 1.136 . . . . 72.2 111.046 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.13 13.69 6.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 73.4 108.31 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 408' ' ' CYS . 14.8 tpp85 38.61 48.82 1.34 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.541 1.151 . . . . 73.02 110.347 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 1.2 m -125.89 150.92 47.55 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.468 1.105 . . . . 51.43 108.281 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 415' ' ' ILE . 5.1 tt0 -59.29 147.62 35.15 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.486 1.117 . . . . 71.01 110.271 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.605 HG21 HG21 ' A' ' 418' ' ' THR . 1.2 mt -89.04 149.11 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.484 1.115 . . . . 62.02 109.283 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.74 -49.82 2.63 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 74.22 109.324 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -140.58 131.89 5.2 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 124.498 1.124 . . . . 74.13 110.993 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . 0.605 HG21 HG21 ' A' ' 415' ' ' ILE . 1.5 p -147.56 117.89 7.38 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.571 0.807 . . . . 64.12 110.434 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.433 ' O ' HG23 ' A' ' 421' ' ' ILE . 20.5 pt-20 -128.08 150.83 74.85 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.459 1.099 . . . . 70.21 110.309 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 98.51 1.17 Allowed 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.467 1.772 . . . . 65.41 110.994 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.817 HD11 HG22 ' A' ' 423' ' ' VAL . 0.7 OUTLIER -107.45 154.88 8.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.5 1.125 . . . . 71.23 109.292 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . 0.489 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 4.0 mp -110.67 105.39 18.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.502 1.126 . . . . 74.33 109.306 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.817 HG22 HD11 ' A' ' 421' ' ' ILE . 38.9 t -77.1 145.62 9.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.488 1.118 . . . . 74.5 109.294 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.445 ' O ' HG23 ' A' ' 355' ' ' VAL . 4.5 m-20 -130.54 143.53 49.67 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.491 1.119 . . . . 75.53 109.283 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 161.63 38.46 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.516 1.798 . . . . 62.4 110.997 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . 0.696 ' CE1' ' CG ' ' A' ' 357' ' ' GLN . 3.5 t80 . . . . . 0 C--N 1.326 -0.453 0 O-C-N 124.509 1.131 . . . . 73.14 111.004 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 109.964 -0.384 . . . . 70.02 109.964 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -99.67 169.24 9.41 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.511 1.132 . . . . 63.22 109.259 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . 0.506 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 38.4 m-70 -136.3 125.15 24.05 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 72.22 109.629 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . 0.552 HG13 HD13 ' A' ' 421' ' ' ILE . 7.7 mt -105.47 149.76 8.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.521 1.138 . . . . 64.34 109.322 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 13.0 tptp -123.27 123.32 40.49 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.458 1.099 . . . . 73.33 109.3 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 424' ' ' ASP . 55.2 t -79.71 148.87 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.487 1.117 . . . . 74.01 109.298 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 40.2 p -114.2 -178.47 3.38 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.493 1.121 . . . . 74.35 110.385 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -72.81 -36.7 67.59 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 54.34 110.336 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -54.94 -35.33 64.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.537 1.148 . . . . 75.23 110.322 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -79.6 -66.73 0.83 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 1.135 . . . . 75.15 110.306 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 364' ' ' CYS . 12.3 t80 -38.2 -43.23 0.75 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.499 1.124 . . . . 64.01 111.004 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -61.48 -54.15 47.17 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.464 1.103 . . . . 75.35 110.266 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.4 tt . . . . . 0 C--N 1.325 -0.466 0 O-C-N 124.485 1.116 . . . . 70.13 109.267 -179.952 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 360' ' ' TYR . 3.3 m . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 108.255 -1.017 . . . . 61.33 108.255 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -71.79 -16.09 62.17 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.535 1.147 . . . . 64.41 110.29 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.94 2.6 6.59 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.461 1.101 . . . . 74.14 110.973 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 50.79 58.69 8.92 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.522 1.139 . . . . 72.34 111.019 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 84.5 p -129.36 177.99 6.78 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 0.757 . . . . 54.35 109.969 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.413 ' HB ' ' NE2' ' A' ' 371' ' ' GLN . 2.3 p -126.03 142.11 51.67 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.479 1.112 . . . . 64.01 110.388 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.615 ' CZ ' ' CD1' ' A' ' 391' ' ' LEU . 54.1 t80 -66.22 -67.96 0.41 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.485 1.116 . . . . 73.33 111.056 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' GLN . . . . . 0.535 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -41.32 -31.8 0.26 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.453 1.096 . . . . 70.3 110.295 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.921 HD22 ' N ' ' A' ' 373' ' ' CYS . 0.5 OUTLIER -67.07 136.39 55.13 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.436 1.085 . . . . 64.42 109.293 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . 0.921 ' N ' HD22 ' A' ' 372' ' ' LEU . 19.3 p -72.17 129.61 38.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.004 -0.998 . . . . 70.02 110.925 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -90.99 18.35 6.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.453 1.096 . . . . 73.1 109.334 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . 0.696 HD11 ' HE1' ' A' ' 410' ' ' PHE . 12.1 mt -92.13 -60.45 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.485 1.116 . . . . 73.14 109.282 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 23.9 p -107.68 -24.04 11.88 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.472 1.108 . . . . 63.21 108.284 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.489 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 60.93 43.24 11.91 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.462 1.102 . . . . 45.1 109.315 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -127.75 -43.65 1.54 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.522 1.139 . . . . 73.24 110.307 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 39.0 m-20 -119.7 177.7 4.85 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.452 1.095 . . . . 74.13 109.349 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -88.3 169.41 11.86 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 73.51 109.303 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.426 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 24.5 mttt -70.55 -62.07 1.53 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.499 1.124 . . . . 63.12 109.312 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 59.92 25.05 14.17 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 63.23 109.301 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.842 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -160.8 155.34 3.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 54.23 109.293 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.854 ' HE3' HD21 ' A' ' 391' ' ' LEU . 4.1 ttmt -139.29 137.32 35.75 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.516 1.135 . . . . 65.51 109.274 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.718 HG23 ' CG2' ' A' ' 415' ' ' ILE . 20.2 mm -97.99 139.57 19.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.523 1.139 . . . . 74.25 109.284 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.524 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.0 OUTLIER -138.0 161.39 60.0 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.46 1.1 . . . . 72.04 110.28 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.524 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.0 -8.94 23.86 Favored 'Cis proline' 0 C--N 1.36 1.147 0 C-N-CA 121.021 -2.491 . . . . 74.24 111.017 -0.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . 0.544 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 31.3 t -36.55 -72.89 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.951 -1.022 . . . . 70.14 110.926 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 115.58 18.28 6.19 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.485 1.115 . . . . 75.01 111.004 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.544 ' CG ' ' SG ' ' A' ' 388' ' ' CYS . 61.7 m170 -87.77 129.3 35.22 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.518 0.775 . . . . 65.13 109.546 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.854 HD21 ' HE3' ' A' ' 384' ' ' LYS . 0.8 OUTLIER -96.1 160.31 14.51 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.459 1.099 . . . . 72.11 109.262 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.842 ' O ' HG12 ' A' ' 383' ' ' VAL . 15.5 ptp -170.52 173.44 5.53 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.477 1.111 . . . . 73.33 111.019 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . 1.131 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 5.0 p -99.15 115.0 28.04 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.483 1.115 . . . . 74.52 108.333 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 17.4 m -42.0 -59.7 1.65 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.496 1.123 . . . . 75.31 110.425 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 10.6 t -41.62 -36.58 0.97 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.478 1.111 . . . . 63.35 109.985 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . 1.131 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 2.3 m -75.88 -54.93 6.14 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.467 1.105 . . . . 60.23 108.281 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . 0.734 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.3 OUTLIER -41.34 -35.19 0.61 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.128 . . . . 75.21 109.28 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' THR . . . . . 0.414 ' N ' HD13 ' A' ' 397' ' ' LEU . 83.2 m -62.05 -49.76 74.7 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.512 1.133 . . . . 53.24 110.431 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -55.16 -22.16 16.13 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.473 1.108 . . . . 72.43 109.349 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' TRP . . . . . 0.602 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 16.3 t-105 -84.6 -65.16 1.04 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.516 1.135 . . . . 64.45 108.048 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.51 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 38.3 mm-40 -49.18 -20.81 0.65 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.544 1.152 . . . . 51.2 110.304 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 401' ' ' GLN . 10.4 mt-10 -37.47 -63.53 0.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.479 1.112 . . . . 75.44 110.345 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 3.3 m -122.41 -24.22 5.05 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.497 1.123 . . . . 71.13 109.97 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . 0.602 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 16.9 m-20 -83.54 -95.17 0.06 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.51 1.131 . . . . 74.44 109.253 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.51 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 67.92 23.22 74.29 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.479 1.112 . . . . 61.22 111.01 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -81.51 58.11 3.56 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.556 0.797 . . . . 75.23 110.326 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 69.95 -160.74 53.18 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.503 1.127 . . . . 70.45 111.023 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . 0.616 ' SG ' HG21 ' A' ' 385' ' ' ILE . 4.7 t -56.3 120.3 34.23 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.267 -1.012 . . . . 64.54 108.267 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.412 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.2 Cg_endo -74.95 0.43 8.89 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.454 1.765 . . . . 74.33 110.978 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . 0.696 ' HE1' HD11 ' A' ' 375' ' ' ILE . 3.6 m-30 -93.8 -37.23 11.88 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.485 1.116 . . . . 74.03 111.0 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -123.26 13.49 9.61 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.49 1.119 . . . . 64.45 108.321 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 408' ' ' CYS . 11.4 mmt85 38.43 40.45 0.37 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 74.54 110.285 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 16.0 t -126.66 140.1 52.66 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.49 1.119 . . . . 73.43 108.301 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -45.32 154.25 0.18 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.467 1.104 . . . . 54.33 110.228 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.718 ' CG2' HG23 ' A' ' 385' ' ' ILE . 2.7 mt -109.8 157.19 10.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.48 1.113 . . . . 61.43 109.327 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -129.9 -46.6 1.14 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.492 1.12 . . . . 73.52 109.259 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . 0.555 ' O ' HG23 ' A' ' 418' ' ' THR . . . -107.22 127.14 8.68 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.53 1.144 . . . . 45.14 110.964 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 417' ' ' GLY . 17.5 p -157.47 128.65 6.73 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 0.76 . . . . 71.54 110.395 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.644 ' OE2' HG22 ' A' ' 421' ' ' ILE . 0.0 OUTLIER -160.02 166.39 15.96 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.466 1.104 . . . . 73.11 110.283 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 101.85 1.52 Allowed 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.541 1.811 . . . . 71.3 110.984 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.913 HD12 ' N ' ' A' ' 422' ' ' ILE . 0.6 OUTLIER -103.89 170.18 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.146 . . . . 73.44 109.313 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . 0.913 ' N ' HD12 ' A' ' 421' ' ' ILE . 5.9 mt -137.8 107.63 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.448 1.093 . . . . 71.32 109.284 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.652 ' CG2' HD11 ' A' ' 421' ' ' ILE . 30.7 t -78.16 147.42 7.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.436 1.085 . . . . 70.34 109.264 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.678 ' O ' HG23 ' A' ' 355' ' ' VAL . 5.9 m-20 -129.68 143.72 50.09 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.478 1.112 . . . . 61.12 109.292 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 173.42 14.55 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.489 1.784 . . . . 74.4 111.007 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 15.5 t80 . . . . . 0 C--N 1.324 -0.503 0 O-C-N 124.556 1.16 . . . . 74.22 111.023 179.994 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 64.5 m . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 110.007 -0.368 . . . . 61.23 110.007 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . 0.485 ' CG ' HG22 ' A' ' 421' ' ' ILE . 0.3 OUTLIER -79.91 168.41 19.27 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.502 1.126 . . . . 63.13 109.312 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . 0.519 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 26.3 m-70 -132.94 135.85 45.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 64.2 109.578 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 3.3 mm -113.78 153.34 15.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.545 1.153 . . . . 62.03 109.308 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.413 ' CD ' ' O ' ' A' ' 355' ' ' VAL . 0.8 OUTLIER -114.31 136.24 53.19 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.471 1.107 . . . . 74.33 109.298 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 424' ' ' ASP . 5.7 t -98.77 163.74 2.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.539 1.149 . . . . 43.13 109.342 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.494 ' N ' ' CG1' ' A' ' 355' ' ' VAL . 2.4 p -125.63 179.68 5.04 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.536 1.147 . . . . 64.53 110.438 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' GLN . . . . . 0.564 ' HG3' ' CZ ' ' A' ' 426' ' ' PHE . 13.0 mt-30 -75.38 -37.54 60.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.545 1.153 . . . . 71.31 110.281 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -60.88 -31.19 70.66 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.502 1.126 . . . . 65.31 110.305 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . 0.438 ' NE2' ' OG1' ' A' ' 356' ' ' THR . 62.3 mt-30 -74.2 -66.92 0.66 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.5 1.125 . . . . 72.12 110.293 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -47.07 -34.95 6.33 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.531 1.144 . . . . 63.15 111.031 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -73.53 -57.54 3.93 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.439 1.087 . . . . 73.22 110.273 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.669 ' O ' HD23 ' A' ' 362' ' ' LEU . 7.0 tt . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.555 1.159 . . . . 72.12 109.28 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 108.268 -1.012 . . . . 54.03 108.268 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -75.56 -3.93 37.01 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.5 1.125 . . . . 70.32 110.293 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 19.4 mtm -111.38 -33.91 6.27 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.504 1.127 . . . . 72.1 110.98 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 99.66 13.97 36.2 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.485 1.116 . . . . 73.43 111.028 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 66.1 m -120.86 -176.43 3.25 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.505 0.767 . . . . 75.31 109.99 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.813 HG22 ' NE2' ' A' ' 371' ' ' GLN . 1.9 m -115.81 161.54 18.6 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.463 1.102 . . . . 62.04 110.4 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.489 ' CD2' HG22 ' A' ' 355' ' ' VAL . 89.1 t80 -64.39 -68.76 0.33 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.138 . . . . 74.5 110.981 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' GLN . . . . . 0.813 ' NE2' HG22 ' A' ' 369' ' ' THR . 0.1 OUTLIER -46.69 -34.1 4.83 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.52 1.138 . . . . 71.24 110.268 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.709 HD13 ' O ' ' A' ' 373' ' ' CYS . 2.3 tm? -60.49 141.13 56.86 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 75.3 109.332 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . 0.709 ' O ' HD13 ' A' ' 372' ' ' LEU . 24.0 p -72.13 159.95 33.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.03 -0.986 . . . . 74.12 110.882 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -117.17 28.54 8.43 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.523 1.14 . . . . 71.12 109.314 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . 0.614 HD11 ' HE1' ' A' ' 410' ' ' PHE . 11.5 mt -112.72 -59.64 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.453 1.096 . . . . 63.24 109.329 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 2.0 m -105.05 -14.85 15.27 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.484 1.115 . . . . 51.11 108.334 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.59 ' HA ' HD11 ' A' ' 372' ' ' LEU . . . 52.14 44.98 29.16 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.505 1.128 . . . . 73.1 109.311 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -131.6 -61.93 0.88 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 70.15 110.298 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -95.18 162.88 13.52 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 70.23 109.313 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -85.42 167.89 15.1 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.514 1.134 . . . . 73.34 109.305 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.515 ' HZ3' HD13 ' A' ' 391' ' ' LEU . 0.7 OUTLIER -70.17 -61.05 1.93 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.117 . . . . 73.32 109.282 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . 0.406 ' CG ' ' C ' ' A' ' 381' ' ' LYS . 0.2 OUTLIER 47.51 25.04 0.57 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 72.45 109.278 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.864 HG12 ' O ' ' A' ' 392' ' ' MET . 0.3 OUTLIER -150.91 170.17 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.528 1.143 . . . . 72.32 109.274 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 22.9 tttm -155.29 147.03 23.23 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.454 1.096 . . . . 73.54 109.274 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.823 HD12 HD13 ' A' ' 415' ' ' ILE . 20.6 mm -108.97 135.06 48.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.504 1.127 . . . . 72.43 109.29 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.515 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.8 mt-10 -137.76 161.11 62.01 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.448 1.093 . . . . 74.1 110.326 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.515 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.99 -5.63 21.6 Favored 'Cis proline' 0 C--N 1.36 1.155 0 C-N-CA 120.985 -2.506 . . . . 61.4 110.979 0.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . 0.541 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 17.6 t -37.99 -78.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.008 -0.996 . . . . 55.02 110.892 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 119.23 36.46 0.86 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.485 1.115 . . . . 71.13 110.965 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.541 ' CG ' ' SG ' ' A' ' 388' ' ' CYS . 63.3 m170 -108.5 129.73 55.28 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.52 0.777 . . . . 55.31 109.543 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.515 HD13 ' HZ3' ' A' ' 381' ' ' LYS . 0.8 OUTLIER -98.66 160.41 14.29 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.471 1.107 . . . . 72.4 109.307 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.864 ' O ' HG12 ' A' ' 383' ' ' VAL . 20.5 ptp -177.99 170.9 1.82 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.544 1.152 . . . . 62.34 110.999 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 5.0 p -89.83 114.78 26.58 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.463 1.102 . . . . 64.34 108.296 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 397' ' ' LEU . 3.4 m -46.98 -55.53 7.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.48 1.113 . . . . 73.21 110.447 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 71.5 m -46.41 -29.29 1.64 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 61.02 110.047 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 399' ' ' ALA . 1.9 m -86.19 -37.92 18.2 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.565 1.166 . . . . 71.12 108.266 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . 0.74 ' O ' HD23 ' A' ' 397' ' ' LEU . 3.0 tt -53.88 -47.05 71.46 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.534 1.146 . . . . 63.44 109.338 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.09 -35.28 61.93 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 1.114 . . . . 73.13 110.409 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -63.01 -26.49 68.88 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.515 1.135 . . . . 64.1 109.305 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' TRP . . . . . 0.492 ' CD2' ' HB3' ' A' ' 409' ' ' PRO . 3.7 t-105 -80.85 -52.87 7.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.97 -1.122 . . . . 74.44 107.97 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.509 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.2 mm-40 -61.74 -10.28 8.41 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.512 1.132 . . . . 65.03 110.339 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 401' ' ' GLN . 37.7 mt-10 -37.23 -63.7 0.42 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.531 1.145 . . . . 65.44 110.287 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.8 m -123.12 -24.88 4.62 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.487 1.117 . . . . 73.34 109.985 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . 0.491 ' OD2' ' CH2' ' A' ' 400' ' ' TRP . 0.6 OUTLIER -81.71 -90.9 0.07 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.486 1.116 . . . . 65.22 109.283 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.509 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 69.41 32.51 71.79 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.461 1.101 . . . . 54.4 111.02 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -91.11 64.85 5.4 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.503 0.766 . . . . 74.2 110.295 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 66.07 -156.41 49.96 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.528 1.143 . . . . 74.01 111.006 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . 0.754 ' SG ' HG21 ' A' ' 385' ' ' ILE . 5.4 t -57.39 127.22 76.78 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 108.267 -1.012 . . . . 71.32 108.267 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.617 ' HD2' ' HE1' ' A' ' 392' ' ' MET . 18.3 Cg_endo -75.04 0.33 9.05 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.506 1.793 . . . . 75.31 110.99 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . 0.614 ' HE1' HD11 ' A' ' 375' ' ' ILE . 3.3 m-85 -93.59 -39.49 10.8 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.54 1.15 . . . . 74.01 110.991 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.5 OUTLIER -119.8 12.47 12.14 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.505 1.128 . . . . 72.43 108.254 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' ARG . . . . . 0.442 ' HD2' ' CH2' ' A' ' 400' ' ' TRP . 37.4 mmm-85 38.5 31.73 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.509 1.131 . . . . 72.51 110.274 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' CYS . . . . . 0.422 ' N ' ' O ' ' A' ' 411' ' ' CYS . 42.8 t -114.74 151.12 34.24 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.513 1.133 . . . . 75.32 108.255 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -55.16 149.1 12.93 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.516 1.135 . . . . 74.02 110.335 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.823 HD13 HD12 ' A' ' 385' ' ' ILE . 4.0 mt -107.24 157.2 7.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.546 1.154 . . . . 73.14 109.294 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -126.64 -46.78 1.57 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.48 1.113 . . . . 72.14 109.275 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 418' ' ' THR . . . -107.32 127.08 8.64 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.535 1.147 . . . . 42.44 110.97 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 417' ' ' GLY . 17.1 p -157.57 117.79 3.44 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.48 0.753 . . . . 75.33 110.413 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -143.6 150.59 51.27 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.521 1.138 . . . . 73.14 110.273 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.49 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.3 Cg_endo -75.06 102.47 1.59 Allowed 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.475 1.776 . . . . 74.21 110.972 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.673 HD12 ' N ' ' A' ' 422' ' ' ILE . 1.2 pp -103.88 172.05 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.466 1.104 . . . . 71.43 109.267 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . 0.673 ' N ' HD12 ' A' ' 421' ' ' ILE . 19.5 mm -130.83 115.14 29.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.512 1.133 . . . . 72.24 109.266 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.418 ' CG2' HD11 ' A' ' 421' ' ' ILE . 18.9 t -84.68 141.67 14.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.488 1.118 . . . . 74.13 109.326 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.577 ' O ' HG23 ' A' ' 355' ' ' VAL . 1.0 OUTLIER -128.61 143.44 48.43 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.506 1.129 . . . . 74.23 109.327 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.04 174.44 12.79 Favored 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.5 1.789 . . . . 73.2 110.974 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . 0.564 ' CZ ' ' HG3' ' A' ' 357' ' ' GLN . 10.1 t80 . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.489 1.118 . . . . 73.03 111.037 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.979 -0.378 . . . . 73.41 109.979 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -93.48 -178.88 4.87 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 1.12 . . . . 65.23 109.306 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . 0.531 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 30.8 m-70 -139.31 145.96 39.74 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.469 1.105 . . . . 61.44 109.58 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 96.5 mt -133.71 142.6 41.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.528 1.142 . . . . 71.12 109.33 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.84 148.2 29.87 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.503 1.127 . . . . 65.0 109.258 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 424' ' ' ASP . 51.8 t -112.99 164.18 9.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.499 1.124 . . . . 63.01 109.331 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.464 ' N ' HG12 ' A' ' 355' ' ' VAL . 2.5 p -124.17 171.92 9.45 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.51 1.131 . . . . 71.23 110.441 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' GLN . . . . . 0.545 ' HG3' ' CZ ' ' A' ' 426' ' ' PHE . 5.4 mt-30 -66.32 -35.88 81.51 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.514 1.134 . . . . 71.05 110.28 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -55.94 -47.62 77.23 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.51 1.131 . . . . 74.24 110.351 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -59.48 -58.67 7.57 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.477 1.11 . . . . 65.04 110.305 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . 0.438 ' O ' ' N ' ' A' ' 364' ' ' CYS . 13.1 t80 -55.0 -33.12 62.31 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.486 1.116 . . . . 71.33 110.992 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -60.73 -47.71 85.09 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.466 1.104 . . . . 62.52 110.247 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.427 ' N ' ' CD1' ' A' ' 362' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.325 -0.461 0 O-C-N 124.493 1.12 . . . . 41.44 109.309 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 108.287 -1.005 . . . . 73.02 108.287 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -77.64 -4.65 47.09 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.485 1.115 . . . . 73.43 110.312 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 19.8 ptp -116.44 -32.24 5.32 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.47 1.106 . . . . 74.21 110.978 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.62 40.37 3.65 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.566 1.166 . . . . 43.42 111.01 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 68.5 m -145.1 171.84 13.93 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.539 0.788 . . . . 61.11 109.987 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.807 HG22 ' NE2' ' A' ' 371' ' ' GLN . 1.8 m -115.07 162.71 16.64 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.547 1.155 . . . . 43.22 110.37 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -66.46 -68.53 0.37 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 63.12 111.004 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' GLN . . . . . 0.807 ' NE2' HG22 ' A' ' 369' ' ' THR . 0.2 OUTLIER -46.05 -26.82 0.8 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.493 1.121 . . . . 74.23 110.29 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.939 HD22 ' N ' ' A' ' 373' ' ' CYS . 0.4 OUTLIER -71.18 135.74 47.73 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.501 1.126 . . . . 70.15 109.298 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . 0.939 ' N ' HD22 ' A' ' 372' ' ' LEU . 12.3 p -67.19 134.23 51.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.018 -0.992 . . . . 62.15 110.928 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -92.41 34.5 1.05 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.565 1.166 . . . . 74.52 109.312 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 49.8 mt -112.6 -60.35 2.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.545 1.153 . . . . 71.43 109.292 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -109.04 -18.31 13.69 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.484 1.115 . . . . 63.22 108.298 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.761 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 52.57 52.86 13.25 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.485 1.116 . . . . 63.32 109.328 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -135.19 -49.41 0.73 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.504 1.128 . . . . 75.42 110.326 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -111.89 165.36 12.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.531 1.144 . . . . 75.43 109.305 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -79.89 163.01 24.68 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 63.32 109.28 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.462 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 22.5 mttt -70.13 -62.6 1.32 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.475 1.109 . . . . 73.01 109.286 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 26.5 t0 60.25 23.74 13.14 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.541 1.151 . . . . 73.42 109.291 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.916 HG12 ' O ' ' A' ' 392' ' ' MET . 0.4 OUTLIER -153.4 176.12 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.463 1.102 . . . . 45.41 109.312 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -157.91 154.66 28.25 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.475 1.109 . . . . 71.11 109.296 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.804 HG22 ' SG ' ' A' ' 388' ' ' CYS . 11.6 mm -122.04 142.48 38.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.455 1.097 . . . . 73.14 109.321 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.557 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.1 mt-10 -136.9 162.91 53.1 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.467 1.104 . . . . 64.5 110.29 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.557 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.02 -13.47 23.65 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 120.97 -2.513 . . . . 70.24 110.999 -0.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . 0.804 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.12 -71.53 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.978 -1.01 . . . . 52.25 110.911 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.97 16.38 6.28 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.497 1.123 . . . . 74.32 110.985 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.568 ' CE1' ' HB2' ' A' ' 388' ' ' CYS . 20.9 m80 -73.48 145.16 45.87 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 0.763 . . . . 53.43 109.568 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.814 HD22 ' N ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -117.37 156.57 27.66 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.126 . . . . 75.34 109.345 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.916 ' O ' HG12 ' A' ' 383' ' ' VAL . 12.3 ptp -173.9 173.93 3.14 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.512 1.133 . . . . 73.3 110.999 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . 1.127 ' SG ' ' CB ' ' A' ' 396' ' ' CYS . 5.3 p -91.39 137.45 32.35 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.446 1.091 . . . . 63.23 108.286 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 98.4 m -65.81 -31.54 72.56 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.466 1.104 . . . . 53.21 110.386 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 60.9 m -72.46 -58.2 3.57 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.523 1.139 . . . . 75.04 109.99 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . 1.127 ' CB ' ' SG ' ' A' ' 393' ' ' CYS . 1.9 p -55.87 -42.84 76.49 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.508 1.13 . . . . 54.41 108.285 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . 0.74 HD22 ' O ' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -45.12 -44.02 10.22 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.519 1.137 . . . . 72.11 109.311 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 402' ' ' GLU . 86.2 m -54.61 -38.47 66.83 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.527 1.142 . . . . 71.2 110.414 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -55.35 -26.91 43.8 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.46 1.1 . . . . 74.15 109.299 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' TRP . . . . . 0.602 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 8.1 t-105 -85.0 -60.91 1.9 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.985 -1.117 . . . . 72.12 107.985 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.496 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 7.3 mm-40 -56.69 -13.75 2.72 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.482 1.114 . . . . 74.22 110.265 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 398' ' ' THR . 3.6 mm-40 -37.14 -63.41 0.43 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.506 1.129 . . . . 70.44 110.303 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 5.2 t -121.23 -24.62 5.44 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.567 1.167 . . . . 73.52 109.938 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . 0.602 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 17.1 m-20 -82.87 -94.54 0.06 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.457 1.098 . . . . 73.1 109.296 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.496 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 73.17 29.72 64.07 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.46 1.1 . . . . 62.44 110.97 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -88.07 66.09 8.44 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.513 0.773 . . . . 73.24 110.308 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 68.45 -160.03 51.6 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.479 1.112 . . . . 63.23 111.018 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . 0.696 ' SG ' HG21 ' A' ' 385' ' ' ILE . 7.5 t -59.98 131.79 89.44 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 108.282 -1.007 . . . . 74.02 108.282 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -0.07 9.53 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.547 1.814 . . . . 53.33 110.988 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . 0.566 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 8.4 m-85 -95.11 -43.02 8.3 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 72.32 111.002 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' CYS . . . . . 0.445 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.5 OUTLIER -111.67 9.18 20.98 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.518 1.136 . . . . 73.25 108.285 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' ARG . . . . . . . . . . . . . 39.8 mmm-85 38.58 30.24 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.478 1.111 . . . . 70.33 110.253 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' CYS . . . . . 0.445 ' N ' ' O ' ' A' ' 411' ' ' CYS . 24.2 t -127.46 146.15 50.59 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.463 1.102 . . . . 75.02 108.287 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -42.58 152.13 0.1 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 72.44 110.296 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.731 HG23 HG23 ' A' ' 385' ' ' ILE . 2.1 mt -98.86 148.67 5.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.493 1.121 . . . . 64.14 109.303 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -112.29 -48.42 3.03 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.504 1.128 . . . . 74.43 109.331 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . 0.45 ' C ' HG23 ' A' ' 418' ' ' THR . . . -116.51 129.04 8.23 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.489 1.118 . . . . 61.33 110.979 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . 0.604 ' CG2' HG21 ' A' ' 415' ' ' ILE . 82.0 p -152.82 138.95 18.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.492 0.76 . . . . 71.14 110.386 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.41 ' O ' HG23 ' A' ' 421' ' ' ILE . 1.1 pm0 -167.14 150.84 6.26 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.499 1.124 . . . . 74.33 110.309 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 101.08 1.43 Allowed 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.451 1.764 . . . . 74.02 110.977 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.732 HD11 HG22 ' A' ' 423' ' ' VAL . 0.6 OUTLIER -105.32 157.55 6.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 72.43 109.303 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . 0.672 ' N ' HD12 ' A' ' 421' ' ' ILE . 13.2 mt -114.82 105.39 18.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.529 1.143 . . . . 71.21 109.3 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.732 HG22 HD11 ' A' ' 421' ' ' ILE . 42.5 t -75.18 146.8 8.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.447 1.092 . . . . 75.13 109.267 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.7 ' O ' HG23 ' A' ' 355' ' ' VAL . 1.1 m-20 -128.73 133.59 25.36 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.462 1.101 . . . . 62.2 109.297 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . 0.491 ' CD ' ' OE1' ' A' ' 371' ' ' GLN . 18.2 Cg_endo -74.96 169.71 22.03 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.513 1.796 . . . . 74.52 110.961 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . 0.545 ' CZ ' ' HG3' ' A' ' 357' ' ' GLN . 5.1 t80 . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.449 1.093 . . . . 72.11 111.012 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 70.5 m . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 109.997 -0.371 . . . . 65.03 109.997 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -83.59 178.39 8.01 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.511 1.132 . . . . 73.11 109.327 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . 0.537 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 37.6 m-70 -141.97 134.73 28.52 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.534 1.146 . . . . 63.25 109.609 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 23.4 mt -124.86 158.7 32.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.529 1.143 . . . . 60.11 109.302 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 355' ' ' VAL . 0.3 OUTLIER -124.12 150.51 44.99 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.492 1.12 . . . . 72.42 109.312 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 424' ' ' ASP . 70.3 t -109.09 146.96 14.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.539 1.149 . . . . 62.31 109.293 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 58.1 p -117.96 -173.16 2.39 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.464 1.103 . . . . 75.2 110.369 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' GLN . . . . . 0.4 ' HG2' ' CE1' ' A' ' 426' ' ' PHE . 4.6 mm100 -77.52 -35.04 53.81 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.508 1.13 . . . . 74.11 110.285 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . 0.764 ' O ' HD12 ' A' ' 362' ' ' LEU . 4.7 pt-20 -60.27 -31.4 70.19 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.102 . . . . 73.53 110.281 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . 0.421 ' OE1' ' CE2' ' A' ' 370' ' ' PHE . 73.3 mt-30 -77.34 -63.42 1.38 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.46 1.1 . . . . 74.41 110.287 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -39.07 -42.87 0.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.518 1.136 . . . . 74.13 111.036 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -61.2 -53.87 51.49 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.482 1.114 . . . . 72.43 110.28 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.764 HD12 ' O ' ' A' ' 358' ' ' GLU . 3.7 mt . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.125 . . . . 64.14 109.33 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 108.318 -0.993 . . . . 64.31 108.318 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.21 -65.82 0.5 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.487 1.117 . . . . 73.24 110.301 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 23.2 ptp -55.23 -34.2 63.77 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.425 1.078 . . . . 74.25 110.975 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 88.92 50.01 3.41 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.488 1.118 . . . . 54.53 110.988 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' SER . . . . . 0.505 ' HB3' HD12 ' A' ' 372' ' ' LEU . 3.6 m -145.58 179.39 7.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.508 0.77 . . . . 60.42 109.963 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.775 HG22 ' NE2' ' A' ' 371' ' ' GLN . 2.0 m -118.42 161.11 20.52 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.508 1.13 . . . . 71.2 110.383 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.426 ' HD1' HG11 ' A' ' 423' ' ' VAL . 2.7 t80 -59.31 -64.51 0.92 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.507 1.129 . . . . 74.54 111.028 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' GLN . . . . . 0.775 ' NE2' HG22 ' A' ' 369' ' ' THR . 0.2 OUTLIER -60.7 -29.52 69.38 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.488 1.117 . . . . 61.12 110.325 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.791 HD22 ' N ' ' A' ' 373' ' ' CYS . 1.2 tm? -60.93 135.61 57.84 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 74.32 109.337 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . 0.791 ' N ' HD22 ' A' ' 372' ' ' LEU . 32.1 p -77.9 136.01 37.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.02 -0.991 . . . . 72.14 110.884 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.536 ' N ' ' CD ' ' A' ' 374' ' ' LYS . 0.2 OUTLIER -92.66 26.45 2.68 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.514 1.134 . . . . 62.4 109.306 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 7.0 mt -107.79 -56.67 4.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.495 1.122 . . . . 70.31 109.268 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 14.2 m -108.28 -21.73 12.64 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.513 1.133 . . . . 41.5 108.354 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.627 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 57.71 38.01 27.41 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.511 1.132 . . . . 74.43 109.298 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -129.57 -43.92 1.24 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.448 1.093 . . . . 64.5 110.274 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -108.81 -172.96 2.16 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 72.24 109.287 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.15 175.47 6.28 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.528 1.142 . . . . 74.1 109.332 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.663 ' HZ2' HD12 ' A' ' 391' ' ' LEU . 16.8 mttt -78.59 -50.79 10.92 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 64.41 109.301 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . 0.406 ' CG ' ' C ' ' A' ' 381' ' ' LYS . 0.1 OUTLIER 47.65 26.61 0.88 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.473 1.108 . . . . 71.14 109.261 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.886 HG12 ' O ' ' A' ' 392' ' ' MET . 0.3 OUTLIER -156.13 176.1 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.481 1.113 . . . . 62.51 109.274 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -160.52 157.33 27.29 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.522 1.139 . . . . 72.24 109.29 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.864 HG22 ' SG ' ' A' ' 388' ' ' CYS . 11.6 mm -123.82 143.76 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.542 1.152 . . . . 64.5 109.301 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.54 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 7.0 mt-10 -137.72 162.39 54.82 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.575 1.172 . . . . 74.25 110.282 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.54 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.95 -12.49 23.85 Favored 'Cis proline' 0 C--N 1.36 1.163 0 C-N-CA 120.981 -2.508 . . . . 44.15 111.026 -0.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . 0.864 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.41 -71.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.983 -1.008 . . . . 75.23 110.914 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.49 15.9 6.77 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.441 1.088 . . . . 51.44 110.946 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.567 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 21.4 m80 -73.07 148.0 44.46 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.522 0.777 . . . . 73.11 109.591 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.663 HD12 ' HZ2' ' A' ' 381' ' ' LYS . 1.3 mt -119.47 158.14 26.85 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.518 1.136 . . . . 73.1 109.302 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.886 ' O ' HG12 ' A' ' 383' ' ' VAL . 12.6 ptp -174.41 172.18 3.23 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.524 1.14 . . . . 74.02 111.016 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . 1.064 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 7.2 p -89.69 118.07 29.03 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.497 1.123 . . . . 71.2 108.275 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 73.4 m -52.51 -45.13 66.13 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.529 1.143 . . . . 74.03 110.374 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 37.2 m -55.69 -29.51 59.51 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.468 1.105 . . . . 62.31 109.971 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . 1.064 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 2.5 m -81.15 -47.51 13.37 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.452 1.095 . . . . 62.54 108.25 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . 0.719 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.5 OUTLIER -41.49 -36.09 0.82 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 74.34 109.327 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' THR . . . . . 0.486 ' CG2' ' N ' ' A' ' 399' ' ' ALA . 0.5 OUTLIER -61.17 -52.54 64.41 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.43 1.081 . . . . 75.14 110.38 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 398' ' ' THR . . . -51.44 -23.23 3.68 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.543 1.152 . . . . 71.32 109.285 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' TRP . . . . . 0.607 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 8.9 t-105 -84.44 -64.91 1.08 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.534 1.146 . . . . 74.1 108.034 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.494 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.7 mm-40 -52.34 -17.37 1.14 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.487 1.117 . . . . 74.1 110.316 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 401' ' ' GLN . 7.0 mm-40 -37.18 -63.41 0.43 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 74.2 110.29 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.6 m -120.39 -24.56 5.84 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.515 1.134 . . . . 50.3 110.006 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . 0.607 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 8.2 m-20 -82.25 -94.92 0.05 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 64.52 109.327 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.494 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 70.5 28.73 70.69 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.475 1.11 . . . . 44.43 111.036 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -90.17 68.19 7.02 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.465 0.744 . . . . 72.21 110.297 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 65.34 -163.81 38.32 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.517 1.136 . . . . 73.41 111.01 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . 0.699 ' SG ' HG21 ' A' ' 385' ' ' ILE . 6.3 t -58.21 129.27 82.98 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 108.363 -0.977 . . . . 71.44 108.363 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 -3.57 14.12 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.489 1.784 . . . . 75.3 111.042 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . 0.567 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 4.5 m-85 -92.91 -41.48 10.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.119 . . . . 72.34 111.01 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' CYS . . . . . 0.493 ' HG ' ' CE1' ' A' ' 390' ' ' HIS . 0.1 OUTLIER -111.01 9.02 22.14 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.123 . . . . 71.03 108.285 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 408' ' ' CYS . 9.1 mmt85 38.56 30.23 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.555 1.159 . . . . 73.51 110.333 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' CYS . . . . . 0.442 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.3 m -125.55 163.01 23.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.531 1.144 . . . . 72.33 108.289 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -59.02 146.99 36.3 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.435 1.085 . . . . 75.42 110.275 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.638 HG23 HG23 ' A' ' 385' ' ' ILE . 1.4 mt -93.06 153.41 3.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.477 1.111 . . . . 62.31 109.278 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.11 -46.33 3.01 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.526 1.141 . . . . 63.51 109.258 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . 0.554 ' O ' HG23 ' A' ' 418' ' ' THR . . . -131.11 144.73 16.28 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.501 1.125 . . . . 23.35 110.985 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . 0.618 ' CG2' HG21 ' A' ' 415' ' ' ILE . 17.6 p -157.59 116.26 3.2 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.512 0.772 . . . . 75.3 110.428 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -136.32 149.21 67.13 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.509 1.131 . . . . 71.03 110.314 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.491 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.3 Cg_endo -74.97 102.46 1.59 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.492 1.785 . . . . 73.24 111.0 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.799 HD11 HG22 ' A' ' 423' ' ' VAL . 0.6 OUTLIER -103.83 158.9 5.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.46 1.1 . . . . 75.33 109.244 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . 0.696 ' N ' HD12 ' A' ' 421' ' ' ILE . 11.2 mt -118.61 105.39 17.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.482 1.114 . . . . 73.54 109.311 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.799 HG22 HD11 ' A' ' 421' ' ' ILE . 21.5 t -76.78 149.25 6.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.502 1.127 . . . . 64.0 109.293 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.865 ' O ' HG23 ' A' ' 355' ' ' VAL . 9.2 m-20 -127.64 143.33 47.1 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.494 1.121 . . . . 73.24 109.32 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 179.25 6.26 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.488 1.783 . . . . 63.33 111.032 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . 0.4 ' CE1' ' HG2' ' A' ' 357' ' ' GLN . 10.5 t80 . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.499 1.125 . . . . 74.14 111.011 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 29.6 p . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 110.03 -0.359 . . . . 74.41 110.03 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.14 175.08 10.97 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.501 1.126 . . . . 75.22 109.347 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -136.6 138.86 41.65 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 70.13 109.582 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 52.7 mt -121.73 158.75 24.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.525 1.141 . . . . 72.33 109.323 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -123.2 139.61 53.87 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.476 1.11 . . . . 62.2 109.269 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 424' ' ' ASP . 24.6 t -99.49 144.23 12.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.494 1.121 . . . . 71.42 109.318 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.9 p -110.19 153.02 25.35 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.505 1.128 . . . . 64.1 110.386 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' GLN . . . . . 0.464 ' HG3' ' CE1' ' A' ' 426' ' ' PHE . 24.7 mt-30 -43.35 -52.04 6.08 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.481 1.113 . . . . 74.21 110.284 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -43.85 -49.83 8.11 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 72.1 110.297 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . 0.485 ' OE1' ' CD1' ' A' ' 370' ' ' PHE . 18.2 mt-30 -59.62 -32.8 70.76 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.49 1.119 . . . . 74.4 110.274 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . 0.443 ' O ' ' N ' ' A' ' 364' ' ' CYS . 3.7 t80 -71.02 -62.07 1.53 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.537 1.148 . . . . 74.21 111.016 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -53.67 -53.69 48.38 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.535 1.147 . . . . 74.43 110.28 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.508 1.13 . . . . 72.14 109.244 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 108.319 -0.993 . . . . 75.52 108.319 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -73.96 -13.64 60.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.462 1.101 . . . . 73.42 110.286 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 12.0 ptp -121.49 -0.98 9.66 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.493 1.12 . . . . 70.33 111.02 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 57.0 43.79 93.07 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.434 1.084 . . . . 65.41 110.966 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 3.6 p -132.85 173.96 10.83 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.438 0.728 . . . . 74.22 109.967 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.764 HG22 HE21 ' A' ' 371' ' ' GLN . 2.2 m -116.94 161.57 19.15 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.484 1.115 . . . . 74.03 110.383 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.564 ' CD2' HG22 ' A' ' 355' ' ' VAL . 78.2 t80 -64.02 -68.63 0.33 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.519 1.137 . . . . 72.23 110.982 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' GLN . . . . . 0.764 HE21 HG22 ' A' ' 369' ' ' THR . 0.0 OUTLIER -44.31 -35.82 2.5 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.541 1.15 . . . . 73.34 110.31 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.747 HD13 ' N ' ' A' ' 373' ' ' CYS . 1.8 tm? -50.93 140.85 14.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.484 1.115 . . . . 75.34 109.247 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . 0.747 ' N ' HD13 ' A' ' 372' ' ' LEU . 19.7 p -85.42 147.08 26.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.97 -1.014 . . . . 63.44 110.913 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.557 ' N ' ' CD ' ' A' ' 374' ' ' LYS . 0.7 OUTLIER -99.54 17.44 20.41 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 63.12 109.29 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 5.9 mt -94.5 -61.69 2.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.458 1.099 . . . . 70.02 109.3 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' CYS . . . . . 0.656 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 2.6 m -102.67 -24.65 13.74 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.532 1.145 . . . . 72.22 108.273 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.682 ' HA ' HD11 ' A' ' 372' ' ' LEU . . . 63.04 46.42 4.73 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.478 1.111 . . . . 74.3 109.323 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -139.53 -49.58 0.49 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.548 1.155 . . . . 74.3 110.279 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . 0.429 ' O ' HD22 ' A' ' 372' ' ' LEU . 4.3 m-20 -104.91 174.35 5.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 72.33 109.333 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -85.86 173.18 10.19 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.542 1.151 . . . . 72.2 109.292 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 392' ' ' MET . 15.3 mttt -79.33 -54.86 5.53 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.515 1.134 . . . . 72.32 109.265 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . 0.401 ' OD2' ' O ' ' A' ' 381' ' ' LYS . 1.2 p30 51.87 26.78 3.8 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.478 1.111 . . . . 73.15 109.267 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' VAL . . . . . 0.914 HG12 ' O ' ' A' ' 392' ' ' MET . 0.4 OUTLIER -156.03 175.4 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.116 . . . . 54.42 109.35 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.417 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 62.5 tttt -158.53 151.81 22.87 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.503 1.127 . . . . 61.44 109.293 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.822 HG21 ' SG ' ' A' ' 408' ' ' CYS . 24.7 mm -115.28 133.59 61.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.126 . . . . 72.03 109.337 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.522 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 5.9 mt-10 -137.67 161.11 62.13 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.534 1.146 . . . . 73.12 110.286 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.522 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.4 Cg_endo -75.01 -5.2 21.25 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 121.034 -2.486 . . . . 73.23 111.004 -0.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 32.6 t -37.99 -78.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.0 -1.0 . . . . 71.51 110.946 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 119.53 36.51 0.84 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.483 1.114 . . . . 50.24 111.002 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.551 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 51.0 m170 -108.5 131.9 54.36 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.491 0.759 . . . . 73.3 109.581 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.71 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -99.87 158.55 15.72 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.486 1.116 . . . . 72.13 109.303 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' MET . . . . . 0.914 ' O ' HG12 ' A' ' 383' ' ' VAL . 17.1 ptp -172.6 174.42 3.74 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.473 1.108 . . . . 73.45 111.04 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' CYS . . . . . 1.176 ' SG ' ' SG ' ' A' ' 396' ' ' CYS . 28.1 p -97.53 115.55 28.06 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.469 1.106 . . . . 72.53 108.296 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 3.8 m -44.61 -58.99 2.69 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 75.33 110.364 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 29.6 m -41.11 -36.59 0.73 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.527 1.142 . . . . 62.24 109.989 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . 1.176 ' SG ' ' SG ' ' A' ' 393' ' ' CYS . 2.5 m -76.76 -50.42 13.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.477 1.11 . . . . 51.4 108.257 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . 0.695 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.3 OUTLIER -43.0 -35.69 1.32 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.492 1.12 . . . . 74.21 109.282 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 53.4 m -63.01 -45.31 92.98 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.481 1.113 . . . . 63.24 110.447 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -57.65 -21.72 41.43 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.451 1.094 . . . . 63.0 109.309 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' TRP . . . . . 0.588 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 14.7 t-105 -86.09 -65.21 1.04 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.496 1.123 . . . . 73.34 107.98 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.503 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 40.1 mm-40 -48.83 -20.96 0.55 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.479 1.112 . . . . 73.04 110.288 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 401' ' ' GLN . 7.3 mt-10 -37.64 -63.65 0.44 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.538 1.149 . . . . 74.52 110.276 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 23.0 t -122.41 -24.45 5.0 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.477 1.111 . . . . 74.44 109.98 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . 0.588 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 3.0 m-20 -82.85 -94.42 0.06 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.512 1.133 . . . . 75.41 109.311 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.503 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 67.29 21.37 72.1 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.435 1.084 . . . . 53.44 110.965 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -81.0 62.46 4.99 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 0.767 . . . . 62.1 110.287 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 68.15 -163.46 48.2 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.536 1.147 . . . . 70.11 111.002 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' CYS . . . . . 0.822 ' SG ' HG21 ' A' ' 385' ' ' ILE . 2.3 t -56.12 121.45 41.56 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.303 -0.999 . . . . 73.24 108.303 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.447 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.3 Cg_endo -75.03 0.65 8.67 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.53 1.805 . . . . 73.25 110.965 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . 0.551 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 2.7 m-85 -92.49 -37.99 12.21 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 74.3 111.047 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' CYS . . . . . 0.435 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.8 OUTLIER -126.02 17.13 7.89 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.475 1.109 . . . . 73.12 108.335 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 408' ' ' CYS . 47.5 mmm-85 38.43 30.99 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.526 1.141 . . . . 73.01 110.302 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 411' ' ' CYS . 15.2 t -115.35 139.15 50.24 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 63.04 108.302 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -45.8 158.97 0.08 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.443 1.09 . . . . 64.24 110.344 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.741 HG23 HG23 ' A' ' 385' ' ' ILE . 2.2 mt -114.45 157.24 15.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.448 1.093 . . . . 74.21 109.309 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -128.98 -47.79 1.23 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.514 1.134 . . . . 63.41 109.295 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . 0.553 ' O ' HG23 ' A' ' 418' ' ' THR . . . -108.76 127.9 8.8 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.541 1.15 . . . . 60.1 111.031 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 417' ' ' GLY . 17.5 p -157.51 116.74 3.29 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.502 0.766 . . . . 75.53 110.357 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -140.61 151.29 63.08 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.115 . . . . 71.54 110.296 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.2 Cg_endo -75.05 101.64 1.5 Allowed 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.485 1.781 . . . . 71.22 110.979 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.803 HD11 HG22 ' A' ' 423' ' ' VAL . 0.7 OUTLIER -105.71 167.58 3.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.441 1.088 . . . . 74.31 109.335 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . 0.782 ' N ' HD12 ' A' ' 421' ' ' ILE . 12.7 mt -126.52 106.32 15.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.505 1.128 . . . . 72.0 109.293 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.803 HG22 HD11 ' A' ' 421' ' ' ILE . 15.4 t -78.89 145.74 9.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.479 1.112 . . . . 60.32 109.284 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.66 ' O ' HG23 ' A' ' 355' ' ' VAL . 73.0 m-20 -128.38 143.68 49.1 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 64.55 109.302 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . 0.438 ' N ' ' OE1' ' A' ' 371' ' ' GLN . 18.1 Cg_endo -75.01 175.65 10.97 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.559 1.82 . . . . 75.14 110.999 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' PHE . . . . . 0.464 ' CE1' ' HG3' ' A' ' 357' ' ' GLN . 39.8 t80 . . . . . 0 C--N 1.324 -0.507 0 O-C-N 124.505 1.128 . . . . 75.32 111.015 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.999 0 N-CA-C 111.012 -0.835 . . . . 32.51 111.012 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 177.87 7.99 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.497 1.788 . . . . 44.11 111.002 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 7.0 m80 70.77 47.33 0.46 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.48 1.113 . . . . 72.42 109.631 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -46.07 -75.34 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 74.52 111.039 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -57.6 178.47 1.1 Allowed Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.526 1.141 . . . . 71.44 110.984 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 29.0 t -91.46 135.25 33.98 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.472 0.748 . . . . 65.14 110.016 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . 0.727 ' HB2' HG22 ' A' ' 421' ' ' ILE . 10.8 m-20 -78.54 174.45 11.34 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.429 1.081 . . . . 72.13 109.266 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . 0.459 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 28.2 m-70 -131.43 126.46 35.17 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.478 1.111 . . . . 64.23 109.597 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.475 HD11 ' HD2' ' A' ' 384' ' ' LYS . 9.0 mt -111.34 149.16 14.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.481 1.113 . . . . 44.52 109.302 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 32.1 tptt -112.77 133.25 54.86 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.468 1.105 . . . . 72.03 109.353 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 424' ' ' ASP . 40.0 t -87.75 149.53 4.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 71.53 109.33 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 5.9 p -114.15 149.19 36.02 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 72.04 110.413 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' GLN . . . . . 0.556 ' CG ' ' CE1' ' A' ' 426' ' ' PHE . 27.6 mt-30 -50.15 -34.33 21.99 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.479 1.112 . . . . 72.32 110.344 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -56.34 -52.53 64.2 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.497 1.123 . . . . 74.44 110.294 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . 0.463 ' OE1' HG13 ' A' ' 355' ' ' VAL . 35.3 mt-30 -55.8 -67.18 0.31 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.521 1.138 . . . . 64.53 110.329 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 364' ' ' CYS . 1.2 t80 -44.25 -45.77 8.71 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.473 1.108 . . . . 72.53 111.021 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -61.61 -42.67 99.2 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.499 1.124 . . . . 72.13 110.314 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 7.8 mt -61.12 -49.4 77.43 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.472 1.107 . . . . 50.02 109.257 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' PTR . . . . . 0.569 ' HE2' ' HZ3' ' A' ' 374' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.6 m -64.9 -36.48 84.5 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.488 1.117 . . . . 61.45 108.345 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -68.67 -7.79 36.55 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.476 1.11 . . . . 75.15 110.316 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 7.4 mmt -106.2 -35.01 7.33 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.501 1.126 . . . . 74.35 111.015 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 90.55 46.97 3.87 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.54 1.15 . . . . 72.13 110.977 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 8.3 t -142.95 -174.63 4.23 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.489 0.758 . . . . 72.53 109.978 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.437 ' O ' ' NZ ' ' A' ' 374' ' ' LYS . 2.0 p -126.47 140.89 52.12 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.492 1.12 . . . . 44.13 110.422 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.445 ' O ' ' N ' ' A' ' 372' ' ' LEU . 76.0 t80 -56.18 -70.96 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.522 1.139 . . . . 74.43 111.027 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.552 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -38.52 -30.44 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 63.22 110.27 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 370' ' ' PHE . 0.0 OUTLIER -71.46 122.78 21.02 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.506 1.129 . . . . 72.14 109.327 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 14.8 p -59.13 134.8 57.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.035 -0.984 . . . . 61.14 110.919 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.569 ' HZ3' ' HE2' ' A' ' 363' ' ' PTR . 23.0 mmtm -97.31 32.35 2.24 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.47 1.106 . . . . 71.35 109.33 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 2.7 mt -113.42 -59.62 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.116 . . . . 74.31 109.29 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 20.7 p -108.27 -13.92 14.8 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 64.4 108.293 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 47.66 41.83 14.28 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.482 1.114 . . . . 75.12 109.32 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -122.92 -41.02 2.37 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.128 . . . . 71.1 110.28 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.58 170.75 11.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.512 1.133 . . . . 74.32 109.313 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -76.72 175.47 9.35 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 74.24 109.33 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.455 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 21.9 mttt -73.78 -62.38 1.51 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.486 1.116 . . . . 64.1 109.314 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 59.91 25.93 15.12 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.478 1.112 . . . . 64.11 109.315 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.909 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -158.01 171.8 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.502 1.127 . . . . 64.24 109.292 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.475 ' HD2' HD11 ' A' ' 353' ' ' ILE . 40.4 tttp -155.21 142.05 19.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.47 1.106 . . . . 71.15 109.303 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.84 HD12 HD13 ' A' ' 415' ' ' ILE . 21.7 mm -105.22 133.93 48.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.479 1.112 . . . . 71.13 109.297 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.511 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.1 mt-10 -137.84 161.19 61.39 Favored Pre-proline 0 C--N 1.324 -0.532 0 O-C-N 124.531 1.144 . . . . 72.43 110.293 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.511 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.02 -5.82 21.88 Favored 'Cis proline' 0 C--N 1.361 1.197 0 C-N-CA 120.982 -2.507 . . . . 75.11 111.035 0.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . 0.432 ' SG ' ' ND1' ' A' ' 390' ' ' HIS . 43.1 t -37.43 -76.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.017 -0.992 . . . . 73.41 110.905 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 118.22 34.79 1.08 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.499 1.124 . . . . 64.42 111.018 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.432 ' ND1' ' SG ' ' A' ' 388' ' ' CYS . 46.1 m170 -105.79 130.82 53.7 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.529 0.782 . . . . 72.21 109.569 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.697 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -101.06 156.73 17.24 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 74.22 109.257 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.909 ' O ' HG12 ' A' ' 383' ' ' VAL . 19.8 ptp -173.64 176.19 2.79 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.517 1.136 . . . . 60.35 110.98 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 7.3 p -94.04 114.93 27.19 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.508 1.13 . . . . 64.41 108.276 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 397' ' ' LEU . 94.6 m -48.43 -56.6 7.79 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.539 1.149 . . . . 54.44 110.422 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.5 t -45.82 -25.96 0.6 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 74.32 109.944 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . 0.576 ' O ' ' HB3' ' A' ' 399' ' ' ALA . 1.8 m -87.63 -42.53 12.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.478 1.111 . . . . 64.24 108.322 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.619 HD13 ' C ' ' A' ' 397' ' ' LEU . 1.0 OUTLIER -48.0 -54.55 12.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 71.22 109.31 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . 0.552 ' N ' HD13 ' A' ' 397' ' ' LEU . 61.6 m -45.63 -36.48 4.84 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.465 1.103 . . . . 70.32 110.438 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -63.06 -39.61 95.22 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.513 1.133 . . . . 55.44 109.272 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' TRP . . . . . 0.507 ' CD2' ' HB3' ' A' ' 409' ' ' PRO . 2.1 t-105 -69.2 -52.61 26.11 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.496 1.123 . . . . 74.02 108.01 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -62.68 -16.3 56.52 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.546 1.154 . . . . 70.53 110.339 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -86.78 -11.4 51.1 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.448 1.092 . . . . 70.41 110.268 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.4 t -111.9 -23.0 10.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 71.22 109.985 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 404' ' ' ASP . 8.7 t0 -153.19 -88.46 0.05 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.483 1.115 . . . . 71.43 109.307 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 108.3 32.62 3.17 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.493 1.121 . . . . 64.54 111.004 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.433 ' O ' ' CG ' ' A' ' 406' ' ' GLN . 3.1 tt0 -91.27 79.28 5.69 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.514 0.773 . . . . 72.22 110.286 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 43.91 -159.06 0.12 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.53 1.144 . . . . 73.14 111.013 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . 0.633 ' SG ' HG21 ' A' ' 385' ' ' ILE . 4.9 t -56.38 125.61 66.37 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 108.319 -0.993 . . . . 75.32 108.319 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.507 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.2 Cg_endo -74.98 -2.48 12.59 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.48 1.779 . . . . 74.3 110.968 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . 0.565 ' CE1' ' HE2' ' A' ' 392' ' ' MET . 6.7 m-85 -89.12 -37.93 14.71 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.466 1.104 . . . . 73.51 110.975 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' CYS . . . . . . . . . . . . . 1.2 p -121.17 10.37 10.66 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.492 1.12 . . . . 62.23 108.286 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 408' ' ' CYS . 49.1 mmm-85 38.68 49.94 1.54 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.507 1.129 . . . . 63.2 110.343 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 41.8 t -138.14 148.84 45.33 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.511 1.132 . . . . 53.24 108.328 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -52.2 159.0 1.01 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.561 1.163 . . . . 65.15 110.273 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.84 HD13 HD12 ' A' ' 385' ' ' ILE . 2.3 mt -113.83 147.36 17.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.429 1.081 . . . . 71.34 109.293 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -114.85 -44.31 3.06 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.138 . . . . 73.22 109.312 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.502 ' C ' HG23 ' A' ' 418' ' ' THR . . . -111.77 127.78 8.29 Favored Glycine 0 CA--C 1.531 1.053 0 O-C-N 124.537 1.148 . . . . 72.44 110.984 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . 0.502 HG23 ' C ' ' A' ' 417' ' ' GLY . 38.8 p -156.15 136.26 12.86 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.547 0.792 . . . . 54.5 110.405 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -171.98 156.13 3.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.495 1.122 . . . . 72.43 110.304 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.439 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.5 Cg_endo -74.94 101.87 1.52 Allowed 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.445 1.761 . . . . 73.4 111.011 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.739 ' C ' HD12 ' A' ' 421' ' ' ILE . 1.1 pp -103.93 167.69 2.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.496 1.123 . . . . 74.14 109.326 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . 0.554 ' N ' HD12 ' A' ' 421' ' ' ILE . 10.4 mm -113.97 112.22 39.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.53 1.144 . . . . 72.42 109.252 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.631 HG22 HD11 ' A' ' 421' ' ' ILE . 2.2 t -77.43 136.68 23.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.473 1.108 . . . . 72.34 109.27 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.539 ' O ' HG23 ' A' ' 355' ' ' VAL . 10.3 m-20 -131.33 131.85 23.26 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.477 1.111 . . . . 74.45 109.282 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 176.96 9.22 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.467 1.772 . . . . 53.11 110.999 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . 0.556 ' CE1' ' CG ' ' A' ' 357' ' ' GLN . 19.6 t80 . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.489 1.118 . . . . 71.45 111.052 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.956 0 N-CA-C 111.027 -0.829 . . . . 64.34 111.027 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 178.61 7.03 Favored 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.45 1.763 . . . . 63.22 110.966 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -74.82 -175.0 2.35 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.507 1.129 . . . . 72.42 109.586 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 4.6 ttp -119.01 177.13 4.98 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.498 1.124 . . . . 53.54 111.03 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 109.24 154.31 15.75 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.486 1.117 . . . . 40.21 111.002 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 69.8 m -74.91 124.75 27.48 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.484 0.756 . . . . 74.11 110.045 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . 0.428 ' H ' HG22 ' A' ' 421' ' ' ILE . 2.5 t70 -91.31 169.46 10.79 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 74.33 109.29 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -124.71 114.52 19.41 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.547 1.154 . . . . 74.33 109.629 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.845 HD13 HD13 ' A' ' 421' ' ' ILE . 1.6 mp -102.96 142.68 16.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.469 1.106 . . . . 74.52 109.309 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.402 ' NZ ' ' OD2' ' A' ' 424' ' ' ASP . 17.6 tppt? -124.91 117.93 25.16 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.465 1.103 . . . . 72.44 109.289 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 424' ' ' ASP . 61.9 t -66.25 154.8 7.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.492 1.12 . . . . 73.12 109.315 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 15.0 p -126.25 161.35 27.94 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.509 1.13 . . . . 72.34 110.43 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -56.05 -38.69 70.94 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.509 1.131 . . . . 73.34 110.332 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.14 -32.15 54.39 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.481 1.113 . . . . 75.24 110.29 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -83.79 -66.89 0.84 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.546 1.154 . . . . 74.4 110.281 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -41.89 -35.9 0.94 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.568 1.168 . . . . 74.34 111.039 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -66.41 -62.51 1.43 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.507 1.129 . . . . 73.5 110.281 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 9.8 tt -52.24 -30.53 28.02 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.462 1.101 . . . . 65.22 109.326 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' PTR . . . . . 0.416 ' CE1' ' O2P' ' A' ' 363' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.8 m -67.08 -24.16 65.93 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.465 1.103 . . . . 53.43 108.314 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.25 -21.13 62.15 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 64.22 110.305 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 2.0 mtm -103.33 -28.2 11.99 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 71.4 111.016 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 87.68 40.15 6.87 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.479 1.112 . . . . 61.41 110.954 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 20.8 t -139.22 177.73 7.69 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.502 0.766 . . . . 71.51 109.969 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 12.7 p -113.4 179.53 3.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 73.41 110.402 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.458 ' CD2' HG11 ' A' ' 423' ' ' VAL . 43.9 t80 -85.17 -65.97 0.95 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.555 1.159 . . . . 73.22 111.039 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.559 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -40.0 -31.72 0.13 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.522 1.139 . . . . 75.12 110.319 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.706 HD22 ' N ' ' A' ' 373' ' ' CYS . 1.5 tm? -66.89 136.73 55.84 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.525 1.141 . . . . 71.22 109.259 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . 0.706 ' N ' HD22 ' A' ' 372' ' ' LEU . 13.2 t -79.47 130.18 35.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.965 -1.016 . . . . 72.52 110.931 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.442 ' NZ ' ' O ' ' A' ' 372' ' ' LEU . 10.8 mmtm -87.31 11.31 14.66 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.539 1.15 . . . . 74.32 109.305 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 3.9 mt -102.83 -40.5 6.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.464 1.103 . . . . 75.52 109.262 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 86.1 m -110.21 -35.63 6.04 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.494 1.121 . . . . 53.04 108.321 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.649 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 55.87 35.9 26.31 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.514 1.134 . . . . 72.24 109.327 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -131.79 -44.74 0.97 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.465 1.103 . . . . 74.1 110.314 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -113.69 -176.54 2.92 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.511 1.132 . . . . 74.32 109.32 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -97.66 158.93 15.23 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.502 1.126 . . . . 72.2 109.319 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.415 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 23.9 mttt -59.48 -62.46 1.86 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.47 1.106 . . . . 74.52 109.303 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 13.6 t70 59.54 27.0 16.08 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.459 1.099 . . . . 72.43 109.312 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.895 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -157.84 173.43 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.536 1.147 . . . . 52.32 109.29 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 23.5 tttp -156.68 137.39 13.28 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.469 1.105 . . . . 74.23 109.27 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.824 HG23 HG23 ' A' ' 415' ' ' ILE . 10.4 mm -101.02 132.32 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 63.24 109.341 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.51 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 7.9 mt-10 -137.8 161.16 61.62 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 75.51 110.314 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.51 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.94 -4.73 20.57 Favored 'Cis proline' 0 C--N 1.36 1.159 0 C-N-CA 121.004 -2.498 . . . . 73.52 111.035 -0.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . 0.502 ' SG ' ' CE1' ' A' ' 390' ' ' HIS . 44.1 t -37.45 -76.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.96 -1.018 . . . . 73.32 110.907 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 118.15 34.65 1.1 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.512 1.132 . . . . 73.42 111.0 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.502 ' CE1' ' SG ' ' A' ' 388' ' ' CYS . 66.4 m170 -108.6 127.88 54.34 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.509 0.77 . . . . 72.34 109.594 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.717 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -97.46 157.86 15.78 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.463 1.102 . . . . 71.51 109.353 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.895 ' O ' HG12 ' A' ' 383' ' ' VAL . 19.5 ptp -174.37 175.38 2.62 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.452 1.095 . . . . 74.34 110.991 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 23.4 p -97.91 115.51 28.26 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.527 1.142 . . . . 70.53 108.29 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 396' ' ' CYS . 85.5 m -46.15 -60.0 2.55 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.53 1.144 . . . . 72.33 110.415 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 8.1 m -39.91 -29.7 0.07 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.471 1.107 . . . . 74.05 109.956 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . 0.524 ' O ' ' HB3' ' A' ' 399' ' ' ALA . 2.8 m -85.44 -53.88 4.92 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.524 1.14 . . . . 73.34 108.296 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.615 ' O ' HD23 ' A' ' 397' ' ' LEU . 2.1 tt -43.01 -55.4 3.81 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.513 1.133 . . . . 72.44 109.319 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 61.3 m -45.56 -38.14 6.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.508 1.13 . . . . 74.2 110.413 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -64.22 -38.49 91.24 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.121 . . . . 71.1 109.313 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' TRP . . . . . 0.449 ' N ' ' O ' ' A' ' 397' ' ' LEU . 2.8 t-105 -63.35 -47.12 83.47 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.549 1.156 . . . . 73.51 107.986 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -58.65 -35.72 73.0 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.482 1.114 . . . . 74.33 110.25 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -74.36 -2.74 26.58 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.512 1.133 . . . . 75.11 110.268 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 29.4 t -113.73 -23.13 9.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 1.131 . . . . 71.11 109.956 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.16 -78.34 0.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.452 1.095 . . . . 74.41 109.259 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 100.1 32.86 5.41 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.473 1.108 . . . . 33.55 110.988 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -93.94 76.51 4.16 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.478 0.752 . . . . 73.53 110.29 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 44.41 -157.68 0.18 Allowed Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.522 1.139 . . . . 53.52 111.026 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . 0.514 ' SG ' HG21 ' A' ' 385' ' ' ILE . 5.3 t -56.14 127.01 69.22 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.323 -0.991 . . . . 63.54 108.323 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 0.63 8.69 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.511 1.795 . . . . 74.31 110.986 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . 0.432 ' CD2' ' HE2' ' A' ' 392' ' ' MET . 15.8 m-85 -94.76 -36.5 11.68 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.455 1.097 . . . . 75.21 110.984 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' CYS . . . . . 0.449 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.8 OUTLIER -122.83 12.63 9.82 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.464 1.103 . . . . 75.31 108.335 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 408' ' ' CYS . 1.6 tpt180 38.19 30.75 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.513 1.133 . . . . 73.32 110.313 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' CYS . . . . . 0.449 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.7 m -113.82 150.5 33.43 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.523 1.139 . . . . 44.21 108.278 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -55.96 149.24 15.6 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.437 1.086 . . . . 70.35 110.299 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.824 HG23 HG23 ' A' ' 385' ' ' ILE . 2.1 mt -99.02 136.29 30.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.499 1.124 . . . . 55.0 109.308 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -114.67 -54.72 2.55 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.499 1.124 . . . . 72.24 109.286 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.55 ' O ' HG23 ' A' ' 418' ' ' THR . . . -95.89 127.78 9.29 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.467 1.104 . . . . 73.52 110.956 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 417' ' ' GLY . 18.2 p -157.47 137.01 12.09 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.541 0.789 . . . . 61.33 110.367 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -172.18 155.97 3.67 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.407 1.067 . . . . 74.24 110.348 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.431 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.4 Cg_endo -75.04 102.82 1.64 Allowed 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.458 1.768 . . . . 74.51 110.974 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.845 HD13 HD13 ' A' ' 353' ' ' ILE . 0.7 OUTLIER -103.82 155.27 5.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.491 1.119 . . . . 65.5 109.301 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . 0.574 ' N ' HD12 ' A' ' 421' ' ' ILE . 17.1 mt -108.0 108.49 25.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.545 1.153 . . . . 75.12 109.261 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.773 HG22 HD11 ' A' ' 421' ' ' ILE . 14.6 t -76.57 146.42 8.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.489 1.118 . . . . 72.24 109.25 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.453 ' O ' HG23 ' A' ' 355' ' ' VAL . 3.0 t70 -127.98 127.97 23.83 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.536 1.147 . . . . 75.12 109.336 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 179.52 6.0 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.535 1.808 . . . . 71.21 110.983 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 76.9 t80 . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.461 1.1 . . . . 72.13 111.047 179.939 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.021 0 N-CA-C 111.009 -0.836 . . . . 71.33 111.009 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.04 178.19 7.61 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.521 1.801 . . . . 70.33 110.996 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -100.56 148.57 24.65 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.468 1.105 . . . . 74.23 109.56 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -122.27 1.8 9.69 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.51 1.131 . . . . 73.22 111.012 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -94.77 23.82 30.99 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.516 1.135 . . . . 52.15 110.992 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 4.3 m -143.46 136.46 27.73 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.529 0.782 . . . . 73.15 109.951 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -90.64 179.83 5.72 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.483 1.114 . . . . 72.13 109.296 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . 0.461 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 61.2 m-70 -138.23 150.17 46.46 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 73.03 109.595 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 17.2 mt -136.55 156.68 36.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.496 1.122 . . . . 74.14 109.308 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 12.0 tptm -117.92 152.66 34.98 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.464 1.102 . . . . 62.41 109.322 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 424' ' ' ASP . 32.1 t -109.09 156.72 9.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.454 1.096 . . . . 73.55 109.337 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 12.3 p -122.7 152.87 40.13 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.507 1.13 . . . . 63.32 110.402 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' GLN . . . . . 0.546 ' HG2' ' CE2' ' A' ' 426' ' ' PHE . 1.7 mm100 -45.84 -53.36 9.84 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.475 1.109 . . . . 72.31 110.325 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -43.55 -40.27 3.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.537 1.148 . . . . 73.04 110.308 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -70.89 -66.49 0.6 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.486 1.116 . . . . 72.53 110.282 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 364' ' ' CYS . 7.4 t80 -45.07 -63.77 0.86 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 73.22 110.997 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -45.34 -52.28 10.05 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.52 1.137 . . . . 71.54 110.267 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.3 tt -55.18 -33.46 63.02 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.548 1.155 . . . . 74.51 109.312 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' PTR . . . . . 0.608 ' CD1' ' HZ1' ' A' ' 374' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . 0.449 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.9 m -66.79 -21.89 66.04 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.515 1.134 . . . . 71.51 108.283 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -79.51 -2.71 43.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.545 1.153 . . . . 74.11 110.277 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 8.3 mmt -108.3 -34.82 6.7 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.54 1.15 . . . . 64.51 110.982 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.02 4.61 41.63 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.479 1.112 . . . . 63.0 110.968 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 1.2 m -127.92 -176.2 3.71 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.529 0.782 . . . . 44.43 109.992 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.434 ' O ' ' CE ' ' A' ' 374' ' ' LYS . 15.1 p -114.29 -179.34 3.6 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.518 1.136 . . . . 75.04 110.394 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.495 ' HA ' ' CE1' ' A' ' 363' ' ' PTR . 62.7 t80 -78.49 -67.63 0.72 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 1.12 . . . . 75.11 110.979 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.556 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -38.89 -29.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.538 1.149 . . . . 73.4 110.3 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.907 HD22 ' N ' ' A' ' 373' ' ' CYS . 0.5 OUTLIER -72.56 136.54 45.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.547 1.154 . . . . 74.21 109.273 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . 0.907 ' N ' HD22 ' A' ' 372' ' ' LEU . 11.5 t -70.97 133.54 46.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.004 -0.998 . . . . 63.42 110.928 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.608 ' HZ1' ' CD1' ' A' ' 363' ' ' PTR . 29.8 mmtp -93.9 24.39 4.25 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.547 1.154 . . . . 71.3 109.285 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.612 HD11 ' CE1' ' A' ' 410' ' ' PHE . 36.3 mt -107.38 -56.17 4.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.498 1.124 . . . . 75.31 109.308 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 1.8 m -104.75 -23.15 13.09 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.482 1.114 . . . . 61.13 108.309 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.639 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 50.61 39.77 22.2 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.516 1.135 . . . . 62.54 109.302 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -124.57 -42.13 2.1 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.13 . . . . 73.52 110.271 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -123.62 171.0 9.88 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.52 1.138 . . . . 72.21 109.303 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -81.35 164.59 22.04 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.484 1.115 . . . . 64.13 109.302 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.458 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 20.0 mttt -67.75 -62.47 1.4 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.55 1.156 . . . . 74.34 109.292 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 1.9 t70 59.29 24.55 13.06 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.546 1.154 . . . . 63.23 109.283 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.923 HG12 ' O ' ' A' ' 392' ' ' MET . 0.6 OUTLIER -155.42 171.01 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.478 1.111 . . . . 75.22 109.305 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -154.19 147.25 24.61 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.462 1.101 . . . . 70.31 109.307 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.811 HG21 ' SG ' ' A' ' 408' ' ' CYS . 22.8 mm -110.4 134.33 52.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.477 1.11 . . . . 74.34 109.285 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.513 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 9.8 mt-10 -137.65 160.97 62.93 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.546 1.154 . . . . 60.5 110.276 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.513 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.5 Cg_endo -74.97 -5.13 21.03 Favored 'Cis proline' 0 C--N 1.36 1.14 0 C-N-CA 121.003 -2.499 . . . . 63.45 111.056 -0.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . 0.594 ' SG ' ' CE1' ' A' ' 390' ' ' HIS . 43.0 t -38.11 -79.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.964 -1.016 . . . . 64.33 110.942 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 119.92 36.98 0.79 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.485 1.115 . . . . 62.03 111.012 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.594 ' CE1' ' SG ' ' A' ' 388' ' ' CYS . 65.6 m170 -108.45 130.89 55.23 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 0.76 . . . . 74.32 109.6 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.708 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -98.43 157.48 16.18 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.133 . . . . 73.11 109.28 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.923 ' O ' HG12 ' A' ' 383' ' ' VAL . 15.5 ptp -171.81 174.38 4.24 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.509 1.13 . . . . 74.33 111.036 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 26.3 p -98.13 115.98 29.4 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.531 1.145 . . . . 72.35 108.291 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 26.2 m -42.12 -59.37 1.79 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.559 1.162 . . . . 61.11 110.421 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.7 t -42.82 -37.09 1.68 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.553 1.158 . . . . 64.24 109.983 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 3.5 m -73.69 -53.6 10.02 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.542 1.151 . . . . 52.2 108.297 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.748 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.8 OUTLIER -43.89 -37.18 2.71 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.536 1.147 . . . . 43.22 109.265 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 53.1 m -61.14 -46.07 92.07 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.514 1.134 . . . . 74.23 110.406 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -59.97 -19.88 54.59 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.498 1.124 . . . . 61.5 109.33 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' TRP . . . . . 0.605 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 9.7 t-105 -85.75 -64.94 1.07 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.5 1.125 . . . . 71.04 108.022 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.495 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 10.3 mm-40 -52.44 -17.18 1.1 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.457 1.098 . . . . 73.44 110.313 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 401' ' ' GLN . 2.3 mm-40 -37.19 -63.31 0.44 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.516 1.135 . . . . 63.41 110.281 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 2.5 m -121.0 -24.57 5.55 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.512 1.133 . . . . 54.5 110.004 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . 0.605 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 13.2 m-20 -82.05 -94.25 0.05 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.45 1.094 . . . . 73.0 109.298 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.495 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 69.18 30.89 71.67 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 124.5 1.125 . . . . 72.5 111.002 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -90.66 57.34 3.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.569 0.805 . . . . 60.41 110.326 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 69.27 -160.54 52.65 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.472 1.108 . . . . 35.54 110.971 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . 0.811 ' SG ' HG21 ' A' ' 385' ' ' ILE . 1.4 t -56.53 121.74 45.64 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 108.282 -1.007 . . . . 74.5 108.282 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.405 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.0 Cg_endo -75.07 0.3 9.1 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.538 1.809 . . . . 73.15 110.969 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . 0.612 ' CE1' HD11 ' A' ' 375' ' ' ILE . 10.8 m-85 -89.35 -38.83 13.86 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 62.23 111.0 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' CYS . . . . . 0.402 ' O ' ' C ' ' A' ' 412' ' ' ARG . 0.7 OUTLIER -126.49 15.85 7.64 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 73.2 108.322 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 408' ' ' CYS . 0.4 OUTLIER 38.71 41.27 0.48 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.561 1.163 . . . . 63.52 110.279 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 14.9 t -124.19 140.48 52.93 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 51.12 108.316 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -47.63 157.44 0.24 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.543 1.152 . . . . 62.45 110.307 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.761 HD13 HD12 ' A' ' 385' ' ' ILE . 2.3 mt -111.75 155.12 13.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.442 1.089 . . . . 75.25 109.319 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -120.91 -46.11 2.35 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.499 1.124 . . . . 72.21 109.308 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.52 ' O ' HG23 ' A' ' 418' ' ' THR . . . -115.55 132.73 10.47 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.525 1.14 . . . . 45.3 110.967 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . 0.546 ' CG2' HG21 ' A' ' 415' ' ' ILE . 21.0 p -157.23 117.37 3.48 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.443 0.731 . . . . 60.51 110.397 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.401 ' O ' HG23 ' A' ' 421' ' ' ILE . 1.9 pm0 -144.82 151.55 49.82 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.51 1.131 . . . . 74.53 110.291 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 100.82 1.4 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.502 1.791 . . . . 64.04 110.995 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.875 HD11 HG22 ' A' ' 423' ' ' VAL . 0.7 OUTLIER -104.68 169.51 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.502 1.126 . . . . 75.1 109.312 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . 0.815 ' N ' HD12 ' A' ' 421' ' ' ILE . 9.7 mt -124.95 105.43 15.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.518 1.136 . . . . 53.42 109.304 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.875 HG22 HD11 ' A' ' 421' ' ' ILE . 11.2 t -78.51 142.29 14.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.472 1.107 . . . . 63.41 109.301 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.544 ' O ' HG23 ' A' ' 355' ' ' VAL . 0.8 OUTLIER -127.92 143.7 48.72 Favored Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.486 1.116 . . . . 74.13 109.324 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 176.44 9.92 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.451 1.764 . . . . 71.31 110.983 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . 0.546 ' CE2' ' HG2' ' A' ' 357' ' ' GLN . 3.3 t80 . . . . . 0 C--N 1.325 -0.48 0 O-C-N 124.55 1.156 . . . . 50.13 111.04 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.969 0 N-CA-C 111.036 -0.826 . . . . 24.23 111.036 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 178.59 7.06 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.464 1.77 . . . . 74.34 111.015 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -115.04 112.7 23.03 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 1.136 . . . . 75.3 109.628 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 11.3 mmt -92.51 20.64 6.06 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.554 1.159 . . . . 61.22 111.03 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -142.94 20.36 2.33 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.527 1.142 . . . . 70.21 110.958 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 63.8 m -142.7 140.43 31.52 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.534 0.785 . . . . 55.41 109.998 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -96.3 -174.33 3.04 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.527 1.142 . . . . 61.11 109.318 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . 0.518 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 31.3 m-70 -138.99 140.66 38.25 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.461 1.101 . . . . 72.34 109.55 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 3.9 mm -122.07 156.19 26.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.503 1.127 . . . . 73.43 109.336 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -122.28 138.86 54.36 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.526 1.141 . . . . 65.21 109.322 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 424' ' ' ASP . 37.3 t -97.58 148.92 5.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.49 1.119 . . . . 72.22 109.347 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.6 p -108.55 141.86 39.83 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.547 1.154 . . . . 65.44 110.392 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' GLN . . . . . 0.538 ' HG2' ' CE2' ' A' ' 426' ' ' PHE . 4.9 mt-30 -39.66 -32.98 0.16 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.483 1.114 . . . . 72.01 110.32 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -57.05 -53.51 57.28 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.499 1.125 . . . . 53.51 110.322 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . 0.466 ' HB2' HG13 ' A' ' 355' ' ' VAL . 5.8 mt-30 -66.07 -22.67 66.42 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.546 1.154 . . . . 64.0 110.331 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -86.82 -23.73 25.24 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.492 1.12 . . . . 75.24 111.03 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 357' ' ' GLN . 4.6 mm-40 -84.41 -50.27 7.94 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.519 1.137 . . . . 72.43 110.235 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.468 ' CD1' ' N ' ' A' ' 362' ' ' LEU . 0.2 OUTLIER -59.97 -41.04 91.1 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.515 1.134 . . . . 72.04 109.288 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -53.26 60.23 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.119 . . . . 32.55 108.284 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -43.35 -68.31 0.21 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.514 1.134 . . . . 73.43 110.326 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 21.7 ptp -56.65 -31.12 64.06 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.53 1.144 . . . . 73.35 111.001 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 82.42 50.9 4.57 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.533 1.145 . . . . 53.13 111.015 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 1.5 t -126.29 -179.24 4.64 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.477 0.751 . . . . 75.52 110.026 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.435 ' HB ' ' NE2' ' A' ' 371' ' ' GLN . 2.8 p -129.1 140.46 51.56 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.521 1.138 . . . . 72.32 110.365 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.529 ' CE2' HG11 ' A' ' 423' ' ' VAL . 60.8 t80 -64.52 -68.2 0.37 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.451 1.094 . . . . 74.04 111.035 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.569 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -39.44 -30.02 0.06 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.124 . . . . 61.0 110.327 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.926 HD22 ' N ' ' A' ' 373' ' ' CYS . 0.4 OUTLIER -73.4 136.14 44.3 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.489 1.118 . . . . 74.02 109.339 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . 0.926 ' N ' HD22 ' A' ' 372' ' ' LEU . 26.9 p -67.88 131.85 46.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.015 -0.993 . . . . 34.51 110.926 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -93.21 29.57 1.87 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 65.04 109.328 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.776 HD11 ' HE1' ' A' ' 410' ' ' PHE . 17.1 mt -107.65 -59.78 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.469 1.106 . . . . 71.04 109.315 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 3.7 m -107.71 -23.17 12.21 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.516 1.135 . . . . 65.22 108.279 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.668 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 56.81 42.55 26.43 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 63.03 109.321 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -124.17 -42.45 2.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.516 1.135 . . . . 63.12 110.296 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -121.89 170.57 9.66 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.553 1.158 . . . . 61.14 109.309 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 17.3 p30 -83.24 162.1 21.29 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.472 1.108 . . . . 73.12 109.294 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 392' ' ' MET . 24.1 mttt -64.37 -55.57 20.25 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.489 1.118 . . . . 71.3 109.298 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 1.1 p30 52.22 25.71 3.51 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 74.44 109.308 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.869 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -153.21 176.09 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.53 1.143 . . . . 74.13 109.286 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.412 ' H ' HG22 ' A' ' 383' ' ' VAL . 79.0 tttt -160.94 142.23 11.83 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.448 1.093 . . . . 63.22 109.294 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.825 HD13 HG22 ' A' ' 418' ' ' THR . 10.4 mm -108.12 138.58 34.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 124.554 1.159 . . . . 72.23 109.308 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.518 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.1 OUTLIER -138.06 161.39 59.9 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.511 1.132 . . . . 64.12 110.27 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.518 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.98 -7.16 22.99 Favored 'Cis proline' 0 C--N 1.36 1.158 0 C-N-CA 120.983 -2.507 . . . . 75.21 111.024 -0.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . 0.442 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 41.2 t -36.83 -73.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.002 -0.999 . . . . 71.22 110.919 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 115.95 16.5 6.78 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.478 1.111 . . . . 73.2 111.043 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.513 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 49.6 m170 -86.85 131.42 34.12 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.525 0.779 . . . . 72.32 109.623 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.676 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -100.78 161.8 13.35 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.506 1.129 . . . . 74.3 109.285 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.869 ' O ' HG12 ' A' ' 383' ' ' VAL . 18.6 ptp -174.72 174.83 2.55 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.508 1.13 . . . . 64.03 110.973 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 7.0 p -96.55 119.56 35.25 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.521 1.138 . . . . 75.12 108.289 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 44.1 m -44.01 -59.22 2.4 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.486 1.117 . . . . 74.21 110.365 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 14.6 m -43.41 -34.2 1.23 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.499 1.124 . . . . 61.44 109.999 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . 0.435 ' O ' ' N ' ' A' ' 399' ' ' ALA . 1.8 m -76.1 -57.81 3.65 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.531 1.144 . . . . 65.11 108.34 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.667 HD13 ' C ' ' A' ' 397' ' ' LEU . 1.2 tm? -41.96 -39.03 1.75 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.452 1.095 . . . . 53.33 109.242 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 2.8 m -60.59 -46.52 89.93 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.509 1.131 . . . . 71.55 110.418 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -58.8 -20.65 52.0 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.142 . . . . 73.2 109.293 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' TRP . . . . . 0.607 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 7.7 t-105 -85.94 -64.92 1.07 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.526 1.141 . . . . 72.13 108.005 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.491 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.1 mm-40 -52.23 -17.4 1.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.498 1.124 . . . . 62.12 110.297 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 401' ' ' GLN . 2.3 mm-40 -37.14 -63.36 0.44 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.525 1.14 . . . . 74.2 110.26 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.6 m -120.82 -24.65 5.61 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.482 1.114 . . . . 73.11 110.01 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . 0.607 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 12.2 m-20 -81.58 -93.86 0.05 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.516 1.135 . . . . 75.23 109.312 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.491 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 69.93 29.67 70.69 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.485 1.115 . . . . 52.0 111.009 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -92.02 68.13 5.22 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.528 0.781 . . . . 74.12 110.312 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 63.34 -167.01 24.37 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 124.502 1.126 . . . . 50.01 111.005 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . 0.663 ' SG ' HG21 ' A' ' 385' ' ' ILE . 2.0 t -56.21 123.22 53.61 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 108.307 -0.997 . . . . 52.32 108.307 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.421 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.2 Cg_endo -74.99 0.3 9.07 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.451 1.763 . . . . 63.21 110.986 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . 0.776 ' HE1' HD11 ' A' ' 375' ' ' ILE . 3.3 m-30 -91.38 -40.77 11.26 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.478 1.111 . . . . 65.44 110.986 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' CYS . . . . . 0.442 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.8 OUTLIER -122.36 16.19 10.54 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.533 1.145 . . . . 74.12 108.267 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 408' ' ' CYS . 5.3 tpt180 38.6 30.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.54 1.15 . . . . 74.54 110.32 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' CYS . . . . . 0.442 ' N ' ' O ' ' A' ' 411' ' ' CYS . 6.9 t -111.97 142.65 44.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 63.13 108.265 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . 0.445 ' CG ' ' N ' ' A' ' 415' ' ' ILE . 24.7 tt0 -50.9 158.88 0.63 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.462 1.101 . . . . 74.55 110.34 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.766 HD13 HD12 ' A' ' 385' ' ' ILE . 2.3 mt -110.44 157.33 11.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.478 1.112 . . . . 72.32 109.244 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -119.91 -44.56 2.51 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.48 1.112 . . . . 64.34 109.303 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.6 ' O ' HG23 ' A' ' 418' ' ' THR . . . -134.72 146.55 18.55 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.549 1.156 . . . . 61.05 110.964 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . 0.825 HG22 HD13 ' A' ' 385' ' ' ILE . 2.3 p -157.52 117.68 3.44 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.533 0.784 . . . . 73.15 110.394 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -138.17 151.27 69.42 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.51 1.131 . . . . 74.33 110.346 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 101.68 1.5 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.51 1.795 . . . . 72.3 111.0 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.835 HD11 HG22 ' A' ' 423' ' ' VAL . 0.8 OUTLIER -104.14 155.72 5.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.488 1.117 . . . . 74.5 109.247 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . 0.532 ' N ' HD12 ' A' ' 421' ' ' ILE . 17.0 mt -107.01 105.41 18.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.502 1.126 . . . . 75.13 109.281 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.835 HG22 HD11 ' A' ' 421' ' ' ILE . 38.2 t -76.86 146.98 7.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 54.14 109.247 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.681 ' O ' HG23 ' A' ' 355' ' ' VAL . 0.8 OUTLIER -130.08 143.66 50.01 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.461 1.101 . . . . 54.41 109.237 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 170.35 20.61 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.497 1.788 . . . . 73.33 111.001 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . 0.538 ' CE2' ' HG2' ' A' ' 357' ' ' GLN . 3.3 t80 . . . . . 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 73.41 111.006 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.99 0 N-CA-C 111.006 -0.838 . . . . 64.0 111.006 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 178.61 7.04 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.557 1.819 . . . . 73.2 111.026 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -119.7 125.39 48.55 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.504 1.127 . . . . 61.43 109.626 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 26.9 tpp -105.62 91.78 3.9 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.531 1.145 . . . . 63.51 111.018 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -125.52 55.69 0.72 Allowed Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.502 1.126 . . . . 34.44 110.977 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 3.0 p -132.7 139.33 47.6 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.48 0.753 . . . . 75.24 110.037 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -97.46 176.85 5.72 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.466 1.104 . . . . 75.21 109.323 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . 0.439 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 42.5 m-70 -136.47 134.57 37.78 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.498 1.124 . . . . 63.31 109.604 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 67.0 mt -114.69 135.87 53.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.517 1.135 . . . . 65.21 109.302 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -107.84 118.94 38.06 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.473 1.108 . . . . 64.21 109.282 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.464 ' O ' ' CD2' ' A' ' 426' ' ' PHE . 8.6 t -64.33 140.55 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.539 1.149 . . . . 62.31 109.317 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.44 ' OG1' ' CG ' ' A' ' 359' ' ' GLN . 27.0 p -91.85 156.55 17.42 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 70.1 110.365 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -57.99 -32.5 67.95 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.454 1.096 . . . . 73.13 110.321 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . 0.462 ' CG ' ' N ' ' A' ' 359' ' ' GLN . 18.0 pt-20 -66.05 -47.48 74.2 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.517 1.136 . . . . 74.45 110.305 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . 0.462 ' N ' ' CG ' ' A' ' 358' ' ' GLU . 11.9 mm-40 -60.73 -52.77 63.69 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.518 1.136 . . . . 43.22 110.313 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -51.15 -60.63 2.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.527 1.142 . . . . 71.34 111.031 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -58.52 -36.76 74.34 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.491 1.119 . . . . 74.4 110.334 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.0 tp -61.53 -39.51 91.31 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.505 1.128 . . . . 64.14 109.289 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' PTR . . . . . 0.403 ' HD1' ' N ' ' A' ' 363' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 2.1 m -62.01 -41.27 97.9 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.529 1.143 . . . . 60.32 108.258 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -59.25 -17.64 30.2 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.5 1.125 . . . . 74.05 110.291 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 5.0 mtt -109.0 -16.18 14.19 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.487 1.117 . . . . 71.2 110.991 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 65.5 40.25 96.07 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.486 1.116 . . . . 74.43 111.006 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 16.1 m -125.13 -175.34 3.28 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.446 0.733 . . . . 73.0 109.971 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.433 ' HB ' ' NE2' ' A' ' 371' ' ' GLN . 2.3 p -128.22 136.36 50.95 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.456 1.098 . . . . 75.24 110.451 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.503 ' CZ ' HD12 ' A' ' 391' ' ' LEU . 73.7 t80 -60.58 -68.42 0.3 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.5 1.125 . . . . 75.14 111.002 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.537 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -40.09 -29.23 0.07 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 71.35 110.255 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.416 ' N ' ' C ' ' A' ' 370' ' ' PHE . 0.0 OUTLIER -69.48 115.01 8.25 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.127 . . . . 55.43 109.344 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 30.3 p -45.96 145.87 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.009 -0.996 . . . . 73.32 110.937 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -105.53 31.6 4.86 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.512 1.133 . . . . 62.1 109.31 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.57 HG21 ' HB3' ' A' ' 396' ' ' CYS . 46.4 mt -112.42 -58.39 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.51 1.131 . . . . 72.45 109.282 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 5.3 p -107.98 -21.81 12.67 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.479 1.112 . . . . 73.14 108.312 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 56.46 41.51 28.69 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.524 1.14 . . . . 52.31 109.336 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -126.16 -49.06 1.58 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.463 1.102 . . . . 73.22 110.329 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 49.4 m-20 -109.4 167.92 9.77 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.543 1.152 . . . . 63.25 109.323 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 16.6 p30 -84.6 162.66 19.7 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.486 1.116 . . . . 73.33 109.276 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 392' ' ' MET . 22.7 mttt -63.07 -62.4 1.73 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.469 1.106 . . . . 74.13 109.294 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 58.45 25.04 12.48 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.513 1.133 . . . . 74.15 109.262 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.892 HG12 ' O ' ' A' ' 392' ' ' MET . 0.7 OUTLIER -154.85 170.64 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 71.32 109.268 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -154.61 144.45 21.66 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.484 1.115 . . . . 71.35 109.314 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.808 HG21 ' SG ' ' A' ' 408' ' ' CYS . 11.1 mm -107.79 133.66 51.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.505 1.128 . . . . 73.24 109.293 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.517 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 10.5 mt-10 -137.67 160.98 62.86 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 62.14 110.297 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.517 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -75.07 -5.19 21.46 Favored 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 120.995 -2.502 . . . . 63.14 110.995 0.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . 0.512 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 16.5 t -38.13 -79.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.985 -1.007 . . . . 74.54 110.92 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 119.64 36.58 0.83 Allowed Glycine 0 CA--C 1.531 1.068 0 O-C-N 124.537 1.148 . . . . 60.35 110.965 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.559 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 67.4 m170 -108.54 127.14 53.68 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.545 0.791 . . . . 74.12 109.596 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.503 HD12 ' CZ ' ' A' ' 370' ' ' PHE . 1.8 mt -95.65 157.27 15.97 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.507 1.13 . . . . 72.33 109.297 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.892 ' O ' HG12 ' A' ' 383' ' ' VAL . 14.2 ptp -171.17 174.57 4.57 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.492 1.12 . . . . 74.5 111.001 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . 0.438 ' O ' ' N ' ' A' ' 396' ' ' CYS . 2.8 p -97.85 120.82 38.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.562 1.164 . . . . 73.23 108.289 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 48.8 m -41.11 -59.17 1.56 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.501 1.126 . . . . 62.54 110.339 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 2.7 t -49.3 -36.24 20.32 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.518 1.136 . . . . 63.23 109.999 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . 0.57 ' HB3' HG21 ' A' ' 375' ' ' ILE . 2.2 m -71.06 -38.17 72.51 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.461 1.101 . . . . 73.24 108.3 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.698 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -65.03 -36.57 84.8 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.511 1.132 . . . . 63.31 109.32 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 45.8 m -61.96 -45.47 93.51 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.54 1.15 . . . . 51.41 110.392 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -56.77 -23.87 46.14 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.496 1.123 . . . . 55.42 109.304 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' TRP . . . . . 0.601 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 15.8 t-105 -85.13 -65.22 1.03 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.498 1.124 . . . . 72.14 108.023 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.506 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 39.8 mm-40 -48.94 -20.85 0.56 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.53 1.144 . . . . 74.24 110.349 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 401' ' ' GLN . 2.7 mm-40 -37.45 -63.66 0.43 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.123 . . . . 74.32 110.347 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 42.6 t -122.77 -24.46 4.84 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 74.03 110.006 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . 0.601 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 18.6 m-20 -82.42 -93.67 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.503 1.127 . . . . 71.05 109.326 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.506 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 66.8 21.74 71.43 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 124.493 1.121 . . . . 74.31 110.991 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -80.34 59.72 3.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.476 0.75 . . . . 64.14 110.337 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 71.67 -165.58 53.6 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.481 1.113 . . . . 55.11 110.99 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . 0.808 ' SG ' HG21 ' A' ' 385' ' ' ILE . 1.8 t -56.2 120.9 38.24 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.296 -1.001 . . . . 73.31 108.296 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.427 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.3 Cg_endo -75.04 -0.01 9.47 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.496 1.787 . . . . 64.54 111.015 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . 0.559 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 3.5 m-85 -91.51 -37.01 13.4 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.46 1.1 . . . . 72.33 111.014 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.6 OUTLIER -127.38 17.33 7.06 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.106 . . . . 63.32 108.253 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 408' ' ' CYS . 6.3 tpp180 38.69 30.12 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.505 1.128 . . . . 75.54 110.279 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 411' ' ' CYS . 51.1 t -114.41 138.72 50.21 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.545 1.153 . . . . 64.34 108.325 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . 0.444 ' CG ' ' N ' ' A' ' 415' ' ' ILE . 34.1 tt0 -45.11 159.0 0.06 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 1.113 . . . . 74.14 110.317 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.704 HG23 HG23 ' A' ' 385' ' ' ILE . 2.3 mt -113.22 157.04 14.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 72.44 109.271 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 10.4 mttm -132.3 -47.17 0.91 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.53 1.144 . . . . 74.52 109.286 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.526 ' O ' HG23 ' A' ' 418' ' ' THR . . . -109.51 130.78 10.15 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.493 1.121 . . . . 71.53 111.015 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 417' ' ' GLY . 20.8 p -157.2 118.5 3.68 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.492 0.76 . . . . 51.55 110.409 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -141.57 151.44 60.55 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.539 1.149 . . . . 52.41 110.28 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.03 101.3 1.45 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.474 1.776 . . . . 65.11 110.988 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.898 HD12 ' N ' ' A' ' 422' ' ' ILE . 1.1 pp -105.94 178.19 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.463 1.102 . . . . 64.35 109.253 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . 0.898 ' N ' HD12 ' A' ' 421' ' ' ILE . 6.1 mt -139.69 111.81 5.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.502 1.126 . . . . 72.53 109.292 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.566 ' CG2' HD11 ' A' ' 421' ' ' ILE . 18.5 t -84.04 142.71 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.477 1.111 . . . . 74.43 109.304 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -131.1 143.73 50.62 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 50.42 109.309 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 174.98 11.86 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.489 1.784 . . . . 73.4 110.956 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . 0.464 ' CD2' ' O ' ' A' ' 355' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.521 1.138 . . . . 75.15 111.004 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.028 0 N-CA-C 111.027 -0.829 . . . . 65.43 111.027 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 178.31 7.44 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.536 1.809 . . . . 54.45 110.992 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -174.49 150.19 1.38 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.537 1.148 . . . . 73.33 109.57 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 39.7 mtp -154.19 133.63 12.72 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.464 1.102 . . . . 72.24 111.014 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 97.94 50.34 1.64 Allowed Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.527 1.142 . . . . 61.23 111.008 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 69.9 m -143.37 154.28 43.57 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.502 0.766 . . . . 73.32 109.973 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . 0.566 ' HB2' HG22 ' A' ' 421' ' ' ILE . 11.4 m-20 -98.43 171.99 7.81 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.476 1.11 . . . . 74.5 109.281 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . 0.416 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 22.4 m-70 -130.37 126.59 37.48 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.474 1.109 . . . . 73.11 109.581 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.518 HG13 HD13 ' A' ' 421' ' ' ILE . 48.0 mt -115.76 127.39 73.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.486 1.116 . . . . 72.33 109.326 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 8.4 tptp -105.58 118.85 37.64 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.544 1.152 . . . . 65.21 109.304 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 424' ' ' ASP . 48.5 t -59.39 164.03 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.528 1.142 . . . . 71.0 109.288 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.455 ' N ' ' CG1' ' A' ' 355' ' ' VAL . 3.0 p -122.89 146.12 47.86 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.506 1.129 . . . . 63.13 110.37 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' GLN . . . . . 0.577 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 5.8 mt-30 -42.46 -53.72 4.17 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 71.23 110.288 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -39.95 -41.22 1.15 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.468 1.105 . . . . 62.03 110.327 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -67.06 -66.84 0.51 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.475 1.109 . . . . 61.04 110.305 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . 0.431 ' O ' ' N ' ' A' ' 364' ' ' CYS . 8.4 t80 -40.61 -52.22 2.9 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.434 1.084 . . . . 65.51 110.991 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -55.4 -44.02 75.76 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.493 1.12 . . . . 72.12 110.273 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 10.1 tt -63.12 -34.24 77.19 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.481 1.113 . . . . 63.53 109.331 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' PTR . . . . . 0.438 ' O ' ' N ' ' A' ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m -65.59 -34.27 77.86 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.508 1.13 . . . . 54.31 108.327 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -62.29 -18.62 61.79 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.472 1.107 . . . . 52.22 110.29 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -128.4 8.52 5.98 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.473 1.108 . . . . 73.15 110.995 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 363' ' ' PTR . . . 38.04 63.61 0.89 Allowed Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.521 1.138 . . . . 71.5 111.042 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 64.1 p -132.09 -174.03 3.32 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.463 0.743 . . . . 71.14 110.009 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.484 ' O ' ' CE ' ' A' ' 374' ' ' LYS . 33.7 p -126.47 146.53 50.06 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.535 1.147 . . . . 62.03 110.388 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.456 ' CE2' HG11 ' A' ' 423' ' ' VAL . 31.8 t80 -77.23 -63.83 1.28 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.489 1.118 . . . . 62.4 111.003 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.563 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -40.71 -28.78 0.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.489 1.118 . . . . 70.4 110.323 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.721 HD11 ' HA ' ' A' ' 377' ' ' ALA . 3.0 tm? -67.3 139.91 57.29 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.116 . . . . 65.44 109.283 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . 0.72 ' N ' HD13 ' A' ' 372' ' ' LEU . 1.9 t -76.16 126.17 30.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.016 -0.993 . . . . 75.3 110.925 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.484 ' CE ' ' O ' ' A' ' 369' ' ' THR . 12.9 mmtm -91.06 18.51 6.69 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.527 1.142 . . . . 53.24 109.297 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 20.3 mt -99.17 -51.61 9.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.457 1.098 . . . . 65.53 109.306 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.54 -30.3 8.32 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.512 1.132 . . . . 60.31 108.305 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.721 ' HA ' HD11 ' A' ' 372' ' ' LEU . . . 65.82 43.69 3.05 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.545 1.153 . . . . 74.05 109.279 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -136.29 -61.89 0.68 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.53 1.144 . . . . 73.24 110.301 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -96.88 161.43 13.85 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.471 1.107 . . . . 72.11 109.298 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 37.4 p30 -81.14 160.73 24.33 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.517 1.136 . . . . 74.21 109.314 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.461 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 23.4 mttt -65.01 -62.49 1.52 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.49 1.119 . . . . 73.1 109.308 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 9.7 t70 60.07 27.05 16.44 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.501 1.126 . . . . 73.32 109.309 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.922 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -157.94 175.26 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.442 1.089 . . . . 72.35 109.313 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.424 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 17.0 tttp -159.4 140.86 13.02 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.481 1.113 . . . . 75.42 109.316 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 1.059 HD12 HD13 ' A' ' 415' ' ' ILE . 24.6 mm -104.91 132.74 50.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.511 1.132 . . . . 71.13 109.268 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.511 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 10.8 mt-10 -137.79 161.08 62.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 74.31 110.312 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.511 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -75.01 -4.65 20.7 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 121.012 -2.495 . . . . 61.45 110.989 0.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . 0.523 ' SG ' ' CD2' ' A' ' 390' ' ' HIS . 25.2 t -37.6 -77.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.986 -1.007 . . . . 52.34 110.939 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 118.72 35.45 0.98 Allowed Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.566 1.166 . . . . 45.52 111.01 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.523 ' CD2' ' SG ' ' A' ' 388' ' ' CYS . 51.7 m170 -108.51 126.89 53.43 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.504 0.767 . . . . 71.22 109.579 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.71 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -97.56 157.53 15.97 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.465 1.103 . . . . 74.31 109.306 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.922 ' O ' HG12 ' A' ' 383' ' ' VAL . 11.4 ptp -173.81 173.71 3.23 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.492 1.12 . . . . 71.25 110.99 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 19.4 p -90.39 140.88 29.29 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 73.4 108.303 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 48.4 m -61.93 -43.35 99.03 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.433 1.083 . . . . 75.31 110.394 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 23.3 t -55.37 -64.54 0.81 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.459 1.099 . . . . 74.23 110.021 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 399' ' ' ALA . 1.6 p -50.24 -51.38 45.02 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.518 1.136 . . . . 65.01 108.323 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.447 HD13 ' C ' ' A' ' 397' ' ' LEU . 1.3 tm? -45.13 -49.53 11.8 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.496 1.123 . . . . 75.22 109.292 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 76.5 m -54.59 -38.63 66.97 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.509 1.131 . . . . 75.54 110.427 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -60.71 -25.13 66.2 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.461 1.1 . . . . 75.21 109.375 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' TRP . . . . . 0.602 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 10.7 t-105 -85.7 -62.75 1.45 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.498 1.124 . . . . 70.04 108.02 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.49 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 8.2 mm-40 -55.98 -14.34 2.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.545 1.153 . . . . 63.32 110.323 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 401' ' ' GLN . 0.6 OUTLIER -37.23 -63.29 0.44 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.495 1.122 . . . . 60.42 110.302 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 7.8 t -121.13 -24.58 5.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.499 1.124 . . . . 61.32 109.968 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . 0.602 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 8.7 m-20 -83.0 -94.86 0.06 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.484 1.115 . . . . 74.02 109.327 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.49 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 73.3 28.99 64.94 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.469 1.106 . . . . 72.23 111.01 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -90.91 70.36 6.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.446 0.733 . . . . 70.53 110.307 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 66.58 -169.03 34.31 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.559 1.162 . . . . 54.33 110.993 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . 0.464 ' HB2' HG21 ' A' ' 385' ' ' ILE . 6.0 t -56.55 131.55 77.21 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.329 -0.989 . . . . 63.14 108.329 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 0.34 9.05 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.475 1.776 . . . . 74.31 110.958 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -93.66 -55.63 3.19 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.462 1.101 . . . . 51.31 110.969 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' CYS . . . . . 0.451 ' O ' ' N ' ' A' ' 413' ' ' CYS . 2.6 p -98.56 10.07 41.8 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.558 1.161 . . . . 61.01 108.319 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 411' ' ' CYS . 3.4 tpt85 38.59 30.19 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.475 1.11 . . . . 63.01 110.325 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' CYS . . . . . 0.451 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.5 m -115.48 154.24 29.67 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.489 1.118 . . . . 54.41 108.309 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -59.35 156.6 12.43 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.531 1.144 . . . . 75.45 110.284 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 1.059 HD13 HD12 ' A' ' 385' ' ' ILE . 5.6 mt -115.48 157.1 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 61.03 109.345 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.405 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 5.9 mmtp -120.26 -44.5 2.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.529 1.143 . . . . 75.24 109.269 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.506 ' C ' HG23 ' A' ' 418' ' ' THR . . . -112.44 127.78 8.19 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.461 1.1 . . . . 63.42 111.009 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . 0.543 ' CG2' HG21 ' A' ' 415' ' ' ILE . 34.9 p -156.56 125.51 5.97 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.531 0.783 . . . . 71.13 110.419 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 421' ' ' ILE . 4.4 pt-20 -158.06 151.43 18.94 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.484 1.115 . . . . 61.42 110.3 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 99.17 1.23 Allowed 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.551 1.817 . . . . 73.32 111.031 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.877 HD11 HG22 ' A' ' 423' ' ' VAL . 0.8 OUTLIER -104.38 163.93 3.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.48 1.113 . . . . 71.45 109.341 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . 0.717 ' N ' HD12 ' A' ' 421' ' ' ILE . 3.3 mp -113.18 105.44 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.496 1.123 . . . . 74.23 109.301 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.877 HG22 HD11 ' A' ' 421' ' ' ILE . 12.9 t -78.22 140.19 17.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.465 1.103 . . . . 65.12 109.307 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.767 ' O ' HG23 ' A' ' 355' ' ' VAL . 23.6 m-20 -130.2 143.72 50.32 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.519 1.137 . . . . 70.14 109.309 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 160.29 40.29 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.493 1.786 . . . . 63.24 110.96 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . 0.577 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 26.4 t80 . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.481 1.113 . . . . 64.32 111.033 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.994 0 N-CA-C 111.024 -0.83 . . . . 41.55 111.024 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.92 178.65 6.96 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.446 1.761 . . . . 74.52 111.02 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -95.61 -177.05 3.94 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.456 1.098 . . . . 74.3 109.587 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 7.4 mmt -109.86 19.23 19.31 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.127 . . . . 74.34 111.001 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -97.45 -16.96 32.74 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.48 1.113 . . . . 73.52 110.991 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 3.2 p -77.86 137.08 38.19 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.521 0.777 . . . . 63.42 109.967 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -87.22 -177.28 5.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.463 1.102 . . . . 74.21 109.263 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . 0.543 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 25.0 m-70 -138.3 149.9 46.12 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.509 1.13 . . . . 71.3 109.588 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.47 HG13 HD13 ' A' ' 421' ' ' ILE . 7.7 mt -136.11 158.65 38.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.564 1.165 . . . . 63.23 109.266 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.411 ' N ' ' CG2' ' A' ' 353' ' ' ILE . 0.1 OUTLIER -123.38 152.74 41.23 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.461 1.1 . . . . 64.31 109.317 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.667 HG22 ' CD2' ' A' ' 370' ' ' PHE . 9.2 t -107.94 162.05 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 71.31 109.288 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.466 ' N ' ' CG1' ' A' ' 355' ' ' VAL . 13.1 p -112.95 158.7 19.91 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.499 1.124 . . . . 71.43 110.43 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' GLN . . . . . 0.525 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 11.5 mt-30 -59.87 -45.7 91.66 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.54 1.15 . . . . 71.32 110.341 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -49.25 -44.92 44.08 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.495 1.122 . . . . 71.14 110.299 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -66.42 -43.49 85.57 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.445 1.091 . . . . 54.34 110.311 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -58.26 -27.22 63.81 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.453 1.095 . . . . 73.51 110.953 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -89.58 -40.39 12.64 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.527 1.142 . . . . 72.2 110.358 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.994 ' O ' HD12 ' A' ' 362' ' ' LEU . 0.5 OUTLIER -63.87 -32.82 74.47 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.127 . . . . 65.14 109.3 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' PTR . . . . . 0.597 ' CE1' ' NZ ' ' A' ' 374' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.64 -54.87 37.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.517 1.135 . . . . 63.12 108.287 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -41.55 -66.68 0.32 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.546 1.154 . . . . 72.04 110.264 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . 0.41 ' CG ' ' O ' ' A' ' 363' ' ' PTR . 19.1 ptp -53.73 -34.49 59.09 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.486 1.116 . . . . 71.32 111.001 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 88.45 50.21 3.45 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.429 1.081 . . . . 61.35 110.953 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 3.3 m -146.21 179.05 7.77 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.498 0.763 . . . . 70.35 109.989 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.772 HG22 ' NE2' ' A' ' 371' ' ' GLN . 2.3 m -117.89 160.66 21.04 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.528 1.143 . . . . 74.12 110.395 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.667 ' CD2' HG22 ' A' ' 355' ' ' VAL . 64.3 t80 -62.59 -68.67 0.31 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.53 1.144 . . . . 61.53 111.015 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.772 ' NE2' HG22 ' A' ' 369' ' ' THR . 0.1 OUTLIER -47.33 -24.95 0.87 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.529 1.143 . . . . 73.23 110.283 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.418 ' CD2' ' HA ' ' A' ' 377' ' ' ALA . 0.0 OUTLIER -69.75 117.7 11.67 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 44.53 109.236 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 25.1 t -52.22 145.24 11.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.947 -1.024 . . . . 64.14 110.89 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.597 ' NZ ' ' CE1' ' A' ' 363' ' ' PTR . 25.5 mmtp -103.36 24.26 11.25 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.463 1.102 . . . . 42.32 109.267 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.743 HD11 ' HE1' ' A' ' 410' ' ' PHE . 52.8 mt -111.47 -49.29 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.451 1.094 . . . . 62.24 109.316 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 3.5 m -109.04 -32.65 7.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.501 1.126 . . . . 34.32 108.285 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.418 ' HA ' ' CD2' ' A' ' 372' ' ' LEU . . . 61.03 28.21 18.0 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.499 1.124 . . . . 33.2 109.322 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -121.83 -40.32 2.54 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.497 1.123 . . . . 53.3 110.28 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -115.53 169.65 9.02 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.514 1.134 . . . . 74.5 109.294 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -87.52 166.19 14.94 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 72.45 109.354 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.454 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 19.2 mttt -67.12 -62.53 1.38 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.476 1.11 . . . . 65.41 109.268 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 4.8 t0 60.56 20.89 10.71 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.452 1.095 . . . . 75.32 109.281 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.928 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -151.19 175.42 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.539 1.149 . . . . 61.25 109.285 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.416 ' H ' HG22 ' A' ' 383' ' ' VAL . 20.8 tttm -158.13 156.66 31.32 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.492 1.12 . . . . 64.03 109.318 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.859 HG22 ' SG ' ' A' ' 388' ' ' CYS . 11.8 mm -122.72 144.3 32.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.562 1.164 . . . . 54.31 109.331 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.536 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.4 mt-10 -137.74 162.4 54.72 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.501 1.125 . . . . 61.03 110.282 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.536 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.03 -12.15 24.12 Favored 'Cis proline' 0 C--N 1.36 1.172 0 C-N-CA 121.032 -2.487 . . . . 42.44 110.986 0.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . 0.859 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.63 -71.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.04 -0.982 . . . . 72.33 110.881 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 115.77 18.15 6.16 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.492 1.12 . . . . 72.45 111.022 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.529 ' CE1' ' HB2' ' A' ' 388' ' ' CYS . 20.0 m170 -75.58 147.13 39.88 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.529 0.782 . . . . 74.24 109.565 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.813 HD22 ' N ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -117.3 156.47 27.75 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.132 . . . . 65.3 109.308 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.928 ' O ' HG12 ' A' ' 383' ' ' VAL . 18.8 ptp -172.01 173.54 4.36 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.502 1.126 . . . . 75.23 110.958 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 26.1 p -95.18 126.08 40.26 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.471 1.107 . . . . 70.34 108.278 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 6.4 m -54.12 -56.25 19.86 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.508 1.13 . . . . 74.04 110.381 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.6 t -43.61 -30.71 0.64 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.546 1.153 . . . . 42.32 109.988 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 2.5 m -80.79 -52.32 7.64 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.544 1.153 . . . . 63.12 108.287 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.683 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.7 OUTLIER -43.56 -37.91 2.72 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.452 1.095 . . . . 74.31 109.326 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 1.1 m -60.75 -46.8 89.07 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.482 1.114 . . . . 74.41 110.413 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . -58.12 -21.94 48.68 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.482 1.114 . . . . 71.24 109.308 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' TRP . . . . . 0.608 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 8.9 t-105 -84.77 -64.88 1.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.523 1.139 . . . . 75.1 108.006 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.497 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.6 mm-40 -52.77 -16.99 1.13 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.472 1.107 . . . . 74.12 110.319 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 401' ' ' GLN . 5.8 mm-40 -37.09 -63.42 0.43 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.492 1.12 . . . . 73.14 110.303 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 2.8 m -120.61 -24.51 5.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.496 1.122 . . . . 72.21 109.995 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . 0.608 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 16.6 m-20 -82.09 -94.51 0.05 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.114 . . . . 70.13 109.282 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.497 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 70.5 29.96 69.38 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.488 1.117 . . . . 43.41 110.981 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -91.71 68.0 5.48 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.567 0.804 . . . . 75.44 110.279 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 66.0 -166.46 36.55 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.471 1.107 . . . . 64.1 110.976 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . 0.693 ' SG ' HG21 ' A' ' 385' ' ' ILE . 6.5 t -57.31 128.9 79.37 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 108.324 -0.991 . . . . 65.54 108.324 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 0.3 9.07 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.511 1.795 . . . . 71.25 110.958 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . 0.743 ' HE1' HD11 ' A' ' 375' ' ' ILE . 3.2 m-85 -97.91 -41.54 7.96 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.505 1.128 . . . . 74.34 111.019 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' CYS . . . . . 0.444 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.1 OUTLIER -111.32 8.98 21.58 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.522 1.138 . . . . 61.04 108.284 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 408' ' ' CYS . 8.0 tpp85 38.49 30.28 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.546 1.154 . . . . 72.23 110.294 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' CYS . . . . . 0.444 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.3 m -123.09 164.85 17.83 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.501 1.126 . . . . 74.3 108.265 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -63.07 145.08 56.23 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.494 1.121 . . . . 71.12 110.281 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.739 HG23 HG23 ' A' ' 385' ' ' ILE . 1.6 mt -94.92 147.01 6.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.522 1.139 . . . . 61.52 109.304 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -117.26 -43.78 2.82 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.489 1.118 . . . . 75.12 109.305 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.453 ' C ' HG23 ' A' ' 418' ' ' THR . . . -119.21 130.0 8.34 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.452 1.095 . . . . 75.33 110.976 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . 0.578 ' CG2' HG21 ' A' ' 415' ' ' ILE . 80.6 p -152.69 138.86 18.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.477 0.751 . . . . 62.22 110.359 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -171.86 151.12 2.69 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.458 1.099 . . . . 74.05 110.275 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.08 101.66 1.5 Allowed 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.518 1.799 . . . . 63.0 110.981 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.793 HD11 HG22 ' A' ' 423' ' ' VAL . 0.8 OUTLIER -104.18 159.42 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.444 1.09 . . . . 73.15 109.289 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . 0.543 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 8.1 mt -111.47 105.51 18.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.488 1.118 . . . . 45.11 109.27 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.793 HG22 HD11 ' A' ' 421' ' ' ILE . 39.5 t -76.97 146.78 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.509 1.131 . . . . 73.0 109.322 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.514 ' O ' HG23 ' A' ' 355' ' ' VAL . 9.3 m-20 -129.49 143.87 50.63 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.478 1.111 . . . . 60.41 109.34 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.96 174.05 13.45 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.492 1.785 . . . . 72.1 110.993 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . 0.525 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 4.8 t80 . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.118 . . . . 74.4 111.058 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.966 0 N-CA-C 111.018 -0.833 . . . . 74.41 111.018 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 178.39 7.33 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.502 1.791 . . . . 64.12 110.958 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -78.63 129.13 34.41 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.479 1.112 . . . . 61.44 109.612 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 18.9 mtt -118.97 -47.64 2.49 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.486 1.116 . . . . 75.14 111.044 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 125.6 -21.11 6.39 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.496 1.123 . . . . 25.0 110.983 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 67.0 m -51.99 148.95 5.45 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.484 0.755 . . . . 63.04 109.966 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -94.22 -174.75 3.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.488 1.117 . . . . 72.24 109.28 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . 0.568 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 28.9 m-70 -140.15 141.55 36.04 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.551 1.157 . . . . 74.35 109.578 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' A' ' 354' ' ' LYS . 3.7 mm -128.2 158.46 40.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.445 1.091 . . . . 64.04 109.293 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.404 ' N ' ' CG2' ' A' ' 353' ' ' ILE . 0.0 OUTLIER -117.91 153.66 33.21 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.498 1.124 . . . . 74.02 109.304 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 424' ' ' ASP . 14.3 t -105.44 149.12 9.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.115 . . . . 75.2 109.272 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 19.8 p -117.2 176.9 4.93 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.485 1.116 . . . . 72.35 110.395 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -74.49 -33.85 62.94 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.497 1.123 . . . . 73.22 110.292 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . 0.41 ' CG ' ' N ' ' A' ' 359' ' ' GLN . 15.3 pt-20 -57.98 -47.64 82.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.474 1.109 . . . . 75.22 110.305 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . 0.41 ' N ' ' CG ' ' A' ' 358' ' ' GLU . 29.1 mm-40 -60.9 -66.65 0.5 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 74.14 110.297 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . 0.41 ' O ' ' N ' ' A' ' 364' ' ' CYS . 4.9 t80 -44.02 -42.9 6.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 75.11 110.995 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -65.71 -42.38 91.19 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.453 1.096 . . . . 73.13 110.263 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.7 tp -62.03 -39.36 92.06 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.47 1.106 . . . . 64.11 109.338 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . 0.41 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.7 m -63.27 -21.93 66.55 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.491 1.119 . . . . 71.25 108.302 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -75.47 -29.28 59.55 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.525 1.141 . . . . 62.2 110.305 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . 0.405 ' SD ' ' N ' ' A' ' 366' ' ' MET . 0.0 OUTLIER -113.49 21.02 15.55 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.514 1.134 . . . . 53.42 110.979 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 37.78 47.71 1.8 Allowed Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.448 1.093 . . . . 75.14 110.987 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 31.6 m -121.42 152.84 38.61 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.504 0.767 . . . . 62.42 109.989 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.791 HG22 HE21 ' A' ' 371' ' ' GLN . 2.2 m -98.51 159.77 14.72 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 72.24 110.369 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.535 ' CD1' HG11 ' A' ' 423' ' ' VAL . 5.9 t80 -66.34 -65.66 0.65 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.483 1.114 . . . . 74.53 110.981 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.791 HE21 HG22 ' A' ' 369' ' ' THR . 0.0 OUTLIER -53.34 -32.8 50.85 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.128 . . . . 64.44 110.322 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.883 HD22 ' N ' ' A' ' 373' ' ' CYS . 0.7 OUTLIER -58.67 135.87 57.52 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.507 1.129 . . . . 65.13 109.278 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . 0.883 ' N ' HD22 ' A' ' 372' ' ' LEU . 16.4 t -76.68 135.91 39.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.965 -1.016 . . . . 74.43 110.896 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.402 ' HD2' ' N ' ' A' ' 374' ' ' LYS . 0.6 OUTLIER -92.94 22.17 5.13 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.506 1.129 . . . . 73.45 109.317 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 5.0 mt -110.68 -52.18 6.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.524 1.14 . . . . 61.54 109.33 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 7.5 m -102.75 -27.04 12.93 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.485 1.116 . . . . 45.04 108.313 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.704 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 55.52 29.05 12.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.464 1.103 . . . . 54.01 109.327 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -122.45 -40.86 2.43 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.468 1.105 . . . . 74.45 110.31 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -119.06 -179.94 3.98 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.463 1.102 . . . . 65.3 109.348 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -89.55 171.76 9.46 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.52 1.137 . . . . 73.12 109.327 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.449 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 11.6 mttt -79.14 -62.49 1.68 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 74.42 109.284 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 15.7 t0 62.4 22.2 13.07 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.464 1.102 . . . . 74.15 109.324 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.872 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -158.25 172.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.488 1.117 . . . . 71.5 109.298 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.404 ' CE ' ' HA2' ' A' ' 389' ' ' GLY . 76.4 tttt -156.74 159.5 38.39 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.464 1.102 . . . . 74.24 109.312 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.886 HG22 ' SG ' ' A' ' 388' ' ' CYS . 18.1 mm -117.21 139.92 42.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.522 1.138 . . . . 70.25 109.298 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.534 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.9 mt-10 -130.61 162.26 55.93 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.446 1.091 . . . . 64.43 110.271 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.534 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.4 Cg_endo -74.93 -14.72 22.76 Favored 'Cis proline' 0 C--N 1.36 1.157 0 C-N-CA 121.034 -2.486 . . . . 63.41 110.986 -0.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . 0.886 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.82 -87.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.047 -0.979 . . . . 55.4 110.915 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 130.91 42.9 0.19 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.467 1.104 . . . . 41.33 111.027 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.499 ' C ' HD13 ' A' ' 391' ' ' LEU . 27.8 m170 -97.45 131.49 44.04 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.49 0.759 . . . . 73.44 109.643 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.697 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -100.21 151.83 20.99 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.462 1.102 . . . . 70.11 109.309 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.872 ' O ' HG12 ' A' ' 383' ' ' VAL . 16.8 ptp -167.61 170.74 10.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.536 1.147 . . . . 75.22 110.933 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 26.1 p -97.14 115.28 27.25 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.452 1.095 . . . . 74.21 108.334 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 24.3 m -39.71 -58.69 1.28 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.552 1.157 . . . . 34.54 110.389 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.4 t -42.64 -43.61 3.91 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.513 1.133 . . . . 53.25 110.004 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . 0.401 ' O ' ' N ' ' A' ' 399' ' ' ALA . 3.6 m -67.52 -55.2 14.44 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.474 1.109 . . . . 61.34 108.293 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.749 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -44.15 -36.26 2.55 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.476 1.11 . . . . 73.31 109.308 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 17.5 m -61.35 -46.06 91.79 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 71.5 110.436 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -56.89 -22.6 38.46 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.458 1.098 . . . . 75.04 109.302 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' TRP . . . . . 0.605 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 9.1 t-105 -85.56 -64.77 1.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.982 -1.118 . . . . 73.02 107.982 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.497 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 10.1 mm-40 -52.94 -16.88 1.16 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 72.24 110.316 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 401' ' ' GLN . 5.1 mt-10 -37.16 -63.29 0.44 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.489 1.118 . . . . 73.23 110.323 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 5.4 t -120.51 -24.46 5.81 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.443 1.089 . . . . 53.53 109.986 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . 0.605 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 4.6 m-20 -82.62 -95.08 0.05 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.478 1.111 . . . . 65.34 109.288 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.497 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 70.57 32.45 67.6 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.57 1.169 . . . . 62.52 110.992 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -92.02 66.94 5.06 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 0.773 . . . . 74.23 110.344 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 66.19 -161.89 44.1 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.532 1.145 . . . . 64.55 111.05 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . 0.673 ' SG ' HG21 ' A' ' 385' ' ' ILE . 5.5 t -60.21 126.25 83.58 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 108.332 -0.988 . . . . 74.12 108.332 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.06 -1.56 11.39 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.518 1.799 . . . . 65.04 110.998 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -94.9 -42.19 8.8 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 1.136 . . . . 65.32 111.001 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' CYS . . . . . 0.445 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.2 OUTLIER -111.79 10.45 20.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.135 . . . . 52.31 108.265 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 408' ' ' CYS . 4.8 tpt180 38.48 30.35 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.534 1.146 . . . . 75.34 110.316 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' CYS . . . . . 0.445 ' N ' ' O ' ' A' ' 411' ' ' CYS . 16.0 t -125.3 145.65 49.92 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.487 1.117 . . . . 74.53 108.311 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -46.59 152.67 0.44 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.552 1.158 . . . . 73.32 110.292 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.798 HG23 HG23 ' A' ' 385' ' ' ILE . 2.1 mt -100.54 153.11 4.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.463 1.102 . . . . 63.4 109.323 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.468 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 5.1 mmtt -113.98 -46.24 3.02 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 74.25 109.273 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.457 ' C ' HG23 ' A' ' 418' ' ' THR . . . -121.5 129.66 7.81 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.466 1.103 . . . . 72.45 111.03 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . 0.647 ' CG2' HG21 ' A' ' 415' ' ' ILE . 82.8 p -152.96 136.17 15.7 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.473 0.749 . . . . 64.5 110.378 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 13.4 pm0 -168.1 150.54 5.27 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.534 1.146 . . . . 63.32 110.327 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.4 Cg_endo -74.95 102.11 1.55 Allowed 'Trans proline' 0 C--N 1.359 1.11 0 O-C-N 124.514 1.797 . . . . 74.25 111.052 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.885 HD11 HG22 ' A' ' 423' ' ' VAL . 0.7 OUTLIER -103.9 156.4 5.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.475 1.11 . . . . 70.2 109.308 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . 0.568 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 14.2 mt -110.39 105.9 19.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.501 1.125 . . . . 74.33 109.293 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.885 HG22 HD11 ' A' ' 421' ' ' ILE . 18.7 t -77.79 146.74 7.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.493 1.12 . . . . 73.15 109.302 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.639 ' O ' HG23 ' A' ' 355' ' ' VAL . 76.0 m-20 -129.2 143.55 49.28 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.504 1.127 . . . . 64.13 109.299 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 174.03 13.5 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.529 1.805 . . . . 64.03 111.018 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . 0.483 ' CD1' ' C ' ' A' ' 426' ' ' PHE . 2.8 t80 . . . . . 0 C--N 1.325 -0.491 0 O-C-N 124.482 1.114 . . . . 73.53 111.01 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.019 0 N-CA-C 111.009 -0.836 . . . . 72.13 111.009 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 178.68 6.94 Favored 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.54 1.81 . . . . 71.22 111.005 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -69.33 -174.6 0.68 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.449 1.093 . . . . 71.34 109.626 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 6.0 ptt? -130.98 6.31 4.6 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.499 1.124 . . . . 71.04 111.031 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -90.54 -10.56 63.39 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.502 1.126 . . . . 62.21 111.02 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 2.3 p -87.36 144.43 26.77 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.473 0.749 . . . . 73.3 109.993 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -91.28 -178.09 5.04 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.539 1.149 . . . . 74.01 109.297 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . 0.534 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 25.9 m-70 -138.95 140.87 38.41 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.53 1.143 . . . . 53.13 109.608 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.454 HG13 HD13 ' A' ' 421' ' ' ILE . 35.8 mt -130.16 136.02 59.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.125 . . . . 74.41 109.311 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -103.37 129.93 50.56 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.471 1.107 . . . . 72.11 109.319 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 424' ' ' ASP . 12.7 t -77.56 157.62 5.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 75.1 109.328 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.5 p -122.25 148.81 44.54 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.505 1.128 . . . . 62.32 110.398 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' GLN . . . . . 0.618 ' CG ' ' CE2' ' A' ' 426' ' ' PHE . 3.1 mt-30 -47.52 -38.44 14.06 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.133 . . . . 72.01 110.29 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -58.28 -37.1 74.32 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.511 1.132 . . . . 71.02 110.296 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -74.56 -66.74 0.7 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.52 1.138 . . . . 44.44 110.292 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . 0.42 ' O ' ' N ' ' A' ' 364' ' ' CYS . 7.0 t80 -40.98 -62.07 0.88 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.553 1.158 . . . . 75.51 111.056 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -48.84 -48.83 41.47 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.535 1.147 . . . . 73.41 110.303 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 9.9 tt -58.62 -32.4 68.99 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.493 1.121 . . . . 35.01 109.313 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' PTR . . . . . 0.657 ' CD1' ' HZ1' ' A' ' 374' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . 0.42 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m -67.5 -27.33 66.91 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.55 1.156 . . . . 71.31 108.318 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -77.23 -8.24 57.25 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.493 1.121 . . . . 52.22 110.342 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 8.0 mmt -102.61 -29.93 11.25 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.528 1.143 . . . . 55.41 111.003 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 89.93 30.01 14.04 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.498 1.124 . . . . 54.21 110.997 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 1.1 p -144.66 -175.01 4.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.469 0.746 . . . . 71.32 109.991 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.416 ' O ' ' CE ' ' A' ' 374' ' ' LYS . 11.7 p -118.79 167.32 11.81 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.452 1.095 . . . . 72.3 110.395 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.574 ' CD2' HG11 ' A' ' 423' ' ' VAL . 38.2 t80 -71.2 -65.37 0.75 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 63.41 110.999 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.542 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.3 OUTLIER -43.67 -27.2 0.29 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 51.14 110.335 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.901 HD22 ' N ' ' A' ' 373' ' ' CYS . 0.5 OUTLIER -74.16 136.08 42.86 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.472 1.108 . . . . 71.01 109.309 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . 0.901 ' N ' HD22 ' A' ' 372' ' ' LEU . 32.1 p -68.48 130.75 43.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.008 -0.996 . . . . 71.55 110.878 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.657 ' HZ1' ' CD1' ' A' ' 363' ' ' PTR . 28.8 mmtp -92.97 31.46 1.41 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.488 1.118 . . . . 75.21 109.337 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.655 HD11 ' HE1' ' A' ' 410' ' ' PHE . 18.8 mt -112.31 -59.74 3.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.509 1.13 . . . . 34.52 109.276 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 4.0 m -107.41 -22.01 12.72 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.471 1.107 . . . . 54.24 108.312 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.703 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 54.76 40.3 31.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.511 1.132 . . . . 64.31 109.335 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -121.51 -40.28 2.58 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.499 1.125 . . . . 74.33 110.322 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -124.03 179.18 4.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.527 1.142 . . . . 71.3 109.278 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -89.45 165.84 14.07 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.557 1.161 . . . . 72.44 109.307 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.467 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 17.2 mttt -66.49 -62.63 1.36 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.561 1.163 . . . . 75.22 109.28 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 33.9 t0 59.91 22.71 11.74 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.51 1.131 . . . . 52.11 109.301 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.901 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -156.75 174.62 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.524 1.14 . . . . 53.13 109.29 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.405 ' CG ' ' N ' ' A' ' 385' ' ' ILE . 47.1 tttt -158.44 158.48 34.23 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.442 1.089 . . . . 64.22 109.311 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.831 HG22 ' SG ' ' A' ' 388' ' ' CYS . 14.8 mm -118.32 144.75 25.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.521 1.138 . . . . 74.03 109.268 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.537 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.0 mt-10 -136.86 162.35 56.36 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.435 1.084 . . . . 74.03 110.291 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.537 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.04 -13.69 23.59 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 121.023 -2.491 . . . . 75.32 111.02 0.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . 0.831 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.8 -84.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.953 -1.021 . . . . 45.52 110.892 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 128.36 41.99 0.26 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.507 1.129 . . . . 73.55 110.964 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.52 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 27.2 m80 -97.55 137.9 35.78 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.526 0.78 . . . . 72.41 109.56 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.706 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -106.64 150.82 25.83 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.501 1.126 . . . . 62.02 109.286 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.901 ' O ' HG12 ' A' ' 383' ' ' VAL . 16.3 ptp -167.48 166.33 14.33 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.467 1.104 . . . . 44.15 111.011 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 8.8 p -90.9 124.54 35.27 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 1.128 . . . . 61.5 108.254 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 10.6 m -47.93 -56.85 6.64 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.5 1.125 . . . . 52.32 110.39 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 4.1 m -44.94 -27.15 0.5 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.521 1.138 . . . . 72.55 110.019 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . 0.442 ' O ' ' HB3' ' A' ' 399' ' ' ALA . 1.9 m -83.26 -51.61 7.3 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.495 1.122 . . . . 72.35 108.346 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.661 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -40.97 -52.25 3.14 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.532 1.145 . . . . 75.55 109.292 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . 0.63 ' N ' HD13 ' A' ' 397' ' ' LEU . 2.7 m -53.04 -43.11 66.36 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.525 1.141 . . . . 71.22 110.416 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -57.19 -26.13 60.14 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.538 1.149 . . . . 73.45 109.329 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' TRP . . . . . 0.596 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 10.3 t-105 -85.62 -62.52 1.51 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.998 -1.112 . . . . 70.23 107.998 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.499 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.4 mm-40 -56.13 -14.15 2.5 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.514 1.134 . . . . 64.14 110.342 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 398' ' ' THR . 3.0 mm-40 -37.12 -63.39 0.43 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.488 1.118 . . . . 75.32 110.292 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.4 t -121.3 -24.61 5.42 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.543 1.152 . . . . 75.22 109.978 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . 0.596 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 15.0 m-20 -82.63 -94.28 0.06 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.458 1.098 . . . . 74.3 109.334 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.499 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 72.56 30.23 64.59 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.516 1.135 . . . . 63.51 111.002 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.901 HE21 HH21 ' A' ' 412' ' ' ARG . 0.6 OUTLIER -91.36 71.37 6.09 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.508 0.769 . . . . 74.4 110.322 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 61.74 -167.81 14.58 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.547 1.154 . . . . 72.22 111.011 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . 0.657 ' SG ' HG21 ' A' ' 385' ' ' ILE . 5.7 t -56.26 125.99 66.77 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 108.29 -1.004 . . . . 75.25 108.29 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.94 0.17 9.2 Favored 'Trans proline' 0 C--N 1.359 1.104 0 O-C-N 124.521 1.801 . . . . 74.52 111.003 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . 0.655 ' HE1' HD11 ' A' ' 375' ' ' ILE . 3.6 m-85 -94.67 -55.78 3.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.107 . . . . 72.52 111.027 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' CYS . . . . . 0.436 ' O ' ' N ' ' A' ' 413' ' ' CYS . 2.4 p -98.95 12.86 34.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 62.23 108.293 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' ARG . . . . . 0.901 HH21 HE21 ' A' ' 406' ' ' GLN . 14.2 mmm-85 38.55 30.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.476 1.11 . . . . 61.42 110.288 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.3 m -119.76 163.22 17.79 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.53 1.144 . . . . 75.21 108.332 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.31 154.8 34.15 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.525 1.141 . . . . 74.41 110.293 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.749 HG23 HG23 ' A' ' 385' ' ' ILE . 1.9 mt -104.61 143.49 16.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.438 1.087 . . . . 64.33 109.279 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.451 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 3.5 mmtp -109.85 -46.37 3.5 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.559 1.162 . . . . 53.12 109.321 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.479 ' C ' HG23 ' A' ' 418' ' ' THR . . . -124.36 139.66 12.05 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.541 1.151 . . . . 73.12 110.994 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . 0.598 ' CG2' HG21 ' A' ' 415' ' ' ILE . 72.3 p -153.92 126.43 8.07 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.517 0.775 . . . . 63.41 110.359 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.21 151.12 23.65 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.489 1.118 . . . . 73.13 110.332 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.96 102.11 1.55 Allowed 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.514 1.797 . . . . 72.03 111.037 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.883 HD11 HG22 ' A' ' 423' ' ' VAL . 0.7 OUTLIER -103.87 155.03 5.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.131 . . . . 71.34 109.29 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . 0.541 ' N ' HD12 ' A' ' 421' ' ' ILE . 19.4 mt -109.37 105.99 19.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.567 1.167 . . . . 73.43 109.307 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.883 HG22 HD11 ' A' ' 421' ' ' ILE . 17.1 t -76.23 146.94 8.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.434 1.084 . . . . 74.34 109.265 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.768 ' O ' HG23 ' A' ' 355' ' ' VAL . 1.8 t70 -128.68 143.5 48.7 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.523 1.139 . . . . 73.11 109.352 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 176.19 10.22 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.481 1.779 . . . . 63.3 111.053 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . 0.618 ' CE2' ' CG ' ' A' ' 357' ' ' GLN . 5.9 t80 . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.542 1.151 . . . . 74.51 111.042 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.005 0 N-CA-C 110.995 -0.842 . . . . 62.22 110.995 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 178.73 6.88 Favored 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.496 1.788 . . . . 75.21 111.056 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -136.83 124.02 21.76 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.551 1.157 . . . . 73.01 109.61 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 55.4 tpp -151.07 144.99 25.19 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.5 1.125 . . . . 44.33 110.966 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -88.54 67.72 2.99 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.51 1.131 . . . . 70.25 111.032 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.7 p -122.95 134.46 54.34 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.481 0.754 . . . . 74.42 110.043 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -87.89 -175.07 4.99 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.514 1.134 . . . . 73.51 109.28 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . 0.547 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 39.0 m-70 -142.05 146.93 36.04 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.517 1.136 . . . . 73.13 109.627 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 58.4 mt -130.83 158.63 43.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.484 1.115 . . . . 62.42 109.247 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -128.36 134.03 48.77 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.547 1.154 . . . . 72.25 109.3 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 424' ' ' ASP . 43.8 t -95.28 164.29 2.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.487 1.117 . . . . 72.23 109.274 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.468 ' N ' ' CG1' ' A' ' 355' ' ' VAL . 71.2 p -125.69 157.39 37.45 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.542 1.151 . . . . 63.33 110.406 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' GLN . . . . . 0.597 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 7.1 mt-30 -53.9 -46.29 71.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.469 1.105 . . . . 72.33 110.275 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -44.04 -30.46 0.74 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.504 1.127 . . . . 75.1 110.339 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . 0.529 ' OE1' ' CD1' ' A' ' 370' ' ' PHE . 58.8 mt-30 -83.58 -66.86 0.84 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.471 1.107 . . . . 42.43 110.287 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 364' ' ' CYS . 3.9 t80 -38.15 -38.56 0.34 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.499 1.124 . . . . 64.33 110.999 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -63.71 -52.36 60.86 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.431 1.082 . . . . 63.55 110.292 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 2.1 tp -61.59 -32.11 72.2 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.442 1.089 . . . . 55.43 109.287 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' PTR . . . . . 0.501 ' CE2' ' HA ' ' A' ' 370' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m -72.92 -21.68 60.86 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.531 1.145 . . . . 52.44 108.317 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -75.14 -51.95 12.16 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.461 1.101 . . . . 71.41 110.306 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 24.3 ptp -68.06 -15.14 63.47 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.506 1.128 . . . . 71.41 111.0 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 75.04 34.65 51.88 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.482 1.114 . . . . 54.22 111.012 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.1 -178.03 4.91 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 0.759 . . . . 64.24 110.026 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.823 HG22 ' NE2' ' A' ' 371' ' ' GLN . 2.0 m -117.35 161.22 19.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.132 . . . . 72.05 110.424 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.529 ' CD1' ' OE1' ' A' ' 359' ' ' GLN . 67.2 t80 -62.51 -69.39 0.26 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.51 1.131 . . . . 74.43 110.954 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.823 ' NE2' HG22 ' A' ' 369' ' ' THR . 0.2 OUTLIER -44.95 -25.9 0.36 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.533 1.146 . . . . 73.31 110.295 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.511 HD22 ' HA ' ' A' ' 377' ' ' ALA . 0.2 OUTLIER -62.26 132.32 52.32 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.479 1.112 . . . . 71.35 109.263 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 5.1 t -68.32 124.43 23.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.954 -1.021 . . . . 73.11 110.893 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.611 ' HB3' ' HZ3' ' A' ' 374' ' ' LYS . 1.4 mmmm -90.88 18.46 6.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.517 1.136 . . . . 72.33 109.294 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 1.011 HD11 ' CZ ' ' A' ' 410' ' ' PHE . 64.2 mt -109.81 -25.7 3.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.524 1.14 . . . . 64.35 109.283 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' CYS . . . . . 0.54 ' O ' ' HB3' ' A' ' 377' ' ' ALA . 5.8 p -132.28 -48.66 0.92 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.131 . . . . 65.44 108.31 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 376' ' ' CYS . . . 73.79 44.54 0.27 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.459 1.1 . . . . 75.2 109.318 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -123.68 -42.27 2.21 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.497 1.123 . . . . 75.14 110.297 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -133.82 176.83 8.21 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.509 1.131 . . . . 74.5 109.316 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -84.96 149.53 25.56 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.499 1.124 . . . . 75.33 109.264 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 392' ' ' MET . 22.1 mttt -51.83 -55.9 17.22 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.455 1.097 . . . . 52.52 109.313 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 1.1 p30 52.28 25.45 3.4 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.511 1.132 . . . . 61.52 109.301 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.895 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -153.92 176.09 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.475 1.109 . . . . 71.22 109.343 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.601 ' HE3' HD11 ' A' ' 391' ' ' LEU . 8.9 ttmt -158.46 148.26 19.63 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.498 1.124 . . . . 74.2 109.347 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.738 HD12 HD13 ' A' ' 415' ' ' ILE . 16.8 mm -112.16 141.25 28.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.53 1.144 . . . . 73.32 109.283 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.523 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.2 mt-10 -138.14 161.34 60.02 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.498 1.124 . . . . 73.5 110.331 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.523 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.99 -9.76 24.02 Favored 'Cis proline' 0 C--N 1.36 1.144 0 C-N-CA 121.006 -2.498 . . . . 74.02 111.031 0.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . 0.446 ' SG ' ' ND1' ' A' ' 390' ' ' HIS . 4.2 t -36.68 -72.96 0.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.965 -1.016 . . . . 73.35 110.936 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.34 15.72 6.94 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.47 1.106 . . . . 73.32 111.018 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.446 ' ND1' ' SG ' ' A' ' 388' ' ' CYS . 16.6 m170 -82.08 135.94 35.26 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 0.767 . . . . 73.34 109.627 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.678 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -102.63 160.1 14.87 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.537 1.148 . . . . 73.11 109.327 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.895 ' O ' HG12 ' A' ' 383' ' ' VAL . 15.2 ptp -173.07 175.31 3.25 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 1.131 . . . . 74.14 111.016 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . 0.424 ' O ' ' N ' ' A' ' 396' ' ' CYS . 20.0 p -96.94 114.92 26.58 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.55 1.156 . . . . 62.13 108.307 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 28.6 m -38.85 -59.8 0.92 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.49 1.119 . . . . 64.1 110.4 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.3 p -43.27 -42.46 4.41 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.509 1.13 . . . . 61.32 109.976 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . 0.424 ' N ' ' O ' ' A' ' 393' ' ' CYS . 2.8 m -67.8 -51.39 49.37 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.456 1.098 . . . . 72.3 108.312 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.688 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -45.67 -46.51 14.74 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.5 1.125 . . . . 71.24 109.319 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . 0.559 ' N ' HD13 ' A' ' 397' ' ' LEU . 1.1 m -56.67 -35.55 68.54 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 74.14 110.434 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -69.08 -21.13 64.08 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.522 1.139 . . . . 62.25 109.283 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' TRP . . . . . 0.602 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 8.9 t-105 -85.71 -61.29 1.79 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.506 1.129 . . . . 63.12 108.025 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.501 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 8.6 mm-40 -56.2 -14.24 2.63 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.121 . . . . 63.31 110.34 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 401' ' ' GLN . 1.0 OUTLIER -37.14 -63.36 0.44 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.513 1.133 . . . . 74.23 110.277 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.5 m -121.08 -24.57 5.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.102 . . . . 75.43 109.959 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . 0.602 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 3.1 m-20 -83.21 -95.09 0.06 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 70.51 109.341 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.501 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 73.96 27.6 66.32 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.548 1.155 . . . . 61.32 111.001 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -89.37 67.83 7.82 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.497 0.763 . . . . 75.31 110.279 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 61.86 -163.25 24.9 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.546 1.154 . . . . 71.25 110.989 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . 0.424 ' SG ' HG21 ' A' ' 385' ' ' ILE . 4.9 t -56.23 127.6 70.98 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 108.325 -0.991 . . . . 54.23 108.325 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 0.3 9.06 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.452 1.764 . . . . 65.13 111.014 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . 1.011 ' CZ ' HD11 ' A' ' 375' ' ' ILE . 9.1 m-85 -93.37 -48.15 6.55 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.56 1.162 . . . . 71.21 111.016 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' CYS . . . . . 0.44 ' O ' ' N ' ' A' ' 413' ' ' CYS . 1.1 p -109.35 13.06 24.4 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.535 1.147 . . . . 74.51 108.312 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 38.48 30.46 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.471 1.107 . . . . 74.03 110.282 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' CYS . . . . . 0.44 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.6 m -113.31 155.06 25.82 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.587 1.179 . . . . 72.35 108.296 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -59.25 158.95 8.3 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.451 1.094 . . . . 63.12 110.307 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.738 HD13 HD12 ' A' ' 385' ' ' ILE . 7.2 mt -114.31 156.86 15.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.518 1.136 . . . . 54.43 109.329 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.428 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 20.3 mmtt -125.63 -46.72 1.72 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 73.24 109.305 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 418' ' ' THR . . . -111.28 133.56 11.59 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.494 1.122 . . . . 72.52 111.008 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 417' ' ' GLY . 23.4 p -157.06 116.21 3.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.513 0.772 . . . . 74.45 110.386 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.65 151.42 42.7 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.501 1.125 . . . . 74.4 110.325 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 101.79 1.51 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.56 1.821 . . . . 72.21 111.047 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.768 HD11 HG22 ' A' ' 423' ' ' VAL . 0.8 OUTLIER -103.89 158.67 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.484 1.115 . . . . 74.34 109.248 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . 0.593 ' N ' HD12 ' A' ' 421' ' ' ILE . 11.4 mt -112.29 107.16 22.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.532 1.145 . . . . 65.01 109.277 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.768 HG22 HD11 ' A' ' 421' ' ' ILE . 20.5 t -75.39 149.6 6.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.472 1.107 . . . . 71.52 109.293 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.663 ' O ' HG23 ' A' ' 355' ' ' VAL . 6.9 t0 -126.73 132.95 24.53 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.498 1.124 . . . . 73.34 109.336 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 163.03 36.21 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.543 1.812 . . . . 71.12 111.039 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . 0.597 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 1.1 t80 . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.485 1.116 . . . . 72.34 111.037 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.028 0 N-CA-C 111.002 -0.839 . . . . 55.11 111.002 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 178.59 7.05 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.501 1.79 . . . . 73.43 110.998 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -111.39 121.37 45.04 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 1.135 . . . . 70.34 109.621 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 6.9 mtt -91.15 134.21 34.72 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.473 1.108 . . . . 70.24 110.991 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 152.21 -51.29 0.5 Allowed Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.484 1.115 . . . . 52.24 111.022 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . 0.459 ' HB3' ' CD1' ' A' ' 422' ' ' ILE . 60.7 m -64.95 140.48 58.87 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.497 0.763 . . . . 73.34 110.026 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -90.68 172.75 8.45 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.533 1.146 . . . . 71.43 109.309 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . 0.522 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 27.3 m-70 -132.99 130.93 40.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 1.14 . . . . 73.42 109.653 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.612 HD12 ' CD1' ' A' ' 421' ' ' ILE . 61.9 mt -119.0 150.71 21.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 65.54 109.29 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.29 139.12 50.72 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.569 1.168 . . . . 51.54 109.285 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 424' ' ' ASP . 21.9 t -87.74 122.59 39.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.504 1.127 . . . . 65.13 109.281 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.7 p -84.52 140.97 31.08 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.532 1.145 . . . . 72.12 110.391 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' GLN . . . . . 0.456 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 7.1 mt-30 -41.06 -33.66 0.35 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.537 1.148 . . . . 62.43 110.304 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -56.55 -49.1 75.82 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.531 1.144 . . . . 61.02 110.306 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . 0.443 ' HB2' HG13 ' A' ' 355' ' ' VAL . 11.0 mm-40 -60.24 -66.76 0.47 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 74.33 110.325 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . 0.442 ' O ' ' N ' ' A' ' 364' ' ' CYS . 5.7 t80 -38.89 -41.36 0.74 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.481 1.113 . . . . 71.51 110.985 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -63.63 -54.03 42.22 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.5 1.125 . . . . 75.1 110.301 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.6 tp -56.26 -33.83 65.82 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.485 1.116 . . . . 54.31 109.329 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' PTR . . . . . 0.411 ' N ' ' HD1' ' A' ' 363' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . 0.442 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.9 m -70.15 -32.36 70.3 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.523 1.14 . . . . 73.1 108.304 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -65.38 -15.21 62.35 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.485 1.116 . . . . 75.43 110.269 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 2.5 ptp -126.0 2.07 7.28 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.54 1.15 . . . . 72.34 110.979 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 49.96 48.38 38.3 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.492 1.12 . . . . 71.11 111.034 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 6.5 t -115.88 177.99 4.48 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.45 0.735 . . . . 73.24 110.003 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 2.2 p -124.37 135.21 53.14 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.539 1.149 . . . . 74.42 110.373 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.545 ' CD2' HG11 ' A' ' 423' ' ' VAL . 32.5 t80 -64.1 -66.08 0.59 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.126 . . . . 65.13 110.997 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.581 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.3 OUTLIER -43.08 -27.16 0.19 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.499 1.124 . . . . 74.24 110.345 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.933 HD22 ' N ' ' A' ' 373' ' ' CYS . 0.4 OUTLIER -73.18 135.91 44.68 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.539 1.149 . . . . 65.51 109.281 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . 0.933 ' N ' HD22 ' A' ' 372' ' ' LEU . 31.6 p -64.13 128.53 36.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.025 -0.989 . . . . 64.35 110.908 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.4 ' HZ1' ' CD2' ' A' ' 363' ' ' PTR . 25.5 mmtp -93.07 29.26 1.9 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.491 1.119 . . . . 73.25 109.279 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.653 HG21 ' HB3' ' A' ' 396' ' ' CYS . 35.4 mt -108.29 -60.5 2.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.539 1.149 . . . . 71.32 109.276 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 14.3 p -107.93 -22.36 12.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 52.25 108.278 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.567 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 58.79 46.97 13.35 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.463 1.102 . . . . 75.33 109.306 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -131.64 -44.77 0.98 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.453 1.096 . . . . 63.42 110.275 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -113.24 -179.98 3.8 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.492 1.12 . . . . 64.52 109.283 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -94.63 162.73 13.67 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.458 1.099 . . . . 72.51 109.284 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.44 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 20.3 mttt -65.76 -62.54 1.45 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.461 1.1 . . . . 75.1 109.324 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 420' ' ' PRO . 4.1 t70 60.17 20.34 9.67 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.487 1.117 . . . . 61.35 109.314 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.924 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -149.71 176.09 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.483 1.114 . . . . 72.3 109.296 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.437 ' HD2' HD11 ' A' ' 353' ' ' ILE . 17.5 tttm -159.13 156.39 28.98 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.478 1.111 . . . . 71.42 109.27 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.855 HG22 ' SG ' ' A' ' 388' ' ' CYS . 11.5 mm -122.67 144.16 33.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.51 1.132 . . . . 74.42 109.277 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.537 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.0 OUTLIER -137.68 162.34 55.18 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.554 1.159 . . . . 75.11 110.283 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.537 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.99 -12.46 23.95 Favored 'Cis proline' 0 C--N 1.36 1.153 0 C-N-CA 120.983 -2.507 . . . . 70.11 110.98 -0.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . 0.855 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.34 -71.72 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.011 -0.995 . . . . 73.33 110.925 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.0 16.86 6.57 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.545 1.153 . . . . 73.15 110.981 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.564 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 20.0 m80 -74.46 146.41 42.82 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.483 0.755 . . . . 63.33 109.622 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.814 HD22 ' N ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -116.85 158.2 24.35 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.527 1.142 . . . . 65.14 109.301 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.924 ' O ' HG12 ' A' ' 383' ' ' VAL . 14.2 ptp -173.45 173.37 3.49 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.507 1.129 . . . . 71.42 111.032 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 4.7 p -97.33 119.13 35.29 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.489 1.118 . . . . 74.21 108.309 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 4.5 m -47.05 -41.04 16.09 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.543 1.152 . . . . 64.1 110.378 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.5 p -55.42 -43.12 75.02 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 73.43 110.028 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . 0.653 ' HB3' HG21 ' A' ' 375' ' ' ILE . 4.9 m -70.17 -44.32 69.02 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.133 . . . . 55.11 108.32 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.432 HD13 ' C ' ' A' ' 397' ' ' LEU . 1.6 tm? -44.97 -47.84 11.41 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.529 1.143 . . . . 75.32 109.27 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 3.2 m -55.75 -35.24 65.97 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.464 1.103 . . . . 73.15 110.388 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -66.93 -23.45 65.97 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.127 . . . . 65.4 109.271 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' TRP . . . . . 0.414 ' O ' ' HB2' ' A' ' 404' ' ' ASP . 7.7 t-105 -85.91 -58.69 2.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 73.54 107.985 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.51 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 5.5 mm-40 -62.45 -9.84 9.73 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.564 1.165 . . . . 75.51 110.314 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 401' ' ' GLN . 1.0 OUTLIER -37.14 -63.9 0.4 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.428 1.08 . . . . 75.2 110.311 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 6.2 p -121.98 -25.04 5.04 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.505 1.128 . . . . 74.34 109.987 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 400' ' ' TRP . 3.1 m-20 -82.33 -92.52 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 61.13 109.289 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.51 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 75.53 32.19 55.17 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.516 1.135 . . . . 70.53 111.006 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -89.35 75.56 7.68 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.473 0.749 . . . . 73.51 110.275 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 57.34 -161.58 8.75 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.471 1.107 . . . . 40.0 110.986 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . 0.681 ' SG ' HG21 ' A' ' 385' ' ' ILE . 6.8 t -58.02 130.03 82.81 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 108.291 -1.003 . . . . 72.42 108.291 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -0.16 9.63 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.449 1.763 . . . . 65.4 110.994 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . 0.564 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 3.8 m-85 -97.64 -41.46 8.11 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.492 1.12 . . . . 60.15 111.004 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' CYS . . . . . 0.442 ' C ' ' N ' ' A' ' 413' ' ' CYS . 0.1 OUTLIER -111.19 8.75 21.73 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.537 1.148 . . . . 54.31 108.322 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 408' ' ' CYS . 12.7 tpp85 38.44 30.35 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.462 1.101 . . . . 32.4 110.275 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' CYS . . . . . 0.442 ' N ' ' C ' ' A' ' 411' ' ' CYS . 1.2 m -124.97 160.77 28.18 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.534 1.146 . . . . 74.01 108.335 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -55.79 149.06 15.29 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.516 1.135 . . . . 63.34 110.276 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.659 HG23 HG23 ' A' ' 385' ' ' ILE . 1.7 mt -94.06 146.35 6.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.544 1.152 . . . . 75.5 109.28 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.93 -49.11 3.18 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.523 1.139 . . . . 74.02 109.305 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.419 ' C ' ' CG2' ' A' ' 418' ' ' THR . . . -129.19 139.24 10.82 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.532 1.145 . . . . 53.35 111.015 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . 0.658 ' CG2' HG21 ' A' ' 415' ' ' ILE . 50.7 p -151.84 141.21 21.52 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.503 0.766 . . . . 73.14 110.369 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -170.25 149.66 3.28 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.466 1.104 . . . . 73.23 110.325 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 382' ' ' ASP . 18.3 Cg_endo -75.01 102.24 1.57 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.505 1.792 . . . . 73.33 111.013 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.735 HD11 HG22 ' A' ' 423' ' ' VAL . 0.9 OUTLIER -103.86 162.76 4.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.559 1.162 . . . . 63.15 109.315 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . 0.568 ' N ' HD12 ' A' ' 421' ' ' ILE . 3.3 mp -113.27 106.41 20.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 71.33 109.322 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.735 HG22 HD11 ' A' ' 421' ' ' ILE . 40.5 t -76.95 144.65 11.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.482 1.114 . . . . 73.04 109.307 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.774 ' O ' HG23 ' A' ' 355' ' ' VAL . 1.1 m-20 -130.72 143.68 50.34 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.501 1.125 . . . . 65.31 109.323 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 172.46 16.33 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.51 1.795 . . . . 62.02 110.992 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . 0.456 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 7.5 t80 . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.502 1.126 . . . . 73.12 110.958 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.97 0 N-CA-C 111.024 -0.83 . . . . 35.34 111.024 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 178.65 6.99 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.523 1.802 . . . . 74.44 111.03 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -152.58 153.46 33.43 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.538 1.149 . . . . 44.34 109.608 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 29.7 ttp -103.2 -67.42 0.88 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.51 1.131 . . . . 73.14 110.983 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -155.29 99.08 0.18 Allowed Glycine 0 CA--C 1.531 1.053 0 O-C-N 124.488 1.118 . . . . 51.14 111.002 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 64.8 m -143.38 153.28 42.54 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.55 0.794 . . . . 40.15 109.944 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . 0.497 ' CG ' HG22 ' A' ' 421' ' ' ILE . 0.1 OUTLIER -84.55 176.64 8.49 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.507 1.129 . . . . 71.24 109.308 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -134.62 137.65 43.85 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.529 1.143 . . . . 72.24 109.567 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 2.1 mm -117.45 155.54 19.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.511 1.132 . . . . 64.4 109.276 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.09 137.54 53.5 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.459 1.1 . . . . 73.51 109.289 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 424' ' ' ASP . 23.5 t -96.81 140.23 17.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.521 1.138 . . . . 73.11 109.254 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 22.0 p -107.31 154.14 21.72 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.54 1.15 . . . . 72.11 110.404 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' GLN . . . . . 0.557 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 12.4 mt-30 -49.92 -44.21 50.16 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.517 1.136 . . . . 74.41 110.31 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -45.13 -38.13 4.92 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.455 1.097 . . . . 75.12 110.283 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -74.22 -59.41 2.74 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.444 1.09 . . . . 75.33 110.304 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -43.48 -55.46 4.19 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.488 1.117 . . . . 73.41 111.035 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -55.33 -37.69 67.75 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.539 1.149 . . . . 70.2 110.325 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.472 HD22 ' HA ' ' A' ' 362' ' ' LEU . 1.0 OUTLIER -63.29 -38.4 91.02 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.48 1.113 . . . . 70.31 109.309 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' PTR . . . . . 0.458 ' CE1' ' HA ' ' A' ' 370' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 3.0 m -66.7 -25.61 66.62 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.472 1.108 . . . . 73.4 108.344 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -71.74 -20.61 61.87 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.486 1.116 . . . . 64.51 110.326 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -124.06 6.13 8.58 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.443 1.09 . . . . 52.22 110.993 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 363' ' ' PTR . . . 45.27 52.91 8.21 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.47 1.106 . . . . 62.12 110.985 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 10.6 t -119.91 -174.83 2.84 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.522 0.778 . . . . 52.34 110.011 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 5.6 p -127.87 133.66 49.35 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.496 1.123 . . . . 74.32 110.42 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.458 ' HA ' ' CE1' ' A' ' 363' ' ' PTR . 68.0 t80 -64.33 -63.95 1.01 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.466 1.104 . . . . 65.2 110.997 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.556 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -44.1 -26.85 0.33 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.564 1.165 . . . . 65.32 110.301 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.653 HD11 ' HA ' ' A' ' 377' ' ' ALA . 2.0 tm? -78.81 141.82 37.43 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.496 1.123 . . . . 72.01 109.279 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . 0.623 ' O ' HD13 ' A' ' 372' ' ' LEU . 15.1 t -75.63 150.99 37.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.967 -1.015 . . . . 72.44 110.89 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -110.9 23.7 13.84 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.534 1.146 . . . . 75.03 109.282 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 12.0 mt -108.12 -50.81 7.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 75.42 109.265 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' CYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 377' ' ' ALA . 1.6 m -107.52 -42.55 4.75 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.524 1.14 . . . . 75.55 108.283 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.653 ' HA ' HD11 ' A' ' 372' ' ' LEU . . . 72.09 47.43 0.3 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.533 1.146 . . . . 74.25 109.306 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -132.25 -66.56 0.69 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.517 1.136 . . . . 61.01 110.321 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -99.49 159.73 14.81 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.495 1.122 . . . . 64.3 109.304 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -73.14 152.05 41.31 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.506 1.129 . . . . 73.31 109.274 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.465 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 23.5 mttt -49.88 -62.51 1.52 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.476 1.11 . . . . 71.32 109.284 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . 0.406 ' HA ' ' O ' ' A' ' 421' ' ' ILE . 40.5 m-20 59.73 24.96 13.9 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.472 1.108 . . . . 75.14 109.253 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.93 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -156.08 172.83 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.462 1.101 . . . . 72.42 109.289 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.451 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 48.5 tttp -155.67 136.58 13.61 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.491 1.119 . . . . 71.35 109.293 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.72 HG21 ' SG ' ' A' ' 408' ' ' CYS . 15.2 mm -102.18 137.3 30.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.467 1.104 . . . . 73.24 109.317 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.521 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.0 OUTLIER -138.02 161.31 60.4 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.5 1.125 . . . . 71.25 110.298 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.521 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.97 -7.17 22.95 Favored 'Cis proline' 0 C--N 1.36 1.136 0 C-N-CA 120.982 -2.508 . . . . 74.12 111.034 -0.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . 0.54 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 50.7 t -36.8 -73.89 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.967 -1.015 . . . . 64.1 110.932 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.32 15.52 7.05 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.544 1.152 . . . . 72.4 110.987 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.54 ' CG ' ' SG ' ' A' ' 388' ' ' CYS . 68.3 m170 -86.7 126.07 34.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.538 0.787 . . . . 74.01 109.605 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.703 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -96.11 158.83 15.26 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.475 1.109 . . . . 62.23 109.272 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.93 ' O ' HG12 ' A' ' 383' ' ' VAL . 20.4 ptp -172.78 175.87 3.27 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 73.24 110.996 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 2.3 p -99.64 114.75 28.02 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.478 1.111 . . . . 70.03 108.293 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 29.2 m -46.54 -24.81 0.58 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.492 1.12 . . . . 72.23 110.448 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.4 p -67.11 -42.49 84.43 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.102 . . . . 72.42 109.99 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 399' ' ' ALA . 76.1 m -80.74 -49.83 10.66 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.507 1.129 . . . . 64.41 108.279 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.778 HD12 ' SD ' ' A' ' 392' ' ' MET . 2.7 tt -45.62 -48.3 14.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.116 . . . . 73.0 109.315 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.11 -34.77 61.09 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.533 1.145 . . . . 64.52 110.398 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -62.83 -27.11 69.1 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.436 1.085 . . . . 73.35 109.275 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' TRP . . . . . 0.52 ' CD2' ' HB3' ' A' ' 409' ' ' PRO . 3.7 t-105 -79.59 -53.15 7.13 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.518 1.136 . . . . 73.4 108.019 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.51 HE21 HD21 ' A' ' 397' ' ' LEU . 7.1 mm-40 -62.13 -10.02 9.2 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.49 1.119 . . . . 75.42 110.318 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 401' ' ' GLN . 5.3 mm-40 -37.08 -63.59 0.42 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.103 . . . . 73.44 110.293 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 18.2 t -121.54 -24.58 5.32 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.525 1.14 . . . . 73.22 110.015 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . 0.46 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 3.1 m-20 -83.88 -94.76 0.06 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.492 1.12 . . . . 70.21 109.281 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.498 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 73.93 32.59 58.65 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.504 1.128 . . . . 44.01 111.022 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -89.02 63.18 6.6 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.541 0.789 . . . . 75.35 110.304 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 68.52 -162.59 50.03 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.52 1.138 . . . . 64.12 110.978 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . 0.72 ' SG ' HG21 ' A' ' 385' ' ' ILE . 3.2 t -56.56 122.86 53.48 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 108.313 -0.995 . . . . 50.41 108.313 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.52 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.3 Cg_endo -74.98 -1.87 11.79 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.497 1.788 . . . . 61.24 111.017 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . 0.55 ' CD2' ' HE2' ' A' ' 392' ' ' MET . 2.6 m-85 -89.16 -41.3 12.34 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 73.0 111.031 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' A' ' 412' ' ' ARG . 0.7 OUTLIER -117.56 11.86 13.91 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.527 1.142 . . . . 44.11 108.3 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 411' ' ' CYS . 14.5 tpp85 38.53 46.14 0.94 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.517 1.136 . . . . 55.23 110.294 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 4.1 t -131.04 150.44 52.15 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.499 1.124 . . . . 61.1 108.297 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -58.07 152.76 15.99 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.489 1.118 . . . . 75.42 110.329 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.702 HD13 HD12 ' A' ' 385' ' ' ILE . 2.2 mt -107.2 154.81 8.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.457 1.098 . . . . 63.04 109.318 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -119.56 -41.44 2.7 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.478 1.111 . . . . 64.04 109.334 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.477 ' C ' HG23 ' A' ' 418' ' ' THR . . . -119.0 127.73 7.35 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.506 1.129 . . . . 73.1 110.987 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . 0.559 ' CG2' HG21 ' A' ' 415' ' ' ILE . 42.2 p -154.26 125.09 7.15 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.526 0.78 . . . . 64.03 110.356 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -155.4 151.97 23.68 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.484 1.115 . . . . 73.33 110.287 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.451 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.3 Cg_endo -74.99 100.32 1.35 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.501 1.79 . . . . 63.42 111.014 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.75 HD12 ' N ' ' A' ' 422' ' ' ILE . 1.0 OUTLIER -107.18 171.09 2.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 124.512 1.132 . . . . 71.51 109.296 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . 0.75 ' N ' HD12 ' A' ' 421' ' ' ILE . 6.2 mm -121.22 109.92 26.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 73.13 109.3 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.701 HG22 HD11 ' A' ' 421' ' ' ILE . 2.5 t -75.86 140.38 17.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 74.03 109.317 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.742 ' O ' HG23 ' A' ' 355' ' ' VAL . 44.9 m-20 -130.19 143.79 50.57 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.516 1.135 . . . . 72.11 109.282 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 164.97 32.28 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.439 1.757 . . . . 72.31 111.02 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . 0.557 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 19.3 t80 . . . . . 0 C--N 1.324 -0.506 0 O-C-N 124.503 1.127 . . . . 74.4 111.028 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.011 0 N-CA-C 110.984 -0.846 . . . . 75.51 110.984 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.96 178.26 7.48 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.538 1.81 . . . . 74.51 111.033 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.26 167.24 13.47 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.505 1.128 . . . . 64.14 109.586 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . 0.418 ' N ' ' SD ' ' A' ' 348' ' ' MET . 0.0 OUTLIER -119.58 122.91 42.64 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.483 1.115 . . . . 72.41 110.985 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -120.56 47.89 0.99 Allowed Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.53 1.144 . . . . 72.21 110.973 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 67.0 m -58.9 134.3 56.8 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.473 0.749 . . . . 64.02 109.983 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . 0.55 ' HB2' HG22 ' A' ' 421' ' ' ILE . 1.3 m-20 -77.12 -177.95 4.77 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.541 1.151 . . . . 63.45 109.324 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -137.41 125.94 23.59 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 73.32 109.586 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 2.2 mm -118.04 111.88 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.51 1.131 . . . . 64.24 109.262 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.31 149.84 28.76 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.459 1.099 . . . . 75.12 109.3 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 424' ' ' ASP . 13.1 t -96.19 136.54 26.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.534 1.146 . . . . 50.14 109.315 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 11.6 p -95.21 143.16 26.84 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.514 1.134 . . . . 64.11 110.425 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' GLN . . . . . 0.508 ' CG ' ' CZ ' ' A' ' 426' ' ' PHE . 12.0 mt-30 -42.4 -43.4 3.56 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.156 . . . . 52.52 110.3 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -46.8 -50.14 18.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.469 1.106 . . . . 74.14 110.245 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 362' ' ' LEU . 9.9 mm100 -60.09 -66.79 0.46 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.523 1.139 . . . . 74.32 110.285 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -38.25 -39.23 0.41 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 74.15 110.985 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -70.91 -47.38 59.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.494 1.121 . . . . 71.11 110.253 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.791 ' O ' HD23 ' A' ' 362' ' ' LEU . 4.9 tt -58.05 -33.57 69.15 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.456 1.098 . . . . 73.45 109.293 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' PTR . . . . . 0.452 ' CE1' ' O2P' ' A' ' 363' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 2.4 m -64.18 -29.61 70.71 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.504 1.127 . . . . 72.02 108.308 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -66.68 -18.72 65.52 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.462 1.102 . . . . 72.13 110.338 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -126.58 8.6 7.02 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 74.44 110.959 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 42.74 54.61 4.95 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.538 1.149 . . . . 63.13 111.007 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 62.2 m -121.25 179.0 4.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.523 0.778 . . . . 72.32 110.008 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 2.3 p -124.81 131.38 53.45 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.489 1.118 . . . . 62.21 110.44 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.533 ' CD2' HG11 ' A' ' 423' ' ' VAL . 34.9 t80 -60.7 -65.1 0.74 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.472 1.108 . . . . 73.33 111.025 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.546 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -43.54 -26.93 0.25 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.522 1.138 . . . . 73.43 110.227 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.413 ' N ' ' C ' ' A' ' 370' ' ' PHE . 0.0 OUTLIER -71.65 123.28 22.17 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.505 1.128 . . . . 61.12 109.285 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 30.4 p -55.07 132.51 47.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.006 -0.997 . . . . 41.32 110.94 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.414 ' HZ1' ' HA ' ' A' ' 370' ' ' PHE . 29.8 mmtm -92.93 32.2 1.3 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.465 1.103 . . . . 72.13 109.284 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 5.5 mt -113.35 -60.46 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.543 1.152 . . . . 62.01 109.315 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -108.28 -20.87 12.99 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 75.34 108.294 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.407 ' HA ' HD22 ' A' ' 372' ' ' LEU . . . 55.3 41.12 31.55 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.503 1.127 . . . . 54.11 109.308 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -128.38 -44.71 1.39 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.436 1.085 . . . . 74.31 110.324 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -110.21 174.15 6.0 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 75.15 109.293 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -89.03 162.09 16.21 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.517 1.135 . . . . 70.34 109.323 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 392' ' ' MET . 21.9 mttt -65.21 -55.47 18.31 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.132 . . . . 70.23 109.292 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 381' ' ' LYS . 1.8 p30 50.62 25.58 2.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.462 1.101 . . . . 72.11 109.259 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.891 HG12 ' O ' ' A' ' 392' ' ' MET . 0.3 OUTLIER -154.08 174.76 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.478 1.111 . . . . 74.51 109.263 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 21.1 tttm -158.67 155.77 28.75 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.464 1.102 . . . . 74.31 109.326 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.864 HG22 ' SG ' ' A' ' 388' ' ' CYS . 11.6 mm -121.69 143.78 33.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 73.13 109.314 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.542 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 5.3 mt-10 -137.6 162.49 54.44 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.443 1.089 . . . . 74.14 110.287 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.542 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.99 -12.29 23.98 Favored 'Cis proline' 0 C--N 1.361 1.211 0 C-N-CA 120.977 -2.51 . . . . 73.33 111.017 -0.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . 0.864 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.48 -71.81 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.953 -1.021 . . . . 74.41 110.927 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 115.73 18.58 6.0 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.533 1.145 . . . . 74.4 111.028 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.584 ' CE1' ' HB2' ' A' ' 388' ' ' CYS . 20.6 m80 -76.56 145.52 38.96 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.524 0.779 . . . . 72.2 109.58 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.809 HD22 ' N ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -117.3 155.47 29.47 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.477 1.11 . . . . 55.01 109.273 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.891 ' O ' HG12 ' A' ' 383' ' ' VAL . 18.7 ptp -172.14 172.85 4.48 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 72.41 111.016 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 4.5 p -91.69 115.3 27.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.444 1.09 . . . . 73.44 108.295 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 397' ' ' LEU . 27.3 m -47.83 -57.54 5.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.514 1.134 . . . . 62.23 110.401 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.9 t -45.56 -26.11 0.55 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.534 1.146 . . . . 71.44 109.976 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 399' ' ' ALA . 2.2 m -88.01 -41.33 13.19 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.533 1.146 . . . . 54.44 108.288 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.743 ' O ' HD23 ' A' ' 397' ' ' LEU . 3.4 tt -51.61 -45.79 63.35 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.458 1.098 . . . . 74.3 109.306 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.54 -35.91 61.23 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.551 1.157 . . . . 71.04 110.428 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -62.05 -27.87 69.19 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.467 1.105 . . . . 72.11 109.325 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' TRP . . . . . 0.579 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 5.1 t-105 -79.38 -52.42 8.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.026 -1.101 . . . . 74.25 108.026 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.514 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 10.0 mm-40 -62.99 -9.78 11.28 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 1.106 . . . . 65.45 110.291 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 401' ' ' GLN . 9.8 mm-40 -37.05 -63.78 0.4 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.44 1.088 . . . . 54.42 110.298 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 6.6 t -123.61 -24.8 4.46 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.481 1.113 . . . . 74.41 109.972 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . 0.579 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 0.9 OUTLIER -81.61 -90.18 0.07 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.456 1.098 . . . . 74.04 109.295 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.514 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 67.51 32.65 79.4 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.493 1.121 . . . . 70.32 111.037 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -91.74 66.93 5.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 0.772 . . . . 65.42 110.331 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 70.04 -161.21 53.16 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.497 1.123 . . . . 33.4 111.041 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . 0.688 ' SG ' HG21 ' A' ' 385' ' ' ILE . 7.1 t -62.45 130.68 93.52 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.314 -0.995 . . . . 64.12 108.314 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.94 -1.77 11.64 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.504 1.792 . . . . 61.45 111.003 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . 0.479 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 3.2 m-85 -95.63 -41.32 8.96 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.529 1.143 . . . . 72.34 110.982 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' CYS . . . . . 0.452 ' SG ' ' CE1' ' A' ' 390' ' ' HIS . 0.1 OUTLIER -111.08 8.59 21.86 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 75.23 108.277 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 408' ' ' CYS . 5.7 tpt85 38.39 30.71 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.488 1.117 . . . . 72.45 110.318 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' CYS . . . . . 0.441 ' N ' ' O ' ' A' ' 411' ' ' CYS . 42.1 t -127.77 151.1 49.44 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.512 1.133 . . . . 75.0 108.326 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -49.81 151.1 1.9 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.46 1.1 . . . . 75.15 110.292 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.699 HG21 ' CG2' ' A' ' 418' ' ' THR . 1.9 mt -99.38 150.43 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.484 1.115 . . . . 73.33 109.355 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.459 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 15.2 mmtt -110.51 -45.37 3.54 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.515 1.134 . . . . 64.42 109.299 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.448 ' C ' HG23 ' A' ' 418' ' ' THR . . . -129.07 135.0 8.22 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.498 1.124 . . . . 53.24 110.987 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . 0.699 ' CG2' HG21 ' A' ' 415' ' ' ILE . 80.9 p -152.47 130.53 11.85 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.534 0.785 . . . . 73.44 110.421 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -158.26 153.36 21.6 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.534 1.146 . . . . 65.14 110.263 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.44 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.2 Cg_endo -75.01 102.64 1.61 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.498 1.788 . . . . 73.1 110.977 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.68 HD12 ' N ' ' A' ' 422' ' ' ILE . 1.0 OUTLIER -103.85 167.73 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.47 1.106 . . . . 73.55 109.304 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . 0.68 ' N ' HD12 ' A' ' 421' ' ' ILE . 6.0 mm -118.9 109.65 27.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.453 1.096 . . . . 75.42 109.277 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.664 HG22 HD11 ' A' ' 421' ' ' ILE . 23.7 t -79.74 144.35 10.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.495 1.122 . . . . 75.13 109.261 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.749 ' O ' HG23 ' A' ' 355' ' ' VAL . 4.1 m-20 -131.4 143.5 49.5 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.437 1.086 . . . . 71.44 109.299 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 160.47 40.09 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.467 1.772 . . . . 71.4 111.005 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . 0.508 ' CZ ' ' CG ' ' A' ' 357' ' ' GLN . 3.3 t80 . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.494 1.121 . . . . 73.3 111.013 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.031 0 N-CA-C 110.994 -0.842 . . . . 24.54 110.994 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 178.16 7.63 Favored 'Trans proline' 0 C--N 1.359 1.115 0 O-C-N 124.558 1.82 . . . . 71.15 111.004 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 48.0 54.43 10.08 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.483 1.114 . . . . 72.34 109.59 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 8.0 ttp -61.42 97.81 0.07 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.524 1.14 . . . . 73.5 111.047 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -173.47 152.82 16.31 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.506 1.129 . . . . 42.42 110.975 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 44.6 m -90.32 134.23 34.45 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.519 0.776 . . . . 75.23 109.973 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . 0.551 ' HB2' HG22 ' A' ' 421' ' ' ILE . 13.3 m-20 -88.77 162.7 16.08 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.522 1.139 . . . . 71.1 109.295 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . 0.426 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 14.2 m-70 -126.18 138.64 53.67 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.488 1.117 . . . . 75.44 109.579 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 21.9 mt -121.72 137.1 56.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.47 1.106 . . . . 74.32 109.298 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -107.93 123.55 48.79 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.513 1.133 . . . . 71.42 109.345 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 424' ' ' ASP . 4.4 t -72.42 156.6 6.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.456 1.097 . . . . 72.03 109.29 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 359' ' ' GLN . 2.8 p -124.04 145.29 49.32 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.527 1.142 . . . . 62.05 110.414 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' GLN . . . . . 0.518 ' HG2' ' CE2' ' A' ' 426' ' ' PHE . 10.7 mt-30 -40.86 -46.75 2.81 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.47 1.106 . . . . 72.11 110.305 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -50.16 -45.07 53.03 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 1.139 . . . . 64.41 110.299 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 356' ' ' THR . 70.4 mt-30 -64.28 -66.55 0.53 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.521 1.138 . . . . 75.35 110.309 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . 0.421 ' O ' ' N ' ' A' ' 364' ' ' CYS . 2.4 t80 -41.47 -39.12 1.43 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.562 1.164 . . . . 73.42 110.987 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -66.67 -54.11 26.66 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.522 1.139 . . . . 72.31 110.278 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.8 tp -54.89 -34.33 62.91 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.562 1.163 . . . . 72.54 109.281 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' PTR . . . . . 0.534 ' HD1' ' HZ1' ' A' ' 374' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . 0.421 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m -63.99 -25.25 68.04 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.435 1.085 . . . . 71.12 108.293 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.84 -2.73 44.78 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 64.22 110.28 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 8.1 mmt -105.88 -34.91 7.49 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.518 1.137 . . . . 72.3 111.026 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 100.79 16.88 24.98 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.461 1.101 . . . . 54.45 110.998 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 7.0 m -142.84 172.57 12.52 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.521 0.777 . . . . 54.23 110.019 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 11.6 p -98.9 -175.19 2.97 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.532 1.145 . . . . 55.13 110.411 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.533 ' CD2' HG11 ' A' ' 423' ' ' VAL . 27.6 t80 -83.55 -67.18 0.81 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.539 1.149 . . . . 70.01 111.02 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.547 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -39.41 -29.76 0.05 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.499 1.125 . . . . 61.25 110.275 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.427 ' N ' ' C ' ' A' ' 370' ' ' PHE . 0.0 OUTLIER -69.97 115.43 9.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.508 1.13 . . . . 70.41 109.322 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 25.3 p -47.48 149.82 1.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.99 -1.005 . . . . 73.34 110.9 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.534 ' HZ1' ' HD1' ' A' ' 363' ' ' PTR . 24.5 mmtp -106.08 24.14 12.9 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 70.43 109.307 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.499 HD11 ' HE1' ' A' ' 410' ' ' PHE . 14.6 mt -100.73 -61.13 2.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 72.1 109.271 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 26.9 p -107.92 -22.41 12.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 65.35 108.274 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . 61.89 41.39 11.53 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.109 . . . . 71.24 109.294 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -134.64 -45.93 0.74 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.481 1.113 . . . . 75.33 110.249 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -101.41 168.28 9.62 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.538 1.149 . . . . 72.23 109.314 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.82 157.27 17.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.564 1.165 . . . . 72.14 109.296 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 392' ' ' MET . 0.7 OUTLIER -70.22 -62.1 1.52 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.442 1.089 . . . . 72.33 109.311 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 421' ' ' ILE . 1.3 p30 51.86 21.85 1.57 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.509 1.131 . . . . 74.45 109.306 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.869 HG12 ' O ' ' A' ' 392' ' ' MET . 0.3 OUTLIER -152.75 154.69 7.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.122 . . . . 72.3 109.24 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -141.73 153.72 44.81 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 65.33 109.292 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.887 HG22 ' SG ' ' A' ' 388' ' ' CYS . 22.8 mm -113.85 138.71 42.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.514 1.134 . . . . 72.0 109.275 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.571 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 1.8 mt-10 -129.73 163.32 47.76 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.472 1.108 . . . . 63.31 110.278 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.571 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.98 -18.56 18.59 Favored 'Cis proline' 0 C--N 1.36 1.158 0 C-N-CA 120.975 -2.51 . . . . 53.25 111.022 -0.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . 0.887 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -35.61 -91.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.991 -1.004 . . . . 64.03 110.899 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 136.22 44.24 0.1 OUTLIER Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.499 1.124 . . . . 73.21 110.995 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 19.6 m170 -104.37 114.12 28.14 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.461 0.742 . . . . 64.55 109.648 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 391' ' ' LEU . 5.9 mp -84.72 169.73 13.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.123 . . . . 73.45 109.311 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.869 ' O ' HG12 ' A' ' 383' ' ' VAL . 17.2 ptp -179.76 165.6 1.3 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.54 1.15 . . . . 65.14 111.01 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 396' ' ' CYS . 4.8 p -90.78 115.43 27.84 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.493 1.121 . . . . 64.5 108.301 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 20.7 m -38.72 -59.45 0.94 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.46 1.1 . . . . 53.44 110.4 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 6.7 m -42.24 -41.97 2.91 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.533 1.146 . . . . 72.1 109.983 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . 0.445 ' O ' ' N ' ' A' ' 399' ' ' ALA . 3.6 m -68.86 -56.68 7.17 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.463 1.102 . . . . 75.45 108.34 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.716 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -40.95 -36.02 0.6 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.503 1.127 . . . . 73.13 109.283 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 22.7 m -62.61 -49.44 75.21 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 72.14 110.394 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -54.33 -22.45 12.15 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.475 1.109 . . . . 35.0 109.313 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' TRP . . . . . 0.606 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 11.8 t-105 -85.44 -64.9 1.08 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.483 1.115 . . . . 73.31 108.01 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.502 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 12.5 mm-40 -52.34 -17.5 1.19 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.478 1.111 . . . . 63.21 110.312 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 401' ' ' GLN . 7.5 mt-10 -37.02 -63.31 0.43 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.481 1.113 . . . . 74.32 110.332 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 10.3 t -121.65 -24.5 5.3 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.5 1.125 . . . . 63.15 110.006 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . 0.606 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 19.5 m-20 -82.34 -93.78 0.06 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.501 1.125 . . . . 75.45 109.293 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.502 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 68.1 27.63 73.63 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.477 1.11 . . . . 53.12 111.03 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -88.68 67.04 8.3 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.539 0.788 . . . . 64.3 110.263 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 67.87 -162.7 48.17 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.537 1.148 . . . . 73.0 110.993 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . 0.67 ' SG ' HG21 ' A' ' 385' ' ' ILE . 5.6 t -59.11 125.76 79.42 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 108.324 -0.991 . . . . 63.51 108.324 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.403 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.3 Cg_endo -74.97 -0.28 9.76 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.48 1.779 . . . . 62.04 111.012 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . 0.544 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 5.4 m-85 -95.85 -41.64 8.72 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.48 1.112 . . . . 70.33 110.996 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' CYS . . . . . 0.447 ' SG ' ' ND1' ' A' ' 390' ' ' HIS . 0.4 OUTLIER -112.8 10.43 19.16 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.525 1.14 . . . . 75.33 108.333 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 411' ' ' CYS . 27.5 mmm-85 38.5 31.75 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.448 1.092 . . . . 75.51 110.291 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' CYS . . . . . 0.42 ' N ' ' O ' ' A' ' 411' ' ' CYS . 10.5 t -125.09 146.36 49.49 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.419 1.074 . . . . 65.33 108.289 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -46.42 155.74 0.21 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.533 1.146 . . . . 75.4 110.351 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.705 HG23 HG23 ' A' ' 385' ' ' ILE . 2.3 mt -102.44 156.91 4.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.449 1.093 . . . . 75.43 109.313 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.409 ' CG ' ' HD3' ' A' ' 387' ' ' PRO . 10.3 mmtt -120.28 -43.48 2.52 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.471 1.107 . . . . 70.15 109.297 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 418' ' ' THR . . . -126.78 140.54 12.02 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.486 1.116 . . . . 63.02 111.001 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . 0.595 ' CG2' HG21 ' A' ' 415' ' ' ILE . 17.3 p -157.53 116.7 3.28 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.46 0.741 . . . . 61.44 110.407 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.423 ' OE1' ' N ' ' A' ' 419' ' ' GLU . 23.3 pm0 -139.82 150.5 62.97 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.537 1.148 . . . . 72.43 110.313 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.99 102.34 1.58 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.504 1.791 . . . . 73.41 111.005 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.845 HD12 ' N ' ' A' ' 422' ' ' ILE . 1.3 pp -103.85 -178.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.535 1.147 . . . . 65.51 109.258 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . 0.845 ' N ' HD12 ' A' ' 421' ' ' ILE . 15.2 mt -144.64 115.49 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 64.2 109.305 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.533 HG11 ' CD2' ' A' ' 370' ' ' PHE . 38.9 t -86.45 144.89 8.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.51 1.131 . . . . 73.5 109.326 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.642 ' O ' HG23 ' A' ' 355' ' ' VAL . 5.1 t70 -131.31 143.64 50.14 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.456 1.098 . . . . 74.12 109.345 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . 0.415 ' CD ' ' OE1' ' A' ' 371' ' ' GLN . 18.2 Cg_endo -75.04 170.67 19.91 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.475 1.776 . . . . 61.11 110.963 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . 0.518 ' CE2' ' HG2' ' A' ' 357' ' ' GLN . 6.5 t80 . . . . . 0 C--N 1.325 -0.468 0 O-C-N 124.503 1.127 . . . . 72.22 111.013 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.972 0 N-CA-C 111.016 -0.833 . . . . 63.11 111.016 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 178.7 6.91 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.519 1.8 . . . . 72.32 111.035 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -72.42 82.46 1.07 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 71.43 109.554 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 12.8 mmt -56.57 129.43 40.85 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.53 1.144 . . . . 74.4 110.983 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 163.66 43.06 0.02 OUTLIER Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.512 1.133 . . . . 54.21 111.01 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 2.6 p -118.45 132.07 56.25 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.467 0.746 . . . . 61.12 110.061 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -96.59 179.63 4.93 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.5 1.125 . . . . 73.32 109.292 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . 0.489 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 29.1 m-70 -134.2 135.44 43.03 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.48 1.113 . . . . 54.45 109.587 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.504 HG13 HD13 ' A' ' 421' ' ' ILE . 11.2 mt -116.21 149.14 18.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 75.24 109.262 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.79 137.29 52.84 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 71.22 109.326 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.487 HG22 ' CD2' ' A' ' 370' ' ' PHE . 5.0 t -89.03 141.62 14.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.472 1.107 . . . . 75.12 109.31 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.414 ' OG1' ' CG ' ' A' ' 359' ' ' GLN . 16.6 p -91.55 135.98 33.46 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.486 1.117 . . . . 70.31 110.371 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' GLN . . . . . 0.696 ' CG ' ' CE1' ' A' ' 426' ' ' PHE . 4.4 mt-30 -41.13 -33.15 0.32 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.523 1.139 . . . . 75.11 110.311 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . 0.449 ' CG ' ' N ' ' A' ' 359' ' ' GLN . 13.5 pt-20 -63.56 -50.41 69.59 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.515 1.134 . . . . 72.1 110.324 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . 0.449 ' N ' ' CG ' ' A' ' 358' ' ' GLU . 9.4 mm100 -56.57 -66.72 0.39 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.453 1.096 . . . . 72.21 110.329 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 364' ' ' CYS . 10.1 t80 -38.37 -51.94 1.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.522 1.139 . . . . 73.41 110.961 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -58.28 -60.96 2.95 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.493 1.121 . . . . 65.44 110.275 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 6.0 mt -45.47 -63.9 0.85 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.514 1.134 . . . . 72.34 109.271 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . 0.404 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.5 m -69.06 -23.29 64.02 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.472 1.108 . . . . 72.31 108.275 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -73.54 -3.74 29.66 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.511 1.132 . . . . 74.11 110.297 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 8.0 mmt -114.38 -33.5 5.59 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.527 1.142 . . . . 63.35 110.995 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.14 35.52 3.14 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.499 1.125 . . . . 62.03 110.994 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 24.0 m -148.76 161.16 42.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 0.771 . . . . 74.42 109.965 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.4 ' OG1' ' CB ' ' A' ' 372' ' ' LEU . 11.5 p -96.48 178.93 5.18 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.506 1.129 . . . . 64.24 110.364 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.487 ' CD2' HG22 ' A' ' 355' ' ' VAL . 50.1 t80 -85.03 -58.91 2.5 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 70.34 110.992 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.449 ' CB ' ' HB ' ' A' ' 423' ' ' VAL . 0.1 OUTLIER -54.66 -19.37 5.99 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.49 1.119 . . . . 70.33 110.254 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.797 HD22 ' N ' ' A' ' 373' ' ' CYS . 1.2 tm? -73.15 135.5 44.69 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.503 1.127 . . . . 71.21 109.307 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . 0.797 ' N ' HD22 ' A' ' 372' ' ' LEU . 7.6 t -72.2 132.37 44.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.987 -1.006 . . . . 72.51 110.901 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.439 ' NZ ' ' O ' ' A' ' 372' ' ' LEU . 12.5 mmtm -90.19 17.12 7.41 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.51 1.131 . . . . 52.45 109.289 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.888 HD11 ' CE1' ' A' ' 410' ' ' PHE . 83.0 mt -102.45 -41.62 7.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.505 1.128 . . . . 71.25 109.328 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' CYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 377' ' ' ALA . 0.0 OUTLIER -115.6 -44.49 2.96 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.534 1.146 . . . . 64.31 108.317 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.762 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 70.23 37.96 1.54 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.477 1.111 . . . . 63.03 109.299 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -131.63 -44.48 0.99 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.483 1.114 . . . . 72.44 110.311 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -107.38 172.79 6.63 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.453 1.096 . . . . 42.25 109.34 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -95.52 147.58 23.4 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.512 1.132 . . . . 73.31 109.274 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.465 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 27.4 mttt -55.41 -62.53 1.62 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 72.33 109.3 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 57.89 28.25 15.81 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 63.43 109.284 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.897 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -158.38 175.83 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.515 1.134 . . . . 61.5 109.293 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.456 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 72.6 tttt -157.83 149.34 21.62 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.502 1.126 . . . . 65.41 109.314 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.691 HG13 ' HE3' ' A' ' 392' ' ' MET . 2.6 mm -114.13 138.16 44.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.115 . . . . 75.34 109.328 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.513 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.2 OUTLIER -138.04 160.86 62.68 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.544 1.153 . . . . 74.34 110.303 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.513 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.98 -8.91 23.79 Favored 'Cis proline' 0 C--N 1.36 1.163 0 C-N-CA 120.979 -2.509 . . . . 72.11 111.012 -0.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . 0.539 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 17.5 t -36.84 -75.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.956 -1.02 . . . . 62.11 110.912 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 120.62 7.41 8.9 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.532 1.145 . . . . 72.21 111.015 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.539 ' CG ' ' SG ' ' A' ' 388' ' ' CYS . 56.6 m170 -77.0 131.78 38.63 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.524 0.779 . . . . 74.21 109.612 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.615 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -102.48 168.09 9.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.447 1.092 . . . . 72.15 109.317 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.897 ' O ' HG12 ' A' ' 383' ' ' VAL . 17.3 ptp -179.25 173.84 1.09 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.51 1.131 . . . . 74.42 111.006 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . 0.418 ' O ' ' N ' ' A' ' 396' ' ' CYS . 1.7 p -102.66 117.69 35.21 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 63.45 108.281 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 397' ' ' LEU . 2.5 m -38.7 -60.11 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.484 1.115 . . . . 70.53 110.441 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.8 m -39.3 -41.64 0.93 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.505 1.128 . . . . 44.15 110.042 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . 0.495 ' SG ' HG21 ' A' ' 375' ' ' ILE . 38.3 t -73.9 -49.85 22.94 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.471 1.107 . . . . 44.12 108.284 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.436 ' CD1' ' HG3' ' A' ' 401' ' ' GLN . 1.5 tm? -42.61 -51.03 5.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.469 1.106 . . . . 73.01 109.328 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 402' ' ' GLU . 1.2 m -53.89 -42.05 68.25 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.509 1.131 . . . . 52.43 110.411 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -57.98 -26.59 62.53 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.505 1.128 . . . . 63.22 109.276 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' TRP . . . . . 0.601 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 10.5 t-105 -85.42 -62.58 1.5 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.52 1.137 . . . . 72.35 108.023 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.501 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 8.3 mm-40 -55.94 -14.37 2.46 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 1.122 . . . . 72.54 110.284 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 398' ' ' THR . 2.9 mm-40 -37.12 -63.36 0.44 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 71.13 110.32 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 22.7 t -121.4 -24.59 5.38 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.508 1.13 . . . . 42.42 109.995 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . 0.601 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 6.9 m-20 -82.51 -94.05 0.06 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.475 1.109 . . . . 53.31 109.326 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.501 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 72.42 31.04 63.73 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.475 1.109 . . . . 50.22 110.993 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -88.65 54.13 2.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 0.765 . . . . 74.4 110.272 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 72.02 -163.88 54.39 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.541 1.151 . . . . 33.11 111.024 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . 0.455 ' O ' ' N ' ' A' ' 412' ' ' ARG . 3.7 t -56.05 121.3 40.23 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.31 -0.996 . . . . 63.44 108.31 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 0.69 8.62 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.492 1.785 . . . . 71.31 110.998 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . 0.888 ' CE1' HD11 ' A' ' 375' ' ' ILE . 24.3 m-85 -90.24 -36.34 14.79 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.518 1.136 . . . . 72.2 111.046 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.13 13.69 6.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 73.4 108.31 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 408' ' ' CYS . 14.8 tpp85 38.61 48.82 1.34 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.541 1.151 . . . . 73.02 110.347 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 1.2 m -125.89 150.92 47.55 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.468 1.105 . . . . 51.43 108.281 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 415' ' ' ILE . 5.1 tt0 -59.29 147.62 35.15 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.486 1.117 . . . . 71.01 110.271 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.605 HG21 HG21 ' A' ' 418' ' ' THR . 1.2 mt -89.04 149.11 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.484 1.115 . . . . 62.02 109.283 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.74 -49.82 2.63 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 74.22 109.324 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . -140.58 131.89 5.2 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 124.498 1.124 . . . . 74.13 110.993 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . 0.605 HG21 HG21 ' A' ' 415' ' ' ILE . 1.5 p -147.56 117.89 7.38 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.571 0.807 . . . . 64.12 110.434 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.433 ' O ' HG23 ' A' ' 421' ' ' ILE . 20.5 pt-20 -128.08 150.83 74.85 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.459 1.099 . . . . 70.21 110.309 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 98.51 1.17 Allowed 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.467 1.772 . . . . 65.41 110.994 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.817 HD11 HG22 ' A' ' 423' ' ' VAL . 0.7 OUTLIER -107.45 154.88 8.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.5 1.125 . . . . 71.23 109.292 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . 0.489 ' HB ' ' CE1' ' A' ' 352' ' ' HIS . 4.0 mp -110.67 105.39 18.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.502 1.126 . . . . 74.33 109.306 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.817 HG22 HD11 ' A' ' 421' ' ' ILE . 38.9 t -77.1 145.62 9.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.488 1.118 . . . . 74.5 109.294 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.445 ' O ' HG23 ' A' ' 355' ' ' VAL . 4.5 m-20 -130.54 143.53 49.67 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.491 1.119 . . . . 75.53 109.283 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 161.63 38.46 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.516 1.798 . . . . 62.4 110.997 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . 0.696 ' CE1' ' CG ' ' A' ' 357' ' ' GLN . 3.5 t80 . . . . . 0 C--N 1.326 -0.453 0 O-C-N 124.509 1.131 . . . . 73.14 111.004 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.028 0 N-CA-C 111.022 -0.831 . . . . 43.42 111.022 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 178.66 6.97 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.503 1.791 . . . . 65.14 111.008 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 8.5 m170 62.51 25.6 15.25 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.512 1.133 . . . . 73.13 109.635 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 14.4 ptm -90.68 17.01 8.1 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.481 1.113 . . . . 72.34 111.04 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -83.48 69.52 3.35 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.473 1.108 . . . . 65.12 111.008 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 16.2 m -49.14 145.39 4.26 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.443 0.731 . . . . 70.02 109.964 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -99.67 169.24 9.41 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.511 1.132 . . . . 63.22 109.259 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . 0.506 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 38.4 m-70 -136.3 125.15 24.05 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 72.22 109.629 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.552 HG13 HD13 ' A' ' 421' ' ' ILE . 7.7 mt -105.47 149.76 8.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.521 1.138 . . . . 64.34 109.322 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 13.0 tptp -123.27 123.32 40.49 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.458 1.099 . . . . 73.33 109.3 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 424' ' ' ASP . 55.2 t -79.71 148.87 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.487 1.117 . . . . 74.01 109.298 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 40.2 p -114.2 -178.47 3.38 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.493 1.121 . . . . 74.35 110.385 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -72.81 -36.7 67.59 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 54.34 110.336 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -54.94 -35.33 64.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.537 1.148 . . . . 75.23 110.322 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -79.6 -66.73 0.83 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 1.135 . . . . 75.15 110.306 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 364' ' ' CYS . 12.3 t80 -38.2 -43.23 0.75 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.499 1.124 . . . . 64.01 111.004 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -61.48 -54.15 47.17 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.464 1.103 . . . . 75.35 110.266 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.4 tt -55.36 -35.75 65.59 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.485 1.116 . . . . 70.13 109.267 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 360' ' ' TYR . 3.3 m -71.65 -25.6 62.2 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.463 1.102 . . . . 61.33 108.255 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -71.79 -16.09 62.17 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.535 1.147 . . . . 64.41 110.29 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.94 2.6 6.59 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.461 1.101 . . . . 74.14 110.973 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 50.79 58.69 8.92 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.522 1.139 . . . . 72.34 111.019 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 84.5 p -129.36 177.99 6.78 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 0.757 . . . . 54.35 109.969 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.413 ' HB ' ' NE2' ' A' ' 371' ' ' GLN . 2.3 p -126.03 142.11 51.67 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.479 1.112 . . . . 64.01 110.388 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.615 ' CZ ' ' CD1' ' A' ' 391' ' ' LEU . 54.1 t80 -66.22 -67.96 0.41 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.485 1.116 . . . . 73.33 111.056 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.535 ' NE2' ' H ' ' A' ' 371' ' ' GLN . 0.2 OUTLIER -41.32 -31.8 0.26 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.453 1.096 . . . . 70.3 110.295 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.921 HD22 ' N ' ' A' ' 373' ' ' CYS . 0.5 OUTLIER -67.07 136.39 55.13 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.436 1.085 . . . . 64.42 109.293 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . 0.921 ' N ' HD22 ' A' ' 372' ' ' LEU . 19.3 p -72.17 129.61 38.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.004 -0.998 . . . . 70.02 110.925 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -90.99 18.35 6.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.453 1.096 . . . . 73.1 109.334 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.696 HD11 ' HE1' ' A' ' 410' ' ' PHE . 12.1 mt -92.13 -60.45 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.485 1.116 . . . . 73.14 109.282 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 23.9 p -107.68 -24.04 11.88 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.472 1.108 . . . . 63.21 108.284 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.489 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 60.93 43.24 11.91 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.462 1.102 . . . . 45.1 109.315 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -127.75 -43.65 1.54 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.522 1.139 . . . . 73.24 110.307 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 39.0 m-20 -119.7 177.7 4.85 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.452 1.095 . . . . 74.13 109.349 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -88.3 169.41 11.86 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 73.51 109.303 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.426 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 24.5 mttt -70.55 -62.07 1.53 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.499 1.124 . . . . 63.12 109.312 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 59.92 25.05 14.17 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 63.23 109.301 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.842 HG12 ' O ' ' A' ' 392' ' ' MET . 0.5 OUTLIER -160.8 155.34 3.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 54.23 109.293 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.854 ' HE3' HD21 ' A' ' 391' ' ' LEU . 4.1 ttmt -139.29 137.32 35.75 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.516 1.135 . . . . 65.51 109.274 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.718 HG23 ' CG2' ' A' ' 415' ' ' ILE . 20.2 mm -97.99 139.57 19.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.523 1.139 . . . . 74.25 109.284 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.524 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 0.0 OUTLIER -138.0 161.39 60.0 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.46 1.1 . . . . 72.04 110.28 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.524 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.0 -8.94 23.86 Favored 'Cis proline' 0 C--N 1.36 1.147 0 C-N-CA 121.021 -2.491 . . . . 74.24 111.017 -0.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . 0.544 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 31.3 t -36.55 -72.89 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.951 -1.022 . . . . 70.14 110.926 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 115.58 18.28 6.19 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.485 1.115 . . . . 75.01 111.004 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.544 ' CG ' ' SG ' ' A' ' 388' ' ' CYS . 61.7 m170 -87.77 129.3 35.22 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.518 0.775 . . . . 65.13 109.546 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.854 HD21 ' HE3' ' A' ' 384' ' ' LYS . 0.8 OUTLIER -96.1 160.31 14.51 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.459 1.099 . . . . 72.11 109.262 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.842 ' O ' HG12 ' A' ' 383' ' ' VAL . 15.5 ptp -170.52 173.44 5.53 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.477 1.111 . . . . 73.33 111.019 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 5.0 p -99.15 115.0 28.04 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.483 1.115 . . . . 74.52 108.333 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 17.4 m -42.0 -59.7 1.65 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.496 1.123 . . . . 75.31 110.425 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 10.6 t -41.62 -36.58 0.97 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.478 1.111 . . . . 63.35 109.985 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . 0.455 ' HB3' HG21 ' A' ' 375' ' ' ILE . 2.3 m -75.88 -54.93 6.14 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.467 1.105 . . . . 60.23 108.281 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.734 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.3 OUTLIER -41.34 -35.19 0.61 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.128 . . . . 75.21 109.28 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . 0.414 ' N ' HD13 ' A' ' 397' ' ' LEU . 83.2 m -62.05 -49.76 74.7 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.512 1.133 . . . . 53.24 110.431 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -55.16 -22.16 16.13 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.473 1.108 . . . . 72.43 109.349 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' TRP . . . . . 0.602 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 16.3 t-105 -84.6 -65.16 1.04 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.516 1.135 . . . . 64.45 108.048 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.51 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 38.3 mm-40 -49.18 -20.81 0.65 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.544 1.152 . . . . 51.2 110.304 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 401' ' ' GLN . 10.4 mt-10 -37.47 -63.53 0.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.479 1.112 . . . . 75.44 110.345 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 3.3 m -122.41 -24.22 5.05 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.497 1.123 . . . . 71.13 109.97 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . 0.602 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 16.9 m-20 -83.54 -95.17 0.06 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.51 1.131 . . . . 74.44 109.253 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.51 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 67.92 23.22 74.29 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.479 1.112 . . . . 61.22 111.01 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -81.51 58.11 3.56 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.556 0.797 . . . . 75.23 110.326 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 69.95 -160.74 53.18 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.503 1.127 . . . . 70.45 111.023 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . 0.616 ' SG ' HG21 ' A' ' 385' ' ' ILE . 4.7 t -56.3 120.3 34.23 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.267 -1.012 . . . . 64.54 108.267 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.412 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.2 Cg_endo -74.95 0.43 8.89 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.454 1.765 . . . . 74.33 110.978 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . 0.696 ' HE1' HD11 ' A' ' 375' ' ' ILE . 3.6 m-30 -93.8 -37.23 11.88 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.485 1.116 . . . . 74.03 111.0 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -123.26 13.49 9.61 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.49 1.119 . . . . 64.45 108.321 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 408' ' ' CYS . 11.4 mmt85 38.43 40.45 0.37 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 74.54 110.285 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' CYS . . . . . . . . . . . . . 16.0 t -126.66 140.1 52.66 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.49 1.119 . . . . 73.43 108.301 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -45.32 154.25 0.18 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.467 1.104 . . . . 54.33 110.228 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.718 ' CG2' HG23 ' A' ' 385' ' ' ILE . 2.7 mt -109.8 157.19 10.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.48 1.113 . . . . 61.43 109.327 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -129.9 -46.6 1.14 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.492 1.12 . . . . 73.52 109.259 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.555 ' O ' HG23 ' A' ' 418' ' ' THR . . . -107.22 127.14 8.68 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.53 1.144 . . . . 45.14 110.964 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 417' ' ' GLY . 17.5 p -157.47 128.65 6.73 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 0.76 . . . . 71.54 110.395 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.644 ' OE2' HG22 ' A' ' 421' ' ' ILE . 0.0 OUTLIER -160.02 166.39 15.96 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.466 1.104 . . . . 73.11 110.283 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 101.85 1.52 Allowed 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.541 1.811 . . . . 71.3 110.984 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.913 HD12 ' N ' ' A' ' 422' ' ' ILE . 0.6 OUTLIER -103.89 170.18 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.146 . . . . 73.44 109.313 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . 0.913 ' N ' HD12 ' A' ' 421' ' ' ILE . 5.9 mt -137.8 107.63 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.448 1.093 . . . . 71.32 109.284 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.652 ' CG2' HD11 ' A' ' 421' ' ' ILE . 30.7 t -78.16 147.42 7.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.436 1.085 . . . . 70.34 109.264 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.678 ' O ' HG23 ' A' ' 355' ' ' VAL . 5.9 m-20 -129.68 143.72 50.09 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.478 1.112 . . . . 61.12 109.292 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 173.42 14.55 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.489 1.784 . . . . 74.4 111.007 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 15.5 t80 . . . . . 0 C--N 1.324 -0.503 0 O-C-N 124.556 1.16 . . . . 74.22 111.023 179.994 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.01 0 N-CA-C 111.02 -0.832 . . . . 55.12 111.02 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 178.72 6.88 Favored 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.56 1.821 . . . . 71.44 110.985 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -98.22 177.14 5.48 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.46 1.1 . . . . 62.41 109.551 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . 0.41 ' N ' ' SD ' ' A' ' 348' ' ' MET . 1.9 mpt? -123.73 140.66 52.77 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.53 1.144 . . . . 73.44 110.98 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 107.3 -5.68 35.96 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.451 1.094 . . . . 74.13 110.997 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 64.5 m -113.13 144.36 42.78 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.457 0.739 . . . . 61.23 110.007 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . 0.485 ' CG ' HG22 ' A' ' 421' ' ' ILE . 0.3 OUTLIER -79.91 168.41 19.27 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.502 1.126 . . . . 63.13 109.312 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . 0.519 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 26.3 m-70 -132.94 135.85 45.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 64.2 109.578 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 3.3 mm -113.78 153.34 15.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.545 1.153 . . . . 62.03 109.308 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.413 ' CD ' ' O ' ' A' ' 355' ' ' VAL . 0.8 OUTLIER -114.31 136.24 53.19 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.471 1.107 . . . . 74.33 109.298 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 424' ' ' ASP . 5.7 t -98.77 163.74 2.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.539 1.149 . . . . 43.13 109.342 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.494 ' N ' ' CG1' ' A' ' 355' ' ' VAL . 2.4 p -125.63 179.68 5.04 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.536 1.147 . . . . 64.53 110.438 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' GLN . . . . . 0.564 ' HG3' ' CZ ' ' A' ' 426' ' ' PHE . 13.0 mt-30 -75.38 -37.54 60.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.545 1.153 . . . . 71.31 110.281 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -60.88 -31.19 70.66 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.502 1.126 . . . . 65.31 110.305 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . 0.438 ' NE2' ' OG1' ' A' ' 356' ' ' THR . 62.3 mt-30 -74.2 -66.92 0.66 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.5 1.125 . . . . 72.12 110.293 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -47.07 -34.95 6.33 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.531 1.144 . . . . 63.15 111.031 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -73.53 -57.54 3.93 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.439 1.087 . . . . 73.22 110.273 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.669 ' O ' HD23 ' A' ' 362' ' ' LEU . 7.0 tt -51.15 -32.3 22.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.555 1.159 . . . . 72.12 109.28 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' PTR . . . . . 0.752 ' CD2' ' HZ1' ' A' ' 374' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 1.8 m -66.68 -24.35 66.26 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.523 1.14 . . . . 54.03 108.268 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -75.56 -3.93 37.01 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.5 1.125 . . . . 70.32 110.293 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 19.4 mtm -111.38 -33.91 6.27 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.504 1.127 . . . . 72.1 110.98 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 99.66 13.97 36.2 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.485 1.116 . . . . 73.43 111.028 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 66.1 m -120.86 -176.43 3.25 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.505 0.767 . . . . 75.31 109.99 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.813 HG22 ' NE2' ' A' ' 371' ' ' GLN . 1.9 m -115.81 161.54 18.6 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.463 1.102 . . . . 62.04 110.4 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.489 ' CD2' HG22 ' A' ' 355' ' ' VAL . 89.1 t80 -64.39 -68.76 0.33 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.138 . . . . 74.5 110.981 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.813 ' NE2' HG22 ' A' ' 369' ' ' THR . 0.1 OUTLIER -46.69 -34.1 4.83 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.52 1.138 . . . . 71.24 110.268 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.709 HD13 ' O ' ' A' ' 373' ' ' CYS . 2.3 tm? -60.49 141.13 56.86 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 75.3 109.332 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . 0.709 ' O ' HD13 ' A' ' 372' ' ' LEU . 24.0 p -72.13 159.95 33.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.03 -0.986 . . . . 74.12 110.882 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.752 ' HZ1' ' CD2' ' A' ' 363' ' ' PTR . 21.8 mmtp -117.17 28.54 8.43 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.523 1.14 . . . . 71.12 109.314 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.614 HD11 ' HE1' ' A' ' 410' ' ' PHE . 11.5 mt -112.72 -59.64 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.453 1.096 . . . . 63.24 109.329 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 2.0 m -105.05 -14.85 15.27 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.484 1.115 . . . . 51.11 108.334 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.59 ' HA ' HD11 ' A' ' 372' ' ' LEU . . . 52.14 44.98 29.16 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.505 1.128 . . . . 73.1 109.311 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -131.6 -61.93 0.88 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 70.15 110.298 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -95.18 162.88 13.52 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 70.23 109.313 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -85.42 167.89 15.1 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.514 1.134 . . . . 73.34 109.305 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.514 ' HZ1' HD12 ' A' ' 391' ' ' LEU . 0.7 OUTLIER -70.17 -61.05 1.93 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.117 . . . . 73.32 109.282 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . 0.406 ' CG ' ' C ' ' A' ' 381' ' ' LYS . 0.2 OUTLIER 47.51 25.04 0.57 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 72.45 109.278 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.864 HG12 ' O ' ' A' ' 392' ' ' MET . 0.3 OUTLIER -150.91 170.17 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.528 1.143 . . . . 72.32 109.274 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 22.9 tttm -155.29 147.03 23.23 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.454 1.096 . . . . 73.54 109.274 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.823 HD12 HD13 ' A' ' 415' ' ' ILE . 20.6 mm -108.97 135.06 48.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.504 1.127 . . . . 72.43 109.29 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.515 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.8 mt-10 -137.76 161.11 62.01 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.448 1.093 . . . . 74.1 110.326 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.515 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -74.99 -5.63 21.6 Favored 'Cis proline' 0 C--N 1.36 1.155 0 C-N-CA 120.985 -2.506 . . . . 61.4 110.979 0.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . 0.541 ' SG ' ' CG ' ' A' ' 390' ' ' HIS . 17.6 t -37.99 -78.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.008 -0.996 . . . . 55.02 110.892 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 119.23 36.46 0.86 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.485 1.115 . . . . 71.13 110.965 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.541 ' CG ' ' SG ' ' A' ' 388' ' ' CYS . 63.3 m170 -108.5 129.73 55.28 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.52 0.777 . . . . 55.31 109.543 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.514 HD12 ' HZ1' ' A' ' 381' ' ' LYS . 0.8 OUTLIER -98.66 160.41 14.29 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.471 1.107 . . . . 72.4 109.307 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.864 ' O ' HG12 ' A' ' 383' ' ' VAL . 20.5 ptp -177.99 170.9 1.82 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.544 1.152 . . . . 62.34 110.999 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 5.0 p -89.83 114.78 26.58 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.463 1.102 . . . . 64.34 108.296 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 397' ' ' LEU . 3.4 m -46.98 -55.53 7.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.48 1.113 . . . . 73.21 110.447 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 71.5 m -46.41 -29.29 1.64 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 61.02 110.047 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 399' ' ' ALA . 1.9 m -86.19 -37.92 18.2 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.565 1.166 . . . . 71.12 108.266 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.74 ' O ' HD23 ' A' ' 397' ' ' LEU . 3.0 tt -53.88 -47.05 71.46 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.534 1.146 . . . . 63.44 109.338 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.09 -35.28 61.93 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 1.114 . . . . 73.13 110.409 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -63.01 -26.49 68.88 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.515 1.135 . . . . 64.1 109.305 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' TRP . . . . . 0.492 ' CD2' ' HB3' ' A' ' 409' ' ' PRO . 3.7 t-105 -80.85 -52.87 7.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.97 -1.122 . . . . 74.44 107.97 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.509 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.2 mm-40 -61.74 -10.28 8.41 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.512 1.132 . . . . 65.03 110.339 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 401' ' ' GLN . 37.7 mt-10 -37.23 -63.7 0.42 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.531 1.145 . . . . 65.44 110.287 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.8 m -123.12 -24.88 4.62 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.487 1.117 . . . . 73.34 109.985 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . 0.491 ' OD2' ' CH2' ' A' ' 400' ' ' TRP . 0.6 OUTLIER -81.71 -90.9 0.07 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.486 1.116 . . . . 65.22 109.283 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.509 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 69.41 32.51 71.79 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.461 1.101 . . . . 54.4 111.02 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -91.11 64.85 5.4 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.503 0.766 . . . . 74.2 110.295 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 66.07 -156.41 49.96 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.528 1.143 . . . . 74.01 111.006 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . 0.754 ' SG ' HG21 ' A' ' 385' ' ' ILE . 5.4 t -57.39 127.22 76.78 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 108.267 -1.012 . . . . 71.32 108.267 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.552 ' HD2' ' HE1' ' A' ' 392' ' ' MET . 18.3 Cg_endo -75.04 0.33 9.05 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.506 1.793 . . . . 75.31 110.99 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . 0.614 ' HE1' HD11 ' A' ' 375' ' ' ILE . 3.3 m-85 -93.59 -39.49 10.8 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.54 1.15 . . . . 74.01 110.991 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.5 OUTLIER -119.8 12.47 12.14 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.505 1.128 . . . . 72.43 108.254 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' ARG . . . . . 0.442 ' HD2' ' CH2' ' A' ' 400' ' ' TRP . 37.4 mmm-85 38.5 31.73 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.509 1.131 . . . . 72.51 110.274 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' CYS . . . . . 0.422 ' N ' ' O ' ' A' ' 411' ' ' CYS . 42.8 t -114.74 151.12 34.24 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.513 1.133 . . . . 75.32 108.255 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -55.16 149.1 12.93 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.516 1.135 . . . . 74.02 110.335 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.823 HD13 HD12 ' A' ' 385' ' ' ILE . 4.0 mt -107.24 157.2 7.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.546 1.154 . . . . 73.14 109.294 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -126.64 -46.78 1.57 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.48 1.113 . . . . 72.14 109.275 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 418' ' ' THR . . . -107.32 127.08 8.64 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.535 1.147 . . . . 42.44 110.97 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 417' ' ' GLY . 17.1 p -157.57 117.79 3.44 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.48 0.753 . . . . 75.33 110.413 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -143.6 150.59 51.27 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.521 1.138 . . . . 73.14 110.273 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.49 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.3 Cg_endo -75.06 102.47 1.59 Allowed 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.475 1.776 . . . . 74.21 110.972 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.673 HD12 ' N ' ' A' ' 422' ' ' ILE . 1.2 pp -103.88 172.05 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.466 1.104 . . . . 71.43 109.267 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . 0.673 ' N ' HD12 ' A' ' 421' ' ' ILE . 19.5 mm -130.83 115.14 29.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.512 1.133 . . . . 72.24 109.266 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.418 ' CG2' HD11 ' A' ' 421' ' ' ILE . 18.9 t -84.68 141.67 14.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.488 1.118 . . . . 74.13 109.326 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.577 ' O ' HG23 ' A' ' 355' ' ' VAL . 1.0 OUTLIER -128.61 143.44 48.43 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.506 1.129 . . . . 74.23 109.327 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.04 174.44 12.79 Favored 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.5 1.789 . . . . 73.2 110.974 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . 0.564 ' CZ ' ' HG3' ' A' ' 357' ' ' GLN . 10.1 t80 . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.489 1.118 . . . . 73.03 111.037 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.035 0 N-CA-C 110.964 -0.854 . . . . 73.32 110.964 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 178.71 6.9 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.513 1.796 . . . . 60.15 111.028 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.54 146.37 41.83 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.451 1.094 . . . . 72.5 109.596 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . 0.45 ' N ' ' SD ' ' A' ' 348' ' ' MET . 0.0 OUTLIER -44.93 167.34 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.524 1.14 . . . . 63.25 110.978 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -59.48 108.51 1.7 Allowed Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.504 1.128 . . . . 71.21 111.006 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 5.7 p -142.73 143.47 32.27 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.496 0.763 . . . . 73.41 109.979 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -93.48 -178.88 4.87 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 1.12 . . . . 65.23 109.306 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . 0.531 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 30.8 m-70 -139.31 145.96 39.74 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.469 1.105 . . . . 61.44 109.58 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 96.5 mt -133.71 142.6 41.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.528 1.142 . . . . 71.12 109.33 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.84 148.2 29.87 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.503 1.127 . . . . 65.0 109.258 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 424' ' ' ASP . 51.8 t -112.99 164.18 9.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.499 1.124 . . . . 63.01 109.331 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.464 ' N ' HG12 ' A' ' 355' ' ' VAL . 2.5 p -124.17 171.92 9.45 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.51 1.131 . . . . 71.23 110.441 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' GLN . . . . . 0.545 ' HG3' ' CZ ' ' A' ' 426' ' ' PHE . 5.4 mt-30 -66.32 -35.88 81.51 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.514 1.134 . . . . 71.05 110.28 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -55.94 -47.62 77.23 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.51 1.131 . . . . 74.24 110.351 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -59.48 -58.67 7.57 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.477 1.11 . . . . 65.04 110.305 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . 0.438 ' O ' ' N ' ' A' ' 364' ' ' CYS . 13.1 t80 -55.0 -33.12 62.31 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.486 1.116 . . . . 71.33 110.992 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -60.73 -47.71 85.09 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.466 1.104 . . . . 62.52 110.247 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.427 ' N ' ' CD1' ' A' ' 362' ' ' LEU . 0.4 OUTLIER -70.44 -44.84 67.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.493 1.12 . . . . 41.44 109.309 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' PTR . . . . . 0.434 ' CD2' ' HZ1' ' A' ' 374' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m -84.27 -21.57 31.06 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.456 1.097 . . . . 73.02 108.287 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -77.64 -4.65 47.09 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.485 1.115 . . . . 73.43 110.312 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . 0.427 ' CG ' ' O ' ' A' ' 363' ' ' PTR . 19.8 ptp -116.44 -32.24 5.32 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.47 1.106 . . . . 74.21 110.978 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.62 40.37 3.65 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.566 1.166 . . . . 43.42 111.01 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 68.5 m -145.1 171.84 13.93 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.539 0.788 . . . . 61.11 109.987 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.807 HG22 ' NE2' ' A' ' 371' ' ' GLN . 1.8 m -115.07 162.71 16.64 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.547 1.155 . . . . 43.22 110.37 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.416 ' HA ' ' CE2' ' A' ' 363' ' ' PTR . 43.7 t80 -66.46 -68.53 0.37 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 63.12 111.004 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.807 ' NE2' HG22 ' A' ' 369' ' ' THR . 0.2 OUTLIER -46.05 -26.82 0.8 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.493 1.121 . . . . 74.23 110.29 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.939 HD22 ' N ' ' A' ' 373' ' ' CYS . 0.4 OUTLIER -71.18 135.74 47.73 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.501 1.126 . . . . 70.15 109.298 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . 0.939 ' N ' HD22 ' A' ' 372' ' ' LEU . 12.3 p -67.19 134.23 51.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.018 -0.992 . . . . 62.15 110.928 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.434 ' HZ1' ' CD2' ' A' ' 363' ' ' PTR . 28.8 mmtp -92.41 34.5 1.05 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.565 1.166 . . . . 74.52 109.312 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 49.8 mt -112.6 -60.35 2.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.545 1.153 . . . . 71.43 109.292 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -109.04 -18.31 13.69 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.484 1.115 . . . . 63.22 108.298 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.761 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 52.57 52.86 13.25 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.485 1.116 . . . . 63.32 109.328 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -135.19 -49.41 0.73 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.504 1.128 . . . . 75.42 110.326 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -111.89 165.36 12.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.531 1.144 . . . . 75.43 109.305 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -79.89 163.01 24.68 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 63.32 109.28 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.462 ' CE ' ' HB2' ' A' ' 391' ' ' LEU . 22.5 mttt -70.13 -62.6 1.32 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.475 1.109 . . . . 73.01 109.286 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 26.5 t0 60.25 23.74 13.14 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.541 1.151 . . . . 73.42 109.291 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.916 HG12 ' O ' ' A' ' 392' ' ' MET . 0.4 OUTLIER -153.4 176.12 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.463 1.102 . . . . 45.41 109.312 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -157.91 154.66 28.25 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.475 1.109 . . . . 71.11 109.296 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.804 HG22 ' SG ' ' A' ' 388' ' ' CYS . 11.6 mm -122.04 142.48 38.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.455 1.097 . . . . 73.14 109.321 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.557 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 3.1 mt-10 -136.9 162.91 53.1 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.467 1.104 . . . . 64.5 110.29 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.557 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.3 Cg_endo -75.02 -13.47 23.65 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 120.97 -2.513 . . . . 70.24 110.999 -0.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . 0.804 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.12 -71.53 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.978 -1.01 . . . . 52.25 110.911 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.97 16.38 6.28 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.497 1.123 . . . . 74.32 110.985 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.568 ' CE1' ' HB2' ' A' ' 388' ' ' CYS . 20.9 m80 -73.48 145.16 45.87 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 0.763 . . . . 53.43 109.568 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.814 HD22 ' N ' ' A' ' 391' ' ' LEU . 0.0 OUTLIER -117.37 156.57 27.66 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.126 . . . . 75.34 109.345 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.916 ' O ' HG12 ' A' ' 383' ' ' VAL . 12.3 ptp -173.9 173.93 3.14 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.512 1.133 . . . . 73.3 110.999 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 5.3 p -91.39 137.45 32.35 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.446 1.091 . . . . 63.23 108.286 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 98.4 m -65.81 -31.54 72.56 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.466 1.104 . . . . 53.21 110.386 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 60.9 m -72.46 -58.2 3.57 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.523 1.139 . . . . 75.04 109.99 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 399' ' ' ALA . 1.9 p -55.87 -42.84 76.49 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.508 1.13 . . . . 54.41 108.285 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.74 HD22 ' O ' ' A' ' 397' ' ' LEU . 0.4 OUTLIER -45.12 -44.02 10.22 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.519 1.137 . . . . 72.11 109.311 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 402' ' ' GLU . 86.2 m -54.61 -38.47 66.83 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.527 1.142 . . . . 71.2 110.414 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 396' ' ' CYS . . . -55.35 -26.91 43.8 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.46 1.1 . . . . 74.15 109.299 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' TRP . . . . . 0.602 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 8.1 t-105 -85.0 -60.91 1.9 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.985 -1.117 . . . . 72.12 107.985 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.496 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 7.3 mm-40 -56.69 -13.75 2.72 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.482 1.114 . . . . 74.22 110.265 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 398' ' ' THR . 3.6 mm-40 -37.14 -63.41 0.43 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.506 1.129 . . . . 70.44 110.303 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 5.2 t -121.23 -24.62 5.44 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.567 1.167 . . . . 73.52 109.938 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . 0.602 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 17.1 m-20 -82.87 -94.54 0.06 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.457 1.098 . . . . 73.1 109.296 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.496 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 73.17 29.72 64.07 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.46 1.1 . . . . 62.44 110.97 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -88.07 66.09 8.44 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.513 0.773 . . . . 73.24 110.308 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 68.45 -160.03 51.6 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.479 1.112 . . . . 63.23 111.018 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . 0.696 ' SG ' HG21 ' A' ' 385' ' ' ILE . 7.5 t -59.98 131.79 89.44 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 108.282 -1.007 . . . . 74.02 108.282 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -0.07 9.53 Favored 'Trans proline' 0 C--N 1.359 1.124 0 O-C-N 124.547 1.814 . . . . 53.33 110.988 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . 0.568 ' CD1' ' HE1' ' A' ' 392' ' ' MET . 8.4 m-85 -95.11 -43.02 8.3 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 72.32 111.002 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' CYS . . . . . 0.445 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.5 OUTLIER -111.67 9.18 20.98 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.518 1.136 . . . . 73.25 108.285 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' ARG . . . . . . . . . . . . . 39.8 mmm-85 38.58 30.24 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.478 1.111 . . . . 70.33 110.253 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' CYS . . . . . 0.445 ' N ' ' O ' ' A' ' 411' ' ' CYS . 24.2 t -127.46 146.15 50.59 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.463 1.102 . . . . 75.02 108.287 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -42.58 152.13 0.1 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 72.44 110.296 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.731 HG23 HG23 ' A' ' 385' ' ' ILE . 2.1 mt -98.86 148.67 5.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.493 1.121 . . . . 64.14 109.303 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -112.29 -48.42 3.03 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.504 1.128 . . . . 74.43 109.331 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.45 ' C ' HG23 ' A' ' 418' ' ' THR . . . -116.51 129.04 8.23 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.489 1.118 . . . . 61.33 110.979 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . 0.604 ' CG2' HG21 ' A' ' 415' ' ' ILE . 82.0 p -152.82 138.95 18.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.492 0.76 . . . . 71.14 110.386 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.41 ' O ' HG23 ' A' ' 421' ' ' ILE . 1.1 pm0 -167.14 150.84 6.26 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.499 1.124 . . . . 74.33 110.309 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 101.08 1.43 Allowed 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.451 1.764 . . . . 74.02 110.977 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.732 HD11 HG22 ' A' ' 423' ' ' VAL . 0.6 OUTLIER -105.32 157.55 6.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 72.43 109.303 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . 0.672 ' N ' HD12 ' A' ' 421' ' ' ILE . 13.2 mt -114.82 105.39 18.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.529 1.143 . . . . 71.21 109.3 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.732 HG22 HD11 ' A' ' 421' ' ' ILE . 42.5 t -75.18 146.8 8.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.447 1.092 . . . . 75.13 109.267 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.7 ' O ' HG23 ' A' ' 355' ' ' VAL . 1.1 m-20 -128.73 133.59 25.36 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.462 1.101 . . . . 62.2 109.297 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . 0.491 ' CD ' ' OE1' ' A' ' 371' ' ' GLN . 18.2 Cg_endo -74.96 169.71 22.03 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.513 1.796 . . . . 74.52 110.961 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . 0.545 ' CZ ' ' HG3' ' A' ' 357' ' ' GLN . 5.1 t80 . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.449 1.093 . . . . 72.11 111.012 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.003 0 N-CA-C 111.006 -0.838 . . . . 30.24 111.006 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 178.58 7.07 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.475 1.776 . . . . 54.0 110.979 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.401 ' C ' ' SD ' ' A' ' 348' ' ' MET . 2.5 m-70 -125.75 69.65 1.19 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.444 1.09 . . . . 71.43 109.601 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . 0.401 ' SD ' ' C ' ' A' ' 347' ' ' HIS . 3.0 mpp? -150.37 157.25 42.84 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.504 1.127 . . . . 75.5 110.985 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 43.46 52.52 6.23 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.538 1.149 . . . . 63.23 110.996 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 70.5 m -143.67 144.71 31.99 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.44 0.729 . . . . 65.03 109.997 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -83.59 178.39 8.01 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.511 1.132 . . . . 73.11 109.327 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . 0.537 ' CE1' ' HB ' ' A' ' 422' ' ' ILE . 37.6 m-70 -141.97 134.73 28.52 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.534 1.146 . . . . 63.25 109.609 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 23.4 mt -124.86 158.7 32.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.529 1.143 . . . . 60.11 109.302 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 355' ' ' VAL . 0.3 OUTLIER -124.12 150.51 44.99 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.492 1.12 . . . . 72.42 109.312 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 424' ' ' ASP . 70.3 t -109.09 146.96 14.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.539 1.149 . . . . 62.31 109.293 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 58.1 p -117.96 -173.16 2.39 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.464 1.103 . . . . 75.2 110.369 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' GLN . . . . . 0.4 ' HG2' ' CE1' ' A' ' 426' ' ' PHE . 4.6 mm100 -77.52 -35.04 53.81 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.508 1.13 . . . . 74.11 110.285 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . 0.764 ' O ' HD12 ' A' ' 362' ' ' LEU . 4.7 pt-20 -60.27 -31.4 70.19 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.102 . . . . 73.53 110.281 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . 0.421 ' OE1' ' CE2' ' A' ' 370' ' ' PHE . 73.3 mt-30 -77.34 -63.42 1.38 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.46 1.1 . . . . 74.41 110.287 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -39.07 -42.87 0.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.518 1.136 . . . . 74.13 111.036 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -61.2 -53.87 51.49 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.482 1.114 . . . . 72.43 110.28 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.764 HD12 ' O ' ' A' ' 358' ' ' GLU . 3.7 mt -55.46 -54.5 43.12 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.125 . . . . 64.14 109.33 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' PTR . . . . . 0.469 ' HE1' ' CE ' ' A' ' 374' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -48.22 82.66 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.498 1.124 . . . . 64.31 108.318 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.21 -65.82 0.5 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.487 1.117 . . . . 73.24 110.301 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . . . . . . . . . 23.2 ptp -55.23 -34.2 63.77 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.425 1.078 . . . . 74.25 110.975 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 88.92 50.01 3.41 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.488 1.118 . . . . 54.53 110.988 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . 0.505 ' HB3' HD12 ' A' ' 372' ' ' LEU . 3.6 m -145.58 179.39 7.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.508 0.77 . . . . 60.42 109.963 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.775 HG22 ' NE2' ' A' ' 371' ' ' GLN . 2.0 m -118.42 161.11 20.52 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.508 1.13 . . . . 71.2 110.383 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.453 ' HA ' ' CE1' ' A' ' 363' ' ' PTR . 2.7 t80 -59.31 -64.51 0.92 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.507 1.129 . . . . 74.54 111.028 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.775 ' NE2' HG22 ' A' ' 369' ' ' THR . 0.2 OUTLIER -60.7 -29.52 69.38 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.488 1.117 . . . . 61.12 110.325 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.791 HD22 ' N ' ' A' ' 373' ' ' CYS . 1.2 tm? -60.93 135.61 57.84 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 74.32 109.337 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . 0.791 ' N ' HD22 ' A' ' 372' ' ' LEU . 32.1 p -77.9 136.01 37.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.02 -0.991 . . . . 72.14 110.884 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.536 ' N ' ' CD ' ' A' ' 374' ' ' LYS . 0.2 OUTLIER -92.66 26.45 2.68 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.514 1.134 . . . . 62.4 109.306 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 7.0 mt -107.79 -56.67 4.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.495 1.122 . . . . 70.31 109.268 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 14.2 m -108.28 -21.73 12.64 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.513 1.133 . . . . 41.5 108.354 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.627 ' HA ' HD21 ' A' ' 372' ' ' LEU . . . 57.71 38.01 27.41 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.511 1.132 . . . . 74.43 109.298 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -129.57 -43.92 1.24 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.448 1.093 . . . . 64.5 110.274 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -108.81 -172.96 2.16 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 72.24 109.287 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.15 175.47 6.28 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.528 1.142 . . . . 74.1 109.332 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.663 ' HZ2' HD12 ' A' ' 391' ' ' LEU . 16.8 mttt -78.59 -50.79 10.92 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 64.41 109.301 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . 0.406 ' CG ' ' C ' ' A' ' 381' ' ' LYS . 0.1 OUTLIER 47.65 26.61 0.88 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.473 1.108 . . . . 71.14 109.261 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.886 HG12 ' O ' ' A' ' 392' ' ' MET . 0.3 OUTLIER -156.13 176.1 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.481 1.113 . . . . 62.51 109.274 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -160.52 157.33 27.29 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.522 1.139 . . . . 72.24 109.29 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.864 HG22 ' SG ' ' A' ' 388' ' ' CYS . 11.6 mm -123.82 143.76 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.542 1.152 . . . . 64.5 109.301 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.54 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 7.0 mt-10 -137.72 162.39 54.82 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.575 1.172 . . . . 74.25 110.282 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.54 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.2 Cg_endo -74.95 -12.49 23.85 Favored 'Cis proline' 0 C--N 1.36 1.163 0 C-N-CA 120.981 -2.508 . . . . 44.15 111.026 -0.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . 0.864 ' SG ' HG22 ' A' ' 385' ' ' ILE . 0.8 OUTLIER -36.41 -71.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.983 -1.008 . . . . 75.23 110.914 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 116.49 15.9 6.77 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.441 1.088 . . . . 51.44 110.946 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.567 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 21.4 m80 -73.07 148.0 44.46 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.522 0.777 . . . . 73.11 109.591 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.663 HD12 ' HZ2' ' A' ' 381' ' ' LYS . 1.3 mt -119.47 158.14 26.85 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.518 1.136 . . . . 73.1 109.302 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.886 ' O ' HG12 ' A' ' 383' ' ' VAL . 12.6 ptp -174.41 172.18 3.23 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.524 1.14 . . . . 74.02 111.016 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 7.2 p -89.69 118.07 29.03 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.497 1.123 . . . . 71.2 108.275 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 73.4 m -52.51 -45.13 66.13 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.529 1.143 . . . . 74.03 110.374 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 37.2 m -55.69 -29.51 59.51 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.468 1.105 . . . . 62.31 109.971 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 2.5 m -81.15 -47.51 13.37 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.452 1.095 . . . . 62.54 108.25 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.719 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.5 OUTLIER -41.49 -36.09 0.82 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 74.34 109.327 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . 0.486 ' CG2' ' N ' ' A' ' 399' ' ' ALA . 0.5 OUTLIER -61.17 -52.54 64.41 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.43 1.081 . . . . 75.14 110.38 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . 0.486 ' N ' ' CG2' ' A' ' 398' ' ' THR . . . -51.44 -23.23 3.68 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.543 1.152 . . . . 71.32 109.285 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' TRP . . . . . 0.607 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 8.9 t-105 -84.44 -64.91 1.08 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.534 1.146 . . . . 74.1 108.034 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.494 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 9.7 mm-40 -52.34 -17.37 1.14 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.487 1.117 . . . . 74.1 110.316 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 401' ' ' GLN . 7.0 mm-40 -37.18 -63.41 0.43 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 74.2 110.29 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.6 m -120.39 -24.56 5.84 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.515 1.134 . . . . 50.3 110.006 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . 0.607 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 8.2 m-20 -82.25 -94.92 0.05 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 64.52 109.327 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.494 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 70.5 28.73 70.69 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.475 1.11 . . . . 44.43 111.036 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -90.17 68.19 7.02 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.465 0.744 . . . . 72.21 110.297 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 65.34 -163.81 38.32 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.517 1.136 . . . . 73.41 111.01 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . 0.699 ' SG ' HG21 ' A' ' 385' ' ' ILE . 6.3 t -58.21 129.27 82.98 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 108.363 -0.977 . . . . 71.44 108.363 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 -3.57 14.12 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.489 1.784 . . . . 75.3 111.042 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . 0.567 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 4.5 m-85 -92.91 -41.48 10.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.119 . . . . 72.34 111.01 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' CYS . . . . . 0.456 ' SG ' ' CE1' ' A' ' 390' ' ' HIS . 0.1 OUTLIER -111.01 9.02 22.14 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.123 . . . . 71.03 108.285 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 408' ' ' CYS . 9.1 mmt85 38.56 30.23 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.555 1.159 . . . . 73.51 110.333 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' CYS . . . . . 0.442 ' N ' ' O ' ' A' ' 411' ' ' CYS . 1.3 m -125.55 163.01 23.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.531 1.144 . . . . 72.33 108.289 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -59.02 146.99 36.3 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.435 1.085 . . . . 75.42 110.275 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.638 HG23 HG23 ' A' ' 385' ' ' ILE . 1.4 mt -93.06 153.41 3.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.477 1.111 . . . . 62.31 109.278 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.11 -46.33 3.01 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.526 1.141 . . . . 63.51 109.258 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.554 ' O ' HG23 ' A' ' 418' ' ' THR . . . -131.11 144.73 16.28 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.501 1.125 . . . . 23.35 110.985 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . 0.618 ' CG2' HG21 ' A' ' 415' ' ' ILE . 17.6 p -157.59 116.26 3.2 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.512 0.772 . . . . 75.3 110.428 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -136.32 149.21 67.13 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.509 1.131 . . . . 71.03 110.314 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.491 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.3 Cg_endo -74.97 102.46 1.59 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.492 1.785 . . . . 73.24 111.0 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.799 HD11 HG22 ' A' ' 423' ' ' VAL . 0.6 OUTLIER -103.83 158.9 5.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.46 1.1 . . . . 75.33 109.244 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . 0.696 ' N ' HD12 ' A' ' 421' ' ' ILE . 11.2 mt -118.61 105.39 17.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.482 1.114 . . . . 73.54 109.311 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.799 HG22 HD11 ' A' ' 421' ' ' ILE . 21.5 t -76.78 149.25 6.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.502 1.127 . . . . 64.0 109.293 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.865 ' O ' HG23 ' A' ' 355' ' ' VAL . 9.2 m-20 -127.64 143.33 47.1 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.494 1.121 . . . . 73.24 109.32 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 179.25 6.26 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.488 1.783 . . . . 63.33 111.032 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . 0.4 ' CE1' ' HG2' ' A' ' 357' ' ' GLN . 10.5 t80 . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.499 1.125 . . . . 74.14 111.011 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . 0.404 ' N ' ' CD ' ' A' ' 346' ' ' PRO . . . . . . . . 0 CA--C 1.53 1.001 0 N-CA-C 110.99 -0.844 . . . . 74.11 110.99 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . 0.523 ' O ' ' CG ' ' A' ' 347' ' ' HIS . 18.4 Cg_endo -74.95 178.65 6.97 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.446 1.761 . . . . 62.11 111.052 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.523 ' CG ' ' O ' ' A' ' 346' ' ' PRO . 54.3 m80 -161.9 124.27 2.92 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.507 1.13 . . . . 70.25 109.576 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 42.9 mtp -145.79 166.12 26.84 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.535 1.147 . . . . 65.1 111.024 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -70.11 -30.81 69.49 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.477 1.11 . . . . 63.13 110.996 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 420' ' ' PRO . 29.6 p -40.86 151.46 0.06 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.544 0.791 . . . . 74.41 110.03 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.14 175.08 10.97 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.501 1.126 . . . . 75.22 109.347 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -136.6 138.86 41.65 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 70.13 109.582 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 52.7 mt -121.73 158.75 24.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.525 1.141 . . . . 72.33 109.323 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -123.2 139.61 53.87 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.476 1.11 . . . . 62.2 109.269 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 424' ' ' ASP . 24.6 t -99.49 144.23 12.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.494 1.121 . . . . 71.42 109.318 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.9 p -110.19 153.02 25.35 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.505 1.128 . . . . 64.1 110.386 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' GLN . . . . . 0.464 ' HG3' ' CE1' ' A' ' 426' ' ' PHE . 24.7 mt-30 -43.35 -52.04 6.08 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.481 1.113 . . . . 74.21 110.284 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -43.85 -49.83 8.11 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 72.1 110.297 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . 0.546 ' O ' ' CD1' ' A' ' 363' ' ' PTR . 18.2 mt-30 -59.62 -32.8 70.76 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.49 1.119 . . . . 74.4 110.274 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . 0.443 ' O ' ' N ' ' A' ' 364' ' ' CYS . 3.7 t80 -71.02 -62.07 1.53 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.537 1.148 . . . . 74.21 111.016 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -53.67 -53.69 48.38 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.535 1.147 . . . . 74.43 110.28 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.62 -34.96 39.91 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.508 1.13 . . . . 72.14 109.244 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' PTR . . . . . 0.546 ' CD1' ' O ' ' A' ' 359' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 360' ' ' TYR . 1.8 m -64.96 -21.76 66.89 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.414 1.071 . . . . 75.52 108.319 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -73.96 -13.64 60.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.462 1.101 . . . . 73.42 110.286 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' MET . . . . . 0.435 ' CG ' ' O ' ' A' ' 363' ' ' PTR . 12.0 ptp -121.49 -0.98 9.66 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.493 1.12 . . . . 70.33 111.02 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 57.0 43.79 93.07 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.434 1.084 . . . . 65.41 110.966 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 3.6 p -132.85 173.96 10.83 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.438 0.728 . . . . 74.22 109.967 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.764 HG22 HE21 ' A' ' 371' ' ' GLN . 2.2 m -116.94 161.57 19.15 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.484 1.115 . . . . 74.03 110.383 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.564 ' CD2' HG22 ' A' ' 355' ' ' VAL . 78.2 t80 -64.02 -68.63 0.33 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.519 1.137 . . . . 72.23 110.982 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' GLN . . . . . 0.764 HE21 HG22 ' A' ' 369' ' ' THR . 0.0 OUTLIER -44.31 -35.82 2.5 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.541 1.15 . . . . 73.34 110.31 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.747 HD13 ' N ' ' A' ' 373' ' ' CYS . 1.8 tm? -50.93 140.85 14.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.484 1.115 . . . . 75.34 109.247 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . 0.747 ' N ' HD13 ' A' ' 372' ' ' LEU . 19.7 p -85.42 147.08 26.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.97 -1.014 . . . . 63.44 110.913 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.557 ' N ' ' CD ' ' A' ' 374' ' ' LYS . 0.7 OUTLIER -99.54 17.44 20.41 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 63.12 109.29 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 5.9 mt -94.5 -61.69 2.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.458 1.099 . . . . 70.02 109.3 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' CYS . . . . . . . . . . . . . 2.6 m -102.67 -24.65 13.74 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.532 1.145 . . . . 72.22 108.273 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.682 ' HA ' HD11 ' A' ' 372' ' ' LEU . . . 63.04 46.42 4.73 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.478 1.111 . . . . 74.3 109.323 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -139.53 -49.58 0.49 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.548 1.155 . . . . 74.3 110.279 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . 0.429 ' O ' HD22 ' A' ' 372' ' ' LEU . 4.3 m-20 -104.91 174.35 5.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 72.33 109.333 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -85.86 173.18 10.19 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.542 1.151 . . . . 72.2 109.292 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 392' ' ' MET . 15.3 mttt -79.33 -54.86 5.53 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.515 1.134 . . . . 72.32 109.265 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . 0.401 ' OD2' ' O ' ' A' ' 381' ' ' LYS . 1.2 p30 51.87 26.78 3.8 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.478 1.111 . . . . 73.15 109.267 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' VAL . . . . . 0.914 HG12 ' O ' ' A' ' 392' ' ' MET . 0.4 OUTLIER -156.03 175.4 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.116 . . . . 54.42 109.35 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.417 ' HG3' ' CD1' ' A' ' 391' ' ' LEU . 62.5 tttt -158.53 151.81 22.87 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.503 1.127 . . . . 61.44 109.293 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.822 HG21 ' SG ' ' A' ' 408' ' ' CYS . 24.7 mm -115.28 133.59 61.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.126 . . . . 72.03 109.337 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.522 ' CB ' ' HA ' ' A' ' 387' ' ' PRO . 5.9 mt-10 -137.67 161.11 62.13 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.534 1.146 . . . . 73.12 110.286 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.522 ' HA ' ' CB ' ' A' ' 386' ' ' GLU . 18.4 Cg_endo -75.01 -5.2 21.25 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 121.034 -2.486 . . . . 73.23 111.004 -0.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 32.6 t -37.99 -78.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.0 -1.0 . . . . 71.51 110.946 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 385' ' ' ILE . . . 119.53 36.51 0.84 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.483 1.114 . . . . 50.24 111.002 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.551 ' HB3' ' CD2' ' A' ' 410' ' ' PHE . 51.0 m170 -108.5 131.9 54.36 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.491 0.759 . . . . 73.3 109.581 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.71 ' H ' HD22 ' A' ' 391' ' ' LEU . 0.0 OUTLIER -99.87 158.55 15.72 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.486 1.116 . . . . 72.13 109.303 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . 0.914 ' O ' HG12 ' A' ' 383' ' ' VAL . 17.1 ptp -172.6 174.42 3.74 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.473 1.108 . . . . 73.45 111.04 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' CYS . . . . . . . . . . . . . 28.1 p -97.53 115.55 28.06 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.469 1.106 . . . . 72.53 108.296 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 3.8 m -44.61 -58.99 2.69 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 75.33 110.364 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 29.6 m -41.11 -36.59 0.73 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.527 1.142 . . . . 62.24 109.989 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 399' ' ' ALA . 2.5 m -76.76 -50.42 13.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.477 1.11 . . . . 51.4 108.257 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.695 HD13 ' C ' ' A' ' 397' ' ' LEU . 0.3 OUTLIER -43.0 -35.69 1.32 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.492 1.12 . . . . 74.21 109.282 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 53.4 m -63.01 -45.31 92.98 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.481 1.113 . . . . 63.24 110.447 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 396' ' ' CYS . . . -57.65 -21.72 41.43 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.451 1.094 . . . . 63.0 109.309 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' TRP . . . . . 0.588 ' CZ3' ' CG ' ' A' ' 404' ' ' ASP . 14.7 t-105 -86.09 -65.21 1.04 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.496 1.123 . . . . 73.34 107.98 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.503 ' HA ' ' CA ' ' A' ' 405' ' ' GLY . 40.1 mm-40 -48.83 -20.96 0.55 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.479 1.112 . . . . 73.04 110.288 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 401' ' ' GLN . 7.3 mt-10 -37.64 -63.65 0.44 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.538 1.149 . . . . 74.52 110.276 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 23.0 t -122.41 -24.45 5.0 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.477 1.111 . . . . 74.44 109.98 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . 0.588 ' CG ' ' CZ3' ' A' ' 400' ' ' TRP . 3.0 m-20 -82.85 -94.42 0.06 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.512 1.133 . . . . 75.41 109.311 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.503 ' CA ' ' HA ' ' A' ' 401' ' ' GLN . . . 67.29 21.37 72.1 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.435 1.084 . . . . 53.44 110.965 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -81.0 62.46 4.99 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 0.767 . . . . 62.1 110.287 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 68.15 -163.46 48.2 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.536 1.147 . . . . 70.11 111.002 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . 0.822 ' SG ' HG21 ' A' ' 385' ' ' ILE . 2.3 t -56.12 121.45 41.56 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.303 -0.999 . . . . 73.24 108.303 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.447 ' HB3' ' CD2' ' A' ' 400' ' ' TRP . 18.3 Cg_endo -75.03 0.65 8.67 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.53 1.805 . . . . 73.25 110.965 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . 0.551 ' CD2' ' HB3' ' A' ' 390' ' ' HIS . 2.7 m-85 -92.49 -37.99 12.21 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 74.3 111.047 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' CYS . . . . . 0.435 ' O ' ' N ' ' A' ' 413' ' ' CYS . 0.8 OUTLIER -126.02 17.13 7.89 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.475 1.109 . . . . 73.12 108.335 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 408' ' ' CYS . 47.5 mmm-85 38.43 30.99 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.526 1.141 . . . . 73.01 110.302 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 411' ' ' CYS . 15.2 t -115.35 139.15 50.24 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 63.04 108.302 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -45.8 158.97 0.08 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.443 1.09 . . . . 64.24 110.344 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.741 HG23 HG23 ' A' ' 385' ' ' ILE . 2.2 mt -114.45 157.24 15.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.448 1.093 . . . . 74.21 109.309 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -128.98 -47.79 1.23 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.514 1.134 . . . . 63.41 109.295 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.553 ' O ' HG23 ' A' ' 418' ' ' THR . . . -108.76 127.9 8.8 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.541 1.15 . . . . 60.1 111.031 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 417' ' ' GLY . 17.5 p -157.51 116.74 3.29 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.502 0.766 . . . . 75.53 110.357 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -140.61 151.29 63.08 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.115 . . . . 71.54 110.296 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 350' ' ' SER . 18.2 Cg_endo -75.05 101.64 1.5 Allowed 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.485 1.781 . . . . 71.22 110.979 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.803 HD11 HG22 ' A' ' 423' ' ' VAL . 0.7 OUTLIER -105.71 167.58 3.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.441 1.088 . . . . 74.31 109.335 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . 0.782 ' N ' HD12 ' A' ' 421' ' ' ILE . 12.7 mt -126.52 106.32 15.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.505 1.128 . . . . 72.0 109.293 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.803 HG22 HD11 ' A' ' 421' ' ' ILE . 15.4 t -78.89 145.74 9.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.479 1.112 . . . . 60.32 109.284 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.66 ' O ' HG23 ' A' ' 355' ' ' VAL . 73.0 m-20 -128.38 143.68 49.1 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 64.55 109.302 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . 0.438 ' N ' ' OE1' ' A' ' 371' ' ' GLN . 18.1 Cg_endo -75.01 175.65 10.97 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.559 1.82 . . . . 75.14 110.999 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . 0.464 ' CE1' ' HG3' ' A' ' 357' ' ' GLN . 39.8 t80 . . . . . 0 C--N 1.324 -0.507 0 O-C-N 124.505 1.128 . . . . 75.32 111.015 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1373 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A 1388 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_